1 00:00:05,331 --> 00:00:08,301 GOOD MORNING, EVERYONE. 2 00:00:08,301 --> 00:00:12,205 MY NAME IS DR. TIFFANI BAILEY 3 00:00:12,205 --> 00:00:16,876 LASH THE DIRECTOR OF THE NIBIB 4 00:00:16,876 --> 00:00:17,644 POINT-OF-CARE TECHNOLOGY 5 00:00:17,644 --> 00:00:20,480 RESEARCH NETWORK. 6 00:00:20,480 --> 00:00:21,681 I'M CHAIRING THIS WITH 7 00:00:21,681 --> 00:00:23,383 DR. DHAWAN WHO UNFORTUNATELY 8 00:00:23,383 --> 00:00:24,651 COULDN'T BE HERE TODAY. 9 00:00:24,651 --> 00:00:25,885 ON BEHALF OF THE NATIONAL 10 00:00:25,885 --> 00:00:27,787 INSTITUTE OF HEALTH AND THE 11 00:00:27,787 --> 00:00:28,921 NATIONAL INSTITUTE OF BIO 12 00:00:28,921 --> 00:00:30,957 MEDICAL IMAGING AND BIO 13 00:00:30,957 --> 00:00:32,959 ENGINEERING WHERE OUR GOAL IS TO 14 00:00:32,959 --> 00:00:34,027 TRANSFORM THROUGH TECHNOLOGY 15 00:00:34,027 --> 00:00:38,998 DEVELOPMENT OUR UNDERSTANDING OF 16 00:00:38,998 --> 00:00:39,766 DISEASE, ITS PREVENTION, 17 00:00:39,766 --> 00:00:40,500 DETECTION, DIAGNOSIS AND 18 00:00:40,500 --> 00:00:41,134 TREATMENT. 19 00:00:41,134 --> 00:00:42,669 WELCOME TO THE RESEARCH AND 20 00:00:42,669 --> 00:00:45,872 INNOVATION TRANSLATION 21 00:00:45,872 --> 00:00:47,774 PARTNERSHIPS IN POINT-OF-CARE 22 00:00:47,774 --> 00:00:48,374 TECHNOLOGIES CONFERENCE AND 23 00:00:48,374 --> 00:00:51,678 TECHNOLOGY SHOWCASE. 24 00:00:51,678 --> 00:00:52,078 THAT'S A MOUTHFUL. 25 00:00:52,078 --> 00:00:53,813 SO A SHOW OF HANDS FOR THOSE WHO 26 00:00:53,813 --> 00:00:55,982 THIS IS YOUR FIRST TIME AT OUR 27 00:00:55,982 --> 00:01:03,256 BEAUTIFUL CAMPUS AT NIH? 28 00:01:03,256 --> 00:01:04,891 WELL, THANK YOU AND WELCOME. 29 00:01:04,891 --> 00:01:06,859 IF THIS IS YOUR FIRST CONFERENCE 30 00:01:06,859 --> 00:01:07,760 SINCE THE PANDEMIC, PLEASE RAISE 31 00:01:07,760 --> 00:01:08,027 YOUR HAND. 32 00:01:08,027 --> 00:01:12,865 A FEW. 33 00:01:12,865 --> 00:01:14,967 WELL, WE CERTAINLY THANK YOU FOR 34 00:01:14,967 --> 00:01:15,835 CHOOSING THIS CONFERENCE TO 35 00:01:15,835 --> 00:01:16,069 ATTEND. 36 00:01:16,069 --> 00:01:17,970 IT MAY BE YOUR FIRST DAY OF THE 37 00:01:17,970 --> 00:01:19,839 CONFERENCE BUT ACTUALLY THERE 38 00:01:19,839 --> 00:01:21,574 WAS A LOT OF INFORMATION THAT 39 00:01:21,574 --> 00:01:23,476 WAS SHARED THAT TOOK PLACE 40 00:01:23,476 --> 00:01:26,045 YESTERDAY DURING THE SPIR 41 00:01:26,045 --> 00:01:27,814 INFORMATION PRE-MEETING SESSION 42 00:01:27,814 --> 00:01:32,318 LED BY DR. ASHMONT FROM NIBIB. 43 00:01:32,318 --> 00:01:35,288 THERE IT WAS GREAT TO SEE FROM 44 00:01:35,288 --> 00:01:37,290 SELF OF THE PARTICIPANTS THOSE 45 00:01:37,290 --> 00:01:41,027 WHO ARE LEARNING ABOUT THE NIHs 46 00:01:41,027 --> 00:01:41,728 SMALL BUSINESS PROGRAM FROM 47 00:01:41,728 --> 00:01:43,396 THOSE WHO ARE APPLYING, TO THOSE 48 00:01:43,396 --> 00:01:45,398 WHO HAVE APPLIED AND TRYING TO 49 00:01:45,398 --> 00:01:48,468 FIGURE OUT WHAT THEIR NEXT STEPS 50 00:01:48,468 --> 00:01:48,735 ARE. 51 00:01:48,735 --> 00:01:51,104 SO EVEN WITH THAT THE GREAT NEWS 52 00:01:51,104 --> 00:01:53,406 IS THERE WERE NIH PARTNERING 53 00:01:53,406 --> 00:01:55,274 STAFF FROM THE NIH SEED OFFICE 54 00:01:55,274 --> 00:02:02,281 AND NIBIB, NIMHD AND NCCIH THERE 55 00:02:02,281 --> 00:02:03,349 TO HELP. 56 00:02:03,349 --> 00:02:04,751 SO WE ARE THRILLED TO BRING 57 00:02:04,751 --> 00:02:07,053 TOGETHER OVER THE NEXT TWO DAYS 58 00:02:07,053 --> 00:02:09,555 A DIVERSE COMMUNITY OF 59 00:02:09,555 --> 00:02:10,690 RESEARCHERS, TECHNOLOGY, 60 00:02:10,690 --> 00:02:13,593 DEVELOPERS, CLINICIANS, INDUSTRY 61 00:02:13,593 --> 00:02:15,094 PARTNERS, REGULATORY 62 00:02:15,094 --> 00:02:16,696 ADMINISTRATORS, LEADERS, 63 00:02:16,696 --> 00:02:20,299 INVESTORS AND REPRESENTATIVES 64 00:02:20,299 --> 00:02:24,170 FROM ALL THE NIBIB POINT-OF-CARE 65 00:02:24,170 --> 00:02:25,371 RESEARCH TECHNOLOGY CENTERS. 66 00:02:25,371 --> 00:02:27,907 THE OVER ALL GOAL IS TO BRING 67 00:02:27,907 --> 00:02:30,643 THE STAKEHOLDERS TOGETHER TO 68 00:02:30,643 --> 00:02:31,944 LEARN ABOUT THE AVAILABLE 69 00:02:31,944 --> 00:02:34,013 RESOURCES AND RECENT EXPERIENCES 70 00:02:34,013 --> 00:02:36,449 AND OPPORTUNITIES TO DEVELOP AND 71 00:02:36,449 --> 00:02:38,017 ENHANCE COLLABORATIVE RESEARCH 72 00:02:38,017 --> 00:02:40,920 SYNERGIES AND INNOVATION IN 73 00:02:40,920 --> 00:02:42,722 PARTNERSHIPS TOWARDS STRATEGIC 74 00:02:42,722 --> 00:02:44,791 IMPLEMENTATION OF ACCELERATED 75 00:02:44,791 --> 00:02:45,525 TRANSLATION OF POINT-OF-CARE 76 00:02:45,525 --> 00:02:47,860 TECHNOLOGIES FOR THE USERS FOR 77 00:02:47,860 --> 00:02:49,662 HEALTH CARE AND CLINICAL 78 00:02:49,662 --> 00:02:50,029 APPLICATIONS. 79 00:02:50,029 --> 00:02:52,498 WE'RE DOING THIS THROUGH OPEN 80 00:02:52,498 --> 00:02:54,901 FORUMS WITH RESEARCHERS AND THE 81 00:02:54,901 --> 00:02:57,170 STAKEHOLDERS TO DISCUSS HOW TO 82 00:02:57,170 --> 00:02:59,272 FURTHER PROMOTE AND FACILITATE 83 00:02:59,272 --> 00:03:01,774 STRATEGIC PARTNERSHIPS AND 84 00:03:01,774 --> 00:03:03,810 PATHWAYS. 85 00:03:03,810 --> 00:03:06,746 SUCH AS ARCHIVING AND BASE 86 00:03:06,746 --> 00:03:09,115 MODELS AND ASSEMBLE DATA SETS TO 87 00:03:09,115 --> 00:03:11,551 HELP RESEARCHERS AND 88 00:03:11,551 --> 00:03:13,052 INVESTIGATORS FURTHER EXPLORE 89 00:03:13,052 --> 00:03:15,121 THE POTENTIAL SPIN-OFF 90 00:03:15,121 --> 00:03:15,721 APPLICATIONS TO POINT-OF-CARE 91 00:03:15,721 --> 00:03:19,258 TECHNOLOGY INNOVATIONS. 92 00:03:19,258 --> 00:03:21,394 SO WE HOPE YOU SHARE YOUR 93 00:03:21,394 --> 00:03:22,795 DIVERSE EXPERTISE, JOIN IN THE 94 00:03:22,795 --> 00:03:25,264 CONVERGENCE OF MINDS INCLUDING 95 00:03:25,264 --> 00:03:27,567 THOSE STAKEHOLDERS WITH 96 00:03:27,567 --> 00:03:29,435 COMPLEMENTARY EXPERTISE AND 97 00:03:29,435 --> 00:03:30,770 RESOURCES ACROSS THE DIAGNOSTIC 98 00:03:30,770 --> 00:03:31,804 TECHNOLOGY DEVELOPMENT PLATFORM. 99 00:03:31,804 --> 00:03:33,973 WE ALSO HOPE YOU ENGAGE IN THE 100 00:03:33,973 --> 00:03:35,641 SHOWCASE AND WITNESS PROJECTS 101 00:03:35,641 --> 00:03:38,778 THAT ARE TECHNICALLY DERISK AND 102 00:03:38,778 --> 00:03:41,347 READY AND READY TO ADVANCE TO 103 00:03:41,347 --> 00:03:42,481 LATER STAGES OF 104 00:03:42,481 --> 00:03:44,951 PRE-COMMERCIALIZATION AND ENGAGE 105 00:03:44,951 --> 00:03:48,020 WITH INNOVATORS FOR POTENTIAL 106 00:03:48,020 --> 00:03:49,222 PARTNERSHIPS OR INVEST STUNTS. 107 00:03:49,222 --> 00:03:51,224 WE HOPE YOU NETWORK AND CONNECT 108 00:03:51,224 --> 00:03:52,491 WITH STAKEHOLDERS AND ALL THE 109 00:03:52,491 --> 00:03:57,330 PEOPLE HERE TODAY. 110 00:03:57,330 --> 00:03:59,565 AGAIN, THIS EVENT AIMS TO FOSTER 111 00:03:59,565 --> 00:04:00,566 COLLABORATIVE DISCUSSIONS. 112 00:04:00,566 --> 00:04:02,702 YOU'LL HEAR PARTNERSHIPS SEVERAL 113 00:04:02,702 --> 00:04:03,703 TIMES DURING THE MEETING. 114 00:04:03,703 --> 00:04:06,072 WE LOOK FORWARD TO AN ENRICHING 115 00:04:06,072 --> 00:04:08,674 CONFERENCE WHERE IDEAS CONVERGE, 116 00:04:08,674 --> 00:04:10,776 PARTNERSHIPS, FLOURISH AND THE 117 00:04:10,776 --> 00:04:12,211 FUTURE OF POINT OF CARE 118 00:04:12,211 --> 00:04:13,112 TECHNOLOGIES TAKE BOLD STEPS 119 00:04:13,112 --> 00:04:13,880 FORWARD. 120 00:04:13,880 --> 00:04:17,183 WE WELCOME YOU TO THIS 121 00:04:17,183 --> 00:04:20,019 TRANSFORMATIVE EXPERIENCE AND 122 00:04:20,019 --> 00:04:23,823 NOW I'LL TURN IT MY INSTITUTE 123 00:04:23,823 --> 00:04:29,095 DIRECTOR AND OUR FEARLESS LEADER 124 00:04:29,095 --> 00:04:31,864 DR. TROMBERG WITH THOUGHTS ON 125 00:04:31,864 --> 00:04:32,765 POINT-OF-CARE INNOVATIONS AND 126 00:04:32,765 --> 00:04:35,968 APPLICATIONS. 127 00:04:35,968 --> 00:04:39,071 THANK YOU. 128 00:04:39,071 --> 00:04:46,946 >> IF I COULD GET MY SLIDES UP. 129 00:04:46,946 --> 00:04:48,748 I'M NOT GOING TO STAND HERE TOO 130 00:04:48,748 --> 00:04:49,181 LONG. 131 00:04:49,181 --> 00:04:50,516 I'M GOING INTRODUCE OUR KEY NOTE 132 00:04:50,516 --> 00:04:57,323 SPEAKER. 133 00:04:57,323 --> 00:05:00,192 WELCOME HERE AS THE SLIDES ARE 134 00:05:00,192 --> 00:05:01,260 COMING IT'S WONDERFUL TO HAVE 135 00:05:01,260 --> 00:05:01,928 YOU ALL HERE. 136 00:05:01,928 --> 00:05:04,463 I FEEL LIKE THIS IS MORE OF A 137 00:05:04,463 --> 00:05:07,333 FAMILY REUNION CELEBRATION THAN 138 00:05:07,333 --> 00:05:08,401 A SCIENTIFIC CONFERENCE. 139 00:05:08,401 --> 00:05:10,403 IT'S GREAT TO SEE MANY OF YOU. 140 00:05:10,403 --> 00:05:11,971 I HAVEN'T SEEN SEVERAL OF YOU IN 141 00:05:11,971 --> 00:05:14,273 PERSON THOUGH WE'VE BEEN WORKING 142 00:05:14,273 --> 00:05:15,474 TOGETHER FOR YEARS AND IT'S GOOD 143 00:05:15,474 --> 00:05:17,376 TO SEE SEVERAL PEOPLE THAT I 144 00:05:17,376 --> 00:05:19,145 HAVEN'T SEEN IN SUCH A LONG 145 00:05:19,145 --> 00:05:22,715 TIME. 146 00:05:22,715 --> 00:05:23,249 WELCOME. 147 00:05:23,249 --> 00:05:25,685 IT'S ALSO A LITTLE BIT OF MAYBE 148 00:05:25,685 --> 00:05:28,387 I DON'T KNOW WE'RE ALL DEVOTEES 149 00:05:28,387 --> 00:05:30,122 AND TRUE BELIEVERS IN POINT OF 150 00:05:30,122 --> 00:05:33,893 CARE TECHNOLOGY. 151 00:05:33,893 --> 00:05:39,165 IT'S A LITTLE BIT OF A -- 152 00:05:39,165 --> 00:05:42,535 THERE'S A BIT OF RELIGIOUSITY TO 153 00:05:42,535 --> 00:05:47,940 THE GROUP WHICH I'M PROUD TO BE 154 00:05:47,940 --> 00:05:58,084 PART OF. 155 00:06:00,553 --> 00:06:02,955 WELL, A SLIDE IS NOT THAT 156 00:06:02,955 --> 00:06:03,889 NECESSARY TO INTRODUCE AND 157 00:06:03,889 --> 00:06:06,659 EXCITED AND PROUD TO BE ABLE TO 158 00:06:06,659 --> 00:06:10,596 HAVE THE 17th NIH DIRECTOR WITH 159 00:06:10,596 --> 00:06:14,500 US, DR. MONICA BERTAGNOLLI. 160 00:06:14,500 --> 00:06:15,935 SHE IS ONLY ON THE JOB FOR 20 161 00:06:15,935 --> 00:06:22,675 DAYS NOW. 162 00:06:22,675 --> 00:06:24,377 AND HAS SIMULTANEOUS MULTIPLE 163 00:06:24,377 --> 00:06:26,145 MEETINGS GOING ON AT THIS MOMENT 164 00:06:26,145 --> 00:06:28,047 AND WILL JUST BE WITH US FOR A 165 00:06:28,047 --> 00:06:30,182 SHORT TIME WHICH WE'RE VERY 166 00:06:30,182 --> 00:06:30,783 APPRECIATIVE OF. 167 00:06:30,783 --> 00:06:33,652 WE TRIED TO PUT HER DIGITAL TWIN 168 00:06:33,652 --> 00:06:35,855 TOGETHER BUT IT DIDN'T -- LIKE 169 00:06:35,855 --> 00:06:37,523 THE TECHNOLOGY IT'S NOT QUITE 170 00:06:37,523 --> 00:06:38,457 READY YET SO WE'RE DEPENDENT ON 171 00:06:38,457 --> 00:06:40,960 YOU FOR ALL OF THAT. 172 00:06:40,960 --> 00:06:42,361 DR. BERTAGNOLLI RECENTLY WENT 173 00:06:42,361 --> 00:06:46,632 THROUGH A CONFIRMATION HEARING 174 00:06:46,632 --> 00:06:50,169 AND I HAVE A LITTLE BIT -- I 175 00:06:50,169 --> 00:06:51,904 HAVE A VISUAL AND I'LL GO INTO 176 00:06:51,904 --> 00:06:53,039 THAT IN JUST A MOMENT. 177 00:06:53,039 --> 00:06:55,508 HER BACKGROUND, SHE WAS 178 00:06:55,508 --> 00:06:57,309 PREVIOUSLY THE DIRECTOR OF THE 179 00:06:57,309 --> 00:06:58,110 NATIONAL CANCER INSTITUTE AND I 180 00:06:58,110 --> 00:07:03,682 THINK ALL OF YOU ARE FAMILIAR 181 00:07:03,682 --> 00:07:05,284 WITH HER CAREER AS A SURGEON AND 182 00:07:05,284 --> 00:07:07,887 PROFESSOR OF SURGERY AT HARVARD 183 00:07:07,887 --> 00:07:08,854 MEDICAL SCHOOL. 184 00:07:08,854 --> 00:07:10,823 SURGERY AT BRIGHAM, A MEMBER OF 185 00:07:10,823 --> 00:07:12,258 DANA FARER. 186 00:07:12,258 --> 00:07:22,802 A LONG AND DISTINGUISHED CAREER 187 00:07:25,037 --> 00:07:32,144 OVER 30 YEARS AS A SURGICAL 188 00:07:32,144 --> 00:07:32,778 ONCOLOGIST. 189 00:07:32,778 --> 00:07:37,383 I HAVE A LETTER FROM OVER 120 190 00:07:37,383 --> 00:07:38,117 PROFESSIONAL ORGANIZATIONS. 191 00:07:38,117 --> 00:07:40,152 I'D LIKE TO QUOTE FROM IT. 192 00:07:40,152 --> 00:07:41,620 YOU CAN GO INTO A PERSON'S 193 00:07:41,620 --> 00:07:43,823 BACKGROUND BUT WHEN YOU GET A 194 00:07:43,823 --> 00:07:46,625 LETTER THAT DESCRIBES HOW WELL 195 00:07:46,625 --> 00:07:48,794 SUITED AND FIT THEY ARE FOR 196 00:07:48,794 --> 00:07:50,129 BEING NIH DIRECTOR I'M JUST 197 00:07:50,129 --> 00:07:51,530 GOING TO READ A LITTLE BIT OF 198 00:07:51,530 --> 00:07:54,266 THAT LANGUAGE IF WE EVER GET THE 199 00:07:54,266 --> 00:07:56,936 LETTER UP. 200 00:07:56,936 --> 00:07:59,071 THERE WAS THIS OUTPOURING OF 201 00:07:59,071 --> 00:08:00,272 SUPPORT FROM ACROSS OUR 202 00:08:00,272 --> 00:08:01,574 COMMUNITY AND THE ENTIRE 203 00:08:01,574 --> 00:08:02,908 SCIENTIFIC COMMUNITY WHICH WAS 204 00:08:02,908 --> 00:08:03,742 GRATIFYING TO SEE. 205 00:08:03,742 --> 00:08:06,345 IT'S CONDENSED AND EXPRESSED IN 206 00:08:06,345 --> 00:08:06,946 THIS LETTER. 207 00:08:06,946 --> 00:08:13,919 AND IN ADDITION TO THAT SHE HAS 208 00:08:13,919 --> 00:08:17,790 AN ENORMOUS BACKGROUND AND 209 00:08:17,790 --> 00:08:20,292 CAPACITY FOR BEING PERSONAL, 210 00:08:20,292 --> 00:08:22,027 ENTHUSIASTIC AND MAKING 211 00:08:22,027 --> 00:08:23,963 CONNECTIONS WITH BOTH SIDES OF 212 00:08:23,963 --> 00:08:27,967 THE AISLE WHICH IS AN EXTREMELY 213 00:08:27,967 --> 00:08:33,606 IMPORTANT SKILL. 214 00:08:33,606 --> 00:08:35,441 THIS BECAME APPARENT IN HER 215 00:08:35,441 --> 00:08:35,975 CONFIRMATION HEARING. 216 00:08:35,975 --> 00:08:40,880 IF YOU TAKE A LOOK AT THAT IN C 217 00:08:40,880 --> 00:08:41,113 SPAN. 218 00:08:41,113 --> 00:08:43,182 YOU'RE INSIDE THE BELTWAY SO 219 00:08:43,182 --> 00:08:44,917 IT'S OKAY TO WATCH ESPECIALLY 220 00:08:44,917 --> 00:08:46,986 RERUNS BUT YOU CAN GET A SENSE 221 00:08:46,986 --> 00:08:48,687 OF HER POISE AND ABILITY TO MAKE 222 00:08:48,687 --> 00:08:51,157 THOSE CONNECTIONS WITH PEOPLE. 223 00:08:51,157 --> 00:08:54,026 IT WAS A TWO-HOUR GRILLING BY 224 00:08:54,026 --> 00:08:56,695 ALL THE SENATORS AND I THINK 225 00:08:56,695 --> 00:08:59,331 MANY OF YOU HAVE SEEN EXCERPTS 226 00:08:59,331 --> 00:09:00,699 OF THESE. 227 00:09:00,699 --> 00:09:02,101 IT'S REMARKABLE HOW MUCH 228 00:09:02,101 --> 00:09:05,271 INFORMATION SHE WAS ABLE TO 229 00:09:05,271 --> 00:09:09,375 CONVEY AND HOW HER CORE 230 00:09:09,375 --> 00:09:10,943 PERSONALITY CAME THROUGH AND 231 00:09:10,943 --> 00:09:12,578 IMPRESSIVE HOW CERTAIN QUESTIONS 232 00:09:12,578 --> 00:09:14,513 SHE RESISTED ANSWERING. 233 00:09:14,513 --> 00:09:16,015 YOU GET THE SENSE THAT SOME OF 234 00:09:16,015 --> 00:09:18,250 THOSE QUESTIONS WERE NOT THE 235 00:09:18,250 --> 00:09:20,019 MOST IMPORTANT OR SCIENTIFIC 236 00:09:20,019 --> 00:09:20,286 QUESTIONS. 237 00:09:20,286 --> 00:09:21,620 SHE HAD A WONDERFUL SENSE OF HOW 238 00:09:21,620 --> 00:09:25,891 TO NAVIGATE THROUGH THOSE. 239 00:09:25,891 --> 00:09:27,860 SO I'M TALKING THROUGH MY ENTIRE 240 00:09:27,860 --> 00:09:28,427 SLIDE NOW. 241 00:09:28,427 --> 00:09:30,196 YOU PROBABLY DON'T NEED TO SEE 242 00:09:30,196 --> 00:09:31,964 IT WITH A PICTURE OF HER BUT THE 243 00:09:31,964 --> 00:09:37,536 LAST THING I WANT TO SAY THAT IN 244 00:09:37,536 --> 00:09:38,470 PARTICULAR -- SHE WAS GRILLED -- 245 00:09:38,470 --> 00:09:40,539 YOU CAN READ ABOUT IT IN NATURE. 246 00:09:40,539 --> 00:09:43,275 HERE'S THIS WONDERFUL LETTER 247 00:09:43,275 --> 00:09:45,911 FROM 120 SIGNED BY EVERY 248 00:09:45,911 --> 00:09:47,746 NONPROFIT ORGANIZATION REALLY 249 00:09:47,746 --> 00:09:52,051 THE MOST IMPORTANT POINTING OUT 250 00:09:52,051 --> 00:09:53,485 HER EXCEPTIONAL SKILLS AND 251 00:09:53,485 --> 00:09:55,287 COMPASSION AND ABILITY TO LEAD 252 00:09:55,287 --> 00:09:58,424 US AS THE NEXT NIH DIRECTOR. 253 00:09:58,424 --> 00:10:01,427 WHAT'S MOST IMPORTANT IS THAT 254 00:10:01,427 --> 00:10:03,762 SHE WAS IN UNDERGRADUATE 255 00:10:03,762 --> 00:10:05,164 CHEMICAL ENGINEERING. 256 00:10:05,164 --> 00:10:07,066 SHE WAS AT PRINCETON, SHE DID 257 00:10:07,066 --> 00:10:11,070 HER UNDERGRADUATE RESEARCH ON 258 00:10:11,070 --> 00:10:13,505 SOLUTE TRANSFER ON SEMI 259 00:10:13,505 --> 00:10:20,479 PERMEABLE MEMBRANES AND HER 260 00:10:20,479 --> 00:10:21,447 FAVORITE EQUATION. 261 00:10:21,447 --> 00:10:24,650 MONICA IS USED TO PRESSURE, 262 00:10:24,650 --> 00:10:26,919 VELOCITY AND KNOWS HOW 263 00:10:26,919 --> 00:10:29,054 CONSERVATION OF ENERGY WORKS. 264 00:10:29,054 --> 00:10:30,756 LET'S WELCOME MONICA BERTAGNOLLI 265 00:10:30,756 --> 00:10:31,290 OUR KEY NOTE SPEAKER THIS 266 00:10:31,290 --> 00:10:39,632 MORNING. 267 00:10:39,632 --> 00:10:41,467 >> THANK YOU, EVERYONE. 268 00:10:41,467 --> 00:10:43,469 I'M SO DELIGHTED TO BE HERE. 269 00:10:43,469 --> 00:10:47,940 I WISH I COULD STAY ALL DAY 270 00:10:47,940 --> 00:10:50,075 BECAUSE THIS IS CLEARLY GOING TO 271 00:10:50,075 --> 00:10:58,817 BE EXCITING AND MANY THINGS YOU 272 00:10:58,817 --> 00:11:03,489 DO ARE THE THINGS I I LOVE MOST. 273 00:11:03,489 --> 00:11:05,124 I HAVE TO SAY THIS IS ONE OF THE 274 00:11:05,124 --> 00:11:08,961 FIRST INVITATIONS I ACCEPTED 275 00:11:08,961 --> 00:11:10,763 SINCE BECOMING NIH DIRECTOR NOT 276 00:11:10,763 --> 00:11:14,033 QUITE THREE WEEKS AGO AND WANTED 277 00:11:14,033 --> 00:11:19,305 TO COME HERE TODAY BECAUSE YOU 278 00:11:19,305 --> 00:11:23,409 ALL DESERVE SO MUCH CREDIT FOR 279 00:11:23,409 --> 00:11:24,276 THE POINT-OF-CARE TECHNOLOGY 280 00:11:24,276 --> 00:11:25,377 RESEARCH NETWORK. 281 00:11:25,377 --> 00:11:27,913 IT PLAYED A KEY ROLE IN OUR 282 00:11:27,913 --> 00:11:29,815 RESPONSE TO COVID. 283 00:11:29,815 --> 00:11:32,151 I THINK EVERYONE KNOWS ABOUT 284 00:11:32,151 --> 00:11:37,289 THIS TEAM BECAUSE OF THAT. 285 00:11:37,289 --> 00:11:38,524 IT'S A SPECIAL ACCOMPLISHMENT 286 00:11:38,524 --> 00:11:46,265 WITH NIH FUNDING TRANSLATES SO 287 00:11:46,265 --> 00:11:49,134 QUICKLY AND CAPABLY PUTTING 288 00:11:49,134 --> 00:11:51,270 PRODUCTS IN PEOPLE'S HOLDS. 289 00:11:51,270 --> 00:11:53,272 PRODUCTS THAT HELP THEM FEEL 290 00:11:53,272 --> 00:11:54,640 BETTER PREPARED TO SAFEGUARD 291 00:11:54,640 --> 00:11:55,941 THEIR HEALTH AND THE HEALTH OF 292 00:11:55,941 --> 00:11:59,978 THOSE AROUND THEM. 293 00:11:59,978 --> 00:12:01,947 THAT KIND OF RESEARCH REACH IS 294 00:12:01,947 --> 00:12:04,049 WHAT PROCTORED PROMISES. 295 00:12:04,049 --> 00:12:05,851 THE NETWORK PLAYS A CRITICAL 296 00:12:05,851 --> 00:12:07,753 ROLE NOT ONLY IN EMERGENCIES BUT 297 00:12:07,753 --> 00:12:10,289 IN MOVING THE PROMISE OF NIH 298 00:12:10,289 --> 00:12:11,623 RESEARCH INTO PEOPLE'S LIVES ON 299 00:12:11,623 --> 00:12:13,459 MULTIPLE FRONTS. 300 00:12:13,459 --> 00:12:16,061 THOSE OF US IN THIS ROOM CAN 301 00:12:16,061 --> 00:12:18,731 IMAGINE A DAY WHEN THIS NETWORK 302 00:12:18,731 --> 00:12:21,734 WILL BE RESPONSIBLE FOR OVER THE 303 00:12:21,734 --> 00:12:23,402 COUNTER AND POINT-OF-CARE TESTS 304 00:12:23,402 --> 00:12:23,869 FOR SO MANY DIFFERENT 305 00:12:23,869 --> 00:12:27,439 CONDITIONS. 306 00:12:27,439 --> 00:12:32,344 TESTS FOR MATERNAL HEALTH, FETAL 307 00:12:32,344 --> 00:12:34,046 METABOLIC SEIZES AND HEPATITIS C 308 00:12:34,046 --> 00:12:35,547 AND NEUROLOGICAL CONDITIONS. 309 00:12:35,547 --> 00:12:37,816 YOU ALL IN THE ROOM KNOW WE ARE 310 00:12:37,816 --> 00:12:39,318 NOT FAR OFF FROM SEEING THIS 311 00:12:39,318 --> 00:12:46,592 RESULTING FROM YOUR GREAT WORK. 312 00:12:46,592 --> 00:12:49,595 I WAS AN ENGINEERING MAJOR AND 313 00:12:49,595 --> 00:12:50,863 BEEN DRAWN TO THE PROMISE OF 314 00:12:50,863 --> 00:12:52,064 BUILDING THINGS THAT MAKE 315 00:12:52,064 --> 00:12:52,898 PEOPLE'S LIVES BETTER. 316 00:12:52,898 --> 00:12:54,767 THE PROMISE OF TECHNOLOGY TO 317 00:12:54,767 --> 00:12:56,702 REALLY CHANGE THE WORLD AS WE 318 00:12:56,702 --> 00:13:07,246 ARE SEEING LITERALLY EVERY DAY. 319 00:13:11,083 --> 00:13:13,185 OUR JOB IS ONLY DONE WHEN OUR 320 00:13:13,185 --> 00:13:14,420 DISCOVERIES HELP PEOPLE LIVE 321 00:13:14,420 --> 00:13:17,956 LONG AND HEALTHY LIVES WHEN THEY 322 00:13:17,956 --> 00:13:19,425 TOUCH INDIVIDUAL PEOPLE. 323 00:13:19,425 --> 00:13:23,128 AND YOU ALSO PUT INTO PRACTICE 324 00:13:23,128 --> 00:13:25,764 BETTER THAN REALLY ANYTHING I 325 00:13:25,764 --> 00:13:29,301 CAN POINT TO RIGHT NOW ONE OF 326 00:13:29,301 --> 00:13:33,038 ANOTHER MAIN GOAL FOR NIH THAT 327 00:13:33,038 --> 00:13:34,506 OUR WORK ENGAGE AND HELP EVERY 328 00:13:34,506 --> 00:13:42,748 SINGLE COMMUNITY. 329 00:13:42,748 --> 00:13:44,583 IT IS ESSENTIAL OUR WORK REACHES 330 00:13:44,583 --> 00:13:46,852 PEOPLE NO MATTER WHERE THEY 331 00:13:46,852 --> 00:13:47,286 LIVE. 332 00:13:47,286 --> 00:13:48,954 WE MUTT BRING EVERY COMMUNITY 333 00:13:48,954 --> 00:13:49,822 INTO READINESS WHETHER THAT 334 00:13:49,822 --> 00:13:50,989 MEANS BEING PREPARED FOR A 335 00:13:50,989 --> 00:13:52,958 PANDEMIC OR CONDUCTING RESEARCH 336 00:13:52,958 --> 00:13:54,860 LOOKING FOR WAYS TO HELP PEOPLE 337 00:13:54,860 --> 00:13:59,898 TAKE THE STEPS REQUIRED TO LEAD 338 00:13:59,898 --> 00:14:00,265 HEALTHIER LIVES. 339 00:14:00,265 --> 00:14:01,366 LIKE SO MUCH ABOUT OUR RESPONSE 340 00:14:01,366 --> 00:14:03,969 TO COVID WE NEVER WOULD HAVE 341 00:14:03,969 --> 00:14:05,537 BEEN ABLE TO REACT AS WELL AS WE 342 00:14:05,537 --> 00:14:07,473 DID WITHOUT HAVING LAID THE 343 00:14:07,473 --> 00:14:10,409 SOLID FOUNDATION MANY YEARS 344 00:14:10,409 --> 00:14:10,809 BEFORE. 345 00:14:10,809 --> 00:14:13,812 THIS NETWORK WAS IN ITS THIRD 346 00:14:13,812 --> 00:14:14,446 FIVE-YEAR CYCLE WHEN COVID 347 00:14:14,446 --> 00:14:17,516 EMERGED. 348 00:14:17,516 --> 00:14:19,852 GIVEN THE NETWORK'S STELLAR 349 00:14:19,852 --> 00:14:22,187 RESPONSE TO THE CRISIS, NO 350 00:14:22,187 --> 00:14:24,423 WONDER THAT IN 2023 NIH RENEWED 351 00:14:24,423 --> 00:14:27,793 THE PROGRAM WITH MORE GRANT 352 00:14:27,793 --> 00:14:29,194 RECIPIENTS THAN IN ANY PREVIOUS 353 00:14:29,194 --> 00:14:29,962 CYCLE. 354 00:14:29,962 --> 00:14:31,897 THE SEVEN AWARD RECIPIENTS IN 355 00:14:31,897 --> 00:14:34,333 THE FOURTH CYCLE FOCUS ON 356 00:14:34,333 --> 00:14:35,501 EVERYTHING FROM ENGINEERING 357 00:14:35,501 --> 00:14:37,436 MICROSYSTEMS TO DEVELOPING TESTS 358 00:14:37,436 --> 00:14:40,772 THAT DETECT INFECTIONS LIKE 359 00:14:40,772 --> 00:14:43,809 STDs, IMPROVE THE DIAGNOSIS AND 360 00:14:43,809 --> 00:14:46,812 MANAGEMENT OF HEART, LUNG, BLOOD 361 00:14:46,812 --> 00:14:48,947 AND SLEEP DISORDERS. 362 00:14:48,947 --> 00:14:52,084 SCREEN FOR CANCER AND ADDRESS 363 00:14:52,084 --> 00:14:53,652 NUTRITION, INFECTION AND CANCER 364 00:14:53,652 --> 00:14:57,055 IN AND ESPECIALLY VULNERABLE 365 00:14:57,055 --> 00:14:57,723 POPULATIONS IN THE UNITED STATES 366 00:14:57,723 --> 00:15:01,693 AND GLOBALLY. 367 00:15:01,693 --> 00:15:05,364 IT'S MUCH MORE THAN A NETWORK AS 368 00:15:05,364 --> 00:15:07,799 BRUCE ALLUDED TO IT'S MORE LIKE 369 00:15:07,799 --> 00:15:09,468 A MULTI-DISCIPLINARY ECO SYSTEM 370 00:15:09,468 --> 00:15:12,304 WHERE NIH-FUNDED ACADEMIC 371 00:15:12,304 --> 00:15:14,239 CENTERS WORK WITH MULTIPLE 372 00:15:14,239 --> 00:15:16,208 GOVERNMENT AGENCIES FROM BARDA 373 00:15:16,208 --> 00:15:17,843 TO THE WHITE HOUSE. 374 00:15:17,843 --> 00:15:19,411 OTHER ACADEMIC INSTITUTIONS AND 375 00:15:19,411 --> 00:15:23,348 OF COURSE INDUSTRY. 376 00:15:23,348 --> 00:15:24,950 EACH CENTER SUPPORTS 377 00:15:24,950 --> 00:15:27,452 COLLABORATION AMONG PHYSICAL, 378 00:15:27,452 --> 00:15:29,521 BIO CHEMICAL AND COMPUTATIONAL 379 00:15:29,521 --> 00:15:30,689 SCIENTISTS AS WELL AS 380 00:15:30,689 --> 00:15:31,256 ENGINEERING ON EXPLORE TRY 381 00:15:31,256 --> 00:15:33,759 PROJECTS. 382 00:15:33,759 --> 00:15:36,328 EACH CENTER CONDUCTS IN-HOUSE 383 00:15:36,328 --> 00:15:39,298 CLINICAL TESTS OF PROTOTYPE 384 00:15:39,298 --> 00:15:40,999 DEVICES AND PROVIDES TRAINING TO 385 00:15:40,999 --> 00:15:43,969 TECHNOLOGY DEVELOPERS ON 386 00:15:43,969 --> 00:15:45,771 CLINICAL ISSUES RELATED TO THE 387 00:15:45,771 --> 00:15:46,405 POINT-OF-CARE DEVICES THEY WORK 388 00:15:46,405 --> 00:15:50,876 ON. 389 00:15:50,876 --> 00:15:53,545 ONE OF THE AREAS THAT'S BEEN THE 390 00:15:53,545 --> 00:16:00,252 MAIN FOCUS OF MY CAREER HAS BEEN 391 00:16:00,252 --> 00:16:02,020 THE IMPLEMENTATION OF CLINICAL 392 00:16:02,020 --> 00:16:03,755 RESEARCH THROUGH RIGOROUS 393 00:16:03,755 --> 00:16:04,823 CLINICAL TRIALS AND INCREASINGLY 394 00:16:04,823 --> 00:16:06,058 THROUGH THE TECHNOLOGIES THAT 395 00:16:06,058 --> 00:16:12,297 ARE GOING TO ALLOW US TO GATHER 396 00:16:12,297 --> 00:16:13,999 DATA FROM EVERY PERSON AND 397 00:16:13,999 --> 00:16:15,434 GATHER DATA FROM EVERY 398 00:16:15,434 --> 00:16:15,801 COMMUNITY. 399 00:16:15,801 --> 00:16:19,504 I ALSO KNOW THAT MANY OF THE 400 00:16:19,504 --> 00:16:20,772 THINGS THAT ARE BEING DEVELOPED 401 00:16:20,772 --> 00:16:21,406 WILL BE CRITICAL IN MOVING THAT 402 00:16:21,406 --> 00:16:27,512 FORWARD. 403 00:16:27,512 --> 00:16:31,483 WHEN COVID HIT THIS COMMUNITY 404 00:16:31,483 --> 00:16:33,885 CAME TOGETHER TO STAND UP RADX 405 00:16:33,885 --> 00:16:35,721 AS SOON AS IT BECAME CLEAR THERE 406 00:16:35,721 --> 00:16:39,591 WAS NO WAY TO COMBAT THE NOVEL 407 00:16:39,591 --> 00:16:41,593 CORONAVIRUS WITHOUT ADEQUATE 408 00:16:41,593 --> 00:16:42,761 TESTING AND RADX LAUNCHED. 409 00:16:42,761 --> 00:16:45,063 BY FALL OF 2020, SIX MONTHS 410 00:16:45,063 --> 00:16:46,832 LATER, RADX WAS ABLE TO GET TENS 411 00:16:46,832 --> 00:16:50,569 OF MILLIONS OF TESTS PER MONTH 412 00:16:50,569 --> 00:16:54,006 OUT FOR PEOPLE TO USE. 413 00:16:54,006 --> 00:16:57,409 NOW IN LATE NOVEMBER 2023 THE 414 00:16:57,409 --> 00:17:02,547 FDA AUTHORIZED 55 DIFFERENT 415 00:17:02,547 --> 00:17:07,953 COVID TESTS 7 BILLION TESTS HAVE 416 00:17:07,953 --> 00:17:13,692 BEEN TURNED OUT AND THIS WILL 417 00:17:13,692 --> 00:17:16,161 HELP THOSE DISPROPORTIONATELY 418 00:17:16,161 --> 00:17:17,963 AFFECTED BY OR AT GREATER RISK 419 00:17:17,963 --> 00:17:19,831 OF COVID-19 AND TESTS ACCESSIBLE 420 00:17:19,831 --> 00:17:24,169 TO PEOPLE WITH DISABILITIES. 421 00:17:24,169 --> 00:17:29,241 THIS SUCCESS IS HIGHLY VISIBLE 422 00:17:29,241 --> 00:17:31,977 TO EVERYONE BUT I KNOW THIS IS 423 00:17:31,977 --> 00:17:37,516 ONLY ONE ASPECT OF THE WORK. 424 00:17:37,516 --> 00:17:39,284 CONLATGRATULATIONS FOR WHAT YOU 425 00:17:39,284 --> 00:17:40,585 HAVE ACCOMPLISHED AND WE'RE 426 00:17:40,585 --> 00:17:42,154 EXCITED TO SEE WHAT'S COMING 427 00:17:42,154 --> 00:17:42,688 NEXT. 428 00:17:42,688 --> 00:17:44,556 DESPITE THE AMAZING WORK YOU 429 00:17:44,556 --> 00:17:46,858 HAVE DONE I'M MOST EXCITED ABOUT 430 00:17:46,858 --> 00:17:52,464 WHAT YOU WILL DO NEXT NO MATTER 431 00:17:52,464 --> 00:17:52,664 WHAT. 432 00:17:52,664 --> 00:17:54,433 ALL OF US MUST CENTER ON 433 00:17:54,433 --> 00:17:55,000 PEOPLE'S NEEDS. 434 00:17:55,000 --> 00:17:57,402 THIS NETWORK HAS BEEN A STAND 435 00:17:57,402 --> 00:17:59,604 OUT PROGRAM BECAUSE OF ITS REACH 436 00:17:59,604 --> 00:18:01,840 WORKING WITH EVERYONE WHO MUST 437 00:18:01,840 --> 00:18:03,442 BE INVOLVED IN ORDER TO ENGAGE 438 00:18:03,442 --> 00:18:05,143 WITH COMMUNITIES WHERE EVER. 439 00:18:05,143 --> 00:18:06,978 I'LL GIVE YOU ONE EXAMPLE OF 440 00:18:06,978 --> 00:18:13,218 WHERE I KNOW FIRST HAND THE 441 00:18:13,218 --> 00:18:14,619 CAPABILITIES. 442 00:18:14,619 --> 00:18:17,856 I SAW HOW RADX DELIVERED TESTING 443 00:18:17,856 --> 00:18:20,125 SERVICES TO WYOMING AT THE WIND 444 00:18:20,125 --> 00:18:21,727 RIVER INDIAN RESERVATION WHERE 445 00:18:21,727 --> 00:18:24,362 THE NEAREST FULL-SERVICE 446 00:18:24,362 --> 00:18:26,298 HOSPITAL WAS A HUNDRED MILES 447 00:18:26,298 --> 00:18:26,665 AWAY. 448 00:18:26,665 --> 00:18:27,599 THIS REQUIRED UNDERSTANDING AND 449 00:18:27,599 --> 00:18:31,169 ADDRESSING THE NEEDS OF A UNIQUE 450 00:18:31,169 --> 00:18:33,438 AND REMOTE COMMUNITY. 451 00:18:33,438 --> 00:18:35,574 I KNOW YOUR WORK SAVED LIVED AND 452 00:18:35,574 --> 00:18:39,978 I KNOW THIS IS ONLY ONE OF 453 00:18:39,978 --> 00:18:47,652 COUNTLESS EXAMPLES OF THIS. 454 00:18:47,652 --> 00:18:50,388 AND THIS IS CHANGING THE QUALITY 455 00:18:50,388 --> 00:18:52,190 OF CARE PATIENTS RECEIVE. 456 00:18:52,190 --> 00:18:55,727 YOUR TECHNOLOGIES AND 457 00:18:55,727 --> 00:18:56,461 PARTNERSHIPS HELP MEET PEOPLE 458 00:18:56,461 --> 00:18:58,363 WHERE THEY LIVE INCLUDING IN 459 00:18:58,363 --> 00:18:59,965 THEIR OWN HOMES DELIVERING WHAT 460 00:18:59,965 --> 00:19:01,233 THEY NEED TO LIVE LONG AND 461 00:19:01,233 --> 00:19:02,734 HEALTHY LIVES. 462 00:19:02,734 --> 00:19:05,504 I LOOK FORWARD TO ALL YOU WILL 463 00:19:05,504 --> 00:19:09,407 ACCOMPLISH AND I REALLY HOPE YOU 464 00:19:09,407 --> 00:19:10,008 ALL ENJOY THESE TWO DAYS OF 465 00:19:10,008 --> 00:19:10,242 MEETING. 466 00:19:10,242 --> 00:19:20,552 THANK YOU SO MUCH. 467 00:19:29,661 --> 00:19:31,296 A FEW QUESTIONS IF ANYONE WANTS. 468 00:19:31,296 --> 00:19:41,540 DON'T BE SHY. 469 00:20:00,392 --> 00:20:02,794 TRADITIONALLY, WELL, THAT'S NOT 470 00:20:02,794 --> 00:20:04,296 THE WAY TO SAY IT. 471 00:20:04,296 --> 00:20:06,198 IN THE RECENT PAST, LET'S SAY, 472 00:20:06,198 --> 00:20:08,466 THE FUNDING FOR TECHNOLOGY HAS 473 00:20:08,466 --> 00:20:14,673 FELT TO BE IN AREAS OTHER THAN 474 00:20:14,673 --> 00:20:14,840 NIH. 475 00:20:14,840 --> 00:20:17,876 I THINK THE IMMEDIACY OF 476 00:20:17,876 --> 00:20:19,711 TECHNOLOGY AND IMMEDIATE 477 00:20:19,711 --> 00:20:21,213 APPLICATIONS TO THE KIND OF WORK 478 00:20:21,213 --> 00:20:23,849 NIH HAS DONE HAVE NOT BEEN AS 479 00:20:23,849 --> 00:20:26,051 READILY APPARENT. 480 00:20:26,051 --> 00:20:29,221 BOY, IT CERTAINLY IS NOW. 481 00:20:29,221 --> 00:20:31,790 AND I THINK WHEN TECHNOLOGY 482 00:20:31,790 --> 00:20:35,193 STARTS TO DIRECTLY AND TANGIBLY 483 00:20:35,193 --> 00:20:38,296 ADDRESS NEEDS IN INDIVIDUAL 484 00:20:38,296 --> 00:20:48,840 PEOPLE'S HEALTH AS WHAT POCTRN 485 00:20:52,043 --> 00:20:53,345 IS DOING AND IT BECOMES EASIER 486 00:20:53,345 --> 00:20:55,780 TO DIRECT RESOURCES IN THAT 487 00:20:55,780 --> 00:20:56,047 DIRECTION. 488 00:20:56,047 --> 00:20:57,215 ANYBODY KNOWS TECHNOLOGY IS CORE 489 00:20:57,215 --> 00:20:59,384 TO HEALTH. 490 00:20:59,384 --> 00:21:00,819 WE LIVE IN AN ENVIRONMENT OF 491 00:21:00,819 --> 00:21:08,627 MEDICAL CARE THAT IS GROUNDED IB 492 00:21:08,627 --> 00:21:11,429 IN MORE THAN 150 YEARS OF 493 00:21:11,429 --> 00:21:15,467 TECHNOLOGY DEVELOPMENT BUT AGAIN 494 00:21:15,467 --> 00:21:16,935 IF PEOPLE ASSUME IT'S THERE AND 495 00:21:16,935 --> 00:21:20,105 ASSUME IT WILL BE THERE WHEN 496 00:21:20,105 --> 00:21:24,709 THEY GO TO THE DOCTOR'S OFFICE. 497 00:21:24,709 --> 00:21:27,946 IT'S MAKING TA FROM A BUILT FOR 498 00:21:27,946 --> 00:21:31,950 THE MEDICAL ESTABLISHMENT TO 499 00:21:31,950 --> 00:21:34,352 SOMETHING THAT MATTERS 500 00:21:34,352 --> 00:21:37,522 INDIVIDUALLY TO EVERY PERSON 501 00:21:37,522 --> 00:21:37,822 IMMEDIATELY. 502 00:21:37,822 --> 00:21:39,357 I THINK THAT WAS SEEN IN THE 503 00:21:39,357 --> 00:21:40,091 FUNDAMENTAL DIFFERENCE OF WHAT 504 00:21:40,091 --> 00:21:40,959 THE GROUP DOES. 505 00:21:40,959 --> 00:21:42,394 I THINK WE'LL SEE BIG CHANGES 506 00:21:42,394 --> 00:21:45,163 WITH THAT. 507 00:21:45,163 --> 00:21:47,232 THIS IS A TIME WHEN THE IMPACT 508 00:21:47,232 --> 00:21:51,403 OF THE NETWORK ON SCIENCE IS 509 00:21:51,403 --> 00:21:53,171 REALLY CLEAR ALSO A TIME WHEN A 510 00:21:53,171 --> 00:21:59,511 LOT OF THE PUBLIC HAS MAYBE LOST 511 00:21:59,511 --> 00:22:03,949 CONFIDENCE DO YOU HAVE ADVICE 512 00:22:03,949 --> 00:22:06,718 FOR HOW THE NETWORK SHOULD 513 00:22:06,718 --> 00:22:10,088 APPROACH ITS WORK GOING FORWARD 514 00:22:10,088 --> 00:22:12,257 SO PEOPLE WANT TO TAKE ADVANTAGE 515 00:22:12,257 --> 00:22:15,961 OF THE BENEFITS OF THAT NEW 516 00:22:15,961 --> 00:22:16,861 PROGRESS? 517 00:22:16,861 --> 00:22:19,597 >> I THINK YOUR WORK IS -- IF I 518 00:22:19,597 --> 00:22:24,803 HAD TO POINT TO SOMETHING ACROSS 519 00:22:24,803 --> 00:22:25,904 NIH THAT'S DOING THE MOST 520 00:22:25,904 --> 00:22:28,306 TOWARDS THIS END IT WOULD 521 00:22:28,306 --> 00:22:30,108 SOMETHING LIKE POCTRN. 522 00:22:30,108 --> 00:22:35,647 WHY IN WHAT WE NEED IS TO TRULY 523 00:22:35,647 --> 00:22:36,681 ENGAGE PEOPLE A VERY DIVERSE 524 00:22:36,681 --> 00:22:41,920 RANGE OF PEOPLE IN OUR RESEARCH. 525 00:22:41,920 --> 00:22:47,359 WE NEED TO HAVE EVERYONE 526 00:22:47,359 --> 00:22:48,126 UNDERSTAND WE'RE ADDRESSING 527 00:22:48,126 --> 00:22:49,094 PEOPLE'S NEEDS AND WE'RE 528 00:22:49,094 --> 00:22:50,061 ACCOUNTABLE TO THEM AND 529 00:22:50,061 --> 00:22:51,329 TRANSPARENT AND THE BEST WAY TO 530 00:22:51,329 --> 00:22:54,432 DO THAT IS TO DIRECTLY ENGAGE 531 00:22:54,432 --> 00:22:55,367 THEM IN RESEARCH. 532 00:22:55,367 --> 00:22:58,536 ONE OF MY MANTRAS YOU'LL 533 00:22:58,536 --> 00:22:59,571 PROBABLY HEAR IT A LOT IS THE 534 00:22:59,571 --> 00:23:05,977 ONE THAT COMES FROM THE PATIENT 535 00:23:05,977 --> 00:23:07,812 ADVOCACY COMMUNITY NOTHING ABOUT 536 00:23:07,812 --> 00:23:10,148 US WITHOUT US AND BY NATURE THE 537 00:23:10,148 --> 00:23:17,655 WORK HAS TO DIRECTLY ENGAGE WITH 538 00:23:17,655 --> 00:23:19,758 PEOPLE TO BE POSSIBLE AND WHY 539 00:23:19,758 --> 00:23:21,159 CLINICAL TRIALS ARE IMPORTANT TO 540 00:23:21,159 --> 00:23:26,398 ENDEND ER -- ENGENDER TRUST AN 541 00:23:26,398 --> 00:23:27,365 REBUILD WITH THE COMMUNITY AND 542 00:23:27,365 --> 00:23:29,567 KEEP DOING WHAT YOU'RE DOING AND 543 00:23:29,567 --> 00:23:32,203 COMMUNICATE IT WELL AND HAVE 544 00:23:32,203 --> 00:23:38,009 EVERYONE INVOLVED. 545 00:23:38,009 --> 00:23:38,910 THAT'S ANOTHER BENEFIT OF THIS 546 00:23:38,910 --> 00:23:49,220 PARTICULAR GROUP. 547 00:23:51,089 --> 00:23:57,262 >> IS THERE SOMETHING THAT YOU 548 00:23:57,262 --> 00:23:59,798 SEE THE NIH MISSION IS GOING TO 549 00:23:59,798 --> 00:23:59,964 BE? 550 00:23:59,964 --> 00:24:01,466 >> YOU'VE ASKED THAT QUESTION 551 00:24:01,466 --> 00:24:08,206 TWO DAYS TOO EARLY. 552 00:24:08,206 --> 00:24:10,575 WHAT WE'RE GOING TO DO -- WHAT 553 00:24:10,575 --> 00:24:11,743 I'M GOING TO DID -- I'LL TELL 554 00:24:11,743 --> 00:24:13,645 YOU WHY I WANTED TO BE NIH 555 00:24:13,645 --> 00:24:13,912 DIRECTOR. 556 00:24:13,912 --> 00:24:17,382 I'VE HAD AN AMAZING -- I'VE BEEN 557 00:24:17,382 --> 00:24:22,754 SO FORTUNATE IN MY CAREER TO 558 00:24:22,754 --> 00:24:26,491 WORK WITH INCREDIBLE PEOPLE AND 559 00:24:26,491 --> 00:24:27,659 I WANTED TO BE NIH DIRECTOR 560 00:24:27,659 --> 00:24:32,864 BECAUSE THIS IS AN ORGANIZATION 561 00:24:32,864 --> 00:24:36,534 OF 27 INSTITUTES OF THE BIGGER 562 00:24:36,534 --> 00:24:42,006 AGENCY OF HEALTH AND HUMAN 563 00:24:42,006 --> 00:24:44,142 SERVICES AND THESE ARE 564 00:24:44,142 --> 00:24:45,076 UNBELIEVABLE PEOPLE WHO HAVE A 565 00:24:45,076 --> 00:24:46,711 BEAT ON HOW TO IMPROVE THE 566 00:24:46,711 --> 00:24:46,978 WORLD. 567 00:24:46,978 --> 00:24:52,550 IN ANSWER TO YOUR QUESTION, THE 568 00:24:52,550 --> 00:24:57,522 WHOLE REASON I'M HONORED TO RUN 569 00:24:57,522 --> 00:24:59,724 NIH IS THE PEOPLE WHO SIT AROUND 570 00:24:59,724 --> 00:25:01,493 THE TABLE AT THE DIRECTORS' 571 00:25:01,493 --> 00:25:02,994 MEETING AND WHAT WE'LL DO ON 572 00:25:02,994 --> 00:25:07,866 THURSDAY IS SIT DOWN, ALL 29 OF 573 00:25:07,866 --> 00:25:11,002 US AND WE NOW HAVE AN AGENCY, 574 00:25:11,002 --> 00:25:13,204 ARPA-H AND WE 27 INSTITUTES AND 575 00:25:13,204 --> 00:25:15,874 ONE AGENCY ARPA-H AND ONE 576 00:25:15,874 --> 00:25:19,944 DIRECTOR, ALL 29 OF US WILL SIT 577 00:25:19,944 --> 00:25:21,980 DOWN ON THURSDAY AND DECIDE WHAT 578 00:25:21,980 --> 00:25:23,515 OUR PRIORITIES ARE GOING TO BE 579 00:25:23,515 --> 00:25:24,349 FOR NIH FOR THE FORESEEABLE 580 00:25:24,349 --> 00:25:31,756 FUTURE. 581 00:25:31,756 --> 00:25:35,894 I CAN TELL YOU THE WORK OF 582 00:25:35,894 --> 00:25:38,363 POCTRN WILL BE INVOLVED AND I'LL 583 00:25:38,363 --> 00:25:48,907 HEAR ABOUT THIS SOON. 584 00:25:48,907 --> 00:25:50,775 >> ONE OF THE IMPLICATIONS IS 585 00:25:50,775 --> 00:25:51,843 CAPTURING THE LIVED EXPERIENCE 586 00:25:51,843 --> 00:25:54,045 OF FOLKS AT HOME AND YET WHEN WE 587 00:25:54,045 --> 00:25:55,346 GENERATE THIS DATA IN THE 588 00:25:55,346 --> 00:25:57,248 CONDUCT OF SCIENCE SEEMS THE 589 00:25:57,248 --> 00:26:03,788 GOLD STANDARD WANTS TO HAVE 590 00:26:03,788 --> 00:26:09,127 FORMATIVE COMPARISONS AND 591 00:26:09,127 --> 00:26:15,133 DIFFERENT TESTS IN ACCEPTING 592 00:26:15,133 --> 00:26:16,768 THIS DISPARATE DATA. 593 00:26:16,768 --> 00:26:17,902 IT'S A CONSEQUENCE OF THESE 594 00:26:17,902 --> 00:26:18,236 TECHNOLOGIES. 595 00:26:18,236 --> 00:26:26,311 >> TOUGH ONE. 596 00:26:26,311 --> 00:26:28,947 IT'S THE SAME THROUGHOUT ALL OF 597 00:26:28,947 --> 00:26:29,981 CLINICAL RESEARCH. 598 00:26:29,981 --> 00:26:35,320 WHAT BEST ACHIEVE THE NEEDS OF 599 00:26:35,320 --> 00:26:41,759 THE PATIENT IS WE HAVE TO 600 00:26:41,759 --> 00:26:46,631 DELIVER THE SYSTEMS. 601 00:26:46,631 --> 00:26:49,734 THINK ABOUT HOW WE MEASURE BLOOD 602 00:26:49,734 --> 00:26:50,868 PRESSURE TODAY AND WHAT'S 603 00:26:50,868 --> 00:26:51,736 HAPPENED TODAY. 604 00:26:51,736 --> 00:26:54,439 THINK OF ALL THE CARDIOVASCULAR 605 00:26:54,439 --> 00:26:58,776 TRIALS DEVELOPED USING THAT 606 00:26:58,776 --> 00:27:01,512 REALLY LUM SI AND INACCURATE 607 00:27:01,512 --> 00:27:02,647 MEASURE OF MEASURING BLOOD 608 00:27:02,647 --> 00:27:02,914 PRESSURE. 609 00:27:02,914 --> 00:27:04,983 WE CAN DO BETTER. 610 00:27:04,983 --> 00:27:07,252 AS WE DO BETTER, WHEN THINGS ARE 611 00:27:07,252 --> 00:27:08,419 TESTED AND SHOW THEY ARE MORE 612 00:27:08,419 --> 00:27:10,288 RELIABLE AND MORE ABLE TO 613 00:27:10,288 --> 00:27:13,224 DELIVER WHAT PATIENTS NEED, GAME 614 00:27:13,224 --> 00:27:13,491 OVER. 615 00:27:13,491 --> 00:27:13,992 YOU'RE DONE. 616 00:27:13,992 --> 00:27:15,660 I THINK WE ALL NEED TO ADOPT 617 00:27:15,660 --> 00:27:23,001 THAT STANDARD. 618 00:27:23,001 --> 00:27:24,702 NO MATTER WHAT WE PRODUCE WE 619 00:27:24,702 --> 00:27:27,238 HAVE TO PRODUCE BETTER THAT'S 620 00:27:27,238 --> 00:27:29,807 WHAT'S THERE TODAY AND BETTER 621 00:27:29,807 --> 00:27:30,608 MEET THE NEEDS OF THE PATIENT 622 00:27:30,608 --> 00:27:33,511 AND THE DOCTOR TO MAKE DECISIONS 623 00:27:33,511 --> 00:27:40,084 THAT GUIDE BETTER CARE. 624 00:27:40,084 --> 00:27:41,819 AS IT NOT EASY AND ANOTHER THING 625 00:27:41,819 --> 00:27:46,291 THAT IS GOING TO HELP THIS A LOT 626 00:27:46,291 --> 00:27:48,159 IS BROAD SHARING OF DATA. 627 00:27:48,159 --> 00:27:50,295 SO WE KNOW -- WE DON'T HAVE TO 628 00:27:50,295 --> 00:27:51,129 REINVENT EVERYTHING. 629 00:27:51,129 --> 00:27:53,398 WE KNOW HOW TO COMPARE THE PAST 630 00:27:53,398 --> 00:27:58,636 TO THE PRESENT VERY CAREFULLY. 631 00:27:58,636 --> 00:28:08,313 WE CAN DO MANY MORE IN SILICO 632 00:28:08,313 --> 00:28:10,214 TRIALS IF THAT HELPS. 633 00:28:10,214 --> 00:28:11,082 ONE MORE. 634 00:28:11,082 --> 00:28:13,051 I DON'T WANT TO USURP YOUR WHOLE 635 00:28:13,051 --> 00:28:17,822 MEETING HERE. 636 00:28:17,822 --> 00:28:18,489 THIS IS GREAT. 637 00:28:18,489 --> 00:28:23,561 >> ONE OF THE THINGS THAT MADE 638 00:28:23,561 --> 00:28:24,696 THE RADX POCTRN EXPERIENCES WAS 639 00:28:24,696 --> 00:28:26,831 SO IMPACTFUL AND EFFECTIVE WAS 640 00:28:26,831 --> 00:28:27,765 THE COLLABORATION WITH OUR 641 00:28:27,765 --> 00:28:32,403 SISTER AGENCIES, FDA AND CMS. 642 00:28:32,403 --> 00:28:42,947 AS YOU ENTER THIS POSITION, IF 643 00:28:44,048 --> 00:28:48,886 YOU CAN DESCRIBE HOW TO KEEP 644 00:28:48,886 --> 00:28:51,189 THAT IMPACTFUL WILL BE USEFUL. 645 00:28:51,189 --> 00:28:53,624 I WORK IN THE OER AND I WOULD 646 00:28:53,624 --> 00:28:55,259 LOVE TO HELP BE PART OF THAT 647 00:28:55,259 --> 00:28:55,993 INITIATIVE IF YOU CHOOSE TO GO 648 00:28:55,993 --> 00:28:56,194 THERE. 649 00:28:56,194 --> 00:28:59,097 THANK YOU. 650 00:28:59,097 --> 00:29:00,932 >> THANK YOU SO MUCH FOR THAT. 651 00:29:00,932 --> 00:29:03,501 I TOLD YOU THERE WERE TWO 652 00:29:03,501 --> 00:29:06,070 REASONS WHY I WAS SO THRILLED TO 653 00:29:06,070 --> 00:29:07,972 BE ASSUMING THIS POSITION. 654 00:29:07,972 --> 00:29:09,507 NUMBER ONE WAS THE 28 PEOPLE 655 00:29:09,507 --> 00:29:12,043 SITTING AROUND THE PEOPLE AT THE 656 00:29:12,043 --> 00:29:15,446 DIRECTORS FOR NIH, THE OTHER IS 657 00:29:15,446 --> 00:29:16,981 THE OPPORTUNITY TO WORK WITH 658 00:29:16,981 --> 00:29:18,950 THAT AND THE INCREDIBLE BREADTH 659 00:29:18,950 --> 00:29:21,953 AND DEPTH OF HHS. 660 00:29:21,953 --> 00:29:24,856 OUR SISTER AGENCIES HAVE LEADERS 661 00:29:24,856 --> 00:29:26,958 THAT REALLY DO EMBRACE THIS GOAL 662 00:29:26,958 --> 00:29:29,427 OF WORKING TOGETHER. 663 00:29:29,427 --> 00:29:30,762 MAYBE IT WAS COVID. 664 00:29:30,762 --> 00:29:31,796 I SUSPECT IT'S ALSO THE RIGHT 665 00:29:31,796 --> 00:29:33,131 KIND OF PEOPLE THAT WENT TO SEE 666 00:29:33,131 --> 00:29:34,532 THIS AS A MISSION. 667 00:29:34,532 --> 00:29:37,835 AND WE'RE ALREADY DOING THAT 668 00:29:37,835 --> 00:29:38,102 ACTIVELY. 669 00:29:38,102 --> 00:29:39,537 THANK YOU FOR THAT. 670 00:29:39,537 --> 00:29:41,072 IT'S CRITICALLY IMPORTANT AND WE 671 00:29:41,072 --> 00:29:43,741 CAN DO MORE IF WE ADOPT THAT 672 00:29:43,741 --> 00:29:45,109 POLICY, THAT APPROACH. 673 00:29:45,109 --> 00:29:47,145 TIME FOR UP WITH MORE, BRUCE? 674 00:29:47,145 --> 00:29:52,417 >> A QUICK ONE? 675 00:29:52,417 --> 00:29:56,421 >> SO, I'M FROM PUBLIC HEALTH 676 00:29:56,421 --> 00:29:58,089 AND A LAB DIRECTOR DURING THE 677 00:29:58,089 --> 00:30:00,658 PANDEMIC IN NEW YORK. 678 00:30:00,658 --> 00:30:03,461 I'M A TRUE BELIEVER AS BRUCE 679 00:30:03,461 --> 00:30:04,962 SAID IN POINT-OF-CARE AND HOME 680 00:30:04,962 --> 00:30:06,464 USE BECAUSE I THINK IT WILL 681 00:30:06,464 --> 00:30:07,632 FUNDAMENTALLY CHANGE THE WAY WE 682 00:30:07,632 --> 00:30:09,167 DO PUBLIC HEALTH. 683 00:30:09,167 --> 00:30:12,637 I'M INCREDIBLY EXCITED. 684 00:30:12,637 --> 00:30:18,042 I DON'T SEE PUBLIC HEALTH ON THE 685 00:30:18,042 --> 00:30:20,978 AGENDA THE NEXT TWO WEEKS AND 686 00:30:20,978 --> 00:30:23,414 FOR REGULATORS AND 687 00:30:23,414 --> 00:30:26,417 MANUFACTURERS, I HOPE YOU KEEP 688 00:30:26,417 --> 00:30:31,956 PUBLIC HEALTH IN MIND WHERE THE 689 00:30:31,956 --> 00:30:32,590 TRADITIONAL FIRST RESPONDERS, 690 00:30:32,590 --> 00:30:33,858 DID WE DO SO WELL LAST TIME? 691 00:30:33,858 --> 00:30:35,693 I THINK WE CAN DO BETTER AND 692 00:30:35,693 --> 00:30:37,328 THINK THE TOOLS WILL ALLOW US TO 693 00:30:37,328 --> 00:30:38,062 DO BETTER. 694 00:30:38,062 --> 00:30:43,601 >> THANK YOU AND I'LL REMIND 695 00:30:43,601 --> 00:30:47,305 EVERYBODY THAT NIH SCOPE GOES 696 00:30:47,305 --> 00:30:50,875 FROM FUNDAMENTAL SCIENCE THROUGH 697 00:30:50,875 --> 00:30:52,844 CARE DELIVERY ACHIEVE THE 698 00:30:52,844 --> 00:30:54,078 RESULTS WE NEED. 699 00:30:54,078 --> 00:30:55,947 PUBLIC HEALTH IS IS WITHIN THE 700 00:30:55,947 --> 00:30:57,915 THINGS YOU'RE TALKING ABOUT IS 701 00:30:57,915 --> 00:31:03,521 VERY MUCH -- HOW TO DELIVER AWE 702 00:31:03,521 --> 00:31:04,922 KNOW WORKS IS JUST AS MUCH AS 703 00:31:04,922 --> 00:31:06,958 SUCH AS IMPORTANT PART OF OUR 704 00:31:06,958 --> 00:31:07,959 RESEARCH AS THE FUNDAMENTAL 705 00:31:07,959 --> 00:31:12,063 SCIENCE. 706 00:31:12,063 --> 00:31:13,664 IT DOESN'T MATTER WHAT WE DO IN 707 00:31:13,664 --> 00:31:15,099 THE LABORATORY IF IT DOESN'T 708 00:31:15,099 --> 00:31:20,338 HELP A PERSON OR GET US TO THE 709 00:31:20,338 --> 00:31:21,339 IMPORTANT WHO NEEDS IT. 710 00:31:21,339 --> 00:31:22,807 I AGREE ENTIRELY AND IT'S PART 711 00:31:22,807 --> 00:31:23,608 OF WHAT WE DO. 712 00:31:23,608 --> 00:31:24,675 THANK YOU EVERYTHING AND HAVE A 713 00:31:24,675 --> 00:31:25,042 GREAT MEETING. 714 00:31:25,042 --> 00:31:35,419 >> THANK YOU, MONICA. 715 00:31:43,761 --> 00:31:44,562 >> MANY THANKS TO 716 00:31:44,562 --> 00:31:45,930 DR. BERTAGNOLLI. 717 00:31:45,930 --> 00:31:48,332 THE QUESTIONS WERE OUTSTANDING 718 00:31:48,332 --> 00:31:52,537 AND HOPE TO TOUCH ON THE THEMES. 719 00:31:52,537 --> 00:31:54,105 THE LAST QUESTION ON PUBLIC 720 00:31:54,105 --> 00:31:55,172 HEALTH AS A RESULT OF THIS 721 00:31:55,172 --> 00:31:55,940 EXPERIENCE THE MOST IMPORTANT 722 00:31:55,940 --> 00:31:57,608 CONTRIBUTION WE CAN MAKE AS A 723 00:31:57,608 --> 00:31:59,410 COMMUNITY IS TO THROUGH TRAINING 724 00:31:59,410 --> 00:32:01,279 AND EDUCATION OF OUR BIO MEDICAL 725 00:32:01,279 --> 00:32:02,680 ENGINEERS TO MOVE THEM INTO 726 00:32:02,680 --> 00:32:03,614 PUBLIC HEALTH. 727 00:32:03,614 --> 00:32:08,052 IT'S NOT TRADITIONALLY BEEN AN 728 00:32:08,052 --> 00:32:10,655 AREA OF FOCUS FOR BIOMEDICAL 729 00:32:10,655 --> 00:32:12,189 ENGINEERING STUDENTS AND 730 00:32:12,189 --> 00:32:13,391 TRAINEES BUT NEEDED AND MAGICAL 731 00:32:13,391 --> 00:32:16,027 THINGS CAN HAPPEN AS WE EXPAND 732 00:32:16,027 --> 00:32:17,328 OUR ENGAGEMENT WITH MENTAL 733 00:32:17,328 --> 00:32:18,462 HEALTH AS WE'VE SEEN IN THE 734 00:32:18,462 --> 00:32:23,401 PANDEMIC. 735 00:32:23,401 --> 00:32:27,939 SO LET'S SEE IF I CAN GET MY 736 00:32:27,939 --> 00:32:38,149 NEXT SLIDE. 737 00:32:40,384 --> 00:32:45,790 I MAY NEED TECHNOLOGY ASS 738 00:32:45,790 --> 00:32:46,090 ASSISTANCE. 739 00:32:46,090 --> 00:32:47,124 I THINK IT'S JUST ME. 740 00:32:47,124 --> 00:32:57,535 DO I JUST HIT AN ARROW? 741 00:33:10,381 --> 00:33:12,850 CAN I GET REMEDIAL INSTRUCTION? 742 00:33:12,850 --> 00:33:23,260 I CAN'T SEE THE MONITOR. 743 00:33:38,209 --> 00:33:39,710 SO I'M NOT ACTUALLY RUNNING. 744 00:33:39,710 --> 00:33:41,345 YOU THINK YOU'RE IN CONTROL BUT 745 00:33:41,345 --> 00:33:42,246 YOU'RE REALLY NOT. 746 00:33:42,246 --> 00:33:47,218 THE SLIDE I WAS LOOKING FOR. 747 00:33:47,218 --> 00:33:47,485 OKAY. 748 00:33:47,485 --> 00:33:49,620 I WANTED TO TAKE A MOMENT AND 749 00:33:49,620 --> 00:33:53,524 THANK OUR ORGANIZERS, ESPECIALLY 750 00:33:53,524 --> 00:33:59,563 DR. LASH WHO PRNURTURED THIS FR 751 00:33:59,563 --> 00:34:00,831 THE BEGINNING RECENTLY THE 752 00:34:00,831 --> 00:34:03,467 NETWORK HAD RENEWED AND TIFFANI 753 00:34:03,467 --> 00:34:06,504 STARTED IT OFF AGAIN AND THIS 754 00:34:06,504 --> 00:34:07,638 NETWORK DROVE US THROUGH THE 755 00:34:07,638 --> 00:34:11,575 COVID PANDEMIC AND NOW IT'S 756 00:34:11,575 --> 00:34:14,011 EXPANDED WITH TWO MORE SITES AND 757 00:34:14,011 --> 00:34:16,914 WE'RE PLEASED ABOUT THAT. 758 00:34:16,914 --> 00:34:20,651 TIFFANI AND AUTUMN CO-CHAIRED 759 00:34:20,651 --> 00:34:20,851 THIS. 760 00:34:20,851 --> 00:34:22,720 AS DR. BERTAGNOLLI ALLUDED TO, 761 00:34:22,720 --> 00:34:23,954 WE CAN'T MAKE THINGS WORK 762 00:34:23,954 --> 00:34:24,789 WITHOUT PARTNERSHIPS. 763 00:34:24,789 --> 00:34:26,857 THIS IS ONE OF THE MOST 764 00:34:26,857 --> 00:34:28,793 SPECTACULAR PARTNERSHIPS AT THE 765 00:34:28,793 --> 00:34:29,060 NIH. 766 00:34:29,060 --> 00:34:32,296 YOU SEE ALL THE MULTIPLE 767 00:34:32,296 --> 00:34:34,231 PARTICIPATING AGENCIES. 768 00:34:34,231 --> 00:34:36,801 ALL OF OUR PROGRAM AND REVIEW 769 00:34:36,801 --> 00:34:39,837 STAFF AND HIGHER STAFF AT THE 770 00:34:39,837 --> 00:34:41,472 NIBIB ARE ALL ENGAGED IN THE 771 00:34:41,472 --> 00:34:47,545 NETWORK IN SOME KIND OF WAY. 772 00:34:47,545 --> 00:34:49,413 AND RELEVANT TO THE PUBLIC 773 00:34:49,413 --> 00:34:50,247 HEALTH COMMENT AND SEVERAL OF 774 00:34:50,247 --> 00:34:55,286 THE OTHER QUESTIONS THAT CAME 775 00:34:55,286 --> 00:35:00,157 UP, NIBIB IS UNIQUE IN THAT 776 00:35:00,157 --> 00:35:01,959 WE'RE OBSESSED WITH THE DATA 777 00:35:01,959 --> 00:35:06,330 SOURCES AND INSTRUMENTS AND 778 00:35:06,330 --> 00:35:08,566 GETTING CONCEPTS AND IDEAS FROM 779 00:35:08,566 --> 00:35:10,701 THE CONCEPTUAL STAGE AND BENCH 780 00:35:10,701 --> 00:35:15,005 TALK AND MOVE IT INTO FULLY 781 00:35:15,005 --> 00:35:17,074 DISSEMINATED MANUFACTURED 782 00:35:17,074 --> 00:35:20,344 DEVICES THAT IMPACT PUBLIC 783 00:35:20,344 --> 00:35:20,578 HEALTH. 784 00:35:20,578 --> 00:35:22,012 TO UNDERSTAND THAT YOU NEED TO 785 00:35:22,012 --> 00:35:23,681 UNDERSTAND THE CREATION STORY. 786 00:35:23,681 --> 00:35:25,683 I SAID THIS WAS A LITTLE BIT OF 787 00:35:25,683 --> 00:35:27,785 A RELIGIOUS GATHERING AND WE 788 00:35:27,785 --> 00:35:30,521 HAVE A CREATION STORY BACK TO 789 00:35:30,521 --> 00:35:33,157 CONGRESS IN 2000 THAT PULLS OUT 790 00:35:33,157 --> 00:35:36,894 THE LANGUAGE AND UNDER SCORES 791 00:35:36,894 --> 00:35:39,363 TECHNOLOGY, BIOMEDICAL IMAGING 792 00:35:39,363 --> 00:35:41,932 AND BIO ENGINEERING AND RELATED 793 00:35:41,932 --> 00:35:44,001 TECHNOLOGIES NEED A HOME AT THE 794 00:35:44,001 --> 00:35:44,235 NIH. 795 00:35:44,235 --> 00:35:47,905 AT THAT TIME THROUGHOUT THE '90s 796 00:35:47,905 --> 00:35:50,241 THERE WAS NO HOME. 797 00:35:50,241 --> 00:35:52,576 THE GENERAL IMPRESSION OF NIH 798 00:35:52,576 --> 00:35:55,146 WAS COOL RESEARCH AND BIOLOGY 799 00:35:55,146 --> 00:35:56,046 WAS GOING ON. 800 00:35:56,046 --> 00:36:01,152 ZEBRAFISH WAS A COMMON PLATFORM 801 00:36:01,152 --> 00:36:03,454 TO BE USED IN RESEARCH BUT NOT 802 00:36:03,454 --> 00:36:04,455 SO FRIENDLY TO THE DEVELOPMENT 803 00:36:04,455 --> 00:36:05,356 OF NEW TECHNOLOGIES. 804 00:36:05,356 --> 00:36:10,361 AFTER A DECADE OF STRUGGLE, 805 00:36:10,361 --> 00:36:11,796 MULTIPLE PROFESSIONAL SOCIETIES 806 00:36:11,796 --> 00:36:13,397 COMING TOGETHER FROM THE IMAGING 807 00:36:13,397 --> 00:36:19,537 AND NEENKI IING -- AND ENGINEEG 808 00:36:19,537 --> 00:36:22,473 AND NIBIB AND THERE'S BEEN 809 00:36:22,473 --> 00:36:23,941 REMARKABLE GROWTH IN BIO 810 00:36:23,941 --> 00:36:26,911 ENGINEERING AROUND THE COUNTRY. 811 00:36:26,911 --> 00:36:28,679 AND UNDERGRADUATE DEPARTMENTS 812 00:36:28,679 --> 00:36:30,514 OVER 200 GRADUATE PROGRAMS. 813 00:36:30,514 --> 00:36:32,983 YOU SEE THE INFLEXION POINT 814 00:36:32,983 --> 00:36:33,450 TAKING PLACE. 815 00:36:33,450 --> 00:36:35,953 A LOT OF THIS HAS BEEN DRIVEN, 816 00:36:35,953 --> 00:36:39,657 THE FOUNDATION SET FROM THE 817 00:36:39,657 --> 00:36:40,825 WHITAKER FOUNDATION PUTTING 818 00:36:40,825 --> 00:36:44,328 AROUND $760 MILLION INTO 819 00:36:44,328 --> 00:36:45,429 BIOMEDICAL ENGINEERING AND 820 00:36:45,429 --> 00:36:46,163 DEPARTMENTS. 821 00:36:46,163 --> 00:36:47,331 MANY HAVE BEEN THE 822 00:36:47,331 --> 00:36:47,731 BENEFICIARIES. 823 00:36:47,731 --> 00:36:49,967 I HAVE BEEN A BENEFICIARY OF 824 00:36:49,967 --> 00:36:51,101 THAT IN THE FORMATION AND GROWTH 825 00:36:51,101 --> 00:36:52,469 OF A DEPARTMENT THAT I JUST WENT 826 00:36:52,469 --> 00:36:56,807 BACK FOR THE 20th REUNION. 827 00:36:56,807 --> 00:36:59,743 THERE'S 800 STUDENT 828 00:36:59,743 --> 00:37:00,744 UNDERGRADUATE GRADUATE STUDENTS. 829 00:37:00,744 --> 00:37:03,848 WE HAD NO IDEA ANY OF THIS WOULD 830 00:37:03,848 --> 00:37:04,381 HAPPEN. 831 00:37:04,381 --> 00:37:05,816 MULTIPLY THAT BY MANY ORDERS 832 00:37:05,816 --> 00:37:12,823 AROUND THE COUNTRY AND YOU SEE 833 00:37:12,823 --> 00:37:23,434 THIS INCREDIBLE MULTIPLICATIVE 834 00:37:25,469 --> 00:37:25,970 EFFECT AND IT'S QUITE A 835 00:37:25,970 --> 00:37:34,211 TRANSFORMATION. 836 00:37:34,211 --> 00:37:36,881 WHAT DO WE DO AT NIBIB. 837 00:37:36,881 --> 00:37:40,784 THIS IS OUR ICONOGRAPHY AT WHAT 838 00:37:40,784 --> 00:37:43,153 WE DO TO SUPPORT OUR COMMUNITY. 839 00:37:43,153 --> 00:37:45,956 WE SUPPORT THINGS LIKE 840 00:37:45,956 --> 00:37:47,358 ENGINEERED BIOLOGY. 841 00:37:47,358 --> 00:37:49,660 FROM SYNTHETIC TO 842 00:37:49,660 --> 00:37:50,561 MICROPHYSIOLOGIC SYSTEMS AND 843 00:37:50,561 --> 00:37:53,764 EVERYTHING IN BETWEEN AND 844 00:37:53,764 --> 00:37:58,202 REPROGRAMMING SINGLE CELLS AND 845 00:37:58,202 --> 00:38:01,572 ORGANOIDS AND TRANSDUCING 846 00:38:01,572 --> 00:38:04,375 ENERGY, ACOUSTIC, THERMAL, 847 00:38:04,375 --> 00:38:12,016 CHEMICAL, PLATONIC, ALL SORTS OF 848 00:38:12,016 --> 00:38:14,451 WEARABLE AND IMPLANTABLE AND 849 00:38:14,451 --> 00:38:17,421 MOVING THEM TO POINT OF CARE AND 850 00:38:17,421 --> 00:38:22,793 BIG PHYSIC DEVICE TO PORTABLE 851 00:38:22,793 --> 00:38:23,994 BEDSIDE AND THERAPEUTIC SYSTEMS 852 00:38:23,994 --> 00:38:26,397 MINIMALLY AND NON-INVASIVE 853 00:38:26,397 --> 00:38:29,199 ENERGY DELIVERY AND ACTIVATION 854 00:38:29,199 --> 00:38:30,534 OF MOLECULES SPECIFICALLY AS 855 00:38:30,534 --> 00:38:33,304 WELL AS ROBOTICS AND ROBOTIC 856 00:38:33,304 --> 00:38:35,673 ASSISTED DEVICES AND EVERYTHING 857 00:38:35,673 --> 00:38:37,007 IS BROUGHT TOGETHER BY 858 00:38:37,007 --> 00:38:38,042 COMPUTATIONAL TECHNIQUE. 859 00:38:38,042 --> 00:38:40,544 SO DATA SCIENCE, MODELLING, 860 00:38:40,544 --> 00:38:43,347 COMPUTATION, THEY'RE AT THE CORE 861 00:38:43,347 --> 00:38:45,916 OF EVERYTHING WE DO ALL THOSE 862 00:38:45,916 --> 00:38:47,017 TECHNOLOGIES INVOLVE DESIGN BY 863 00:38:47,017 --> 00:38:49,520 DATA SCIENCE AND MODELLING AND 864 00:38:49,520 --> 00:38:50,854 EXTRACTION OF GREATER 865 00:38:50,854 --> 00:38:52,089 INFORMATION CONTENT WITH NEW 866 00:38:52,089 --> 00:38:54,658 INSIGHTS BY LOOKING AT HOW THAT 867 00:38:54,658 --> 00:38:56,293 MODEL MAY COMPARE WITH 868 00:38:56,293 --> 00:38:59,964 EXPERIMENTAL DATA THAT'S DERIVED 869 00:38:59,964 --> 00:39:06,403 FROM A PARTICULAR SYSTEM. 870 00:39:06,403 --> 00:39:11,375 THE CORE PROGRAMS AT NIBIB AND 871 00:39:11,375 --> 00:39:13,711 ALL OF NIH HAVE BEEN 872 00:39:13,711 --> 00:39:14,278 DRAMATICALLY IMPACTED AND 873 00:39:14,278 --> 00:39:15,946 TRANSFORMED BY THE PANDEMIC. 874 00:39:15,946 --> 00:39:19,049 THIS IS MY SIMPLE ENGINEERING 875 00:39:19,049 --> 00:39:22,019 DIAGRAM TO ILLUSTRATE THAT WE 876 00:39:22,019 --> 00:39:24,121 TOOK OUR CORE PROGRAMS, THE NIH 877 00:39:24,121 --> 00:39:26,857 DIRECTOR WAS REALLY AWARE OF OUR 878 00:39:26,857 --> 00:39:27,791 CAPABILITIES IN ALL OF THESE 879 00:39:27,791 --> 00:39:32,262 AREAS AND WE HAD AN OPPORTUNITY 880 00:39:32,262 --> 00:39:35,799 TO BRING OUR EXPERTISE IN 881 00:39:35,799 --> 00:39:36,667 IMAGING AND ARTIFICIAL 882 00:39:36,667 --> 00:39:38,168 INTELLIGENCE AND DIGITAL 883 00:39:38,168 --> 00:39:39,303 PLATFORMS DURING THE PANDEMIC TO 884 00:39:39,303 --> 00:39:42,740 BEAR ON TO SOLUTIONS AND CREATED 885 00:39:42,740 --> 00:39:44,508 TWO FLAGSHIP PROGRAMS WITH THOSE 886 00:39:44,508 --> 00:39:48,445 NEW RESOURCES. 887 00:39:48,445 --> 00:39:51,115 ONE IS RADX FOR RAPID ACC 888 00:39:51,115 --> 00:39:56,120 ACCELERATION AND THE DATA IMA 889 00:39:56,120 --> 00:39:59,289 IMAGING RESOURCE CENTER A WAY TO 890 00:39:59,289 --> 00:40:01,425 CONSERVE MEDICAL IMAGE DATA AND 891 00:40:01,425 --> 00:40:04,828 INCREASING AND ACCELERATING THE 892 00:40:04,828 --> 00:40:06,463 DEVELOPMENT AND VALIDATION OF 893 00:40:06,463 --> 00:40:09,466 A.I.-BASED ALGORITHMS TO IMPROVE 894 00:40:09,466 --> 00:40:10,634 DIAGNOSTICS AND PROGNOSTICS. 895 00:40:10,634 --> 00:40:13,604 THOSE TWO PRODUCTS, SO TO SPEAK, 896 00:40:13,604 --> 00:40:15,806 OF THE PANDEMIC, FED BACK TOO 897 00:40:15,806 --> 00:40:20,310 THE ETHOS AND THE CULTURE OF 898 00:40:20,310 --> 00:40:23,447 EVERYTHING THAT WE DO AT NIBIB 899 00:40:23,447 --> 00:40:26,683 AND ITS EXTENDED ACROSS THE NIH 900 00:40:26,683 --> 00:40:28,652 AS IMPACTED IN INFLUENCED ALL 27 901 00:40:28,652 --> 00:40:36,493 INSTITUTE CENTERS AND OFFICES. 902 00:40:36,493 --> 00:40:38,228 WHAT ARE THOSE THOSE RADX 903 00:40:38,228 --> 00:40:38,495 PRODUCTS. 904 00:40:38,495 --> 00:40:43,567 I'LL GO INTO DETAIL ON THAT. 905 00:40:43,567 --> 00:40:47,538 AT THE CENTER WAS THE POCTRN 906 00:40:47,538 --> 00:40:50,474 NETWORK AND THERE'S THE 907 00:40:50,474 --> 00:40:52,976 INSTITUTE AT NGH AT THE 908 00:40:52,976 --> 00:40:53,844 ORGANIZING CENTER AND BECAUSE 909 00:40:53,844 --> 00:40:55,813 THE WAY IT'S STRUCTURED WE WERE 910 00:40:55,813 --> 00:40:57,281 ABLE TO DELIVER RESOURCE TO THE 911 00:40:57,281 --> 00:40:59,750 NETWORK WHICH THEN COULD DELIVER 912 00:40:59,750 --> 00:41:00,551 RESOURCES TO ALL OF YOU TO 913 00:41:00,551 --> 00:41:01,452 INVESTIGATORS ALL AROUND THE 914 00:41:01,452 --> 00:41:01,952 COUNT RI. 915 00:41:01,952 --> 00:41:04,521 AND DO IT QUICKLY BECAUSE TIME 916 00:41:04,521 --> 00:41:06,423 WAS OF THE ESSENCE. 917 00:41:06,423 --> 00:41:12,029 WE NEEDED TO BE ABLE TO DELIVER 918 00:41:12,029 --> 00:41:14,231 THE RESOURCES IN WEEKS MIGHT A 919 00:41:14,231 --> 00:41:15,766 MONTH OR TWO MONTHS NOT IN THE 920 00:41:15,766 --> 00:41:17,568 TYPICAL ONE-YEAR TIME FRAME 921 00:41:17,568 --> 00:41:19,069 BECAUSE THE PROBLEM WAS URGENT. 922 00:41:19,069 --> 00:41:20,838 THAT ABILITY IS RESIDUAL NOW. 923 00:41:20,838 --> 00:41:22,906 IT'S EMBEDDED IN OUR SYSTEM AND 924 00:41:22,906 --> 00:41:24,942 WE WORKED OUT THE PROCESS TO DO 925 00:41:24,942 --> 00:41:27,578 THAT NOT JUST IN TIMES OF 926 00:41:27,578 --> 00:41:28,679 NATIONAL EMERGENCY BUT IN TIMES 927 00:41:28,679 --> 00:41:31,648 WHERE WE NEED TO ACCELERATE THE 928 00:41:31,648 --> 00:41:32,616 DEVELOPMENT OF TECHNOLOGIES. 929 00:41:32,616 --> 00:41:34,585 SO TO MAKE THIS HAPPEN, OUR 930 00:41:34,585 --> 00:41:43,527 FIRST PRODUCT WITHIN THE NETWORK 931 00:41:43,527 --> 00:41:45,496 WAS A SHARK TANK OR INNOVATION 932 00:41:45,496 --> 00:41:47,498 TUNNEL TO MOVE THEM THROUGH WITH 933 00:41:47,498 --> 00:41:50,000 MULTIPLE STAGES WHERE 934 00:41:50,000 --> 00:41:50,734 INVESTIGATORS COULD RECEIVE 935 00:41:50,734 --> 00:41:52,236 MONEY OR RESOURCES TO ACCELERATE 936 00:41:52,236 --> 00:41:54,171 AND VALIDATE THE CONCEPTS. 937 00:41:54,171 --> 00:41:56,773 WHAT WAS CRITICAL IN ALL THIS 938 00:41:56,773 --> 00:41:58,709 THE NETWORK PULLED TOGETHER 939 00:41:58,709 --> 00:42:01,879 THREE MAJOR CORES TO GIVE US AN 940 00:42:01,879 --> 00:42:02,246 ABSOLUTE TRUTH. 941 00:42:02,246 --> 00:42:05,015 FIRST AS ALL OF YOU KNOW, EVERY 942 00:42:05,015 --> 00:42:07,084 TECHNOLOGY THAT YOU DEVELOP 943 00:42:07,084 --> 00:42:08,318 RIGHT AT THE BEGINNING WORKS 944 00:42:08,318 --> 00:42:09,686 PERFECTLY IN YOUR MINDS BUT IT 945 00:42:09,686 --> 00:42:12,022 HAS TO GO THROUGH A VALIDATION 946 00:42:12,022 --> 00:42:14,124 CORE TO REALLY SEE, PUT IT 947 00:42:14,124 --> 00:42:17,761 THROUGH ITS FACES AND GET TO A 948 00:42:17,761 --> 00:42:20,264 TRUTH. 949 00:42:20,264 --> 00:42:24,701 EMORY AND GEORGIA TECH U-MASS 950 00:42:24,701 --> 00:42:25,969 BUILT A CORE WITH NOVEL 951 00:42:25,969 --> 00:42:27,271 APPROACHES IN DIGITAL TRIALS AND 952 00:42:27,271 --> 00:42:29,072 THEN A DEPLOYMENT CORE BECAUSE 953 00:42:29,072 --> 00:42:30,574 AFTER YOU GET ALL THESE THINGS 954 00:42:30,574 --> 00:42:33,911 YOU HAVE TO FIGURE OUT ISSUES OF 955 00:42:33,911 --> 00:42:34,778 MANUFACTURING AND SUPPLY WHICH 956 00:42:34,778 --> 00:42:36,213 BECAME HUGELY IMPORTANT DURING 957 00:42:36,213 --> 00:42:36,780 THE PANDEMIC. 958 00:42:36,780 --> 00:42:37,981 EVERYBODY WANTED THE SAME PARTS 959 00:42:37,981 --> 00:42:39,950 AND PIECES AND COMPONENTS. 960 00:42:39,950 --> 00:42:47,791 THIS WAS AN INCREDIBLY IMPORTANT 961 00:42:47,791 --> 00:42:48,025 ELEMENT. 962 00:42:48,025 --> 00:42:49,059 OVER THE COURSE OF THE PANDEMIC 963 00:42:49,059 --> 00:42:50,627 THOUGH WE STARTED WITH A SHARK 964 00:42:50,627 --> 00:42:56,200 TANK WE HAD TO CREATE NEW 965 00:42:56,200 --> 00:42:56,466 PRODUCTS. 966 00:42:56,466 --> 00:43:00,804 BECAUSE ALL THE TIME THERE WERE 967 00:43:00,804 --> 00:43:03,407 NEW CHALLENGES AND I THOUGHT THE 968 00:43:03,407 --> 00:43:04,708 TECHNOLOGY WILL BE THE HARDEST 969 00:43:04,708 --> 00:43:07,344 PART BUT ENDED UP BEING THE 970 00:43:07,344 --> 00:43:07,911 EASIEST PART. 971 00:43:07,911 --> 00:43:10,147 WE HAD LOTS OF CULTURE AND 972 00:43:10,147 --> 00:43:11,848 HUMANS TO DEAL WITH AND CREATED 973 00:43:11,848 --> 00:43:15,986 ADDITIONAL PRODUCTS, DIGITAL 974 00:43:15,986 --> 00:43:18,121 HEALTH PLATFORMS, OUR COVID TEST 975 00:43:18,121 --> 00:43:23,360 PROGRAM AND IN ORDER TO REALLY 976 00:43:23,360 --> 00:43:23,994 BRING TESTING AND UNDERSTAND 977 00:43:23,994 --> 00:43:26,830 WHAT EXPERIENCES WERE AT HOME. 978 00:43:26,830 --> 00:43:28,799 NOBODY HAD DONE TESTING AT THIS 979 00:43:28,799 --> 00:43:30,667 SCALE AT HOME BEFORE. 980 00:43:30,667 --> 00:43:33,804 IT WAS UNHEARD OF. 981 00:43:33,804 --> 00:43:34,438 WOULD IT WORK. 982 00:43:34,438 --> 00:43:34,838 ? 983 00:43:34,838 --> 00:43:37,874 VARIANTS CAME UP AND WE HAD 984 00:43:37,874 --> 00:43:38,408 VARIANTS TASK FORCE? 985 00:43:38,408 --> 00:43:41,078 THE BOTTLENECK IS FDA APPROVAL 986 00:43:41,078 --> 00:43:42,980 OR AUTHORIZATION AND WE FORMED A 987 00:43:42,980 --> 00:43:44,615 STRONG COLLABORATIVE 988 00:43:44,615 --> 00:43:46,350 RELATIONSHIP WITH THE IN DEPEND 989 00:43:46,350 --> 00:43:47,050 EPT TEST AT THE SAME TIME 990 00:43:47,050 --> 00:43:47,317 PROGRAM. 991 00:43:47,317 --> 00:43:51,154 WE HAVE A WEB-BASED APP NOW. 992 00:43:51,154 --> 00:43:53,090 HOPEFULLY THIS WON'T BE A SUPER 993 00:43:53,090 --> 00:43:55,759 SPREADER EVENT BUT IF YOU DO GET 994 00:43:55,759 --> 00:44:00,998 COVID GO ON TO MAKE MY TEST 995 00:44:00,998 --> 00:44:05,602 COUNT.org AND TEST ANONYMOUSLY. 996 00:44:05,602 --> 00:44:08,138 WE HAVE A HOME TEST AND TREAT 997 00:44:08,138 --> 00:44:10,874 PROGRAM IN PARTNERSHIP WITH ASPR 998 00:44:10,874 --> 00:44:17,014 AND CDC AND HAVE REALLY ADVANCED 999 00:44:17,014 --> 00:44:19,383 TEST ACCESSIBILITY. 1000 00:44:19,383 --> 00:44:21,184 YOU KNOW IT'S HARD TO COUNT THE 1001 00:44:21,184 --> 00:44:23,086 DROPS AND OPEN UP THE PACKAGES 1002 00:44:23,086 --> 00:44:24,788 IT'S LIKE A CHEMISTRY SET IN 1003 00:44:24,788 --> 00:44:25,956 HIGH SCHOOL. 1004 00:44:25,956 --> 00:44:27,591 THESE HAVE ADVANCED 1005 00:44:27,591 --> 00:44:28,225 SIGNIFICANTLY THROUGH OUR TEST 1006 00:44:28,225 --> 00:44:35,098 ACCESSIBILITY PROGRAM. 1007 00:44:35,098 --> 00:44:38,268 BOTTOM LINE, THERE'S BEEN 1008 00:44:38,268 --> 00:44:39,403 ENORMOUS GROWTH AND EXPANSE IN 1009 00:44:39,403 --> 00:44:43,006 THE TESTS WE SUPPORTED OR THE 1010 00:44:43,006 --> 00:44:44,274 COMPANIES WE SUPPORTED THEY'VE 1011 00:44:44,274 --> 00:44:47,210 INCREASED TESTING CAPACITY BY 1012 00:44:47,210 --> 00:44:53,183 NEARLY 8 BILLION TESTS OVER 1013 00:44:53,183 --> 00:44:56,520 THREE YEARS AND THE BIG DRIVER 1014 00:44:56,520 --> 00:44:57,754 HAVE BEEN THE INDEPENDENT TEST 1015 00:44:57,754 --> 00:44:58,255 ASSESSMENT PROGRAM. 1016 00:44:58,255 --> 00:45:00,791 GOING BACK TO APRIL OF 2020 YOU 1017 00:45:00,791 --> 00:45:03,794 ONLY THOUGHT OF TESTS IN 1018 00:45:03,794 --> 00:45:06,096 LABORATORY AND PUBLIC HEALTH WAS 1019 00:45:06,096 --> 00:45:08,332 COMFORTABLE WITH THAT. 1020 00:45:08,332 --> 00:45:10,767 THEY TOLD US THEY SHOULD BE AND 1021 00:45:10,767 --> 00:45:13,437 DOCTORS SHOULD PRESCRIBE TESTS 1022 00:45:13,437 --> 00:45:15,372 BUT THERE'S A PARADIGM SHIFT. 1023 00:45:15,372 --> 00:45:17,407 IN FEBRUARY OF 2022 ALONE THE 1024 00:45:17,407 --> 00:45:19,443 GOVERNMENT DISTRIBUTED WITH LOTS 1025 00:45:19,443 --> 00:45:21,345 OF HELP FROM RADX A BILLION OVER 1026 00:45:21,345 --> 00:45:23,647 THE COUNTER TESTS. 1027 00:45:23,647 --> 00:45:25,415 1.1 BILLION TESTS IN TOTAL AND 1 1028 00:45:25,415 --> 00:45:28,785 BILLION OVER THE COUNTER. 1029 00:45:28,785 --> 00:45:30,454 2.5 BILLION OVER THE COUNTER 1030 00:45:30,454 --> 00:45:35,959 TESTS AND STILL HAVE THOSE TEST 1031 00:45:35,959 --> 00:45:37,627 STOCKPILES AND HOPEFULLY STILL 1032 00:45:37,627 --> 00:45:38,295 GET DISTRIBUTIONS ON THOSE AND 1033 00:45:38,295 --> 00:45:48,839 THE NEW ONES ARE COMING AS WELL. 1034 00:45:53,243 --> 00:45:54,745 I DON'T KNOW IF PAM IS HERE BUT 1035 00:45:54,745 --> 00:45:56,680 YOU SHOULD TALK TO THEM AND THIS 1036 00:45:56,680 --> 00:46:00,517 REDUCED THE TIME TO 1037 00:46:00,517 --> 00:46:01,551 AUTHORIZATION THROUGH PROCESS 1038 00:46:01,551 --> 00:46:02,753 EFFICIENCIES DRAMATICALLY. 1039 00:46:02,753 --> 00:46:05,722 LESS THAN TWO MONTHS WAS THE 1040 00:46:05,722 --> 00:46:09,326 RECORD 55 OR 53 DAYS, ERIK CAN 1041 00:46:09,326 --> 00:46:11,495 TELL YOU EXACTLY AND MANY STEPS 1042 00:46:11,495 --> 00:46:16,767 IN AND PARTNERSHIP FROM THE FDA 1043 00:46:16,767 --> 00:46:19,569 AND OCTC7 WAS AN IMPORTANT 1044 00:46:19,569 --> 00:46:19,870 PARTNERSHIP. 1045 00:46:19,870 --> 00:46:22,539 NOT ONLY WAS THE OUTPUT IN TERMS 1046 00:46:22,539 --> 00:46:25,776 OF THE UAs AND TEST CAPACITY 1047 00:46:25,776 --> 00:46:28,412 INCREASE WERE DRAMATIC WE 1048 00:46:28,412 --> 00:46:30,247 THROUGH CLOSE COLLABORATION 1049 00:46:30,247 --> 00:46:30,814 INFLUENCED FDA POLICY AND 1050 00:46:30,814 --> 00:46:33,383 THERE'S A NUMBER OF CHANGES THAT 1051 00:46:33,383 --> 00:46:33,650 OCCURRED. 1052 00:46:33,650 --> 00:46:35,419 I WON'T GO INTO DETAILS. 1053 00:46:35,419 --> 00:46:37,921 THE BIGGEST WAS THE SERIAL 1054 00:46:37,921 --> 00:46:38,688 TESTING AUTHORIZATION. 1055 00:46:38,688 --> 00:46:41,758 THE FULL LABELLING OF TESTS FOR 1056 00:46:41,758 --> 00:46:46,830 SERIAL TESTS WHICH CAME AS A 1057 00:46:46,830 --> 00:46:49,766 RESULT OF THE YOU MASS STUDIES 1058 00:46:49,766 --> 00:46:54,070 THAT SHOWED MULTIPLE TESTS OVER 1059 00:46:54,070 --> 00:46:59,910 A PERIOD OF TIME 2 AND 48 HOURS 1060 00:46:59,910 --> 00:47:02,612 ARE AS GOOD AS NUCLEIC ACID TEST 1061 00:47:02,612 --> 00:47:03,647 AND THIS IS CRITICAL IN 1062 00:47:03,647 --> 00:47:12,289 INFORMING THE PUBLIC. 1063 00:47:12,289 --> 00:47:14,191 WHEN FDA CHANGED POLICY WITHOUT 1064 00:47:14,191 --> 00:47:14,891 TALKING TO US. 1065 00:47:14,891 --> 00:47:18,628 FOR EXAMPLE, THEY SENT A NOTICE 1066 00:47:18,628 --> 00:47:21,965 WE HAD TO SWITCH FROM NASAL WASH 1067 00:47:21,965 --> 00:47:26,336 YOU COULD BUY IT RELATIVELY 1068 00:47:26,336 --> 00:47:27,304 INEXPENSIVELY TO NASAL SWAB 1069 00:47:27,304 --> 00:47:29,306 MATRIX FOR THE STUDIES, THAT 1070 00:47:29,306 --> 00:47:30,807 SENT EVERYONE INTO A TIZZY 1071 00:47:30,807 --> 00:47:34,544 BECAUSE THAT STUFF IS $100 PER 1072 00:47:34,544 --> 00:47:35,212 MIL. 1073 00:47:35,212 --> 00:47:38,815 INCREDIBLY EXPENSIVE AND EMORY 1074 00:47:38,815 --> 00:47:41,251 ROLLED UP THEIR SLEEVES. 1075 00:47:41,251 --> 00:47:44,754 EVERYONE GAVE NASAL SWAB AT THE 1076 00:47:44,754 --> 00:47:49,292 OFFICE AND BASICALLY SIX LITERS 1077 00:47:49,292 --> 00:47:52,462 OF NASAL SWAB MATRIX WERE 1078 00:47:52,462 --> 00:47:53,463 PRODUCED AND SHOWS THE 1079 00:47:53,463 --> 00:47:54,731 COMMITMENT AND DEDICATION OF THE 1080 00:47:54,731 --> 00:47:54,965 NETWORK. 1081 00:47:54,965 --> 00:48:05,642 THANK YOU, EMORY FOR DOING THIS. 1082 00:48:05,642 --> 00:48:12,782 IS THAT SAVED US ABOUT $600,000. 1083 00:48:12,782 --> 00:48:20,323 AS I ED -- SAID, HERE'S SOME 1084 00:48:20,323 --> 00:48:21,057 PROJECTS ONGOING. 1085 00:48:21,057 --> 00:48:24,194 DR. BERTAGNOLLI MENTIONED SOME. 1086 00:48:24,194 --> 00:48:28,365 WE HAVE MULTIPLEXED HIGH 1087 00:48:28,365 --> 00:48:32,802 PERFORMANCE TESTS AND WE HAVE 1088 00:48:32,802 --> 00:48:37,841 STD TESTS, HIV AND VIRAL LOAD 1089 00:48:37,841 --> 00:48:40,710 AND HEP C TESTS BEING ADVANCED 1090 00:48:40,710 --> 00:48:41,945 AND FETAL MONITORING 1091 00:48:41,945 --> 00:48:42,279 TECHNOLOGIES. 1092 00:48:42,279 --> 00:48:44,481 NOT JUST INFECTIOUS DISEASES BUT 1093 00:48:44,481 --> 00:48:46,983 ALSO A VARIETY OF OTHER PROBLEMS 1094 00:48:46,983 --> 00:48:47,951 THAT CAN BE ADDRESSED 1095 00:48:47,951 --> 00:48:49,052 POINT-OF-CARE TECHNOLOGIES THAT 1096 00:48:49,052 --> 00:48:51,054 ALL OF YOU ARE PASSIONATE ABOUT. 1097 00:48:51,054 --> 00:49:01,498 I'LL SHOW QUICK EXAMPLES. 1098 00:49:08,438 --> 00:49:10,006 AND THESE ARE THE ABILITY TO 1099 00:49:10,006 --> 00:49:11,207 SENSE WHAT'S HAPPENING IN THE 1100 00:49:11,207 --> 00:49:15,979 BRAIN THROUGH OPTICAL IMAGING 1101 00:49:15,979 --> 00:49:17,581 APPROACHES INTEGRATED INTO A 1102 00:49:17,581 --> 00:49:18,381 SINGLE WEARABLE DEVICE. 1103 00:49:18,381 --> 00:49:20,750 IT'S BEEN SUPPORTED THROUGH THE 1104 00:49:20,750 --> 00:49:23,186 BLUEPRINT MED TECH PROGRAM WHICH 1105 00:49:23,186 --> 00:49:25,755 IS A CONSORTIUM OF 12 NIH 1106 00:49:25,755 --> 00:49:27,223 CENTERS COMING TOGETHER, 1107 00:49:27,223 --> 00:49:29,492 GATHERING AROUND THE CONCEPT 1108 00:49:29,492 --> 00:49:30,760 THROUGH SOME VERY PERSUASIVE 1109 00:49:30,760 --> 00:49:34,631 PROGRAM DIRECTORS WHO HAVE BEEN 1110 00:49:34,631 --> 00:49:35,298 ABLE TO CONVINCE THE NIH CENTERS 1111 00:49:35,298 --> 00:49:36,766 IT'S A GOOD WAY TO ADVANCE 1112 00:49:36,766 --> 00:49:37,200 TECHNOLOGIES. 1113 00:49:37,200 --> 00:49:39,035 ANOTHER ONE SUPPORTED BY THE 1114 00:49:39,035 --> 00:49:41,671 HEAL INITIATIVE IS A 1115 00:49:41,671 --> 00:49:45,809 NON-INVASIVE, NON-ADDICTIVE 1116 00:49:45,809 --> 00:49:48,778 ULTRASOUND TREATMENT FOR 1117 00:49:48,778 --> 00:49:49,779 NEUROPATHIC TREATMENT AND 1118 00:49:49,779 --> 00:49:50,747 ULTRASOUND AND INDIVIDUALS CAN 1119 00:49:50,747 --> 00:49:55,518 DRIVE THIS AT HOME. 1120 00:49:55,518 --> 00:49:59,055 WE HAVE THE RADX MATERNAL HEALTH 1121 00:49:59,055 --> 00:50:03,326 PROGRAM WITH 10 SEMI FINALISTS 1122 00:50:03,326 --> 00:50:06,196 BEING EVALUATED FROM ANEMIA TO 1123 00:50:06,196 --> 00:50:07,564 CONTINUOUS BLOOD PRESSURE 1124 00:50:07,564 --> 00:50:10,767 MONITORING, HEMORRHAGE AND 1125 00:50:10,767 --> 00:50:13,436 RESUSCITATION AND POINT-OF-CARE 1126 00:50:13,436 --> 00:50:17,073 UTI DIAGNOSTICS AND MHEALTH, 1127 00:50:17,073 --> 00:50:18,842 MENTAL HEALTH EVALUATIONS USING 1128 00:50:18,842 --> 00:50:20,343 DIGITAL HEALTH PLATFORMS. 1129 00:50:20,343 --> 00:50:22,379 A BEAUTIFUL RANGE OF REALLY 1130 00:50:22,379 --> 00:50:23,947 POTENTIALLY VERY EXCITING 1131 00:50:23,947 --> 00:50:30,920 TECHNOLOGIES. 1132 00:50:30,920 --> 00:50:32,622 THIS IS A TIPPING POINT IN SOME 1133 00:50:32,622 --> 00:50:32,789 WAY. 1134 00:50:32,789 --> 00:50:35,592 WE'VE GOTTEN THE ATTENTION OF 1135 00:50:35,592 --> 00:50:37,027 MANY COMMUNITIES TRADITIONAL 1136 00:50:37,027 --> 00:50:39,729 COMMUNITIES WHICH WOULD NOT 1137 00:50:39,729 --> 00:50:41,364 NORMALLY GRAVITATE TO 1138 00:50:41,364 --> 00:50:42,766 POINT-OF-CARE AND AT-HOME 1139 00:50:42,766 --> 00:50:43,466 DIAGNOSTICS. 1140 00:50:43,466 --> 00:50:47,971 THEY'RE PAYING ATTENTION. 1141 00:50:47,971 --> 00:50:49,205 THE NIH DIRECTOR IS PAYING 1142 00:50:49,205 --> 00:50:50,473 ATTENTION AND COLLEAGUES ARE 1143 00:50:50,473 --> 00:50:50,807 EXCITED. 1144 00:50:50,807 --> 00:50:52,575 THIS IS WHERE I TOSS THE BALL 1145 00:50:52,575 --> 00:50:54,044 BACK INTO YOUR COURT. 1146 00:50:54,044 --> 00:50:58,181 HERE THE PROJECTIONS WE SEE FROM 1147 00:50:58,181 --> 00:50:58,648 INDUSTRY. 1148 00:50:58,648 --> 00:51:00,817 CONSUMERS AT HOME AND AT THE 1149 00:51:00,817 --> 00:51:02,786 POINT-OF-CARE, THEY'RE THE NEW 1150 00:51:02,786 --> 00:51:03,019 TARGETS. 1151 00:51:03,019 --> 00:51:06,723 THE NEW MARKET FOR DIAGNOSTICS. 1152 00:51:06,723 --> 00:51:09,793 IT'S BOTH A LUCRATIVE MARKET AS 1153 00:51:09,793 --> 00:51:11,161 WELL AS AN IMPORTANT AND 1154 00:51:11,161 --> 00:51:13,029 COMPELLING PUBLIC HEALTH NEED. 1155 00:51:13,029 --> 00:51:14,197 WE'RE SEEING THE CONVERGENCE OF 1156 00:51:14,197 --> 00:51:17,200 THE TWO AND THE TECHNOLOGIES 1157 00:51:17,200 --> 00:51:19,102 THEMSELVES HAVE MOVED TO A PRICE 1158 00:51:19,102 --> 00:51:20,637 POINT WHERE IT'S POSSIBLE THAT 1159 00:51:20,637 --> 00:51:23,573 THIS CAN IMPROVE ACCESS AND 1160 00:51:23,573 --> 00:51:25,208 OUTCOMES FOR MANY MANY PEOPLE. 1161 00:51:25,208 --> 00:51:29,846 SO WE SEE THIS PROJECTED GROWTH. 1162 00:51:29,846 --> 00:51:32,315 WE SEE WE'VE INVESTED IN THANK 1163 00:51:32,315 --> 00:51:33,650 YOU PLATFORMS WITH THE RADX 1164 00:51:33,650 --> 00:51:41,491 PROGRAM THAT CAN BE LEVERAGED 1165 00:51:41,491 --> 00:51:46,563 AND WE'VE SEEN A REMARKABLE 1166 00:51:46,563 --> 00:51:49,232 EXPANSION OF TELEHEALTH AND THAT 1167 00:51:49,232 --> 00:51:52,569 CAN BE BETTER AND DOCTORS CAN 1168 00:51:52,569 --> 00:51:54,571 RELY ON VOICE A BIT BUT 1169 00:51:54,571 --> 00:51:56,773 ULTIMATELY YOU WANT TO MAKE SOME 1170 00:51:56,773 --> 00:51:58,074 MEASUREMENTS WITH A HIGH DEGREE 1171 00:51:58,074 --> 00:51:59,909 OF RELIABILITY AND 1172 00:51:59,909 --> 00:52:00,276 STANDARDIZATION. 1173 00:52:00,276 --> 00:52:03,046 WE CAN EXTEND THIS TO OTHER 1174 00:52:03,046 --> 00:52:04,447 PATHOGENS AND CHRONIC DISEASES. 1175 00:52:04,447 --> 00:52:09,986 THE BIG CHALLENGE BACK TO ALL OF 1176 00:52:09,986 --> 00:52:12,889 YOU, HI IT MANAGE THE EXPLOSION 1177 00:52:12,889 --> 00:52:15,425 OF DIAGNOSTICS AND USE THE TESTS 1178 00:52:15,425 --> 00:52:22,899 ACCURATELY, REPORT THEM RELIABLY 1179 00:52:22,899 --> 00:52:27,003 STANDARDIZE THEM AND INTERPRET 1180 00:52:27,003 --> 00:52:29,873 OVERWHELMING NUMBERS LIKE THE 1181 00:52:29,873 --> 00:52:33,143 BILLION WE SAW DISTRIBUTES IN 1182 00:52:33,143 --> 00:52:33,409 FEBRUARY. 1183 00:52:33,409 --> 00:52:35,111 WE'LL STOP THERE AND I DON'T 1184 00:52:35,111 --> 00:52:36,012 KNOW IF WE HAVE TIME FOR 1185 00:52:36,012 --> 00:52:38,915 QUESTIONS BUT I'M HANGING OUT 1186 00:52:38,915 --> 00:52:41,184 AND SCHMOOZING OVER THE NEXT FEW 1187 00:52:41,184 --> 00:52:41,384 HOURS. 1188 00:52:41,384 --> 00:52:51,728 THANK YOU VERY MUCH. 1189 00:53:05,341 --> 00:53:07,110 I THINK ON ZOOM WE'D SAY IF 1190 00:53:07,110 --> 00:53:08,912 THERE'S NO FURTHER QUESTIONS. 1191 00:53:08,912 --> 00:53:09,779 WE ARE ON ZOOM. 1192 00:53:09,779 --> 00:53:11,181 SO I'LL BE AROUND. 1193 00:53:11,181 --> 00:53:13,316 THANK YOU ALL VERY MUCH FOR YOUR 1194 00:53:13,316 --> 00:53:14,350 WORK AND THANK YOU FOR COMING. 1195 00:53:14,350 --> 00:53:18,755 AND I LOOK FORWARD TO CATCHING 1196 00:53:18,755 --> 00:53:29,065 UP WITH EVERYONE. 1197 00:53:35,605 --> 00:53:39,175 >> SO NOW THE FUN BEGINS WITH 1198 00:53:39,175 --> 00:53:41,578 WELL, WE'D LIKE TO THANK SOME 1199 00:53:41,578 --> 00:53:44,547 CERTAIN PEOPLE BEFORE WE GET 1200 00:53:44,547 --> 00:53:45,248 STARTED INTO THE PROGRAM A 1201 00:53:45,248 --> 00:53:46,916 LITTLE FURTHER. 1202 00:53:46,916 --> 00:53:48,551 IF YOU ARE PART OF THE 1203 00:53:48,551 --> 00:53:49,118 ORGANIZATION TEAM, CAN YOU 1204 00:53:49,118 --> 00:53:59,395 PLEASE STAND UP? 1205 00:54:03,700 --> 00:54:05,668 SO THERE'S BEEN A LOT OF HARD 1206 00:54:05,668 --> 00:54:07,437 WORK IN GETTING EVERYBODY TO 1207 00:54:07,437 --> 00:54:11,407 THIS POINT OF THE PROGRAM AND 1208 00:54:11,407 --> 00:54:13,309 WE'D LIKE TO THANK THE PEOPLE 1209 00:54:13,309 --> 00:54:14,711 PART OF THIS OPERATION HERE. 1210 00:54:14,711 --> 00:54:16,079 SO WITHOUT FURTHER ADO, WE'RE 1211 00:54:16,079 --> 00:54:19,148 GOING TO GET STARTED WITH OUR 1212 00:54:19,148 --> 00:54:21,251 FIRST DISTINGUISHED PANEL. 1213 00:54:21,251 --> 00:54:28,224 IT'S LED BY DAVID McMANUS ON POC 1214 00:54:28,224 --> 00:54:29,792 TECHNOLOGIES AND PERSPECTIVES 1215 00:54:29,792 --> 00:54:30,894 AND CHALLENGES. 1216 00:54:30,894 --> 00:54:32,428 IF YOUR PART OF THIS PANEL, CAN 1217 00:54:32,428 --> 00:54:42,839 YOU PLEASE COME UP NOW. 1218 00:55:11,734 --> 00:55:13,937 >> GOOD MORNING AND WHAT A 1219 00:55:13,937 --> 00:55:16,572 WONDERFUL PRIVILEGE IT IS TOON 1220 00:55:16,572 --> 00:55:18,574 YOU ON THE CAMPUS TO A GREAT 1221 00:55:18,574 --> 00:55:23,980 KICKOFF AND CONNECT WITH PEOPLE. 1222 00:55:23,980 --> 00:55:26,482 I'M STRUCK BY MANY THINGS 1223 00:55:26,482 --> 00:55:36,993 INCLUDING HOW TALL HE IS AND 1224 00:55:39,495 --> 00:55:41,798 THERE'S SEVERAL SESSIONS AND 1225 00:55:41,798 --> 00:55:44,600 GIVE THE AUDIENCE PERSPECTIVES 1226 00:55:44,600 --> 00:55:45,768 ON DIFFERENT STAKEHOLDER GROUPS. 1227 00:55:45,768 --> 00:55:48,771 WE'RE REALLY GRITFUL FOR THE 1228 00:55:48,771 --> 00:55:50,340 OPPORTUNITY TO DISCUSS -- 1229 00:55:50,340 --> 00:55:51,741 GRATEFUL TO FOR THE OPPORTUNITY 1230 00:55:51,741 --> 00:55:53,176 TO DISCUSS CLINICAL 1231 00:55:53,176 --> 00:55:53,576 PERSPECTIVES. 1232 00:55:53,576 --> 00:55:56,646 IT MEANS BOTH NURSING, 1233 00:55:56,646 --> 00:55:59,382 PHYSICIAN, MEDICAL ASSISTANT AND 1234 00:55:59,382 --> 00:56:00,717 PERSONNEL BOTH PHYSICIANS AND 1235 00:56:00,717 --> 00:56:03,052 OTHER GROUPS AND WE PUT TOGETHER 1236 00:56:03,052 --> 00:56:06,289 A PANEL TO DISCUSS THAT A LITTLE 1237 00:56:06,289 --> 00:56:08,358 BIT FOR A VARIETY OF REASONS 1238 00:56:08,358 --> 00:56:11,294 DECIDED TO AVOID SLIDES AND 1239 00:56:11,294 --> 00:56:13,363 INSTEAD WE'LL KEEP THIS 1240 00:56:13,363 --> 00:56:13,730 CONVERSATIONAL. 1241 00:56:13,730 --> 00:56:21,170 I'LL KICK OFF BY ASKING DR. NATE 1242 00:56:21,170 --> 00:56:23,272 HEYFUR AND LED AS PART OF OUR 1243 00:56:23,272 --> 00:56:24,073 POCTRN NEEDS ASSESSMENT TO 1244 00:56:24,073 --> 00:56:25,475 DISCUSS SOME OF THE PERSPECTIVES 1245 00:56:25,475 --> 00:56:27,377 THAT THEY'VE ASCERTAINED BACK 1246 00:56:27,377 --> 00:56:30,279 FROM PHYSICIANS, NURSES AND 1247 00:56:30,279 --> 00:56:35,685 MEDICAL PROFESSIONALS 1248 00:56:35,685 --> 00:56:35,985 PARAMEDICS. 1249 00:56:35,985 --> 00:56:36,853 WHAT ARE CURRENT PERSPECTIVES ON 1250 00:56:36,853 --> 00:56:39,055 THE POSITIVE AND SOME CHALLENGES 1251 00:56:39,055 --> 00:56:41,324 AND PLEASE, HELP US KICK OFF 1252 00:56:41,324 --> 00:56:43,459 WITH A VARIETY OF PIECES OF 1253 00:56:43,459 --> 00:56:45,261 INFORMATION THAT ARE RELEVANT. 1254 00:56:45,261 --> 00:56:45,628 THANK YOU. 1255 00:56:45,628 --> 00:56:49,232 >> THANK YOU, DAVE AND HAPPY TO 1256 00:56:49,232 --> 00:56:49,665 BE HERE TODAY. 1257 00:56:49,665 --> 00:56:51,834 AS DAVE MENTIONED ONE OF OUR 1258 00:56:51,834 --> 00:56:56,606 CHARGES IS TO REALLY UNDERSTAND 1259 00:56:56,606 --> 00:56:57,940 THE NEEDS CLINICIANS AND 1260 00:56:57,940 --> 00:57:00,543 PATIENTS AS WE DEVELOP NEW 1261 00:57:00,543 --> 00:57:00,877 TECHNOLOGIES. 1262 00:57:00,877 --> 00:57:01,811 WE TOOK THAT CHALLENGE HEAD ON 1263 00:57:01,811 --> 00:57:05,348 AND HAVE BEEN OVER THE LAST FIVE 1264 00:57:05,348 --> 00:57:10,453 YEARS PUTTING OUT ANNUAL CALLS 1265 00:57:10,453 --> 00:57:17,326 TO OUR DIFFERENT COMMUNITYIES W 1266 00:57:17,326 --> 00:57:18,327 E-MAILED OUT PEOPLE IN THE 1267 00:57:18,327 --> 00:57:20,263 AUDIENCE AND OTHER FOLKS TO GET 1268 00:57:20,263 --> 00:57:20,663 THEIR PERSPECTIVE. 1269 00:57:20,663 --> 00:57:26,569 WE HAD RESPONDENTS FROM NEARLY 1270 00:57:26,569 --> 00:57:30,940 ALL 50 STATES HAVE BEEN HAPPY 1271 00:57:30,940 --> 00:57:33,910 WITH A BROAD PERSPECTIVE OF 1272 00:57:33,910 --> 00:57:36,712 CLINICIANS AND NOT JUST M.D.s 1273 00:57:36,712 --> 00:57:37,914 AND ADVANCE PRACTICE NURSES AND 1274 00:57:37,914 --> 00:57:44,087 OTHER TYPES OF PEOPLE REALLY 1275 00:57:44,087 --> 00:57:45,555 THOSE DELIVERING CARE AND WILL 1276 00:57:45,555 --> 00:57:47,957 BE IMPORTANT IN DELIVERING CARE 1277 00:57:47,957 --> 00:57:52,628 IN THE FUTURE. 1278 00:57:52,628 --> 00:57:53,863 PUSH HEALTH CARE OUT IT PEOPLE 1279 00:57:53,863 --> 00:57:58,067 AT THEIR HOMES OR THEIR PHARMACY 1280 00:57:58,067 --> 00:57:58,968 OR NON-TRADITIONAL CLINICAL 1281 00:57:58,968 --> 00:58:02,972 SITES. 1282 00:58:02,972 --> 00:58:06,776 WE'VE DONE THESE SURVEYS A 1283 00:58:06,776 --> 00:58:09,078 NUMBER OF YEARS. 1284 00:58:09,078 --> 00:58:12,782 WE'VE SEEN THE CHARACTERISTIC OF 1285 00:58:12,782 --> 00:58:15,184 THE TECHNOLOGY MOST IMPORTANT 1286 00:58:15,184 --> 00:58:21,491 ARE EASE OF USE, NOT DISRUPTING 1287 00:58:21,491 --> 00:58:31,968 WORK FLOW INTUITIVE TO USE. 1288 00:58:34,737 --> 00:58:39,041 THESE MAY NOT BE SHOCKERS BUT 1289 00:58:39,041 --> 00:58:40,810 IT'S GOOD TO GET FEEDBACK FROM 1290 00:58:40,810 --> 00:58:41,944 THE COMMUNITY IN WHAT PEOPLE ARE 1291 00:58:41,944 --> 00:58:43,112 LOOKING FOR AS THEY USE THE 1292 00:58:43,112 --> 00:58:44,547 TECHNOLOGIES ON THE FRONT LINES. 1293 00:58:44,547 --> 00:58:45,648 WE'RE TAKING THE INFORMATION 1294 00:58:45,648 --> 00:58:48,451 WE'RE GATHERING FROM THE SURVEYS 1295 00:58:48,451 --> 00:58:51,187 AND REFLECTING THEM BACK TO THE 1296 00:58:51,187 --> 00:58:53,256 DEVELOPER COMMUNITY AS WE PUT 1297 00:58:53,256 --> 00:58:58,928 OUT OUR CALLS FOR PROPOSALS AND 1298 00:58:58,928 --> 00:59:00,730 SAY WE WANT YOU IN YOUR 1299 00:59:00,730 --> 00:59:02,798 APPLICATION TO TALK ABOUT HOW 1300 00:59:02,798 --> 00:59:05,067 EASY YOUR TECHNOLOGY USES AND 1301 00:59:05,067 --> 00:59:10,306 DOESN'T RESULT THE CURRENT WORK 1302 00:59:10,306 --> 00:59:10,806 FLOW. 1303 00:59:10,806 --> 00:59:11,240 THAT'S OTHER 1304 00:59:11,240 --> 00:59:14,277 AS WE DEVELOP THE SURVEYS AND 1305 00:59:14,277 --> 00:59:20,082 LIKE WE HEARD THIS MORNING, 1306 00:59:20,082 --> 00:59:25,621 DEVELOPING TECHNOLOGYIES THAT 1307 00:59:25,621 --> 00:59:26,722 PEOPLE WANT BACK AND FORTH TO 1308 00:59:26,722 --> 00:59:27,557 MAKE SURE WE'RE DEVELOPING 1309 00:59:27,557 --> 00:59:32,361 THINGS THAT HAVE THE MOST VALUE. 1310 00:59:32,361 --> 00:59:38,935 >> THANK YOU. 1311 00:59:38,935 --> 00:59:41,304 >> IT'S NOT JUST GOOD AT THE 1312 00:59:41,304 --> 00:59:42,371 PATIENT HEALTH LEVEL BUT LOWER 1313 00:59:42,371 --> 00:59:43,739 HEALTH CARE COSTS. 1314 00:59:43,739 --> 00:59:44,941 THAT HASN'T HAPPENED IN MY 1315 00:59:44,941 --> 00:59:46,142 HEALTH CARE SYSTEM YET. 1316 00:59:46,142 --> 00:59:48,411 IN FACT ONE OF THE PAIN POINTS 1317 00:59:48,411 --> 00:59:50,279 IDENTIFIED BY CLINICIANS IN THE 1318 00:59:50,279 --> 00:59:51,080 NEGATIVE WAS CONCERN OVER 1319 00:59:51,080 --> 00:59:52,982 DISRUPTION OF THEIR WORK FLOW, 1320 00:59:52,982 --> 00:59:55,218 ADDED WORK AND ADDED IN-BASKET 1321 00:59:55,218 --> 00:59:56,786 MESSAGE, LACK OF DATA THEY COULD 1322 00:59:56,786 --> 00:59:58,254 USE TO MAKE A TREATMENT 1323 00:59:58,254 --> 00:59:58,821 DECISION. 1324 00:59:58,821 --> 01:00:05,828 COULD YOU HIGHLIGHT SOME OF THE 1325 01:00:05,828 --> 01:00:10,666 CONCERNS DR. LILLY, AND IN A 1326 01:00:10,666 --> 01:00:12,368 MOMENT WE'LL ASK DR. MANABE TO 1327 01:00:12,368 --> 01:00:17,840 TALK ABOUT THE INFECTIOUS 1328 01:00:17,840 --> 01:00:24,947 DISEASE CHALLENGES. 1329 01:00:24,947 --> 01:00:27,149 >> I WAS HONORED TO WORK WITH 1330 01:00:27,149 --> 01:00:31,187 NATE AND WE SELECTED A VERY 1331 01:00:31,187 --> 01:00:32,521 DIVERSE GROUP OF FOCUS GROUPS TO 1332 01:00:32,521 --> 01:00:33,656 MAKE SURE THE INSTRUMENT WE'RE 1333 01:00:33,656 --> 01:00:35,958 USING TO GATHER THE INFORMATION 1334 01:00:35,958 --> 01:00:39,295 WAS DOING SO ACCURATELY AND 1335 01:00:39,295 --> 01:00:40,096 ACCESSIBLE REGARDLESS OF 1336 01:00:40,096 --> 01:00:42,765 EDUCATIONAL LEVEL AND OTHER 1337 01:00:42,765 --> 01:00:43,132 BARRIERS. 1338 01:00:43,132 --> 01:00:45,568 SO EVERY YEAR HAVE DEPLOYED THE 1339 01:00:45,568 --> 01:00:46,035 SURVEYS. 1340 01:00:46,035 --> 01:00:48,537 WE HAVE LONGITUDINAL DATA AND 1341 01:00:48,537 --> 01:00:49,572 WHAT'S REALLY IMPORTANT AND 1342 01:00:49,572 --> 01:00:53,709 CONSISTENT ACROSS THE YEARS. 1343 01:00:53,709 --> 01:00:56,279 WHERE WE STARTED WAS WITH KEY 1344 01:00:56,279 --> 01:00:59,115 TECHNICAL ASPECTS WHICH ARE 1345 01:00:59,115 --> 01:01:01,717 ACCURACY. 1346 01:01:01,717 --> 01:01:03,286 THE GENERAL PUBLIC WANTS 1347 01:01:03,286 --> 01:01:05,554 ACCURATE TESTS BECAUSE THEY WANT 1348 01:01:05,554 --> 01:01:14,330 TO USE THEM FOR SELF-CARE. 1349 01:01:14,330 --> 01:01:16,165 ACCURACY MATTERS THAT BRUCE WAS 1350 01:01:16,165 --> 01:01:26,042 TALKING ABOUT EARLIER. 1351 01:01:26,042 --> 01:01:28,010 WE STARTED TO SEE PATIENTS WERE 1352 01:01:28,010 --> 01:01:30,479 TALKING ABOUT WANTING ACCESS TO 1353 01:01:30,479 --> 01:01:35,785 THE TEST AND WHO PAID FOR THEM 1354 01:01:35,785 --> 01:01:46,295 WAS INCREASINGLY IMPORTANT WE 1355 01:01:47,396 --> 01:01:49,965 WENT FROM MODEST LEVELS TO 1356 01:01:49,965 --> 01:01:51,534 PENETRATION AND WITH THAT IT 1357 01:01:51,534 --> 01:01:52,702 BECAME INCREASINGLY IMPORTANT 1358 01:01:52,702 --> 01:01:54,337 FOR PEOPLE TO BE ABLE TO AFFORD 1359 01:01:54,337 --> 01:01:54,670 THE TESTING. 1360 01:01:54,670 --> 01:01:56,339 THE OTHER THING WE FOUND IN THE 1361 01:01:56,339 --> 01:02:00,443 SURVEY WAS EASE OF USE. 1362 01:02:00,443 --> 01:02:01,344 IT'S IMPORTANT. 1363 01:02:01,344 --> 01:02:03,112 AND TALKING EARLIER ABOUT NEW 1364 01:02:03,112 --> 01:02:05,548 CHEMISTRY SETS AND WHATNOT. 1365 01:02:05,548 --> 01:02:07,116 THE TESTS HAVE TO BE EASY TO DO 1366 01:02:07,116 --> 01:02:12,388 AND IMPORTANTLY AND THIS IS 1367 01:02:12,388 --> 01:02:15,958 DIFFERENT THAN THE CLINICIAN 1368 01:02:15,958 --> 01:02:20,329 INFORMATION SIMPLE THINGS THAT 1369 01:02:20,329 --> 01:02:21,430 MAKING SURE WHEN YOU PRESENT THE 1370 01:02:21,430 --> 01:02:23,733 TEST RESULTS YOU DO IT IN MORE 1371 01:02:23,733 --> 01:02:24,834 THAN ONE LANGUAGE WAS IMPORTANT 1372 01:02:24,834 --> 01:02:27,503 TO THE PUBLIC. 1373 01:02:27,503 --> 01:02:29,038 SO I WANTED TO CLOSE WITH OUR 1374 01:02:29,038 --> 01:02:31,140 NUMBER ONE THING WHICH I THINK 1375 01:02:31,140 --> 01:02:33,209 IS SOMETHING I HOLD CLOSE TO MY 1376 01:02:33,209 --> 01:02:33,442 HEART. 1377 01:02:33,442 --> 01:02:34,844 WHEN WE SENT OUT THE FIRST 1378 01:02:34,844 --> 01:02:38,848 SURVEY I WASN'T SURE THE PUBLIC 1379 01:02:38,848 --> 01:02:39,982 WON'T LIKE POINT OF CARE TESTING 1380 01:02:39,982 --> 01:02:41,217 OR THOUGHT ABOUT WHAT WE WERE 1381 01:02:41,217 --> 01:02:42,785 DOING WAS A WASTE OF TIME. 1382 01:02:42,785 --> 01:02:44,854 THE 92% THE HIGHEST LEVEL OF 1383 01:02:44,854 --> 01:02:46,555 AGREEMENT OR EACH OF THESE ITEMS 1384 01:02:46,555 --> 01:02:49,125 YOU CAN AGREE OR DISAGREE AND 1385 01:02:49,125 --> 01:02:56,132 THERE'S A SCALE AND 92% FELT THE 1386 01:02:56,132 --> 01:02:56,699 INNOVATIVE PROGRAMS AT NIH 1387 01:02:56,699 --> 01:03:06,041 IMPROVED THEIR HEALTH. 1388 01:03:06,041 --> 01:03:08,244 >> WILL GIVEN YOUR EXPERTISE AS 1389 01:03:08,244 --> 01:03:11,180 AN INFECTIOUS DISEASE SPECIALIST 1390 01:03:11,180 --> 01:03:13,048 AND RESEARCHERS, WHAT DO YOU SEE 1391 01:03:13,048 --> 01:03:14,016 IN TERMS OF THE I.D. SPACE. 1392 01:03:14,016 --> 01:03:15,985 IN ADDITION TO SOME OF THE 1393 01:03:15,985 --> 01:03:17,720 CHALLENGES IN HEART AND 1394 01:03:17,720 --> 01:03:18,821 VASCULAR, THERE'S A STIGMA 1395 01:03:18,821 --> 01:03:20,823 ASSOCIATED IN SOME CASES AND 1396 01:03:20,823 --> 01:03:22,691 SOCIAL ELEMENTS WITH INFECTIOUS 1397 01:03:22,691 --> 01:03:24,794 DISEASES THAT ADDS A FURTHER 1398 01:03:24,794 --> 01:03:28,664 WRINKLE TO A PATIENT DOESN'T 1399 01:03:28,664 --> 01:03:31,066 WANT TO KNOW AND MAY NOT BE 1400 01:03:31,066 --> 01:03:32,802 COMFORTABLE SHARING THAT WITH 1401 01:03:32,802 --> 01:03:33,068 CLINICIAN. 1402 01:03:33,068 --> 01:03:36,238 WHERE DO YOU SEE OPPORTUNITY AND 1403 01:03:36,238 --> 01:03:38,407 CHALLENGES FOR POINT OF CARE OF 1404 01:03:38,407 --> 01:03:40,342 THE CLINICAL PERSPECTIVE OF I.D. 1405 01:03:40,342 --> 01:03:40,876 >> THANK YOU. 1406 01:03:40,876 --> 01:03:46,182 IT'S NICE TO BE A MEMBER OF THE 1407 01:03:46,182 --> 01:03:47,817 U-MASS CREW AND LOVELY TO WORK 1408 01:03:47,817 --> 01:03:52,621 WITH SO MANY IN THE AUDIENCE. 1409 01:03:52,621 --> 01:03:54,957 IT'S A GREAT MEETING. 1410 01:03:54,957 --> 01:04:02,298 IT'S A YIN AND YANG AND YOU NEED 1411 01:04:02,298 --> 01:04:05,067 HIGH SPECIFICITY TEST TO NOT 1412 01:04:05,067 --> 01:04:10,172 LOSE THE PUBLIC'S TRUST AND A 1413 01:04:10,172 --> 01:04:11,373 TEST NOT DONE HAS ZERO PERCENT 1414 01:04:11,373 --> 01:04:13,976 SENSITIVITY AND WE'VE COME UP 1415 01:04:13,976 --> 01:04:15,978 WITH THAT IN HIV, HEALTH OR 1416 01:04:15,978 --> 01:04:17,713 INFECTIOUS DISEASES WHERE 1417 01:04:17,713 --> 01:04:19,081 THERE'S GREAT STIGMA ASSOCIATED 1418 01:04:19,081 --> 01:04:20,850 PARTICULARLY IF THERE IS NO 1419 01:04:20,850 --> 01:04:21,851 CURATIVE THERAPY. 1420 01:04:21,851 --> 01:04:23,152 IT'S IMPORTANT TO THINK ABOUT 1421 01:04:23,152 --> 01:04:23,352 THAT. 1422 01:04:23,352 --> 01:04:24,720 THE OTHER AREA WHERE THERE'S A 1423 01:04:24,720 --> 01:04:29,058 YIN AND YANG IS IMPACT. 1424 01:04:29,058 --> 01:04:30,359 A DIAGNOSTIC TEST IS ONLY AS 1425 01:04:30,359 --> 01:04:31,060 GOOD AS USED. 1426 01:04:31,060 --> 01:04:33,762 IF YOU DO THE TEST AND LINK TO 1427 01:04:33,762 --> 01:04:35,798 CARE, YOU MAY NOT HAVE ANY 1428 01:04:35,798 --> 01:04:36,832 IMPACT OF HAVING DONE THE TEST 1429 01:04:36,832 --> 01:04:37,566 AT ALL. 1430 01:04:37,566 --> 01:04:41,270 ON THE OTHER HAND, IF YOU DON'T 1431 01:04:41,270 --> 01:04:44,073 AT LEAST KNOW YOUR STATUS IT'S 1432 01:04:44,073 --> 01:04:46,375 THE FIRST STEP IN THE CASCADE. 1433 01:04:46,375 --> 01:04:47,676 WOULDN'T YOU RATHER HAVE 1434 01:04:47,676 --> 01:04:48,811 SOMEBODY DO THE TEST AND MAYBE 1435 01:04:48,811 --> 01:04:50,279 YOU DO THAT IN THE FUTURE BUT AT 1436 01:04:50,279 --> 01:04:52,314 LEAST THEY HAVE AN OPPORTUNITY 1437 01:04:52,314 --> 01:04:53,883 TO KNOW WHERE THEY STAND WITH 1438 01:04:53,883 --> 01:04:57,953 MANY INFECTIOUS DISEASES AND 1439 01:04:57,953 --> 01:04:58,988 TRUE FOR HEPATITIS C AND HIV 1440 01:04:58,988 --> 01:05:02,858 WHERE THERE'S NO CURE AND FOR 1441 01:05:02,858 --> 01:05:05,995 CURATIVE ONE LIKE HEPATITIS C 1442 01:05:05,995 --> 01:05:09,899 AND STIs LIKE GONORRHEA AND 1443 01:05:09,899 --> 01:05:10,966 CHLAMYDIA AND AS A PHYSICIAN IF 1444 01:05:10,966 --> 01:05:13,068 YOU ASKED ME DO YOU WANT MORE 1445 01:05:13,068 --> 01:05:14,737 INFORMATION, ALL PHYSICIANS WILL 1446 01:05:14,737 --> 01:05:15,337 SAY YES. 1447 01:05:15,337 --> 01:05:17,306 THEY'RE NEVER GOING TO SAY, YOU 1448 01:05:17,306 --> 01:05:19,441 CAN KEEP THAT HIDDEN. 1449 01:05:19,441 --> 01:05:20,376 I'M NOT INTERESTED. 1450 01:05:20,376 --> 01:05:21,310 EVERYBODY WANTS MORE 1451 01:05:21,310 --> 01:05:22,411 INFORMATION. 1452 01:05:22,411 --> 01:05:23,679 IT'S VERY INTERESTING TO ME. 1453 01:05:23,679 --> 01:05:25,314 BUT PATIENTS DON'T ALWAYS WANT 1454 01:05:25,314 --> 01:05:30,386 TO KNOW SO WE TRY TESTING FOR 1455 01:05:30,386 --> 01:05:33,222 SYPHILIS AND HIV AT THE BALLS IN 1456 01:05:33,222 --> 01:05:35,157 BALTIMORE WHERE MANY MEN WHO 1457 01:05:35,157 --> 01:05:38,260 HAVE SEX WITH MEN WOULD GET 1458 01:05:38,260 --> 01:05:42,498 TOGETHER AND HAVE RAGING PART 1459 01:05:42,498 --> 01:05:47,536 YEAR AND WE THOUGHT WE'LL IS 1460 01:05:47,536 --> 01:05:51,240 HAVE A TABLE AND ON SYPHILIS BUT 1461 01:05:51,240 --> 01:05:54,043 NO ONE WANTED TO KNOW BEFORE 1462 01:05:54,043 --> 01:05:59,348 THEY GO PARTY AND WE COULD KNOW 1463 01:05:59,348 --> 01:06:02,017 AND NOT OVER USE ANTIBIOTICS AND 1464 01:06:02,017 --> 01:06:03,819 THOSE BALANCES ARE WHAT WE HAVE 1465 01:06:03,819 --> 01:06:05,154 IN MIND PARTICULARLY IN THE AREA 1466 01:06:05,154 --> 01:06:07,523 OF INFECTIOUS DISEASE AND FOR 1467 01:06:07,523 --> 01:06:08,791 THOSE OF US WHO CARE DEEPLY 1468 01:06:08,791 --> 01:06:11,627 ABOUT PUBLIC HEALTH. 1469 01:06:11,627 --> 01:06:15,397 >> THANK YOU, DR. MANABE. 1470 01:06:15,397 --> 01:06:16,565 I'VE SEEN IN POCTRN THE 1471 01:06:16,565 --> 01:06:17,232 IMPORTANCE OF PRESENTATION OF 1472 01:06:17,232 --> 01:06:18,567 DATA TO HAVE IMPACT. 1473 01:06:18,567 --> 01:06:20,302 IT'S NOT ENOUGH TO DO A TEST. 1474 01:06:20,302 --> 01:06:21,704 IT'S LIKE A TREE FALLING IN THE 1475 01:06:21,704 --> 01:06:22,938 FOREST WITH THE RESULT. 1476 01:06:22,938 --> 01:06:24,640 IT'S THE PERSON BEING THERE TO 1477 01:06:24,640 --> 01:06:26,308 WITNESS IT. 1478 01:06:26,308 --> 01:06:27,910 IT'S GETTING THE INFORMATION 1479 01:06:27,910 --> 01:06:29,845 INTO A HOSPITAL SYSTEM OR 1480 01:06:29,845 --> 01:06:40,022 CLINICIAN. 1481 01:06:46,795 --> 01:06:54,103 AND TRANSMISSAL OF IMPACT AND I 1482 01:06:54,103 --> 01:06:57,139 DON'T SEE A LOT OF POINT-OF-CARE 1483 01:06:57,139 --> 01:06:59,174 TESTS HAVING THAT 1484 01:06:59,174 --> 01:07:01,243 INTEROPERABILITY TO MY 1485 01:07:01,243 --> 01:07:02,144 ELECTRONIC HEALTH RECORDS TO SEE 1486 01:07:02,144 --> 01:07:03,078 OR USE A RESULT. 1487 01:07:03,078 --> 01:07:07,182 WHAT DO YOU SEE IN TERMS OF 1488 01:07:07,182 --> 01:07:09,084 CHALLENGES IN ACTIONABILITY OF 1489 01:07:09,084 --> 01:07:11,086 FINDINGS FROM A CLINICAL AND 1490 01:07:11,086 --> 01:07:12,588 HEALTH SYSTEMS PERSPECTIVE. 1491 01:07:12,588 --> 01:07:14,923 >> THANK YOU, DAVID. 1492 01:07:14,923 --> 01:07:16,525 ONE OF THE FIRST COMMENTS I HAD 1493 01:07:16,525 --> 01:07:19,395 RECEIVED AS I GOT INTO THE SPACE 1494 01:07:19,395 --> 01:07:23,332 WAS MANY OF MY MENTORS WHICH IS 1495 01:07:23,332 --> 01:07:26,769 HISTORY IS LITTERED WITH UNUSED 1496 01:07:26,769 --> 01:07:27,436 PREDICTIVE MODELS AND 1497 01:07:27,436 --> 01:07:32,307 POINT-OF-CARE TESTS. 1498 01:07:32,307 --> 01:07:35,678 THAT HAS BEEN TOP OF MIND IN 1499 01:07:35,678 --> 01:07:40,649 INTEGRATE THE RESULTS AND 1500 01:07:40,649 --> 01:07:43,686 INSIGHTS INTO THE DAY TO DAY 1501 01:07:43,686 --> 01:07:45,020 PRACTICE OF CLINICAL MEDICINE 1502 01:07:45,020 --> 01:07:48,424 NOT JUST FOR PHYSICIANS AND 1503 01:07:48,424 --> 01:07:51,393 ANCILLARY PROVIDERS AND NURSES. 1504 01:07:51,393 --> 01:07:55,898 I WANT TO BE ABLE TO WORK AT THE 1505 01:07:55,898 --> 01:07:59,268 TOP OF YOUR LICENSE AND LICENSE 1506 01:07:59,268 --> 01:08:02,504 IS SOMETHING STATIC WITH 1507 01:08:02,504 --> 01:08:03,739 POINT-OF-CARE TECHNOLOGIES WE 1508 01:08:03,739 --> 01:08:05,374 CAN EXTEND THE CEILING OF THE 1509 01:08:05,374 --> 01:08:07,643 LICENSES AND A CRITICAL FACTOR 1510 01:08:07,643 --> 01:08:11,447 IN BEING ABLE TO DO THAT IS 1511 01:08:11,447 --> 01:08:13,082 HAVING THE RESULTS AVAILABLE OF 1512 01:08:13,082 --> 01:08:15,184 THE CLINICAL WORK FLOW AND THE 1513 01:08:15,184 --> 01:08:16,985 CYCLE OF DATA TO KNOWLEDGE AND 1514 01:08:16,985 --> 01:08:21,857 KNOWLEDGE TO PRACTICE AND THEN 1515 01:08:21,857 --> 01:08:23,192 PRACTICE BACK TO DATA BEING ABLE 1516 01:08:23,192 --> 01:08:25,027 TO USE AND FUNDAMENTAL TO THAT 1517 01:08:25,027 --> 01:08:28,263 IS BRINGING IN INTEROPERABILITY 1518 01:08:28,263 --> 01:08:30,599 OF RESULTS TO CLINICAL WORK 1519 01:08:30,599 --> 01:08:30,866 FLOW. 1520 01:08:30,866 --> 01:08:33,235 THE ONLY THING WORSE THAN 1521 01:08:33,235 --> 01:08:35,270 CLINICIANS IS HAVING ONE MORE 1522 01:08:35,270 --> 01:08:38,140 INVESTED MESSAGE IS TO LOG INTO 1523 01:08:38,140 --> 01:08:40,175 A DIFFERENT PORTAL TO LOOK AT 1524 01:08:40,175 --> 01:08:42,111 THE RESULTS AND THEN BACK TO THE 1525 01:08:42,111 --> 01:08:44,046 AMR TO TAKE ACTION ON IT. 1526 01:08:44,046 --> 01:08:46,081 >> I WOULD CHALLENGE US ALL TO 1527 01:08:46,081 --> 01:08:51,520 THINK MORE DEEPLY ABOUT THIS. 1528 01:08:51,520 --> 01:08:53,856 OUR HOSPITAL SYSTEM IS TOO 1529 01:08:53,856 --> 01:08:55,958 ATYPICAL AND WHEN WE TRY TO 1530 01:08:55,958 --> 01:08:58,127 HANDLE HOW MANY IMAGES OF 1531 01:08:58,127 --> 01:08:59,795 POINT-OF-CARE TEST RESULTS AS 1532 01:08:59,795 --> 01:09:02,765 PART OF OUR DIGITAL HEALTH TRIAL 1533 01:09:02,765 --> 01:09:12,775 OUR WHOLE HEALTH SYSTEM WE 1534 01:09:12,775 --> 01:09:15,043 DIDN'T HAVE THE WAY TO SAVE THE 1535 01:09:15,043 --> 01:09:17,079 INFORMATION AND WHERE'S IT GO? 1536 01:09:17,079 --> 01:09:18,947 WHO STORES IT AND WHAT ARE THE 1537 01:09:18,947 --> 01:09:21,150 CHALLENGES TO PULL INSIGHT AT A 1538 01:09:21,150 --> 01:09:22,851 PARTICULAR TIME BE IT A 1539 01:09:22,851 --> 01:09:27,089 PARAMEDIC IN THE HOME, A NURSE 1540 01:09:27,089 --> 01:09:29,658 DOING POINT-OF-CARE ULTRASOUND 1541 01:09:29,658 --> 01:09:32,895 AND FACILITATE IN INTERPRETATION 1542 01:09:32,895 --> 01:09:34,463 AND WHEREAS OUR CURRENT MODEL 1543 01:09:34,463 --> 01:09:36,398 BASED ON CLINICAL CARE DELIVERED 1544 01:09:36,398 --> 01:09:39,101 IN A SILO NOW THAT THAT DATA'S 1545 01:09:39,101 --> 01:09:43,205 BEING GENERATED OUTSIDE THE SILO 1546 01:09:43,205 --> 01:09:46,141 IT INTRODUCES CHALLENGES TO 1547 01:09:46,141 --> 01:09:48,377 ACTIONABILITY AND IT'S MORE OF A 1548 01:09:48,377 --> 01:09:50,112 STATEMENT BUT I'D LIKE A 1549 01:09:50,112 --> 01:09:51,346 REACTION TO THAT. 1550 01:09:51,346 --> 01:09:54,316 >> ABSOLUTELY. 1551 01:09:54,316 --> 01:09:55,250 ELECTRONIC HEALTH RECORD SHOULD 1552 01:09:55,250 --> 01:09:57,653 BE A FINAL DESTINATION NOT THE 1553 01:09:57,653 --> 01:09:58,954 FIRST DESTINATION OF A LOT OF 1554 01:09:58,954 --> 01:10:05,928 THIS DATA ESPECIALLY GIVEN THE 1555 01:10:05,928 --> 01:10:07,963 INFO GRAPHIC OF THE 1556 01:10:07,963 --> 01:10:10,232 COMPUTATIONAL AND MODELLING WORK 1557 01:10:10,232 --> 01:10:12,401 BEING UNDER PINNING OF THE 1558 01:10:12,401 --> 01:10:14,136 ADVANCEMENT IN INNOVATION 1559 01:10:14,136 --> 01:10:14,436 HAPPENING. 1560 01:10:14,436 --> 01:10:17,406 SOME HAPPENS NATIVELY IN THE 1561 01:10:17,406 --> 01:10:18,040 TECHNOLOGY BUT THERE'S STILL A 1562 01:10:18,040 --> 01:10:23,946 LOT OF LEARNING THAT THAT NEEDS 1563 01:10:23,946 --> 01:10:30,052 TO HAPPEN IN THE MODELS OF 1564 01:10:30,052 --> 01:10:31,954 MACHINE LEARNING ALGORITHMS AND 1565 01:10:31,954 --> 01:10:33,589 IF WE BRING THAT IN WITHOUT 1566 01:10:33,589 --> 01:10:35,324 PROPER CONTEXT OR ACTION 1567 01:10:35,324 --> 01:10:39,261 ASSOCIATED WITH THAT IT'S GOING 1568 01:10:39,261 --> 01:10:42,364 TO FURTHER DILUTE THE STAGING 1569 01:10:42,364 --> 01:10:43,465 AND HAVE A RICH ENVIRONMENT 1570 01:10:43,465 --> 01:10:46,568 WHERE ALL THE DATA CAN BE 1571 01:10:46,568 --> 01:10:48,170 AVAILABLE TO FOLLOW THE TENET OF 1572 01:10:48,170 --> 01:10:49,504 NO DATA LEFT BEHIND. 1573 01:10:49,504 --> 01:10:51,039 WE UNDERSTAND MORE FROM NOT JUST 1574 01:10:51,039 --> 01:10:53,108 THE GOLD STANDARD CLINICAL 1575 01:10:53,108 --> 01:10:54,877 METRICS WE'RE SO WELL VERSED IN 1576 01:10:54,877 --> 01:10:58,380 BUT ALSO WHAT ARE THE MORE 1577 01:10:58,380 --> 01:10:59,948 RAPIDLY MEASURED AND MORE 1578 01:10:59,948 --> 01:11:01,149 FREQUENTLY MEASURED METRICS FROM 1579 01:11:01,149 --> 01:11:02,951 PATIENT'S HOME. 1580 01:11:02,951 --> 01:11:04,820 SOMETHING WE HAVE AS CLINICIANS 1581 01:11:04,820 --> 01:11:07,456 BECAUSE A LOT OF THE DATA WE ACT 1582 01:11:07,456 --> 01:11:09,291 ON IS WHAT'S AVAILABLE IN THE 1583 01:11:09,291 --> 01:11:11,960 EMR AND BRING THAT INTO A 1584 01:11:11,960 --> 01:11:14,663 STAGING ENVIRONMENT, INTO A 1585 01:11:14,663 --> 01:11:15,330 COMPUTATIONAL ENVIRONMENT WHERE 1586 01:11:15,330 --> 01:11:17,099 WE CAN CONTINUE TO LEARN AND 1587 01:11:17,099 --> 01:11:19,768 BRING THE INSIGHTS TO MEDICAL 1588 01:11:19,768 --> 01:11:22,170 RECORDS SO ACTION CAN HAPPEN BUT 1589 01:11:22,170 --> 01:11:24,273 BE CAREFUL AND INTENTIONAL ABOUT 1590 01:11:24,273 --> 01:11:26,975 WHAT DATA AND INSIGHTS WE'RE 1591 01:11:26,975 --> 01:11:28,944 BRINGING IN AND PARTICIPATORY 1592 01:11:28,944 --> 01:11:32,314 METHODS ARE IMPORTANT IN 1593 01:11:32,314 --> 01:11:37,119 THINKING ABOUT CAREGIVERS AND 1594 01:11:37,119 --> 01:11:37,419 CARETAKERS. 1595 01:11:37,419 --> 01:11:39,154 >> DR. MANABE. 1596 01:11:39,154 --> 01:11:41,223 >> I HAVE A FRIEND WHO SAY 1597 01:11:41,223 --> 01:11:43,125 PEDIATRICIAN AND DURING THE 1598 01:11:43,125 --> 01:11:46,061 HEIGHT OF COVID DID 126 TESTS ON 1599 01:11:46,061 --> 01:11:47,062 PATIENTS DURING HER BUSIEST DAY 1600 01:11:47,062 --> 01:11:52,000 AND I SAID DON'T YOU WANT A TEST 1601 01:11:52,000 --> 01:11:54,870 TO DIFFERENTIATE FLU AND COLD 1602 01:11:54,870 --> 01:11:56,138 SEASON SHE SAID I DON'T WANT 1603 01:11:56,138 --> 01:11:57,706 THAT TEST BECAUSE I DON'T WANT 1604 01:11:57,706 --> 01:12:00,876 THEM IN MY OFFICE. 1605 01:12:00,876 --> 01:12:02,577 I WANT THEM TO STAY HOME AND 1606 01:12:02,577 --> 01:12:04,246 CALL IN A PRESCRIPTION FOR FLU. 1607 01:12:04,246 --> 01:12:06,381 HE WERE WERE TRYING TO DEVELOP 1608 01:12:06,381 --> 01:12:09,751 THE MULTIPLEX TEST WE THOUGHT 1609 01:12:09,751 --> 01:12:14,523 WOULD BE SO USEFUL AND IF IT 1610 01:12:14,523 --> 01:12:17,059 TURNS OUT IF IT LOOKS AND SMELLS 1611 01:12:17,059 --> 01:12:18,961 LIKE FLU THEY'LL TREAT IT LIKE 1612 01:12:18,961 --> 01:12:20,562 FLU SO WE HAVE TO BE CAREFUL IN 1613 01:12:20,562 --> 01:12:22,130 WHAT WE DEVELOP AND EXPECT IT TO 1614 01:12:22,130 --> 01:12:24,333 BE USED AND I SPENT TIME TALKING 1615 01:12:24,333 --> 01:12:26,401 ABOUT USE CASE BUT IT'S USE 1616 01:12:26,401 --> 01:12:28,203 CASE, USE CASE. 1617 01:12:28,203 --> 01:12:35,143 WHO WILL USE IT AND WHY AND WHAT 1618 01:12:35,143 --> 01:12:38,480 IS IT USED FOR AND WE HAVE A 1619 01:12:38,480 --> 01:12:39,815 COLLECTION CALLED I WANT KIT. 1620 01:12:39,815 --> 01:12:41,216 IT'S FREE IN THE STATE OF 1621 01:12:41,216 --> 01:12:42,551 MARYLAND AND OTHER STATES AS 1622 01:12:42,551 --> 01:12:43,452 WELL AND WHAT'S INTERESTING 1623 01:12:43,452 --> 01:12:45,020 ABOUT THIS SERVICE IS IF YOU GO 1624 01:12:45,020 --> 01:12:46,121 BACK AND FIND OUT HOW MANY 1625 01:12:46,121 --> 01:12:49,024 PEOPLE WHO HAD GONORRHEA GOT 1626 01:12:49,024 --> 01:12:51,126 TREATED, MOST EVERYBODY GETS 1627 01:12:51,126 --> 01:12:51,493 TREATED. 1628 01:12:51,493 --> 01:12:53,228 MOST PEOPLE DON'T WANT TO WALK 1629 01:12:53,228 --> 01:12:59,167 AROUND WITH GONORRGONORRHEA. 1630 01:12:59,167 --> 01:13:02,270 THE 8% ARE THOSE WE CAN'T 1631 01:13:02,270 --> 01:13:05,607 CONTACT BUT TURNS OUT IF IT'S A 1632 01:13:05,607 --> 01:13:06,675 CURABLE ILLNESS WILL GET TREATED 1633 01:13:06,675 --> 01:13:08,710 AND THE OBSESSION OF KNOWING THE 1634 01:13:08,710 --> 01:13:13,382 RESULT AT A CENTRAL PLACE TO 1635 01:13:13,382 --> 01:13:15,984 PERSON WILL LINK TO CARE IS 1636 01:13:15,984 --> 01:13:16,318 PATERNALISTIC. 1637 01:13:16,318 --> 01:13:18,253 I THINK IF IT'S A CURABLE 1638 01:13:18,253 --> 01:13:21,423 ILLNESS PEOPLE WILL GET TREATED. 1639 01:13:21,423 --> 01:13:25,460 WITH DISEASES NOT CURABLE IT'S 1640 01:13:25,460 --> 01:13:28,830 HARDER BECAUSE OF THE STIGMA 1641 01:13:28,830 --> 01:13:31,600 LIKE RECURRENT HERPES OR HIV. 1642 01:13:31,600 --> 01:13:33,301 I THINK WE NEED TO DIFFERENTIATE 1643 01:13:33,301 --> 01:13:34,836 WHO WILL USE IT AND WHY AND WHEN 1644 01:13:34,836 --> 01:13:36,571 AND WE NEED IT TO BE CLEARER 1645 01:13:36,571 --> 01:13:37,172 ABOUT THE USE CASE AS WE'RE 1646 01:13:37,172 --> 01:13:43,145 DEVELOPING. 1647 01:13:43,145 --> 01:13:47,015 >> I THINK I'M HEARING DON'T 1648 01:13:47,015 --> 01:13:49,051 GENERATE DATA AND THROW IT AT ME 1649 01:13:49,051 --> 01:13:50,585 AT 5:00 ON FRIDAY WHERE I DON'T 1650 01:13:50,585 --> 01:13:52,220 KNOW WHAT MEANS AND DON'T HAVE 1651 01:13:52,220 --> 01:13:53,722 RESULTS AND HAVE TO DEAL WITH 1652 01:13:53,722 --> 01:13:56,625 IT. 1653 01:13:56,625 --> 01:13:58,760 YOU GOT THE DATA CHALLENGE 1654 01:13:58,760 --> 01:14:02,030 GENERATING GREAT STUFF BUT WHEN 1655 01:14:02,030 --> 01:14:05,700 THE ONUS THINK ABOUT 1656 01:14:05,700 --> 01:14:10,105 INTEROPERABILITY AND INTEGRATION 1657 01:14:10,105 --> 01:14:11,306 OF THE WORK FLOW AND IF YOU 1658 01:14:11,306 --> 01:14:12,674 REQUIRE THEM TO GO TO THE 1659 01:14:12,674 --> 01:14:15,410 WEBSITE AND THE DATA IS CLUNKY 1660 01:14:15,410 --> 01:14:17,345 TO INTEGRATE IN THE ELECTRONIC 1661 01:14:17,345 --> 01:14:18,980 HEALTH RECORD, LOWER ADOPTION 1662 01:14:18,980 --> 01:14:22,184 LIKELY WILL HAPPEN AND GIVE 1663 01:14:22,184 --> 01:14:23,718 THOUGHT TO THE WORK FLOW 1664 01:14:23,718 --> 01:14:25,087 ELEMENTS OF GENERATING DATA AT 1665 01:14:25,087 --> 01:14:27,255 THE RIGHT TIME AND GENERATING AN 1666 01:14:27,255 --> 01:14:28,924 INSIGHT WHEN IT WOULD LEAD TO 1667 01:14:28,924 --> 01:14:29,157 IMPACT. 1668 01:14:29,157 --> 01:14:30,892 I WANT TO GO INTO A SLIGHTLY 1669 01:14:30,892 --> 01:14:32,360 DIFFERENT PLACE WHICH IS A 1670 01:14:32,360 --> 01:14:34,930 POSITIVE PLACE BECAUSE AGAIN YOU 1671 01:14:34,930 --> 01:14:36,331 WERE EXPECTING CRUSTY CLINICIAN 1672 01:14:36,331 --> 01:14:38,767 BUT WE'RE PART OF THE FAMILY. 1673 01:14:38,767 --> 01:14:40,969 WE WANT TO GO INTO POTENTIAL 1674 01:14:40,969 --> 01:14:42,804 CLINICAL APPLICATIONS OUTSIDE 1675 01:14:42,804 --> 01:14:44,473 THE TELEMEDICINE CONSTRUCT WHICH 1676 01:14:44,473 --> 01:14:45,907 IS WHERE THE CENTER OF WHERE 1677 01:14:45,907 --> 01:14:46,608 PEOPLE START. 1678 01:14:46,608 --> 01:14:48,543 CLICK ON MY AMAZON BUTTON AND I 1679 01:14:48,543 --> 01:14:51,580 CAN GET A NURSE PRACTITIONER TO 1680 01:14:51,580 --> 01:14:53,915 SEE ME TO GET MY RESPIRATORY 1681 01:14:53,915 --> 01:14:56,084 TREATMENT OFTEN AUGMENTED WITH A 1682 01:14:56,084 --> 01:15:00,589 TEST E-MAILED TO MY CLUBHOHOUSE. 1683 01:15:00,589 --> 01:15:03,024 IT MAY ALSO REPLACE ALL HEALTH 1684 01:15:03,024 --> 01:15:05,627 CARE WITH AMAZON BUT THAT'S A 1685 01:15:05,627 --> 01:15:07,062 CONVERSATION FOR ANOTHER DAY. 1686 01:15:07,062 --> 01:15:13,068 THE OTHER USE CASES ONE IS THE 1687 01:15:13,068 --> 01:15:14,369 CONCEPT OF HOSPITAL AT HOME, 1688 01:15:14,369 --> 01:15:15,804 SKILLED NURSING AT HOME. 1689 01:15:15,804 --> 01:15:18,573 WE'RE SEEING MOVEMENT TO TAKE 1690 01:15:18,573 --> 01:15:23,979 CERTAIN CARE OUTSIDE THE BRICK 1691 01:15:23,979 --> 01:15:29,985 AND MORTAR HOSPITAL AND WITH 1692 01:15:29,985 --> 01:15:34,322 LICK ELECTRONIC ICUs TO ALLOW 1693 01:15:34,322 --> 01:15:37,392 FOR ICU MONITORING IN RURAL 1694 01:15:37,392 --> 01:15:38,493 SETTINGS AND OTHER SETTINGS 1695 01:15:38,493 --> 01:15:43,231 WHERE THERE'S NOT INTENSIVISM 1696 01:15:43,231 --> 01:15:47,802 AND THOSE ARE POINT-OF-CARE 1697 01:15:47,802 --> 01:15:50,372 TECHNOLOGIES IMPACTFUL. 1698 01:15:50,372 --> 01:15:52,541 PERHAPS YOU CAN TALK ABOUT THE 1699 01:15:52,541 --> 01:15:53,742 MOVEMENT IN THE HOSPITAL AT HOME 1700 01:15:53,742 --> 01:15:56,411 SPACE AND SOME INNOVATIVE WORK 1701 01:15:56,411 --> 01:15:59,447 WITH GETTING THERAPISTS TO USE 1702 01:15:59,447 --> 01:16:00,115 POINT-OF-CARE TECHNOLOGIES TO DO 1703 01:16:00,115 --> 01:16:07,722 SKILLED NURSING AT HOME. 1704 01:16:07,722 --> 01:16:11,927 >> PART OF THE RAPID 1705 01:16:11,927 --> 01:16:13,662 ACCELERATION OF CLINICIANS AND 1706 01:16:13,662 --> 01:16:14,296 ACCEPTANCE OF HEALTH 1707 01:16:14,296 --> 01:16:16,031 TECHNOLOGIES EXPANDED OUR 1708 01:16:16,031 --> 01:16:18,533 ABILITY TO PROVIDE CARE WHERE 1709 01:16:18,533 --> 01:16:18,967 AND WHEN. 1710 01:16:18,967 --> 01:16:21,069 A LOT OF IT WAS OUT OF NECESSITY 1711 01:16:21,069 --> 01:16:22,704 WITH HOSPITALS THAT NEEDED TO BE 1712 01:16:22,704 --> 01:16:25,073 STOOD UP BUT THE HOSPITAL BED 1713 01:16:25,073 --> 01:16:28,510 SHORTAGE CRISIS IS HERE TO STAY. 1714 01:16:28,510 --> 01:16:36,618 ANY GIVEN DAY IN WORCESTER, 1715 01:16:36,618 --> 01:16:39,321 MASSACHUSETTS WE'RE 80 TO 90 1716 01:16:39,321 --> 01:16:42,157 HOSPITAL BEDS SHORT AND WE 1717 01:16:42,157 --> 01:16:44,392 STARTED ONE OF THE LARGERER 1718 01:16:44,392 --> 01:16:45,627 HOSPITAL AT HOME PROGRAMS WHERE 1719 01:16:45,627 --> 01:16:51,032 ACUTE CARE IS IS PROVIDED 1720 01:16:51,032 --> 01:16:52,234 INPATIENT CARE IN A HOSPITAL BED 1721 01:16:52,234 --> 01:16:53,635 WHICH HAPPENS TO BE IN THE 1722 01:16:53,635 --> 01:16:53,868 BEDROOM. 1723 01:16:53,868 --> 01:16:58,106 THE ABILITY TO PROVIDE THE CARE 1724 01:16:58,106 --> 01:17:00,542 WITH CONFIDENCE WE'RE NOT GOING 1725 01:17:00,542 --> 01:17:04,679 TO LET SOMETHING ADVERSE HAPPEN 1726 01:17:04,679 --> 01:17:06,181 IS POSSIBLE BECAUSE OF THE 1727 01:17:06,181 --> 01:17:07,315 WEARABLE AND HOME-BASED 1728 01:17:07,315 --> 01:17:12,654 TECHNOLOGIES THAT ALLOW US TO DO 1729 01:17:12,654 --> 01:17:18,960 MORE MONITORING THEN WHEN 1730 01:17:18,960 --> 01:17:22,030 ADMITTED TO A HOSPITAL FLOOR AND 1731 01:17:22,030 --> 01:17:24,699 BY PROVIDING TO PATIENTS WE CAN 1732 01:17:24,699 --> 01:17:27,168 DECREASE RE-ADMISSION BY 50% 1733 01:17:27,168 --> 01:17:31,940 THROUGH REHAB AS OPPOSED TO A 1734 01:17:31,940 --> 01:17:33,275 SERVICE THAT UNFORTUNATELY AT 1735 01:17:33,275 --> 01:17:38,913 OUR MEDICAL CENTER WE CURRENTLY 1736 01:17:38,913 --> 01:17:41,683 HAVE. 1737 01:17:41,683 --> 01:17:46,154 WE NEED MULTIPLE PARTICIPANTS 1738 01:17:46,154 --> 01:17:48,556 TO INVOLVE CONTROLLERS LOOKING 1739 01:17:48,556 --> 01:17:53,328 AT THE DATA COMING IN AND 1740 01:17:53,328 --> 01:17:54,829 TRIGGERING AN ACTION AND WE HAVE 1741 01:17:54,829 --> 01:18:00,068 A PROGRAM CALLED MOBILE 1742 01:18:00,068 --> 01:18:02,837 INTEGRATED HEALTH AND WE CAN 1743 01:18:02,837 --> 01:18:05,273 EXTEND THE OPTIONS OF THE 1744 01:18:05,273 --> 01:18:06,374 TRADITIONAL EMERGENCY MEDICAL 1745 01:18:06,374 --> 01:18:09,210 SERVICES WHEN THEY GO TO A 1746 01:18:09,210 --> 01:18:09,711 PATIENTS HOLE. 1747 01:18:09,711 --> 01:18:11,946 IT'S EITHER DO YOU BRING THE 1748 01:18:11,946 --> 01:18:13,548 PATIENT IN TO EMERGENCY ROOM IF 1749 01:18:13,548 --> 01:18:15,116 THE PATIENT IS FEELING SICK AND 1750 01:18:15,116 --> 01:18:18,286 WANT TO COME IN OR YOU DO NOT DO 1751 01:18:18,286 --> 01:18:18,920 ANYTHING ELSE. 1752 01:18:18,920 --> 01:18:22,290 BUT WITH PARAMEDIC AT HOME 1753 01:18:22,290 --> 01:18:23,591 PROGRAM WE'RE ALSO EXTENDING 1754 01:18:23,591 --> 01:18:25,126 THAT TO INCREASE THE OPTION OF 1755 01:18:25,126 --> 01:18:26,661 ALLOWING THE OPTION OF 1756 01:18:26,661 --> 01:18:28,963 MAINTAINING THE PATIENT'S HEALTH 1757 01:18:28,963 --> 01:18:30,699 AT HOME WITH CLINICAL 1758 01:18:30,699 --> 01:18:33,335 SUPERVISION. 1759 01:18:33,335 --> 01:18:34,969 THE ACTION ARM OF BOTH WORKFORCE 1760 01:18:34,969 --> 01:18:36,705 LOOKING AT ALL THE SIGNALS 1761 01:18:36,705 --> 01:18:39,774 COMING IN FROM HOME-BASED 1762 01:18:39,774 --> 01:18:42,043 MONITORING AND ALSO HAVING THE 1763 01:18:42,043 --> 01:18:43,978 RESPONSE OF PARAMEDIC GOING TO 1764 01:18:43,978 --> 01:18:45,747 PATIENTS HOME TO STABILIZE AND 1765 01:18:45,747 --> 01:18:56,257 RESPOND TO ANY PROGRESSION OF 1766 01:18:59,361 --> 01:19:00,295 THE DISEASE. 1767 01:19:00,295 --> 01:19:02,964 >> COMMENT ON THE CONSTRUCT AND 1768 01:19:02,964 --> 01:19:06,868 HOW THAT WORKS WITH TYPES OF 1769 01:19:06,868 --> 01:19:07,268 SEN 1770 01:19:07,268 --> 01:19:09,871 SENSORS AND I DON'T THINK OF 1771 01:19:09,871 --> 01:19:11,172 POINT-OF-CARE IN THE ICU CARE 1772 01:19:11,172 --> 01:19:16,478 BUT THAT'S WRONG TO TELL US 1773 01:19:16,478 --> 01:19:16,911 ABOUT THAT. 1774 01:19:16,911 --> 01:19:22,050 >> STARTING WITH WHERE BRUCE WAS 1775 01:19:22,050 --> 01:19:23,551 WITH HOW IMPORTANT THE DATA IS 1776 01:19:23,551 --> 01:19:25,186 BECAUSE THERE'S A HUGE AMOUNT OF 1777 01:19:25,186 --> 01:19:27,222 DATA OUT THERE BUT THERE'S ALSO 1778 01:19:27,222 --> 01:19:29,224 AN IMPORTANT PROBLEM. 1779 01:19:29,224 --> 01:19:32,327 IF YOU'VE EVER BEEN IN AN ICU 1780 01:19:32,327 --> 01:19:39,567 YOU NOTICE IT'S NOISY IN HERE. 1781 01:19:39,567 --> 01:19:40,368 THERE'S B 1782 01:19:40,368 --> 01:19:41,803 THERE'S BEEPS. 1783 01:19:41,803 --> 01:19:43,471 THE BEEPS ARE PROBLEMATIC 1784 01:19:43,471 --> 01:19:44,939 BECAUSE THE PEOPLE GET 1785 01:19:44,939 --> 01:19:47,342 DESENSITIZED AND DON'T RESPOND. 1786 01:19:47,342 --> 01:19:50,044 WE REALIZED PEOPLE WERE GETTING 1787 01:19:50,044 --> 01:19:52,380 INTO TROUBLE BECAUSE THEY HAVE A 1788 01:19:52,380 --> 01:19:53,848 HIGH FALSE POSITIVE RATE SO WHAT 1789 01:19:53,848 --> 01:19:55,984 YOU DO WITH THE DATA MATTERS AND 1790 01:19:55,984 --> 01:19:57,552 PEOPLE WEREN'T RESPONDING. 1791 01:19:57,552 --> 01:20:00,255 WE HAD AN OFF-SITE TEAM THAT 1792 01:20:00,255 --> 01:20:02,223 USED ANALYTIC CHANGES OVER TIME 1793 01:20:02,223 --> 01:20:04,292 IF THE HEART RATE WENT UP AND 1794 01:20:04,292 --> 01:20:07,162 THE OXYGEN SATURATION WAS GOING 1795 01:20:07,162 --> 01:20:09,798 ON DIRECTED THE CARE. 1796 01:20:09,798 --> 01:20:12,267 THEY LOOKED AT THE SITUATION AND 1797 01:20:12,267 --> 01:20:13,601 SAID, OKAY, IS THERE A PROBLEM 1798 01:20:13,601 --> 01:20:15,303 HERE OR NOT AND IF THERE'S A 1799 01:20:15,303 --> 01:20:16,004 PROBLEM THE SECOND QUESTION THEY 1800 01:20:16,004 --> 01:20:17,338 ASKED IS WHERE THE NURSES ON TOP 1801 01:20:17,338 --> 01:20:17,906 OF IT? 1802 01:20:17,906 --> 01:20:22,644 YOU TURN ON THE CAMERAS AND 1803 01:20:22,644 --> 01:20:24,078 THERE'S NURSES IN THE ROOM 1804 01:20:24,078 --> 01:20:25,914 DEALING WITH IT AND A LOT OF 1805 01:20:25,914 --> 01:20:27,148 TIMES THERE AREN'T WHEN THAT'S 1806 01:20:27,148 --> 01:20:28,616 THE CASE AND YOU KNOW IT'S THE 1807 01:20:28,616 --> 01:20:30,318 REAL DEAL YOU REACH OUT AND SAY 1808 01:20:30,318 --> 01:20:31,786 IT'S NOT A FALSE POSITIVE. 1809 01:20:31,786 --> 01:20:33,354 WE NEED TO DEAL WITH THIS. 1810 01:20:33,354 --> 01:20:35,790 WHEN WE DID THAT, OUR MORTALITY 1811 01:20:35,790 --> 01:20:40,929 RATE WENT DOWN BY 30%. 1812 01:20:40,929 --> 01:20:43,631 OUR LENGTH OF STAY WENT DOWN AND 1813 01:20:43,631 --> 01:20:45,433 THE PROFIT OR MARGIN WENT WAY 1814 01:20:45,433 --> 01:20:46,201 UP. 1815 01:20:46,201 --> 01:20:47,969 WE PUBLISHED THAT IN THE 1816 01:20:47,969 --> 01:20:48,603 TELEMEDICINE SPACE. 1817 01:20:48,603 --> 01:20:51,639 ONE OF THE THINGS THAT ENABLED 1818 01:20:51,639 --> 01:20:53,274 THAT WAS THE BETTER THE DATA THE 1819 01:20:53,274 --> 01:20:55,910 BETTER WE WERE ABLE TO PREDICT. 1820 01:20:55,910 --> 01:20:58,780 WHEN WE WERE IN A WORLD OF HURT 1821 01:20:58,780 --> 01:21:01,883 BECAUSE WE STARTED OUT WITH A 1822 01:21:01,883 --> 01:21:02,951 BUNCH OF COVID PATIENTS COMING 1823 01:21:02,951 --> 01:21:04,319 IN AND SOME PATIENTS GET SICK 1824 01:21:04,319 --> 01:21:06,888 WITH THAT AND WE DON'T WANT TO 1825 01:21:06,888 --> 01:21:09,324 SEND ANYBODY HOME BECAUSE WE 1826 01:21:09,324 --> 01:21:11,359 THINK IT'S TOO DANGEROUS AN 1827 01:21:11,359 --> 01:21:16,097 DON'T HAVE THE SENSORS WE SHOULD 1828 01:21:16,097 --> 01:21:18,533 HAVE AND SENT IT OVER AND IT WAS 1829 01:21:18,533 --> 01:21:20,001 NOT THE MOST COMFORTABLE PLACE 1830 01:21:20,001 --> 01:21:23,137 TO STAY WITH BUT CAMERAS, 1831 01:21:23,137 --> 01:21:23,972 MICROPHONES AND WITH REGARDING 1832 01:21:23,972 --> 01:21:26,674 THE VITAL SIGNS AND BRINGING 1833 01:21:26,674 --> 01:21:28,977 THEM IN WE'RE ABLE TO KEEP TRACK 1834 01:21:28,977 --> 01:21:32,146 OF THOSE FOLKS. 1835 01:21:32,146 --> 01:21:36,484 DAVE AND PURVE SAID YOU CAN'T GO 1836 01:21:36,484 --> 01:21:38,286 OVER THERE BECAUSE YOU ARE 1837 01:21:38,286 --> 01:21:40,288 LIKELY TO GET SICK BUT IT WASN'T 1838 01:21:40,288 --> 01:21:40,822 PERFECT. 1839 01:21:40,822 --> 01:21:46,094 WHAT IS AMAZING IS THEY WENT 1840 01:21:46,094 --> 01:21:51,432 THROUGH AND SAID THAT GUY WILL 1841 01:21:51,432 --> 01:21:52,233 GET SICK. 1842 01:21:52,233 --> 01:21:53,935 AND WHEN WE CALLED AT THE DCU 1843 01:21:53,935 --> 01:21:55,770 AND SAID YOU HAVE TO CHECK OUT 1844 01:21:55,770 --> 01:21:59,007 THE GUY IN BED 23 IS GOING TO 1845 01:21:59,007 --> 01:22:01,376 GET SICK AND THE CONDITIONS ARE 1846 01:22:01,376 --> 01:22:02,076 INTERESTING. 1847 01:22:02,076 --> 01:22:03,912 THEY SAID WE'VE SEEN BED 23, 1848 01:22:03,912 --> 01:22:06,014 HE'S FINE AND TWO HOURS LATER 1849 01:22:06,014 --> 01:22:07,549 THEY'RE BACK ON THE PHONE SAYING 1850 01:22:07,549 --> 01:22:11,119 YOU SHOULD MOVE THEM BACK TO THE 1851 01:22:11,119 --> 01:22:12,186 MEDICAL CENTER. 1852 01:22:12,186 --> 01:22:14,322 WHEN APURV TALK ABOUT THE DATA 1853 01:22:14,322 --> 01:22:16,624 IN THE SPACE IT'S ANALYZING IT 1854 01:22:16,624 --> 01:22:18,493 AND FLIPPING THE PARADIGM, 1855 01:22:18,493 --> 01:22:19,427 SOMETHING'S WRONG WITH MY SEFT 1856 01:22:19,427 --> 01:22:23,965 I'M GOING TO CALL MY DOCTOR 1857 01:22:23,965 --> 01:22:26,568 PARADIGM ISN'T IT GOOD THE 1858 01:22:26,568 --> 01:22:27,835 DOCTOR REACHES OUT TO YOU AND 1859 01:22:27,835 --> 01:22:32,874 SAYING I'M CONCERNED. 1860 01:22:32,874 --> 01:22:37,245 >> GREAT, I'M CONSCIOUS OF 1861 01:22:37,245 --> 01:22:40,815 WRAPPING UP BY 10:15 AND PERHAPS 1862 01:22:40,815 --> 01:22:46,588 GET PANEL AND AUDIENCE REACTION. 1863 01:22:46,588 --> 01:22:51,426 WE SAW A REMARKABLE CHANGE IT'S 1864 01:22:51,426 --> 01:22:57,999 NOT JUST PATIENT'S WILLINGNESS 1865 01:22:57,999 --> 01:23:08,309 TO ACCEPT RESULTS AND THERE'S 1866 01:23:08,309 --> 01:23:12,046 LUNG ORE YENTDED RESULTS AND 1867 01:23:12,046 --> 01:23:14,682 THAT'S A TRANSFORMATIVE FACTOR. 1868 01:23:14,682 --> 01:23:16,618 NEVER LET A GOOD CRISIS PASS YOU 1869 01:23:16,618 --> 01:23:16,951 BY. 1870 01:23:16,951 --> 01:23:21,155 THE OTHER IS RESIGNATIONS. 1871 01:23:21,155 --> 01:23:24,659 WE'VE SEEN HALF OUR NURSES LEAVE 1872 01:23:24,659 --> 01:23:26,561 HEALTH CARE AND MANY PHYSICIANS 1873 01:23:26,561 --> 01:23:26,794 AS WELL. 1874 01:23:26,794 --> 01:23:31,566 IN FACT I BELIEVE ONE OF EVERY 1875 01:23:31,566 --> 01:23:32,800 THREE OR FOUR PRIMARY CARE 1876 01:23:32,800 --> 01:23:34,035 PHYSICIANS IS PLANNING TO RETIRE 1877 01:23:34,035 --> 01:23:35,303 OR LEAVE MEDICINE WITHIN THE 1878 01:23:35,303 --> 01:23:36,971 NEXT TWO YEARS AND WE DON'T HAVE 1879 01:23:36,971 --> 01:23:39,974 A PIPELINE TO REPLACE THEM. 1880 01:23:39,974 --> 01:23:41,342 POINT-OF-CARE TECHNOLOGIES WILL 1881 01:23:41,342 --> 01:23:51,853 PLAY A CRUCIAL ROLE AND WE'RE 1882 01:23:53,187 --> 01:23:54,822 RETHINKING THE ROLES OF HEALTH 1883 01:23:54,822 --> 01:23:57,458 CARE PROVIDERS WITH MUCH LESS OR 1884 01:23:57,458 --> 01:23:59,093 SHORTER TRAINING PERIODS 1885 01:23:59,093 --> 01:24:01,329 AUGMENTED BY PERHAPS A.I. 1886 01:24:01,329 --> 01:24:02,563 RUNNING ON A POINT-OF-CARE 1887 01:24:02,563 --> 01:24:05,266 DIAGNOSTIC INSTEAD OF RELYING ON 1888 01:24:05,266 --> 01:24:07,702 A PHYSICIAN'S DIAGNOSTIC 1889 01:24:07,702 --> 01:24:09,437 CAPABILITY AND THAT'S IN A NEW 1890 01:24:09,437 --> 01:24:09,704 HOSPITAL. 1891 01:24:09,704 --> 01:24:12,240 IN A NEW TOWER WE HAVE A 1892 01:24:12,240 --> 01:24:16,310 PARAMEDIC RUNNING ON AN A.I. 1893 01:24:16,310 --> 01:24:20,448 FACILITATED TELEMEDICINE 1894 01:24:20,448 --> 01:24:22,216 PLATFORM IN PATIENT. 1895 01:24:22,216 --> 01:24:24,752 AND THERE ARE NOW TEAMS BE 1896 01:24:24,752 --> 01:24:26,020 CONSTRUCTED WITHIN HEALTH CARE 1897 01:24:26,020 --> 01:24:28,156 THE DIGITAL HEALTH HUBS 1898 01:24:28,156 --> 01:24:29,590 MONITORING, REACTING AND ARE 1899 01:24:29,590 --> 01:24:34,662 MANAGING THE DATA GENERATED BY 1900 01:24:34,662 --> 01:24:36,297 POINT-OF-CARE OF SENSOR 1901 01:24:36,297 --> 01:24:41,035 TECHNOLOGY ONE IN THE ICU HOME 1902 01:24:41,035 --> 01:24:43,404 AND CREATING A VIRTUAL 1903 01:24:43,404 --> 01:24:43,705 HOSPITALIST? 1904 01:24:43,705 --> 01:24:46,774 I DIDN'T KNOW ABOUT THAT AND NOW 1905 01:24:46,774 --> 01:24:48,142 THEY EXIST. 1906 01:24:48,142 --> 01:24:51,679 SIMILARLY WITH THE CONTEXT OF 1907 01:24:51,679 --> 01:24:54,982 TELEMEDICINE AND IT TAKES A 1908 01:24:54,982 --> 01:24:57,785 SKILL SET TO PICK UP ON CUES AND 1909 01:24:57,785 --> 01:24:59,887 IT CHANGES THE LOCUST OF CONTROL 1910 01:24:59,887 --> 01:25:02,790 IN HOME-BASED CARE TO THE NURSE. 1911 01:25:02,790 --> 01:25:06,027 THE NURSE PLAYS A MORE CENTRAL 1912 01:25:06,027 --> 01:25:07,995 DIAGNOSTIC ROLE AND WE'RE SEEING 1913 01:25:07,995 --> 01:25:13,334 NEW TRAINING PROGRAMS EMERGE FOR 1914 01:25:13,334 --> 01:25:17,138 NURSES AND PHYSICIANS AND 1915 01:25:17,138 --> 01:25:19,307 THERE'S PHYSICIAN ENGINEERS AND 1916 01:25:19,307 --> 01:25:23,678 WE'RE SEEING AN EMERGENCE OF 1917 01:25:23,678 --> 01:25:25,012 TRAINING HEALTH PROGRAMS TO BE 1918 01:25:25,012 --> 01:25:25,913 MORE EXPERT USES OF 1919 01:25:25,913 --> 01:25:27,915 POINT-OF-CARE TECHNOLOGIES AND 1920 01:25:27,915 --> 01:25:29,550 BECOMING FAMILIAR WITH THE 1921 01:25:29,550 --> 01:25:30,985 NUANCED RESULTS THAT COME FROM 1922 01:25:30,985 --> 01:25:32,320 THEM AND DATA SCIENTISTS. 1923 01:25:32,320 --> 01:25:34,655 THAT'S A COHORT OF PEOPLE THAT 1924 01:25:34,655 --> 01:25:39,560 ARE REALLY ESSENTIAL FOR 1925 01:25:39,560 --> 01:25:41,929 POINT-OF-CARE INTEGRATION I HOPE 1926 01:25:41,929 --> 01:25:42,964 APURV'S COMMENTS HELPED. 1927 01:25:42,964 --> 01:25:45,333 WE WANTED TO LEAVE YOU WITH 1928 01:25:45,333 --> 01:25:47,068 POSITIVE CLINICAL SCENARIOS AND 1929 01:25:47,068 --> 01:25:48,770 PERSPECTIVES YOU MAY NOT HAVE 1930 01:25:48,770 --> 01:25:50,671 HEARD AND SOME CHALLENGES AROUND 1931 01:25:50,671 --> 01:25:54,942 WORK FLOW INTEGRATION AND LEAVE 1932 01:25:54,942 --> 01:25:57,879 YOU WITH FACTS THAT SHOW HOW 1933 01:25:57,879 --> 01:25:59,781 CLINICIANS ARE MORE OPEN TO 1934 01:25:59,781 --> 01:26:01,215 POINT-OF-CARE TECHNOLOGIES THEN 1935 01:26:01,215 --> 01:26:03,918 WHEN WE MET LAST IN PERSON AT 1936 01:26:03,918 --> 01:26:04,652 NIH. 1937 01:26:04,652 --> 01:26:06,087 A LOT OF CHANGE IN THE AREA. 1938 01:26:06,087 --> 01:26:11,592 WE'RE ALL GRATEFUL TO BE PART OF 1939 01:26:11,592 --> 01:26:13,327 THE FAMILY. 1940 01:26:13,327 --> 01:26:15,296 WE'RE PART OF THE POCTRN FAMILY 1941 01:26:15,296 --> 01:26:16,330 AND THANK YOU TO THE PANELISTS. 1942 01:26:16,330 --> 01:26:19,834 I APPRECIATED YOUR INSIGHTS AND 1943 01:26:19,834 --> 01:26:23,971 I'M SURE THE AUDIENCE DID TOO. 1944 01:26:23,971 --> 01:26:32,647 THANK YOU. 1945 01:26:32,647 --> 01:26:34,949 TIFFANI, I'LL LEAVE IT TO YOU IF 1946 01:26:34,949 --> 01:26:35,783 YOU THINK WE SHOULD TAKE A 1947 01:26:35,783 --> 01:26:36,717 QUESTION OR WRAP UP. 1948 01:26:36,717 --> 01:26:38,119 WE'LL BE HAPPY TO TALK WITH 1949 01:26:38,119 --> 01:26:40,121 FOLKS DURING THE MINGLING 1950 01:26:40,121 --> 01:26:40,855 PERIOD. 1951 01:26:40,855 --> 01:26:41,789 >> SOUNDS GREAT. 1952 01:26:41,789 --> 01:26:45,693 SO OUR PANELISTS WILL BE AROUND. 1953 01:26:45,693 --> 01:26:47,762 WE'RE GOING TO TAKE A QUICK 1954 01:26:47,762 --> 01:26:51,165 BREAK RIGHT NOW AND RECONVENE AT 1955 01:26:51,165 --> 01:26:51,599 10:30. 1956 01:26:51,599 --> 01:26:53,534 WE ALSO HAVE SNACKS AND SOME 1957 01:26:53,534 --> 01:26:54,135 CAFFEINE IN THE BACK. 1958 01:26:54,135 --> 01:26:56,893 ENJOY YOURSELVES. 1959 01:26:56,893 --> 01:26:58,595 LET'S GO AHEAD AND GET 1960 01:26:58,595 --> 01:27:01,832 STARTED HERE WITH OUR 1961 01:27:01,832 --> 01:27:03,200 DISTINGUISHED PANEL NUMBER TWO. 1962 01:27:03,200 --> 01:27:07,938 SO WE'RE WELCOMING THE INDUSTRY 1963 01:27:07,938 --> 01:27:12,976 PERSPECTIVES AND CHALLENGES 1964 01:27:12,976 --> 01:27:20,083 WHICH WILL BE CHAIRED BY WILBUR 1965 01:27:20,083 --> 01:27:21,184 LAM FROM EMORY UNIVERSITY AND 1966 01:27:21,184 --> 01:27:21,885 HIS PANEL. 1967 01:27:21,885 --> 01:27:23,320 >> THANK YOU EVERYONE FOR HAVING 1968 01:27:23,320 --> 01:27:25,589 ME HERE. 1969 01:27:25,589 --> 01:27:27,958 WE ARE MISSING ONE PANEL MEMBER 1970 01:27:27,958 --> 01:27:30,594 IF ANY OF YOU SEE DR. FERGUSON, 1971 01:27:30,594 --> 01:27:31,027 HE LOOKS LIKE THAT. 1972 01:27:31,027 --> 01:27:36,733 SEND HIM UP. 1973 01:27:36,733 --> 01:27:39,770 SO I'M SUPER EXCITED TO HEAD 1974 01:27:39,770 --> 01:27:41,505 THIS PANEL AND I REALLY WANT TO 1975 01:27:41,505 --> 01:27:47,344 MAKE THIS MORE OF A DISCUSSION. 1976 01:27:47,344 --> 01:27:49,146 WE HAVE THREE EXPERTS FROM 1977 01:27:49,146 --> 01:27:50,747 INDUSTRY AND I THINK THIS IS A 1978 01:27:50,747 --> 01:27:52,382 REALLY INTERESTING TOPIC BECAUSE 1979 01:27:52,382 --> 01:27:53,583 WE GET EXCITED ABOUT 1980 01:27:53,583 --> 01:27:54,651 POINT-OF-CARE TECHNOLOGIES AND 1981 01:27:54,651 --> 01:27:57,320 TALK ABOUT THE GREAT THINGS 1982 01:27:57,320 --> 01:27:57,587 COMING. 1983 01:27:57,587 --> 01:28:02,192 DR. TROMBERG TALKED ABOUT THE 1984 01:28:02,192 --> 01:28:02,893 VISION OF THE FUTURE AND 1985 01:28:02,893 --> 01:28:06,696 DR. McMANUS AND HIS GROUP 1986 01:28:06,696 --> 01:28:07,898 POINTED OUT EXCELLENT POINTS 1987 01:28:07,898 --> 01:28:10,200 ABOUT CLINICAL USE CASES. 1988 01:28:10,200 --> 01:28:12,402 WHAT ARE -- HOW WILL WE USE THIS 1989 01:28:12,402 --> 01:28:14,704 TECHNOLOGY, WHO WILL USE IT, 1990 01:28:14,704 --> 01:28:15,539 WHAT WILL THEY USE THE 1991 01:28:15,539 --> 01:28:17,874 INFORMATION AND HOW WILL THAT 1992 01:28:17,874 --> 01:28:20,444 CHANGE KLIN CAL MANAGEMENT AND 1993 01:28:20,444 --> 01:28:21,611 THERE'S ANOTHER BIG QUESTION 1994 01:28:21,611 --> 01:28:22,779 HERE. 1995 01:28:22,779 --> 01:28:24,714 WHO WILL BUY IT? 1996 01:28:24,714 --> 01:28:27,484 THAT IS A NECESSARY QUESTION IN 1997 01:28:27,484 --> 01:28:32,222 THE ENTIRE ECO SYSTEM. 1998 01:28:32,222 --> 01:28:34,858 IN THE ENTIRE PROCESS. 1999 01:28:34,858 --> 01:28:37,727 THESE GUYS THINK ABOUT THIS ALL 2000 01:28:37,727 --> 01:28:39,796 THE TIME AND WHAT WE DON'T OFTEN 2001 01:28:39,796 --> 01:28:41,331 TALK ABOUT ARE CHALLENGES FROM 2002 01:28:41,331 --> 01:28:42,466 THE INDUSTRY PERSPECTIVE. 2003 01:28:42,466 --> 01:28:44,401 I'M HONORED THE THREE OF OUR 2004 01:28:44,401 --> 01:28:49,606 EXPERTS ARE HERE. 2005 01:28:49,606 --> 01:28:56,046 IN FACT WHAT I'M GOING TO DO AND 2006 01:28:56,046 --> 01:28:57,347 I'LL HAVE EACH INTRODUCE 2007 01:28:57,347 --> 01:29:00,350 THEMSELVES AND SPEND A COUPLE 2008 01:29:00,350 --> 01:29:01,518 MINUTES TALKING ABOUT THEIR 2009 01:29:01,518 --> 01:29:04,020 COMPANY'S ORIGIN STORY AND WHAT 2010 01:29:04,020 --> 01:29:05,822 THEY'RE ABOUT AND GO ONE BY ONE 2011 01:29:05,822 --> 01:29:08,425 AND THEN WE'LL START DIVING INTO 2012 01:29:08,425 --> 01:29:11,061 QUESTIONS THAT EVERY SINGLE 2013 01:29:11,061 --> 01:29:13,597 INDUSTRY PARTNER THAT WE HAVE IN 2014 01:29:13,597 --> 01:29:14,464 OUR POINT-OF-CARE ECO SYSTEM HAS 2015 01:29:14,464 --> 01:29:16,099 TO DEAL WITH. 2016 01:29:16,099 --> 01:29:17,701 SEVERAL QUESTIONS. 2017 01:29:17,701 --> 01:29:20,036 SO FIRST IS DR. FERGUSON WITH 2018 01:29:20,036 --> 01:29:21,338 APT TUTE YOU CAN ADVANCE THE 2019 01:29:21,338 --> 01:29:31,448 SLIDE. 2020 01:29:44,060 --> 01:29:48,365 I'M SCOTT FERGUSON, FOUNDER AND 2021 01:29:48,365 --> 01:29:49,833 CEO OF APTITUDE. 2022 01:29:49,833 --> 01:29:55,772 WHAT I PUT ON THE SLIDE IS 2023 01:29:55,772 --> 01:29:59,442 APTITUDE'S CORE GOAL TO 2024 01:29:59,442 --> 01:30:04,848 DEMOCRA 2025 01:30:04,848 --> 01:30:07,417 DEMOCRATIZE DIAGNOSTICS. 2026 01:30:07,417 --> 01:30:10,086 ONE CRITICAL ELEMENT IS IMPROVE 2027 01:30:10,086 --> 01:30:10,420 ACCESSIBILITY. 2028 01:30:10,420 --> 01:30:17,561 SO ALLOW INDIVIDUALS TO BE ABLE 2029 01:30:17,561 --> 01:30:23,533 TO ACCESS DIAGNOSTIC INFORMATION 2030 01:30:23,533 --> 01:30:27,304 AND WHAT IF WE CAN EMPOWER 2031 01:30:27,304 --> 01:30:28,672 PATIENTS AS PARTICIPANTS IN 2032 01:30:28,672 --> 01:30:29,873 HEALTH CARE AND NOT JUST BE 2033 01:30:29,873 --> 01:30:30,140 PATIENTS. 2034 01:30:30,140 --> 01:30:40,517 THAN ONE CORE ELEMENT. 2035 01:30:50,393 --> 01:30:53,096 SECOND, LAB QUALITY IN A FORM 2036 01:30:53,096 --> 01:30:55,131 ANYONE CAN EXECUTE ANYWHERE AND 2037 01:30:55,131 --> 01:31:05,575 THE THIRD ELEMENT IS COST. 2038 01:31:11,314 --> 01:31:14,484 ALL YOU TYPICALLY PAY IS A 2039 01:31:14,484 --> 01:31:17,153 CO-PAY IF WE'RE GOING TO ENABLE 2040 01:31:17,153 --> 01:31:22,092 BROADER USE OF DIAGNOSTICS 2041 01:31:22,092 --> 01:31:32,602 OUTSIDE THE TRADITIONAL CARE 2042 01:31:33,370 --> 01:31:34,337 PARADIGM AND APT TUESDAY' 2043 01:31:34,337 --> 01:31:36,172 PURSUING A NUMBER OF PRODUCTS 2044 01:31:36,172 --> 01:31:38,975 BUT WE HAVE ONE THROUGH UA. 2045 01:31:38,975 --> 01:31:43,046 IT WAS CALLED THE METRICS 2046 01:31:43,046 --> 01:31:45,682 COVID-19 TEST. 2047 01:31:45,682 --> 01:31:48,885 IT WAS THE FIRST OVER THE 2048 01:31:48,885 --> 01:31:54,391 COUNTER TEST WITH SALIVA AND 2049 01:31:54,391 --> 01:32:01,031 SWAB SAMPLES. 2050 01:32:01,031 --> 01:32:03,333 AND THESE ARE AUTHORIZED FOR USE 2051 01:32:03,333 --> 01:32:05,201 IN THE HOME SETTING BY LAY 2052 01:32:05,201 --> 01:32:05,402 USERS. 2053 01:32:05,402 --> 01:32:06,836 ALSO CAN BE USED IN PROFESSIONAL 2054 01:32:06,836 --> 01:32:08,071 SETTINGS AND I'LL TALK MORE 2055 01:32:08,071 --> 01:32:08,838 ABOUT THAT LATER. 2056 01:32:08,838 --> 01:32:10,040 THAT'S THE KEY THING. 2057 01:32:10,040 --> 01:32:15,011 IT CAN BE USED BY LAY USERS FOR 2058 01:32:15,011 --> 01:32:15,979 ASYMPTOMATIC USE WITH GREAT 2059 01:32:15,979 --> 01:32:20,517 PERFORMANCE. 2060 01:32:20,517 --> 01:32:23,620 WE WERE ABLE TO GET ACROSS THE 2061 01:32:23,620 --> 01:32:28,625 USER GROUPS A 97% PPA AND MPA 2062 01:32:28,625 --> 01:32:31,628 COMPARED TO A HIGH PERFORMANCE 2063 01:32:31,628 --> 01:32:41,905 LAB-BASED RPTCR. 2064 01:32:46,309 --> 01:32:47,911 WE'RE DELIVERING ON THAT PROMISE 2065 01:32:47,911 --> 01:32:50,547 AND WE'VE GOT A NUMBER OF OTHER 2066 01:32:50,547 --> 01:32:51,915 PRODUCTS IN THE PIPELINE WE'LL 2067 01:32:51,915 --> 01:32:57,454 CONTINUE WITH THIS THEME. 2068 01:32:57,454 --> 01:33:00,056 THAT'S A BIT ABOUT APTITUDE. 2069 01:33:00,056 --> 01:33:01,991 >> GREAT. 2070 01:33:01,991 --> 01:33:08,498 NEXT IS ERIKA TYBURSKI AND I'M A 2071 01:33:08,498 --> 01:33:11,401 CO-FOUNDER AND ERIKA'S CHIEF 2072 01:33:11,401 --> 01:33:16,573 MEDICAL OFFICER AND SHE'S CEO 2073 01:33:16,573 --> 01:33:18,808 THEREFORE SHE'S MY BOSS SO GO 2074 01:33:18,808 --> 01:33:29,285 AHEAD AND TALK TO SANGUINEA. 2075 01:33:29,686 --> 01:33:33,256 >> I STARTED IN THE MEDICAL TECH 2076 01:33:33,256 --> 01:33:36,559 PROJECT AND MYSELF I DEALT WITH 2077 01:33:36,559 --> 01:33:39,763 NUTRITIONAL DEFICIENCY ANEMIA MY 2078 01:33:39,763 --> 01:33:42,499 WHOLE LIFE AND WILBUR BEING A 2079 01:33:42,499 --> 01:33:43,900 HEMATOLOGIST SEEING PATIENTS ALL 2080 01:33:43,900 --> 01:33:46,302 THE TIME WE HAD A PROFOUND 2081 01:33:46,302 --> 01:33:48,371 EXPERIENCE WITH IT AND REALIZED 2082 01:33:48,371 --> 01:33:50,607 BETTER ACCESS TO UNDERSTANDING 2083 01:33:50,607 --> 01:33:54,077 WHERE YOUR BODY IS AT A CERTAIN 2084 01:33:54,077 --> 01:33:56,312 POINT IN TIME IS CRITICAL IN 2085 01:33:56,312 --> 01:34:01,684 SYSTEMS AND IN HOME. 2086 01:34:01,684 --> 01:34:06,156 WE SPUN OUT OF THE GEORGIA TECH 2087 01:34:06,156 --> 01:34:07,724 SYSTEMS AND GOT THROUGH SEED 2088 01:34:07,724 --> 01:34:08,558 FUNDING AND OUR FIRST PLATFORM 2089 01:34:08,558 --> 01:34:13,530 IS ON ANEMIA MANAGEMENT. 2090 01:34:13,530 --> 01:34:17,167 WE HAVE A SIMPLE POINT OF CARE 2091 01:34:17,167 --> 01:34:20,136 TEST AND SIMPLE BLOOD SAMPLE 2092 01:34:20,136 --> 01:34:22,539 TEST WHERE YOU MIX IT WITH OUR 2093 01:34:22,539 --> 01:34:24,574 VIAL AND IT WAS FDA CLEARED 2094 01:34:24,574 --> 01:34:34,884 SEPTEMBER 29th OF THIS YEAR. 2095 01:34:34,884 --> 01:34:42,158 AND WE HAVE AN ONLINE PART AND 2096 01:34:42,158 --> 01:34:43,459 HAPPY TO DIVE INTO ANY OF THAT. 2097 01:34:43,459 --> 01:34:46,029 WE ALSO HAVE A PIPELINE OF OTHER 2098 01:34:46,029 --> 01:34:47,831 BIOMARKERS WE'RE LOOKING AT THAT 2099 01:34:47,831 --> 01:34:51,835 FOR US UNIQUELY ARE NOT ONLY AT 2100 01:34:51,835 --> 01:34:54,204 THE POINT OF DISEASE BUT CAN 2101 01:34:54,204 --> 01:34:55,004 POTENTIALLY BE LOOKED AT EARLIER 2102 01:34:55,004 --> 01:34:57,040 AS VITAL SIGNS TO PREVENT ANY OF 2103 01:34:57,040 --> 01:34:57,907 THESE PROBLEMS. 2104 01:34:57,907 --> 01:34:59,609 THERE'S A BIG DICHOTOMY GOING ON 2105 01:34:59,609 --> 01:35:01,344 WHEN YOU ASK WHO CAN PAY FOR IT 2106 01:35:01,344 --> 01:35:02,679 AND WHO SHOULD PAY FOR IT AND 2107 01:35:02,679 --> 01:35:03,880 WHO IS WILLING TO AT THIS POINT 2108 01:35:03,880 --> 01:35:05,882 IN TIME BECAUSE I THINK THERE'S 2109 01:35:05,882 --> 01:35:07,717 A LOT OF PAYMENT OPTIONS ON WHEN 2110 01:35:07,717 --> 01:35:10,320 YOU ALREADY HAVE A DIAGNOSIS AND 2111 01:35:10,320 --> 01:35:12,555 IN THE TEST TO TREAT PHASE BUT 2112 01:35:12,555 --> 01:35:13,590 WE'RE LOOKING AT THE BIOMARKER 2113 01:35:13,590 --> 01:35:18,995 AND HOW IT EXISTS IN PEOPLE AND 2114 01:35:18,995 --> 01:35:21,731 PARTICIPATE IN THE PREVENTIVE 2115 01:35:21,731 --> 01:35:22,398 SIDE. 2116 01:35:22,398 --> 01:35:23,199 PASSIONATE ABOUT EVERYTHING 2117 01:35:23,199 --> 01:35:25,468 SCOTT WENT THROUGH AND HAPPY TO 2118 01:35:25,468 --> 01:35:26,736 BE HERE. 2119 01:35:26,736 --> 01:35:32,475 >> GREAT, THANKS ERIKA SHE'S 2120 01:35:32,475 --> 01:35:33,943 ALSO A REGULATORY EXPERT AND 2121 01:35:33,943 --> 01:35:36,179 MANY WORK WITH HER UNDER THAT 2122 01:35:36,179 --> 01:35:37,113 PURVIEW. 2123 01:35:37,113 --> 01:35:41,017 OUR LAST PANELIST, ERIK 2124 01:35:41,017 --> 01:35:43,419 ENGELSON, PLEASE TALK ABOUT YOUR 2125 01:35:43,419 --> 01:35:49,058 ADVENTURES WITH LUCERA. 2126 01:35:49,058 --> 01:35:52,662 >> THANK YOU, I'M A 2127 01:35:52,662 --> 01:35:53,663 MICROBIOLOGIST AND BIO ENGINEER 2128 01:35:53,663 --> 01:35:55,398 AND STUDIED BUSINESS AND 2129 01:35:55,398 --> 01:35:57,400 CURRENTLY STUDYING A.I. 2130 01:35:57,400 --> 01:35:59,736 IT'S GREAT HAVING STANFORD AT 2131 01:35:59,736 --> 01:36:01,704 THE BACK DOOR. 2132 01:36:01,704 --> 01:36:03,406 I'M BASED IN SILICON VALLEY. 2133 01:36:03,406 --> 01:36:05,074 HAVE BEEN FOR MY ENTIRE CAREER 2134 01:36:05,074 --> 01:36:08,711 AND THERE'S A BIG MEDICAL DEVICE 2135 01:36:08,711 --> 01:36:10,546 INDUSTRY IN SILICON VALLEY. 2136 01:36:10,546 --> 01:36:14,017 I SPENT ALMOST ALL MY CAREER 2137 01:36:14,017 --> 01:36:17,186 WITH THE EXCEPTION OF LUCERA IN 2138 01:36:17,186 --> 01:36:19,789 INTERVENTIONAL MEDICAL DEVICES 2139 01:36:19,789 --> 01:36:24,761 ON THE VENTURE SIDE AND RUNNING 2140 01:36:24,761 --> 01:36:25,128 COMPANIES. 2141 01:36:25,128 --> 01:36:33,937 IF ANYONE KNOWS WHOSE CEREBRAL 2142 01:36:33,937 --> 01:36:37,674 ANEURYSM WAS CURED BY COILS WE 2143 01:36:37,674 --> 01:36:40,410 CREATED THAT COMPANY AND WHILE 2144 01:36:40,410 --> 01:36:43,346 I'M PROUD OF THE ANEURYSM 2145 01:36:43,346 --> 01:36:47,951 DEVICES, ESPECIALLY OF THIS 2146 01:36:47,951 --> 01:36:51,020 GORGEOUS PRODUCT WHICH PFIZER 2147 01:36:51,020 --> 01:36:53,556 NOW OWNS AND MANY WENT TO PFIZER 2148 01:36:53,556 --> 01:36:56,359 AND EXCITED TO SEE THE PRODUCT 2149 01:36:56,359 --> 01:37:00,330 AVAILABLE ON AMAZON STILL. 2150 01:37:00,330 --> 01:37:03,333 THIS IS OUR FIRST PRODUCT AT 2151 01:37:03,333 --> 01:37:05,435 LUCIRA WAS A COVID-ONLY PRODUCT. 2152 01:37:05,435 --> 01:37:09,305 THIS IS A KIND PRODUCT WITH FLU, 2153 01:37:09,305 --> 01:37:12,342 A FLU B THAT GIVES THE 2154 01:37:12,342 --> 01:37:13,977 DIFFERENTIAL DIAGNOSIS BASED ON 2155 01:37:13,977 --> 01:37:14,844 ONE NASAL SWAB. 2156 01:37:14,844 --> 01:37:16,512 IF YOU'RE CONFUSED ABOUT YOUR 2157 01:37:16,512 --> 01:37:18,748 SYSTEMS AND GET THE ANSWER ON 2158 01:37:18,748 --> 01:37:24,554 THE SPOT AS WAS MENTIONED UP 2159 01:37:24,554 --> 01:37:31,194 HERE EARLIER YOU CAN TAKE AN 2160 01:37:31,194 --> 01:37:34,697 ANTIVIRAL AND BE ON YOUR WAY AND 2161 01:37:34,697 --> 01:37:36,799 MY FAMILY'S USED IT AND TAKEN 2162 01:37:36,799 --> 01:37:39,569 THE ANTIVIRALS AND WORKED AS 2163 01:37:39,569 --> 01:37:39,836 EXPECTED. 2164 01:37:39,836 --> 01:37:43,139 THE LIMIT OF DETECTION OF THE 2165 01:37:43,139 --> 01:37:47,110 COVID ASSAY IS TEN TO THE SECOND 2166 01:37:47,110 --> 01:37:50,279 YOU CAN FIND ASYMPTOMATIC 2167 01:37:50,279 --> 01:37:50,546 POSITIVES. 2168 01:37:50,546 --> 01:37:54,283 THAT'S CRITICAL OR HAS BEEN IN 2169 01:37:54,283 --> 01:37:55,218 OUR MINDS AND SO WE'RE VERY 2170 01:37:55,218 --> 01:38:05,395 PROUD OF THIS PRODUCT. 2171 01:38:05,395 --> 01:38:09,832 >> LOOKING FORWARD TO HEARING 2172 01:38:09,832 --> 01:38:17,273 MORE AND LET'S DIVE INTO IT. 2173 01:38:17,273 --> 01:38:27,717 WHEN I WAS INTERESTED IN 2174 01:38:28,918 --> 01:38:34,357 DIAGNOSTICS IN SILICON VALLEY 2175 01:38:34,357 --> 01:38:38,461 AND IN YEARS PAST THE ROI IN THE 2176 01:38:38,461 --> 01:38:39,662 DIAGNOSTIC INDUSTRY WAS LOW 2177 01:38:39,662 --> 01:38:41,731 COMPARED TO OTHER THINGS LIKE 2178 01:38:41,731 --> 01:38:42,832 THERAPEUTICS AND CERTAIN DRUGS 2179 01:38:42,832 --> 01:38:44,033 AND SO FORTH. 2180 01:38:44,033 --> 01:38:45,701 SO HOW DID YOU GUYS DEAL WITH 2181 01:38:45,701 --> 01:38:48,438 THAT AND HAS THAT CHANGED WITH 2182 01:38:48,438 --> 01:38:51,040 THE PANDEMIC OR EVEN NOW? 2183 01:38:51,040 --> 01:38:52,642 HAS IT GONE BACK? 2184 01:38:52,642 --> 01:38:54,277 I'D LOVE TO HEAR EACH OF YOUR 2185 01:38:54,277 --> 01:38:54,544 THOUGHTS. 2186 01:38:54,544 --> 01:38:55,978 MAYBE STARTING WITH SCOTT. 2187 01:38:55,978 --> 01:39:00,850 >> SO I THINK THE ROI EQUATION 2188 01:39:00,850 --> 01:39:01,584 DEFINITELY HAS BEEN VARIABLE 2189 01:39:01,584 --> 01:39:09,459 OVER THE PAST FEW YEARS. 2190 01:39:09,459 --> 01:39:11,594 SPECIFICALLY THAT'S IMPORTANT 2191 01:39:11,594 --> 01:39:13,029 FOR HOW A DIAGNOSTIC COMPANY 2192 01:39:13,029 --> 01:39:14,797 GOES FROM NOTHING TO HAVING A 2193 01:39:14,797 --> 01:39:15,031 PRODUCT. 2194 01:39:15,031 --> 01:39:16,732 YOU NEED MONEY TO BE ABLE TO DO 2195 01:39:16,732 --> 01:39:17,433 THAT. 2196 01:39:17,433 --> 01:39:19,001 YOU NEED TO BE ABLE TO 2197 01:39:19,001 --> 01:39:22,805 COMMUNICATE THE ROI STORY. 2198 01:39:22,805 --> 01:39:25,308 THERE'S DIFFERENT BUCKETS OF 2199 01:39:25,308 --> 01:39:30,947 FUNDING SOURCES THAT CAN 2200 01:39:30,947 --> 01:39:31,547 RESONATE. 2201 01:39:31,547 --> 01:39:36,853 SOME ARE INSTITUTIONAL 2202 01:39:36,853 --> 01:39:37,120 INVESTORS. 2203 01:39:37,120 --> 01:39:39,755 AND OTHERS ARE FOR EXAMPLE THE 2204 01:39:39,755 --> 01:39:41,524 NIH AND THE RADX PROGRAM AND 2205 01:39:41,524 --> 01:39:43,893 BARDA AND OTHER FUNDING SOURCES 2206 01:39:43,893 --> 01:39:49,165 AND GATES FOUNDATION THAT CAN 2207 01:39:49,165 --> 01:39:54,437 HELP TO NAVIGATE STAGES WHERE 2208 01:39:54,437 --> 01:39:58,708 THE ROI EQUATION DOESN'T LOOK 2209 01:39:58,708 --> 01:40:00,376 GOOD FOR AN INSTITUTIONAL 2210 01:40:00,376 --> 01:40:01,677 INVESTOR. 2211 01:40:01,677 --> 01:40:03,679 FOR DIAGNOSTIC COMPANIES THAT 2212 01:40:03,679 --> 01:40:06,816 COME INTO THE SPACE TYPICALLY 2213 01:40:06,816 --> 01:40:09,519 THIS IS BECAUSE OF SOME 2214 01:40:09,519 --> 01:40:10,286 BREAKTHROUGH USUALLY ON THE 2215 01:40:10,286 --> 01:40:11,154 TECHNOLOGY SIDE. 2216 01:40:11,154 --> 01:40:14,790 THAT'S GREAT BUT IT'S ONE PIECE 2217 01:40:14,790 --> 01:40:16,626 OF A LARGE PUFL THAT NEEDS TO 2218 01:40:16,626 --> 01:40:20,062 COME TOGETHER IN ORDER FOR THAT 2219 01:40:20,062 --> 01:40:28,404 R TO BE REALIZED DOWN THE LINE. 2220 01:40:28,404 --> 01:40:29,872 THERE'S A NUMBER OF DERISKING 2221 01:40:29,872 --> 01:40:35,244 STEPS THAT HAVE TO HAPPEN ON 2222 01:40:35,244 --> 01:40:36,979 THAT JOURNEY. 2223 01:40:36,979 --> 01:40:37,747 THERE ARE CERTAIN DERISKING 2224 01:40:37,747 --> 01:40:40,383 STEPS THAT ARE REALLY GOOD FOR 2225 01:40:40,383 --> 01:40:43,586 VENTURE MONEY TO PARTICIPATE IN 2226 01:40:43,586 --> 01:40:46,422 AND CERTAIN DE RISKING STEPS 2227 01:40:46,422 --> 01:40:48,157 THAT ARE DIFFICULT FOR VENTURE 2228 01:40:48,157 --> 01:40:52,828 MONEY TO PARTICIPATE IN. 2229 01:40:52,828 --> 01:40:54,096 MY ADVICE FOR ANOTHER DIAGNOSTIC 2230 01:40:54,096 --> 01:40:55,364 COMPANY IS TO LOOK AT THE 2231 01:40:55,364 --> 01:40:56,499 DIFFERENT BUCKETS OF MONEY THAT 2232 01:40:56,499 --> 01:40:58,534 CAN BE OUT THERE AND USE THEM AS 2233 01:40:58,534 --> 01:41:04,240 A PORTFOLIO TO HELP GET THE JOB 2234 01:41:04,240 --> 01:41:11,581 DONE AND REALIZE THAT ULTIMATE 2235 01:41:11,581 --> 01:41:18,688 POWER. 2236 01:41:18,688 --> 01:41:23,960 >> THE PANDEMIC FOR OUR COMPANY 2237 01:41:23,960 --> 01:41:25,528 WAS A SILVER LINING. 2238 01:41:25,528 --> 01:41:27,096 THE MODEL WE WERE FACING WHEN WE 2239 01:41:27,096 --> 01:41:28,397 WOULD PITCH AND GET TO THE POINT 2240 01:41:28,397 --> 01:41:30,666 IS WELL, I'VE GOT THIS GIANT 2241 01:41:30,666 --> 01:41:33,636 MACHINE THAT LIVES IN A TERTIARY 2242 01:41:33,636 --> 01:41:35,338 HOSPITAL AND WE RUN BLOOD DRAWS 2243 01:41:35,338 --> 01:41:37,373 AND GET THIS PARAMETER AMONGST 2244 01:41:37,373 --> 01:41:39,609 OTHERS ON THE PANEL SO WHY WOULD 2245 01:41:39,609 --> 01:41:44,113 I BE INTERESTED IN USING THIS 2246 01:41:44,113 --> 01:41:45,548 AND REIMBURSEMENT IS ALREADY SET 2247 01:41:45,548 --> 01:41:46,682 LOW AND SOMETHING DIAGNOSTICS 2248 01:41:46,682 --> 01:41:48,784 FACE BUT DURING THE PANDEMIC THE 2249 01:41:48,784 --> 01:41:52,088 MODEL OF SENDING PEOPLE SICK AND 2250 01:41:52,088 --> 01:41:53,789 HEALTHY TO ONE PLACE WAS FLIPPED 2251 01:41:53,789 --> 01:41:54,357 ON ITS HEAD. 2252 01:41:54,357 --> 01:41:57,326 WE NOW HAD THE NEED FOR 2253 01:41:57,326 --> 01:42:00,329 POINT-OF-CARE AND HOME TEST 2254 01:42:00,329 --> 01:42:01,130 SITES CAN DO. 2255 01:42:01,130 --> 01:42:04,333 THE CVSs AND WALGREENs OF THE 2256 01:42:04,333 --> 01:42:06,168 WORLD ENDED UP BEING THE NORM 2257 01:42:06,168 --> 01:42:08,037 OPPOSED TO GOING INTO A CLINIC 2258 01:42:08,037 --> 01:42:09,205 WHERE YOU WERE TRYING TO SERVE 2259 01:42:09,205 --> 01:42:15,878 THE SICKEST OF THE SICK. 2260 01:42:15,878 --> 01:42:17,580 THAT MANTRA HELPED WITH OUR 2261 01:42:17,580 --> 01:42:17,947 INVESTORS. 2262 01:42:17,947 --> 01:42:19,949 WE CLOSED OUR FIRST SEED ROUND 2263 01:42:19,949 --> 01:42:21,484 IN JULY OF 2020 WHEN THIS WAS 2264 01:42:21,484 --> 01:42:24,086 ALREADY STARTING AND WERE ABLE 2265 01:42:24,086 --> 01:42:25,988 TO CLOSE A SMALL SERIES A IN 2266 01:42:25,988 --> 01:42:27,723 JUNE OF THIS YEAR. 2267 01:42:27,723 --> 01:42:29,625 WHEN WE THINK OF ROI IT'S NOW 2268 01:42:29,625 --> 01:42:39,602 BROADENED TO THE MODEL BREAKING 2269 01:42:39,602 --> 01:42:40,970 THE TECHNOLOGY AND A HUGE DATA 2270 01:42:40,970 --> 01:42:43,172 ELEMENT WE'LL LIKELY GET INTO 2271 01:42:43,172 --> 01:42:43,839 AND UNDERSTANDING ON THE 2272 01:42:43,839 --> 01:42:46,309 INDIVIDUAL LEVEL WHAT YOU CAN DO 2273 01:42:46,309 --> 01:42:48,077 WITH DATA AND THE POPULATION 2274 01:42:48,077 --> 01:42:48,811 LEVEL WE'VE SEEN EXAMPLES WITH 2275 01:42:48,811 --> 01:42:59,088 IN THE PANDEMIC. 2276 01:42:59,755 --> 01:43:01,557 >> WHILE I'VE BEEN INVOLVED IN 2277 01:43:01,557 --> 01:43:04,260 START-UPS AND IN ANY LAST FOUR 2278 01:43:04,260 --> 01:43:06,495 COMPANIES I'VE BEEN CEO I'M COME 2279 01:43:06,495 --> 01:43:08,130 IN LATER AFTER THE TECHNOLOGY 2280 01:43:08,130 --> 01:43:12,735 RISK HAS BEEN SHAKEN OUT ON $10, 2281 01:43:12,735 --> 01:43:14,503 $15 MILLION AND NOW IT'S TIME TO 2282 01:43:14,503 --> 01:43:18,074 SCALE AND GET THROUGH FDA AND 2283 01:43:18,074 --> 01:43:21,577 BUILD A COMMERCIAL TEAM AND 2284 01:43:21,577 --> 01:43:26,749 REALLY GO FROM WHERE EVERYTHING 2285 01:43:26,749 --> 01:43:29,885 ARE TO 60 MILES AN HOUR. 2286 01:43:29,885 --> 01:43:33,989 AT LUCIRA IT TOOK A LOT OF 2287 01:43:33,989 --> 01:43:37,326 CAPITAL AND TWO-THIRDS WAS FROM 2288 01:43:37,326 --> 01:43:38,994 THE PUBLIC MARKETS. 2289 01:43:38,994 --> 01:43:40,429 IT IS VERY EXPENSIVE. 2290 01:43:40,429 --> 01:43:43,666 AND THE THING THAT MAKES THIS 2291 01:43:43,666 --> 01:43:44,467 CHALLENGING NUMBER ONE THIS IS 2292 01:43:44,467 --> 01:43:52,007 AN OTC PRODUCT. 2293 01:43:52,007 --> 01:43:55,177 OUR DEVELOPMENT AIM WAS NOT TO 2294 01:43:55,177 --> 01:43:57,113 PUT IN PHYSICIAN OFFICES THOUGH 2295 01:43:57,113 --> 01:43:59,815 IT WILL HAVE A GREAT USE CASE 2296 01:43:59,815 --> 01:44:02,885 THERE AND WILL BE PURSUED BUT 2297 01:44:02,885 --> 01:44:04,754 NOT RECEIVING OTC FIRST BUT 2298 01:44:04,754 --> 01:44:05,855 GOING THROUGH POC LABEL FIRST 2299 01:44:05,855 --> 01:44:08,758 AND THEN OTC WAS NOT HELPFUL TO 2300 01:44:08,758 --> 01:44:09,959 US. 2301 01:44:09,959 --> 01:44:11,127 WE WERE GEARED TO SELL INTO OTC 2302 01:44:11,127 --> 01:44:16,732 FOR HOME USE. 2303 01:44:16,732 --> 01:44:19,502 SO IT TAKES A LOT OF MONEY FOR 2304 01:44:19,502 --> 01:44:24,240 THE SUPPLY CHAIN TO GET READY 2305 01:44:24,240 --> 01:44:30,446 FOR RERP -- RESPIRATORY SEASON 2306 01:44:30,446 --> 01:44:33,716 AND YOU HAVE TO BE ABLE TO CARRY 2307 01:44:33,716 --> 01:44:35,918 THE WORKFORCE IN OUR CASE, 13 2308 01:44:35,918 --> 01:44:37,720 PEOPLE THROUGH THE NEXT 2309 01:44:37,720 --> 01:44:40,689 RESPIRATORY SEASON. 2310 01:44:40,689 --> 01:44:49,064 THAT'S NOT TRIVIAL. 2311 01:44:49,064 --> 01:44:50,266 INVESTORS ARE WATCHING AND WILL 2312 01:44:50,266 --> 01:44:52,301 NOT INVEST IF THE PROCESS IS NOT 2313 01:44:52,301 --> 01:44:53,769 MORE PREDICTABLE. 2314 01:44:53,769 --> 01:44:56,305 THAL THAT'S ONE CHALLENGE AND 2315 01:44:56,305 --> 01:44:57,840 INTERVENTIONAL DEVICE WHERE I 2316 01:44:57,840 --> 01:45:00,709 SPENT MOST MY CAREER THE GROSS 2317 01:45:00,709 --> 01:45:03,045 MARGINS IS IN THE RANGE OF 75% 2318 01:45:03,045 --> 01:45:03,245 NORTH. 2319 01:45:03,245 --> 01:45:04,747 SO THAT GIVES YOU SOME 2320 01:45:04,747 --> 01:45:11,554 FLEXIBILITY. 2321 01:45:11,554 --> 01:45:13,322 IN DIAGNOSTICS THE GROSS MARGINS 2322 01:45:13,322 --> 01:45:17,760 ARE MAYBE 55% IF YOU'RE LUCKY. 2323 01:45:17,760 --> 01:45:20,529 THAT MEANS THINGS RUN TIGHT. 2324 01:45:20,529 --> 01:45:24,733 IN Q1 OF '22 WE HAD A $90 2325 01:45:24,733 --> 01:45:26,435 MILLION QUARTER AND THAT 2326 01:45:26,435 --> 01:45:28,304 PRODUCED NET INCOME. 2327 01:45:28,304 --> 01:45:30,239 NOT PROFITABILITY BUT NET 2328 01:45:30,239 --> 01:45:30,606 INCOME. 2329 01:45:30,606 --> 01:45:31,273 WE'RE ON THE RIGHT PATH AT THAT 2330 01:45:31,273 --> 01:45:36,245 POINT. 2331 01:45:36,245 --> 01:45:40,449 THAT'S VERY HARD TO GET TO AND 2332 01:45:40,449 --> 01:45:41,517 AGAIN IT WAS THE PANDEMIC THAT 2333 01:45:41,517 --> 01:45:42,251 GOT US THERE. 2334 01:45:42,251 --> 01:45:43,152 IT'S A CHALLENGING SPACE FOR 2335 01:45:43,152 --> 01:45:53,062 THOSE REASONS. 2336 01:45:53,062 --> 01:45:54,864 WHEN YOU HAVE INVESTORS WHAT DO 2337 01:45:54,864 --> 01:45:58,400 YOU DO TO GET THEM TO BUY IN? 2338 01:45:58,400 --> 01:45:59,335 ANYBODY. 2339 01:45:59,335 --> 01:46:00,903 >> I HAD THAT CONVERSATION THE 2340 01:46:00,903 --> 01:46:03,939 OTHER DAY FOR AN INVESTOR FOR 2341 01:46:03,939 --> 01:46:06,575 ANOTHER COMPANY AND DOING CHEST 2342 01:46:06,575 --> 01:46:12,014 THUMPING HOW LUCIRA TOLD $250 2343 01:46:12,014 --> 01:46:12,882 MILLION WORTH OF THE PRODUCT AND 2344 01:46:12,882 --> 01:46:16,785 HE SAID THAT WAS THE PANDEMIC. 2345 01:46:16,785 --> 01:46:18,120 SO THEY COMPLETELY DISCOUNT WHAT 2346 01:46:18,120 --> 01:46:26,562 WAS ACHIEVED IN THE PANDEMIC. 2347 01:46:26,562 --> 01:46:28,731 >> IT'S FRANKLY A BLOOD WATH OUT 2348 01:46:28,731 --> 01:46:37,273 THERE. 2349 01:46:37,273 --> 01:46:39,775 >> THERE'S A GLUT OF COMPANIES 2350 01:46:39,775 --> 01:46:40,743 RIGHT NOW. 2351 01:46:40,743 --> 01:46:41,443 THE PANDEMIC BROUGHT TOGETHER A 2352 01:46:41,443 --> 01:46:44,813 LOT OF APPROACH TO TRY TO SOLVE 2353 01:46:44,813 --> 01:46:47,650 SINGULAR PROBLEM AND THEN THAT 2354 01:46:47,650 --> 01:46:49,051 SINGULAR PROBLEM WHICH 2355 01:46:49,051 --> 01:46:50,653 PREVIOUSLY REQUIRED TESTING THAT 2356 01:46:50,653 --> 01:46:52,221 WENT AWAY. 2357 01:46:52,221 --> 01:46:53,289 THE GOVERNMENT'S ALSO PROVIDING 2358 01:46:53,289 --> 01:46:57,359 FREE TESTS WHICH MAKES IT A 2359 01:46:57,359 --> 01:47:00,296 DIFFICULT COMPETITOR OUT THERE. 2360 01:47:00,296 --> 01:47:05,668 AND SO FOR COVID ITSELF AS A 2361 01:47:05,668 --> 01:47:08,437 LEAD PRODUCT IS THE COVID TEST, 2362 01:47:08,437 --> 01:47:10,506 THAT'S A TOUGH MARKET AND 2363 01:47:10,506 --> 01:47:11,607 DIFFICULT FOR INVESTORS TO 2364 01:47:11,607 --> 01:47:21,483 COMPUTE A GOOD ROI ON. 2365 01:47:21,483 --> 01:47:24,987 I LIKE THE SLIDE THAT SHOWS HOW 2366 01:47:24,987 --> 01:47:27,022 BIG AT-HOME TESTING WILL BE IN 2367 01:47:27,022 --> 01:47:28,657 THE FUTURE AHEAD BUT AT THE SAME 2368 01:47:28,657 --> 01:47:30,059 TIME THERE'S SIGNIFICANT MARKET 2369 01:47:30,059 --> 01:47:31,160 DEVELOPMENT THAT HAS TO EXIST ON 2370 01:47:31,160 --> 01:47:38,500 THAT FRONT. 2371 01:47:38,500 --> 01:47:39,335 PREVIOUS TESTING WAS REQUIRED 2372 01:47:39,335 --> 01:47:41,103 AND WHEN YOU REMOVE THAT 2373 01:47:41,103 --> 01:47:46,241 REQUIREMENT YOU'RE RELYING ON 2374 01:47:46,241 --> 01:47:50,279 THE OTHER FACTORS AND IT'S NOT 2375 01:47:50,279 --> 01:47:51,547 SO SAY THEY'RE NOT THERE BUT AT 2376 01:47:51,547 --> 01:47:53,082 THE ORDER OF MAGNITUDE MORE 2377 01:47:53,082 --> 01:48:01,223 DIFFERENT SCALE. 2378 01:48:01,223 --> 01:48:02,691 >> THEY'RE REQUIRED TO TEST 2379 01:48:02,691 --> 01:48:04,560 VERSUS WANT IT AND NICE TO TEST 2380 01:48:04,560 --> 01:48:05,628 IS SOMETHING WE'RE SEEING. 2381 01:48:05,628 --> 01:48:08,497 I THINK I'M THE ONLY COMPANY 2382 01:48:08,497 --> 01:48:10,666 HERE WHERE THE LEAD PRODUCT IS 2383 01:48:10,666 --> 01:48:12,134 NOT WITH AN INFECTIOUS DISEASE. 2384 01:48:12,134 --> 01:48:14,169 WE DON'T HAVE A COVID-19 TEST. 2385 01:48:14,169 --> 01:48:19,908 FROM MY PERSPECTIVE I GET THAT 2386 01:48:19,908 --> 01:48:30,452 QUESTION AND WE'VE BEEN ABLE TO 2387 01:48:32,621 --> 01:48:34,490 WORK IN THE CHRONIC DISEASE 2388 01:48:34,490 --> 01:48:35,224 MANAGEMENT SPACE FIRST WHERE 2389 01:48:35,224 --> 01:48:37,259 THERE'S REQUIREMENTS TO TEST. 2390 01:48:37,259 --> 01:48:39,795 THERE'S CERTAIN LEVELS OF 2391 01:48:39,795 --> 01:48:40,829 HEMOGLOBIN WHERE CERTAIN DRUGS 2392 01:48:40,829 --> 01:48:42,564 CAN AND CAN'T BE ADMINISTERED 2393 01:48:42,564 --> 01:48:44,833 AND YOU CAN WORK IN THAT PATH. 2394 01:48:44,833 --> 01:48:47,369 THAT'S A FORTUNATE ANGLE FOR ME 2395 01:48:47,369 --> 01:48:49,338 BUT IF IT WERE TOTALLY 2396 01:48:49,338 --> 01:48:50,773 PREVENTIVE IT'S NEAR IMPOSSIBLE 2397 01:48:50,773 --> 01:48:52,641 TO GET AN INVESTOR TO ALIGN 2398 01:48:52,641 --> 01:48:54,877 BECAUSE IT'S NICE TO HAVE AND IT 2399 01:48:54,877 --> 01:48:56,679 RELIES ON EDUCATION ALMOST 2400 01:48:56,679 --> 01:49:02,951 ENTIRELY DIRECT TO CONSUMER 2401 01:49:02,951 --> 01:49:04,687 WHICH EVERYBODY KNOWS IS 2402 01:49:04,687 --> 01:49:04,953 EXPENSIVE. 2403 01:49:04,953 --> 01:49:07,656 IT CAN BE EXPENSIVE SO INVESTORS 2404 01:49:07,656 --> 01:49:09,358 WILL SEE I NEED HUNDREDS OF 2405 01:49:09,358 --> 01:49:11,160 MILLIONS TO DO THIS. 2406 01:49:11,160 --> 01:49:14,029 FOR ME THE PANDEMIC OPENED EYES. 2407 01:49:14,029 --> 01:49:15,264 THEY'RE MORE INTERESTED IN 2408 01:49:15,264 --> 01:49:16,432 ACCESSIBLE CARE AND WHAT NOT AND 2409 01:49:16,432 --> 01:49:20,903 FOR US WE'VE BEEN ABLE TO WORK 2410 01:49:20,903 --> 01:49:22,938 IN MANY SEGMENTS WHILE TRYING TO 2411 01:49:22,938 --> 01:49:28,410 WORK ON THE ENGAGEMENT AND 2412 01:49:28,410 --> 01:49:29,111 EDUCATION PIECE. 2413 01:49:29,111 --> 01:49:39,655 >> ONE TIDBIT IS FOCUS AND THERE 2414 01:49:40,789 --> 01:49:51,066 NEEDS TO BE A PIVOT. 2415 01:50:00,008 --> 01:50:02,411 >> WE'RE STILL A SMALL COMPANY 2416 01:50:02,411 --> 01:50:04,980 THERE'S ABOUT 50 AND A SPINOUT 2417 01:50:04,980 --> 01:50:07,583 FROM U.C. SANTA BARBARA AND 2418 01:50:07,583 --> 01:50:11,854 EXISTED ABOUT 10 YEARS OR SO. 2419 01:50:11,854 --> 01:50:13,088 WE'RE JUST NOW GETTING OUR FIRST 2420 01:50:13,088 --> 01:50:14,389 PRODUCT OUT THERE. 2421 01:50:14,389 --> 01:50:19,027 IT'S BEEN A LONG JOURNEY. 2422 01:50:19,027 --> 01:50:21,363 THE PRIOR TO COVID-19 WE'RE 2423 01:50:21,363 --> 01:50:24,032 STILL WORKING ON DIAGNOSTICS BUT 2424 01:50:24,032 --> 01:50:25,367 DIFFERENT DIAGNOSTIC PRODUCT 2425 01:50:25,367 --> 01:50:28,937 WITH THE SAME UNDERLYING GOAL OF 2426 01:50:28,937 --> 01:50:30,873 IMPROVING ACCESSIBILITY TO TEST 2427 01:50:30,873 --> 01:50:32,174 THAT HAVE IMPORTANT INFORMATION 2428 01:50:32,174 --> 01:50:37,379 THAT CAN INFLUENCE THE COARSE 2429 01:50:37,379 --> 01:50:39,448 -- COURSE OF PATIENT CARE AND 2430 01:50:39,448 --> 01:50:40,749 MANAGEMENT AND TREATMENT. 2431 01:50:40,749 --> 01:50:41,784 WELL, COVID WAS HAPPENING AND 2432 01:50:41,784 --> 01:50:45,454 THE THINGS THAT WERE HARD TO DO 2433 01:50:45,454 --> 01:50:50,025 GOT HARDER. 2434 01:50:50,025 --> 01:50:54,763 WE PERCEIVE THE POTENTIAL TO 2435 01:50:54,763 --> 01:50:56,098 EXPAND COVID AND CAPABILITIES 2436 01:50:56,098 --> 01:50:57,299 AND WE MADE THAT PIVOT AT THAT 2437 01:50:57,299 --> 01:51:07,409 TIME. 2438 01:51:12,781 --> 01:51:14,850 EVEN IN COVID HEYDAY WE HAD SOME 2439 01:51:14,850 --> 01:51:16,819 REASONABLE AMOUNT OF FUNDING 2440 01:51:16,819 --> 01:51:20,789 THROUGH A STRATEGIC INVESTMENT. 2441 01:51:20,789 --> 01:51:25,360 WE HAD A WE WERE PART OF THE 2442 01:51:25,360 --> 01:51:26,929 RADX REDIRECT GROUP AND RADX 2443 01:51:26,929 --> 01:51:27,196 ONE. 2444 01:51:27,196 --> 01:51:29,498 THEY WERE HELPFUL BUT WE NEEDED 2445 01:51:29,498 --> 01:51:33,535 MORE MONEY TO GET STUFF DONE. 2446 01:51:33,535 --> 01:51:35,370 WELL, WE WERE -- YOU MENTIONED 2447 01:51:35,370 --> 01:51:35,671 FOCUS. 2448 01:51:35,671 --> 01:51:37,739 WE WERE LASER FOCUSSED ON THIS 2449 01:51:37,739 --> 01:51:39,374 PRODUCT BUT WHAT WE ALSO 2450 01:51:39,374 --> 01:51:42,611 RECOGNIZED AT THE SAME TIME WAS 2451 01:51:42,611 --> 01:51:44,980 WE'RE LOCATED IN CENTRAL, 2452 01:51:44,980 --> 01:51:46,248 CALIFORNIA, THERE WAS A DEARTH 2453 01:51:46,248 --> 01:51:49,051 OF TESTING CAPABILITIES. 2454 01:51:49,051 --> 01:51:54,056 WE SET UP A LAB AND DEVELOPED AN 2455 01:51:54,056 --> 01:51:58,293 LDT TO DO HIGH THROUGHPUT 2456 01:51:58,293 --> 01:52:00,662 TESTING FOR CENTRAL CALIFORNIA 2457 01:52:00,662 --> 01:52:02,798 AND BECAME THE LEADING COVID 2458 01:52:02,798 --> 01:52:04,399 PROVIDER TEST AND RAN 400 TESTS 2459 01:52:04,399 --> 01:52:11,173 OR SO AND GENERATED REVENUE WE 2460 01:52:11,173 --> 01:52:12,241 WERE ABLE TO PUT INTO DEVELOPING 2461 01:52:12,241 --> 01:52:14,676 PRODUCT AND THAT WAS A GOOD 2462 01:52:14,676 --> 01:52:16,011 PIVOT BUT AT THE TIME YOU DON'T 2463 01:52:16,011 --> 01:52:17,346 KNOW IT'S GOING TO TURN OUT 2464 01:52:17,346 --> 01:52:17,579 OKAY. 2465 01:52:17,579 --> 01:52:21,483 THOSE PIVOTS CAN BE SCARY. 2466 01:52:21,483 --> 01:52:24,086 THAT'S THE NATURE OF A LOT OF 2467 01:52:24,086 --> 01:52:29,591 THE CHALLENGE FOR A START-UP. 2468 01:52:29,591 --> 01:52:32,828 YOU REQUIRE GOOD JUDGMENT. 2469 01:52:32,828 --> 01:52:34,730 I'M NOT TRYING TO SAY WE HAVE 2470 01:52:34,730 --> 01:52:36,164 REALLY GOOD JUDGMENT, WE GOT 2471 01:52:36,164 --> 01:52:38,033 LUCKY THERE BUT A LOT OF THE 2472 01:52:38,033 --> 01:52:47,776 DECISION HAVE TO GET MADE ARE 2473 01:52:47,776 --> 01:52:53,348 VERY HIGH STAKES DECISION AND 2474 01:52:53,348 --> 01:52:54,716 YOU HAVE TO PLACE BETS. 2475 01:52:54,716 --> 01:52:55,617 WE DID THAT. 2476 01:52:55,617 --> 01:52:59,354 SO PIVOTING COULD BE A NATURAL 2477 01:52:59,354 --> 01:53:01,556 THING TO DO BECAUSE OFTEN TIMES 2478 01:53:01,556 --> 01:53:03,058 YOU MADE A JUDGMENT CALL THAT 2479 01:53:03,058 --> 01:53:04,927 WAS KIND OF CRAPPY EARLIER AND 2480 01:53:04,927 --> 01:53:08,597 YOU HAVE TO PIVOT BASED ON NEW 2481 01:53:08,597 --> 01:53:12,100 LEARNINGS AND I CAN GO ON ABOUT 2482 01:53:12,100 --> 01:53:13,902 OTHER PIVOTS TOO BUT THOSE WERE 2483 01:53:13,902 --> 01:53:17,239 TWO SUCCESSFUL ONES. 2484 01:53:17,239 --> 01:53:20,842 >> TWO PIVOTS. 2485 01:53:20,842 --> 01:53:24,079 ONE IN THE ANEURYSM DAY AND ONE 2486 01:53:24,079 --> 01:53:28,417 STARTED WITH A NEED OF 2487 01:53:28,417 --> 01:53:30,719 MICROCATHETERS AND HELP WITH THE 2488 01:53:30,719 --> 01:53:30,986 LIVER. 2489 01:53:30,986 --> 01:53:34,756 IT TURNED OUT SERENDIPITOUSLY 2490 01:53:34,756 --> 01:53:38,727 THAT MICROCATHETER CAN ACCESS 2491 01:53:38,727 --> 01:53:41,997 FIRST-ORDER VESSELS OFF CIRCUITS 2492 01:53:41,997 --> 01:53:44,833 IN THE BRAIN AND THE FIRST TOOL 2493 01:53:44,833 --> 01:53:47,235 FOR THE RADIOLOGY WHICH WAS 2494 01:53:47,235 --> 01:53:47,502 EXCITING. 2495 01:53:47,502 --> 01:53:53,275 AT LUCIRA PRIOR TO MY ARRIVAL 2496 01:53:53,275 --> 01:53:55,577 STARTED DEVELOPING STI TESTS AND 2497 01:53:55,577 --> 01:53:57,879 MOVED TON FLU BECAUSE THEY 2498 01:53:57,879 --> 01:54:01,049 THOUGHT THAT WOULD BE MORE 2499 01:54:01,049 --> 01:54:03,085 READILY APPROVABLE AND COVID HIT 2500 01:54:03,085 --> 01:54:05,220 WHEN I WAS ALREADY AT THE 2501 01:54:05,220 --> 01:54:07,055 COMPANY AND SWITCHED TO COVID. 2502 01:54:07,055 --> 01:54:08,523 SCOTT'S RIGHT ON THESE ARE HUGE 2503 01:54:08,523 --> 01:54:10,625 BET THE COMPANY DECISIONS 2504 01:54:10,625 --> 01:54:13,328 ESPECIALLY WITH A SUPPLY CHAIN 2505 01:54:13,328 --> 01:54:20,402 AND DIAGNOSTICS. 2506 01:54:20,402 --> 01:54:25,407 >> FUR OUR FIRST BIOMARKER BEING 2507 01:54:25,407 --> 01:54:28,610 ANEMIA MY FIRST NAIVETY IS I'LL 2508 01:54:28,610 --> 01:54:30,078 FIND THE BIGGEST DISEASE STATE 2509 01:54:30,078 --> 01:54:32,814 WHERE ANEMIA EXISTS AND GO AFTER 2510 01:54:32,814 --> 01:54:34,416 PATIENTS WITHOUT CONSIDERING WHO 2511 01:54:34,416 --> 01:54:36,184 WILL USE IT, WHY AND ULTIMATELY 2512 01:54:36,184 --> 01:54:38,720 IT WAS A PIVOT AND MIND SET HOW 2513 01:54:38,720 --> 01:54:40,555 TO PITCH AND WHO IS GOING TO USE 2514 01:54:40,555 --> 01:54:40,756 THIS. 2515 01:54:40,756 --> 01:54:43,258 WE ACTUALLY HAD ENTITIES COMING 2516 01:54:43,258 --> 01:54:46,395 TO US AND FIND US DOING GOOGLE 2517 01:54:46,395 --> 01:54:47,629 SEARCH SAYING BIG PHARMA 2518 01:54:47,629 --> 01:54:49,731 COMPANIES SAYING IT'S NICE 2519 01:54:49,731 --> 01:54:51,099 YOU'RE DOING THIS BUT COULD YOU 2520 01:54:51,099 --> 01:54:52,434 HELP ME IN MY CLINICAL TRIAL 2521 01:54:52,434 --> 01:54:53,668 HERE BECAUSE I'D LIKE TO CAPTURE 2522 01:54:53,668 --> 01:54:56,605 THE DATA AND IT'S TAKING A BET 2523 01:54:56,605 --> 01:54:57,806 PUTTING SOME EFFORT THERE BUT AT 2524 01:54:57,806 --> 01:54:59,674 THE END OF THE DAY BECAME A PAID 2525 01:54:59,674 --> 01:55:01,176 CONTRACT AND ENDS UP BEING PART 2526 01:55:01,176 --> 01:55:08,784 OF YOUR MODEL AND STORY. 2527 01:55:08,784 --> 01:55:11,420 >> ONE THING WE TEND TO NOT TALK 2528 01:55:11,420 --> 01:55:16,558 TOO MUCH IS THE ISSUES RELATED 2529 01:55:16,558 --> 01:55:23,231 TO MANUFACTURING 2530 01:55:23,231 --> 01:55:25,367 >> IF YOU CAN OFFER TIDBITS IN 2531 01:55:25,367 --> 01:55:32,941 MANUFACTURING. 2532 01:55:32,941 --> 01:55:34,810 >> I THINK IT DEPENDS ON THE 2533 01:55:34,810 --> 01:55:35,510 NATURE OF THE COMPANY AND WHAT 2534 01:55:35,510 --> 01:55:37,379 IT'S TRYING TO DO AND MARGINS 2535 01:55:37,379 --> 01:55:39,247 AND DIAGNOSTICS IN GENERAL DON'T 2536 01:55:39,247 --> 01:55:41,349 GIVE YOU THAT MUCH ROOM TO PLAY. 2537 01:55:41,349 --> 01:55:42,484 WHEN YOU'RE TRYING TO DO WHAT 2538 01:55:42,484 --> 01:55:44,486 WE'RE TRYING TO DO WHICH IS ALSO 2539 01:55:44,486 --> 01:55:46,788 BRING DOWN COST A WHOLE LOT, 2540 01:55:46,788 --> 01:55:50,025 THAT MARGIN BECOMES EVEN MORE 2541 01:55:50,025 --> 01:55:52,828 APPRECIATION. 2542 01:55:52,828 --> 01:55:54,529 -- PRECIOUS. 2543 01:55:54,529 --> 01:55:55,464 THE ALLURE OF HOW DO YOU 2544 01:55:55,464 --> 01:55:56,398 MANUFACTURE STUFF? 2545 01:55:56,398 --> 01:55:57,599 GENERALLY, IF YOU'RE A LITTLE 2546 01:55:57,599 --> 01:55:58,800 COMPANY AND DIDN'T HAVE THAT 2547 01:55:58,800 --> 01:56:00,869 MUCH MONEY BEFORE YOU DON'T HAVE 2548 01:56:00,869 --> 01:56:08,510 A BUNCH OF EQUIPMENT AND PEOPLE 2549 01:56:08,510 --> 01:56:09,544 AND A MANUFACTURING OPERATION 2550 01:56:09,544 --> 01:56:11,713 AND WANT TO REPLY CONTRACTORS 2551 01:56:11,713 --> 01:56:13,348 FOR SPEED AND INITIAL 2552 01:56:13,348 --> 01:56:14,249 EFFICIENCIES AND SO ON. 2553 01:56:14,249 --> 01:56:17,586 THIS BECOMES A TRICKY THING TO 2554 01:56:17,586 --> 01:56:23,125 DO BECAUSE I REMEMBER WHEN I 2555 01:56:23,125 --> 01:56:25,494 WAS -- I'M STILL PRESENTEE DUMB, 2556 01:56:25,494 --> 01:56:28,930 BUT WHEN I WAS DUMBER, I THOUGHT 2557 01:56:28,930 --> 01:56:30,532 ONCE YOU GET TO MANUFACTURE ALL 2558 01:56:30,532 --> 01:56:31,466 THE PROBLEMS GO AWAY AND THEY 2559 01:56:31,466 --> 01:56:36,338 JUST AMPLIFY. 2560 01:56:36,338 --> 01:56:37,606 YOU HAVE TO SORT THEM OUT. 2561 01:56:37,606 --> 01:56:40,242 FOR US, OUR VALUE PROPOSITION IS 2562 01:56:40,242 --> 01:56:41,910 TIED NOT JUST TO THE PERFORMANCE 2563 01:56:41,910 --> 01:56:46,915 BUT ALSO THE COST. 2564 01:56:46,915 --> 01:56:52,454 SO THAT THING WE HAVE TO 2565 01:56:52,454 --> 01:56:54,156 UNDERSTAND THE PROCESSES MORE 2566 01:56:54,156 --> 01:56:55,323 THAN ANYBODY ELSE BECAUSE THAT'S 2567 01:56:55,323 --> 01:57:05,534 ALSO WHERE WE KNOW -- INNOVATE 2568 01:57:05,534 --> 01:57:06,868 AND DON'T HAVE THE RESOURCES TO 2569 01:57:06,868 --> 01:57:07,903 DO IT. 2570 01:57:07,903 --> 01:57:09,804 YOU NEED TO COME UP AGAIN WITH 2571 01:57:09,804 --> 01:57:13,642 CLEVER STRATEGIES FOR HOW TO NOT 2572 01:57:13,642 --> 01:57:15,744 JUST ESSENTIALLY HAND OVER LIKE 2573 01:57:15,744 --> 01:57:17,345 HEY, GUYS, PLEASE MAKE THIS 2574 01:57:17,345 --> 01:57:17,612 THING NOW. 2575 01:57:17,612 --> 01:57:19,514 THAT'S NOT GOING TO WORK OUT. 2576 01:57:19,514 --> 01:57:24,452 YOU'RE NOT GOING TO BE ABLE 2577 01:57:24,452 --> 01:57:26,421 TO -- FOR US IT'S NOT GOING TO 2578 01:57:26,421 --> 01:57:30,659 WORK OUT BECAUSE WE NEED THAT 2579 01:57:30,659 --> 01:57:31,860 INFORMATION AND NEED TO COMPLETE 2580 01:57:31,860 --> 01:57:34,696 THE INNOVATION CYCLES AND DRIVE 2581 01:57:34,696 --> 01:57:36,097 COSTS DOWN NOT JUST FOR THE 2582 01:57:36,097 --> 01:57:39,634 PROCESSES TO MAKE THE THING BUT 2583 01:57:39,634 --> 01:57:46,107 ALSO FOR THE DESIGN ITSELF IF 2584 01:57:46,107 --> 01:57:47,676 YOU START WITH A DESIGN THAT'S 2585 01:57:47,676 --> 01:57:48,476 GOING TO BE HARD TO MANUFACTURE 2586 01:57:48,476 --> 01:57:50,879 YOU'LL HAVE A BAD TIME. 2587 01:57:50,879 --> 01:57:54,649 SO THE EXTENT YOU CAN GET THIS 2588 01:57:54,649 --> 01:57:56,384 INFORMATION VERY EARLY ON IN THE 2589 01:57:56,384 --> 01:57:59,387 DEVELOPMENT PROCESS OF YOUR 2590 01:57:59,387 --> 01:58:01,623 PRODUCT, YOU WILL AVOID A LOT OF 2591 01:58:01,623 --> 01:58:03,124 FUTURE PAIN. 2592 01:58:03,124 --> 01:58:06,127 AND SO IT CAN BE DONE. 2593 01:58:06,127 --> 01:58:07,462 YOU CAN GET KNOWLEDGE ABOUT 2594 01:58:07,462 --> 01:58:09,297 MANUFACTURE AND DO SOME SMALL 2595 01:58:09,297 --> 01:58:10,498 SCALE PILOT MANUFACTURE STUFF 2596 01:58:10,498 --> 01:58:13,335 WITH METHODS THAT CAN TRANSLATE 2597 01:58:13,335 --> 01:58:15,870 WITH CONTRACT MANUFACTURERS. 2598 01:58:15,870 --> 01:58:19,140 MY SUGGESTION FOR ANYONE IN THIS 2599 01:58:19,140 --> 01:58:20,408 CONUNDRUM IS DON'T JUST THROW IT 2600 01:58:20,408 --> 01:58:22,811 OVER THE FENCE AND HOPE THESE 2601 01:58:22,811 --> 01:58:25,113 GUYS WILL SOLVE EVERYTHING FOR 2602 01:58:25,113 --> 01:58:25,280 YOU. 2603 01:58:25,280 --> 01:58:28,917 >> SCOTT'S GIVING AN IMPORTANT 2604 01:58:28,917 --> 01:58:33,555 WARNING SOMETIMES EARLY STAGE 2605 01:58:33,555 --> 01:58:34,689 FOLKS THINK THEY CAN JUST SIGN 2606 01:58:34,689 --> 01:58:36,725 UP A CONTRACT MANUFACTURER AND 2607 01:58:36,725 --> 01:58:37,525 IT WILL ALL BE FINE. 2608 01:58:37,525 --> 01:58:42,731 YOU NEED TO HAVE YOUR OWN AT 2609 01:58:42,731 --> 01:58:44,599 LEAST DEEPLY EXPERIENCED IN 2610 01:58:44,599 --> 01:58:46,234 MANUFACTURING AND SOMEONE IN 2611 01:58:46,234 --> 01:58:47,269 QUALITY, ETCETERA, EVEN IF YOU 2612 01:58:47,269 --> 01:58:53,008 HAVE CONTRACT MANUFACTURER BUT 2613 01:58:53,008 --> 01:58:54,576 KEEP IN MIND YOUR TRYING TO 2614 01:58:54,576 --> 01:58:57,612 SPLIT HAIRS TO GET MARGIN AND SO 2615 01:58:57,612 --> 01:58:59,948 ARE THEY AND NO ONE WILL CARE 2616 01:58:59,948 --> 01:59:00,982 MORE ABOUT YOUR PRODUCT THAN YOU 2617 01:59:00,982 --> 01:59:03,518 DO AND THEY HAVE A PORTFOLIO OF 2618 01:59:03,518 --> 01:59:04,886 CUSTOMERS, YOU HAVE JUST 2619 01:59:04,886 --> 01:59:05,153 YOURSELF. 2620 01:59:05,153 --> 01:59:13,461 IT'S ANOTHER CRITICAL DECISION. 2621 01:59:13,461 --> 01:59:15,030 >> I'D LOVE TO INVITE ANY 2622 01:59:15,030 --> 01:59:16,798 QUESTIONS FROM THE AUDIENCE. 2623 01:59:16,798 --> 01:59:18,333 FEEL FREE TO COME UP TO THE MIC. 2624 01:59:18,333 --> 01:59:28,810 THERE'S ALREADY A QUESTION. 2625 01:59:36,351 --> 01:59:40,155 CLEARLY WITH A BILLION TESTS 2626 01:59:40,155 --> 01:59:41,890 DISTRIBUTED THE CULTURE HAS 2627 01:59:41,890 --> 01:59:45,026 CHANGED AND THE MOST PRIOR TO 2628 01:59:45,026 --> 01:59:48,430 THAT HOME PREGNANCY TEST ON THE 2629 01:59:48,430 --> 01:59:52,567 ORDER TO $7 MILLION TO $8 2630 01:59:52,567 --> 01:59:54,135 MILLION A YEAR AND THE CULTURE 2631 01:59:54,135 --> 01:59:55,704 IS A POSITIVE FEATURE. 2632 01:59:55,704 --> 01:59:57,972 AS YOU POINT OUT, THERE'S A LOT 2633 01:59:57,972 --> 02:00:00,809 OF COMPLICATIONS AND 2634 02:00:00,809 --> 02:00:03,011 DIFFICULTIES WITH MARGINS, 2635 02:00:03,011 --> 02:00:03,945 RETURN ON INVESTMENT. 2636 02:00:03,945 --> 02:00:05,180 PARTIALLY BECAUSE OF THE 2637 02:00:05,180 --> 02:00:07,048 REGULATORY PATH AND IF I GO BACK 2638 02:00:07,048 --> 02:00:12,420 IN TIME WHEN WE FIRST STARTED 2639 02:00:12,420 --> 02:00:14,122 THE PERFORMANCE OF HOME TESTS 2640 02:00:14,122 --> 02:00:16,891 THE FDA HAD THE BAR REVERSED. 2641 02:00:16,891 --> 02:00:18,993 NOW THE HOME TEST PERFORMANCE IS 2642 02:00:18,993 --> 02:00:21,830 ACTUALLY LESS IN TERMS OF RIGOR 2643 02:00:21,830 --> 02:00:23,231 THAN THE POINT OF CARE. 2644 02:00:23,231 --> 02:00:25,233 IT WAS HARDER TO GET A HOME 2645 02:00:25,233 --> 02:00:27,035 AUTHORIZATION AT THE BEGINNING 2646 02:00:27,035 --> 02:00:28,370 OF THE PANDEMIC. 2647 02:00:28,370 --> 02:00:30,372 THE PERFORMANCE I THINK THE PPA 2648 02:00:30,372 --> 02:00:33,007 HAD TO BE BETTER THAN 90% OR I 2649 02:00:33,007 --> 02:00:35,076 DIDN'T REMEMBER -- THERE WAS 2650 02:00:35,076 --> 02:00:37,078 HOME BY CONSUMERS AND THE FDA 2651 02:00:37,078 --> 02:00:42,183 DIDN'T WANT CONSUMERS TO HAVE 2652 02:00:42,183 --> 02:00:46,821 ANY POSSIBILITY OF APE INCORRECT 2653 02:00:46,821 --> 02:00:50,825 ANSWER AND THERE WAS 2654 02:00:50,825 --> 02:00:51,826 PRESCRIPTION AND POINT OF CARE 2655 02:00:51,826 --> 02:00:53,895 AND THOSE WERE THE CATEGORIES. 2656 02:00:53,895 --> 02:01:00,068 THE PPA IS DIFFERENT FROM HOME. 2657 02:01:00,068 --> 02:01:01,970 I'M LOOKING AT WHAT IS THE ROLE 2658 02:01:01,970 --> 02:01:03,671 OF REGULATORY IN YOUR ABILITY TO 2659 02:01:03,671 --> 02:01:05,173 REACH THE MARKET. 2660 02:01:05,173 --> 02:01:12,147 WE'VE SEEN SO MANY CONSUMER 2661 02:01:12,147 --> 02:01:13,248 DEVICES AND ARE YOU GOING TO TRY 2662 02:01:13,248 --> 02:01:17,018 TO GO THE WAY OF DIRECT TO 2663 02:01:17,018 --> 02:01:19,788 CONSUMER WITHOUT STOPPING AT THE 2664 02:01:19,788 --> 02:01:21,523 FDA FIRST OR DO YOU THINK THERE 2665 02:01:21,523 --> 02:01:23,358 ARE OPPORTUNITIES LIKE WITH OVER 2666 02:01:23,358 --> 02:01:26,494 THE COUNTER HEARING AIDS TO 2667 02:01:26,494 --> 02:01:28,263 CREATE ENTIRE NEW REGULATORY 2668 02:01:28,263 --> 02:01:29,197 CATEGORIES PERHAPS WITH SOME 2669 02:01:29,197 --> 02:01:30,365 STANDARDIZATION LIKE HAS BEEN 2670 02:01:30,365 --> 02:01:32,467 DONE WITH HEARING AIDS? 2671 02:01:32,467 --> 02:01:37,806 HOW CAN YOU REALLY QUICKLY TAKE 2672 02:01:37,806 --> 02:01:40,375 ADVANTAGE OF THIS NEW MARKET 2673 02:01:40,375 --> 02:01:41,810 LIKE EVERYBODY'S AWAKE AND YOU 2674 02:01:41,810 --> 02:01:43,044 HAVE EVERYBODY'S ATTENTION BUT 2675 02:01:43,044 --> 02:01:45,980 DOES IT FIT INTO THE TRADITIONAL 2676 02:01:45,980 --> 02:01:47,849 MODEL OF HEALTH CARE DELIVERY 2677 02:01:47,849 --> 02:01:56,491 AND WHERE'S PREVENTION IN ALL 2678 02:01:56,491 --> 02:01:56,825 TH 2679 02:01:56,825 --> 02:01:57,025 THIS. 2680 02:01:57,025 --> 02:01:58,660 >> GREAT QUESTION AND WE WERE 2681 02:01:58,660 --> 02:02:01,362 THINKING OF HOW TO BRING UP 2682 02:02:01,362 --> 02:02:03,531 REGULATORY ASPECTS AND WE CAN 2683 02:02:03,531 --> 02:02:12,207 BLAME BRUCE FOR BRINGING IT UP. 2684 02:02:12,207 --> 02:02:13,875 >> YOU USE WORDS QUICK AND I 2685 02:02:13,875 --> 02:02:18,980 THINK FOR TECHNOLOGY DEVELOPMENT 2686 02:02:18,980 --> 02:02:22,317 THAT'S IT'S HARD TO GET A 2687 02:02:22,317 --> 02:02:23,284 REGULATORY PACKAGE THROUGH AND 2688 02:02:23,284 --> 02:02:28,957 REVIEWED AND GO TO MARKET. 2689 02:02:28,957 --> 02:02:31,926 IT'S HARD TO MAKE THOSE THINGS 2690 02:02:31,926 --> 02:02:33,061 QUICK AND PUTTING ON THE 2691 02:02:33,061 --> 02:02:33,828 REGULATORY HAT. 2692 02:02:33,828 --> 02:02:37,031 THE EMERGENCY USE PATHWAY IS 2693 02:02:37,031 --> 02:02:37,832 DIFFERENT FROM THE FULL 2694 02:02:37,832 --> 02:02:39,000 AUTHORIZATION PATHWAY. 2695 02:02:39,000 --> 02:02:40,268 IN THE NEXT PANEL I'LL GO 2696 02:02:40,268 --> 02:02:41,536 THROUGH THIS IN MORE DETAIL BUT 2697 02:02:41,536 --> 02:02:42,604 IT COMES DOWN TO RISK AND WHAT 2698 02:02:42,604 --> 02:02:51,045 THE NEED IS AT THE TIME. 2699 02:02:51,045 --> 02:02:54,516 AND WHAT IS ACCEPTABLE FOR A 2700 02:02:54,516 --> 02:02:57,018 HOME TEST VERSUS NOT AND THINK 2701 02:02:57,018 --> 02:02:59,521 WHAT IS THE USE CASE HERE? 2702 02:02:59,521 --> 02:03:00,288 TYPICALLY WITH A FULL 2703 02:03:00,288 --> 02:03:01,356 AUTHORIZATION PATH YOU'RE 2704 02:03:01,356 --> 02:03:02,757 TALKING ABOUT AN INDIVIDUAL. 2705 02:03:02,757 --> 02:03:05,460 WHAT IS THEIR TREATMENT AND HOW 2706 02:03:05,460 --> 02:03:07,061 SENSITIVE IS IT FOR THEM. 2707 02:03:07,061 --> 02:03:08,530 THE REASON WE WERE USING A LOT 2708 02:03:08,530 --> 02:03:11,533 OF THE HOME TESTS IS FOR THE 2709 02:03:11,533 --> 02:03:13,134 POPULATION MODEL AND THAT'S NEW 2710 02:03:13,134 --> 02:03:15,637 TO THAT BROAD AND WIDE SCALE YOU 2711 02:03:15,637 --> 02:03:15,904 MENTIONED. 2712 02:03:15,904 --> 02:03:17,105 SOMETHING TO THINK ABOUT. 2713 02:03:17,105 --> 02:03:19,674 I THINK THE REGULATORY MIND SET 2714 02:03:19,674 --> 02:03:21,175 NOW CONSIDERS BOTH AND WOULD BE 2715 02:03:21,175 --> 02:03:23,845 GREAT TO BE ABLE TO PAVE NEW 2716 02:03:23,845 --> 02:03:27,815 PATHS AND MAKING IT CLEAR THIS 2717 02:03:27,815 --> 02:03:30,184 IS SOMETHING DESIGN FOR PUBLIC 2718 02:03:30,184 --> 02:03:31,419 HEALTH AND INDIVIDUAL MEDICAL 2719 02:03:31,419 --> 02:03:31,619 CARE. 2720 02:03:31,619 --> 02:03:33,054 IT'S NOT A SIMPLE QUESTION. 2721 02:03:33,054 --> 02:03:40,662 BACK TO THE BEGINNING WITH OUR 2722 02:03:40,662 --> 02:03:43,064 DIRECTOR AND GET PEOPLE INVOLVED 2723 02:03:43,064 --> 02:03:44,232 IN THEIR OWN HEALTH CARE IS 2724 02:03:44,232 --> 02:03:44,999 SOMETHING I'M PERSONAL TRYING TO 2725 02:03:44,999 --> 02:03:51,472 WORK THROUGH WITH MY COMPANY. 2726 02:03:51,472 --> 02:03:53,908 WE HAVE A D TO C WELLNESS TOOL 2727 02:03:53,908 --> 02:03:55,510 AND YOU'D LIKE TO TELL PEOPLE IF 2728 02:03:55,510 --> 02:03:57,779 YOU START PREVENTING NOW YOU CAN 2729 02:03:57,779 --> 02:04:00,348 PREVENT THIS LATER. 2730 02:04:00,348 --> 02:04:07,255 HAVING THE EDUCATIONAL PIECE 2731 02:04:07,255 --> 02:04:08,990 PROVES TO BE VALUABLE AND 2732 02:04:08,990 --> 02:04:09,891 FIGURING OUT WHAT YOU CAN AND 2733 02:04:09,891 --> 02:04:12,694 CAN'T SAY FROM A REGULATORY 2734 02:04:12,694 --> 02:04:14,429 PERSPECTIVE HAS PROVEN TO BE A 2735 02:04:14,429 --> 02:04:16,064 CHALLENGE AND SOMETHING I'M 2736 02:04:16,064 --> 02:04:17,298 WORKING ON PERSONALLY FOR OUR 2737 02:04:17,298 --> 02:04:18,533 COMPANY AND AS A PROFESSIONAL. 2738 02:04:18,533 --> 02:04:20,401 I THINK THE MIND SET WE HAD 2739 02:04:20,401 --> 02:04:22,103 GOING INTO THE CONVERSATION THE 2740 02:04:22,103 --> 02:04:24,205 TESTING BECAME SO UNIVERSAL SO 2741 02:04:24,205 --> 02:04:25,707 QUICKLY EVERYBODY KNEW HOW TO DO 2742 02:04:25,707 --> 02:04:26,874 A TEST. 2743 02:04:26,874 --> 02:04:28,977 COULD WE MAKE IT SIMILAR FOR ING 2744 02:04:28,977 --> 02:04:30,078 PEOPLE ABOUT HEALTH AND WHAT 2745 02:04:30,078 --> 02:04:32,647 THEY SHOULD BE DOING SIMILAR TO 2746 02:04:32,647 --> 02:04:33,748 CHECKING BLOOD PRESSURE AND 2747 02:04:33,748 --> 02:04:37,418 WALKING 10 ,000 STEPS A DAY. 2748 02:04:37,418 --> 02:04:39,253 THERE HAS TO BE MORE THERE AND 2749 02:04:39,253 --> 02:04:40,888 THE SHORT ANSWER WOULD BE 2750 02:04:40,888 --> 02:04:42,490 GETTING THE EDUCATION AND 2751 02:04:42,490 --> 02:04:43,291 ENGAGEMENT OUT THERE AND 2752 02:04:43,291 --> 02:04:44,659 FIGURING OUT IN THE CONTEXT OF 2753 02:04:44,659 --> 02:04:47,395 REGULATORY HOW TO MAKE IT ALL 2754 02:04:47,395 --> 02:04:48,763 WORK IN ORDER TO PUT THAT 2755 02:04:48,763 --> 02:04:49,330 MISSION FORWARD. 2756 02:04:49,330 --> 02:04:56,404 >> IT'S GREAT QUESTION. 2757 02:04:56,404 --> 02:04:57,905 ANYTHING WE CAN DO TO HELP THE 2758 02:04:57,905 --> 02:05:00,041 PROCESS WE'D BE HAPPY TO SIT 2759 02:05:00,041 --> 02:05:02,677 DOWN AND HAVE THE CONVERSATIONS 2760 02:05:02,677 --> 02:05:07,849 BECAUSE THIS IS THE BIGGEST 2761 02:05:07,849 --> 02:05:13,588 VARIABLE IF IT'S POSSIBLE TO 2762 02:05:13,588 --> 02:05:16,958 MEASURE LOD RATHER THAN 2763 02:05:16,958 --> 02:05:18,626 SPECIFICITY AND RELATIVE 2764 02:05:18,626 --> 02:05:20,795 MEASURES AND HOW ELSE DO TESTS 2765 02:05:20,795 --> 02:05:27,969 ORDERS OF MAGNITUDE DIFFERENT IN 2766 02:05:27,969 --> 02:05:30,304 LOD HAVE 95% SPECIFICITY. 2767 02:05:30,304 --> 02:05:31,539 WHAT'S THE METRIC? 2768 02:05:31,539 --> 02:05:34,142 THAT'S A HEAD-SCRATCHER FOR ME. 2769 02:05:34,142 --> 02:05:35,376 MAYBE THERE ARE THINGS WE CAN 2770 02:05:35,376 --> 02:05:36,744 SIT DOWN AND DISCUSS AND MAKE 2771 02:05:36,744 --> 02:05:47,188 WORK A LITTLE BIT BETTER. 2772 02:05:49,724 --> 02:05:53,161 >> IT WILL FALL UNDER FDA 2773 02:05:53,161 --> 02:05:53,428 OVERSIGHT. 2774 02:05:53,428 --> 02:05:58,366 SO BACK TO THE INVESTOR THING, 2775 02:05:58,366 --> 02:05:59,467 THAT'S ANOTHER BAR THAT HAS TO 2776 02:05:59,467 --> 02:06:00,435 BE CROSSED BEFORE A PRODUCT IS 2777 02:06:00,435 --> 02:06:03,337 ON THE MARKET AND BEFORE IT CAN 2778 02:06:03,337 --> 02:06:13,748 START GENERATING ANY R. 2779 02:06:18,286 --> 02:06:20,588 TO GET PROLIFERATION OF 2780 02:06:20,588 --> 02:06:21,823 TECHNOLOGIES OUT THERE TO 2781 02:06:21,823 --> 02:06:23,891 ADDRESS UNMET MEDICAL NEEDS, A 2782 02:06:23,891 --> 02:06:25,560 HUGE WAY TO ACCELERATE THAT IS 2783 02:06:25,560 --> 02:06:26,260 TO LOWER THE RISK ASSOCIATED 2784 02:06:26,260 --> 02:06:36,370 WITH THAT. 2785 02:06:36,370 --> 02:06:40,174 THE CLARITY IN IT. 2786 02:06:40,174 --> 02:06:40,875 INCREASE THE SPEED IN WHICH 2787 02:06:40,875 --> 02:06:44,212 CLARITY CAN BE REEFED. 2788 02:06:44,212 --> 02:06:46,981 -- REEFED -- REACHED. 2789 02:06:46,981 --> 02:06:55,389 THOSE ARE DEFINITELY VERY TASTY 2790 02:06:55,389 --> 02:06:57,825 FRUIT THAT CAN HELP THE START-UP 2791 02:06:57,825 --> 02:07:04,599 GROW UP TO A STRONG ADULT. 2792 02:07:04,599 --> 02:07:07,969 I WOULD HEAVILY ADVOCACY FOR 2793 02:07:07,969 --> 02:07:08,236 THAT. 2794 02:07:08,236 --> 02:07:10,471 THE EUA WAS GREAT. 2795 02:07:10,471 --> 02:07:11,773 HERE'S A TEMPLATE THAT LAID OUT 2796 02:07:11,773 --> 02:07:16,410 THE THINGS YOU NEEDED TO DO. 2797 02:07:16,410 --> 02:07:22,350 TOWN HALLS TOOK PLACE ON A 2798 02:07:22,350 --> 02:07:32,827 WEEKLY BASIS AND AND ALLOWS 2799 02:07:35,096 --> 02:07:36,697 COMPANY TO ENTER SPACE THEY 2800 02:07:36,697 --> 02:07:37,999 WOULDN'T HAVE OTHERWISE AND 2801 02:07:37,999 --> 02:07:39,634 THAT'S WHAT THE THING WAS DESIGN 2802 02:07:39,634 --> 02:07:40,034 TO DO. 2803 02:07:40,034 --> 02:07:44,705 THAT DEMONSTRATED THE POWER OF 2804 02:07:44,705 --> 02:07:50,211 AN ACCELERATED AND POTENTIALLY 2805 02:07:50,211 --> 02:07:54,549 MORE CLEAR FOR FOLKS -- IF WE DO 2806 02:07:54,549 --> 02:07:57,118 THESE THINGS AND HIT THE 2807 02:07:57,118 --> 02:07:59,987 OUTCOMES, GOOD THINGS WILL 2808 02:07:59,987 --> 02:08:01,622 HAPPEN, THAT'S HELPFUL AND 2809 02:08:01,622 --> 02:08:07,862 MAKING IT MORE TRANSPARENCY. 2810 02:08:07,862 --> 02:08:10,932 BEFORE REGULATORY SEEMS LIKE A 2811 02:08:10,932 --> 02:08:12,166 BIG R FOR SOMEONE FROM THE 2812 02:08:12,166 --> 02:08:13,100 TECHNOLOGY SIDE. 2813 02:08:13,100 --> 02:08:15,303 I KNOW IT'S OBVIOUSLY NOT THE 2814 02:08:15,303 --> 02:08:18,940 CASE BUT FURTHER TRANSPARENCY ON 2815 02:08:18,940 --> 02:08:24,178 THE FRONT HELPS THOUGHT JUST 2816 02:08:24,178 --> 02:08:31,018 HELP THE REGULATORY STUFF. 2817 02:08:31,018 --> 02:08:40,127 >> ONE MORE AND FOLLOW UP. 2818 02:08:40,127 --> 02:08:42,864 >> IN OTC USE CASE, IF IT'S JUST 2819 02:08:42,864 --> 02:08:45,499 AN OTC USE CASE WHERE IT'S A 2820 02:08:45,499 --> 02:08:47,268 PERSON IN THEIR HOUSE, WE HAVE 2821 02:08:47,268 --> 02:08:49,470 TO BE CLEAR IT WOULD BE 2822 02:08:49,470 --> 02:08:51,973 SYSTEMATIC PATIENTS AND THEY'LL 2823 02:08:51,973 --> 02:08:53,441 INCREASE THE PRE-TEST 2824 02:08:53,441 --> 02:08:55,643 PROBABILITY TO FAVOR NOT HAVING 2825 02:08:55,643 --> 02:08:57,578 A FALSE POSITIVE. 2826 02:08:57,578 --> 02:09:00,081 TO THE PUBLIC HEALTH USE CASE 2827 02:09:00,081 --> 02:09:01,949 THOUGH YOU MIGHT ACCEPT SLIGHTLY 2828 02:09:01,949 --> 02:09:03,251 DIFFERENT PARAMETERS IN ORDER TO 2829 02:09:03,251 --> 02:09:05,186 TRY TO GET AT OTHER SYNDEMICS WE 2830 02:09:05,186 --> 02:09:05,820 HAVE NOW. 2831 02:09:05,820 --> 02:09:11,259 I PARTICULARLY CASE ABOUT THE 2832 02:09:11,259 --> 02:09:12,560 STI SPACE BUT IT'S IMPORTANT TO 2833 02:09:12,560 --> 02:09:16,530 HAVE A DISTINCTION. 2834 02:09:16,530 --> 02:09:18,366 HOW DO YOU ALL FEEL ABOUT HAVING 2835 02:09:18,366 --> 02:09:21,068 AN OTC PUBLIC HEALTH USE CASE 2836 02:09:21,068 --> 02:09:26,741 AND HAVING THE FDA HAVE A 2837 02:09:26,741 --> 02:09:27,775 PATHWAY FOR THAT? 2838 02:09:27,775 --> 02:09:30,711 WHERE IT CAN YOU REALLY IMPACT 2839 02:09:30,711 --> 02:09:31,512 HOW MUCH CHLAMYDIA WE HAVE FOR 2840 02:09:31,512 --> 02:09:35,783 EXAMPLE. 2841 02:09:35,783 --> 02:09:38,352 >> YOU MENTIONED THE SENSITIVITY 2842 02:09:38,352 --> 02:09:42,056 OF A TEST NOT TAKING ZERO 2843 02:09:42,056 --> 02:09:52,533 PERCENT AND IT'S SUPER TRUE. 2844 02:09:54,535 --> 02:09:56,604 I WOULD SUPPORT THAT TO IMPROVE 2845 02:09:56,604 --> 02:10:01,776 PUBLIC HEALTH. 2846 02:10:01,776 --> 02:10:02,076 ABSOLUTELY. 2847 02:10:02,076 --> 02:10:05,012 >> I THINK EXPLAINING WHAT THE 2848 02:10:05,012 --> 02:10:06,914 CONTEXT WOULD BE IS IMPORTANT 2849 02:10:06,914 --> 02:10:10,117 AND WHAT WE'RE SEEING IN 2850 02:10:10,117 --> 02:10:10,985 ULTIMATE LABELLING LIKE FINE 2851 02:10:10,985 --> 02:10:12,186 PRINT ON HOW TO USE IT MAY NOT 2852 02:10:12,186 --> 02:10:14,622 BE THE BEST WAY TO GET THE 2853 02:10:14,622 --> 02:10:15,056 EDUCATION ACROSS. 2854 02:10:15,056 --> 02:10:16,757 SOME COMPANIES INDIVIDUALLY WERE 2855 02:10:16,757 --> 02:10:18,392 TALKING HOW TO DO THINGS AND 2856 02:10:18,392 --> 02:10:22,196 SIMPLIFYING A LOT OF THE 2857 02:10:22,196 --> 02:10:24,332 LANGUAGE TO TIE INTO THE ONGOING 2858 02:10:24,332 --> 02:10:25,199 INITIATIVES I KNOW PEOPLE ARE 2859 02:10:25,199 --> 02:10:27,268 HERE FROM THEM AND MAKING THINGS 2860 02:10:27,268 --> 02:10:30,972 MORE ACCESSIBLE EVEN FROM A 2861 02:10:30,972 --> 02:10:33,174 DIGESTION PERSPECTIVE OF WHAT 2862 02:10:33,174 --> 02:10:34,141 YOU'RE SUPPOSING TO DOING WITH 2863 02:10:34,141 --> 02:10:37,378 THE RESULT IS ONE ANGLE AND 2864 02:10:37,378 --> 02:10:38,713 BRUCE MENTIONED THE BAR YOU'RE 2865 02:10:38,713 --> 02:10:41,682 MEETING WE'LL CALL IT ON THE 2866 02:10:41,682 --> 02:10:42,783 SENSITIVITY AND SPECIFICITY 2867 02:10:42,783 --> 02:10:45,586 SIDE, WE'RE VERY DIFFERENT BUT I 2868 02:10:45,586 --> 02:10:49,557 DO THINK THE NPA HAS HELD A HIGH 2869 02:10:49,557 --> 02:10:49,724 BAR. 2870 02:10:49,724 --> 02:10:50,658 IF YOU'RE GOING TO SACRIFICE 2871 02:10:50,658 --> 02:10:51,993 YOUR SENSITIVITY, THERE'S GOING 2872 02:10:51,993 --> 02:10:54,628 TO BE NO MISSES ON THE 2873 02:10:54,628 --> 02:10:55,963 SPECIFICITY SIDE. 2874 02:10:55,963 --> 02:10:57,431 YOU WON'T HAVE FALSE POSITIVES 2875 02:10:57,431 --> 02:11:00,301 COMING OUT AND TAKING A POSITION 2876 02:11:00,301 --> 02:11:01,535 FROM THE REGULATORY SIDE AND 2877 02:11:01,535 --> 02:11:03,337 HAVING THAT AS A STANDARD ACROSS 2878 02:11:03,337 --> 02:11:05,873 ALL DEVICES I THINK DID HELP. 2879 02:11:05,873 --> 02:11:07,308 WHEN A TEST CAME BACK POSITIVE 2880 02:11:07,308 --> 02:11:09,377 YOU WERE CERTAIN YOU WERE GOING 2881 02:11:09,377 --> 02:11:12,513 TO BE POSITIVE. 2882 02:11:12,513 --> 02:11:15,249 THERE WERE SOME THINGS DONE WELL 2883 02:11:15,249 --> 02:11:18,586 AND IT'S NOT AN EASY QUESTION 2884 02:11:18,586 --> 02:11:19,687 BUT THEY'RE CONTINUING EFFORTS 2885 02:11:19,687 --> 02:11:21,255 AND TIES INTO ENGAGEMENT AND 2886 02:11:21,255 --> 02:11:22,456 EDUCATION ON WHAT YOU SHOULD BE 2887 02:11:22,456 --> 02:11:31,198 DOING WITH THE TESTS. 2888 02:11:31,198 --> 02:11:33,234 >> IN THE NEAR FUTURE AND IT'S 2889 02:11:33,234 --> 02:11:35,002 HAPPENING NOW, THERE'S GOING TO 2890 02:11:35,002 --> 02:11:37,071 BE A BLURRING OF MEDICAL 2891 02:11:37,071 --> 02:11:38,873 DIAGNOSTICS WITH A CONSUMER 2892 02:11:38,873 --> 02:11:42,343 PRODUCT AND WE WERE TALKING 2893 02:11:42,343 --> 02:11:45,413 ABOUT THIS FROM THE POC AND 2894 02:11:45,413 --> 02:11:46,614 DTCs. 2895 02:11:46,614 --> 02:11:48,215 CAN YOU TALK ABOUT THE 2896 02:11:48,215 --> 02:11:49,016 CHALLENGES WHEN YOU'RE TRYING TO 2897 02:11:49,016 --> 02:11:51,018 MAKE A MEDICAL DEVICE AND 2898 02:11:51,018 --> 02:11:53,621 SUDDENLY IT'S A CONSUMER PRODUCT 2899 02:11:53,621 --> 02:11:55,523 ON AMAZON TALKING ABOUT THE 2900 02:11:55,523 --> 02:11:59,026 COMPANY'S STRATEGIES AND 2901 02:11:59,026 --> 02:12:00,728 CHALLENGES YOU GUYS HAVE FACED 2902 02:12:00,728 --> 02:12:01,328 AND BEING FORWARD LOOKING AS 2903 02:12:01,328 --> 02:12:01,729 WELL. 2904 02:12:01,729 --> 02:12:07,468 FEEL FREE. 2905 02:12:07,468 --> 02:12:08,903 >> 2906 02:12:08,903 --> 02:12:13,374 >> HUMAN FACTOR IS KEY AND WE 2907 02:12:13,374 --> 02:12:16,343 WERE FORTUNATE ENOUGH TO FIND 2908 02:12:16,343 --> 02:12:18,546 SOMEBODY WHO WAS THE PRODUCT 2909 02:12:18,546 --> 02:12:22,683 GURU AT PROCTER& GAMBLE WOULD 2910 02:12:22,683 --> 02:12:26,353 JOINED US AND WE IT RATED THE 2911 02:12:26,353 --> 02:12:36,897 PRODUCT -- ITERATED THE PRODUCT 2912 02:12:37,264 --> 02:12:39,033 AND COULD BE INTERPRETED IN 2913 02:12:39,033 --> 02:12:40,267 OTHER LANGUAGES AND THE RESULTS 2914 02:12:40,267 --> 02:12:50,811 WERE EASY TO INTERPRET AND ALL 2915 02:12:51,779 --> 02:12:54,582 TECHNOLOGIES START CENTRALIZED 2916 02:12:54,582 --> 02:12:57,785 AND BIG AND EVENTUALLY BECOME 2917 02:12:57,785 --> 02:12:59,887 DISSEMINATED AND SMALL AND 2918 02:12:59,887 --> 02:13:00,187 PERSONABLE. 2919 02:13:00,187 --> 02:13:02,857 IT'S COMING AND GOING TO HAPPEN. 2920 02:13:02,857 --> 02:13:07,695 >> I AGREE WITH EVERYTHING YOU 2921 02:13:07,695 --> 02:13:08,462 SAID, ERIK. 2922 02:13:08,462 --> 02:13:09,763 TO ADD ON I THINK THERE'S 2923 02:13:09,763 --> 02:13:12,032 BENEFITS WHEN YOU DESIGN A 2924 02:13:12,032 --> 02:13:13,834 PRODUCT FOR AN END USER WHO IS A 2925 02:13:13,834 --> 02:13:14,802 LAY USER. 2926 02:13:14,802 --> 02:13:16,704 THAT'S WHO WITH YOU WERE 2927 02:13:16,704 --> 02:13:20,574 TARGETING. 2928 02:13:20,574 --> 02:13:26,280 WE DID SOMETHING SIMILAR AND HOW 2929 02:13:26,280 --> 02:13:29,650 SOMEONE WITH ZERO BACKGROUND CAN 2930 02:13:29,650 --> 02:13:31,619 SCREW UP SOMETHING THAT IS SCREW 2931 02:13:31,619 --> 02:13:33,621 UPABLE AND YOU CAN SOLVE THOSE 2932 02:13:33,621 --> 02:13:34,555 THINGS AND THE PRODUCT NOT ONLY 2933 02:13:34,555 --> 02:13:37,525 GOOD FOR THE USERS BUT CAN 2934 02:13:37,525 --> 02:13:40,995 BENEFIT IN PROFESSIONAL 2935 02:13:40,995 --> 02:13:51,172 SETTINGS. 2936 02:13:51,906 --> 02:13:54,041 PUSHING THE ENVELOPE ON 2937 02:13:54,041 --> 02:13:56,844 ACCESSIBILITY IS IN GENERAL A 2938 02:13:56,844 --> 02:13:57,545 REALLY GOOD THING. 2939 02:13:57,545 --> 02:14:00,114 THERE'S SOME WHACKY STUFF. 2940 02:14:00,114 --> 02:14:03,050 MENTIONED AMAZON AND YOU GET TO 2941 02:14:03,050 --> 02:14:04,985 SEE REVIEWS AND PEOPLE POSTING 2942 02:14:04,985 --> 02:14:10,691 ON TWITTER AND IT'S A WEIRD NEW 2943 02:14:10,691 --> 02:14:14,461 WORLD OF HOW PEOPLE INTERACT 2944 02:14:14,461 --> 02:14:19,133 WITH THE MARKET POSTMARKET AND 2945 02:14:19,133 --> 02:14:20,367 INSIGHT YOU NORMALLY WOULDN'T BE 2946 02:14:20,367 --> 02:14:22,369 ABLE TO DO AS A MEDICAL DEVICE 2947 02:14:22,369 --> 02:14:22,836 COMPANY. 2948 02:14:22,836 --> 02:14:24,205 IT'S LIKE A CONSUMER ELECTRONICS 2949 02:14:24,205 --> 02:14:31,712 COMPANY. 2950 02:14:31,712 --> 02:14:33,581 I THINK WE SHOULD KEEP PUSHING 2951 02:14:33,581 --> 02:14:34,014 IN THE DIRECTION. 2952 02:14:34,014 --> 02:14:38,152 IT'S CLEARLY WORKING. 2953 02:14:38,152 --> 02:14:48,662 AS AN ANECDOTE I'M WEARING A 2954 02:14:49,430 --> 02:14:52,266 CONTINUOUS GLUCOSE MONITORING SO 2955 02:14:52,266 --> 02:14:56,036 UNDERSTAND HOW WHEN I EAT 2956 02:14:56,036 --> 02:14:57,805 AFFECTS ME IS IT INFLUENCING MY 2957 02:14:57,805 --> 02:15:01,809 BEHAVIOR IN A WAY THAT'S MORE 2958 02:15:01,809 --> 02:15:02,042 HEALTHY? 2959 02:15:02,042 --> 02:15:04,645 I HAD TO GET A PRESCRIPTION FROM 2960 02:15:04,645 --> 02:15:06,380 MY DOCTOR TO GET IT BUT IT'S 2961 02:15:06,380 --> 02:15:08,282 CLEARLY A GOOD THING. 2962 02:15:08,282 --> 02:15:09,883 I DON'T KNOW WHAT THE RIGHT 2963 02:15:09,883 --> 02:15:13,153 ANSWER IS BUT I HOPE WE CAN KEEP 2964 02:15:13,153 --> 02:15:13,887 PUSHING AND MORE INFORMATION 2965 02:15:13,887 --> 02:15:16,457 WILL CONTINUE TO EMERGE. 2966 02:15:16,457 --> 02:15:18,259 >> SPECIFIC CHALLENGE WITH 2967 02:15:18,259 --> 02:15:19,927 THINKING ABOUT A PRODUCT HOW IT 2968 02:15:19,927 --> 02:15:23,597 EVOLVES FROM A CENTRAL SPACE TO 2969 02:15:23,597 --> 02:15:27,701 BEHIND THE COUNTER IS HOW YOU 2970 02:15:27,701 --> 02:15:29,670 MARKET IT AND IF THERE'S 2971 02:15:29,670 --> 02:15:30,704 OPPORTUNITIES TO PARTICIPATE IN 2972 02:15:30,704 --> 02:15:33,140 ONE OR MORE AT ONE TIME AS A 2973 02:15:33,140 --> 02:15:34,675 SMALL OR LARGE COMPANY HOW 2974 02:15:34,675 --> 02:15:36,477 YOU'LL DO IT. 2975 02:15:36,477 --> 02:15:39,113 AND IF THERE'S GOING TO BE OVER 2976 02:15:39,113 --> 02:15:41,515 TIME IT'S GOING TO HAPPEN AND 2977 02:15:41,515 --> 02:15:42,816 WE'RE CERTAINLY SEEING THE 2978 02:15:42,816 --> 02:15:44,485 OPPORTUNITY FOR OUR PRODUCTS. 2979 02:15:44,485 --> 02:15:47,054 DO I TAKE 10% OF MY BUDGET PUT 2980 02:15:47,054 --> 02:15:50,257 IT HERE AND 30% HERE AND PUSH 2981 02:15:50,257 --> 02:15:50,491 FORWARD. 2982 02:15:50,491 --> 02:15:51,825 AT THE SAME TIME YOU WOULD LIKE 2983 02:15:51,825 --> 02:15:53,294 AS POSSIBLE YOUR ENGAGEMENT IN 2984 02:15:53,294 --> 02:15:55,462 EDUCATION TO BE THE SAME MESSAGE 2985 02:15:55,462 --> 02:15:57,298 SO IF SOMEONE INTERACTS WITH YOU 2986 02:15:57,298 --> 02:15:58,465 IN THIS FORM IT'S NOT DIFFERENT 2987 02:15:58,465 --> 02:16:00,734 THAN THIS MARKET OVER HERE. 2988 02:16:00,734 --> 02:16:06,340 SO THAT IS ONE VERY REAL 2989 02:16:06,340 --> 02:16:07,308 GRANULAR CHALLENGE AND GRATEFUL 2990 02:16:07,308 --> 02:16:09,510 TO HAVE A FULL-PLEDGED MARKETING 2991 02:16:09,510 --> 02:16:12,880 DEPARTMENT TO HELP ME THROUGH 2992 02:16:12,880 --> 02:16:14,381 THE CHALLENGES BUT THERE'S OTHER 2993 02:16:14,381 --> 02:16:16,050 DIRECT TO CONSUMER PRODUCTS. 2994 02:16:16,050 --> 02:16:17,851 IF YOU WANT TO MAKE SURE IT 2995 02:16:17,851 --> 02:16:19,119 WORKS AND MAKE SURE THE 2996 02:16:19,119 --> 02:16:20,721 TECHNOLOGY'S THERE OF COURSE BUT 2997 02:16:20,721 --> 02:16:22,589 TO TAKE IT FURTHER, HUMAN 2998 02:16:22,589 --> 02:16:25,359 FACTORS, FIND OUT WHY PEOPLE 2999 02:16:25,359 --> 02:16:26,827 INTERACT WITH THINGS FOR FUN TO 3000 02:16:26,827 --> 02:16:32,433 PROMOTE THEIR ENGAGEMENT AND 3001 02:16:32,433 --> 02:16:34,068 GETTING INVOLVED. 3002 02:16:34,068 --> 02:16:36,370 ONE REAL THING AFTER DOING 2024 3003 02:16:36,370 --> 02:16:37,171 BUDGETS FOR OUR COMPANY. 3004 02:16:37,171 --> 02:16:37,504 >> ALL RIGHT. 3005 02:16:37,504 --> 02:16:47,815 THANK YOU SO MUCH. 3006 02:16:57,925 --> 02:16:59,727 >> IT SOUNDS LIKE THE PANEL 3007 02:16:59,727 --> 02:17:06,467 WE'VE ALL BEEN WAITING FOR, 3008 02:17:06,467 --> 02:17:06,767 REGULATORY. 3009 02:17:06,767 --> 02:17:11,572 SO WE WILL HAVE THIS PARTICULAR 3010 02:17:11,572 --> 02:17:21,215 PAN CHAIRED BY QI DUAN AND I'LL 3011 02:17:21,215 --> 02:17:31,492 LEAVE IT TO QI. 3012 02:17:37,431 --> 02:17:38,532 >> THANK YOU, EVERYONE. 3013 02:17:38,532 --> 02:17:44,171 I'M QI HERE TO FILL IN FOR MY 3014 02:17:44,171 --> 02:17:45,606 COLLEAGUE WHO PUT IN A LOT OF 3015 02:17:45,606 --> 02:17:47,241 EFFORT IN ORGANIZING THE PANEL 3016 02:17:47,241 --> 02:17:51,311 AND HONORED TO WORK WITH ALL THE 3017 02:17:51,311 --> 02:17:52,746 PANELISTS HERE. 3018 02:17:52,746 --> 02:17:54,681 AND THE TOPIC WHICH IS A PERFECT 3019 02:17:54,681 --> 02:17:56,850 SEGUE FROM THE DISCUSSION IS 3020 02:17:56,850 --> 02:18:01,889 FOCUSSING ON REGULATORY STANDARD 3021 02:18:01,889 --> 02:18:03,490 COMPLIANCE, WHICH I WILL ARGUE 3022 02:18:03,490 --> 02:18:08,562 IS AN AREA NOT WELL KNOWN BY 3023 02:18:08,562 --> 02:18:09,696 GENERAL PUBLIC AND CONVERTS TO 3024 02:18:09,696 --> 02:18:15,436 THE OTHER TWO TOPICS AND AS YOU 3025 02:18:15,436 --> 02:18:18,439 HEARD FROM THE PREVIOUS PANEL 3026 02:18:18,439 --> 02:18:23,677 AND DISCUSSION THERE'S HURDLES 3027 02:18:23,677 --> 02:18:24,578 GETTING THE TECHNOLOGY INTO THE 3028 02:18:24,578 --> 02:18:26,246 MARKET AND I WANT TO TAKE THE 3029 02:18:26,246 --> 02:18:29,016 OPPORTUNITY TO BRING IN ANOTHER 3030 02:18:29,016 --> 02:18:36,290 ASPECT REPEATED IS THAT IF YOU 3031 02:18:36,290 --> 02:18:39,660 LOOK AT THE SPACE FROM ALL THE 3032 02:18:39,660 --> 02:18:41,995 STAKEHOLDERS ARE THE GREAT 3033 02:18:41,995 --> 02:18:47,134 EFFORT TRYING TO ENSURE RELIABLE 3034 02:18:47,134 --> 02:18:48,702 TESTING CAN BE DELIVERED INTO ON 3035 02:18:48,702 --> 02:18:48,902 TIME. 3036 02:18:48,902 --> 02:18:50,804 WE HAVE THREE PANELISTS. 3037 02:18:50,804 --> 02:18:53,774 ONE TODAY AND EACH HAS A SHORT 3038 02:18:53,774 --> 02:19:00,714 PRESENTATION SO WITHOUT FURTHER 3039 02:19:00,714 --> 02:19:08,455 ADO, DR. HEETDERKS. 3040 02:19:08,455 --> 02:19:09,189 >> THANK YOU. 3041 02:19:09,189 --> 02:19:10,591 IT'S A REAL PLEASURE TO BE HERE 3042 02:19:10,591 --> 02:19:12,292 AND WE CAN START WITH THE FIRST 3043 02:19:12,292 --> 02:19:13,894 SLIDES BECAUSE I KNOW WE'RE 3044 02:19:13,894 --> 02:19:17,598 STANDING BETWEEN YOU AND LUNCH 3045 02:19:17,598 --> 02:19:19,032 AND THAT ALWAYS MAKES ONE WANT 3046 02:19:19,032 --> 02:19:20,133 TO HURRY UP A LITTLE BIT. 3047 02:19:20,133 --> 02:19:25,272 I WANT TO TALK A LITTLE BIT 3048 02:19:25,272 --> 02:19:32,179 ABOUT EVOLUTION EYE AND IN 3049 02:19:32,179 --> 02:19:33,981 PARTICULAR HOW OVER THE RAPID 3050 02:19:33,981 --> 02:19:35,849 ANTIGEN TESTS GOT REGULATED. 3051 02:19:35,849 --> 02:19:38,118 AND THE ONLY OTHER THING TO NOTE 3052 02:19:38,118 --> 02:19:40,721 ON THE INTRODUCTORY SLIDE IS I'M 3053 02:19:40,721 --> 02:19:43,524 AN ADVISER WHICH MEANS I'LL BE 3054 02:19:43,524 --> 02:19:48,662 ABLE TO SAY THINGS THAT ARE IN 3055 02:19:48,662 --> 02:19:50,230 NO WAY REPRESENTATIVE OF BEING 3056 02:19:50,230 --> 02:19:51,598 BINDING ON THE FDA OR NIH. 3057 02:19:51,598 --> 02:19:52,900 IF I SAY SOMETHING TO YOU AND 3058 02:19:52,900 --> 02:19:55,002 LATER YOU SAY, WELL, BILL YOU 3059 02:19:55,002 --> 02:19:57,838 SAID I'M SAYING THIS AS AN 3060 02:19:57,838 --> 02:20:00,774 ADVISER NOT AS AN OFFICIAL 3061 02:20:00,774 --> 02:20:02,843 SPOEKDZ PERSON FOR -- 3062 02:20:05,012 --> 02:20:06,513 SPOKESPERSON FOR THE NIH. 3063 02:20:06,513 --> 02:20:12,119 WHEN WE FIRST STARTED THIS I 3064 02:20:12,119 --> 02:20:22,329 SENT AN E-MAIL TO I SENT AN 3065 02:20:22,329 --> 02:20:25,866 E-MAIL TO TIM AT THE SAYING WE 3066 02:20:25,866 --> 02:20:27,000 WANT TO COOPERATE AND 3067 02:20:27,000 --> 02:20:28,168 COLLABORATE ON THE ACTIVITY AND 3068 02:20:28,168 --> 02:20:30,637 HE WROTE BACK AND SAID 3069 02:20:30,637 --> 02:20:30,938 ABSOLUTELY. 3070 02:20:30,938 --> 02:20:32,706 IT'S A GREAT IDEA. 3071 02:20:32,706 --> 02:20:33,574 WE'LL BE JOINED AT THE HIP GOING 3072 02:20:33,574 --> 02:20:38,946 FORWARD ON THIS. 3073 02:20:38,946 --> 02:20:42,249 THAT STRUCK ME AS A GREAT IDEA 3074 02:20:42,249 --> 02:20:44,384 ALSO BUT IT BECAME CLEAR WE 3075 02:20:44,384 --> 02:20:46,219 WEREN'T AS JOINED AS I THOUGHT 3076 02:20:46,219 --> 02:20:47,020 WE WERE GOING TO BE. 3077 02:20:47,020 --> 02:20:48,455 WHEN YOU THINK ABOUT IT A LITTLE 3078 02:20:48,455 --> 02:20:50,057 BIT, WHEN YOU LOOK AT THE 3079 02:20:50,057 --> 02:20:53,060 MISSION YOU REALIZE WHY THAT WAS 3080 02:20:53,060 --> 02:20:53,260 TRUE. 3081 02:20:53,260 --> 02:20:58,632 FDA PROTECTING PUBLIC HEALTH, 3082 02:20:58,632 --> 02:21:02,402 SAVED AN EFFICACY AND NIH IS 3083 02:21:02,402 --> 02:21:03,470 SEEK FUNDAMENTAL KNOWLEDGE AND 3084 02:21:03,470 --> 02:21:05,038 APPLICATION OF THE KNOWLEDGE TO 3085 02:21:05,038 --> 02:21:05,439 ENHANCE HEALTH. 3086 02:21:05,439 --> 02:21:07,774 DIFFERENT MISSIONS. 3087 02:21:07,774 --> 02:21:09,576 WE HAVE DIFFERENT SPECIES JOINED 3088 02:21:09,576 --> 02:21:11,945 AT THE HIP WHICH DOESN'T MAKE 3089 02:21:11,945 --> 02:21:12,212 SENSE. 3090 02:21:12,212 --> 02:21:18,352 THAT ANALOGY BROKE DOWN BUT I 3091 02:21:18,352 --> 02:21:23,724 WANT TO INDICATE AND REALIZE WE 3092 02:21:23,724 --> 02:21:24,524 COULD WORK TOGETHER THOUGH WE 3093 02:21:24,524 --> 02:21:34,935 HAVE DIFFERENT MISSIONS. 3094 02:21:38,138 --> 02:21:40,374 AND WHAT YOU'RE LOOKING AT HERE 3095 02:21:40,374 --> 02:21:43,610 IS STUDIES THAT WERE DONE ON 3096 02:21:43,610 --> 02:21:49,716 PATIENTS WHERE ON THE X AXIS YOU 3097 02:21:49,716 --> 02:21:52,085 HAVE NASAL SWAB AND HOW MUCH 3098 02:21:52,085 --> 02:21:53,453 VIRUS IS PRESENT IN THE NASAL 3099 02:21:53,453 --> 02:21:58,925 SWAB FROM LOW TO HIGH VIRUS HERE 3100 02:21:58,925 --> 02:22:01,061 AND ON THE Y AXIS THE 3101 02:22:01,061 --> 02:22:03,096 PROBABILITY THE ANTIGEN TEST IS 3102 02:22:03,096 --> 02:22:05,332 IS GOING TO BE POSITIVE. 3103 02:22:05,332 --> 02:22:10,771 IT'S PRETTY OBVIOUS. 3104 02:22:10,771 --> 02:22:15,609 THESE ARE THREE DIFFERENT TESTS, 3105 02:22:15,609 --> 02:22:18,945 TWO ARE ALMOST COMPLETELY SUPER 3106 02:22:18,945 --> 02:22:22,749 IMPOSED MOVING FROM LOW VIRAL 3107 02:22:22,749 --> 02:22:24,117 LOAD TO HIGH VIRAL LOAD THE 3108 02:22:24,117 --> 02:22:24,751 PROBABILITY OF DETECTION GOES 3109 02:22:24,751 --> 02:22:27,788 WAY UP. 3110 02:22:27,788 --> 02:22:29,723 SO ALL THE ENGINEERING IN THE 3111 02:22:29,723 --> 02:22:30,524 AUDIENCE KNOW IF YOU'RE 3112 02:22:30,524 --> 02:22:39,299 OPERATING IN THIS REGION HERE 3113 02:22:39,299 --> 02:22:42,402 THOSE TESTS WILL WORK FANTAS 3114 02:22:42,402 --> 02:22:44,271 FANTASTICALLY AND IF YOU WORK 3115 02:22:44,271 --> 02:22:46,440 HERE THEY'LL DROP DOWN UNTIL IT 3116 02:22:46,440 --> 02:22:56,950 DROPS DOWN TO MAYBE 20% OR SO. 3117 02:22:57,417 --> 02:22:58,685 TAKE THAT CURB AND WHAT HAPPENS 3118 02:22:58,685 --> 02:23:00,787 TO YOU WHEN YOU GET THE COVID 3119 02:23:00,787 --> 02:23:01,054 INFECTION. 3120 02:23:01,054 --> 02:23:02,889 THIS IS REFERENCED TO TIME ZERO 3121 02:23:02,889 --> 02:23:08,095 OF THE PEAK LOAD. 3122 02:23:08,095 --> 02:23:09,930 IT GOES FROM LOW VIRUS TO HIGH 3123 02:23:09,930 --> 02:23:11,398 VIRUS BACK DOWN TO LOW VIRUS. 3124 02:23:11,398 --> 02:23:15,335 THE THING TO NOTE ON THIS IS 3125 02:23:15,335 --> 02:23:19,439 REALLY NOT THAT ENVELOPE BUT THE 3126 02:23:19,439 --> 02:23:23,076 SCALE ON THE Y AXIS WE'RE GOING 3127 02:23:23,076 --> 02:23:25,445 FROM 10 TO THE 0 TO 10 TO THE 9. 3128 02:23:25,445 --> 02:23:35,989 THIS RANGES OVER A BILLION FOLD 3129 02:23:41,161 --> 02:23:43,430 IF YOU DO THE ANTIGEN TESTS IN 3130 02:23:43,430 --> 02:23:45,766 THE REGION HERE YOU'LL BE IN 3131 02:23:45,766 --> 02:23:46,032 SHAPE. 3132 02:23:46,032 --> 02:23:47,734 ON THE OTHER HAND IF YOU TEST 3133 02:23:47,734 --> 02:23:51,338 HERE AT THE BEGINNING IT'S GOING 3134 02:23:51,338 --> 02:23:54,174 TO BE DIFFICULT AND YOU WON'T BE 3135 02:23:54,174 --> 02:23:57,544 ABLE TO TEST. 3136 02:23:57,544 --> 02:24:00,080 SO THIS SHOWS IT'S NOT JUST ONE 3137 02:24:00,080 --> 02:24:02,315 PATIENT BUT A LOT OF PATIENTS. 3138 02:24:02,315 --> 02:24:04,184 IN CONTRAST TO THAT, THAT'S THE 3139 02:24:04,184 --> 02:24:07,087 NIH AND WHAT WE FOUND AT NIH IF 3140 02:24:07,087 --> 02:24:09,890 YOU SWITCH OVER NOW TO FDA'S 3141 02:24:09,890 --> 02:24:11,691 PRODUCT REVIEW WHICH IS THIS 3142 02:24:11,691 --> 02:24:13,860 OTHER SPECIES THAT WE'RE TALKING 3143 02:24:13,860 --> 02:24:17,430 ABOUT, YOU START WITH DEVELOPING 3144 02:24:17,430 --> 02:24:20,634 AN INDICATION FOR USE AND GET 3145 02:24:20,634 --> 02:24:24,004 DESIGN FREEZE AND HAVE TO DO 3146 02:24:24,004 --> 02:24:24,638 ANALYTICAL STUDIES, STABILITY 3147 02:24:24,638 --> 02:24:34,948 STUDIES, ETCETERA. 3148 02:24:41,221 --> 02:24:42,856 DIFFERENT COMPANIES WILL SAY I 3149 02:24:42,856 --> 02:24:45,392 HAVE A PRODUCT BUT WHAT'S THE 3150 02:24:45,392 --> 02:24:45,659 PRODUCT. 3151 02:24:45,659 --> 02:24:48,595 AND ONE SAYS AGE 14 YEARS OR 3152 02:24:48,595 --> 02:24:50,764 OLDER AND ONE 15 ONE 15 AND 16 3153 02:24:50,764 --> 02:24:52,632 AND SYMPTOMS WITH SEVEN DAYS, 3154 02:24:52,632 --> 02:24:55,569 FIVE DAYS, FOUR DAYS. 3155 02:24:55,569 --> 02:25:02,709 SO I'LL ASK, ANY OF YOU IF YOU 3156 02:25:02,709 --> 02:25:11,084 HAVE A 14-YEAR-OLD WOULD YOU 3157 02:25:11,084 --> 02:25:13,253 SPECIFICALLY SAY I'M ONLY USE 3158 02:25:13,253 --> 02:25:14,988 THIS PRODUCT BECAUSE IT'S BEEN 3159 02:25:14,988 --> 02:25:17,357 CLEARED FOR 14-YEAR-OLDS OUT IF 3160 02:25:17,357 --> 02:25:24,097 YOU'RE THE FDA IT MAKES SENSE 3161 02:25:24,097 --> 02:25:27,033 BECAUSE THE STUY INCLUDED 3162 02:25:27,033 --> 02:25:28,969 14-YEAR-OLD AND LIKEWISE ON THE 3163 02:25:28,969 --> 02:25:30,670 DAY IT MAKES IT DIFFERENT. 3164 02:25:30,670 --> 02:25:33,907 YOU HAVE SOMEHOW WORK THOSE 3165 02:25:33,907 --> 02:25:34,808 TOGETHER AND WITH DISCUSSION AND 3166 02:25:34,808 --> 02:25:37,777 THIS IS WHERE I TITLED IT 3167 02:25:37,777 --> 02:25:39,546 EVOLUTION BECAUSE THIS HAPPENED 3168 02:25:39,546 --> 02:25:42,482 OVER TIME NOT OVER A DAY OR WEEK 3169 02:25:42,482 --> 02:25:44,718 BUT OVER A PERIOD OF MONTHS AND 3170 02:25:44,718 --> 02:25:45,018 YEARS. 3171 02:25:45,018 --> 02:25:52,259 AND I'LL HAVE TO SAY THAT HAVING 3172 02:25:52,259 --> 02:25:54,761 DR. TROMBERG SAYING YOU NEED A 3173 02:25:54,761 --> 02:25:56,630 CHAMPION AND WE HAD A CHAMPION 3174 02:25:56,630 --> 02:25:59,065 THERE AND THAT HELPED THINGS 3175 02:25:59,065 --> 02:26:06,740 ALONG. 3176 02:26:06,740 --> 02:26:09,075 THERE WAS A STANDARD THAT COULD 3177 02:26:09,075 --> 02:26:10,710 BE USED AND ALSO I'LL SKIP OVER 3178 02:26:10,710 --> 02:26:11,811 THIS A LITTLE BIT BECAUSE MY 3179 02:26:11,811 --> 02:26:16,082 TIME IS ZIPPING ALONG BUT A 3180 02:26:16,082 --> 02:26:17,050 LONGITUDINAL STUDY THAT ALLOWED 3181 02:26:17,050 --> 02:26:19,586 US TO COLLECT DATA THAT COULD BE 3182 02:26:19,586 --> 02:26:23,089 USED NOT JUST FOR ONE TEST BUT 3183 02:26:23,089 --> 02:26:25,659 FOR MULTIPLE TESTS. 3184 02:26:25,659 --> 02:26:28,728 WE HAVE STANDARDIZED IFU AND 3185 02:26:28,728 --> 02:26:31,998 I'LL HIGHLIGHT THE END PART AND 3186 02:26:31,998 --> 02:26:33,500 INDIVIDUALS WITHOUT SYMPTOMS. 3187 02:26:33,500 --> 02:26:36,736 THERE'S THE APPLICATION OF WHERE 3188 02:26:36,736 --> 02:26:38,672 YOU'RE SCREENING AND TESTING AT 3189 02:26:38,672 --> 02:26:40,607 LEAST THREE TIMES OVER FIVE 3190 02:26:40,607 --> 02:26:41,341 DAYS. 3191 02:26:41,341 --> 02:26:42,876 IF YOU LOOK AT THE INITIAL 3192 02:26:42,876 --> 02:26:47,314 CURVES I SHOWED YOU, IT'S VERY 3193 02:26:47,314 --> 02:26:49,149 OBVIOUS WHY FROM THE NIH SIDE 3194 02:26:49,149 --> 02:26:50,417 THE SCIENCE WAS POINTING THAT 3195 02:26:50,417 --> 02:26:53,086 WAY AND TALKING WITH THE FDA 3196 02:26:53,086 --> 02:26:55,155 THEN IF THE FDA GOT ON BOARD 3197 02:26:55,155 --> 02:26:57,557 WITH THAT, WE COULD DO THE 3198 02:26:57,557 --> 02:26:59,960 CLINICAL STUDIES AND AWAY WE 3199 02:26:59,960 --> 02:27:00,160 WENT. 3200 02:27:00,160 --> 02:27:03,430 AND THAT ACTUALLY WORKED. 3201 02:27:03,430 --> 02:27:04,931 ONE OTHER QUICK THING I WANT TO 3202 02:27:04,931 --> 02:27:06,466 TALK ABOUT IS NEED FOR SPEED. 3203 02:27:06,466 --> 02:27:07,634 EVEN WITH THAT, IT WASN'T QUITE 3204 02:27:07,634 --> 02:27:15,075 FAST ENOUGH. 3205 02:27:15,075 --> 02:27:16,977 A WHOLE OTHER APPROACH TO GET 3206 02:27:16,977 --> 02:27:18,211 THROUGH THE PROCESS MORE QUICKLY 3207 02:27:18,211 --> 02:27:20,780 THAT WAS INDEPENDENT TESTING. 3208 02:27:20,780 --> 02:27:21,348 THE PROGRAM ALREADY BRIEFLY 3209 02:27:21,348 --> 02:27:27,687 MENTIONED. 3210 02:27:27,687 --> 02:27:29,723 AGAIN THIS WAS COORDINATED AT 3211 02:27:29,723 --> 02:27:32,025 THE FDA AND NIH WHERE THEY 3212 02:27:32,025 --> 02:27:37,897 NEGOTIATED AND AGREED ON STUDY 3213 02:27:37,897 --> 02:27:44,738 DESIGNS AND FDA TELL ME WHAT YOU 3214 02:27:44,738 --> 02:27:46,272 WANT ME TO DO AND THAT'S WHAT 3215 02:27:46,272 --> 02:27:49,242 I'M GOING TO DO AND FDA WILL 3216 02:27:49,242 --> 02:27:50,744 ANSWER BACK, COMPANY, TELL ME 3217 02:27:50,744 --> 02:27:52,679 WHAT YOU'RE GOING TO DO AND I'LL 3218 02:27:52,679 --> 02:28:03,189 TELL YOU IF THAT'S ALL RIGHT. 3219 02:28:20,173 --> 02:28:21,608 AND ACCEPT THE DATA AS IT BECAME 3220 02:28:21,608 --> 02:28:21,975 AVAILABLE. 3221 02:28:21,975 --> 02:28:32,519 I LISTED ALL THE ITEMS THAT AND 3222 02:28:41,828 --> 02:28:44,531 CONSISTENT PROTOCOLS SO ALL THE 3223 02:28:44,531 --> 02:28:47,067 TESTS WERE BEING EVALUATED IN 3224 02:28:47,067 --> 02:28:48,468 THE SAME WAY AND AS A RESULT OF 3225 02:28:48,468 --> 02:28:50,703 THAT YOU COULD ACTUALLY MUCH 3226 02:28:50,703 --> 02:28:56,376 MORE REASONABLY CARE -- COMPARE 3227 02:28:56,376 --> 02:28:57,877 ONE TO THE OTHER AND SPED THINGS 3228 02:28:57,877 --> 02:29:00,280 UP TREMENDOUSLY. 3229 02:29:00,280 --> 02:29:01,915 TO SUMMARIZE, ORGANIZATIONS HAVE 3230 02:29:01,915 --> 02:29:06,986 TO RESPECT EACH OTHER'S MISSIONS 3231 02:29:06,986 --> 02:29:08,755 BUT CAN WORK TOGETHER FOR A 3232 02:29:08,755 --> 02:29:14,160 COMMON GOOD AND IT WORKED WELL 3233 02:29:14,160 --> 02:29:14,527 HERE. 3234 02:29:14,527 --> 02:29:22,001 THE OTHER THING AND IT CAN 3235 02:29:22,001 --> 02:29:23,970 SIMPLY AND ACCELERATE THE 3236 02:29:23,970 --> 02:29:24,737 APPROVAL PROCESS. 3237 02:29:24,737 --> 02:29:29,876 THIS IS SOMETHING THAT CLEARLY 3238 02:29:29,876 --> 02:29:33,980 WORKED WORKED WELL FOR THE COVID 3239 02:29:33,980 --> 02:29:35,782 TESTS AND INTEGRATING THE 3240 02:29:35,782 --> 02:29:39,152 INSIGHTS TO NORMAL OPERATIONS OF 3241 02:29:39,152 --> 02:29:41,287 NIH AND FDA CAN ENHANCE THE 3242 02:29:41,287 --> 02:29:42,355 ABILITY OF BOTH ORGANIZATIONS 3243 02:29:42,355 --> 02:29:44,424 FOR WHAT WE WERE CALLED TO DO BY 3244 02:29:44,424 --> 02:29:48,628 THE NIH DIRECTOR TO POSITIVELY 3245 02:29:48,628 --> 02:29:50,163 IMPACT HUMAN HEALTH. 3246 02:29:50,163 --> 02:29:53,633 THAT'S OBVIOUSLY AN ASPIRATIONAL 3247 02:29:53,633 --> 02:29:53,833 GOAL. 3248 02:29:53,833 --> 02:29:55,935 BUT I THINK IT'S SOMETHING THAT 3249 02:29:55,935 --> 02:29:58,438 IS ONE OF THE REALLY GREAT 3250 02:29:58,438 --> 02:29:59,772 MESSAGES FROM THE RADX PROGRAM 3251 02:29:59,772 --> 02:30:03,710 THAT WE CAN TAKE HOME. 3252 02:30:03,710 --> 02:30:05,812 SO I WILL TRANSFER OVER NOW TO 3253 02:30:05,812 --> 02:30:06,212 THE NEXT SPEAKER. 3254 02:30:06,212 --> 02:30:16,356 THANKS. 3255 02:31:03,102 --> 02:31:07,740 >> OKAY. 3256 02:31:07,740 --> 02:31:09,642 I THINK YOU SAID -- SET THE TALK 3257 02:31:09,642 --> 02:31:10,677 UP REALLY WELL. 3258 02:31:10,677 --> 02:31:12,779 I WANT TO THANK THE ORGANIZERS 3259 02:31:12,779 --> 02:31:15,548 FOR GIVING ME THE OPPORTUNITY TO 3260 02:31:15,548 --> 02:31:17,116 PRESENT TODAY. 3261 02:31:17,116 --> 02:31:22,555 I'M GOING TO TALK ABOUT WORK WE 3262 02:31:22,555 --> 02:31:29,195 DO IN THE LAB AND TALK HOW 3263 02:31:29,195 --> 02:31:32,432 TESTING HAS IMPACT ED OUR LAB 3264 02:31:32,432 --> 02:31:35,969 TESTING TEST THE TESTING 3265 02:31:35,969 --> 02:31:36,669 LANDSCAPE AS WELL AS THE 3266 02:31:36,669 --> 02:31:41,107 INFLUENCE ON REGULATORY 3267 02:31:41,107 --> 02:31:42,308 STANDARDS COMPLIANCE. 3268 02:31:42,308 --> 02:31:44,277 SO AT THE CENTER WHENEVER WE GET 3269 02:31:44,277 --> 02:31:47,714 A COVID-19 TEST WE FOLLOW A 3270 02:31:47,714 --> 02:31:48,681 MULTI-FACETED APPROACH WE CALL 3271 02:31:48,681 --> 02:31:49,649 TESTING THE TESTS. 3272 02:31:49,649 --> 02:31:54,754 WE HAVE THE PATHOLOGISTS AND THE 3273 02:31:54,754 --> 02:31:56,789 CHILDREN'S HEALTH CARE OF 3274 02:31:56,789 --> 02:31:58,191 ATLANTA AND THE CLINICAL 3275 02:31:58,191 --> 02:31:59,926 LABORATORIES AND BIO ROW POS 3276 02:31:59,926 --> 02:32:00,226 TRIES. 3277 02:32:00,226 --> 02:32:02,128 THE -- REPOSITORIES. 3278 02:32:02,128 --> 02:32:06,899 THE FIELD STUDIES ARE PROSPECTED 3279 02:32:06,899 --> 02:32:08,568 BY OVER THE COUNTER DEVICES 3280 02:32:08,568 --> 02:32:19,045 TESTED HERE BY THEM. 3281 02:32:19,045 --> 02:32:21,381 THEY HAVE THE ENGINEERS DOING 3282 02:32:21,381 --> 02:32:24,317 ADDITIONAL ASSESSMENT INCLUDING 3283 02:32:24,317 --> 02:32:26,319 BUT NOT LIMITED TO TEST 3284 02:32:26,319 --> 02:32:26,653 AVAILABILITY. 3285 02:32:26,653 --> 02:32:29,188 WHAT I'LL FOCUS ON TODAY IS 3286 02:32:29,188 --> 02:32:31,958 TESTING THAT IS IN THE LAB AT 3287 02:32:31,958 --> 02:32:34,427 EMORY UNIVERSITY, WE HAVE 3288 02:32:34,427 --> 02:32:37,997 SEVERAL BIO SAFETY LEVEL 2 AND 3 3289 02:32:37,997 --> 02:32:38,631 LABS. 3290 02:32:38,631 --> 02:32:41,134 WE DO RIGOROUS AND DETAILED 3291 02:32:41,134 --> 02:32:46,172 TESTING OF DEVICES IN THESE 3292 02:32:46,172 --> 02:32:46,539 LABS. 3293 02:32:46,539 --> 02:32:48,608 WE ALSO HAVE CAN PROPAGATE 3294 02:32:48,608 --> 02:32:50,977 VIRUSES AND USE THEM FOR 3295 02:32:50,977 --> 02:32:51,377 TESTING. 3296 02:32:51,377 --> 02:32:53,613 AND ALONG WITH LABORATORY 3297 02:32:53,613 --> 02:32:55,815 TESTING OF DEVICES WE'RE ALSO 3298 02:32:55,815 --> 02:32:56,382 DEEPLY INVOLVED IN PROTOCOL 3299 02:32:56,382 --> 02:33:06,592 INVOLVEMENT. 3300 02:33:19,172 --> 02:33:20,973 I WANT TO TALK ABOUT HOW THE 3301 02:33:20,973 --> 02:33:21,974 TESTS WORK. 3302 02:33:21,974 --> 02:33:24,510 WE USE CONTRITE SAMPLES AND IT'S 3303 02:33:24,510 --> 02:33:26,946 BEEN MENTIONED WE DO LIMITED 3304 02:33:26,946 --> 02:33:29,982 DETECTION MEASUREMENTS AND FOR 3305 02:33:29,982 --> 02:33:33,152 THIS WE USE LAB PROPAGATED VIRUS 3306 02:33:33,152 --> 02:33:36,456 AND WE TAKE THIS AND THEN WE 3307 02:33:36,456 --> 02:33:41,227 ACTUALLY SERIALLY DILUTE THEM IN 3308 02:33:41,227 --> 02:33:43,629 A COMMERCIALLY AVAILABLE USUALLY 3309 02:33:43,629 --> 02:33:49,202 NEGATIVE NASAL WASH AND THEN 3310 02:33:49,202 --> 02:33:59,746 HAVE THIS TEST USING THE GET A 3311 02:34:09,756 --> 02:34:12,458 SENSITIVITY OF TARGET AND THE 3312 02:34:12,458 --> 02:34:15,094 SAMPLES ARE LEFT OVER AFTER 3313 02:34:15,094 --> 02:34:15,495 CLINICAL TESTING. 3314 02:34:15,495 --> 02:34:20,533 WE GET THESE -- WE TAKE HIGHLY 3315 02:34:20,533 --> 02:34:23,002 CONCENTRATED SAMPLES AND DILUTE 3316 02:34:23,002 --> 02:34:29,108 THEM IN MATRIX AND THE BEAUTY OF 3317 02:34:29,108 --> 02:34:34,847 RCS TESTING IS THEY CLOSELY 3318 02:34:34,847 --> 02:34:36,682 MIMIC CLINICAL SAMPLES AND THE 3319 02:34:36,682 --> 02:34:38,818 RESULTS WILL GIVE A GOOD ITE YA 3320 02:34:38,818 --> 02:34:43,856 OF HOW A TEST WILL DO IN REAL 3321 02:34:43,856 --> 02:34:44,056 LIFE. 3322 02:34:44,056 --> 02:34:47,894 THE WEN EXPRESS RESULTS AND ONCE 3323 02:34:47,894 --> 02:34:51,230 THESE TWO TYPES OF SAMPLES ARE 3324 02:34:51,230 --> 02:34:53,433 READY, WE THEN SET UP ASSAYS AND 3325 02:34:53,433 --> 02:34:59,105 I'LL ELABORATE ON THIS LATER ON 3326 02:34:59,105 --> 02:35:03,242 IN MY TALK AND WE HAVE AN 3327 02:35:03,242 --> 02:35:04,477 EXTENSIVE BIO REPOSITORY AT 3328 02:35:04,477 --> 02:35:04,844 EMORY. 3329 02:35:04,844 --> 02:35:08,080 THIS IS FOR EMORY SAMPLES BUT 3330 02:35:08,080 --> 02:35:10,983 ALSO WE GOT THIS AS THE RESULT 3331 02:35:10,983 --> 02:35:13,286 OF WORKING CLOSELY TOGETHER WITH 3332 02:35:13,286 --> 02:35:15,087 THE TASK FORCE. 3333 02:35:15,087 --> 02:35:18,057 WE HAVE LIVE AND ADAPTIVE SARS 3334 02:35:18,057 --> 02:35:21,327 COV2 SAMPLES AND I WANT TO POINT 3335 02:35:21,327 --> 02:35:23,029 OUT THEY'RE EXPANSIVELY 3336 02:35:23,029 --> 02:35:25,198 SEQUENCED AND KNOW THE FULL 3337 02:35:25,198 --> 02:35:27,700 SEQUENCE OF THE SAMPLES AND WE 3338 02:35:27,700 --> 02:35:29,735 KNOW WHICH SUBVARIANT THEY ARE. 3339 02:35:29,735 --> 02:35:33,072 WE ALSO HAVE A BIO REPOSITORY A 3340 02:35:33,072 --> 02:35:38,578 LIVE FLU A AND B AND RSV SAMPLES 3341 02:35:38,578 --> 02:35:41,147 AND ALSO LIVE SAMPLES. 3342 02:35:41,147 --> 02:35:46,085 AS FAR AS METHODOLOGY WE HAVE A 3343 02:35:46,085 --> 02:35:48,821 FIXED FOL UME USUALLY 50 3344 02:35:48,821 --> 02:35:51,424 MICROLITERS AND ALL THE SAMPLES 3345 02:35:51,424 --> 02:35:55,862 ARE DILUTED AN COMMON MATRIX AND 3346 02:35:55,862 --> 02:35:58,764 ALLOWS TEST TO TEST COMPARISON. 3347 02:35:58,764 --> 02:36:06,739 SO WHAT I'M GOING TO TALK ABOUT 3348 02:36:06,739 --> 02:36:09,842 AND THE ROLE OF ASSAYS IN THE 3349 02:36:09,842 --> 02:36:14,046 TESTING LANDSCAPE AND TOUCH UPON 3350 02:36:14,046 --> 02:36:15,348 CONTROLLED ANALYSIS AND EPITOPE 3351 02:36:15,348 --> 02:36:17,750 MAPPING BUT WILL GO OVER THIS 3352 02:36:17,750 --> 02:36:18,885 BRIEFLY BECAUSE THESE HAVE BEEN 3353 02:36:18,885 --> 02:36:20,052 RECENTLY PUBLISHED AND ALL THE 3354 02:36:20,052 --> 02:36:21,954 DETAILS ARE AVAILABLE ONLINE. 3355 02:36:21,954 --> 02:36:23,789 I'M GOING TO END WITH AN EXAMPLE 3356 02:36:23,789 --> 02:36:26,492 OF HOW RAPID TESTING OF A 3357 02:36:26,492 --> 02:36:28,928 VARIANT WAS MADE POSSIBLE 3358 02:36:28,928 --> 02:36:29,896 BECAUSE OF OUR EXTENSIVE BIO 3359 02:36:29,896 --> 02:36:40,106 REPOSITORY. 3360 02:36:43,442 --> 02:36:47,146 I WANT TO TALK ABOUT THE 3361 02:36:47,146 --> 02:36:51,284 DEVELOPMENT OF THESE BOOKEND 3362 02:36:51,284 --> 02:36:52,184 ASSAYS. 3363 02:36:52,184 --> 02:36:54,620 WE WANTED TO DEVELOP A PROCESS 3364 02:36:54,620 --> 02:36:58,758 WE COULD USE TO FOR APPLES TO 3365 02:36:58,758 --> 02:36:59,825 APPLES COMPARISON OF TESTS. 3366 02:36:59,825 --> 02:37:01,661 FOR THAT PURPOSE WE CAME UP WITH 3367 02:37:01,661 --> 02:37:05,197 THIS CONCEPT OF BOOKEND ASSAYS 3368 02:37:05,197 --> 02:37:07,667 TO DEFINE THE TEST PERFORMANCE. 3369 02:37:07,667 --> 02:37:09,502 SHOWN HERE IS A DATA SET THAT 3370 02:37:09,502 --> 02:37:11,571 WAS GENERATED IN THE LAB. 3371 02:37:11,571 --> 02:37:16,175 WE TOOK A POOL OF SAMPLES THAT 3372 02:37:16,175 --> 02:37:22,982 WAS RCS SAMPLES AND HAD A HIGHLY 3373 02:37:22,982 --> 02:37:33,526 CONCENTRATED POOL WE THEN DID A 3374 02:37:37,897 --> 02:37:39,565 DELETION SET AND WE GOT VALUES 3375 02:37:39,565 --> 02:37:44,737 AND DID DIGITAL DROP LET PCR FOR 3376 02:37:44,737 --> 02:37:50,576 VARIANTS AND TESTED ALL THE 3377 02:37:50,576 --> 02:37:52,912 SAMPLES AND GET THE PROTEIN IN 3378 02:37:52,912 --> 02:37:55,247 THE SAMPLE. 3379 02:37:55,247 --> 02:38:00,753 AFTER THE EXTENSIVE QUALITY 3380 02:38:00,753 --> 02:38:11,163 CONTROL THE TESTERS IN 3381 02:38:11,163 --> 02:38:17,503 CONCENTRATED SAMPLE OR NEGATIVE 3382 02:38:17,503 --> 02:38:22,575 CONTROL AND WE TESTED ON THE 3383 02:38:22,575 --> 02:38:22,942 BOOKEND ASSAYS. 3384 02:38:22,942 --> 02:38:24,810 THESE ARE TWO ANTIGEN ASSAYS 3385 02:38:24,810 --> 02:38:26,712 WITH UA AND HAVE BEEN APPROVED 3386 02:38:26,712 --> 02:38:30,783 BY THE FDA FOR USE AS BOOKENDS. 3387 02:38:30,783 --> 02:38:33,352 WE THEN WOULD BE -- AS SOON AS 3388 02:38:33,352 --> 02:38:35,187 WE TEST THIS WE BASICALLY 3389 02:38:35,187 --> 02:38:36,589 ESTABLISHED THE TWO TESTS. 3390 02:38:36,589 --> 02:38:38,491 THE RESULTS OF THE TESTS 3391 02:38:38,491 --> 02:38:40,359 BASICALLY DEFINE ANY NEW TEST 3392 02:38:40,359 --> 02:38:48,234 BOUNDARY OF PERFORMANCE. 3393 02:38:48,234 --> 02:38:51,170 ANY NEW TEST AND HOPE THE TEST 3394 02:38:51,170 --> 02:38:53,172 DOES AT LEAST AS WELL AS THE 3395 02:38:53,172 --> 02:38:55,574 LOWER PERFORMING BOOK END AND 3396 02:38:55,574 --> 02:38:57,476 HISTORICALLY WE HAVE SEEN THAT 3397 02:38:57,476 --> 02:39:02,314 ANY TESTS THAT PERFORMS HAS A 3398 02:39:02,314 --> 02:39:05,651 HARD TIME OF OBTAINING EUA AND 3399 02:39:05,651 --> 02:39:07,953 THIS TYPE OF APPLES TO APPLES 3400 02:39:07,953 --> 02:39:09,922 COMPARISON IS A NOVEL 3401 02:39:09,922 --> 02:39:11,657 DEVELOPMENT AND AS FAR AS I KNOW 3402 02:39:11,657 --> 02:39:13,359 HAS NOT BEEN USED AT THIS SCALE 3403 02:39:13,359 --> 02:39:23,569 PREVIOUSLY. 3404 02:39:29,642 --> 02:39:31,711 AND PORTIONS HAVE MADE IT INTO 3405 02:39:31,711 --> 02:39:41,353 DATA ADDED TO PACKAGES. 3406 02:39:41,353 --> 02:39:45,624 STAYING ON THE TOPIC OF BOOK END 3407 02:39:45,624 --> 02:39:48,761 ASSAYS AND TESTS THAT PROCEED TO 3408 02:39:48,761 --> 02:39:55,668 FIELD CLINICAL TESTING. 3409 02:39:55,668 --> 02:40:00,005 THIS DATA SLIDE IN MY PREVIOUS 3410 02:40:00,005 --> 02:40:01,307 TWO SLIDES IS JUST A LITTLE BIT 3411 02:40:01,307 --> 02:40:04,076 MORE ELABORATED HERE AND I'VE 3412 02:40:04,076 --> 02:40:12,518 ADDED IN DATA FROM 12 TESTS. 3413 02:40:12,518 --> 02:40:15,421 IF YOU LOOK FROM LEFT TO RIGHT 3414 02:40:15,421 --> 02:40:17,022 IT'S LEAST SENSITIVE TO MOST 3415 02:40:17,022 --> 02:40:17,890 SENSITIVE. 3416 02:40:17,890 --> 02:40:20,359 THE FIRST THREE TESTS PERFORMED 3417 02:40:20,359 --> 02:40:22,661 LESS WELL THAN THE LOWER BOOKEND 3418 02:40:22,661 --> 02:40:29,168 AND USUALLY WHEN WE SEE THIS WE 3419 02:40:29,168 --> 02:40:33,906 KNOW IT'S A LOW PERFORMING TEST 3420 02:40:33,906 --> 02:40:35,775 AND LET THE DEVICE MANUFACTURER 3421 02:40:35,775 --> 02:40:37,343 KNOW THE TEST NEED TO BE 3422 02:40:37,343 --> 02:40:45,317 OPTIMIZED MORE. 3423 02:40:45,317 --> 02:40:46,685 AND THE DEVICE MANUFACTURE ENDS 3424 02:40:46,685 --> 02:40:49,388 UP REFORMATTING IT AND OFTEN 3425 02:40:49,388 --> 02:40:51,490 COMES BACK IN A MUCH BETTER 3426 02:40:51,490 --> 02:40:52,057 FORMAT. 3427 02:40:52,057 --> 02:40:54,560 THE LOW-PERFORMING TESTS DON'T 3428 02:40:54,560 --> 02:40:55,995 PROCEED TO FIELD TESTING OR 3429 02:40:55,995 --> 02:40:57,763 CLINICAL STUDIOS AND ACTUALLY 3430 02:40:57,763 --> 02:41:01,167 THIS SAVES TIME AND MONEY. 3431 02:41:01,167 --> 02:41:02,735 HOWEVER, MOST THE TESTS FALL 3432 02:41:02,735 --> 02:41:06,172 BETWEEN THE TWO BOOK ENDS AND 3433 02:41:06,172 --> 02:41:09,575 SOME TESTS ACTUALLY DO BETTER 3434 02:41:09,575 --> 02:41:14,980 AND THEY PROCEED TO CLINICAL 3435 02:41:14,980 --> 02:41:25,224 TRIALS AND TO EUA. 3436 02:41:25,224 --> 02:41:27,626 WE'VE PERFORMED SIMILAR TABLES 3437 02:41:27,626 --> 02:41:29,261 WITH LAB-PROPAGATED VIRUS. 3438 02:41:29,261 --> 02:41:32,731 AND ONE THING I WANT TO POINT 3439 02:41:32,731 --> 02:41:35,234 OUT IS THERE'S EXCELLENCE 3440 02:41:35,234 --> 02:41:37,736 CORRELATION BETWEEN OUR DATA 3441 02:41:37,736 --> 02:41:40,039 WITH CLINICAL STUDIES OUTCOME 3442 02:41:40,039 --> 02:41:43,876 AND BY THE METHOD OF LAB TESTING 3443 02:41:43,876 --> 02:41:46,212 WE SAVED MILLIONS OF DOLLARS 3444 02:41:46,212 --> 02:41:47,713 BECAUSE LESS OPTIMIZED TESTS 3445 02:41:47,713 --> 02:41:48,280 DON'T ENTER INTO CLINICAL 3446 02:41:48,280 --> 02:41:56,622 TRIALS. 3447 02:41:56,622 --> 02:41:58,691 I MAY HAVE TO SKIP OVER THESE 3448 02:41:58,691 --> 02:42:01,594 AND I CAN ELABORATE ON THIS TO 3449 02:42:01,594 --> 02:42:04,930 ANYONE INTERESTED LATER ON. 3450 02:42:04,930 --> 02:42:07,533 BUT THESE ARE THE TWO THINGS 3451 02:42:07,533 --> 02:42:10,703 THAT HAVE BEEN PUBLISHED SO 3452 02:42:10,703 --> 02:42:11,537 THEY'RE AVAILABLE ONLINE AND 3453 02:42:11,537 --> 02:42:16,408 THIS SLIDE AND WHAT I WANTED TO 3454 02:42:16,408 --> 02:42:19,445 COVER WAS COMPARED TO CALIBRATED 3455 02:42:19,445 --> 02:42:23,349 ENABLED EUAs WHERE BASICALLY THE 3456 02:42:23,349 --> 02:42:29,822 4944 WAS ESTABLISHED TO BE A 3457 02:42:29,822 --> 02:42:30,155 LO 3458 02:42:30,155 --> 02:42:34,560 LOW-POSITIVE CUT-OFF FOR SEVEN 3459 02:42:34,560 --> 02:42:35,728 COMPANIES AS OF SEPTEMBER TO 3460 02:42:35,728 --> 02:42:45,938 OBTAIN EUA. 3461 02:42:59,485 --> 02:43:05,557 AND IS WAY TO GENERATE ALL 3462 02:43:05,557 --> 02:43:12,965 POSSIBLE MUTATIONS OF THE 3463 02:43:12,965 --> 02:43:14,133 NUCLEOCAPSID AND ANALYZE 3464 02:43:14,133 --> 02:43:16,035 INTERACTIONS IN ONE SINGLE 3465 02:43:16,035 --> 02:43:16,335 EXPERIMENT. 3466 02:43:16,335 --> 02:43:18,070 THE BEAUTY OF THE TECHNIQUE IS 3467 02:43:18,070 --> 02:43:20,873 IT MEASURES THE INTERACTIONS IN 3468 02:43:20,873 --> 02:43:23,909 THE CONTEXT OF PROTEIN AND SINCE 3469 02:43:23,909 --> 02:43:27,880 ALL MUTATIONS ARE COVERED IT 3470 02:43:27,880 --> 02:43:30,649 COVERS ANY POTENTIAL FUTURE 3471 02:43:30,649 --> 02:43:33,919 MUTATIONS THAT CANNOT GO AS 3472 02:43:33,919 --> 02:43:34,653 WELL. 3473 02:43:34,653 --> 02:43:36,689 IF YOU'RE ANTIBODY IS MAPPED IF 3474 02:43:36,689 --> 02:43:38,490 THERE'S A FUTURE MUTATION OF 3475 02:43:38,490 --> 02:43:41,226 CONCERN THE COMPANY WILL JUST 3476 02:43:41,226 --> 02:43:43,662 HAVE TO LOOK IN THE DATABASE AND 3477 02:43:43,662 --> 02:43:45,564 CHECK TO SEE IF THE MUTATION 3478 02:43:45,564 --> 02:43:49,335 ACTUALLY CAUSES AN ESCAPE IN 3479 02:43:49,335 --> 02:43:59,511 DETECTION. 3480 02:44:26,271 --> 02:44:30,909 AND WORKING WITH A DIAGNOSTICS 3481 02:44:30,909 --> 02:44:35,714 LAB WE HAD A SAMPLE SHIPPED IN A 3482 02:44:35,714 --> 02:44:38,717 BIO REPOSITORY EARLY IN 3483 02:44:38,717 --> 02:44:41,053 SEPTEMBER THE PCR ASSAY ARRIVED 3484 02:44:41,053 --> 02:44:43,022 IN OUR LAB AND THE SAME DAY THEY 3485 02:44:43,022 --> 02:44:45,424 WERE ABLE TO TEST IT USING THE 3486 02:44:45,424 --> 02:44:49,962 SAMPLE AND FOUND IT DETECTED THE 3487 02:44:49,962 --> 02:44:50,963 LOW CD. 3488 02:44:50,963 --> 02:45:01,507 THE NEXT DAY WE CARRIED OUT THE 3489 02:45:02,741 --> 02:45:06,512 DILUTION AND WE CARRIED OUT 3490 02:45:06,512 --> 02:45:07,613 CONTROL AND EQUAL VARIANT 3491 02:45:07,613 --> 02:45:07,980 DETECTION. 3492 02:45:07,980 --> 02:45:12,084 BECAUSE WE HAD ACCESS TO THE BIO 3493 02:45:12,084 --> 02:45:15,054 REPOSITORY IT WAS ABLE TO 3494 02:45:15,054 --> 02:45:16,522 RESPOND RAPIDLY WITHIN 10 DAYS 3495 02:45:16,522 --> 02:45:17,322 AND FOUND THE NEW VARIANT COULD 3496 02:45:17,322 --> 02:45:22,461 BE DETECTED BY THE PCR. 3497 02:45:22,461 --> 02:45:25,230 TO SUMMARIZE AND CONCLUDE I WANT 3498 02:45:25,230 --> 02:45:28,700 TO POINT OUT THE LAB CARRIES OUT 3499 02:45:28,700 --> 02:45:29,868 COMPLETELY INDEPENDENT 3500 02:45:29,868 --> 02:45:31,670 ASSESSMENT OF TESTS AND WE HAVE 3501 02:45:31,670 --> 02:45:33,639 DEVELOPED ASPECTS SUCH AS 3502 02:45:33,639 --> 02:45:38,243 BOOKEND ASSAYS AND UNIFORM 3503 02:45:38,243 --> 02:45:41,847 ASSAYS THAT ENABLES APPLES TO 3504 02:45:41,847 --> 02:45:43,849 APPLES COMPARISON AND SAVED 3505 02:45:43,849 --> 02:45:45,751 RESOURCES AND CREATED EFFICIENCY 3506 02:45:45,751 --> 02:45:47,786 AND CAN DETECT EARLY AND THE 3507 02:45:47,786 --> 02:45:50,255 TEST CAN GO BACK FOR 3508 02:45:50,255 --> 02:45:51,423 OPTIMIZATION. 3509 02:45:51,423 --> 02:45:55,928 SO BASICALLY THE LESS THAN 3510 02:45:55,928 --> 02:45:58,363 OPTIMAL TESTS DON'T ENTER 3511 02:45:58,363 --> 02:46:03,769 CLINICAL STUDIES AND I CAN'T 3512 02:46:03,769 --> 02:46:07,639 STRESS HOW MUCH BIO BANKING IS 3513 02:46:07,639 --> 02:46:09,208 IMPORTANT AND APPLY COVID 3514 02:46:09,208 --> 02:46:10,843 TESTING TO OTHER DIAGNOSTIC 3515 02:46:10,843 --> 02:46:11,610 TESTS. 3516 02:46:11,610 --> 02:46:16,448 WE'RE TESTING A COLD/FLU COMBO 3517 02:46:16,448 --> 02:46:21,220 ASSAYS AND TEXTING POX AND OUR 3518 02:46:21,220 --> 02:46:24,089 CORE HAS A UNIQUE ROLE IN THE 3519 02:46:24,089 --> 02:46:25,424 TESTING LANDSCAPE AND OTHER 3520 02:46:25,424 --> 02:46:26,859 CONTINUES COLLABORATION WITH NIH 3521 02:46:26,859 --> 02:46:29,094 AND FDA IS CRUCIAL. 3522 02:46:29,094 --> 02:46:32,698 AND OF COURSE NONE OF THIS WORK 3523 02:46:32,698 --> 02:46:34,666 WOULD BE POSSIBLE WITHOUT ALL 3524 02:46:34,666 --> 02:46:39,238 THE TEAM OF COURSE BUT ALSO ALL 3525 02:46:39,238 --> 02:46:41,340 THE EXCELLENT COLLABORATORS 3526 02:46:41,340 --> 02:46:45,377 WE'VE HAD THE OPPORTUNITY TO 3527 02:46:45,377 --> 02:46:55,554 WORK WITH. 3528 02:47:04,930 --> 02:47:06,398 >> I'M SEEING THE GUY BEHIND THE 3529 02:47:06,398 --> 02:47:13,138 CURTAIN RIGHT NOW. 3530 02:47:13,138 --> 02:47:13,839 ALL RIGHT. 3531 02:47:13,839 --> 02:47:15,774 SO I'M GOING PULL A DIFFERENT 3532 02:47:15,774 --> 02:47:17,509 HAT FROM THE LAST PANEL. 3533 02:47:17,509 --> 02:47:19,978 I HAD A HUGE ROLE IN THE 3534 02:47:19,978 --> 02:47:21,446 REGULATORY CORE FOR RADX SINCE 3535 02:47:21,446 --> 02:47:24,116 ITS INCEPTION AND THE I TAP 3536 02:47:24,116 --> 02:47:26,718 PROGRAM AND WANTED TO HIGHLIGHT 3537 02:47:26,718 --> 02:47:29,621 A FEW OF THE THINGS THAT WE WERE 3538 02:47:29,621 --> 02:47:31,623 OFTEN EDUCATING THE COMPANIES 3539 02:47:31,623 --> 02:47:33,325 ENTERING THE PROGRAM. 3540 02:47:33,325 --> 02:47:36,528 WE HAD THE WAY IT STARTS WE HAD 3541 02:47:36,528 --> 02:47:37,863 A PUBLIC HEALTH EMERGENCY 3542 02:47:37,863 --> 02:47:40,365 RAPIDLY SPREADING ACROSS THE 3543 02:47:40,365 --> 02:47:41,934 GLOBE AND OUR GOVERNMENT 3544 02:47:41,934 --> 02:47:43,502 DETERMINED THIS WAS NOW A PUBLIC 3545 02:47:43,502 --> 02:47:44,870 HEALTH EMERGENCY STARTING THE 3546 02:47:44,870 --> 02:47:48,607 PATH OR EUAs. 3547 02:47:48,607 --> 02:47:51,243 WE HAD TO STEP BACK AND LOOK AT 3548 02:47:51,243 --> 02:47:52,578 WHY ARE WE DOING THIS PATH? 3549 02:47:52,578 --> 02:47:58,951 TIME IS A VERY IMPORTANT FACTOR 3550 02:47:58,951 --> 02:48:02,754 AND I WANT TO HIGHLIGHT THE 3551 02:48:02,754 --> 02:48:05,490 DOMINO EFFECT YOU HAD A NEW 3552 02:48:05,490 --> 02:48:09,194 VIRUS EMERGING AND SPREADING 3553 02:48:09,194 --> 02:48:13,165 RAPIDLY AND HAD AN EXPONENTIAL 3554 02:48:13,165 --> 02:48:14,132 INCREASE IN DEMAND AND IT WAS 3555 02:48:14,132 --> 02:48:14,900 NOT MANAGED. 3556 02:48:14,900 --> 02:48:18,303 IT COULDN'T BE MANAGED. 3557 02:48:18,303 --> 02:48:20,239 WE ALSO HAD DEMAND FOR NEW 3558 02:48:20,239 --> 02:48:21,373 TESTS. 3559 02:48:21,373 --> 02:48:22,441 MARKERS AND PROBES AND 3560 02:48:22,441 --> 02:48:24,643 ANTIBODIES THAT HAVE NOT BEEN 3561 02:48:24,643 --> 02:48:25,010 STUDIED BEFORE. 3562 02:48:25,010 --> 02:48:30,115 WHAT THIS LEADS TO IS A SHORTAGE 3563 02:48:30,115 --> 02:48:31,416 OF TRADITIONAL SUPPLIES AND THE 3564 02:48:31,416 --> 02:48:33,852 SAME SHORTAGE OF SUPPLIES ALSO 3565 02:48:33,852 --> 02:48:35,153 CAUSED SLOWER ASSAY DEVELOPMENT 3566 02:48:35,153 --> 02:48:38,023 BECAUSE YOU HAD TEAMS TRYING TO 3567 02:48:38,023 --> 02:48:40,025 USE MACHINERY AND RE-AGENTS 3568 02:48:40,025 --> 02:48:41,593 ALREADY IN PLACE BUT EVERYTHING 3569 02:48:41,593 --> 02:48:47,266 WAS TAKING FROM THE PILES. 3570 02:48:47,266 --> 02:48:48,800 IT SLOWED NEW ASSAY DEVELOPMENT 3571 02:48:48,800 --> 02:48:49,368 AS WELL WHICH SLOWED 3572 02:48:49,368 --> 02:48:49,701 MANUFACTURING. 3573 02:48:49,701 --> 02:48:52,304 YOU START TO THINK OF WHAT ARE 3574 02:48:52,304 --> 02:48:55,073 ALTERNATE SUPPLIES I CAN USE AND 3575 02:48:55,073 --> 02:48:57,643 WHAT THAT EVENTUALLY LED TO WAS 3576 02:48:57,643 --> 02:48:59,211 ALTERNATE TEST METHODS AND 3577 02:48:59,211 --> 02:49:01,613 ALTERNATE SAMPLE TYPES. 3578 02:49:01,613 --> 02:49:03,315 IN AN EMERGENCY USE 3579 02:49:03,315 --> 02:49:06,351 AUTHORIZATION IT'S NOT A 3580 02:49:06,351 --> 02:49:08,387 FULL-BLOWN VALIDATION OF SAFETY 3581 02:49:08,387 --> 02:49:10,055 AND ADVOCACY. 3582 02:49:10,055 --> 02:49:12,658 IT'S PLASTERED OVER THE LABELS 3583 02:49:12,658 --> 02:49:13,692 BUT SEMBLANCE OF THE TECHNOLOGY 3584 02:49:13,692 --> 02:49:18,263 WORKS AND AS INTENDED. 3585 02:49:18,263 --> 02:49:22,334 I DON'T NEED TO READ ALL THIS 3586 02:49:22,334 --> 02:49:23,135 OUT. 3587 02:49:23,135 --> 02:49:25,404 THE DIFFERENCE BETWEEN EUA AND 3588 02:49:25,404 --> 02:49:28,240 THE VALIDATION OF AN ASSAY IN 3589 02:49:28,240 --> 02:49:32,077 THE CONTEXT OF SAFETY AND 3590 02:49:32,077 --> 02:49:33,178 EFFICACY BUT THE AGENCY IS 3591 02:49:33,178 --> 02:49:35,681 TAKING INTO CONSIDERATION TIMING 3592 02:49:35,681 --> 02:49:36,948 AND SHORTAGES ON THEIR CALCULUS 3593 02:49:36,948 --> 02:49:38,450 IN MAKING THE DECISION. 3594 02:49:38,450 --> 02:49:43,889 THROUGH THE PROGRAMS, WE WERE 3595 02:49:43,889 --> 02:49:51,697 ABLE TO STREAMLINE OUTSIDE THE 3596 02:49:51,697 --> 02:49:53,065 REGULATORY STORIES DESIGN TO 3597 02:49:53,065 --> 02:49:53,865 SUPPORT SUBMISSIONS. 3598 02:49:53,865 --> 02:49:57,469 WE WERE ABLE TO USE THAT ON THE 3599 02:49:57,469 --> 02:50:01,373 FRONT LINES AND LOOK UNDER THE 3600 02:50:01,373 --> 02:50:05,110 HOOD AND COMPARE AND IDENTIFY 3601 02:50:05,110 --> 02:50:06,678 PROTOCOLS FOR ANALYTICAL STUDIES 3602 02:50:06,678 --> 02:50:08,180 AS POSSIBLE FOR THE DEVICES THAT 3603 02:50:08,180 --> 02:50:12,918 MADE IT THROUGH THOSE BARRIERS. 3604 02:50:12,918 --> 02:50:14,986 THAT LED TO MORE RAPID REVIEW 3605 02:50:14,986 --> 02:50:15,687 TIMES. 3606 02:50:15,687 --> 02:50:18,857 IT WAS LOCKSTEP ATTACHED TO THE 3607 02:50:18,857 --> 02:50:20,659 HIP AS YOU SAID, BILL, NORD TO 3608 02:50:20,659 --> 02:50:23,128 MOVE IT FORWARD. 3609 02:50:23,128 --> 02:50:26,331 WE WERE ALSO ABLE TO DEAL WITH 3610 02:50:26,331 --> 02:50:27,466 THE POST-MARKET REQUIREMENTS FOR 3611 02:50:27,466 --> 02:50:28,567 THE COMPANIES. 3612 02:50:28,567 --> 02:50:32,437 UP SHORT OUR AIM WAS TO HELP THE 3613 02:50:32,437 --> 02:50:33,605 EUA SUBMISSIONS THROUGH AND HELP 3614 02:50:33,605 --> 02:50:35,207 IN ANY WAY WE COULD TO 3615 02:50:35,207 --> 02:50:36,708 FACILITATE THAT WE INTERFACED 3616 02:50:36,708 --> 02:50:38,610 WITH FDA WEEKLY, SOMETIMES MORE 3617 02:50:38,610 --> 02:50:40,712 THAN THAT AT THE HEIGHT OF THE 3618 02:50:40,712 --> 02:50:42,781 PANDEMIC WHICH I WAS 3619 02:50:42,781 --> 02:50:45,450 APPRECIATIVE OF AND INTERFACED 3620 02:50:45,450 --> 02:50:49,388 WITH OUR COLLEAGUES AT CMS AND 3621 02:50:49,388 --> 02:50:52,090 CLIA QUESTIONS THAT CAME ONLINE. 3622 02:50:52,090 --> 02:50:54,793 THIS IS MY FINAL SLIDE AND WHAT 3623 02:50:54,793 --> 02:50:57,028 I LEARNED IN WORKING WITH 20, 3624 02:50:57,028 --> 02:50:57,729 30, RADX COMPANIES. 3625 02:50:57,729 --> 02:50:59,731 THE PORTFOLIO WAS DESIGN TO 3626 02:50:59,731 --> 02:51:03,368 INCLUDE MANY APPROACHES AS PER 3627 02:51:03,368 --> 02:51:05,337 THE MISSION OF NIH, ACCEPTABLE. 3628 02:51:05,337 --> 02:51:09,708 WE LOOKED AT NOVEL SAMPLE TYPES 3629 02:51:09,708 --> 02:51:10,575 AND USE SETTINGS. 3630 02:51:10,575 --> 02:51:13,478 A LOT OF THE TESTING WAS IN A 3631 02:51:13,478 --> 02:51:15,180 HIGH COMPLEXITY LAB WITH 3632 02:51:15,180 --> 02:51:17,482 AUTOMATION AND ROBOTS FOR ONLY 3633 02:51:17,482 --> 02:51:17,816 PCR. 3634 02:51:17,816 --> 02:51:23,188 WE HAD A NUMBER OF TECHNOLOGIES 3635 02:51:23,188 --> 02:51:31,363 THAT USED DIFFERENT THINGS. 3636 02:51:31,363 --> 02:51:35,667 AN CREATES CHALLENGES AND IN AN 3637 02:51:35,667 --> 02:51:38,136 EXAMPLE, SALIVA WAS TOUTED AS A 3638 02:51:38,136 --> 02:51:39,571 SOLUTION AND IN MANY OF THE 3639 02:51:39,571 --> 02:51:40,872 COMPANIES I'D SPEAK TO THERE'S 3640 02:51:40,872 --> 02:51:42,107 EXCITEMENT ABOUT IT AND YOU WANT 3641 02:51:42,107 --> 02:51:45,043 TO MOVE FAST AND IT WORKS AND 3642 02:51:45,043 --> 02:51:46,511 IT'S NON-INVASIVE BUT THERE'S 3643 02:51:46,511 --> 02:51:48,447 THINGS YOU HAVE TO THINK ABOUT. 3644 02:51:48,447 --> 02:51:51,082 WHEN IS VIRUS OR ANTIGEN PRESENT 3645 02:51:51,082 --> 02:51:53,051 IN THE SAMPLE TYPE? 3646 02:51:53,051 --> 02:51:56,354 IS IT STRONG OR AS MUCH AND 3647 02:51:56,354 --> 02:51:58,323 LOOKING AT THE CURVES, BILL WAS 3648 02:51:58,323 --> 02:52:00,525 SHOWING, IT'S DIFFERENT FOR 3649 02:52:00,525 --> 02:52:03,228 EVERY SAME SAMPLE TYPE AND 3650 02:52:03,228 --> 02:52:07,232 LOOKING AT INTERFERENCE AND FLEX 3651 02:52:07,232 --> 02:52:09,935 STUDIES. 3652 02:52:09,935 --> 02:52:13,038 WHAT IF SOMEBODY USES COFFEE FOR 3653 02:52:13,038 --> 02:52:13,405 MOUTH WASH. 3654 02:52:13,405 --> 02:52:14,573 THERE WERE CHALLENGES IN THAT 3655 02:52:14,573 --> 02:52:17,342 THERE WERE MORE STUDIES THE 3656 02:52:17,342 --> 02:52:18,477 COMPANIES ANTICIPATED. 3657 02:52:18,477 --> 02:52:22,113 BUT IN WORKING WITH FDA I THINK 3658 02:52:22,113 --> 02:52:23,515 THERE'S GREAT TEMPLATES AND LIST 3659 02:52:23,515 --> 02:52:25,150 OF INTERFERING SUBJECTS YOU 3660 02:52:25,150 --> 02:52:30,288 SHOULD TEST FOR A SALIVA OR 3661 02:52:30,288 --> 02:52:32,691 SAMPLE TEST AND THE 3662 02:52:32,691 --> 02:52:33,692 STANDARDIZATION HELPED PROVIDE 3663 02:52:33,692 --> 02:52:35,293 APPLES TO APPLES COMPARISON 3664 02:52:35,293 --> 02:52:38,096 WHICH FOR ME IS VERY IMPORTANT 3665 02:52:38,096 --> 02:52:39,831 BECAUSE AS AN ENGINEER AT MY 3666 02:52:39,831 --> 02:52:41,199 CORE THE LESS VARIABLES YOU HAVE 3667 02:52:41,199 --> 02:52:43,902 THE BETTER THE MORE YOU CAN 3668 02:52:43,902 --> 02:52:45,370 LEARN FROM A STUDY. 3669 02:52:45,370 --> 02:52:46,872 IF YOU HAD UNIVERSAL ANYTHING 3670 02:52:46,872 --> 02:52:49,741 YOU HAD YOUR GROUND ZERO AND 3671 02:52:49,741 --> 02:52:52,344 WERE CHANGING ONE HOPEFULLY AND 3672 02:52:52,344 --> 02:52:54,346 A MINIMAL NUMBER OF VARIABLES 3673 02:52:54,346 --> 02:52:55,947 WHICH ENABLED THE COMPARISON. 3674 02:52:55,947 --> 02:52:56,815 IF THERE'S TIME, HAPPY TO TAKE 3675 02:52:56,815 --> 02:53:04,823 QUESTIONS. 3676 02:53:04,823 --> 02:53:05,257 >> THANK YOU. 3677 02:53:05,257 --> 02:53:07,259 UNFORTUNATELY WE ARE RUNNING OUT 3678 02:53:07,259 --> 02:53:08,360 OF TIME. 3679 02:53:08,360 --> 02:53:09,895 LET'S GIVE ANOTHER ROUND OF 3680 02:53:09,895 --> 02:53:11,329 APPLAUSE FOR THE WONDERFUL 3681 02:53:11,329 --> 02:53:16,401 PANELISTS. 3682 02:53:16,401 --> 02:53:17,435 AND PASS IT TO MY COLLEAGUE, 3683 02:53:17,435 --> 02:53:22,774 TIFFANI. 3684 02:53:22,774 --> 02:53:32,851 >> 3685 02:53:33,285 --> 02:53:34,986 >> THANK YOU ALL AND HOPEFULLY 3686 02:53:34,986 --> 02:53:36,187 YOU'LL ALL STAY THROUGH LUNCH 3687 02:53:36,187 --> 02:53:38,490 AND THE REST OF THE DAY HERE. 3688 02:53:38,490 --> 02:53:39,658 WE DO HAVE LUNCH. 3689 02:53:39,658 --> 02:53:41,059 IT IS IN THE CAFETERIA. 3690 02:53:41,059 --> 02:53:44,129 SO WE HAVE ABOUT AN HOUR BREAK 3691 02:53:44,129 --> 02:53:46,197 SO PLEASE MEET US IN THE 3692 02:53:46,197 --> 02:53:46,965 CAFETERIA OUT TO YOUR LEFT AND 3693 02:53:46,965 --> 02:53:50,394 UP THE STEPS. THANK YOU. 3694 02:53:50,394 --> 02:53:51,495 WE'RE GOING TO GETS STARTED 3695 02:53:51,495 --> 02:53:51,695 AGAIN. 3696 02:53:51,695 --> 02:53:54,798 WE HAVE A VERY EXCITING 3697 02:53:54,798 --> 02:53:55,566 AFTERNOON HERE. 3698 02:53:55,566 --> 02:54:01,372 SO WE ARE GOING TO START WITH 3699 02:54:01,372 --> 02:54:03,007 OUR DISTINGUISHED PANEL -- 3700 02:54:03,007 --> 02:54:05,709 ACTUALLY A FORUM THIS TIME 3701 02:54:05,709 --> 02:54:13,617 CALLED RESEARCH AND INCH 3702 02:54:13,617 --> 02:54:15,152 V EGES -- INNOVATION HOT TOPICS, 3703 02:54:15,152 --> 02:54:21,926 LET BY TAYLOR GILLILAND, 3704 02:54:21,926 --> 02:54:23,127 CHAIRING THE PANEL. 3705 02:54:23,127 --> 02:54:23,928 >> GOOD AFTERNOON. 3706 02:54:23,928 --> 02:54:29,967 I'M TAYLOR GILLILAND, OFFICE OF 3707 02:54:29,967 --> 02:54:31,769 DIRECTOR NIBIB, HONORED TO BE 3708 02:54:31,769 --> 02:54:32,770 CHAIRING THIS PANEL. 3709 02:54:32,770 --> 02:54:35,072 AS WE GET STARTED I DID LIKE 3710 02:54:35,072 --> 02:54:36,307 TO -- WOULD LIKE TO ECHO 3711 02:54:36,307 --> 02:54:38,409 COMMENTS WE HEARD THIS MORNING 3712 02:54:38,409 --> 02:54:41,578 FROM THE NIH DIRECTOR, AND NIBIB 3713 02:54:41,578 --> 02:54:43,547 DIRECTOR. 3714 02:54:43,547 --> 02:54:49,153 IT'S A TRUE TESTAMENT TO POCTRN, 3715 02:54:49,153 --> 02:54:50,888 RADx TECH AND OTHERS TO HEAR 3716 02:54:50,888 --> 02:54:53,057 THE NIH DIRECTOR LESS THAN THREE 3717 02:54:53,057 --> 02:54:54,525 WEEKS INTO THE JOBS ALREADY 3718 02:54:54,525 --> 02:54:55,960 RECOGNIZING THE VALUE OF THE 3719 02:54:55,960 --> 02:54:57,227 WORK THAT WE DO. 3720 02:54:57,227 --> 02:55:01,865 AND THE IMPORTANCE OF POINT OF 3721 02:55:01,865 --> 02:55:03,233 CARE, HOME-BASED DIAGNOSTIC 3722 02:55:03,233 --> 02:55:07,304 TECHNOLOGIES. 3723 02:55:07,304 --> 02:55:08,739 SHE EMPHASIZED HOW WE MOVING 3724 02:55:08,739 --> 02:55:10,240 DIRECTLY INTO THE HANDS OF THE 3725 02:55:10,240 --> 02:55:11,508 PUBLIC, EFFORTS BRINGING 3726 02:55:11,508 --> 02:55:13,110 AWARENESS OF IMMEDIACY OF THE 3727 02:55:13,110 --> 02:55:15,312 IMPACT OF NIH INVESTMENTS ON 3728 02:55:15,312 --> 02:55:16,947 PUBLIC HEALTH. 3729 02:55:16,947 --> 02:55:21,251 WE'RE EMPOWERING INDIVIDUALS 3730 02:55:21,251 --> 02:55:22,119 WITH INFORMATION THEY NEED TO 3731 02:55:22,119 --> 02:55:23,988 MANAGE THEIR HEALTH AND LEAD 3732 02:55:23,988 --> 02:55:25,756 HEALTHY LIVES. 3733 02:55:25,756 --> 02:55:26,924 YOU HEARD DR. TROMBERG DESCRIBE 3734 02:55:26,924 --> 02:55:29,893 HOW THE COVID-19 PANDEMIC HAS 3735 02:55:29,893 --> 02:55:34,565 TRANSFORMED CERTAIN WAYS NIH AND 3736 02:55:34,565 --> 02:55:39,737 CERTAINLY NIBIB APPROACH 3737 02:55:39,737 --> 02:55:41,171 CATALYZING BIOMEDICAL 3738 02:55:41,171 --> 02:55:42,373 ILLUSTRATION, WITH OUR 3739 02:55:42,373 --> 02:55:44,775 INVESTMENT IN POCTRN AND RADx 3740 02:55:44,775 --> 02:55:46,243 TECH, A DRAMATIC SUCCESS. 3741 02:55:46,243 --> 02:55:48,212 THEY BROUGHT DOZENS OF NEW 3742 02:55:48,212 --> 02:55:49,413 TESTING PLATFORMS AND BILLIONS 3743 02:55:49,413 --> 02:55:54,018 OF NEW TESTS TO MARKET. 3744 02:55:54,018 --> 02:55:58,255 ENABLED MASSIVE SHIFT TO A MORE 3745 02:55:58,255 --> 02:55:59,023 DISTRIBUTED AND HOME-BASED 3746 02:55:59,023 --> 02:56:00,057 TESTING ONE WHERE EFFORTS 3747 02:56:00,057 --> 02:56:02,426 CONTINUE TO RIPPLE THROUGH THE 3748 02:56:02,426 --> 02:56:03,627 DIAGNOSTIC INDUSTRY, AGAIN AS 3749 02:56:03,627 --> 02:56:04,395 DR. TROMBERG STATED. 3750 02:56:04,395 --> 02:56:14,938 IF WE COULD BRING UP THE SLIDES. 3751 02:56:15,973 --> 02:56:24,882 THIS IS A DIAGRAM YOU'VE SEEN, 3752 02:56:24,882 --> 02:56:25,783 INVASION FUNNEL DESIGN, THE 3753 02:56:25,783 --> 02:56:28,285 HEART OF THE RADx PROGRAM. 3754 02:56:28,285 --> 02:56:30,521 WE HAVE TECHNOLOGY DEVELOPERS 3755 02:56:30,521 --> 02:56:32,790 RECEIVING STAGE GATED OR 3756 02:56:32,790 --> 02:56:34,425 MILESTONE-BASED PAYMENTS AS 3757 02:56:34,425 --> 02:56:35,959 INCENTIVES TO DE-RISK DEVICES, 3758 02:56:35,959 --> 02:56:37,561 SEAMS WILL TECHNOLOGY 3759 02:56:37,561 --> 02:56:38,495 DEVELOPMENT PIPELINE. 3760 02:56:38,495 --> 02:56:40,030 CRUCIAL TO THIS PROGRAM IS 3761 02:56:40,030 --> 02:56:43,067 PROVISION OF SUPPORT FROM TEAMS 3762 02:56:43,067 --> 02:56:45,702 FROM EXPERT CONSULTANTS IN 3763 02:56:45,702 --> 02:56:48,906 PARALLEL TO HELP ADDRESS 3764 02:56:48,906 --> 02:56:49,406 SCIENTIFIC, REGULATORY, 3765 02:56:49,406 --> 02:56:51,942 COMMERCIALIZATION NEEDS OF EACH 3766 02:56:51,942 --> 02:56:52,276 DEVELOPER. 3767 02:56:52,276 --> 02:56:53,444 ANOTHER CRITICAL COMPONENT THAT 3768 02:56:53,444 --> 02:57:01,485 WE HEARD ABOUT ON THE LAST PANEL 3769 02:57:01,485 --> 02:57:04,721 PRESENTATION IS INDEPENDENT 3770 02:57:04,721 --> 02:57:07,925 TESTING THAT ENSURES IT IS 3771 02:57:07,925 --> 02:57:08,258 WARRANTED. 3772 02:57:08,258 --> 02:57:09,760 NIBIB AND SIBLING CENTERS DID 3773 02:57:09,760 --> 02:57:11,662 NOT AND COULD NOT HAVE 3774 02:57:11,662 --> 02:57:13,130 ACCOMPLISHED THIS ALONE. 3775 02:57:13,130 --> 02:57:15,365 CENTRAL TO THE PAST, PRESENT, 3776 02:57:15,365 --> 02:57:17,434 AND FUTURE SUCCESS OF THIS 3777 02:57:17,434 --> 02:57:21,105 ENGINE OF DIAGNOSTIC AND MEDICAL 3778 02:57:21,105 --> 02:57:23,574 TECHNOLOGY INNOVATION ARE 3779 02:57:23,574 --> 02:57:24,141 PARTNERSHIPS. 3780 02:57:24,141 --> 02:57:25,976 THIS COLLABORATION ACROSS 3781 02:57:25,976 --> 02:57:27,744 GOVERNMENT, UNIVERSITIES, 3782 02:57:27,744 --> 02:57:28,378 INDUSTRY, NON-PROFIT 3783 02:57:28,378 --> 02:57:30,347 ORGANIZATIONS AMONG OTHERS IS 3784 02:57:30,347 --> 02:57:32,549 CRITICAL AS WE CONTINUE TO 3785 02:57:32,549 --> 02:57:35,185 ADAPT, EVOLVE, SCALE THE RADx 3786 02:57:35,185 --> 02:57:37,154 TECH PROGRAM AND ADDRESS HEALTH 3787 02:57:37,154 --> 02:57:38,255 TECHNOLOGY NEEDS FAR BEYOND 3788 02:57:38,255 --> 02:57:38,689 COVID-19. 3789 02:57:38,689 --> 02:57:42,126 AND THAT BRINGS US TO THE 3790 02:57:42,126 --> 02:57:43,260 OBJECTIVES OF THIS PANEL. 3791 02:57:43,260 --> 02:57:45,896 IT IS ONE THING TO WAX POETIC 3792 02:57:45,896 --> 02:57:48,866 ABOUT THE VALUE OF 3793 02:57:48,866 --> 02:57:49,466 COLLABORATION, NOT GOING ALONE 3794 02:57:49,466 --> 02:57:51,702 TO SAY IT TAKES A VILLAGE AND 3795 02:57:51,702 --> 02:57:54,905 SUCH BUT ANOTHER TO PROVIDE 3796 02:57:54,905 --> 02:57:56,540 CONCRETE EXAMPLES OF HOW THE 3797 02:57:56,540 --> 02:57:58,075 TALK OF COLLABORATION AND 3798 02:57:58,075 --> 02:58:00,911 WALKING THE WALK. 3799 02:58:00,911 --> 02:58:02,112 MY ESTEEMED PANELISTS WILL 3800 02:58:02,112 --> 02:58:04,214 HIGHLIGHT WAYS WE LEVERAGING THE 3801 02:58:04,214 --> 02:58:06,750 POWER OF PARTNERSHIPS, TO DRIVE 3802 02:58:06,750 --> 02:58:10,821 THE DEVELOPMENT OF DIAGNOSTICS, 3803 02:58:10,821 --> 02:58:13,590 WEARABLES, REMOTE MONITORING 3804 02:58:13,590 --> 02:58:14,358 TECHNOLOGIES, INTEGRATED 3805 02:58:14,358 --> 02:58:15,192 SENSORS, DIGITAL HEALTH 3806 02:58:15,192 --> 02:58:15,526 TECHNOLOGIES. 3807 02:58:15,526 --> 02:58:19,763 BUT THESE PROGRAMS NOT ONLY 3808 02:58:19,763 --> 02:58:20,364 SHOWCASE COLLABORATIVE 3809 02:58:20,364 --> 02:58:20,998 ENDEAVORS, THEY DEMONSTRATE HOW 3810 02:58:20,998 --> 02:58:23,167 WE'RE ADDRESSING SOME OF THE HOT 3811 02:58:23,167 --> 02:58:24,401 TOPICS IN PUBLIC HEALTH. 3812 02:58:24,401 --> 02:58:26,203 THESE ARE THE AREAS WHERE 3813 02:58:26,203 --> 02:58:30,474 SIGNIFICANT GAPS HAVE BEEN 3814 02:58:30,474 --> 02:58:30,774 IDENTIFIED. 3815 02:58:30,774 --> 02:58:35,078 AND TECHNOLOGICAL INNOVATION IS 3816 02:58:35,078 --> 02:58:36,046 SORELY NEEDED INCLUDING FETAL 3817 02:58:36,046 --> 02:58:39,850 HEALTH, POSTPARTUM HEALTH, HIV 3818 02:58:39,850 --> 02:58:41,418 AND TESTS FOR PERSONS WITH 3819 02:58:41,418 --> 02:58:41,885 DISABILITIES. 3820 02:58:41,885 --> 02:58:43,754 NOW THAT WE HAVE THIS STAGE SET 3821 02:58:43,754 --> 02:58:46,690 FOR THIS PANEL LET'S HAVE OUR 3822 02:58:46,690 --> 02:58:48,258 PANELISTS INTRODUCE THEMSELVES 3823 02:58:48,258 --> 02:58:54,731 STARTING WITH ANTONELLO, I'M A 3824 02:58:54,731 --> 02:58:56,366 PROGRAM OFFICER WITH THE 3825 02:58:56,366 --> 02:58:58,101 NATIONAL INSTITUTE OF CHILD 3826 02:58:58,101 --> 02:59:03,173 HEALTH AND HUMAN DEVELOPMENT, 3827 02:59:03,173 --> 02:59:06,777 INCLUDING MEDICAL DEVICES AND 3828 02:59:06,777 --> 02:59:09,980 RADx TECH HEALTH WHICH I 3829 02:59:09,980 --> 02:59:13,617 CO-LED WITH TAYLOR AND KARI 3830 02:59:13,617 --> 02:59:15,652 ASHTON. 3831 02:59:15,652 --> 02:59:17,821 >> GOOD AFTERNOON, I'M SALLY 3832 02:59:17,821 --> 02:59:20,924 MCFAUL, AND I'M ONE OF THE THREE 3833 02:59:20,924 --> 02:59:23,327 CO-P.I.s FOR ONE OF THE POINT 3834 02:59:23,327 --> 02:59:25,829 OF CARE TECHNOLOGY RESEARCH 3835 02:59:25,829 --> 02:59:27,164 NETWORK CENTERS. 3836 02:59:27,164 --> 02:59:33,737 OUR FOCUS IS ON HIV AND 3837 02:59:33,737 --> 02:59:35,505 COMORBIDITIES, DEVELOPING 3838 02:59:35,505 --> 02:59:45,182 TECHNOLOGY FOR LOW AND LOW- AND 3839 02:59:45,182 --> 02:59:46,717 MIDDLE-INCOME COUNTRIES, 3840 02:59:46,717 --> 02:59:49,987 SUB-SAHARAN AFRICA. 3841 02:59:49,987 --> 02:59:51,822 >> I'M BRIAN WALSH, FOR RADx I 3842 02:59:51,822 --> 02:59:56,159 WAS THE DEPLOYMENT CORE LEAD, 3843 02:59:56,159 --> 02:59:57,527 LED THAT GROUP ASSISTANT COMPANY 3844 02:59:57,527 --> 02:59:59,930 SCALE AND MANUFACTURE PRODUCT, A 3845 02:59:59,930 --> 03:00:02,132 YEAR AND A HALF AGO BECAME 3846 03:00:02,132 --> 03:00:03,133 PROGRAM ACCESSIBILITY MANAGER AS 3847 03:00:03,133 --> 03:00:04,034 WELL. 3848 03:00:04,034 --> 03:00:05,802 GREAT TO BE HERE. 3849 03:00:05,802 --> 03:00:06,103 >> GREAT. 3850 03:00:06,103 --> 03:00:06,870 THANK YOU SO. 3851 03:00:06,870 --> 03:00:08,605 YOU'LL HEAR MORE FROM EACH IN A 3852 03:00:08,605 --> 03:00:09,206 FEW MINUTES. 3853 03:00:09,206 --> 03:00:11,908 SO I'M GOING TO KICK OFF OUR 3854 03:00:11,908 --> 03:00:13,777 SERIES OF PRESENTATIONS BY 3855 03:00:13,777 --> 03:00:16,446 TELLING YOU ABOUT A RATHER YOUNG 3856 03:00:16,446 --> 03:00:21,785 PROGRAM, NO PUN INTENDED, RADx 3857 03:00:21,785 --> 03:00:23,220 TECH FETAL MONITORING CHALLENGE, 3858 03:00:23,220 --> 03:00:24,688 BIRTHED, PUN INTENDED THIS PAST 3859 03:00:24,688 --> 03:00:24,955 SEPTEMBER. 3860 03:00:24,955 --> 03:00:27,591 MOTIVATED BY THE FACT THAT FETAL 3861 03:00:27,591 --> 03:00:29,726 MORBIDITY AND MORTALITY ARE 3862 03:00:29,726 --> 03:00:31,395 MAJOR BUT OVERLOOKED PUBLIC 3863 03:00:31,395 --> 03:00:32,462 HEALTH ISSUES. 3864 03:00:32,462 --> 03:00:34,665 MUCH OF THE PUBLIC CONCERN 3865 03:00:34,665 --> 03:00:36,199 SURROUNDING REPRODUCTIVE LOSS 3866 03:00:36,199 --> 03:00:38,902 HAS LARGELY FOCUSED ON INFANT 3867 03:00:38,902 --> 03:00:41,405 MORTALITY, DUE TO A PAUCITY OF 3868 03:00:41,405 --> 03:00:44,941 KNOWLEDGE IN PART, OF THE 3869 03:00:44,941 --> 03:00:48,111 INCIDENCE, ETIOLOGY, PREVENTION 3870 03:00:48,111 --> 03:00:49,513 STRATEGIES FOR FETAL MORTALITY. 3871 03:00:49,513 --> 03:00:51,615 GLOBALLY THERE BE TWO MILLION 3872 03:00:51,615 --> 03:00:52,916 STILL BIRTHS EVERY YEAR, 40% 3873 03:00:52,916 --> 03:00:54,685 AFTER THE ONSET OF LABOR, 3874 03:00:54,685 --> 03:00:59,589 MAJORITY OF WHICH COULD BE 3875 03:00:59,589 --> 03:01:01,658 PREVENTED WITH BETTER QUALITY 3876 03:01:01,658 --> 03:01:02,526 AND RESPECTFUL CARE DURING 3877 03:01:02,526 --> 03:01:03,427 BIRTH. 3878 03:01:03,427 --> 03:01:05,395 IN THE UNITED STATES 21,000 3879 03:01:05,395 --> 03:01:08,265 FAMILIES A YEAR EXPERIENCE A 3880 03:01:08,265 --> 03:01:10,634 STILLBIRTH, A TRAGIC LOSS. 3881 03:01:10,634 --> 03:01:11,501 ADDITIONALLY FETAL MORTALITY 3882 03:01:11,501 --> 03:01:13,470 RATES IN THIS COUNTRY CONTINUE 3883 03:01:13,470 --> 03:01:16,440 TO VARY BY RACE AND ETHNIC 3884 03:01:16,440 --> 03:01:19,443 ORIGIN, BEING HIGHEST RATES FOR 3885 03:01:19,443 --> 03:01:21,144 NATIVE HAWAIIAN OR PACIFIC 3886 03:01:21,144 --> 03:01:22,779 ISLANDER AND BLACK WOMEN AND 3887 03:01:22,779 --> 03:01:24,414 AMERICAN INDIAN AND ALASKA 3888 03:01:24,414 --> 03:01:25,515 NATIVE WOMAN. 3889 03:01:25,515 --> 03:01:27,718 RACIAL DISPARITIES AND HEALTH 3890 03:01:27,718 --> 03:01:33,190 OUTCOMES ARE PERSISTENT AND WELL 3891 03:01:33,190 --> 03:01:33,623 DOCUMENTED. 3892 03:01:33,623 --> 03:01:35,058 FACTORS CONTRIBUTING INCLUDE 3893 03:01:35,058 --> 03:01:36,026 DIFFERENCES IN MATERNAL 3894 03:01:36,026 --> 03:01:38,662 PRE-CONCEPTION HEALTH, ACCESS TO 3895 03:01:38,662 --> 03:01:40,530 QUALITY HEALTH CARE. 3896 03:01:40,530 --> 03:01:44,668 SO, WHAT THIS DEMONSTRATES IS AN 3897 03:01:44,668 --> 03:01:45,969 UNACCEPTABLE STATE, FETAL HEALTH 3898 03:01:45,969 --> 03:01:47,504 OUTCOMES WITHIN THIS COUNTRY AND 3899 03:01:47,504 --> 03:01:48,739 AROUND THE WORLD. 3900 03:01:48,739 --> 03:01:54,544 THIS CALLS FOR IMMEDIATE ACTION. 3901 03:01:54,544 --> 03:01:56,079 ONE IS IMPROVEMENT OF THE 3902 03:01:56,079 --> 03:01:58,148 DIAGNOSIS AND MONITORING OF 3903 03:01:58,148 --> 03:01:59,649 PHYSIOLOGICAL CAUSES AND FACTORS 3904 03:01:59,649 --> 03:02:05,122 ASSOCIATED WITH FETAL MORBIDITY 3905 03:02:05,122 --> 03:02:09,826 AND MORE AT THAT TIMED NEEDED IN 3906 03:02:09,826 --> 03:02:12,362 AREAS WITH LIMITED ACCESS TO 3907 03:02:12,362 --> 03:02:15,599 QUALITY PRENATAL HEALTH CARE. 3908 03:02:15,599 --> 03:02:18,101 IN A SERENDIPITOUS MOMENT, A 3909 03:02:18,101 --> 03:02:21,405 THEME IS PARTNERSHIPS, NIBIB WAS 3910 03:02:21,405 --> 03:02:22,939 HAVING CONVERSATIONS REGARDING 3911 03:02:22,939 --> 03:02:24,241 DIAGNOSTIC DEVELOPMENT IN THE 3912 03:02:24,241 --> 03:02:26,309 MATERNAL FETAL SPACE, WITH TWO 3913 03:02:26,309 --> 03:02:32,449 PARTNERS AT THAT TIME, ONE WAS 3914 03:02:32,449 --> 03:02:33,650 MY COLLEAGUE ANTONNELLO, AND HIS 3915 03:02:33,650 --> 03:02:36,186 COLLEAGUES, THE OTHER WITH A 3916 03:02:36,186 --> 03:02:37,421 LONGTIME PARTNER, THE BILL AND 3917 03:02:37,421 --> 03:02:38,722 MELINDA GATES FOUNDATION. 3918 03:02:38,722 --> 03:02:40,023 WE'RE HAVING THESE DISCUSSIONS 3919 03:02:40,023 --> 03:02:40,991 CONCURRENTLY AND WE CAME 3920 03:02:40,991 --> 03:02:42,426 TOGETHER AND DECIDED WE WERE 3921 03:02:42,426 --> 03:02:45,495 GOING TO DO SOMETHING IN THIS 3922 03:02:45,495 --> 03:02:45,929 SPACE. 3923 03:02:45,929 --> 03:02:47,497 EACH PARTNER AND THIS 3924 03:02:47,497 --> 03:02:49,232 PARTNERSHIP BRINGS THEIR UNIQUE 3925 03:02:49,232 --> 03:02:50,967 STRENGTHS AND ABILITIES. 3926 03:02:50,967 --> 03:02:51,968 MEDICAL TECHNOLOGY DEVELOPMENT 3927 03:02:51,968 --> 03:02:56,673 IS A FOCUS OF NIBIB, MATERNAL, 3928 03:02:56,673 --> 03:03:00,410 FETAL, NEONATAL AND CHILD HEALTH 3929 03:03:00,410 --> 03:03:03,580 IS EMPHASIS IN STRENGTH, THE 3930 03:03:03,580 --> 03:03:05,449 GATES FOUNDATION BRINGS 3931 03:03:05,449 --> 03:03:11,555 EXPERTISE FOR GLOBAL HEALTH 3932 03:03:11,555 --> 03:03:12,789 SETS. 3933 03:03:12,789 --> 03:03:14,224 THE RADx CHALLENGE WAS BORN. 3934 03:03:14,224 --> 03:03:15,625 THROUGH THIS PARTNERSHIP BETWEEN 3935 03:03:15,625 --> 03:03:18,728 GOVERNMENT AND A NON-PROFIT 3936 03:03:18,728 --> 03:03:19,663 ORGANIZATION, WE'RE AIMING TO 3937 03:03:19,663 --> 03:03:21,465 SPEED INNOVATION AND POINT OF 3938 03:03:21,465 --> 03:03:23,333 CARE AND HOME-BASED DIAGNOSTIC 3939 03:03:23,333 --> 03:03:27,304 TECHNOLOGIES, THAT CAN HELP 3940 03:03:27,304 --> 03:03:28,839 IMPROVE FETAL AND NEONATAL 3941 03:03:28,839 --> 03:03:30,574 OUTCOMES THROUGH DETECTION AND 3942 03:03:30,574 --> 03:03:32,108 MONITORING OF FETAL HEALTH 3943 03:03:32,108 --> 03:03:34,411 STATUS AND ENABLE MORE 3944 03:03:34,411 --> 03:03:36,780 APPROPRIATE AND ACTIONABLE 3945 03:03:36,780 --> 03:03:37,481 CLINICAL INTERVENTION. 3946 03:03:37,481 --> 03:03:39,349 OF COURSE, SINCE THIS IS A FOCUS 3947 03:03:39,349 --> 03:03:41,551 ON RADx TECH WE'RE LEVERAGING 3948 03:03:41,551 --> 03:03:43,053 THE RADx TECH INNOVATION 3949 03:03:43,053 --> 03:03:44,254 FUNNEL PROGRAM DESIGN, AND 3950 03:03:44,254 --> 03:03:46,122 MERGING WITH THE PRIZE 3951 03:03:46,122 --> 03:03:47,190 COMPETITION MODEL WHICH YOU'LL 3952 03:03:47,190 --> 03:03:49,559 HEAR MORE IN THE NEXT 3953 03:03:49,559 --> 03:03:51,628 PRESENTATION WITH THE RADx 3954 03:03:51,628 --> 03:03:54,464 TECH MATERNAL HEALTH CHALLENGE. 3955 03:03:54,464 --> 03:03:57,000 WE'RE OFFERING CASH INCENTIVES 3956 03:03:57,000 --> 03:03:59,836 TO INNOVATORS AS THEY DE-RISK 3957 03:03:59,836 --> 03:04:01,371 AND VALIDATE TECHNOLOGIES, 3958 03:04:01,371 --> 03:04:03,907 SERIES OF STAGE-GATED AND 3959 03:04:03,907 --> 03:04:05,275 MILESTONE-BASED PRIZE AWARDS, A 3960 03:04:05,275 --> 03:04:07,410 TOTAL OF $2 MILLION IN CASH 3961 03:04:07,410 --> 03:04:11,681 PRIZEs IN THIS CHALLENGE WITH 3962 03:04:11,681 --> 03:04:13,350 THREE AWARD DISBURSEMENT POINTS 3963 03:04:13,350 --> 03:04:16,419 AND A SELECT GROUP OF INNOVATORS 3964 03:04:16,419 --> 03:04:19,523 INVITED TO NATCHER AT AT THE 3965 03:04:19,523 --> 03:04:22,225 END OF JANUARY DELIVERING LIVE 3966 03:04:22,225 --> 03:04:23,460 TECH DEMOS AND PITCH 3967 03:04:23,460 --> 03:04:24,661 PRESENTATION TO DECIDE WHO WILL 3968 03:04:24,661 --> 03:04:27,297 BE INVITED TO THE FINAL SPRINT 3969 03:04:27,297 --> 03:04:28,798 PHASE THAT WILL OH OTHER TRUE 3970 03:04:28,798 --> 03:04:30,100 THE SUMMER AND INTO THE FALL. 3971 03:04:30,100 --> 03:04:31,601 I WISH I COULD SAY MORE AND TELL 3972 03:04:31,601 --> 03:04:33,103 YOU ABOUT THE TECHNOLOGIES WE 3973 03:04:33,103 --> 03:04:35,272 HAVE IN OUR PORTFOLIO BUT THE 3974 03:04:35,272 --> 03:04:37,007 SUBMISSION DEADLINE WAS JUST TEN 3975 03:04:37,007 --> 03:04:39,309 DAYS AGO, SO THIS REALLY IS A 3976 03:04:39,309 --> 03:04:39,676 YOUNG PROGRAM. 3977 03:04:39,676 --> 03:04:41,745 AND I HOPE YOU ALL STAY TUNED 3978 03:04:41,745 --> 03:04:44,447 AND CONTINUE TO FOLLOW ALONG AS 3979 03:04:44,447 --> 03:04:46,349 WE ANNOUNCE IN THE WINTER WHAT 3980 03:04:46,349 --> 03:04:47,884 TECHNOLOGIES WILL BE ADVANCING 3981 03:04:47,884 --> 03:04:49,553 TO OUR TECH SPRINT PHASE. 3982 03:04:49,553 --> 03:04:52,055 I'M GOING TO CLOSE THERE AND 3983 03:04:52,055 --> 03:05:00,597 HAND THINGS OVER TO DR. PILEGGI. 3984 03:05:00,597 --> 03:05:02,799 >> THANK YOU, TAYLOR, FOR THE 3985 03:05:02,799 --> 03:05:04,634 NICE INTRODUCTION AND 3986 03:05:04,634 --> 03:05:11,775 OPPORTUNITY TO SHARE AN UPDATE 3987 03:05:11,775 --> 03:05:18,815 ON MATERNAL HEALTH CHALLENGE. 3988 03:05:18,815 --> 03:05:19,015 OKAY. 3989 03:05:19,015 --> 03:05:21,318 I'M A MEMBER OF THE EUNICE 3990 03:05:21,318 --> 03:05:25,689 KENNEDY SHRIVER NATIONAL 3991 03:05:25,689 --> 03:05:28,592 INSTITUTE WHICH MISSION IS 3992 03:05:28,592 --> 03:05:31,428 HEALTHY PREGNANCIES, HEALTHY 3993 03:05:31,428 --> 03:05:39,169 CHILDREN, HEALTHY AND OPTIMAL 3994 03:05:39,169 --> 03:05:39,402 LIVES. 3995 03:05:39,402 --> 03:05:42,672 AS PART OF THIS MISSION WE'RE 3996 03:05:42,672 --> 03:05:47,277 TRYING TO CONTRIBUTE TO THE 3997 03:05:47,277 --> 03:05:48,612 ADVANCEMENTS IN THE MED TECH 3998 03:05:48,612 --> 03:05:48,845 SPACE. 3999 03:05:48,845 --> 03:05:53,783 I WANT TO TAKE AN OPPORTUNITY TO 4000 03:05:53,783 --> 03:05:57,821 TALK -- MENTION JUST BRIEFLY 4001 03:05:57,821 --> 03:05:59,189 THIS PARTNERSHIP, PUBLIC/PRIVATE 4002 03:05:59,189 --> 03:06:03,326 PARTNERSHIP WE RECENTLY LAUNCHED 4003 03:06:03,326 --> 03:06:06,596 TOGETHER WITH THE FDA AND BARDA 4004 03:06:06,596 --> 03:06:10,200 DRIVE AND FOUNDATION OF THE NIH 4005 03:06:10,200 --> 03:06:13,703 TO REALLY BRING TOGETHER THE 4006 03:06:13,703 --> 03:06:14,604 PEDIATRIC MEDICAL DEVICE 4007 03:06:14,604 --> 03:06:17,774 ECOSYSTEM, A VERY EARLY STAGE, 4008 03:06:17,774 --> 03:06:20,410 WE LAUNCHED THIS SEPTEMBER, THE 4009 03:06:20,410 --> 03:06:25,315 OBJECTIVE IS TO DE-RISK AND MOVE 4010 03:06:25,315 --> 03:06:26,216 TECHNOLOGIES FOR CHILDREN 4011 03:06:26,216 --> 03:06:29,386 INCLUDING POINT OF CARE 4012 03:06:29,386 --> 03:06:30,053 TECHNOLOGIES, CENTRALIZED HEALTH 4013 03:06:30,053 --> 03:06:35,058 CARE SO WE ARE HOPING THROUGH 4014 03:06:35,058 --> 03:06:37,727 THE EXPERTISE LEVERAGED FROM THE 4015 03:06:37,727 --> 03:06:41,197 NIBIB WHICH IS CO-PARTNER IN 4016 03:06:41,197 --> 03:06:43,733 THIS ENDEAVOR WITH NICHD AND THE 4017 03:06:43,733 --> 03:06:44,601 NIH PEDIATRIC RESEARCH 4018 03:06:44,601 --> 03:06:47,904 CONSORTIUM WHERE WE CAN REALLY 4019 03:06:47,904 --> 03:06:54,044 MAKE IMPORTANT CHANGES IN THE 4020 03:06:54,044 --> 03:06:54,310 LANDSCAPE. 4021 03:06:54,310 --> 03:06:56,680 MATERNAL HEALTH, I WANT TO 4022 03:06:56,680 --> 03:06:58,415 STRESS WE'RE FACING A MATERNAL 4023 03:06:58,415 --> 03:07:03,787 HEALTH CRISIS IN THIS NATION. 4024 03:07:03,787 --> 03:07:07,824 AND THIS IS REALLY ADULTS WITH 4025 03:07:07,824 --> 03:07:09,492 THE TECHNOLOGIES AND THE LEVEL 4026 03:07:09,492 --> 03:07:12,996 OF HEALTH CARE THAT WE HAVE 4027 03:07:12,996 --> 03:07:13,530 AVAILABLE. 4028 03:07:13,530 --> 03:07:15,732 AND MATERNAL HEALTH REFERS TO 4029 03:07:15,732 --> 03:07:17,567 THE CONTINUUM FROM 4030 03:07:17,567 --> 03:07:19,502 PRE-CONCEPTION TO PREGNANCY AND 4031 03:07:19,502 --> 03:07:20,336 POSTPARTUM PERIOD. 4032 03:07:20,336 --> 03:07:22,972 THERE ARE A LOT OF POTENTIAL 4033 03:07:22,972 --> 03:07:24,708 INTERVENTIONS THAT CAN CHANGE 4034 03:07:24,708 --> 03:07:25,775 THE OUTCOMES. 4035 03:07:25,775 --> 03:07:31,715 I WILL GO BRIEFLY ON SOME STATS 4036 03:07:31,715 --> 03:07:34,250 THAT WILL REALLY MAGNIFY THE 4037 03:07:34,250 --> 03:07:36,052 LEVEL OF URGENCY FOR CHANGING 4038 03:07:36,052 --> 03:07:38,054 THE LANDSCAPE. 4039 03:07:38,054 --> 03:07:40,256 THIS IS A COMPARISON, IT'S 4040 03:07:40,256 --> 03:07:43,426 REALLY DATED, BUT THE CURRENT 4041 03:07:43,426 --> 03:07:47,063 STAGES IS NOT DIFFERENT, SHOWING 4042 03:07:47,063 --> 03:07:49,999 THE MATERNAL MORTALITY RATIOS IN 4043 03:07:49,999 --> 03:07:51,768 SELECTED COUNTRIES, ALL WESTERN 4044 03:07:51,768 --> 03:07:52,068 COUNTRIES. 4045 03:07:52,068 --> 03:07:53,937 YOU CAN RECOGNIZE FROM THE FLAGS 4046 03:07:53,937 --> 03:07:55,472 AND SEE THAT THE UNITED STATES 4047 03:07:55,472 --> 03:08:00,276 IS DOUBLE OF THE HIGHEST IN 4048 03:08:00,276 --> 03:08:03,413 TERMS OF MORTALITY RATIOS 4049 03:08:03,413 --> 03:08:05,215 OVERALL, WHICH IS CONCERNING. 4050 03:08:05,215 --> 03:08:07,183 THE TREND HAS BEEN FAIRLY 4051 03:08:07,183 --> 03:08:10,553 OPPOSITE TO WHERE OTHER 4052 03:08:10,553 --> 03:08:12,956 COUNTRIES ARE GOING, THE UNITED 4053 03:08:12,956 --> 03:08:16,292 STATES IS CONTINUING TO GO UP, 4054 03:08:16,292 --> 03:08:20,196 OTHER NATIONS ARE PUTTING IT 4055 03:08:20,196 --> 03:08:20,964 DOWN. 4056 03:08:20,964 --> 03:08:27,337 AND ALSO IN TERMS OF THE WINDOW 4057 03:08:27,337 --> 03:08:30,306 OF WHEN THE MOST OF THE 4058 03:08:30,306 --> 03:08:33,643 FATALITIES AND MORBIDITY AND 4059 03:08:33,643 --> 03:08:36,212 MORTALITY IS GENERALLY IN THE 4060 03:08:36,212 --> 03:08:38,148 PERI DELIVERY PERIOD, CLOSE TO 4061 03:08:38,148 --> 03:08:41,651 DELIVERY, WITHIN THE FIRST YEAR, 4062 03:08:41,651 --> 03:08:43,520 POSTPARTUM PERIOD, ALMOST HALF 4063 03:08:43,520 --> 03:08:45,054 OF THE MORTALITY REALLY IS 4064 03:08:45,054 --> 03:08:46,356 DURING THIS WINDOW OF TIME. 4065 03:08:46,356 --> 03:08:50,326 AND THERE ARE A NUMBER OF 4066 03:08:50,326 --> 03:08:53,263 CONDITIONS THAT CONTRIBUTE TO 4067 03:08:53,263 --> 03:08:54,697 THIS MORTALITY, MOSTLY 4068 03:08:54,697 --> 03:08:57,433 HEMORRHAGE, GENERALLY EARLY 4069 03:08:57,433 --> 03:09:00,737 AFTER DELIVERY, BUT ALSO 4070 03:09:00,737 --> 03:09:03,673 CARDIOVASCULAR INFECTIONS AND 4071 03:09:03,673 --> 03:09:06,609 THAT ARE CONTRIBUTING TO THIS. 4072 03:09:06,609 --> 03:09:10,780 OVER 60% IT'S ESTIMATED OF 4073 03:09:10,780 --> 03:09:11,481 PREGNANCY-RELATED DEATHS ARE 4074 03:09:11,481 --> 03:09:17,220 PREVENTIBLE, AND THERE ARE A 4075 03:09:17,220 --> 03:09:19,222 NUMBER OF VARIABLES AND 4076 03:09:19,222 --> 03:09:20,423 IMPLEMENTABLE INTERVENTIONS THAT 4077 03:09:20,423 --> 03:09:22,392 COULD REALLY CHANGE THE COURSE 4078 03:09:22,392 --> 03:09:23,026 OVER THERE. 4079 03:09:23,026 --> 03:09:25,895 WHO ARE THE MOST AFFECTED 4080 03:09:25,895 --> 03:09:26,196 POPULATIONS? 4081 03:09:26,196 --> 03:09:29,599 GENERALLY THE YOUNGEST AND 4082 03:09:29,599 --> 03:09:31,034 OLDEST PREGNANCY INDIVIDUALS. 4083 03:09:31,034 --> 03:09:37,907 THERE IS ALSO AN ISSUE OF HEALTH 4084 03:09:37,907 --> 03:09:42,212 DISPARITIES RELATED TO RACE AND 4085 03:09:42,212 --> 03:09:42,979 HISPANIC ORIGINALS, BUT MOSTLY 4086 03:09:42,979 --> 03:09:44,814 AMERICANS ARE THE ONES WHO HAVE 4087 03:09:44,814 --> 03:09:45,715 THE WORST OUTCOMES. 4088 03:09:45,715 --> 03:09:49,986 THERE IS ALSO AN IMPACT OF WHERE 4089 03:09:49,986 --> 03:09:51,988 YOU LIVE AND ACCESS TO HEALTH 4090 03:09:51,988 --> 03:09:52,755 CARE. 4091 03:09:52,755 --> 03:09:55,425 AND THIS BRINGS US TO THE BIG 4092 03:09:55,425 --> 03:09:59,429 ISSUE OF MATERNAL HEALTH CARE 4093 03:09:59,429 --> 03:10:01,064 DESERTS, WHICH ARE AREAS WHERE 4094 03:10:01,064 --> 03:10:03,466 MOSTLY RURAL BUT NOT ONLY RURAL, 4095 03:10:03,466 --> 03:10:06,402 THERE ARE ALSO URBAN AREAS WHERE 4096 03:10:06,402 --> 03:10:09,239 THERE ARE NO MATERNAL HEALTH 4097 03:10:09,239 --> 03:10:10,440 CARE CENTERS WHERE INDIVIDUALS 4098 03:10:10,440 --> 03:10:14,878 WHO ARE PREGNANT, WHO HAVE GIVEN 4099 03:10:14,878 --> 03:10:16,246 BIRTH CAN HAVE SPECIALIZED 4100 03:10:16,246 --> 03:10:19,782 ACCESS TO HEALTH CARE. 4101 03:10:19,782 --> 03:10:21,651 AND THIS IS REALLY ASSESSED TO 4102 03:10:21,651 --> 03:10:23,820 BE GETTING WORSE BECAUSE MORE 4103 03:10:23,820 --> 03:10:25,922 AND MORE CENTERS HAVE BEEN 4104 03:10:25,922 --> 03:10:27,991 CLOSED IN THOSE AREAS, THE MAP 4105 03:10:27,991 --> 03:10:30,193 IS QUITE CONCERNING. 4106 03:10:30,193 --> 03:10:32,929 SO, THE NIH HAS INTRODUCED 4107 03:10:32,929 --> 03:10:34,864 SEVERAL YEARS AGO THE 4108 03:10:34,864 --> 03:10:37,000 IMPLEMENTING A MATERNAL HEALTH 4109 03:10:37,000 --> 03:10:39,636 AND PREGNANCY OUTCOME VISION FOR 4110 03:10:39,636 --> 03:10:43,373 EVERYONE IMPROVED INITIATIVE 4111 03:10:43,373 --> 03:10:46,276 WHICH IS REALLY TARGETED TO 4112 03:10:46,276 --> 03:10:49,279 SPECIAL EMPHASIS ON HEALTH 4113 03:10:49,279 --> 03:10:51,180 DISPARITIES IN POPULATIONS 4114 03:10:51,180 --> 03:10:53,750 DISPROPORTIONATELY AFFECTED SUCH 4115 03:10:53,750 --> 03:10:58,254 AFRICAN AMERICAN BLACK WOMEN, 4116 03:10:58,254 --> 03:11:00,990 AMERICAN INDIANS, ALASKA NATIVE, 4117 03:11:00,990 --> 03:11:02,191 ASIAN/PACIFIC ISLANDERS, VERY 4118 03:11:02,191 --> 03:11:04,827 YOUNG WOMEN AND OF ADVANCED 4119 03:11:04,827 --> 03:11:06,562 MATERNAL AGE AND WITH 4120 03:11:06,562 --> 03:11:07,797 DISABILITIES. 4121 03:11:07,797 --> 03:11:09,565 THIS IS A TRANS-NIH INITIATIVE 4122 03:11:09,565 --> 03:11:10,433 THAT TOUCHES MANY INSTITUTES AND 4123 03:11:10,433 --> 03:11:14,070 CENTERS OF THE NIH. 4124 03:11:14,070 --> 03:11:16,039 AND RECENT ACTIVITIES OF THIS 4125 03:11:16,039 --> 03:11:18,541 ADMINISTRATION, THE WHITE HOUSE 4126 03:11:18,541 --> 03:11:20,543 HAS INTRODUCED INCLUDE THE WHITE 4127 03:11:20,543 --> 03:11:22,312 HOUSE BLUEPRINT FOR ADDRESSING 4128 03:11:22,312 --> 03:11:25,014 MATERNAL HEALTH CRISIS, THERE 4129 03:11:25,014 --> 03:11:30,620 WAS RELEASED IN JUNE 2022, AND 4130 03:11:30,620 --> 03:11:31,387 VERY RECENTLY FROM NOVEMBER 13 4131 03:11:31,387 --> 03:11:33,022 WHITE HOUSE INITIATIVE ON 4132 03:11:33,022 --> 03:11:35,325 WOMEN'S HEALTH RESEARCH, IT'S 4133 03:11:35,325 --> 03:11:44,500 TIME TO REALLY ADDRESS THIS 4134 03:11:44,500 --> 03:11:48,438 CRISIS. 4135 03:11:48,438 --> 03:11:49,872 A STATEMENT HAS BEEN PUBLISHED 4136 03:11:49,872 --> 03:11:52,508 IN OCTOBER IN JAMA VIEWPOINTS, 4137 03:11:52,508 --> 03:11:56,379 BRINGS A NICE OVERVIEW OF WHERE 4138 03:11:56,379 --> 03:11:57,313 THE NIH IS CONCENTRATING. 4139 03:11:57,313 --> 03:12:00,350 AS PART OF THE INITIATIVE, THERE 4140 03:12:00,350 --> 03:12:05,288 HAVE BEEN A NUMBER OF 4141 03:12:05,288 --> 03:12:07,790 ACTIVITIES, THE MOST MERITORIOUS 4142 03:12:07,790 --> 03:12:10,426 IS CENTERS OF EXCELLENCE 4143 03:12:10,426 --> 03:12:10,994 RECENTLY RELEASED, SCATTERED 4144 03:12:10,994 --> 03:12:13,396 THROUGHOUT THE NATION TO TRY AND 4145 03:12:13,396 --> 03:12:17,667 ADDRESS THIS IMPORTANT CRISIS. 4146 03:12:17,667 --> 03:12:22,605 AT THE END OF 2022 WE WERE GIVEN 4147 03:12:22,605 --> 03:12:27,510 THE OPPORTUNITY TO PUT TOGETHER 4148 03:12:27,510 --> 03:12:29,746 THE CHALLENGE FOR MATERNAL 4149 03:12:29,746 --> 03:12:34,083 HEALTH -- TRYING TO PRETTY MUCH 4150 03:12:34,083 --> 03:12:35,284 TAKE THE PLATFORM RADx TECH 4151 03:12:35,284 --> 03:12:42,358 FOR THE RESPONSE TO THE COVID, 4152 03:12:42,358 --> 03:12:43,793 AND PUT IT, HIJACK IT TO ADDRESS 4153 03:12:43,793 --> 03:12:44,327 ANOTHER CRISIS. 4154 03:12:44,327 --> 03:12:48,698 I MUST SAY IT WAS A GREAT 4155 03:12:48,698 --> 03:12:49,899 EXPERIENCE, WE JOINED FORCES 4156 03:12:49,899 --> 03:12:53,169 WITH NIBIB AND THE 4157 03:12:53,169 --> 03:12:56,339 INFRASTRUCTURE OF POCTRN IS 4158 03:12:56,339 --> 03:12:57,540 REALLY THE UNDERLYING MOTOR AND 4159 03:12:57,540 --> 03:12:59,842 WE WERE ABLE TO PUT TOGETHER 4160 03:12:59,842 --> 03:13:00,510 THIS CHALLENGE. 4161 03:13:00,510 --> 03:13:04,313 THE PROBLEM THAT WE'RE TRYING TO 4162 03:13:04,313 --> 03:13:07,083 ADDRESS IS IN THE POSTPARTUM 4163 03:13:07,083 --> 03:13:10,119 PHASE, WITHIN THE FIRST YEAR 4164 03:13:10,119 --> 03:13:14,257 AFTER DELIVERY, AND IN TRYING TO 4165 03:13:14,257 --> 03:13:16,359 REALLY BRIDGE THE HEALTH CARE 4166 03:13:16,359 --> 03:13:18,895 THROUGH TECHNOLOGIES THAT CAN 4167 03:13:18,895 --> 03:13:20,430 REALLY REDUCE BURDEN ON 4168 03:13:20,430 --> 03:13:25,902 INDIVIDUALS LIVING IN THOSE 4169 03:13:25,902 --> 03:13:26,335 AREAS. 4170 03:13:26,335 --> 03:13:28,905 AND THIS BASICALLY WAS OPEN TO 4171 03:13:28,905 --> 03:13:31,140 TECHNOLOGY THAT HAD TO BE FAIRLY 4172 03:13:31,140 --> 03:13:34,544 MATURE TO THE POINT THAT THEY 4173 03:13:34,544 --> 03:13:36,746 WOULD BE IN THE COMMERCIAL PHASE 4174 03:13:36,746 --> 03:13:40,483 WITHIN THREE TO FIVE YEARS. 4175 03:13:40,483 --> 03:13:43,719 AND THIS IS A MODIFIED VERSION 4176 03:13:43,719 --> 03:13:46,489 OF THE INNOVATION PANEL. 4177 03:13:46,489 --> 03:13:51,561 WE HAD UP TO 8 MILLION ALLOTTED 4178 03:13:51,561 --> 03:13:55,298 TO PRIZES, WITH STEPWISE 4179 03:13:55,298 --> 03:13:56,799 APPROACH, AT EACH STEP THERE 4180 03:13:56,799 --> 03:13:59,402 WILL BE ASSESSMENT AND A NUMBER 4181 03:13:59,402 --> 03:14:00,436 OF -- REDUCING NUMBER OF 4182 03:14:00,436 --> 03:14:03,473 SOLUTIONS WILL MOVE TO THE NEXT 4183 03:14:03,473 --> 03:14:03,673 PHASE. 4184 03:14:03,673 --> 03:14:06,843 RIGHT NOW WE'RE IN THE LAST 4185 03:14:06,843 --> 03:14:11,147 PHASES OF OF THE TECHNOLOGY 4186 03:14:11,147 --> 03:14:14,750 ASSESSMENT AND WE'RE EXPECTING 4187 03:14:14,750 --> 03:14:16,619 THE FINALISTS TO BE DECIDED AT 4188 03:14:16,619 --> 03:14:21,858 THE BEGINNING OF NEXT YEAR BY 4189 03:14:21,858 --> 03:14:22,291 MARCH SOMEHOW 4190 03:14:22,291 --> 03:14:28,764 >> I WILL SKIP THIS FOR THE SAKE 4191 03:14:28,764 --> 03:14:32,835 OF TIME. 4192 03:14:32,835 --> 03:14:43,379 THERE WERE SPECIFIC EVALUATION 4193 03:14:43,946 --> 03:14:45,915 CRITERIA, IN THE TARGETED 4194 03:14:45,915 --> 03:14:48,451 POPULATIONS IN MATERNAL HEALTH 4195 03:14:48,451 --> 03:14:50,553 CARE DESERTS AND 4196 03:14:50,553 --> 03:14:51,220 UNDERREPRESENTED. 4197 03:14:51,220 --> 03:14:51,687 REGULATORY ASPECT AND 4198 03:14:51,687 --> 03:14:53,656 COMMERCIALIZATION IN THE TIME 4199 03:14:53,656 --> 03:15:02,798 FRAME THAT I ALLUDED TO. 4200 03:15:02,798 --> 03:15:06,102 THOSE ARE THE TEN STILL IN THE 4201 03:15:06,102 --> 03:15:06,402 COMPETITION. 4202 03:15:06,402 --> 03:15:07,937 DR. TROMBERG GAVE A VIEW THIS 4203 03:15:07,937 --> 03:15:10,006 MORNING, WE COVERED A LITTLE BIT 4204 03:15:10,006 --> 03:15:13,309 OF EVERYTHING, SOME FOCUS ON 4205 03:15:13,309 --> 03:15:16,045 INFECTION, SOME FOCUS ON 4206 03:15:16,045 --> 03:15:19,649 CARDIOVASCULAR RISK. 4207 03:15:19,649 --> 03:15:22,185 HEMORRHAGE, AND MENTAL HEALTH, 4208 03:15:22,185 --> 03:15:29,625 SO THERE'S QUITE A WIDE VARIETY 4209 03:15:29,625 --> 03:15:31,928 OF PORTFOLIO IN THIS -- OF 4210 03:15:31,928 --> 03:15:33,663 TECHNOLOGIES WE WERE ABLE TO 4211 03:15:33,663 --> 03:15:34,764 ACCESS. 4212 03:15:34,764 --> 03:15:36,732 IT'S BEEN A FAIRLY COMPRESSED 4213 03:15:36,732 --> 03:15:37,600 SCHEDULE. 4214 03:15:37,600 --> 03:15:41,003 I MUST SAY OUR COLLEAGUES 4215 03:15:41,003 --> 03:15:42,872 WORKING ON THIS WERE FAIRLY 4216 03:15:42,872 --> 03:15:44,774 SURPRISED THIS WAS MORE RELAXING 4217 03:15:44,774 --> 03:15:49,779 IN TERMS OF SCHEDULE AND DEMAND 4218 03:15:49,779 --> 03:15:51,180 THAN FOR COVID. 4219 03:15:51,180 --> 03:15:53,416 SO THERE'S AN URGENCY TO MOVE 4220 03:15:53,416 --> 03:15:57,453 THOSE TECHNOLOGIES AND FOSTER 4221 03:15:57,453 --> 03:16:00,923 THEM INTO IMPLEMENTATION AND WE 4222 03:16:00,923 --> 03:16:03,059 WERE COGNIZANT THAT, YOU KNOW, 4223 03:16:03,059 --> 03:16:04,727 THERE IS THE NEED FOR MORE 4224 03:16:04,727 --> 03:16:06,128 INVESTMENT IN THIS SPACE AND WE 4225 03:16:06,128 --> 03:16:07,763 WANT TO MAKE SURE THOSE 4226 03:16:07,763 --> 03:16:09,599 TECHNOLOGIES THAT WOULD MAKE IT 4227 03:16:09,599 --> 03:16:11,267 THROUGH THE PROGRAM WILL BE ABLE 4228 03:16:11,267 --> 03:16:14,971 TO GET TO THE PATIENTS IN NEED 4229 03:16:14,971 --> 03:16:16,706 WITHIN THE TIME FRAME WE GAVE 4230 03:16:16,706 --> 03:16:17,173 OURSELVES. 4231 03:16:17,173 --> 03:16:18,908 SO THERE ARE NUMBER OF THOSE 4232 03:16:18,908 --> 03:16:21,110 MOST LIKELY WILL BE ABLE TO GET 4233 03:16:21,110 --> 03:16:24,947 INTO THE CENTER OF EXCELLENCE 4234 03:16:24,947 --> 03:16:29,318 FOR IMPLEMENTATION PHASE, BUT WE 4235 03:16:29,318 --> 03:16:30,086 WELCOME ADDITIONAL TECHNOLOGIES 4236 03:16:30,086 --> 03:16:31,687 THAT COME INTO THE PIPELINE 4237 03:16:31,687 --> 03:16:34,457 THROUGH THE NIH TO HELP ADDRESS 4238 03:16:34,457 --> 03:16:35,324 THIS IMPORTANT CRISIS. 4239 03:16:35,324 --> 03:16:38,628 AND THIS IS JUST A SUMMARY OF -- 4240 03:16:38,628 --> 03:16:40,630 ONLY SOME OF THE BIG TEAM THAT 4241 03:16:40,630 --> 03:16:41,631 IS WORKING ON THIS. 4242 03:16:41,631 --> 03:16:42,999 AND I'LL STOP THERE. 4243 03:16:42,999 --> 03:16:53,476 THANK YOU VERY MUCH FOR YOUR 4244 03:17:19,068 --> 03:17:19,435 ATTENTION. 4245 03:17:19,435 --> 03:17:19,769 [APPLAUSE] 4246 03:17:19,769 --> 03:17:24,807 >> I'M HERE TO TALK ABOUT A 4247 03:17:24,807 --> 03:17:25,775 FUNDING OPPORTUNITY THAT WAS 4248 03:17:25,775 --> 03:17:27,410 INITIATED LAST YEAR AROUND THIS 4249 03:17:27,410 --> 03:17:28,844 TIME TO DEVELOP PLATFORMS FOR 4250 03:17:28,844 --> 03:17:32,548 HIV VIRAL LOAD TESTING AT THE 4251 03:17:32,548 --> 03:17:35,918 POINT OF CARE. 4252 03:17:35,918 --> 03:17:40,356 I'M ONE OF THE CO-P.I.s FOR 4253 03:17:40,356 --> 03:17:41,357 THE CENTER FOR INNOVATION AND 4254 03:17:41,357 --> 03:17:43,626 POINT OF CARE FOR HIV/AIDS AND 4255 03:17:43,626 --> 03:17:48,030 EMERGING INFECTIOUS DISEASES. 4256 03:17:48,030 --> 03:17:51,767 I'M ALSO THE DIRECTOR OF THE 4257 03:17:51,767 --> 03:17:53,369 TECHNOLOGY CORE. 4258 03:17:53,369 --> 03:17:57,340 OUR CENTER IS FUNDED BY NIBIB, 4259 03:17:57,340 --> 03:17:58,674 FOGARTY INTERNATIONAL CENTER AND 4260 03:17:58,674 --> 03:18:01,610 OFFICE OF AIDS RESEARCH. 4261 03:18:01,610 --> 03:18:04,347 OUR FOCUS IS ON HIV AND 4262 03:18:04,347 --> 03:18:05,014 CO-MORBIDITIES AND TECHNOLOGIES 4263 03:18:05,014 --> 03:18:08,384 THAT WILL IMPROVE PEOPLE WHO 4264 03:18:08,384 --> 03:18:11,187 LIVE WITH HIV. 4265 03:18:11,187 --> 03:18:14,090 SO, I HAVE A CONFLICT OF 4266 03:18:14,090 --> 03:18:17,393 INTEREST, I WAS A FOUNDER AND 4267 03:18:17,393 --> 03:18:19,929 FORMER CSO OF MINUTE MOLECULAR 4268 03:18:19,929 --> 03:18:21,530 DIAGNOSIS, WE RECEIVED FUNDING 4269 03:18:21,530 --> 03:18:24,834 FROM RADx TO DEVELOP A 4270 03:18:24,834 --> 03:18:25,601 POINT-OF-CARE PLATFORM CALLED 4271 03:18:25,601 --> 03:18:27,837 DASH, WHICH MANY PEOPLE IN THIS 4272 03:18:27,837 --> 03:18:32,541 ROOM HELPED ME TO GET TO THE EUA 4273 03:18:32,541 --> 03:18:37,313 FINISH LINE SO THANK YOU. 4274 03:18:37,313 --> 03:18:47,790 MINUTE MOLECULAR MERGED ARE 4275 03:18:48,758 --> 03:18:50,326 NUCLEIN AND I'M A SHAREHOLDER. 4276 03:18:50,326 --> 03:18:52,995 I DO WANT TO TELL YOU THAT HIV 4277 03:18:52,995 --> 03:18:55,197 DISEASE IS NOT A THING OF THE 4278 03:18:55,197 --> 03:18:55,498 PAST. 4279 03:18:55,498 --> 03:18:59,001 IT REMAINS A PROBLEM IN THE U.S. 4280 03:18:59,001 --> 03:19:00,669 AND GLOBALLY. 4281 03:19:00,669 --> 03:19:04,473 CURRENT U.S. EPIDEMIOLOGY FROM 4282 03:19:04,473 --> 03:19:05,708 2021 IS 1.2 MILLION PEOPLE WITH 4283 03:19:05,708 --> 03:19:06,809 HIV LIVING IN THE U.S. 4284 03:19:06,809 --> 03:19:10,446 MORE THAN HALF OF THEM ARE OVER 4285 03:19:10,446 --> 03:19:11,947 50 YEARS OLD. 4286 03:19:11,947 --> 03:19:16,318 BUT 1 IN 8 ARE UNAWARE OF HIV 4287 03:19:16,318 --> 03:19:16,619 SEROSTATUS. 4288 03:19:16,619 --> 03:19:18,754 AND OF THOSE PEOPLE WHO ARE 4289 03:19:18,754 --> 03:19:21,557 UNAWARE OF THEIR STATUS, 40% 4290 03:19:21,557 --> 03:19:24,860 GENERATE NEW INFECTIONS. 4291 03:19:24,860 --> 03:19:26,629 SO IN 2021, OVER 36,000 NEW 4292 03:19:26,629 --> 03:19:33,335 INFECTIONS WERE IN THE U.S., AND 4293 03:19:33,335 --> 03:19:36,238 THIS WILL BREAK DOWN THE NEW 4294 03:19:36,238 --> 03:19:39,508 INFECTIONS, BUT WHAT I THINK IS 4295 03:19:39,508 --> 03:19:40,876 REALLY IMPORTANT, I'M GOING TO 4296 03:19:40,876 --> 03:19:44,046 SHOW YOU THIS SLIDE FIRST, IS 4297 03:19:44,046 --> 03:19:50,052 IT'S NOT NECESSARILY AN URBAN 4298 03:19:50,052 --> 03:19:50,419 ONLY PROBLEM. 4299 03:19:50,419 --> 03:19:53,122 A LOT OF REGIONS IN THE SOUTH 4300 03:19:53,122 --> 03:19:55,891 HAVE FEWER URBAN AREAS THAT NEED 4301 03:19:55,891 --> 03:19:59,829 HIV SERVICES, AND SO THIS IS A 4302 03:19:59,829 --> 03:20:01,597 REALLY STRONG REASON TO PROMOTE 4303 03:20:01,597 --> 03:20:03,866 POINT OF CARE TECHNOLOGY AND 4304 03:20:03,866 --> 03:20:04,467 HOME-BASED TECHNOLOGY. 4305 03:20:04,467 --> 03:20:08,337 SO THAT WE CAN REALLY TRY TO 4306 03:20:08,337 --> 03:20:11,307 REACH PEOPLE WHO MAY NOT 4307 03:20:11,307 --> 03:20:16,879 RECEIVE -- HAVE ACCESS TO THAT 4308 03:20:16,879 --> 03:20:17,112 CARE. 4309 03:20:17,112 --> 03:20:19,081 UNAID HAS A GOAL OF ENDING THE 4310 03:20:19,081 --> 03:20:21,817 HIV EPIDEMIC AS A PUBLIC HEALTH 4311 03:20:21,817 --> 03:20:22,918 CRISIS IN 2030. 4312 03:20:22,918 --> 03:20:26,222 AND SO THEY HAVE SET GOALS FOR 4313 03:20:26,222 --> 03:20:29,525 PEOPLE WHO KNOW THEIR STATUS, IF 4314 03:20:29,525 --> 03:20:32,461 THEY ARE ON HIV THERAPY, AND IF 4315 03:20:32,461 --> 03:20:39,435 THEIR VIRAL LOAD IS SUPPRESSED. 4316 03:20:39,435 --> 03:20:41,937 IT'S 95-95-95. 4317 03:20:41,937 --> 03:20:42,438 STATISTICS ON THIS SLIDE 4318 03:20:42,438 --> 03:20:45,274 INDICATE WHERE WE WERE IN 2021 4319 03:20:45,274 --> 03:20:50,079 IN THE U.S., STATISTIC CAME FROM 4320 03:20:50,079 --> 03:20:50,646 THE CDC. 4321 03:20:50,646 --> 03:20:55,184 WE STILL HAVE A LARGE NUMBER OF 4322 03:20:55,184 --> 03:20:56,585 NEW INFECTIONS, AND BY 2025 WE'D 4323 03:20:56,585 --> 03:21:04,460 LIKE TO REDUCE THAT BY 75%, AND 4324 03:21:04,460 --> 03:21:06,362 BY 90% BY 2030. 4325 03:21:06,362 --> 03:21:16,839 87% OF PEOPLE DIAGNOSED ARE 4326 03:21:16,839 --> 03:21:21,110 ACCESSING TREATMENT, 66% VIRALLY 4327 03:21:21,110 --> 03:21:21,410 SUPPRESSED. 4328 03:21:21,410 --> 03:21:22,411 TAKING PROPHYLACTIC TREATMENT 4329 03:21:22,411 --> 03:21:24,847 CALLED PREP, 30% OF ELIGIBLE 4330 03:21:24,847 --> 03:21:27,249 PEOPLE TAKE THE MEDICATION. 4331 03:21:27,249 --> 03:21:30,753 BY 2025, THE GOAL IS TO INCREASE 4332 03:21:30,753 --> 03:21:34,256 THAT TO 50%. 4333 03:21:34,256 --> 03:21:37,960 SO, VIRAL LOAD AND PREP USE 4334 03:21:37,960 --> 03:21:40,863 REQUIRE REGULAR DIAGNOSTICS, SO 4335 03:21:40,863 --> 03:21:46,635 THAT ALSO IS A VERY STRONG CALL 4336 03:21:46,635 --> 03:21:51,707 FOR POINT-OF-CARE DIAGNOSTICS 4337 03:21:51,707 --> 03:21:52,908 FOR HIV. 4338 03:21:52,908 --> 03:21:57,413 SO, THANK YOU FOR THIS SLIDE. 4339 03:21:57,413 --> 03:21:59,481 USE CASES FOR HIV, RNA DETECTION 4340 03:21:59,481 --> 03:22:02,017 PLATFORMS, SO WE CAN USE THEM 4341 03:22:02,017 --> 03:22:04,320 FOR ACUTE HIV INFECTION BEFORE 4342 03:22:04,320 --> 03:22:07,089 PEOPLE HAVE ANTIBODIES IN THEIR 4343 03:22:07,089 --> 03:22:10,025 BLOOD, FOR MONITORING VIRAL 4344 03:22:10,025 --> 03:22:11,327 LOADS, MONITORING PREP, EARLY 4345 03:22:11,327 --> 03:22:11,860 INFANT DIAGNOSTICS. 4346 03:22:11,860 --> 03:22:13,529 SO THERE ARE A NUMBER OF 4347 03:22:13,529 --> 03:22:18,701 DIFFERENT USE CASES FOR THESE 4348 03:22:18,701 --> 03:22:21,003 TESTS. 4349 03:22:21,003 --> 03:22:24,807 AS I MENTIONED, CFAN IS FUNDED 4350 03:22:24,807 --> 03:22:31,046 BY OFFICE OF AIDS RESEARCH, LAST 4351 03:22:31,046 --> 03:22:33,949 YEAR SELECTED TO DEVELOP A 4352 03:22:33,949 --> 03:22:36,652 PROJECT WITH POCTRN AND RADx 4353 03:22:36,652 --> 03:22:39,855 TO ACCELERATE DEVELOPMENT OF HIV 4354 03:22:39,855 --> 03:22:43,292 VIRAL LOAD PLATFORMS. 4355 03:22:43,292 --> 03:22:46,528 THE COORDINATING CENTER 4356 03:22:46,528 --> 03:22:52,568 ORGANIZED A PROGRAM INITIATION, 4357 03:22:52,568 --> 03:22:56,105 WROTE THE SOLICITATION, RECEIVED 4358 03:22:56,105 --> 03:22:58,007 APPLICATION, REVIEWED THEM, THEY 4359 03:22:58,007 --> 03:23:00,576 WERE SELECTED AND WE CONTRACTED 4360 03:23:00,576 --> 03:23:01,877 AND WE'VE HAD ONE PROGRESS 4361 03:23:01,877 --> 03:23:04,380 REVIEW AND WE'RE ON OUR SECOND. 4362 03:23:04,380 --> 03:23:09,485 SO EACH PROJECT IS BETWEEN ABOUT 4363 03:23:09,485 --> 03:23:12,187 9 TO 12 MONTHS. 4364 03:23:12,187 --> 03:23:13,822 SO, SOLICITATION WAS PUBLISHED 4365 03:23:13,822 --> 03:23:15,924 LAST YEAR ON NOVEMBER 3, CLOSED 4366 03:23:15,924 --> 03:23:17,893 ON DECEMBER 1. 4367 03:23:17,893 --> 03:23:21,497 WE RECEIVED 16 APPLICATIONS 4368 03:23:21,497 --> 03:23:24,166 REVIEWED BY THE RADx NIH AND 4369 03:23:24,166 --> 03:23:24,833 POCTRN COMMITTEE. 4370 03:23:24,833 --> 03:23:26,468 IT WAS BENEFICIAL THAT WE HAD 4371 03:23:26,468 --> 03:23:29,471 ALL WORKED TOGETHER THROUGH 4372 03:23:29,471 --> 03:23:30,706 RADx FOR THIS REVIEW BECAUSE I 4373 03:23:30,706 --> 03:23:35,711 THINK WE LEARNED A LOT FROM EACH 4374 03:23:35,711 --> 03:23:37,579 OTHER'S VIEWPOINTS, AND PICKED 4375 03:23:37,579 --> 03:23:40,783 SIX PROJECTS FOR RECOMMENDED FOR 4376 03:23:40,783 --> 03:23:41,517 FUNDING. 4377 03:23:41,517 --> 03:23:45,387 ONE OF THE GROUPS DECLINED THE 4378 03:23:45,387 --> 03:23:47,122 FUNDING, AND SO WE WENT AHEAD 4379 03:23:47,122 --> 03:23:50,559 WITH FIVE PROJECTS INITIATED AND 4380 03:23:50,559 --> 03:23:54,396 WORKING TOWARDS MILESTONES. 4381 03:23:54,396 --> 03:23:56,365 SO, THIS PROJECT IS ORGANIZED 4382 03:23:56,365 --> 03:23:58,200 WHERE THERE'S A PRODUCT -- A 4383 03:23:58,200 --> 03:23:59,768 POCTRN AND RADx TEAM FOR EACH 4384 03:23:59,768 --> 03:24:03,739 ONE OF THE FIVE PROJECTS. 4385 03:24:03,739 --> 03:24:06,108 SO, THERE'S EACH OF THE PROJECTS 4386 03:24:06,108 --> 03:24:09,411 HAS A POCTRN MEMBER AND A RADx 4387 03:24:09,411 --> 03:24:11,914 TEAM MEMBER, PLUS A RADx 4388 03:24:11,914 --> 03:24:13,115 PROJECT FACILITATOR AND WE MEET 4389 03:24:13,115 --> 03:24:16,785 ON A REGULAR BASIS AND DISCUSS 4390 03:24:16,785 --> 03:24:19,288 OUR MILESTONES, AND ANY PROBLEMS 4391 03:24:19,288 --> 03:24:21,023 THAT THEY ARE EXPERIENCING, AND 4392 03:24:21,023 --> 03:24:23,859 I HOPE THAT MY GROUP THAT I WORK 4393 03:24:23,859 --> 03:24:26,161 WITH AGREES I THINK IT REALLY IS 4394 03:24:26,161 --> 03:24:29,498 BENEFICIAL TO HAVE SOMEONE WHO 4395 03:24:29,498 --> 03:24:31,734 HAS DEEP HIV EXPERIENCE AND 4396 03:24:31,734 --> 03:24:36,605 COUPLE WITH SOMEONE WHO HAS MORE 4397 03:24:36,605 --> 03:24:37,339 DIAGNOSTIC TECHNOLOGY 4398 03:24:37,339 --> 03:24:38,307 DEVELOPMENT AND MANUFACTURING 4399 03:24:38,307 --> 03:24:43,579 EXPERIENCE SO I THINK TO GET A 4400 03:24:43,579 --> 03:24:45,347 NICE WELL-ROUNDED MAYBE MORE 4401 03:24:45,347 --> 03:24:47,116 ADVICE FROM ME THAN THEY WANT 4402 03:24:47,116 --> 03:24:51,920 BUT IT'S WORKING REALLY WELL. 4403 03:24:51,920 --> 03:24:55,090 IN ADDITION TO OUR REGULAR 4404 03:24:55,090 --> 03:25:00,696 MEETINGS AND OUR SUPPORT THROUGH 4405 03:25:00,696 --> 03:25:03,866 THEIR MILESTONE, THEY HAVE ALSO 4406 03:25:03,866 --> 03:25:06,401 HAD FOUR DIFFERENT WEBINARS FOR 4407 03:25:06,401 --> 03:25:10,038 THESE TEAMS, ON A REALLY 4408 03:25:10,038 --> 03:25:13,242 IMPORTANT TOPIC, HIV TESTING AND 4409 03:25:13,242 --> 03:25:16,945 MARKET LANDSCAPE, REGULATORY 4410 03:25:16,945 --> 03:25:19,815 PATHWAYS AND LANDSCAPE, TWO 4411 03:25:19,815 --> 03:25:22,551 PROJECTS ON REIMBURSEMENT, WHICH 4412 03:25:22,551 --> 03:25:24,286 GIVES THE TEAMS SOME CONTEXT FOR 4413 03:25:24,286 --> 03:25:29,358 HOW TO DEVELOP AND HIV VIRAL 4414 03:25:29,358 --> 03:25:31,093 LOAD TEST. 4415 03:25:31,093 --> 03:25:33,262 ALL THE PROJECTS ARE AT AN EARLY 4416 03:25:33,262 --> 03:25:36,331 STAGE FOR VERY GOOD REASON 4417 03:25:36,331 --> 03:25:42,905 BECAUSE THE FDA JUST MOVED HIV 4418 03:25:42,905 --> 03:25:46,208 VIRAL LOAD INTO THE 510(K) 4419 03:25:46,208 --> 03:25:47,743 CATEGORY, ACCESSIBLE FOR SMALL 4420 03:25:47,743 --> 03:25:54,650 COMPANIES TO DEVELOP A TEST AND 4421 03:25:54,650 --> 03:25:55,517 TO MARKET. 4422 03:25:55,517 --> 03:25:58,887 THE OFFICE OF AIDS RESEARCH HELD 4423 03:25:58,887 --> 03:26:03,158 A WORKSHOP FOR TWO DAYS ON KIND 4424 03:26:03,158 --> 03:26:04,159 OF COMMUNITY VOICES AROUND 4425 03:26:04,159 --> 03:26:08,030 TECHNOLOGY, TO FIND OUT WHAT THE 4426 03:26:08,030 --> 03:26:12,067 COMMUNITY WANTS, WHAT ARE PAIN 4427 03:26:12,067 --> 03:26:14,937 POINTS, WHAT IS HELPFUL IN 4428 03:26:14,937 --> 03:26:16,038 WORKING FOR SELF-TESTING AND 4429 03:26:16,038 --> 03:26:18,574 PERSONALIZED VIRAL LOAD AND THEN 4430 03:26:18,574 --> 03:26:20,409 THE TECHNOLOGY DEVELOPERS LIKE 4431 03:26:20,409 --> 03:26:22,177 MYSELF TALKED ABOUT WHAT IS 4432 03:26:22,177 --> 03:26:25,347 POSSIBLE, AND I THINK THIS 4433 03:26:25,347 --> 03:26:27,249 REALLY -- I PUT THE YouTube 4434 03:26:27,249 --> 03:26:29,751 LINKS SO YOU CAN WATCH IF YOU'D 4435 03:26:29,751 --> 03:26:34,923 LIKE, BUT I THINK IT SHOWS A 4436 03:26:34,923 --> 03:26:41,230 CONTINUED INTEREST TO DEVELOP 4437 03:26:41,230 --> 03:26:41,964 HOME-BASE AND POINT-OF-CARE 4438 03:26:41,964 --> 03:26:43,232 TESTS FOR HIV. 4439 03:26:43,232 --> 03:26:46,301 OUR HOPE IS THIS EARLY PILOT 4440 03:26:46,301 --> 03:26:48,036 PROJECT WHICH IS BRINGING THESE 4441 03:26:48,036 --> 03:26:52,341 COMPANIES ALONG SO THEY HAVE 4442 03:26:52,341 --> 03:26:53,675 KIND OF DE-RISKED ACCELERATED 4443 03:26:53,675 --> 03:26:56,845 DEVELOPMENT SO THAT A LARGER 4444 03:26:56,845 --> 03:26:59,014 RADx-TYPE FUNNEL COULD BE HELD 4445 03:26:59,014 --> 03:27:02,484 AND IF IT IS TO HAPPEN, WHAT WE 4446 03:27:02,484 --> 03:27:05,220 BELIEVE NEEDS TO HAPPEN IS 4447 03:27:05,220 --> 03:27:07,122 DEFINE PLATFORM CAPABILITIES AND 4448 03:27:07,122 --> 03:27:08,624 REALLY DO A DETAILED LANDSCAPE, 4449 03:27:08,624 --> 03:27:12,461 AND ALSO TO FIND THAT USER NEEDS 4450 03:27:12,461 --> 03:27:15,564 AND OAR IS ALREADY WORKING ON 4451 03:27:15,564 --> 03:27:17,165 THAT WITH THEIR COMMUNITY 4452 03:27:17,165 --> 03:27:17,499 WORKSHOP. 4453 03:27:17,499 --> 03:27:21,003 OF COURSE, TO FUND SOME 4454 03:27:21,003 --> 03:27:23,672 PROMISING INNOVATIONS AND THEN 4455 03:27:23,672 --> 03:27:24,940 VALIDATE, VERIFY, OPTIMIZE, 4456 03:27:24,940 --> 03:27:25,340 ACCELERATE. 4457 03:27:25,340 --> 03:27:34,249 THAT SOUNDS LIKE WHAT POCTRN IS 4458 03:27:34,249 --> 03:27:35,150 GOOD AT. 4459 03:27:35,150 --> 03:27:36,752 WE'RE INSPIRED BY THIS. 4460 03:27:36,752 --> 03:27:39,254 WHAT WE'VE DECIDED TO DO IN OUR 4461 03:27:39,254 --> 03:27:41,156 SOLICITATION PUBLISHED NEXT YEAR 4462 03:27:41,156 --> 03:27:46,295 WE THINK SAMPLE VOLUME IS A 4463 03:27:46,295 --> 03:27:47,729 BARRIER, PLASMA CELL VOLUME, SO 4464 03:27:47,729 --> 03:27:49,898 WE'RE GOING TO ASK FOR 4465 03:27:49,898 --> 03:27:53,735 TECHNOLOGY DEVELOPMENT IN THAT 4466 03:27:53,735 --> 03:27:54,069 AREA. 4467 03:27:54,069 --> 03:27:56,838 AND WE WOULD LIKE TO KNOW USE OF 4468 03:27:56,838 --> 03:27:59,341 PREFERENCES, SO WE HAVE A PLAN 4469 03:27:59,341 --> 03:28:08,450 FOR A PROJECT WE'RE GOING TO -- 4470 03:28:08,450 --> 03:28:11,753 KARA AND OUR DISSEMINATION CORE 4471 03:28:11,753 --> 03:28:16,558 PLANS TO PLAN A STUDY TO LOOK AT 4472 03:28:16,558 --> 03:28:20,095 USER PREFERENCES WITH A 4473 03:28:20,095 --> 03:28:21,296 QUANTITATIVE STUDY. 4474 03:28:21,296 --> 03:28:22,965 SO, WE'RE TRYING TO PUSH THIS 4475 03:28:22,965 --> 03:28:26,134 ALONG BECAUSE WE THINK IT'S VERY 4476 03:28:26,134 --> 03:28:27,235 EXCITING, AND REALLY NECESSARY, 4477 03:28:27,235 --> 03:28:28,704 AND ALL THE ADVANCES THAT ARE 4478 03:28:28,704 --> 03:28:31,840 MADE FOR POINT OF CARE 4479 03:28:31,840 --> 03:28:34,476 TECHNOLOGY HERE, ESPECIALLY 4480 03:28:34,476 --> 03:28:42,818 HOME-BASED TECHNOLOGY, CAN BE 4481 03:28:42,818 --> 03:28:44,319 EASILY TRANSFERRED TO LOW- AND 4482 03:28:44,319 --> 03:28:44,987 MIDDLE-INCOME COUNTRIES, OUR 4483 03:28:44,987 --> 03:28:45,654 EXCITEMENT AND PASSION. 4484 03:28:45,654 --> 03:28:47,389 I WANT TO ACKNOWLEDGE THE PEOPLE 4485 03:28:47,389 --> 03:28:51,093 THAT PARTICIPATED IN THIS PILOT 4486 03:28:51,093 --> 03:28:51,893 PROJECT AND ALSO AWARDEES, I 4487 03:28:51,893 --> 03:28:54,629 WANT SURE IF THAT WAS PUBLIC SO 4488 03:28:54,629 --> 03:28:56,465 I DIDN'T DISCUSS YOUR WORK WITH 4489 03:28:56,465 --> 03:28:58,033 YOUR INFORMATION ON THERE, BUT 4490 03:28:58,033 --> 03:29:01,370 OF COURSE YOU ARE WHY WE'RE 4491 03:29:01,370 --> 03:29:11,580 DOING THIS. 4492 03:29:29,998 --> 03:29:38,440 THANK YOU. 4493 03:29:38,440 --> 03:29:46,481 4494 03:29:46,481 --> 03:29:46,882 >> OKAY. 4495 03:29:46,882 --> 03:29:50,152 SORRY ABOUT THAT. 4496 03:29:50,152 --> 03:29:53,121 SO, I'LL SPEND A FEW MOMENTS 4497 03:29:53,121 --> 03:29:55,524 TALKING ABOUT THE ACCESSIBILITY 4498 03:29:55,524 --> 03:29:57,926 PROGRAM, OUR RELATIONSHIP WITH 4499 03:29:57,926 --> 03:29:59,261 ADVOCACY GROUPS, SOMEWHAT UNIQUE 4500 03:29:59,261 --> 03:30:01,596 IN THE OVERALL PROGRAM, AND OUR 4501 03:30:01,596 --> 03:30:02,431 EXPERIENCES WERE SOMEWHAT 4502 03:30:02,431 --> 03:30:03,532 SPECIAL. 4503 03:30:03,532 --> 03:30:05,834 I THINK IT'S ONLY APPROPRIATE 4504 03:30:05,834 --> 03:30:07,702 GIVEN THAT THE ACCESSIBILITY 4505 03:30:07,702 --> 03:30:10,972 PROGRAM ACTUALLY CAME FROM THE 4506 03:30:10,972 --> 03:30:12,674 GROUPS, IN JANUARY 2022, LETTERS 4507 03:30:12,674 --> 03:30:14,976 WERE WRITTEN BY A COLLECTION OF 4508 03:30:14,976 --> 03:30:17,679 ADVOCACY GROUPS TO THE WHITE 4509 03:30:17,679 --> 03:30:19,648 HOUSE, ESSENTIALLY SAYING IT'S 4510 03:30:19,648 --> 03:30:20,749 GREAT, YOU'RE MANUFACTURING A 4511 03:30:20,749 --> 03:30:21,550 TON OF TEST, PROVIDING THEM TO 4512 03:30:21,550 --> 03:30:25,020 THE PUBLIC BUT THEY ARE NOT 4513 03:30:25,020 --> 03:30:26,221 ACCESSIBLE AND DON'T WORK FOR 4514 03:30:26,221 --> 03:30:26,755 US. 4515 03:30:26,755 --> 03:30:28,890 THE WHITE HOUSE IMMEDIATELY 4516 03:30:28,890 --> 03:30:30,926 RESPONDED WITH SOME FUNDING. 4517 03:30:30,926 --> 03:30:32,060 THAT WAS ABOUT $30 MILLION. 4518 03:30:32,060 --> 03:30:34,996 TO START A PROGRAM. 4519 03:30:34,996 --> 03:30:38,533 AND SO, BASED ON THAT WE STOOD 4520 03:30:38,533 --> 03:30:41,837 UP -- WELL, THE FIRST STEP WAS 4521 03:30:41,837 --> 03:30:42,804 ACCESSIBILITY LISTENING SESSION, 4522 03:30:42,804 --> 03:30:44,005 THE GOALS, UNDERSTAND THE 4523 03:30:44,005 --> 03:30:47,175 CHALLENGES TO THE ACCESSIBILITY 4524 03:30:47,175 --> 03:30:48,376 AT HOME TEST, DISCUSS POTENTIAL 4525 03:30:48,376 --> 03:30:49,144 IMPROVEMENT INCLUDING TIMELINE 4526 03:30:49,144 --> 03:30:50,679 AND OPEN LINES OF COMMUNICATION 4527 03:30:50,679 --> 03:30:52,314 FOR ONGOING DISCUSSION. 4528 03:30:52,314 --> 03:30:55,484 IT WAS WELL ATTENDED, MULTIPLE 4529 03:30:55,484 --> 03:30:56,284 BREAKOUT SESSIONS HERE, 4530 03:30:56,284 --> 03:30:58,753 IMPORTANTLY THE LEFT-HAND SIDE 4531 03:30:58,753 --> 03:31:00,322 FOR THE ADVOCACY GROUPS, MOST 4532 03:31:00,322 --> 03:31:01,957 STAYED WITH US IN OUR SUBSEQUENT 4533 03:31:01,957 --> 03:31:04,159 MEETINGS WHICH WE HAD MONTHLY, 4534 03:31:04,159 --> 03:31:05,560 TO KEEP THEM UPDATED. 4535 03:31:05,560 --> 03:31:07,529 ON THE RIGHT-HAND SIDE I THINK 4536 03:31:07,529 --> 03:31:09,064 SOME OF THE AGENCIES 4537 03:31:09,064 --> 03:31:10,031 SELF-SELECTED AS TO WHERE THEIR 4538 03:31:10,031 --> 03:31:13,902 INTEREST WAS BUT IT WAS A 4539 03:31:13,902 --> 03:31:15,604 WELL-ATTENDED AND VERY POPULAR 4540 03:31:15,604 --> 03:31:16,204 EVENT. 4541 03:31:16,204 --> 03:31:18,206 SO, BASED ON THAT FUNDING, THEN 4542 03:31:18,206 --> 03:31:20,509 SUBSEQUENT FUNDING WHICH CAME 4543 03:31:20,509 --> 03:31:22,911 OUT A BIT LATER, ABOUT SIX 4544 03:31:22,911 --> 03:31:23,778 MONTHS LATER, PRETTY 4545 03:31:23,778 --> 03:31:24,980 SIGNIFICANT, TWO PROGRAMS WERE 4546 03:31:24,980 --> 03:31:26,615 STOOD UP. 4547 03:31:26,615 --> 03:31:28,483 ONE IS MINI ACCESSIBILITY 4548 03:31:28,483 --> 03:31:32,420 PROGRAM, THIS WAS DESIGNED TO 4549 03:31:32,420 --> 03:31:33,255 REDESIGN EXISTING OVER THE 4550 03:31:33,255 --> 03:31:36,158 COUNTER TESTS DRAWN OUT OF THE 4551 03:31:36,158 --> 03:31:37,893 RADx TECH OTC POOL, ABOUT 24 4552 03:31:37,893 --> 03:31:39,761 OF THOSE IN THAT POOL. 4553 03:31:39,761 --> 03:31:42,464 AND WE SAID IF YOU'RE IN THIS 4554 03:31:42,464 --> 03:31:43,932 POOL, YOU'RE IN THE PROGRAM 4555 03:31:43,932 --> 03:31:45,534 UNLESS YOU DON'T WANT TO BE. 4556 03:31:45,534 --> 03:31:47,435 THE SECOND GROUP WAS A 4557 03:31:47,435 --> 03:31:49,304 SOLICITATION FOR NEW TESTS, SO 4558 03:31:49,304 --> 03:31:50,405 INSTEAD OF REDESIGNING EXISTING 4559 03:31:50,405 --> 03:31:55,243 TEST WE WOULD TAKE AND SAY 4560 03:31:55,243 --> 03:31:57,078 LET'S DESIGN FROM SCRATCH. 4561 03:31:57,078 --> 03:32:00,382 ONE COMPONENT WAS FOCUSED ON 4562 03:32:00,382 --> 03:32:01,249 ACCESSIBILITY WITH COMPARABLE 4563 03:32:01,249 --> 03:32:02,217 TEST PERFORMANCE AS EXISTING 4564 03:32:02,217 --> 03:32:05,086 TESTS ALREADY ON THE MARKET, AND 4565 03:32:05,086 --> 03:32:07,255 THE SECOND WAS HIGH PERFORMANCE 4566 03:32:07,255 --> 03:32:09,591 TEST WHICH WAS -- PERFORMANCE 4567 03:32:09,591 --> 03:32:12,794 HAD TO EXCEED PERFORMANCE OF 4568 03:32:12,794 --> 03:32:15,697 TESTS ON THE MARKET. 4569 03:32:15,697 --> 03:32:17,766 SO, WHAT OUR FIRST STEPS WERE 4570 03:32:17,766 --> 03:32:20,602 ONCE WE STOOD UP THE PROGRAM WE 4571 03:32:20,602 --> 03:32:21,770 STARTED WITH INTERNAL 4572 03:32:21,770 --> 03:32:22,370 ACCESSIBILITY ASSESSMENTS 4573 03:32:22,370 --> 03:32:25,207 LOOKING AT HOW COMPLEX ARE THESE 4574 03:32:25,207 --> 03:32:27,275 THINGS, HOW MANY STEPS, HOW MANY 4575 03:32:27,275 --> 03:32:28,410 COMPONENTS, HOW SMALL, THINGS 4576 03:32:28,410 --> 03:32:30,245 LIKE THAT. 4577 03:32:30,245 --> 03:32:32,714 WE CONTRACTED WITH EXPERIENCED 4578 03:32:32,714 --> 03:32:34,649 ACCESSIBILITY DESIGN FIRMS, VERY 4579 03:32:34,649 --> 03:32:36,017 COMMERCIAL TYPE APPROACH. 4580 03:32:36,017 --> 03:32:39,154 AND WE STARTED TO KIND OF GET 4581 03:32:39,154 --> 03:32:41,790 INTO IT, AND WE STARTED TO LOOK 4582 03:32:41,790 --> 03:32:43,625 AT HOW THEY SIMULATED THEIR WORK 4583 03:32:43,625 --> 03:32:45,160 ENVIRONMENTS, SO SOME OF THIS 4584 03:32:45,160 --> 03:32:49,264 WAS WE DARKEN A ROOM TO SIMULATE 4585 03:32:49,264 --> 03:32:51,967 BLINDNESS, SOME WAS WEAR MITTENS 4586 03:32:51,967 --> 03:32:54,035 AND GLOVES TO SIMULATE POOR 4587 03:32:54,035 --> 03:32:56,404 DEXTERITY, THIS DOESN'T 4588 03:32:56,404 --> 03:32:58,406 REPRESENT THE POPULATION. 4589 03:32:58,406 --> 03:33:02,811 WHEN WE FIRST STARTED TO WORK 4590 03:33:02,811 --> 03:33:04,212 WITH ADVOCACY GROUPS THEY 4591 03:33:04,212 --> 03:33:07,949 ENCOURAGED US TO INCLUDE TARGET 4592 03:33:07,949 --> 03:33:08,950 POPULATIONS, STRONGLY IS SOFT 4593 03:33:08,950 --> 03:33:10,785 FOR HOW THEY PUT IT. 4594 03:33:10,785 --> 03:33:12,654 THEY WANTED US TO INVOLVE THEM 4595 03:33:12,654 --> 03:33:14,756 DIRECTLY WITH THE TARGET 4596 03:33:14,756 --> 03:33:15,190 POPULATIONS. 4597 03:33:15,190 --> 03:33:17,292 OUR TARGET POPULATIONS WERE LOW 4598 03:33:17,292 --> 03:33:21,463 VISION, NO VISION, POOR 4599 03:33:21,463 --> 03:33:23,298 DEXTERITY, AGING POPULATIONS. 4600 03:33:23,298 --> 03:33:26,234 SO, BASED ON THAT WE CREATED A 4601 03:33:26,234 --> 03:33:28,336 POOL OF SUBJECT MATTER EXPERTS 4602 03:33:28,336 --> 03:33:29,537 FROM TARGET POPULATIONS WITH 4603 03:33:29,537 --> 03:33:31,373 REPRESENTATIVES WHO HAD 4604 03:33:31,373 --> 03:33:35,443 CONDITIONS AS SUBJECT MATTER 4605 03:33:35,443 --> 03:33:36,211 EXPERTS. 4606 03:33:36,211 --> 03:33:37,512 WE SECURED ACADEMIC SUBJECT 4607 03:33:37,512 --> 03:33:39,881 MATTER EXPERTS FUNDED BY NIDILRR 4608 03:33:39,881 --> 03:33:42,684 AND TALKED TO A NUMBER OF 4609 03:33:42,684 --> 03:33:44,886 NIDILRR-FUNDED SITES. 4610 03:33:44,886 --> 03:33:48,490 IT ENDS UP MARYLAND WAS 4611 03:33:48,490 --> 03:33:50,925 ACTUALLY -- HAD SEVEN THAT WERE 4612 03:33:50,925 --> 03:33:53,662 QUITE GOOD, SECURITY THOSE, 4613 03:33:53,662 --> 03:33:56,531 INCORPORATED GEORGIA TECH HOME 4614 03:33:56,531 --> 03:34:06,841 LAB INTO OUR REVIEWS, A 4615 03:34:06,841 --> 03:34:09,144 USABILITY USING QUANTITATIVE, 4616 03:34:09,144 --> 03:34:11,012 USING KNOBS, MORE OF A TACTILE 4617 03:34:11,012 --> 03:34:12,113 APPROACH, AND WORKED WITH 4618 03:34:12,113 --> 03:34:15,083 ADVOCACY GROUP BECAUSE WE NEEDED 4619 03:34:15,083 --> 03:34:15,817 MORE RESOURCES AS THE PROGRAM 4620 03:34:15,817 --> 03:34:16,351 WENT ON. 4621 03:34:16,351 --> 03:34:20,855 THIS IS THE GENERAL FRAMEWORK WE 4622 03:34:20,855 --> 03:34:24,359 USED TO LOOK AT ACCESSIBILITY. 4623 03:34:24,359 --> 03:34:26,428 SO WHAT TYPICALLY -- THIS IS HOW 4624 03:34:26,428 --> 03:34:27,629 WE ASSESSED THEM. 4625 03:34:27,629 --> 03:34:37,472 YOU CAN IMAGINE MORE CRITERIA, 4626 03:34:37,472 --> 03:34:39,574 MOST SAY WE COLLECT AND DO 4627 03:34:39,574 --> 03:34:41,309 SOMETHING AND WE GET A RESULT. 4628 03:34:41,309 --> 03:34:43,178 THAT'S THE WORLD THEY LOOK AT. 4629 03:34:43,178 --> 03:34:47,115 WE WANTED TO LOOK FROM BEGINNING 4630 03:34:47,115 --> 03:34:49,851 TO END BECAUSE IF THERE'S A STEP 4631 03:34:49,851 --> 03:34:51,453 THAT APTS BE PERFORMED IT STOPS 4632 03:34:51,453 --> 03:34:53,021 THE REST OF THE STEPS. 4633 03:34:53,021 --> 03:34:55,223 YOU COULD HAVE THE MIDDLE BIT, 4634 03:34:55,223 --> 03:34:56,424 SUPER ACCESSIBLE, IF YOU CAN'T 4635 03:34:56,424 --> 03:35:01,463 OPEN THE BOX UNLESS YOU USE 4636 03:35:01,463 --> 03:35:03,365 SCISSORS OR A KNIFE AND GRANDMA 4637 03:35:03,365 --> 03:35:06,101 HAS A SAW OR WE'VE HAD TESTS TO 4638 03:35:06,101 --> 03:35:09,170 TEAR OPEN THE BOX, THINGS LIKE 4639 03:35:09,170 --> 03:35:11,606 THAT, YOU CAN'T BUY THE DEVICE 4640 03:35:11,606 --> 03:35:13,441 BECAUSE IT DOESN'T HAVE A 4641 03:35:13,441 --> 03:35:15,210 TACTILE QR CODE THAT LEADS TO A 4642 03:35:15,210 --> 03:35:16,211 PLACE TO DESCRIBES IF IT'S 4643 03:35:16,211 --> 03:35:17,445 EXPIRED AND WHAT THE TEST IS 4644 03:35:17,445 --> 03:35:18,313 ABOUT, THAT'S A PROBLEM. 4645 03:35:18,313 --> 03:35:20,382 YOU HAD TO LOOK AT THE FULL 4646 03:35:20,382 --> 03:35:23,218 SPECTRUM OF THE USE OF THESE 4647 03:35:23,218 --> 03:35:23,585 PRODUCTS. 4648 03:35:23,585 --> 03:35:28,590 THE OTHER THING THAT WE CAME TO 4649 03:35:28,590 --> 03:35:30,825 REALIZE AFTER TEN OF THESE THEY 4650 03:35:30,825 --> 03:35:32,961 START TO BECOME SIMILAR. 4651 03:35:32,961 --> 03:35:34,095 GRANTED TECHNOLOGIES COULD BE 4652 03:35:34,095 --> 03:35:35,163 DIFFERENT, WITH DIFFERENT WAYS 4653 03:35:35,163 --> 03:35:41,436 OF DOING THIS, YOU PUT THEM IN 4654 03:35:41,436 --> 03:35:43,538 GENERAL CATEGORIES, AND YOU 4655 03:35:43,538 --> 03:35:46,708 COULD SYSTEMATIZE AT SOME LEVEL. 4656 03:35:46,708 --> 03:35:49,444 THE OTHER THING, A LOT OF THE 4657 03:35:49,444 --> 03:35:52,714 SUPPLIES OUTSIDE OF COVID 4658 03:35:52,714 --> 03:35:54,582 IVDs, IVDs IN GENERAL, TESTS 4659 03:35:54,582 --> 03:35:55,650 IN GENERAL, POTENTIALLY MEDICAL 4660 03:35:55,650 --> 03:35:56,851 DEVICES IN GENERAL, YOU CAN LOOK 4661 03:35:56,851 --> 03:36:00,488 AT A BEACH HEAD AND ENTRY POINT 4662 03:36:00,488 --> 03:36:01,589 OF BIGGER WORLD. 4663 03:36:01,589 --> 03:36:03,258 THIS IS THE PROCESS WE'VE USED 4664 03:36:03,258 --> 03:36:08,830 IN THE MINI PROGRAM WHERE WE LET 4665 03:36:08,830 --> 03:36:11,332 HOME LAB RUN TESTS THROUGH THEIR 4666 03:36:11,332 --> 03:36:12,333 PROCESS, WITH SUBJECT MATTER 4667 03:36:12,333 --> 03:36:13,535 EXPERTS GO THROUGH A PROCESS AS 4668 03:36:13,535 --> 03:36:15,470 WELL AS GIVE US FEEDBACK. 4669 03:36:15,470 --> 03:36:17,372 WE MET WITH THE DESIGN FIRMS AND 4670 03:36:17,372 --> 03:36:19,574 SUBJECT MATTER EXPERTS. 4671 03:36:19,574 --> 03:36:20,575 THEY WORK TOGETHER. 4672 03:36:20,575 --> 03:36:22,210 WE MET WITH A COMPANY AND SAID 4673 03:36:22,210 --> 03:36:26,147 HERE IS WHAT WE FIND, HERE ARE 4674 03:36:26,147 --> 03:36:27,115 OPTIONS AND THINGS TO THINK 4675 03:36:27,115 --> 03:36:29,384 ABOUT DOING AND WENT THROUGH A 4676 03:36:29,384 --> 03:36:31,853 VALIDATION AND PROTOTYPING 4677 03:36:31,853 --> 03:36:32,387 PHASE. 4678 03:36:32,387 --> 03:36:34,122 WE BUILT 87 COMPONENTS THAT WE 4679 03:36:34,122 --> 03:36:36,891 TESTED AND TRIED TO VALIDATE FOR 4680 03:36:36,891 --> 03:36:37,559 USABILITY AND ACCESSIBILITY, 4681 03:36:37,559 --> 03:36:40,929 TRYING TO FIGURE OUT WHAT'S THE 4682 03:36:40,929 --> 03:36:42,997 BEST STOP OR BOTTLE, HOW DOES IT 4683 03:36:42,997 --> 03:36:45,834 NEED TO BE DESIGNED AND DO THIS 4684 03:36:45,834 --> 03:36:48,303 WELL. 4685 03:36:48,303 --> 03:36:50,138 ULTIMATELY LED TO 4686 03:36:50,138 --> 03:36:50,505 IMPLEMENTATION. 4687 03:36:50,505 --> 03:36:53,775 SO MINI PROGRAM STARTED WITH 24 4688 03:36:53,775 --> 03:36:55,043 TESTS IN THE BEGINNING. 4689 03:36:55,043 --> 03:36:56,911 WE FIRST MET WITH THOSE, AGAIN, 4690 03:36:56,911 --> 03:36:58,780 YOU WERE IN THE PROGRAM UNLESS 4691 03:36:58,780 --> 03:37:04,285 YOU OPTED TO BE OUT, THESE WERE 4692 03:37:04,285 --> 03:37:07,121 RADx OTC TESTS, WEREN'T 4693 03:37:07,121 --> 03:37:09,057 DESIGNED TO BE ACCESSIBLE, SOME 4694 03:37:09,057 --> 03:37:13,995 GOOD, SOME NOT SO MUCH. 4695 03:37:13,995 --> 03:37:16,197 FIFTEEN WENT FORWARD, NINE 4696 03:37:16,197 --> 03:37:17,532 DECLINED OR HAD TECHNICAL 4697 03:37:17,532 --> 03:37:18,833 CHALLENGES, CODE FOR THEY DIDN'T 4698 03:37:18,833 --> 03:37:21,236 SEEM TO WORK WELL SO WE DIDN'T 4699 03:37:21,236 --> 03:37:23,004 PURSUE THEM. 4700 03:37:23,004 --> 03:37:24,305 SOME DECLINED TO PARTICIPATE 4701 03:37:24,305 --> 03:37:25,740 BECAUSE IT DIDN'T MAKE SENSE. 4702 03:37:25,740 --> 03:37:28,910 WE HAD ONE TEST WITH 61 STEPS 4703 03:37:28,910 --> 03:37:30,578 THAT NO MATTER HOW MUCH MONEY 4704 03:37:30,578 --> 03:37:32,647 AND EFFORT AND TIME AND RESOURCE 4705 03:37:32,647 --> 03:37:34,849 WE PUT TOWARDS THAT, WE WEREN'T 4706 03:37:34,849 --> 03:37:38,353 GOING TO FIX 61 STEPS FOR 4707 03:37:38,353 --> 03:37:40,221 SOMEBODY DEALING WITH 4708 03:37:40,221 --> 03:37:40,855 ACCESSIBILITY CHALLENGES. 4709 03:37:40,855 --> 03:37:43,825 ULTIMATELY THOSE WENT THROUGH A 4710 03:37:43,825 --> 03:37:45,159 HOME LAB USABILITY ANALYSIS, 4711 03:37:45,159 --> 03:37:47,161 SUBJECT MATTER EXPERT REVIEW AND 4712 03:37:47,161 --> 03:37:51,199 THEN SOME DESIGN FROM CONCEPTS 4713 03:37:51,199 --> 03:37:53,635 AND ULTIMATELY 12 WENT TO PANEL 4714 03:37:53,635 --> 03:37:56,371 REVIEW, IT ENDS UP YOU SEE THEY 4715 03:37:56,371 --> 03:37:58,239 DECLINED TO PARTICIPATE OR IT 4716 03:37:58,239 --> 03:37:59,307 TECHNICAL CHALLENGES AT THAT 4717 03:37:59,307 --> 03:38:02,277 POINT BECAUSE SOME OF THE DESIGN 4718 03:38:02,277 --> 03:38:03,645 CHANGES WERE SIGNIFICANT. 4719 03:38:03,645 --> 03:38:05,346 IF IT COST $30 MILLION TO REDO A 4720 03:38:05,346 --> 03:38:06,881 PRODUCTION LINE, IT'S NOT A 4721 03:38:06,881 --> 03:38:08,049 GREAT THING, COMPANIES DECLINED 4722 03:38:08,049 --> 03:38:08,650 TO PARTICIPATE. 4723 03:38:08,650 --> 03:38:11,019 IF YOU CHANGED YOUR COST OF GOOD 4724 03:38:11,019 --> 03:38:14,789 BY FACTOR OF 2 1/2 OR 3, THEY 4725 03:38:14,789 --> 03:38:16,424 WOULD DECLINE TO PARTICIPATE. 4726 03:38:16,424 --> 03:38:19,160 SO WE'RE DOWN TO FIVE STILL IN 4727 03:38:19,160 --> 03:38:20,595 THE PROGRAM, THREE ACTIVELY 4728 03:38:20,595 --> 03:38:24,399 BUILDING PRODUCT AND REDESIGNING 4729 03:38:24,399 --> 03:38:26,267 PRODUCT RIGHT NOW FOR RELEASE TO 4730 03:38:26,267 --> 03:38:26,501 MARKET. 4731 03:38:26,501 --> 03:38:28,670 ONE OTHER ONE IS IN THE RADx 4732 03:38:28,670 --> 03:38:30,538 THREE WHICH I'LL TALK ABOUT, THE 4733 03:38:30,538 --> 03:38:32,640 OTHER ONE IS PENDING A DECISION, 4734 03:38:32,640 --> 03:38:34,542 ON THE RIGHT-HAND SIDE YOU CAN 4735 03:38:34,542 --> 03:38:37,912 SEE AN EXAMPLE OF A HOME LAB 4736 03:38:37,912 --> 03:38:44,052 USABILITY TASK ANALYSIS, THIS IS 4737 03:38:44,052 --> 03:38:47,655 ONE TABLE THAT WAS OUT OF THE 4738 03:38:47,655 --> 03:38:49,757 REPORT CATEGORIZING FOUR GROUPS 4739 03:38:49,757 --> 03:38:51,826 AS WELL AS INACCESSIBLE 4740 03:38:51,826 --> 03:38:53,261 ESSENTIAL AND NON-ESSENTIAL 4741 03:38:53,261 --> 03:38:53,995 TASKS, ESSENTIAL TASKS ARE TASKS 4742 03:38:53,995 --> 03:39:01,169 YOU HAVE TO BE ABLE TO DO TO 4743 03:39:01,169 --> 03:39:02,470 PERFORM THE TEST. 4744 03:39:02,470 --> 03:39:03,871 NON-ESSENTIAL TASKS ARE THROWING 4745 03:39:03,871 --> 03:39:05,773 IT WITH A, I STILL COULD PERFORM 4746 03:39:05,773 --> 03:39:07,375 THE TEST BUT AT THE END IT 4747 03:39:07,375 --> 03:39:09,544 DIDN'T MATTER TO THE TEST 4748 03:39:09,544 --> 03:39:12,013 ITSELF. 4749 03:39:12,013 --> 03:39:15,950 THIS IS THE TECH THREE FINAL. 4750 03:39:15,950 --> 03:39:16,651 215 APPLICANTS. 4751 03:39:16,651 --> 03:39:20,488 THEY ALL WENT THROUGH VIABILITY 4752 03:39:20,488 --> 03:39:22,156 REVIEW PANEL, DEEP DIVE 4753 03:39:22,156 --> 03:39:24,225 ASSESSMENTS, 64 OF THOSE. 4754 03:39:24,225 --> 03:39:25,960 STEERING PANEL REVIEWS, 29 IN 4755 03:39:25,960 --> 03:39:26,661 THE DE-RISKING PHASE, SO THAT'S 4756 03:39:26,661 --> 03:39:28,262 AS FAR AS WE'VE GOTTEN THROUGH 4757 03:39:28,262 --> 03:39:30,431 THE PROCESS SO FAR. 4758 03:39:30,431 --> 03:39:34,636 THERE'S STILL MORE REVIEWS, 4759 03:39:34,636 --> 03:39:37,138 IMPLEMENTATION PHASE TO FOLLOW. 4760 03:39:37,138 --> 03:39:41,009 THE BALANCE IS ABOUT 25% TOWARDS 4761 03:39:41,009 --> 03:39:42,543 THE ACCESSIBILITY PROGRAM, ABOUT 4762 03:39:42,543 --> 03:39:47,348 75% MORE TOWARDS THE HIGH 4763 03:39:47,348 --> 03:39:47,915 PERFORMANCE PORTFOLIO. 4764 03:39:47,915 --> 03:39:50,251 SO, I WANTED TO TALK ABOUT BEST 4765 03:39:50,251 --> 03:39:51,619 PRACTICES FOR A SECOND. 4766 03:39:51,619 --> 03:39:53,588 BECAUSE ONE OF THE THINGS WE 4767 03:39:53,588 --> 03:39:56,658 REALIZED IN GOING THROUGH THIS 4768 03:39:56,658 --> 03:39:58,092 PROCESS IS THAT WE SAW CERTAIN 4769 03:39:58,092 --> 03:39:59,260 THINGS WOULD HAPPEN AGAIN AND 4770 03:39:59,260 --> 03:40:00,495 AGAIN AND AGAIN. 4771 03:40:00,495 --> 03:40:02,463 WE REACHED THE POINT AFTER 4772 03:40:02,463 --> 03:40:04,365 MAKING THE 87 MODELS AND TESTING 4773 03:40:04,365 --> 03:40:05,867 THEM AND TRYING TO DECIDE WHICH 4774 03:40:05,867 --> 03:40:08,202 IS THE BEST THAT WE NEEDED TO 4775 03:40:08,202 --> 03:40:09,737 CAPTURE THIS INFORMATION. 4776 03:40:09,737 --> 03:40:14,776 SO, WE DECIDED WE WOULD BUILD A 4777 03:40:14,776 --> 03:40:16,611 BEST PRACTICES DOCUMENT. 4778 03:40:16,611 --> 03:40:18,312 THERE WEREN'T -- THERE AREN'T 4779 03:40:18,312 --> 03:40:19,380 GUIDELINES OR STANDARDS IN THE 4780 03:40:19,380 --> 03:40:22,083 SPACE SO WE WANTED TO BUILD 4781 03:40:22,083 --> 03:40:22,350 SOMETHING. 4782 03:40:22,350 --> 03:40:24,052 AND THERE WAS A LOT OF THINGS WE 4783 03:40:24,052 --> 03:40:25,787 LEARNED IN THIS PROCESS. 4784 03:40:25,787 --> 03:40:27,855 WE KNEW THAT IF THIS PROGRAM 4785 03:40:27,855 --> 03:40:31,025 ENDED, WE WOULD LOSE AULD OF 4786 03:40:31,025 --> 03:40:31,559 THAT. 4787 03:40:31,559 --> 03:40:33,995 WE WANTED TO CAPTURE THAT, 4788 03:40:33,995 --> 03:40:35,596 LEVERAGE LEARNING AND EXPERIENCE 4789 03:40:35,596 --> 03:40:36,497 FROM RADx TECH ACCESSIBILITY 4790 03:40:36,497 --> 03:40:40,535 FOR CURRENT AND FUTURE TESTS, 4791 03:40:40,535 --> 03:40:43,438 THE TARGET AUDIENCE HERE WAS THE 4792 03:40:43,438 --> 03:40:44,005 COMMERCIAL MANUFACTURERS AND 4793 03:40:44,005 --> 03:40:46,174 DESIGNERS, IT WAS NOT DIRECTLY 4794 03:40:46,174 --> 03:40:48,142 RELATED TO ADVOCACY GROUPS 4795 03:40:48,142 --> 03:40:49,677 BECAUSE WE WANTED TO FIND AN 4796 03:40:49,677 --> 03:40:52,447 EASY WAY TO HELP MANUFACTURERS 4797 03:40:52,447 --> 03:40:53,681 GET IT RIGHT. 4798 03:40:53,681 --> 03:40:56,284 SO AN EXAMPLE OF WHAT THE FORMAT 4799 03:40:56,284 --> 03:40:56,517 IS. 4800 03:40:56,517 --> 03:41:00,855 ON THE LEFT-HAND SIDE IT HAS AN 4801 03:41:00,855 --> 03:41:02,190 ISSUE OF TYPICAL IMPLEMENTATION. 4802 03:41:02,190 --> 03:41:05,460 ON THE RIGHT-HAND SIDE AN 4803 03:41:05,460 --> 03:41:05,827 IMPLEMENTATION. 4804 03:41:05,827 --> 03:41:08,896 THIS IS COMMON ON THE LEFT WHERE 4805 03:41:08,896 --> 03:41:10,331 THE TAMPER SEAL IS CLEAR, YOU 4806 03:41:10,331 --> 03:41:11,165 CAN'T SEE IT. 4807 03:41:11,165 --> 03:41:12,600 IT MAY BE HARD TO OPEN. 4808 03:41:12,600 --> 03:41:14,569 YOU MAY NEED A TOOL, IT MAY BE 4809 03:41:14,569 --> 03:41:17,572 SHARP, WHICH IS WORSE IN A 4810 03:41:17,572 --> 03:41:18,206 DISABLED COMMUNITY. 4811 03:41:18,206 --> 03:41:19,073 THE RIGHT-HAND SIDE RECOMMENDS 4812 03:41:19,073 --> 03:41:21,309 SOMETHING YOU CAN SEE THAT YOU 4813 03:41:21,309 --> 03:41:22,577 CAN REACH, PIAL AWAY. 4814 03:41:22,577 --> 03:41:26,214 THIS IS A SIMPLE EXAMPLE, 4815 03:41:26,214 --> 03:41:29,417 140-PAGE DOCUMENT OUTLINES HOW 4816 03:41:29,417 --> 03:41:32,787 TO GET IT RIGHT. 4817 03:41:32,787 --> 03:41:36,591 SO, WE DID -- THIS WAS PUBLISHED 4818 03:41:36,591 --> 03:41:37,625 IN JUNE 30, 2023. 4819 03:41:37,625 --> 03:41:41,763 THERE WAS A FIRST VERSION BEFORE 4820 03:41:41,763 --> 03:41:42,663 CHRISTMAS, WE WANTED TO GET 4821 03:41:42,663 --> 03:41:43,965 SOMETHING TO THE COMMUNITY SO 4822 03:41:43,965 --> 03:41:47,568 TEAMS COULD SEE PARTLY HOW TO 4823 03:41:47,568 --> 03:41:49,003 GET IT RIGHT. 4824 03:41:49,003 --> 03:41:50,972 WE MADE IT ACCESSIBLE IN FORMATS 4825 03:41:50,972 --> 03:41:53,508 SO THE ACCESSIBLE COMMUNITY 4826 03:41:53,508 --> 03:41:57,044 COULD SEE IT, HTML AND PDF. 4827 03:41:57,044 --> 03:41:59,313 1336 VISITS TO VIEW THAT 4828 03:41:59,313 --> 03:41:59,781 DOCUMENT. 4829 03:41:59,781 --> 03:42:04,485 AND WE HAD TWO WEBINARS ON BEST 4830 03:42:04,485 --> 03:42:04,986 PRACTICES, REGISTRATION 4831 03:42:04,986 --> 03:42:05,553 APPROACHED 300. 4832 03:42:05,553 --> 03:42:08,189 DISTRIBUTION YOU CAN SEE BELOW, 4833 03:42:08,189 --> 03:42:09,957 BROADLY DISTRIBUTED BY OUR 4834 03:42:09,957 --> 03:42:11,959 PARTNERS, OUR GOAL WAS TO GET IT 4835 03:42:11,959 --> 03:42:13,895 OUT TO MANUFACTURERS SO THEY 4836 03:42:13,895 --> 03:42:17,398 COULD SEE AND IT WAS PRETTY 4837 03:42:17,398 --> 03:42:18,266 BROADLY DISTRIBUTED. 4838 03:42:18,266 --> 03:42:21,569 IT HAS AN EXAMPLE ON THE RIGHT 4839 03:42:21,569 --> 03:42:22,870 OF READING LAYOUT WHERE -- I'LL 4840 03:42:22,870 --> 03:42:24,972 EXPLAIN TO YOU THE READING 4841 03:42:24,972 --> 03:42:32,747 FORMAT ON THE LEFT OF THAT 4842 03:42:32,747 --> 03:42:34,615 CHANGES FORMAT IN THE MIDDLE, 4843 03:42:34,615 --> 03:42:36,884 DOESN'T WORK WELL WITH ANY OF 4844 03:42:36,884 --> 03:42:37,852 THE ASSISTIVE TECHNOLOGIES 4845 03:42:37,852 --> 03:42:38,986 BECAUSE IT GOES ALL THE WAY 4846 03:42:38,986 --> 03:42:40,655 ACROSS AND BACK. 4847 03:42:40,655 --> 03:42:43,691 THE BEST WAY IS COLUMN FORMAT 4848 03:42:43,691 --> 03:42:46,627 MAKING THEM AS WIDE AS THE BREAK 4849 03:42:46,627 --> 03:42:48,429 POINT ON A FLAT BED SCANNER FOR 4850 03:42:48,429 --> 03:42:50,431 EXAMPLE TO USE OTHER ASSISTIVE 4851 03:42:50,431 --> 03:42:52,733 TECHNOLOGIES TO READ THIS. 4852 03:42:52,733 --> 03:42:55,036 IT HIGHLIGHTS THINGS LIKE THAT. 4853 03:42:55,036 --> 03:42:58,773 I WANTED TO TALK ABOUT OUR 4854 03:42:58,773 --> 03:42:59,106 COLLABORATION. 4855 03:42:59,106 --> 03:43:04,045 WE SPENT A LOT OF TIME WITH 4856 03:43:04,045 --> 03:43:05,446 ADVOCACY GROUPS. 4857 03:43:05,446 --> 03:43:06,581 WE COULD SOLICIT INPUT AND 4858 03:43:06,581 --> 03:43:08,649 EXPLAIN WHERE WE WERE IN MONTHLY 4859 03:43:08,649 --> 03:43:08,916 MEETINGS. 4860 03:43:08,916 --> 03:43:11,018 THERE'S A NUMBER OF THINGS, 4861 03:43:11,018 --> 03:43:12,453 HERE'S A FEW EXAMPLES. 4862 03:43:12,453 --> 03:43:14,689 AT ONE POINT IT WAS OFFERED THAT 4863 03:43:14,689 --> 03:43:17,024 THERE'S AN EXISTING TECHNOLOGY 4864 03:43:17,024 --> 03:43:20,862 USING RFID THAT IS ALREADY IN 4865 03:43:20,862 --> 03:43:22,930 USE FOR THE INDUSTRY, GOES WITH 4866 03:43:22,930 --> 03:43:24,465 THE PILL BOTTLE, GO TO THE 4867 03:43:24,465 --> 03:43:27,301 PHARMACY AND CAN PUT IT IN A 4868 03:43:27,301 --> 03:43:30,137 DEVICE AND WILL READ BACK THE 4869 03:43:30,137 --> 03:43:30,938 INSTRUCTIONS, THEY SUGGESTED 4870 03:43:30,938 --> 03:43:32,106 PERHAPS THAT'S AN ANSWER. 4871 03:43:32,106 --> 03:43:33,541 WE MET WITH COMPANIES THAT 4872 03:43:33,541 --> 03:43:34,842 MANUFACTURED THAT TECHNOLOGY TO 4873 03:43:34,842 --> 03:43:36,377 EXPLORE IT BECAUSE WE CURRENT 4874 03:43:36,377 --> 03:43:38,679 TAKE IT AT FACE VALUE AND FIGURE 4875 03:43:38,679 --> 03:43:40,214 OUT IMPLEMENTATION THAT FIT WITH 4876 03:43:40,214 --> 03:43:41,249 THE EXISTING INFRASTRUCTURE. 4877 03:43:41,249 --> 03:43:42,884 IT ENDED UP NOT TO BE THE CASE 4878 03:43:42,884 --> 03:43:45,086 BECAUSE YOU WANTED TO GO AT HOME 4879 03:43:45,086 --> 03:43:47,221 AND HEAR THE INSTRUCTIONS AT 4880 03:43:47,221 --> 03:43:49,724 HOME AND NOBODY HAS AN RFID 4881 03:43:49,724 --> 03:43:51,392 READER AT HOME. 4882 03:43:51,392 --> 03:43:54,295 THAT DIDN'T WORK OUT. 4883 03:43:54,295 --> 03:43:56,264 WE HAVE QUESTIONS AROUND 4884 03:43:56,264 --> 03:43:58,566 ASSISTIVE TECHNOLOGY, 4885 03:43:58,566 --> 03:43:59,367 PARTICULARLY BRAILLE DISPLAYS, 4886 03:43:59,367 --> 03:44:00,201 TRANSLATING WRITTEN INTO BRAILLE 4887 03:44:00,201 --> 03:44:03,170 FOR THE BLIND AS WELL AS 4888 03:44:03,170 --> 03:44:05,907 TECHNOLOGIES THAT DOES OCR AND 4889 03:44:05,907 --> 03:44:07,308 READS BACK, WHICH ARE CALLED 4890 03:44:07,308 --> 03:44:08,509 SCREEN READERS. 4891 03:44:08,509 --> 03:44:10,311 WE ASKED HOW BIGS, HOW MANY, HOW 4892 03:44:10,311 --> 03:44:11,779 OFTEN ARE THEY USED. 4893 03:44:11,779 --> 03:44:13,781 AND WE COULDN'T GET ACCURATE 4894 03:44:13,781 --> 03:44:17,184 RESULTS OR ANSWERS FROM THE 4895 03:44:17,184 --> 03:44:18,619 GROUPS SO WE MET WITH 4896 03:44:18,619 --> 03:44:20,788 MANUFACTURERS AS WELL TO SIZE 4897 03:44:20,788 --> 03:44:22,757 THE MARKET, WHO HAD THEM, HOW 4898 03:44:22,757 --> 03:44:24,392 MANY HAD THEM, WAS THIS 4899 03:44:24,392 --> 03:44:27,728 SOMETHING, HOW TO PUSH THIS. 4900 03:44:27,728 --> 03:44:31,299 AND THERE'S SURPRISING RESULTS. 4901 03:44:31,299 --> 03:44:34,368 ONE WAS THAT OFTENTIMES BRAILLE 4902 03:44:34,368 --> 03:44:35,569 IS CONSIDERED A GOOD SOLUTION 4903 03:44:35,569 --> 03:44:36,971 FOR THE BLIND COMMUNITY. 4904 03:44:36,971 --> 03:44:39,073 IT ENDS UP 10% OF THE BLIND 4905 03:44:39,073 --> 03:44:40,608 COMMUNITY CAN ACTUALLY READ 4906 03:44:40,608 --> 03:44:41,709 BRAILLE SO IT'S A RELATIVELY 4907 03:44:41,709 --> 03:44:42,576 SMALL GROUP. 4908 03:44:42,576 --> 03:44:47,114 IT'S A VERY LARGE FORMAT, A 4909 03:44:47,114 --> 03:44:48,416 QUARTER INCH PER SQUARE CARE. 4910 03:44:48,416 --> 03:44:51,185 IF YOU TAKE A QRI FOR 4911 03:44:51,185 --> 03:44:53,220 INSTRUCTION, WALL PAPER, IF YOU 4912 03:44:53,220 --> 03:44:55,957 LOOK AT SCREEN READERS, WE SPOKE 4913 03:44:55,957 --> 03:45:00,895 WITH THEM AND LEARNED THAT THE 4914 03:45:00,895 --> 03:45:01,662 UNEMPLOYMENT RATE, SCREEN 4915 03:45:01,662 --> 03:45:03,331 READERS ARE HUNDREDS TO 4916 03:45:03,331 --> 03:45:04,632 THOUSANDS OF DOLLARS, SEVERAL 4917 03:45:04,632 --> 03:45:06,467 THOUSANDS FOR THE NICE ONES. 4918 03:45:06,467 --> 03:45:07,568 AND THE TECHNOLOGY IS COOL AND 4919 03:45:07,568 --> 03:45:09,770 YOU CAN ADD THINGS AND HOOK UP 4920 03:45:09,770 --> 03:45:11,138 THINGS, ALL THIS IS POSSIBLE BUT 4921 03:45:11,138 --> 03:45:13,574 THE UNEMPLOYMENT RATE IN THE 4922 03:45:13,574 --> 03:45:14,675 BLINDNESS COMMUNITY IS AROUND 4923 03:45:14,675 --> 03:45:16,877 75%, AND SO THE ABILITY TO 4924 03:45:16,877 --> 03:45:18,179 AFFORD TECHNOLOGY BECOMES AN 4925 03:45:18,179 --> 03:45:20,481 EVEN BIGGER CHALLENGE AND FOCUS 4926 03:45:20,481 --> 03:45:21,248 ON COST. 4927 03:45:21,248 --> 03:45:22,984 WE LEARNED OTHER THINGS GOING 4928 03:45:22,984 --> 03:45:24,618 THROUGH THE PROCESS. 4929 03:45:24,618 --> 03:45:25,853 WE TALKED TO THE NATIONAL 4930 03:45:25,853 --> 03:45:27,288 LIBRARY SERVICE TO UNDERSTAND 4931 03:45:27,288 --> 03:45:28,723 WHAT THE FEDERAL GOVERNMENT WAS 4932 03:45:28,723 --> 03:45:30,992 DOING BECAUSE IT FLOATS DOWN TO 4933 03:45:30,992 --> 03:45:35,496 STATE LIBRARIES IN TERMS OF 4934 03:45:35,496 --> 03:45:36,397 DISSEMINATION OF FREE 4935 03:45:36,397 --> 03:45:37,465 ACCESSIBILITY TECHNOLOGY TO SEE 4936 03:45:37,465 --> 03:45:40,534 WHERE THEY WERE, WHICH IS VERY 4937 03:45:40,534 --> 03:45:42,970 LARGE INITIATIVE BUT IT'S 4938 03:45:42,970 --> 03:45:44,705 SOMEWHAT FRAGMENTED IN 4939 03:45:44,705 --> 03:45:45,072 IMPLEMENTATION. 4940 03:45:45,072 --> 03:45:46,741 WE INDIVIDUALLY MET WITH 4941 03:45:46,741 --> 03:45:47,875 ORGANIZATIONS TO UNDERSTAND 4942 03:45:47,875 --> 03:45:48,709 THEIR INTERESTS, ALSO RESOURCES 4943 03:45:48,709 --> 03:45:54,315 THEY COULD BRING TO BEAR TO HELP 4944 03:45:54,315 --> 03:45:56,283 US AND IMPORTANTLY AS WE DID 4945 03:45:56,283 --> 03:45:59,487 BEST PRACTICES AND THINGS TO GET 4946 03:45:59,487 --> 03:46:01,355 OUT, WE ESTABLISHED REGULAR 4947 03:46:01,355 --> 03:46:02,523 MARKETING COMMUNICATIONS 4948 03:46:02,523 --> 03:46:03,657 MEETINGS WITH MARKETING 4949 03:46:03,657 --> 03:46:05,059 COMMUNICATION TEAMS FROM THE 4950 03:46:05,059 --> 03:46:07,995 ADVOCACY GROUPS MEET WITH OUR 4951 03:46:07,995 --> 03:46:09,430 TEAM TO FIGURE OUT STRATEGIES, 4952 03:46:09,430 --> 03:46:10,965 WHAT THEY COULD SAY, WHERE THEY 4953 03:46:10,965 --> 03:46:12,933 COULD SAY IT, ET CETERA. 4954 03:46:12,933 --> 03:46:14,368 AND THEN OF COURSE THEY WERE 4955 03:46:14,368 --> 03:46:16,103 CONNECTING US ALL ALONG WITH 4956 03:46:16,103 --> 03:46:17,304 OTHER RESOURCES IN THEIR NETWORK 4957 03:46:17,304 --> 03:46:20,608 BECAUSE THEY WERE THERE AND I 4958 03:46:20,608 --> 03:46:22,109 CAN SAY WITHOUT THEM IT WOULD 4959 03:46:22,109 --> 03:46:23,544 HAVE TAKEN MUCH LONGER AND I'M 4960 03:46:23,544 --> 03:46:25,746 NOT SURE WE COULD HAVE GOTTEN TO 4961 03:46:25,746 --> 03:46:31,752 WHERE WE GOT TO IN THIS PROCESS 4962 03:46:31,752 --> 03:46:33,554 THEY WORKED IN THEIR COMMUNITIES 4963 03:46:33,554 --> 03:46:35,389 TO PUSH OUR MESSAGE. 4964 03:46:35,389 --> 03:46:38,325 THEY HAVE HAD MEETINGS, WE'VE 4965 03:46:38,325 --> 03:46:39,093 MED WITH GOOGLE, MICROSOFT, 4966 03:46:39,093 --> 03:46:42,063 AROUND A.I. AND OTHER 4967 03:46:42,063 --> 03:46:44,765 TECHNOLOGIES THAT MIGHT BE 4968 03:46:44,765 --> 03:46:48,069 ASSISTIVE IN THIS SPACE AND GOT 4969 03:46:48,069 --> 03:46:49,804 MIXED RESULTS, SOME LUKEWARM, 4970 03:46:49,804 --> 03:46:51,305 SOME PLAIN COLD. 4971 03:46:51,305 --> 03:46:52,773 THEY ALSO HAVE MEETINGS, VERY 4972 03:46:52,773 --> 03:46:54,408 LARGE MEETINGS WITH THOSE 4973 03:46:54,408 --> 03:46:55,843 GROUPS, AND THEY PUSHED THE 4974 03:46:55,843 --> 03:46:57,511 AGENDA THAT WE WERE ON WITH 4975 03:46:57,511 --> 03:46:59,980 THOSE GROUPS AS WELL TO HELP US 4976 03:46:59,980 --> 03:47:05,586 IN THAT SPACE SO THAT WAS 4977 03:47:05,586 --> 03:47:07,021 SOMEWHAT UNIQUE. 4978 03:47:07,021 --> 03:47:08,322 AT FIRST BLUSH THEY TELL YOU 4979 03:47:08,322 --> 03:47:11,058 WHAT TO DO AND BUILD A PRODUCT. 4980 03:47:11,058 --> 03:47:12,393 IF YOU BUILT PRODUCT BEFORE 4981 03:47:12,393 --> 03:47:13,694 THAT'S NOT HOW IT WORKS EXACTLY. 4982 03:47:13,694 --> 03:47:15,896 THIS IS A BALANCING ACT, 4983 03:47:15,896 --> 03:47:19,300 BALANCING STAKEHOLDERS. 4984 03:47:19,300 --> 03:47:21,135 WE HAVE ADVOCACY GROUPS, AND FDA 4985 03:47:21,135 --> 03:47:23,337 WANTS IT TO BE SAFE AND 4986 03:47:23,337 --> 03:47:24,772 EFFECTIVE, AND COMPANIES HAVE TO 4987 03:47:24,772 --> 03:47:27,908 BE -- IT HAS TO BE PROFITABLE AT 4988 03:47:27,908 --> 03:47:29,076 SOME LEVEL, SUSTAINABLE, ET 4989 03:47:29,076 --> 03:47:29,310 CETERA. 4990 03:47:29,310 --> 03:47:30,478 WE'RE TRYING TO BALANCE 4991 03:47:30,478 --> 03:47:33,681 INTERESTS TO SOME UP WITH 4992 03:47:33,681 --> 03:47:36,717 SOLUTIONS ACCEPTABLE TO GROUPS 4993 03:47:36,717 --> 03:47:38,018 AND OTHER STAKEHOLDERS. 4994 03:47:38,018 --> 03:47:40,921 SO THE TAKEAWAYS FROM THE 4995 03:47:40,921 --> 03:47:42,756 PROGRAM TO DATE, I THINK AS 4996 03:47:42,756 --> 03:47:43,090 FOLLOWS. 4997 03:47:43,090 --> 03:47:44,925 THERE REALLY AREN'T GOOD 4998 03:47:44,925 --> 03:47:47,728 STANDARDS FOR MANY OF THE AREAS 4999 03:47:47,728 --> 03:47:51,765 THAT ARE ADDRESSED IN 5000 03:47:51,765 --> 03:47:52,633 ACCESSIBILITY. 5001 03:47:52,633 --> 03:47:54,435 THIS STUFF ISN'T TECHNICALLY 5002 03:47:54,435 --> 03:47:56,504 HARD BUT IT'S NUANCED. 5003 03:47:56,504 --> 03:47:58,539 YOU HAVE TO KNOW HOW TO APPROACH 5004 03:47:58,539 --> 03:47:58,772 IT. 5005 03:47:58,772 --> 03:48:00,941 YOU CAN'T JUST SAY LET'S BUILD 5006 03:48:00,941 --> 03:48:03,010 ONE AND WE'RE ACCESSIBLE AND 5007 03:48:03,010 --> 03:48:05,779 PUTTING ON GOGGLES AND MITTENS 5008 03:48:05,779 --> 03:48:10,351 WON'T MAKE YOU BLIND AND HAVE 5009 03:48:10,351 --> 03:48:11,585 ARTHRITIS. 5010 03:48:11,585 --> 03:48:14,321 IT'S NUANCE AND TAKES WORK. 5011 03:48:14,321 --> 03:48:15,523 THE ADVOCACY GROUP SUPPORT WAS 5012 03:48:15,523 --> 03:48:17,591 ESSENTIAL FOR OUR SUCCESS, GAVE 5013 03:48:17,591 --> 03:48:19,160 US CONTEXT, THEY GAVE US 5014 03:48:19,160 --> 03:48:21,028 QUESTIONS, THEY GAVE US LEADS. 5015 03:48:21,028 --> 03:48:22,463 THEY HELPED -- WE HAD 5016 03:48:22,463 --> 03:48:24,331 DISCUSSIONS WITH POLICY PEOPLE 5017 03:48:24,331 --> 03:48:27,168 THAT BROUGHT US INTO OTHER 5018 03:48:27,168 --> 03:48:28,135 AGENCIES, ET CETERA. 5019 03:48:28,135 --> 03:48:30,804 IT WAS CRITICAL TO INVOLVE THE 5020 03:48:30,804 --> 03:48:31,772 ACCESSIBILITY POPULATION AS WELL 5021 03:48:31,772 --> 03:48:32,740 IN THESE. 5022 03:48:32,740 --> 03:48:37,778 WE HAD TO DIRECTLY INVOLVE THAT 5023 03:48:37,778 --> 03:48:38,212 POPULATION. 5024 03:48:38,212 --> 03:48:40,681 THE GENERAL ARGUMENT FOR THE 5025 03:48:40,681 --> 03:48:41,815 ENHANCEMENTS, YOU SAW IN THE 5026 03:48:41,815 --> 03:48:43,350 SECOND SLIDE A NUMBER OF 5027 03:48:43,350 --> 03:48:48,189 DIFFERENTED ADVOCACY GROUPS WE 5028 03:48:48,189 --> 03:48:50,257 MET WITH. 5029 03:48:50,257 --> 03:48:51,492 WITH DISABILITIES IN GENERAL, 5030 03:48:51,492 --> 03:48:53,994 NATIONAL FEDERATION OF THE 5031 03:48:53,994 --> 03:48:57,164 BLIND, DIFFERENT INTERESTS THAT 5032 03:48:57,164 --> 03:49:00,367 OVERLAP HEAVILY BUT NOT 5033 03:49:00,367 --> 03:49:01,335 COMPLETELY, ARGUING IMPROVING 5034 03:49:01,335 --> 03:49:02,536 PRODUCTS FOR ONE IMPROVES FOR 5035 03:49:02,536 --> 03:49:05,272 ALL AND IN GENERAL THAT 5036 03:49:05,272 --> 03:49:06,607 PRINCIPLE APPLIES FOR ALL OF US 5037 03:49:06,607 --> 03:49:10,544 THAT IF IT'S EASIER TO OPEN A 5038 03:49:10,544 --> 03:49:12,613 BOX FOR THEM EASIER FOR US AS 5039 03:49:12,613 --> 03:49:16,150 WELL, TO READ LABELS, RIGHT 5040 03:49:16,150 --> 03:49:17,351 CONTRAST RATIOS, FONT SIZE, ET 5041 03:49:17,351 --> 03:49:17,585 CETERA. 5042 03:49:17,585 --> 03:49:20,287 OVERALL THIS IS A BEACH HEAD 5043 03:49:20,287 --> 03:49:22,823 OPPORTUNITY TO HELP START IN A 5044 03:49:22,823 --> 03:49:26,627 PLACE TO RAISE AWARENESS OF 5045 03:49:26,627 --> 03:49:27,695 ACCESSIBILITY AND THEN 5046 03:49:27,695 --> 03:49:28,229 POSSIBILITIES BECOME MUCH 5047 03:49:28,229 --> 03:49:30,731 GREATER AS WE LOOK AT MEDICAL 5048 03:49:30,731 --> 03:49:34,034 DEVICES IN GENERAL. 5049 03:49:34,034 --> 03:49:34,568 THANK YOU. 5050 03:49:34,568 --> 03:49:42,076 [APPLAUSE] 5051 03:49:42,076 --> 03:49:43,077 >> I'M GOING TO LOOK TO THE 5052 03:49:43,077 --> 03:49:44,712 CHAIR, DO WE HAVE A COUPLE 5053 03:49:44,712 --> 03:49:46,146 MINUTES FOR QUESTIONS OR SHOULD 5054 03:49:46,146 --> 03:49:47,014 WE MOVE ON? 5055 03:49:47,014 --> 03:49:47,681 A FEW MINUTES. 5056 03:49:47,681 --> 03:49:51,485 IF YOU WANT TO HAVE ANY 5057 03:49:51,485 --> 03:49:52,720 QUESTIONS, I'LL HAVE A 5058 03:49:52,720 --> 03:49:54,421 PREROGATIVE TO ASK A QUESTION AS 5059 03:49:54,421 --> 03:49:55,823 PEOPLE ARE COMING UP. 5060 03:49:55,823 --> 03:50:02,730 RAPID FIRE SESSION, I DID NOT 5061 03:50:02,730 --> 03:50:03,264 PREPARE. 5062 03:50:03,264 --> 03:50:07,868 BLANK CHECK, RADx TECH, FILL 5063 03:50:07,868 --> 03:50:10,170 IN THE BLANK, WHAT'S OUR NEXT 5064 03:50:10,170 --> 03:50:12,172 HOT TOPIC TO FOCUS ON UNLIMITED 5065 03:50:12,172 --> 03:50:14,275 SUMS AND WHO WOULD YOU WANT TO 5066 03:50:14,275 --> 03:50:16,110 PARTNER WITH TO DO IT? 5067 03:50:16,110 --> 03:50:21,815 ANY QUESTIONS FROM THE AUDIENCE 5068 03:50:21,815 --> 03:50:23,350 IN THE MEANTIME? 5069 03:50:23,350 --> 03:50:23,550 OKAY. 5070 03:50:23,550 --> 03:50:27,121 LEAD US OFF. 5071 03:50:27,121 --> 03:50:29,590 >> I'M A SHY PERSON. 5072 03:50:29,590 --> 03:50:31,892 NIH CANNOT DISCLOSE ANY PLANNING 5073 03:50:31,892 --> 03:50:36,063 BEFORE IT'S PUBLIC. 5074 03:50:36,063 --> 03:50:38,832 BUT DEFINITELY POLITICALLY 5075 03:50:38,832 --> 03:50:40,801 CORRECT ANSWER, ANY GROUPS, ANY 5076 03:50:40,801 --> 03:50:43,304 OF THE GROUPS OR ORGANIZATIONS 5077 03:50:43,304 --> 03:50:47,708 THAT ARE IN THIS SPACE, TALKING 5078 03:50:47,708 --> 03:50:50,744 ABOUT THE HEALTH CARE WILL BE A 5079 03:50:50,744 --> 03:50:52,179 PERFECT PARTNER. 5080 03:50:52,179 --> 03:50:58,652 WE NEED TO BREAK THOSE BARRIERS 5081 03:50:58,652 --> 03:51:00,721 PREVENTING INDIVIDUALS BEFORE, 5082 03:51:00,721 --> 03:51:02,923 DURING AND AFTER DELIVERY TO GET 5083 03:51:02,923 --> 03:51:05,793 ACCESS TO QUALITY CARE AND TO 5084 03:51:05,793 --> 03:51:07,961 REDUCE MORBIDITY AND MORTALITY. 5085 03:51:07,961 --> 03:51:12,966 SO I WOULD SAY ANY OF 5086 03:51:12,966 --> 03:51:15,703 STAKEHOLDERS WILLING TO 5087 03:51:15,703 --> 03:51:17,471 PARTICIPATE IN ANY FUTURE 5088 03:51:17,471 --> 03:51:21,141 ITERATION OF SUCH AN ENDEAVOR IS 5089 03:51:21,141 --> 03:51:24,244 WELCOME BECAUSE WE A COMMON GOAL 5090 03:51:24,244 --> 03:51:25,245 AT STAKE. 5091 03:51:25,245 --> 03:51:27,014 >> I ASSUME NIBIB IS PART OF 5092 03:51:27,014 --> 03:51:29,616 YOUR DREAM TEAM. 5093 03:51:29,616 --> 03:51:29,983 >> ABSOLUTELY. 5094 03:51:29,983 --> 03:51:34,054 >> JUST MAKING SURE. 5095 03:51:34,054 --> 03:51:38,325 >> I THINK TACKLING HEALTH CARE 5096 03:51:38,325 --> 03:51:40,861 ACCESSIBILITY WOULD BE A DREAM. 5097 03:51:40,861 --> 03:51:43,931 THERE ARE -- YOU MENTIONED FOR 5098 03:51:43,931 --> 03:51:46,433 MATERNAL HEALTH THERE ARE 5099 03:51:46,433 --> 03:51:48,235 DESERTS, PEOPLE LACK RESOURCES 5100 03:51:48,235 --> 03:51:50,904 AND ACCESS TO HEALTH CARE. 5101 03:51:50,904 --> 03:51:52,573 AND POINT OF CARE TECHNOLOGY IS 5102 03:51:52,573 --> 03:51:55,309 ONE OF THE WAYS TO ADDRESS THAT. 5103 03:51:55,309 --> 03:51:59,780 AND SO I'M LEAVING IT KIND OF 5104 03:51:59,780 --> 03:52:03,083 OPEN AS TO WHAT EXACT DISEASE I 5105 03:52:03,083 --> 03:52:04,952 WOULD FOCUS ON, MOSTLY BECAUSE I 5106 03:52:04,952 --> 03:52:08,422 THINK THERE ARE SO MANY AND JUST 5107 03:52:08,422 --> 03:52:09,957 INCREASING ACCESS TO PRIMARY 5108 03:52:09,957 --> 03:52:14,027 CARE, AND OTHER TYPES OF HEALTH 5109 03:52:14,027 --> 03:52:20,501 CARE WOULD BE REALLY IMPACTFUL. 5110 03:52:20,501 --> 03:52:23,771 >> SO, MAYBE I THINK ABOUT IT 5111 03:52:23,771 --> 03:52:24,538 DIFFERENTLY, MORE HORIZONTALLY. 5112 03:52:24,538 --> 03:52:28,142 I THINK SOME OF THE INITIATIVES 5113 03:52:28,142 --> 03:52:30,778 WE'VE UNDERTAKEN LIKE 5114 03:52:30,778 --> 03:52:31,578 ACCESSIBILITY AND OTHERS MIGHT 5115 03:52:31,578 --> 03:52:35,048 BE ABLE TO BE APPLIED ACROSS 5116 03:52:35,048 --> 03:52:36,049 MULTIPLE TECHNOLOGY TYPES, AND I 5117 03:52:36,049 --> 03:52:38,252 THINK THAT COULD BE IMPACTFUL. 5118 03:52:38,252 --> 03:52:39,653 WE'VE DONE IT. 5119 03:52:39,653 --> 03:52:40,754 AND WE KNOW WHAT RESOURCES ARE 5120 03:52:40,754 --> 03:52:43,090 AND WHAT IT TAKES TO DRIVE THAT 5121 03:52:43,090 --> 03:52:44,825 SO IT BECOMES FAIRLY WELL 5122 03:52:44,825 --> 03:52:45,759 CHARACTERIZED DEPENDING HOW FAR 5123 03:52:45,759 --> 03:52:46,794 YOU WANT TO GO. 5124 03:52:46,794 --> 03:52:54,368 I WOULD PERHAPS THINK ABOUT 5125 03:52:54,368 --> 03:52:54,601 THAT. 5126 03:52:54,601 --> 03:52:56,103 >> I SEE NO OTHER QUESTIONS. 5127 03:52:56,103 --> 03:52:57,671 LET'S THANK OUR PANEL AND LET 5128 03:52:57,671 --> 03:52:59,540 THE NEXT GROUP COME UP. 5129 03:52:59,540 --> 03:53:00,174 THANK YOU VERY MUCH. 5130 03:53:00,174 --> 03:53:02,543 [APPLAUSE] 5131 03:53:02,543 --> 03:53:08,515 5132 03:53:08,515 --> 03:53:18,559 5133 03:53:50,858 --> 03:53:52,292 >> FEDERAL AND NON-FEDERAL 5134 03:53:52,292 --> 03:53:57,865 RESOURCES FOR INVESTORS, WITH A 5135 03:53:57,865 --> 03:53:59,733 DISTINGUISHED PANEL, BRIEF 5136 03:53:59,733 --> 03:54:00,634 INTRODUCTIONS, BOB STOREY 5137 03:54:00,634 --> 03:54:02,936 MANAGING PARTNER OF A BALTIMORE 5138 03:54:02,936 --> 03:54:04,137 VENTURE DEVELOPMENT COMPANY, MED 5139 03:54:04,137 --> 03:54:10,577 TECH COMPANIES AND TRAIN EARLY 5140 03:54:10,577 --> 03:54:13,313 MANUFACTURING STAGES. 5141 03:54:13,313 --> 03:54:18,685 FIELD OF CARDIOLOGY, SURGERY, 5142 03:54:18,685 --> 03:54:19,887 HEMODIALYSIS, VICE CHAIR FOR 5143 03:54:19,887 --> 03:54:22,623 MARYLAND LITHE SCIENCE ADVISORY 5144 03:54:22,623 --> 03:54:26,894 BOARD, EXECUTIVE IN RESIDENCE AT 5145 03:54:26,894 --> 03:54:27,561 HOPKINS. 5146 03:54:27,561 --> 03:54:29,162 WITHIN NIH PORTFOLIO EXECUTIVE 5147 03:54:29,162 --> 03:54:31,698 FOR RADx, BLUEPRINT MED TECH 5148 03:54:31,698 --> 03:54:34,434 INITIATIVE, LEAD INSTRUCTOR FOR 5149 03:54:34,434 --> 03:54:44,077 I-CORPS AT NIH. 5150 03:54:44,077 --> 03:54:46,847 LED INTERNATIONAL COHORTS. 5151 03:54:46,847 --> 03:54:51,919 NEXT TO BOB IS CHRIS SASIELA, 5152 03:54:51,919 --> 03:54:54,321 WORKED AROUND NIH SINCE POSTDOC 5153 03:54:54,321 --> 03:55:01,228 AT NIH, EXTRAMURAL IN 2012, 5154 03:55:01,228 --> 03:55:02,329 REGULATORY SPECIALIST AT NHLBI 5155 03:55:02,329 --> 03:55:03,964 BEFORE BECOMING A MEMBER OF THE 5156 03:55:03,964 --> 03:55:07,034 SEED OFFICE, DIRECTOR OF 5157 03:55:07,034 --> 03:55:08,235 INNOVATION AND SUPPORT SERVICES, 5158 03:55:08,235 --> 03:55:10,537 VARIETY OF PROGRAMMING TO 5159 03:55:10,537 --> 03:55:15,809 EDUCATION AND ENABLE NIH-FUNDED 5160 03:55:15,809 --> 03:55:17,044 INNOVATION, BUSINESS STRATEGY, 5161 03:55:17,044 --> 03:55:17,778 REIMBURSEMENT, REGULATORY 5162 03:55:17,778 --> 03:55:21,114 AFFAIRS, THINGS YOU STARTUPS 5163 03:55:21,114 --> 03:55:27,621 MIGHT BE INTERESTED IN. 5164 03:55:27,621 --> 03:55:30,357 REBEKAH NEAL JOINED VENTURE WELL 5165 03:55:30,357 --> 03:55:34,528 IN 2012, MED TECH AND 5166 03:55:34,528 --> 03:55:35,495 DIAGNOSTIC, CHALLENGE 5167 03:55:35,495 --> 03:55:36,196 ADMINISTRATION, BOARD 5168 03:55:36,196 --> 03:55:39,166 ADMINISTRATION, TEAM THERE WHICH 5169 03:55:39,166 --> 03:55:40,834 SUPPORTS SEVERAL NIH ACTIVITIES 5170 03:55:40,834 --> 03:55:45,505 OUT OF NIBIB, INCLUDING RADx, 5171 03:55:45,505 --> 03:55:47,708 THE COMMERCIALIZATION CENTER, 5172 03:55:47,708 --> 03:55:49,109 AND AWARD MANAGEMENT, DESIGN -- 5173 03:55:49,109 --> 03:55:52,646 PART OF OUR DEBUT CHALLENGE FOR 5174 03:55:52,646 --> 03:55:54,715 UNDERGRADUATES WITH FOCUS ON 5175 03:55:54,715 --> 03:56:01,722 ADVANCING ENTREPRENEURSHIP AND 5176 03:56:01,722 --> 03:56:07,394 SCIENCE TECHNOLOGY, WAS A 5177 03:56:07,394 --> 03:56:09,162 PROGRAM MANAGER AT BILL AND 5178 03:56:09,162 --> 03:56:12,466 MELINDA GATES FOUNDATION. 5179 03:56:12,466 --> 03:56:14,334 LAST IS KARI ASHMONT, 5180 03:56:14,334 --> 03:56:18,605 TRANSLATION TEAM AT NIBIB, CAME 5181 03:56:18,605 --> 03:56:24,845 TO US IN 2022, MANAGES SMALL 5182 03:56:24,845 --> 03:56:29,349 BUSINESS PROGRAM AND SUPPORTS 5183 03:56:29,349 --> 03:56:32,853 RADx PROGRAM, ESPECIALLY 5184 03:56:32,853 --> 03:56:34,588 MATERNAL HEALTH INITIATIVES, 5185 03:56:34,588 --> 03:56:36,823 BRAIN INITIATIVE AND JOINED NIH 5186 03:56:36,823 --> 03:56:40,394 IN 2017 AND PREVIOUSLY A PROGRAM 5187 03:56:40,394 --> 03:56:44,731 DIRECTOR AT NINDS, OVERSAW 5188 03:56:44,731 --> 03:56:46,533 TRANSLATIONAL AGREEMENTS AND RAN 5189 03:56:46,533 --> 03:56:48,935 BLUEPRINT FOR NEUROSCIENCE 5190 03:56:48,935 --> 03:56:50,604 INITIATIVE R25 TRAINING PROGRAM. 5191 03:56:50,604 --> 03:56:52,572 I HAVE A FEW SLIDES MYSELF. 5192 03:56:52,572 --> 03:56:53,840 WE'LL JUMP IN. 5193 03:56:53,840 --> 03:56:55,842 I'VE INSTRUCTED THEM TO TAKE TEN 5194 03:56:55,842 --> 03:56:57,811 MINUTES OR LESS SO WE'LL HAVE 20 5195 03:56:57,811 --> 03:57:03,717 MINUTES FOR QUESTIONS AND 5196 03:57:03,717 --> 03:57:03,950 ANSWERS. 5197 03:57:03,950 --> 03:57:05,585 THIS IS A GREAT PANEL TO ANSWER 5198 03:57:05,585 --> 03:57:06,920 QUESTIONS HOW TO TAKE THE FIRST 5199 03:57:06,920 --> 03:57:09,656 STEPS OUT OF THE LAB AND INTO 5200 03:57:09,656 --> 03:57:14,528 STARTING TO DEVELOP PRODUCTS AND 5201 03:57:14,528 --> 03:57:15,595 EVENTUALLY GETTING TO MARKET. 5202 03:57:15,595 --> 03:57:18,865 SO THE THINGS YOU NEED TO GET TO 5203 03:57:18,865 --> 03:57:20,400 MARKET ARE MONEY, ASSISTANCE, 5204 03:57:20,400 --> 03:57:21,368 AND LUCK. 5205 03:57:21,368 --> 03:57:25,338 WE'RE ONLY COVERING THE MIDDLE 5206 03:57:25,338 --> 03:57:31,244 GROUND HERE, CHRIS AND KARI 5207 03:57:31,244 --> 03:57:33,080 WILL TALK ABOUT FEDERAL THINGS. 5208 03:57:33,080 --> 03:57:36,083 I'LL GIVE NOTES ABOUT FEDERAL 5209 03:57:36,083 --> 03:57:39,653 GRANTS BUT THERE'S PRIVATE 5210 03:57:39,653 --> 03:57:40,454 CAPITAL. 5211 03:57:40,454 --> 03:57:41,688 POCTRN ISSUES SOLICITATIONS. 5212 03:57:41,688 --> 03:57:45,125 WE HAVE NOT POSTED FOR 2023, 5213 03:57:45,125 --> 03:57:46,693 RECENTLY RECOMPETED THE CENTERS. 5214 03:57:46,693 --> 03:57:52,299 BLUEPRINT MED TECH, MY BABY, 5215 03:57:52,299 --> 03:57:54,534 WITH NICK LANGHAUL AND SEVERAL 5216 03:57:54,534 --> 03:57:56,603 OTHERS, HE'S HERE IF YOU WANT TO 5217 03:57:56,603 --> 03:58:00,006 ASK ABOUT DEVICES THAT INTERSECT 5218 03:58:00,006 --> 03:58:00,674 BETWEEN DIAGNOSTICS AND 5219 03:58:00,674 --> 03:58:05,712 DISORDERS OF THE NERVOUS 5220 03:58:05,712 --> 03:58:06,613 SYSTEMS. 5221 03:58:06,613 --> 03:58:09,216 ALSO REPRESENTED ARE REACH HUBS, 5222 03:58:09,216 --> 03:58:10,984 MORE REGIONAL FOCUSING ON STATES 5223 03:58:10,984 --> 03:58:15,789 AND REGIONS BUT CERTAINLY THE 5224 03:58:15,789 --> 03:58:16,356 SIMILAR INCUBATION-STYLE 5225 03:58:16,356 --> 03:58:16,723 PROGRAMS. 5226 03:58:16,723 --> 03:58:18,759 THE WORLD DOES NOT ENDS AT NIH'S 5227 03:58:18,759 --> 03:58:22,662 DOORS, OUR FRIENDS AT BARDA HAVE 5228 03:58:22,662 --> 03:58:24,397 AN ACCELERATOR NETWORK CURRENTLY 5229 03:58:24,397 --> 03:58:26,233 RECOMPETING, KEEP YOUR EYES 5230 03:58:26,233 --> 03:58:28,101 PEELED FOR HUBS SOLICITING AND 5231 03:58:28,101 --> 03:58:31,104 FUNDING PROJECTS IN THE IVD 5232 03:58:31,104 --> 03:58:33,373 SPACE. 5233 03:58:33,373 --> 03:58:37,978 THROUGH THE OTHER INVESTIGATOR 5234 03:58:37,978 --> 03:58:39,346 OPEN SOLICITATION, TAKE A LOOK 5235 03:58:39,346 --> 03:58:41,381 AT THE DRIVE WEBSITE. 5236 03:58:41,381 --> 03:58:48,188 AND OUR FRIENDS AT DTRA HAVE A 5237 03:58:48,188 --> 03:58:49,289 MENTOR PROTEGÉ PROGRAM TO 5238 03:58:49,289 --> 03:58:50,924 PARTNER WITH A LARGER 5239 03:58:50,924 --> 03:58:51,358 ORGANIZATION. 5240 03:58:51,358 --> 03:58:55,629 SO, PASSING THE BATON LET'S LOAD 5241 03:58:55,629 --> 03:59:02,469 BOB'S DECK AND MOVE FROM THERE. 5242 03:59:02,469 --> 03:59:05,272 >> THANK YOU, MICHAEL. 5243 03:59:05,272 --> 03:59:08,975 5244 03:59:08,975 --> 03:59:12,379 IT'S GOOD TO SEE SO MANY NIH 5245 03:59:12,379 --> 03:59:15,115 RADx AND NEUROTECH FRIENDS IN 5246 03:59:15,115 --> 03:59:15,816 THE AUDIENCE. 5247 03:59:15,816 --> 03:59:19,319 I'M REAL PLEASED TO BE HERE 5248 03:59:19,319 --> 03:59:19,553 TODAY. 5249 03:59:19,553 --> 03:59:21,955 AS MICHAEL MENTIONED, I SPEND A 5250 03:59:21,955 --> 03:59:25,859 LOT OF TIME IN INVESTMENT 5251 03:59:25,859 --> 03:59:26,893 COMMERCIALIZATION AND ECONOMIC 5252 03:59:26,893 --> 03:59:27,194 DEVELOPMENT. 5253 03:59:27,194 --> 03:59:29,863 AND SO I WANTED TO TALK ABOUT 5254 03:59:29,863 --> 03:59:31,665 SOME OF THE -- MAYBE TO SET THE 5255 03:59:31,665 --> 03:59:33,500 STAGE FOR A LOT OF RESOURCES 5256 03:59:33,500 --> 03:59:36,970 WE'RE GOING TO TALK ABOUT. 5257 03:59:36,970 --> 03:59:40,607 I WANT TO GIVE BACKGROUND, MAYBE 5258 03:59:40,607 --> 03:59:42,375 A LITTLE SETUP FOR SOME OF THE 5259 03:59:42,375 --> 03:59:43,677 ISSUES THAT THE PEOPLE FACE AS 5260 03:59:43,677 --> 03:59:45,679 THEY MOVE INTO THIS 5261 03:59:45,679 --> 03:59:46,313 TRANSLATIONAL PHASE. 5262 03:59:46,313 --> 03:59:48,515 MOST OF THE THINGS WE'RE GOING 5263 03:59:48,515 --> 03:59:51,051 TO TALK ABOUT ARE PRE-EQUITY 5264 03:59:51,051 --> 03:59:53,887 INVESTMENT, ALL THE PREPARATION 5265 03:59:53,887 --> 03:59:56,957 TO GET THROUGH, THE SUPPORT 5266 03:59:56,957 --> 03:59:59,559 NEEDED TO DEMONSTRATE TO THE 5267 03:59:59,559 --> 04:00:02,762 THIRD PARTY INVESTORS YOU HAVE A 5268 04:00:02,762 --> 04:00:05,065 STRAIGHT PATHWAY TO EVENTUAL 5269 04:00:05,065 --> 04:00:05,498 SUSTAINABILITY. 5270 04:00:05,498 --> 04:00:08,768 I LIKE TO START -- I THINK 5271 04:00:08,768 --> 04:00:09,769 I'M -- WITH INTRODUCTION. 5272 04:00:09,769 --> 04:00:12,539 THIS IS MY -- MY OFFICES ARE IN 5273 04:00:12,539 --> 04:00:13,540 DOWNTOWN BALTIMORE AT THE INNER 5274 04:00:13,540 --> 04:00:16,176 HARBOR, I LIVE IN ANNAPOLIS. 5275 04:00:16,176 --> 04:00:17,777 THAT'S THE NAVAL ACADEMY. 5276 04:00:17,777 --> 04:00:23,583 SO ALMOST ALL OF MY STORIES HAVE 5277 04:00:23,583 --> 04:00:24,885 A NAUTICAL THEME. 5278 04:00:24,885 --> 04:00:26,119 I'M A BOATER. 5279 04:00:26,119 --> 04:00:28,588 MOST TECHNOLOGIES WHEN THEY GO 5280 04:00:28,588 --> 04:00:33,093 THROUGH TRANSLATION INITIALLY 5281 04:00:33,093 --> 04:00:38,798 GO THROUGH A START-UP PHASE. 5282 04:00:38,798 --> 04:00:40,066 MOST STRATEGICS, MOST POTENTIAL 5283 04:00:40,066 --> 04:00:41,534 EXIT PARTNERS LIKE TO SEE THE 5284 04:00:41,534 --> 04:00:42,669 FIRST STEPS OF DEMONSTRATION 5285 04:00:42,669 --> 04:00:44,871 THROUGH A START-UP EVEN IN A 5286 04:00:44,871 --> 04:00:46,406 BRIEF PERIOD OF TIME, SO MANY OF 5287 04:00:46,406 --> 04:00:49,242 YOU GOING THROUGH THIS 5288 04:00:49,242 --> 04:00:50,443 TRANSLATIONAL STEP WILL BE 5289 04:00:50,443 --> 04:00:53,313 TAKING YOUR TECHNOLOGY THROUGH 5290 04:00:53,313 --> 04:00:54,714 SOME SORT OF EARLY STAGE 5291 04:00:54,714 --> 04:00:55,715 START-UP OR OPPORTUNITY. 5292 04:00:55,715 --> 04:00:58,351 AND A LOT OF PEOPLE THINK THAT A 5293 04:00:58,351 --> 04:01:01,855 START-UP IS JUST -- IT'S A FUN 5294 04:01:01,855 --> 04:01:08,628 TIME, IT'S A PART PARTY IN THE 5295 04:01:08,628 --> 04:01:09,362 BAHAMAS, UNFORTUNATELY MOST 5296 04:01:09,362 --> 04:01:11,464 STARTUPS END UP AS A BOAT FIRE. 5297 04:01:11,464 --> 04:01:18,672 A LOT OF THINGS YOU HEARD FROM 5298 04:01:18,672 --> 04:01:24,277 BRIAN WALSH THERE ARE COMPLEX 5299 04:01:24,277 --> 04:01:24,945 STAKEHOLDERS. 5300 04:01:24,945 --> 04:01:26,446 TRYING TO ADDRESS THOSE 5301 04:01:26,446 --> 04:01:28,415 REQUIREMENTS, VALIDATING WHAT IT 5302 04:01:28,415 --> 04:01:30,216 TAKES TO SATISFY THOSE 5303 04:01:30,216 --> 04:01:32,152 STAKEHOLDERS IS A BIG EFFORT 5304 04:01:32,152 --> 04:01:34,287 BEYOND VERY GOOD TECHNOLOGY OR 5305 04:01:34,287 --> 04:01:34,988 CLINICAL EVIDENCE. 5306 04:01:34,988 --> 04:01:36,756 AND SO WE TALK ABOUT IT. 5307 04:01:36,756 --> 04:01:38,892 YOU'VE HEARD ABOUT THE IDEA OF 5308 04:01:38,892 --> 04:01:40,360 THE VALLEY OF DEATH. 5309 04:01:40,360 --> 04:01:42,796 THIS PATHWAY TO GET FROM VERY 5310 04:01:42,796 --> 04:01:44,264 GOOD CLINICAL INFORMATION TO 5311 04:01:44,264 --> 04:01:46,232 ACTUALLY GETTING TO THE BEDSIDE, 5312 04:01:46,232 --> 04:01:49,302 AND IT'S MAN TESTED BY A SERIES 5313 04:01:49,302 --> 04:01:50,203 OF EVENTS NECESSARY TO RAISE 5314 04:01:50,203 --> 04:01:57,310 FUNDS TO GET YOU PAWS -- PAST 5315 04:01:57,310 --> 04:01:58,812 THAT INITIAL STATE. 5316 04:01:58,812 --> 04:02:00,780 FAIRLY SAFE ENVIRONMENT, FEDERAL 5317 04:02:00,780 --> 04:02:02,482 FUNDING, FUNDING AT INSTITUTION, 5318 04:02:02,482 --> 04:02:04,284 SECURE JOB, TENURE PERHAPS. 5319 04:02:04,284 --> 04:02:09,422 AS YOU MOVE INTO THE MORE CASH 5320 04:02:09,422 --> 04:02:12,158 INTENSIVE ACTIVITIES, MAYBE 5321 04:02:12,158 --> 04:02:12,826 TECHNOLOGY, DEVELOPMENTS, 5322 04:02:12,826 --> 04:02:14,294 OBVIOUSLY A LOT OF CLINICAL 5323 04:02:14,294 --> 04:02:16,196 WORK, A LOT OF VALIDATION 5324 04:02:16,196 --> 04:02:17,430 NECESSARY WITH STAKEHOLDERS 5325 04:02:17,430 --> 04:02:18,732 DURING THAT PROCESS, THAT 5326 04:02:18,732 --> 04:02:20,567 CONSUMES CASH AND THAT CASH IS 5327 04:02:20,567 --> 04:02:24,304 MADE UP BY A SERIES OF SPONSORS, 5328 04:02:24,304 --> 04:02:25,071 FUNDERS, INVESTORS. 5329 04:02:25,071 --> 04:02:26,172 THAT'S THE VALLEY OF DEATH 5330 04:02:26,172 --> 04:02:29,909 BECAUSE YOU HAVE TO CONVINCE 5331 04:02:29,909 --> 04:02:32,846 FOLKS YOU HAVE A REASONABLE 5332 04:02:32,846 --> 04:02:34,247 PATHWAY TO SUSTAINABILITY THAT 5333 04:02:34,247 --> 04:02:36,783 GETS MORE CHALLENGING AS COMPANY 5334 04:02:36,783 --> 04:02:38,651 OR CONCEPT MATURES. 5335 04:02:38,651 --> 04:02:40,186 THOSE IN THE START-UP SPACE WE 5336 04:02:40,186 --> 04:02:42,956 CALL THAT THE TROUGH OF SORROW, 5337 04:02:42,956 --> 04:02:44,124 BECAUSE GENERALLY YOU'RE EXCITED 5338 04:02:44,124 --> 04:02:46,760 WHEN YOU GET STARTED, YOU RUN 5339 04:02:46,760 --> 04:02:47,494 INTO CHALLENGES. 5340 04:02:47,494 --> 04:02:49,929 AND UNTIL YOU GET TO A REAL 5341 04:02:49,929 --> 04:02:53,466 DEMONSTRATION OF PRODUCT MARKET 5342 04:02:53,466 --> 04:02:54,801 FIT AND PROCEED INTO 5343 04:02:54,801 --> 04:02:57,003 SUSTAINABILITY, IT IS A VERY 5344 04:02:57,003 --> 04:02:57,804 DIFFICULT PATHWAY. 5345 04:02:57,804 --> 04:02:59,839 YOU NEED A LOT OF SUPPORT. 5346 04:02:59,839 --> 04:03:02,876 YOU NEED A NETWORK TO TAP INTO 5347 04:03:02,876 --> 04:03:05,178 TO RAISE YOUR PROBABILITY OF 5348 04:03:05,178 --> 04:03:05,412 SUCCESS. 5349 04:03:05,412 --> 04:03:07,814 WE GENERALLY LOOK AT THE 5350 04:03:07,814 --> 04:03:09,783 PROGRESSION OF LIFE SCIENCES, 5351 04:03:09,783 --> 04:03:12,419 TECHNOLOGY, STARTING WITH THE 5352 04:03:12,419 --> 04:03:14,054 CLEAR STATION, PATIENT 5353 04:03:14,054 --> 04:03:15,088 INDICATION, NEED, ENVIRONMENT, 5354 04:03:15,088 --> 04:03:16,256 THAT'S DELIVERED IN. 5355 04:03:16,256 --> 04:03:18,858 AND WE LOOK CAREFULLY AT WHAT 5356 04:03:18,858 --> 04:03:19,959 THE EXISTING PROCESSES ARE, 5357 04:03:19,959 --> 04:03:21,528 YOU'RE FAMILIAR WITH THOSE VERY 5358 04:03:21,528 --> 04:03:22,729 LIKELY IN YOUR FIELD. 5359 04:03:22,729 --> 04:03:24,764 BUT THEN WE START TO GET INTO 5360 04:03:24,764 --> 04:03:26,433 THE COMPLEXITIES OF THE 5361 04:03:26,433 --> 04:03:29,069 STAKEHOLDERS, HOW DO WE VALIDATE 5362 04:03:29,069 --> 04:03:30,837 WHAT STAKEHOLDERS' NEEDS ARE, 5363 04:03:30,837 --> 04:03:32,572 HOW TO IDENTIFY CRITICAL 5364 04:03:32,572 --> 04:03:35,875 ACTIVITIES NECESSARY TO VALIDATE 5365 04:03:35,875 --> 04:03:37,177 THEIR VALUE PROPOSITIONS AND THE 5366 04:03:37,177 --> 04:03:38,478 MONEY THAT'S REQUIRED TO GET 5367 04:03:38,478 --> 04:03:40,680 THROUGH ALL OF THE STAGES 5368 04:03:40,680 --> 04:03:43,216 EVENTUALLY TO THE SUSTAINABILITY 5369 04:03:43,216 --> 04:03:43,850 POINT. 5370 04:03:43,850 --> 04:03:45,718 AND THAT FEELS LIKE A FIRE 5371 04:03:45,718 --> 04:03:45,952 HYDRANT. 5372 04:03:45,952 --> 04:03:50,757 IF YOU'RE NEW IN THE INNOVATION 5373 04:03:50,757 --> 04:03:52,492 SPACE, IT SEEMS THAT THERE'S SO 5374 04:03:52,492 --> 04:03:53,793 MUCH INFORMATION YOU HAVE TO 5375 04:03:53,793 --> 04:03:55,562 COVER, SO MUCH YOU HAVE TO KNOW, 5376 04:03:55,562 --> 04:03:58,531 YOU WANT TO WORK ON YOUR 5377 04:03:58,531 --> 04:04:00,366 CLINICAL SIDE OR TECHNICAL SIDE, 5378 04:04:00,366 --> 04:04:02,035 HOW DO I APPROACH GETTING 5379 04:04:02,035 --> 04:04:04,537 SUPPORTS NECESSARY TO MAKE IT 5380 04:04:04,537 --> 04:04:05,605 DOWN THIS PATHWAY AND ACROSS THE 5381 04:04:05,605 --> 04:04:07,941 VALLEY OF DEATH. 5382 04:04:07,941 --> 04:04:09,008 FORTUNATELY, WE UNDERSTAND 5383 04:04:09,008 --> 04:04:11,044 PRETTY WELL ABOUT THE DIFFERENT 5384 04:04:11,044 --> 04:04:14,380 STAGES THAT TECHNOLOGY GOES 5385 04:04:14,380 --> 04:04:16,015 THROUGH FROM ACADEMIC INITIATED 5386 04:04:16,015 --> 04:04:19,152 VENTURE, THE SORT OF 5387 04:04:19,152 --> 04:04:19,853 DEMONSTRATIONS NECESSARY, 5388 04:04:19,853 --> 04:04:23,123 FORMATION OF A SEARCH SIDE, YOU 5389 04:04:23,123 --> 04:04:24,691 GO THROUGH VALIDATION TO 5390 04:04:24,691 --> 04:04:26,559 DEMONSTRATE THAT FIT, AND AS YOU 5391 04:04:26,559 --> 04:04:29,596 PROGRESS INTO THE RIGHT HALF OF 5392 04:04:29,596 --> 04:04:31,131 THE PROCESS, WHAT THE 5393 04:04:31,131 --> 04:04:33,099 EXPECTATIONS ARE, HOW YOU BUILD 5394 04:04:33,099 --> 04:04:35,201 YOUR TEAM, HOW YOU EXECUTE, SO 5395 04:04:35,201 --> 04:04:37,370 THE GOOD NEWS IS THERE IS A 5396 04:04:37,370 --> 04:04:38,238 PRESCRIPTIVE PROCESS. 5397 04:04:38,238 --> 04:04:39,772 WE KNOW WHAT SUPPORT IS NEEDED 5398 04:04:39,772 --> 04:04:42,842 AS YOU GO THROUGH THIS PROCESS. 5399 04:04:42,842 --> 04:04:43,977 THERE'S NO SILVER BULLET, 5400 04:04:43,977 --> 04:04:45,078 WHETHER YOU'LL BE SUCCESSFUL OR 5401 04:04:45,078 --> 04:04:47,247 NOT, BUT THERE ARE LOTS OF 5402 04:04:47,247 --> 04:04:49,549 THINGS TO IMPROVE THE 5403 04:04:49,549 --> 04:04:51,417 PROBABILITY THAT YOU HAVE A 5404 04:04:51,417 --> 04:04:53,920 BETTER CHANCE OF SUCCESS VERSUS 5405 04:04:53,920 --> 04:04:55,021 THE COMPETITIVE OFFERINGS YOU 5406 04:04:55,021 --> 04:04:57,323 MAY BE UP AGAINST AS YOU GO TO 5407 04:04:57,323 --> 04:04:57,790 THE MARKET. 5408 04:04:57,790 --> 04:05:02,795 SO I WANT TO TALK ABOUT A 5409 04:05:02,795 --> 04:05:05,598 COUPLE. 5410 04:05:05,598 --> 04:05:07,400 OF THE RESOURCES TO CONSIDER 5411 04:05:07,400 --> 04:05:09,669 MOVING DOWN THIS PATHWAY. 5412 04:05:09,669 --> 04:05:12,505 THIS IS ABOUT NETWORKING, 5413 04:05:12,505 --> 04:05:14,474 ESTABLISHING OFTEN TIMES 5414 04:05:14,474 --> 04:05:15,575 CONNECTIONS WITH PEER GROUPS, 5415 04:05:15,575 --> 04:05:17,010 OUTSIDE OF PEER GROUPS AND 5416 04:05:17,010 --> 04:05:19,512 ORGANIZATIONS THAT YOU MAY NOT 5417 04:05:19,512 --> 04:05:20,180 HAVE CONVENTIONALLY INTERACTED 5418 04:05:20,180 --> 04:05:22,916 WITH BUT THEY FALL INTO THE 5419 04:05:22,916 --> 04:05:24,050 SUPPORT INSTITUTIONALLY THAT HAS 5420 04:05:24,050 --> 04:05:25,485 BEEN GROWING SUBSTANTIALLY OVER 5421 04:05:25,485 --> 04:05:26,753 THE PAST COUPLE DECADES. 5422 04:05:26,753 --> 04:05:28,688 WE'LL TOUCH ON THAT FOR A 5423 04:05:28,688 --> 04:05:28,922 MOMENT. 5424 04:05:28,922 --> 04:05:30,790 THEN THERE'S A SURPRISING AMOUNT 5425 04:05:30,790 --> 04:05:31,991 OF ECONOMIC DEVELOPMENT SUPPORT 5426 04:05:31,991 --> 04:05:33,459 THAT'S OUTSIDE OF THE 5427 04:05:33,459 --> 04:05:37,797 INSTITUTIONS THAT ARE REGIONALLY 5428 04:05:37,797 --> 04:05:39,666 FOCUSED, PROVINCIAL IN TERMS OF 5429 04:05:39,666 --> 04:05:41,467 COMMITMENT TO REGIONS AND 5430 04:05:41,467 --> 04:05:42,535 TREATMENT RESOURCES THAT CASCADE 5431 04:05:42,535 --> 04:05:45,605 OUT OF THOSE ORGANIZATIONS AS 5432 04:05:45,605 --> 04:05:45,805 WELL. 5433 04:05:45,805 --> 04:05:48,841 SO STARTING FIRST ON THE 5434 04:05:48,841 --> 04:05:50,243 INSTITUTIONAL SIDE, MANY OF YOU 5435 04:05:50,243 --> 04:05:53,079 ARE WORKING WITH YOUR TECH 5436 04:05:53,079 --> 04:05:55,181 TRANSFER ORGANIZATIONS AT YOUR 5437 04:05:55,181 --> 04:05:55,515 INSTITUTIONS. 5438 04:05:55,515 --> 04:05:58,351 AND THIS IS A GROUP THAT HAS 5439 04:05:58,351 --> 04:05:59,819 CONSIDERABLY EVOLVED OVER THE 5440 04:05:59,819 --> 04:06:02,388 PAST DECADE OR SO. 5441 04:06:02,388 --> 04:06:03,489 PROBABLY TWO DECADES, THAT THEY 5442 04:06:03,489 --> 04:06:06,125 ARE NOW OPERATING MORE AS TECH 5443 04:06:06,125 --> 04:06:08,094 VENTURES OPERATIONS. 5444 04:06:08,094 --> 04:06:10,730 IF YOU HAVE -- YOU MAY HAVE 5445 04:06:10,730 --> 04:06:14,167 EXPERIENCE GOING AND FILING YOUR 5446 04:06:14,167 --> 04:06:15,335 INVENTION DISCLOSURE, TALKING 5447 04:06:15,335 --> 04:06:19,505 ABOUT LICENSING, ALMOST ALL 5448 04:06:19,505 --> 04:06:22,475 ORGANIZATION AT MANY INTUITIONS 5449 04:06:22,475 --> 04:06:25,745 HAVE IMPLEMENTED SIGNIFICANT 5450 04:06:25,745 --> 04:06:28,815 MENTORSHIP PROGRAMS, MAY OPERATE 5451 04:06:28,815 --> 04:06:29,816 INNOVATION TRAINING THAT'S 5452 04:06:29,816 --> 04:06:32,885 USEFUL IN THE EARLY STAGES, MANY 5453 04:06:32,885 --> 04:06:34,087 HAVE GREAT CONNECTIONS AND 5454 04:06:34,087 --> 04:06:35,388 UNDERSTANDING OF WHAT THE 5455 04:06:35,388 --> 04:06:37,690 ECOSYSTEM IS IN THEIR REGION 5456 04:06:37,690 --> 04:06:40,326 THAT CAN GIVE ADDITIONAL TOOLS. 5457 04:06:40,326 --> 04:06:42,195 AN EXAMPLE ABOUT JOHNS HOPKINS 5458 04:06:42,195 --> 04:06:45,131 AND TRANSFORMATION IN THE PAST 5459 04:06:45,131 --> 04:06:46,332 TEN YEARS, TECH TRANSFER 5460 04:06:46,332 --> 04:06:48,167 ORGANIZATION ABOUT TEN YEARS AGO 5461 04:06:48,167 --> 04:06:50,937 WAS TRANSFORMED INTO BEING 5462 04:06:50,937 --> 04:06:55,208 RESPONSIBLE FOR THE PATENT 5463 04:06:55,208 --> 04:06:56,276 DEVELOPMENT, LICENSING, 5464 04:06:56,276 --> 04:06:58,177 INCUBATORS, THE INNOVATION 5465 04:06:58,177 --> 04:07:01,547 TRAINING PROGRAMS, MANAGEMENT OF 5466 04:07:01,547 --> 04:07:02,415 THE TRANSLATIONAL PHILANTHROPIC 5467 04:07:02,415 --> 04:07:04,584 FUNDS WE HAVE ACCESS TO, AND 5468 04:07:04,584 --> 04:07:07,687 COORDINATING WITH SOME OF THE 5469 04:07:07,687 --> 04:07:09,122 REGIONAL AND FEDERAL INVESTING 5470 04:07:09,122 --> 04:07:10,223 PROGRAMS THAT EXIST THROUGHOUT 5471 04:07:10,223 --> 04:07:11,424 THE COUNTRY. 5472 04:07:11,424 --> 04:07:14,060 A ONE-STOP SHOP FOR AN INNOVATOR 5473 04:07:14,060 --> 04:07:15,828 STARTING TO LOOK AT THEIR 5474 04:07:15,828 --> 04:07:17,897 OPPORTUNITIES COMING DOWN THE 5475 04:07:17,897 --> 04:07:18,531 ROAD. 5476 04:07:18,531 --> 04:07:22,835 THIS STORY IS REPEATED AT MANY 5477 04:07:22,835 --> 04:07:23,303 INSTITUTIONS. 5478 04:07:23,303 --> 04:07:23,936 THAT'S THE TREND. 5479 04:07:23,936 --> 04:07:28,441 IF YOU HAVEN'T HAD THAT DEPTH OF 5480 04:07:28,441 --> 04:07:29,309 CONVERSATIONS IT'S SOMETHING TO 5481 04:07:29,309 --> 04:07:34,681 PUT ON THE LIST TO DO QUICKLY. 5482 04:07:34,681 --> 04:07:40,586 WE'LL HEAR FROM REBEKAH ABOUT 5483 04:07:40,586 --> 04:07:41,888 THINGS THAT VENTUREWELL IS 5484 04:07:41,888 --> 04:07:43,189 INVOLVED IN, BUT A NETWORK 5485 04:07:43,189 --> 04:07:46,025 EXISTS OUT OF THE COUNTRY, A LOT 5486 04:07:46,025 --> 04:07:48,127 GREW OUT OF NATIONAL SCIENCE 5487 04:07:48,127 --> 04:07:48,594 FOUNDATION PROGRAMS, 5488 04:07:48,594 --> 04:07:50,229 ESTABLISHING HUBS AND SITES 5489 04:07:50,229 --> 04:07:52,932 AROUND THE COUNTRY, THAT WERE 5490 04:07:52,932 --> 04:07:57,170 INVOLVED IN VARIOUS INNOVATION 5491 04:07:57,170 --> 04:07:57,804 TRAINING. 5492 04:07:57,804 --> 04:08:00,973 BUT THERE ARE THREE, FOUR 5493 04:08:00,973 --> 04:08:02,742 THOUSAND TEAMS THROUGHOUT THE 5494 04:08:02,742 --> 04:08:03,843 COUNTRY GREAT RESOURCES, PEOPLE 5495 04:08:03,843 --> 04:08:07,547 EVEN NETWORK WITH DOWN THIS 5496 04:08:07,547 --> 04:08:08,848 PATHWAY PERHAPS BEFORE AND 5497 04:08:08,848 --> 04:08:09,982 REBEKAH WILL TALK ABOUT HOW 5498 04:08:09,982 --> 04:08:11,250 IMPORTANT SOME OF THESE 5499 04:08:11,250 --> 04:08:12,585 CONNECTIVE TISSUES ARE IN TERMS 5500 04:08:12,585 --> 04:08:19,125 OF SUPPORTING AS YOU GO FORWARD. 5501 04:08:19,125 --> 04:08:20,360 ECONOMIC DEVELOPMENT POINT OF 5502 04:08:20,360 --> 04:08:21,461 VIEW I'M SURPRISED RESEARCHERS 5503 04:08:21,461 --> 04:08:22,428 ARE NOT AWARE HOW MUCH IS GOING 5504 04:08:22,428 --> 04:08:24,297 ON AT THE STATE LEVEL IN A LOT 5505 04:08:24,297 --> 04:08:26,366 OF CASE IS. 5506 04:08:26,366 --> 04:08:28,368 YOU CAN LOOK UP YOUR BIOSCIENCE 5507 04:08:28,368 --> 04:08:29,802 ASSOCIATION FOR YOUR STATE AT 5508 04:08:29,802 --> 04:08:34,173 THE COUNCIL OF STATE 5509 04:08:34,173 --> 04:08:35,375 BIOSCIENCES, ANOTHER AREA THAT 5510 04:08:35,375 --> 04:08:38,344 HAS CHANGED IN THE PAST TEN OR 5511 04:08:38,344 --> 04:08:40,847 TWENTY YEARS, MOST CAME OUT OF 5512 04:08:40,847 --> 04:08:43,449 THE ADVOCACY AREA, FOCUSED ON 5513 04:08:43,449 --> 04:08:46,152 LOCAL LEGISLATURE, BUT THEY HAVE 5514 04:08:46,152 --> 04:08:48,554 EVOLVED TO BE INNOVATION AND 5515 04:08:48,554 --> 04:08:49,589 INNOVATOR SUPPORT ORGANIZATIONS 5516 04:08:49,589 --> 04:08:50,990 IN ALMOST EVERY STATE. 5517 04:08:50,990 --> 04:08:53,726 I THINK EVERY STATE IS 5518 04:08:53,726 --> 04:08:55,361 REPRESENTED BY A BIOSCIENCE 5519 04:08:55,361 --> 04:08:55,795 ASSOCIATION. 5520 04:08:55,795 --> 04:08:59,565 YOU'LL FIND MANY HAVE PROGRAMS, 5521 04:08:59,565 --> 04:09:01,267 MENTORSHIP PROGRAMS, THAT THEY 5522 04:09:01,267 --> 04:09:03,236 HAVE ACCESS TO LOCAL FUNDING IN 5523 04:09:03,236 --> 04:09:05,972 MANY CASES TO SUPPORT 5524 04:09:05,972 --> 04:09:07,840 TRANSLATION, AND I WOULD 5525 04:09:07,840 --> 04:09:09,909 RECOMMEND IF YOU'RE LOOKING TO 5526 04:09:09,909 --> 04:09:12,745 GO DOWN THIS PATHWAY, JOINING 5527 04:09:12,745 --> 04:09:13,513 THESE ASSOCIATIONS, 5528 04:09:13,513 --> 04:09:14,914 UNDERSTANDING WHAT'S HAPPENING 5529 04:09:14,914 --> 04:09:16,682 OUTSIDE OF JUST THE UNIVERSITY 5530 04:09:16,682 --> 04:09:17,884 OR INSTITUTIONAL LEVEL. 5531 04:09:17,884 --> 04:09:18,985 THEY ARE TREMENDOUS RESOURCES 5532 04:09:18,985 --> 04:09:22,155 AND I KNOW IN OUR REGION THEY 5533 04:09:22,155 --> 04:09:26,025 WERE VERY ACTIVE AND TIE PEOPLE 5534 04:09:26,025 --> 04:09:28,394 INTO GREAT SUPPORT. 5535 04:09:28,394 --> 04:09:29,328 IN ADDITION TO ORGANIZATIONS 5536 04:09:29,328 --> 04:09:32,732 THERE ARE A SERIES OF WHAT I 5537 04:09:32,732 --> 04:09:33,800 CALL PROVINCIAL INVESTMENT 5538 04:09:33,800 --> 04:09:37,336 ORGANIZATIONS THAT EXIST 5539 04:09:37,336 --> 04:09:39,639 THROUGHOUT THE COUNTRY. 5540 04:09:39,639 --> 04:09:40,940 IN MARYLAND TEDCO IS THE FUNDING 5541 04:09:40,940 --> 04:09:43,209 ARM OF THE STATE OF MARYLAND. 5542 04:09:43,209 --> 04:09:45,445 THEY ARE ALLOWED TO TAKE EQUITY 5543 04:09:45,445 --> 04:09:47,780 INVESTMENT IN COMPANIES. 5544 04:09:47,780 --> 04:09:50,383 BUT ALMOST EVERY STATE HAS 5545 04:09:50,383 --> 04:09:52,485 SOMETHING THAT'S EXTRACURRICULAR 5546 04:09:52,485 --> 04:09:53,786 FROM THE BIOSCIENCES 5547 04:09:53,786 --> 04:09:56,088 ASSOCIATIONS THAT ARE OFTENTIMES 5548 04:09:56,088 --> 04:09:59,258 FUNDED BY EITHER INSTITUTIONAL 5549 04:09:59,258 --> 04:10:01,794 OR STATE PROGRAMS TO SUPPORT 5550 04:10:01,794 --> 04:10:03,629 TECHNOLOGIES WITHIN THAT STATE 5551 04:10:03,629 --> 04:10:04,730 OR REGION. 5552 04:10:04,730 --> 04:10:07,366 AND THIS IS AN ECONOMIC 5553 04:10:07,366 --> 04:10:08,034 DEVELOPMENT EFFORT THAT'S 5554 04:10:08,034 --> 04:10:09,035 DIFFERENT APPROACH THAN YOU 5555 04:10:09,035 --> 04:10:12,839 MIGHT RUN INTO IF YOU'RE DEALING 5556 04:10:12,839 --> 04:10:15,475 WITH A VENTURE INVESTOR, PURE 5557 04:10:15,475 --> 04:10:17,543 FINANCIAL INVESTOR, EVEN A 5558 04:10:17,543 --> 04:10:19,545 FEDERAL GRANTEE PROGRAM IS THEY 5559 04:10:19,545 --> 04:10:20,746 ARE BIASED BY THEIR NEED TO 5560 04:10:20,746 --> 04:10:22,582 SUPPORT WHAT IS HAPPENING IN 5561 04:10:22,582 --> 04:10:23,349 THEIR REGION. 5562 04:10:23,349 --> 04:10:28,020 SO THESE ARE OTHER AREAS 5563 04:10:28,020 --> 04:10:29,689 CRITICAL TO EXPLORE AGAIN 5564 04:10:29,689 --> 04:10:31,657 GENERALLY THE TECH VENTURE 5565 04:10:31,657 --> 04:10:35,695 ORGANIZATIONS THAT INSTITUTIONS 5566 04:10:35,695 --> 04:10:36,796 OR BIOSCIENCE ASSOCIATIONS 5567 04:10:36,796 --> 04:10:39,098 ARE -- AM I LOOKING FOR A LIGHT? 5568 04:10:39,098 --> 04:10:39,265 YES. 5569 04:10:39,265 --> 04:10:41,968 ARE AVAILABLE FOR YOU TO GET TO. 5570 04:10:41,968 --> 04:10:42,935 AS THE PROJECTS MATURE, THERE 5571 04:10:42,935 --> 04:10:44,804 ARE OTHER THINGS YOU CAN TAP 5572 04:10:44,804 --> 04:10:45,238 INTO. 5573 04:10:45,238 --> 04:10:49,742 LAUNCH PORT WHICH IS OUR VENTURE 5574 04:10:49,742 --> 04:10:51,844 COMPANY SUPPORTS TECHNOLOGIES 5575 04:10:51,844 --> 04:10:54,113 COMING OUT OF INCUBATION TO HELP 5576 04:10:54,113 --> 04:10:56,315 DOWN MANUFACTURING PATHWAY AND 5577 04:10:56,315 --> 04:11:00,520 SERIES OF NATIONAL PROGRAMS TO 5578 04:11:00,520 --> 04:11:01,821 HELP STARTUPS GET MENTORSHIPS, 5579 04:11:01,821 --> 04:11:03,990 MED TECH INNOVATORS IS THE 5580 04:11:03,990 --> 04:11:05,658 BIGGEST MEDICAL ACCELERATOR FOR 5581 04:11:05,658 --> 04:11:09,729 BOTH DIAGNOSTICS AND MEDICAL 5582 04:11:09,729 --> 04:11:11,230 DEVICES, AFFILIATED WITH THE 5583 04:11:11,230 --> 04:11:12,031 NATIONAL MEDICAL DEVICE 5584 04:11:12,031 --> 04:11:12,365 ORGANIZATION. 5585 04:11:12,365 --> 04:11:14,200 I'M GOING TO STOP THERE AND TURN 5586 04:11:14,200 --> 04:11:16,002 IT OVER. 5587 04:11:16,002 --> 04:11:17,637 I HAVE EXAMPLES OF WHAT WE HAVE 5588 04:11:17,637 --> 04:11:23,242 DONE IN MARYLAND, WE'VE HAD A 5589 04:11:23,242 --> 04:11:27,847 PROGRAM TO INTEGRATE ALL OF 5590 04:11:27,847 --> 04:11:29,615 THOSE DIFFERENT AREAS, DIFFERENT 5591 04:11:29,615 --> 04:11:31,751 RESOURCES, HARMONIZE THEM FOR A 5592 04:11:31,751 --> 04:11:32,952 TRANSLATIONAL INNOVATOR THAT'S 5593 04:11:32,952 --> 04:11:34,487 MOVING THROUGH THAT PATHWAY, 5594 04:11:34,487 --> 04:11:36,889 THAT TAPS THEM INTO EVERY ONE OF 5595 04:11:36,889 --> 04:11:38,124 THOSE MENTORSHIP PROGRAMS AS 5596 04:11:38,124 --> 04:11:41,127 TECHNOLOGY MATURES. 5597 04:11:41,127 --> 04:11:41,861 I'LL LEAVE IT THERE. 5598 04:11:41,861 --> 04:11:50,002 [APPLAUSE] 5599 04:11:50,002 --> 04:12:00,046 5600 04:12:00,346 --> 04:12:10,323 5601 04:12:12,525 --> 04:12:14,226 >> WE'RE THE CENTRALIZED OFFICE 5602 04:12:14,226 --> 04:12:17,029 THAT MANAGES THE SMALL BUSINESS 5603 04:12:17,029 --> 04:12:22,568 PROGRAMS FOR NIH AND HHS IN SOME 5604 04:12:22,568 --> 04:12:24,270 CASES, OTHER SISTER AGENCIES. 5605 04:12:24,270 --> 04:12:27,340 IN ADDITION TO PROVIDING MONEY, 5606 04:12:27,340 --> 04:12:28,007 ADMINISTRATION OF POLICY AND 5607 04:12:28,007 --> 04:12:31,944 REPORT WE GO PROVIDE A VAST 5608 04:12:31,944 --> 04:12:33,379 NUMBER, VAST COMPARED TO OTHER 5609 04:12:33,379 --> 04:12:34,380 FEDERAL AGENCIES, SUPPORT 5610 04:12:34,380 --> 04:12:35,681 SERVICES FOR INNOVATOR 5611 04:12:35,681 --> 04:12:35,948 COMMUNITY. 5612 04:12:35,948 --> 04:12:38,384 I'LL SPEND TIME TALKING ABOUT 5613 04:12:38,384 --> 04:12:38,718 THOSE. 5614 04:12:38,718 --> 04:12:40,586 SOME OF THOSE PROGRAM ALSO 5615 04:12:40,586 --> 04:12:41,821 INVOLVE MONEY. 5616 04:12:41,821 --> 04:12:46,158 MONEY IS ALWAYS A GOOD THING. 5617 04:12:46,158 --> 04:12:48,260 FOR THOSE WHO MAY HAVE A SMALL 5618 04:12:48,260 --> 04:12:51,330 BUSINESS ALREADY, WE HAVE AN 5619 04:12:51,330 --> 04:12:53,966 INNOVATION CORE PROGRAM, I-CORPS 5620 04:12:53,966 --> 04:12:55,868 PROGRAM AT NIH, BOB DESCRIBED 5621 04:12:55,868 --> 04:12:58,838 HIS INVOLVEMENT IN THAT. 5622 04:12:58,838 --> 04:13:02,675 FOR NIH, WE REQUIRE THREE MEMBER 5623 04:13:02,675 --> 04:13:03,909 ENTREPRENEURIAL TEAMS, THE 5624 04:13:03,909 --> 04:13:07,279 PROGRAM RUNS FOR 8 WEEKS, YOU 5625 04:13:07,279 --> 04:13:09,148 ARE EXPECTED TO MINIMIZE YOUR 5626 04:13:09,148 --> 04:13:10,983 TIME IN THE LAB, MAXIMIZE TIME 5627 04:13:10,983 --> 04:13:13,019 DURING THAT IMPORTANT THING THAT 5628 04:13:13,019 --> 04:13:14,186 BOB JUST MENTIONED, NETWORKING. 5629 04:13:14,186 --> 04:13:16,255 FINDING OUT WHAT YOUR CUSTOMERS 5630 04:13:16,255 --> 04:13:17,423 NEED, WHO KEY STAKEHOLDERS ARE, 5631 04:13:17,423 --> 04:13:20,826 WHAT YOU NEED TO DO TO ENGAGE 5632 04:13:20,826 --> 04:13:23,663 THEM IMPACTFULLY TO STREAMLINE 5633 04:13:23,663 --> 04:13:24,997 YOUR DEVELOPMENT. 5634 04:13:24,997 --> 04:13:28,100 WE ALSO HAVE AN ADMINISTRATIVE 5635 04:13:28,100 --> 04:13:30,369 SUPPLEMENT TO PROMOTE DIVERSITY. 5636 04:13:30,369 --> 04:13:35,875 THIS IS SOMETHING IF YOU HAVE 5637 04:13:35,875 --> 04:13:38,811 IDENTIFIED A MEMBER OF YOUR 5638 04:13:38,811 --> 04:13:39,345 SCIENTIFIC COMMUNITY, 5639 04:13:39,345 --> 04:13:40,212 ENTREPRENEURIAL COMMUNITY THAT 5640 04:13:40,212 --> 04:13:42,615 YOU WOULD LIKE TO INCLUDE IN 5641 04:13:42,615 --> 04:13:46,619 YOUR PROGRAM, YOUR PROJECT, YOUR 5642 04:13:46,619 --> 04:13:49,455 COMPANY, YOU CAN APPLY FOR 5643 04:13:49,455 --> 04:13:51,957 ADDITIONAL X AMOUNT OF FUNDING 5644 04:13:51,957 --> 04:13:54,060 TO BRING THAT PERSON IN TO 5645 04:13:54,060 --> 04:13:55,261 ENHANCE THE DIVERSITY OF YOUR 5646 04:13:55,261 --> 04:13:59,198 COMPANY AND THE PROGRESS OF YOUR 5647 04:13:59,198 --> 04:13:59,965 TECHNOLOGY. 5648 04:13:59,965 --> 04:14:01,067 THE SUPPLEMENTS MUST BE TO 5649 04:14:01,067 --> 04:14:03,703 SUPPORT WORK WITHIN THE SCOPE OF 5650 04:14:03,703 --> 04:14:04,770 THE ORIGINAL PROJECT, AND THEY 5651 04:14:04,770 --> 04:14:07,173 ARE ACCEPTED ON A ROLLING BASIS, 5652 04:14:07,173 --> 04:14:08,774 DEPENDING WHICH INSTITUTE OR 5653 04:14:08,774 --> 04:14:10,409 CENTER THEY MAY ALL BE REVIEWED 5654 04:14:10,409 --> 04:14:14,213 TOWARDS THE END OF THE FISCAL 5655 04:14:14,213 --> 04:14:15,614 YEAR. 5656 04:14:15,614 --> 04:14:16,515 THERE IS SOMETHING THAT IS PART 5657 04:14:16,515 --> 04:14:20,352 OF THE SMALL BUSINESS PROGRAM 5658 04:14:20,352 --> 04:14:22,755 FOR QUITE SOME TIME, BUT IN THE 5659 04:14:22,755 --> 04:14:25,057 MOST RECENT REAUTHORIZATION THE 5660 04:14:25,057 --> 04:14:27,560 AMOUNT OF MONEY PUT TOWARDS IT 5661 04:14:27,560 --> 04:14:28,894 WAS SIGNIFICANTLY INCREASED. 5662 04:14:28,894 --> 04:14:31,864 THIS IS THE TECHNICAL AND 5663 04:14:31,864 --> 04:14:33,733 BUSINESS ASSISTANCE FUNDING OR 5664 04:14:33,733 --> 04:14:35,234 IN OUR CASE PROGRAMS BECAUSE 5665 04:14:35,234 --> 04:14:36,802 SOME IS FUNDING, SOME IS NOT 5666 04:14:36,802 --> 04:14:38,637 FUNDING, THAT COMES AS PART OF A 5667 04:14:38,637 --> 04:14:39,739 SMALL BUSINESS AWARD. 5668 04:14:39,739 --> 04:14:42,475 SO THIS IS AVAILABLE TO PHASE 1 5669 04:14:42,475 --> 04:14:43,976 AND PHASE 2 SMALL BUSINESSES, IF 5670 04:14:43,976 --> 04:14:47,279 YOU DON'T KNOW WHAT THAT MEANS 5671 04:14:47,279 --> 04:14:50,249 PHASE 1 IS PROOF-OF-CONCEPT, A 5672 04:14:50,249 --> 04:14:52,551 QUARTER MILLION TO $300,000 5673 04:14:52,551 --> 04:14:54,086 PROJECT, EXPECTED TO TAKE 6 TO 9 5674 04:14:54,086 --> 04:14:55,588 MONTHS TO COMPLETE. 5675 04:14:55,588 --> 04:14:57,323 IF THAT FEASIBILITIES PLAYS OUT 5676 04:14:57,323 --> 04:14:58,891 YOU CAN APPLY FOR PHASE 2 5677 04:14:58,891 --> 04:15:03,529 FUNDING, MORE ON THE ORDER OF $2 5678 04:15:03,529 --> 04:15:04,930 MILLION, $1.05 TO $2 MILLION, 5679 04:15:04,930 --> 04:15:07,366 TWO TO THREE YEARS, FULLER 5680 04:15:07,366 --> 04:15:09,068 RESEARCH AND DEVELOPMENT 5681 04:15:09,068 --> 04:15:11,337 INITIATIVE, AFTER THAT PROOF OF 5682 04:15:11,337 --> 04:15:13,939 CONCEPT HAS COME THROUGH. 5683 04:15:13,939 --> 04:15:15,941 FOR PHASE 1 AWARDS, YOU ARE 5684 04:15:15,941 --> 04:15:18,978 ALLOWED TO REQUEST UP TO $6,500 5685 04:15:18,978 --> 04:15:21,680 PER YEAR OF YOUR AWARD, THAT'S 5686 04:15:21,680 --> 04:15:23,015 IMPORTANT BECAUSE IT'S DIFFERENT 5687 04:15:23,015 --> 04:15:23,549 FOR PHASE 2. 5688 04:15:23,549 --> 04:15:28,087 IF YOU HAVE A MULTI-YEAR PHASE 1 5689 04:15:28,087 --> 04:15:30,456 PROGRAM WHICH CERTAIN TIMES OF 5690 04:15:30,456 --> 04:15:32,424 TECHNOLOGIES LEAD THEMSELVES 5691 04:15:32,424 --> 04:15:34,093 TOWARDS, AGING TECHNOLOGIES, YOU 5692 04:15:34,093 --> 04:15:35,161 NEED RODENTS TO AGE FOR 5693 04:15:35,161 --> 04:15:37,797 INSTANCE, OR TIME FOR SOMETHING 5694 04:15:37,797 --> 04:15:39,765 TO PROVE OUT, THOSE MAY BE 5695 04:15:39,765 --> 04:15:43,602 MULTI-YEAR PROGRAMS AND YOU CAN 5696 04:15:43,602 --> 04:15:45,905 ASK FOR 6500 PER YEAR FOR THOSE 5697 04:15:45,905 --> 04:15:46,172 PROGRAMS. 5698 04:15:46,172 --> 04:15:49,275 FOR THE PHASE 2 AWARDS YOU CAN 5699 04:15:49,275 --> 04:15:53,145 ASK FOR $50,000, FOR THE ENTIRE 5700 04:15:53,145 --> 04:15:54,647 PROJECT PERIOD, REGARDLESS OF 5701 04:15:54,647 --> 04:15:57,149 ONE-YEAR PROGRAM OR FOUR-YEAR 5702 04:15:57,149 --> 04:15:59,051 PROGRAM, DOESN'T MATTER, $50,000 5703 04:15:59,051 --> 04:16:00,152 IS THE CAP. 5704 04:16:00,152 --> 04:16:02,254 THERE ARE INSTRUCTIONS ON HOW TO 5705 04:16:02,254 --> 04:16:10,896 REQUEST THOSE THAT ARE IN THE SF 5706 04:16:10,896 --> 04:16:13,299 424 APPLICATION GUIDE, 5707 04:16:13,299 --> 04:16:14,266 GOVERNMENT-ESE, EXCELLENT CURE 5708 04:16:14,266 --> 04:16:15,901 FOR INSOMNIA, IT'S ALSO THE 5709 04:16:15,901 --> 04:16:16,802 BIBLE FOR EVERY QUESTION YOU'RE 5710 04:16:16,802 --> 04:16:18,204 GOING TO ASK US. 5711 04:16:18,204 --> 04:16:20,172 WE'LL GO THERE, CUT AND PASTE 5712 04:16:20,172 --> 04:16:23,342 AND REPLY TO YOUR E-MAIL WITH 5713 04:16:23,342 --> 04:16:25,010 JUST THAT WORDING. 5714 04:16:25,010 --> 04:16:27,613 THOSE ARE THE MONEY OPTIONS FOR 5715 04:16:27,613 --> 04:16:30,449 THE TECHNICAL AND BUSINESS 5716 04:16:30,449 --> 04:16:31,550 ASSISTANCE. 5717 04:16:31,550 --> 04:16:33,285 HOWEVER, WE HAVE IN-KIND 5718 04:16:33,285 --> 04:16:34,920 PROGRAMS, SO FOR PHASE 1 IF YOU 5719 04:16:34,920 --> 04:16:36,121 HAVE NOT REQUESTED MONEY YOU CAN 5720 04:16:36,121 --> 04:16:38,090 DO ONE OR THE OTHER. 5721 04:16:38,090 --> 04:16:40,426 PROGRAM OR MONEY. 5722 04:16:40,426 --> 04:16:44,263 FOR PHASE 1, WHAT OUR OFFICE 5723 04:16:44,263 --> 04:16:50,636 PROVIDES IS ACCESS TO A TABBA 5724 04:16:50,636 --> 04:16:52,371 NEEDS ASSESSMENT, A THIRD PARTY 5725 04:16:52,371 --> 04:16:54,106 MEMBER TO MEET WITH THE TEAM, 5726 04:16:54,106 --> 04:16:59,078 TALK ABOUT YOUR PROJECT, DO AN 5727 04:16:59,078 --> 04:17:00,479 EVALUATION, FOR CRITICAL AREAS, 5728 04:17:00,479 --> 04:17:03,115 PROVIDE A REPORT, HELPING YOU 5729 04:17:03,115 --> 04:17:04,717 UNDERSTAND STEPS YOU NEED TO 5730 04:17:04,717 --> 04:17:08,187 MAKE MOST EMERGENT NEEDS AND 5731 04:17:08,187 --> 04:17:10,856 TIMELINE FOR SOME OF THE OTHERS. 5732 04:17:10,856 --> 04:17:15,127 FOR PHASE 2 WE HAVE A CONSULTING 5733 04:17:15,127 --> 04:17:17,897 SERVICES PROGRAM, NEEDS 5734 04:17:17,897 --> 04:17:20,633 ASSESSMENT HAS A ROLLING REQUEST 5735 04:17:20,633 --> 04:17:22,601 CYCLE, CONSULTING SERVICES IS 5736 04:17:22,601 --> 04:17:26,105 ONCE A YEAR, HIGHLY COMPETITIVE. 5737 04:17:26,105 --> 04:17:32,044 HOWEVER, IT IS AN ABSOLUTE GEM, 5738 04:17:32,044 --> 04:17:34,146 IF YOU'RE ACCEPTED WE HAVE A 5739 04:17:34,146 --> 04:17:35,414 CONTRACTOR WHO WILL HELP YOU 5740 04:17:35,414 --> 04:17:38,484 DEVELOP A SCOPE OF WORK, 5741 04:17:38,484 --> 04:17:39,785 IDENTIFY VENDORS, SOLICIT 5742 04:17:39,785 --> 04:17:41,387 PROPOSALS, AND THEN ENGAGE THE 5743 04:17:41,387 --> 04:17:43,455 CONTRACT ON YOUR BEHALF. 5744 04:17:43,455 --> 04:17:49,561 SO, THAT IS AN EXCELLENT 5745 04:17:49,561 --> 04:17:50,129 PROGRAM. 5746 04:17:50,129 --> 04:17:51,297 HOWEVER, UNFORTUNATELY, THE BEST 5747 04:17:51,297 --> 04:17:53,299 APPROACH IS ALWAYS FOR YOU TO 5748 04:17:53,299 --> 04:17:56,035 TAKE CONTROL OF YOUR PRODUCT 5749 04:17:56,035 --> 04:17:57,636 DEVELOPMENT WORK, AND PUT THE 5750 04:17:57,636 --> 04:17:58,971 MONEY IN YOUR PROPOSAL AND TELL 5751 04:17:58,971 --> 04:18:00,940 US HOW YOU'RE GOING TO SPEND 5752 04:18:00,940 --> 04:18:01,273 THAT. 5753 04:18:01,273 --> 04:18:04,677 NOW, THIS IS A VERY BUSY SLIDE. 5754 04:18:04,677 --> 04:18:06,445 I WON'T READ THE WHOLE THING. 5755 04:18:06,445 --> 04:18:08,380 I'LL ENCOURAGE YOU IF YOU'RE 5756 04:18:08,380 --> 04:18:10,149 LOOKING TO ENGAGE A VENDSOR TO 5757 04:18:10,149 --> 04:18:12,351 TAKE A LOOK AT SOME OF THOSE 5758 04:18:12,351 --> 04:18:13,719 SAMPLE SCOPE OF WORK DOCUMENTS 5759 04:18:13,719 --> 04:18:16,822 THAT ARE LINKED AT THE BOTTOM OF 5760 04:18:16,822 --> 04:18:19,158 THIS PAGE. 5761 04:18:19,158 --> 04:18:24,296 BEST WAY IS TO CLICK THE LINKS. 5762 04:18:24,296 --> 04:18:27,700 I DON'T HAVE QR CODES YET, IT'S 5763 04:18:27,700 --> 04:18:28,901 A GROWING OFFICE. 5764 04:18:28,901 --> 04:18:31,937 THESE WILL IDENTIFY NEEDS TO 5765 04:18:31,937 --> 04:18:33,672 FIND DELIVERABLES AND IDENTIFY 5766 04:18:33,672 --> 04:18:35,441 WHAT VENDOR QUALIFICATIONS ARE 5767 04:18:35,441 --> 04:18:38,510 MOST IMPORTANT FOR YOU AS YOU 5768 04:18:38,510 --> 04:18:39,611 MOVE INTO YOUR PRODUCT 5769 04:18:39,611 --> 04:18:40,479 DEVELOPMENT WORK. 5770 04:18:40,479 --> 04:18:41,580 SINCE I TALKED ABOUT THAT WHICH 5771 04:18:41,580 --> 04:18:43,716 CAN BE USED FOR ANY OF THE 5772 04:18:43,716 --> 04:18:45,417 FUNDING OPPORTUNITIES AND AS 5773 04:18:45,417 --> 04:18:48,020 PART OF THE TABA CONSULTING 5774 04:18:48,020 --> 04:18:49,154 SERVICES PROCESS I FIGURED I 5775 04:18:49,154 --> 04:18:51,991 WOULD THROW UP A LITTLE BIT OF A 5776 04:18:51,991 --> 04:18:53,225 TEASER, WHAT THOSE NEEDS 5777 04:18:53,225 --> 04:18:54,927 ASSESSMENT REPORTS LOOK LIKE. 5778 04:18:54,927 --> 04:18:57,930 THIS IS POSTED ON THE 5779 04:18:57,930 --> 04:18:59,098 APPROPRIATE WEBSITE, NIH NEEDS 5780 04:18:59,098 --> 04:19:00,099 ASSESSMENT PROGRAM. 5781 04:19:00,099 --> 04:19:02,601 YOU CAN TAKE A LOOK AND SEE HOW 5782 04:19:02,601 --> 04:19:05,771 THAT REPORT LOOKS AS IT WOULD 5783 04:19:05,771 --> 04:19:10,609 COME BACK AS AN INNOVATOR WITH A 5784 04:19:10,609 --> 04:19:11,343 PHASE 1 AWARD. 5785 04:19:11,343 --> 04:19:15,214 ALL OF THE WORK THAT WE DO IN 5786 04:19:15,214 --> 04:19:16,849 THE INNOVATOR SUPPORT SERVICES 5787 04:19:16,849 --> 04:19:18,717 TEAM IS PREDICATED ON OUR 5788 04:19:18,717 --> 04:19:21,553 INTERACTIONS WITH YOU, OUR 5789 04:19:21,553 --> 04:19:25,057 INNOVATOR COMMUNITY. 5790 04:19:25,057 --> 04:19:27,059 THOSE INTERACTIONS START AT A 5791 04:19:27,059 --> 04:19:28,527 ONE-ON-ONE BASIS, USUALLY IN THE 5792 04:19:28,527 --> 04:19:30,763 FORM OF A CONSULTATION. 5793 04:19:30,763 --> 04:19:32,197 WHAT'S A CONSULTATION? 5794 04:19:32,197 --> 04:19:36,135 YOU REMEMBER THAT NETWORKING 5795 04:19:36,135 --> 04:19:38,003 THAT BOB WAS TALKING ABOUT SO 5796 04:19:38,003 --> 04:19:38,270 IMPORTANT? 5797 04:19:38,270 --> 04:19:38,971 THIS IS THAT. 5798 04:19:38,971 --> 04:19:41,240 YOU DON'T HAVE TO PAY FOR IT OR 5799 04:19:41,240 --> 04:19:43,142 HAVE A RUBBER CHICKEN AND DRINK 5800 04:19:43,142 --> 04:19:44,309 A CHEAP GLASS OF WINE. 5801 04:19:44,309 --> 04:19:47,279 YOU CAN DO THIS FROM YOUR DESK. 5802 04:19:47,279 --> 04:19:49,581 WE HAVE ENTREPRENEURS IN 5803 04:19:49,581 --> 04:19:51,016 RESIDENCE AND SUBJECT MATTER 5804 04:19:51,016 --> 04:19:52,785 EXPERTS AVAILABLE TO YOU, YOU 5805 04:19:52,785 --> 04:19:54,753 HAVE ONE DOLLAR FROM NIH IN YOUR 5806 04:19:54,753 --> 04:19:57,256 POCKET, SEND ME AN E-MAIL, I'LL 5807 04:19:57,256 --> 04:19:59,591 GET YOU CONNECTED UP. 5808 04:19:59,591 --> 04:20:00,492 THESE ENTREPRENEURS IN RESIDENCE 5809 04:20:00,492 --> 04:20:03,996 BY AND LARGE HAVE WORKED SAT 5810 04:20:03,996 --> 04:20:09,468 FORTUNE 200 COMPANIES, STARTED 5811 04:20:09,468 --> 04:20:10,536 COMPANIES MULTIPLE TIMES, THEY 5812 04:20:10,536 --> 04:20:12,538 HAVE LEARNED THE LESSONS THAT 5813 04:20:12,538 --> 04:20:14,606 YOU'RE GOING THROUGH NOW. 5814 04:20:14,606 --> 04:20:17,342 AND THEY ARE GREAT RESOURCES. 5815 04:20:17,342 --> 04:20:20,079 THEIR NETWORKS INTO THE 5816 04:20:20,079 --> 04:20:21,613 INVESTMENT COMMUNITY, THE 5817 04:20:21,613 --> 04:20:23,215 MANUFACTURING COMMUNITY, THE 5818 04:20:23,215 --> 04:20:25,317 SCIENTIFIC COMMUNITY, THE 5819 04:20:25,317 --> 04:20:26,085 CLINICAL COMMUNITY, IS 5820 04:20:26,085 --> 04:20:28,153 UNPARALLELED IN THE FEDERAL 5821 04:20:28,153 --> 04:20:28,554 GOVERNMENT. 5822 04:20:28,554 --> 04:20:30,355 THESE ARE AMAZING PEOPLE. 5823 04:20:30,355 --> 04:20:32,424 AND ALL IT TAKES TO REQUEST TIME 5824 04:20:32,424 --> 04:20:33,725 IS AN E-MAIL AND DESCRIPTION OF 5825 04:20:33,725 --> 04:20:35,294 WHAT YOU WANT TO TALK ABOUT. 5826 04:20:35,294 --> 04:20:37,930 WE CAN MAKE THAT HAPPEN. 5827 04:20:37,930 --> 04:20:39,998 THESE ARE MY BUSINESS PEOPLE. 5828 04:20:39,998 --> 04:20:41,934 THEY TALK ABOUT COMPANY 5829 04:20:41,934 --> 04:20:44,369 FORMATION, BUILDING A TEAM, 5830 04:20:44,369 --> 04:20:46,472 BRINGING ON ADVISORS, HOW TO 5831 04:20:46,472 --> 04:20:48,207 DEVELOP A TERM SHEET, CREATE A 5832 04:20:48,207 --> 04:20:52,377 PRO FORMA TO TALK TO INVESTORS, 5833 04:20:52,377 --> 04:20:55,247 THEY COACH PEOPLE HOW TO PRESENT 5834 04:20:55,247 --> 04:20:57,182 A VALUE PROPOSITION WHEN TALKING 5835 04:20:57,182 --> 04:21:00,486 TO AUDIENCES OF ALL TYPES. 5836 04:21:00,486 --> 04:21:02,621 I ALSO HAVE SUBJECT MATTER 5837 04:21:02,621 --> 04:21:05,124 EXPERTS WHO ARE FOCUS KEENLY ON 5838 04:21:05,124 --> 04:21:07,192 THE REGULATORY AND REIMBURSEMENT 5839 04:21:07,192 --> 04:21:09,094 OR PAYMENT SIDE. 5840 04:21:09,094 --> 04:21:10,229 NOT ALWAYS REIMBURSEMENT. 5841 04:21:10,229 --> 04:21:11,930 THERE'S SOMEONE WHO HAS TO PAY 5842 04:21:11,930 --> 04:21:13,065 FOR YOUR TECHNOLOGY SINCE WE 5843 04:21:13,065 --> 04:21:14,133 DON'T MAKE THINGS FOR FREE AND 5844 04:21:14,133 --> 04:21:16,135 GIVE THEM AWAY. 5845 04:21:16,135 --> 04:21:18,871 IT COSTS MONEY. 5846 04:21:18,871 --> 04:21:20,539 THESE SUBJECT MATTER EXPERTS ARE 5847 04:21:20,539 --> 04:21:21,507 AVAILABLE FOR AD HOC 5848 04:21:21,507 --> 04:21:23,575 CONSULTATIONS AND MAY BE PART OF 5849 04:21:23,575 --> 04:21:25,043 THE DEVELOPING AND SOW DEPENDING 5850 04:21:25,043 --> 04:21:27,112 ON THE FOCUS OF THE SERVICE OR 5851 04:21:27,112 --> 04:21:29,281 VENDOR YOU'RE TRYING TO ENGAGE. 5852 04:21:29,281 --> 04:21:32,684 MANY OF THEM HAVE DECADES-LONG 5853 04:21:32,684 --> 04:21:35,120 HISTORIES WORKING WITH FDA, 5854 04:21:35,120 --> 04:21:37,723 WORKING WITH CMS, IN HEALTH CARE 5855 04:21:37,723 --> 04:21:39,691 SYSTEMS, AS NURSES, WORKING AS 5856 04:21:39,691 --> 04:21:42,194 PRODUCT DEVELOPMENT EXPERTS IN 5857 04:21:42,194 --> 04:21:43,395 LARGE COMPANIES. 5858 04:21:43,395 --> 04:21:48,167 AGAIN, EASIEST WAY TO REQUEST A 5859 04:21:48,167 --> 04:21:51,870 CONSULT, SEND AN E-MAIL. 5860 04:21:51,870 --> 04:21:53,071 WE'LL MAKE IT HAPPEN. 5861 04:21:53,071 --> 04:21:54,406 ONE OF THE WAYS TO TAKE THE 5862 04:21:54,406 --> 04:21:59,077 KNOWLEDGE, WE'VE TALKED TO YOU, 5863 04:21:59,077 --> 04:22:00,078 HELPED YOU UNDERSTAND, HOW ARE 5864 04:22:00,078 --> 04:22:01,513 YOU GOING TO GET THE MONEY? 5865 04:22:01,513 --> 04:22:03,615 YOU HAVE TO FIND A PARTNER, 5866 04:22:03,615 --> 04:22:04,917 POSSIBLY GIVE UP EQUITY, 5867 04:22:04,917 --> 04:22:06,485 POSSIBLY FIND A NEW 5868 04:22:06,485 --> 04:22:06,818 MANUFACTURER. 5869 04:22:06,818 --> 04:22:09,421 THERE ARE A LOT OF THINGS THAT 5870 04:22:09,421 --> 04:22:11,490 INNOVATORS NEED AS THEY GROW A 5871 04:22:11,490 --> 04:22:11,723 COMPANY. 5872 04:22:11,723 --> 04:22:17,196 A GREAT WAY TO GET THOSE IS TO 5873 04:22:17,196 --> 04:22:19,064 ATTEND SHOWCASE EVENTS AND TALK 5874 04:22:19,064 --> 04:22:20,532 TO PEOPLE. 5875 04:22:20,532 --> 04:22:23,902 SEED SENDS OVER 120 COMPANIES A 5876 04:22:23,902 --> 04:22:29,341 YEAR OUT TO TALK TO INVESTORS, 5877 04:22:29,341 --> 04:22:30,042 PARTNERS, DEVELOPERS, 5878 04:22:30,042 --> 04:22:32,110 CO-DEVELOPERS, YOU NAME IT. 5879 04:22:32,110 --> 04:22:34,680 WE DO THIS IN MANY DIFFERENT 5880 04:22:34,680 --> 04:22:38,483 PLACES, THE EVENTS WE ATTENDED 5881 04:22:38,483 --> 04:22:39,685 THIS YEAR THAT WE SIGNED 5882 04:22:39,685 --> 04:22:41,653 COMPANIES THIS YEAR ARE LISTED 5883 04:22:41,653 --> 04:22:43,188 ON THIS SLIDE. 5884 04:22:43,188 --> 04:22:45,824 IN ADVANCE OF EVERY EVENT THAT 5885 04:22:45,824 --> 04:22:47,259 WE'RE SENDING TEN OR MORE PEOPLE 5886 04:22:47,259 --> 04:22:51,396 TO, WHICH IS MOST OF THEM. 5887 04:22:51,396 --> 04:22:54,032 WE HOLD A WEBINAR AND WE TALK 5888 04:22:54,032 --> 04:22:55,267 THOSE INNOVATORS THAT WE'RE 5889 04:22:55,267 --> 04:22:57,169 SUPPORTING INTO THAT ROOM. 5890 04:22:57,169 --> 04:22:58,704 WE HELP THEM UNDERSTAND WHO THEY 5891 04:22:58,704 --> 04:23:00,572 ARE GOING TO MEET, HOW THEY 5892 04:23:00,572 --> 04:23:01,773 SHOULD APPROACH THAT MEETING, 5893 04:23:01,773 --> 04:23:03,875 HOW FAR IN ADVANCE THEY SHOULD 5894 04:23:03,875 --> 04:23:09,248 LOOK AT PARTNERING PORTAL, 5895 04:23:09,248 --> 04:23:09,881 IDENTIFYING PARTNERS, 5896 04:23:09,881 --> 04:23:11,850 DEVELOPERS, REACHING OUT AND 5897 04:23:11,850 --> 04:23:12,818 ENGAGING THEM. 5898 04:23:12,818 --> 04:23:14,586 WE THEN ASK THOSE COMPANIES TO 5899 04:23:14,586 --> 04:23:16,655 COME BACK TO US AND TELL US HOW 5900 04:23:16,655 --> 04:23:18,190 EFFECTIVE THEY WERE AT DOING 5901 04:23:18,190 --> 04:23:18,423 THAT. 5902 04:23:18,423 --> 04:23:19,958 WHO DID THEY MEET WITH? 5903 04:23:19,958 --> 04:23:24,229 IF I HAVE TEN OR MORE COMPANIES, 5904 04:23:24,229 --> 04:23:27,432 I HAVE AN EIR AT THAT EVENT SO 5905 04:23:27,432 --> 04:23:29,501 MY COMPANIES WITH TALK TO THAT 5906 04:23:29,501 --> 04:23:34,306 EIR, OH MY WORK, I TALKED TO 5907 04:23:34,306 --> 04:23:36,275 EDWARDS, THEY ASKED ME TO SET UP 5908 04:23:36,275 --> 04:23:37,609 A CALL. 5909 04:23:37,609 --> 04:23:40,345 I DON'T KNOW THE ANXIOUS. 5910 04:23:40,345 --> 04:23:44,082 THE EIR CAN TALK YOU TRUE AND WE 5911 04:23:44,082 --> 04:23:45,717 CAN HAVE A CONVERSATION THERE OR 5912 04:23:45,717 --> 04:23:47,686 SCHEDULE A CONSULT AND HELP YOU 5913 04:23:47,686 --> 04:23:48,553 WALK INTO THAT. 5914 04:23:48,553 --> 04:23:51,290 I TOLD YOU A BUNCH OF TIMES, 5915 04:23:51,290 --> 04:23:52,157 CONTACT ME. 5916 04:23:52,157 --> 04:23:54,026 THE ONLY THING I HAVEN'T HOLD 5917 04:23:54,026 --> 04:23:56,228 YOU IS HOW. 5918 04:23:56,228 --> 04:24:00,499 FIRST, THE SECRET CODES TO NIH, 5919 04:24:00,499 --> 04:24:06,171 FIRST TIME DOT LAST NAME DOT 5920 04:24:06,171 --> 04:24:06,505 NIH.GOV. 5921 04:24:06,505 --> 04:24:08,173 SUPER SECRET. 5922 04:24:08,173 --> 04:24:11,677 SEND MAN E-MAIL TO 5923 04:24:11,677 --> 04:24:13,011 SEEDINFO@NIH.GOV TO GET YOU TO 5924 04:24:13,011 --> 04:24:15,113 ANY AND ALL OF OUR PROGRAMS. 5925 04:24:15,113 --> 04:24:19,885 I THANK YOU SO MUCH FOR YOUR 5926 04:24:19,885 --> 04:24:20,218 TIME. 5927 04:24:20,218 --> 04:24:22,854 CHRIS SASIELA, INNOVATOR SUPPORT 5928 04:24:22,854 --> 04:24:24,723 TEAM DIRECTOR, SMALL BUSINESS 5929 04:24:24,723 --> 04:24:26,525 EDUCATION AND ENTREPRENEURIAL 5930 04:24:26,525 --> 04:24:26,958 DEVELOPMENT OFFICE. 5931 04:24:26,958 --> 04:24:34,966 [APPLAUSE] 5932 04:24:34,966 --> 04:24:40,205 5933 04:24:40,205 --> 04:24:43,175 5934 04:24:43,175 --> 04:24:46,478 >> I AM REBEKAH NEAL, PROGRAM 5935 04:24:46,478 --> 04:24:47,679 DIRECTOR AT VENTUREWELL, I'M 5936 04:24:47,679 --> 04:24:49,681 EXCITED TO SEE EVERYONE IN 5937 04:24:49,681 --> 04:24:49,915 PERSON. 5938 04:24:49,915 --> 04:24:54,252 I'VE BEEN WORKING IT'S ON RADx 5939 04:24:54,252 --> 04:24:56,722 PROGRAMS FOR THREE-ISH, THREE 5940 04:24:56,722 --> 04:24:58,957 AND A HALF YEARS. 5941 04:24:58,957 --> 04:24:59,891 IT'S BEEN REALLY DELIGHTFUL TO 5942 04:24:59,891 --> 04:25:00,859 SEE YOU IN PERSON. 5943 04:25:00,859 --> 04:25:04,196 I'M NOT GOING TO TALK ABOUT OUR 5944 04:25:04,196 --> 04:25:06,598 RADx WORK IN THIS TALK SO 5945 04:25:06,598 --> 04:25:17,142 PLEASE COME UP AFTERWARDS, HAPPY 5946 04:25:25,217 --> 04:25:28,754 TO SHARE MORE FOR THE LAST 5947 04:25:28,754 --> 04:25:31,923 ALMOST 30 YEARS NOW DEVELOPING 5948 04:25:31,923 --> 04:25:33,492 THAT INNOVATION AND 5949 04:25:33,492 --> 04:25:34,893 ENTREPRENEURSHIP ECOSYSTEM IN 5950 04:25:34,893 --> 04:25:37,763 THE U.S. 5951 04:25:37,763 --> 04:25:42,033 WE ARE A NON-PROFIT 5952 04:25:42,033 --> 04:25:45,103 HEADQUARTERED IN MASSACHUSETTS 5953 04:25:45,103 --> 04:25:51,042 SEEKING TO CULTIVATE THE 5954 04:25:51,042 --> 04:25:55,147 PIPELINE STARTING IN HIGHER ED, 5955 04:25:55,147 --> 04:25:58,450 GROWING THE ECOSYSTEM FOR 5956 04:25:58,450 --> 04:25:59,651 ACADEMIC INNOVATORS STUDENT 5957 04:25:59,651 --> 04:26:01,286 TEAMS MOVING INTO MORE VENTURE 5958 04:26:01,286 --> 04:26:03,088 DEVELOPMENT SUPPORT AND TRAINING 5959 04:26:03,088 --> 04:26:04,256 SOME TYPES OF THINGS BOB TALKED 5960 04:26:04,256 --> 04:26:10,996 ABOUT AND SAID YOU SHOULD LOOK 5961 04:26:10,996 --> 04:26:15,567 FOR AND HOW YOU MIGHT DO THAN. 5962 04:26:15,567 --> 04:26:17,669 WE MANAGE A SMALL INVESTMENT 5963 04:26:17,669 --> 04:26:19,004 FUND THAT SUPPORTS MANY 5964 04:26:19,004 --> 04:26:21,173 COMPANIES AND TEAMS AND THEN WE 5965 04:26:21,173 --> 04:26:24,242 DO THAT COMMERCIALIZATION WORK 5966 04:26:24,242 --> 04:26:25,343 ON MY TEAM. 5967 04:26:25,343 --> 04:26:27,746 WE DO THIS SUPPORT IN A VARIETY 5968 04:26:27,746 --> 04:26:29,581 OF WAYS AND ALWAYS THROUGH 5969 04:26:29,581 --> 04:26:30,048 PARTNERSHIPS. 5970 04:26:30,048 --> 04:26:32,584 I'LL TALK ABOUT HOW CRITICAL 5971 04:26:32,584 --> 04:26:35,387 PARTNERSHIP IS AS YOU ARE 5972 04:26:35,387 --> 04:26:36,688 DEVELOPING YOUR INNOVATION AND 5973 04:26:36,688 --> 04:26:39,658 COMPANY IF YOU'RE AN EARLY STAGE 5974 04:26:39,658 --> 04:26:39,925 INNOVATOR. 5975 04:26:39,925 --> 04:26:42,060 BOB AND OTHERS HAVE TALKED ABOUT 5976 04:26:42,060 --> 04:26:42,894 THAT ALREADY. 5977 04:26:42,894 --> 04:26:46,231 WE COULDN'T DO THE WORK WE DO 5978 04:26:46,231 --> 04:26:47,232 WITHOUT THESE PARTNERS. 5979 04:26:47,232 --> 04:26:50,502 REALLY TRYING TO HELP SUPPORT 5980 04:26:50,502 --> 04:26:54,105 THAT, THAT INNOVATION ECOSYSTEM 5981 04:26:54,105 --> 04:26:55,540 THROUGH NETWORK BUILDING, THE 5982 04:26:55,540 --> 04:27:00,479 NETWORK BOB MENTIONED THROUGH 5983 04:27:00,479 --> 04:27:02,781 WORKSHOPS AND TRAININGS, THE 5984 04:27:02,781 --> 04:27:03,648 I-CORPS PROGRAM. 5985 04:27:03,648 --> 04:27:06,084 REALLY GOING IN AND BUILDING 5986 04:27:06,084 --> 04:27:07,219 THAT NETWORK AND INFRASTRUCTURE 5987 04:27:07,219 --> 04:27:08,954 TRYING TO CONNECT THE DOTS AND 5988 04:27:08,954 --> 04:27:11,690 DOING THAT THROUGH THE SPACE OF 5989 04:27:11,690 --> 04:27:14,559 FUNDING OUR OWN -- HAVING OUR 5990 04:27:14,559 --> 04:27:15,694 ACCELERATOR FUNDING THE TEAMS 5991 04:27:15,694 --> 04:27:18,997 THAT COME OUT OF ACCELERATOR, 5992 04:27:18,997 --> 04:27:20,632 DOING COACHING AND MENTORING, 5993 04:27:20,632 --> 04:27:23,168 HAVING FOLKS LIKE BOB AND EIRs 5994 04:27:23,168 --> 04:27:25,103 THAT WE CAN CALL AND SAY, HEY, 5995 04:27:25,103 --> 04:27:26,872 WE NEED SOMEBODY WHO CAN DO THIS 5996 04:27:26,872 --> 04:27:28,940 FOR THIS TEAM FOR A LITTLE 5997 04:27:28,940 --> 04:27:30,275 WHILE, AND BRING THEM INTO 5998 04:27:30,275 --> 04:27:40,819 SUPPORT AS YOU'RE MOVING THROUGH 5999 04:27:42,020 --> 04:27:43,054 YOUR INNOVATION AND SUPPORT IN 6000 04:27:43,054 --> 04:27:53,565 IN VITRO AND MED TECH, FINDING 6001 04:27:58,703 --> 04:28:02,874 RESOURCES FURTHER DOWNSTREAM. 6002 04:28:02,874 --> 04:28:05,410 IF YOU WANT TO THINK ABOUT WHERE 6003 04:28:05,410 --> 04:28:07,178 DO YOU START, ONE OF THE MOST 6004 04:28:07,178 --> 04:28:08,280 CRITICAL THINGS AND WE START 6005 04:28:08,280 --> 04:28:10,448 WITH ALL THE TEAMS THAT COME 6006 04:28:10,448 --> 04:28:11,783 THROUGH THE WORKSHOPS IS BEING 6007 04:28:11,783 --> 04:28:13,652 HONEST AND CLEAR WHAT THE NEED 6008 04:28:13,652 --> 04:28:15,720 IS, WHERE YOU ARE AS AN 6009 04:28:15,720 --> 04:28:17,155 ORGANIZATION, WHERE YOUR IDEA 6010 04:28:17,155 --> 04:28:20,125 IS, YOUR COMPANY LOOKS LIKE, AND 6011 04:28:20,125 --> 04:28:21,326 WE'VE DEVELOPED THIS MENTOR 6012 04:28:21,326 --> 04:28:22,193 DEVELOPMENT FRAMEWORK ON THE 6013 04:28:22,193 --> 04:28:23,628 SLIDE, THERE ARE OTHER VERSIONS 6014 04:28:23,628 --> 04:28:25,597 SO THIS IS OUR VERSION BUT WOULD 6015 04:28:25,597 --> 04:28:27,299 ENCOURAGE YOU TO FINDS A VERSION 6016 04:28:27,299 --> 04:28:28,333 THAT WORKS FOR YOU. 6017 04:28:28,333 --> 04:28:33,605 THIS IS REALLY FOCUSED AROUND 6018 04:28:33,605 --> 04:28:35,140 SCIENCE AND TECHNOLOGY-BASED 6019 04:28:35,140 --> 04:28:36,441 COMPANIES LOOKING FOR EQUITY 6020 04:28:36,441 --> 04:28:37,208 OVER TIME. 6021 04:28:37,208 --> 04:28:38,476 SO THAT'S THE TRAJECTORY THAT 6022 04:28:38,476 --> 04:28:43,281 THIS IS LOOKING AT. 6023 04:28:43,281 --> 04:28:45,984 IT'S ACROSS SIX AXES, TEAM AND 6024 04:28:45,984 --> 04:28:49,054 VENTURE STRUCTURE, LOOKING AT 6025 04:28:49,054 --> 04:28:49,854 INNOVATION, TECHNOLOGY ITSELF, 6026 04:28:49,854 --> 04:28:52,157 IP AND STRATEGIES AND STRUCTURES 6027 04:28:52,157 --> 04:28:53,558 THAT UNDERLIE THAT, THE MARKET 6028 04:28:53,558 --> 04:28:55,226 AND WHAT THAT LOOKS LIKE. 6029 04:28:55,226 --> 04:28:57,295 THINKING ABOUT THE BUSINESS 6030 04:28:57,295 --> 04:28:59,264 MODEL AND RESOURCES. 6031 04:28:59,264 --> 04:29:02,534 WITH A WHAT WE SEE WITH STUDENT 6032 04:29:02,534 --> 04:29:04,069 SEEMS THINKING HARD ABOUT ONE OF 6033 04:29:04,069 --> 04:29:05,770 THESE THINGS, I KNOW WHAT MY 6034 04:29:05,770 --> 04:29:06,838 BUSINESS MODEL IS AND I'M GOING 6035 04:29:06,838 --> 04:29:09,341 TO DO THIS TO GET TO THE END. 6036 04:29:09,341 --> 04:29:10,875 AND IF YOU DO THAT, YOU GET TO 6037 04:29:10,875 --> 04:29:12,744 THE END OF THE BUSINESS MODEL 6038 04:29:12,744 --> 04:29:13,945 BUT HAVEN'T DONE ALL OF THE 6039 04:29:13,945 --> 04:29:16,247 OTHER PIECES TO GET TO A 6040 04:29:16,247 --> 04:29:22,821 SUCCESSFUL VENTURE AT THE END. 6041 04:29:22,821 --> 04:29:23,788 WE ENCOURAGE ANYONE IN OUR 6042 04:29:23,788 --> 04:29:25,991 PROGRAM TO THINK ABOUT ALL OF 6043 04:29:25,991 --> 04:29:27,292 THE DIFFERENCE AREAS THAT YOU 6044 04:29:27,292 --> 04:29:29,060 NEED TO BE FOCUSING ON AS YOU 6045 04:29:29,060 --> 04:29:32,364 MOVE KNOWING THEY ARE NOT ALL 6046 04:29:32,364 --> 04:29:34,666 GOING TO PROCEED SIMULTANEOUSLY 6047 04:29:34,666 --> 04:29:37,502 AT THE SAME PACE, SOMETIMES SOME 6048 04:29:37,502 --> 04:29:39,070 WILL GO FORWARDS, BACK, AND 6049 04:29:39,070 --> 04:29:41,006 OTHERS, BUT IT IS REALLY 6050 04:29:41,006 --> 04:29:43,541 CRITICAL TO LOOK ACROSS THOSE. 6051 04:29:43,541 --> 04:29:45,644 A QUICK EXAMPLE OF THE TEAM THAT 6052 04:29:45,644 --> 04:29:48,913 CAME IN TO ONE OF OUR 6053 04:29:48,913 --> 04:29:50,215 ACCELERATOR PROGRAMS. 6054 04:29:50,215 --> 04:29:53,518 WE MET THEM IN 2015, THE VENTURE 6055 04:29:53,518 --> 04:29:55,420 DEVELOPMENT FRAMEWORK WHEEL ON 6056 04:29:55,420 --> 04:29:56,454 THE LEFT. 6057 04:29:56,454 --> 04:29:59,190 AND SO WE HAD THEM REALLY LOOK. 6058 04:29:59,190 --> 04:30:03,261 WE DO THIS WITH THEM SO YOU'VE 6059 04:30:03,261 --> 04:30:04,229 HERDS ABOUT EXPERT ADVISORS, 6060 04:30:04,229 --> 04:30:06,631 IT'S IMPORTANT TO NOT DO THIS 6061 04:30:06,631 --> 04:30:07,832 ONLY YOURSELF. 6062 04:30:07,832 --> 04:30:08,833 YOU'RE OFTEN NOT HONEST ABOUT 6063 04:30:08,833 --> 04:30:12,337 WHERE YOU ARE AND WANT TO BE. 6064 04:30:12,337 --> 04:30:15,974 SO, HAVE THEM LOOK AT ALL THESE 6065 04:30:15,974 --> 04:30:16,274 THINGS. 6066 04:30:16,274 --> 04:30:18,209 THEY HAVE A STRONG SHOWING IN 6067 04:30:18,209 --> 04:30:26,284 THE 2015 ONE, FOR EXAMPLE, IN 6068 04:30:26,284 --> 04:30:29,854 TECH INNOVATION AND INTELLECTUAL 6069 04:30:29,854 --> 04:30:31,222 PROPERTY, HAD THEIR I.P. 6070 04:30:31,222 --> 04:30:35,260 PROTECTED IN A WAY MANY TEAMS DO 6071 04:30:35,260 --> 04:30:35,493 NOT. 6072 04:30:35,493 --> 04:30:37,562 THEY WERE COMING THROUGH OUR 6073 04:30:37,562 --> 04:30:40,598 PROGRAMS, THROUGH THE DIFFERENT 6074 04:30:40,598 --> 04:30:41,199 MENTORS, EXPERTS, NETWORKING 6075 04:30:41,199 --> 04:30:43,134 EVENTS THEY WERE ABLE TO 6076 04:30:43,134 --> 04:30:44,235 PARTICIPATE IN, WERE ABLE TO 6077 04:30:44,235 --> 04:30:46,871 MOVE EACH OF THESE THINGS 6078 04:30:46,871 --> 04:30:49,974 FORWARD TO THINK ABOUT, FOR 6079 04:30:49,974 --> 04:30:52,143 EXAMPLE, IN THEIR RESOURCE 6080 04:30:52,143 --> 04:30:54,546 STRUCTURE THEY HAD SCIENTIFIC 6081 04:30:54,546 --> 04:30:57,949 EXPERTISE, STRONG TECHNICAL TEAM 6082 04:30:57,949 --> 04:30:59,150 WITH SCIENCE ADVISORS, AS THEY 6083 04:30:59,150 --> 04:31:00,685 WENT TO BUILD OUT WHAT THIS 6084 04:31:00,685 --> 04:31:02,320 LOOKED LIKE AND HOW THEY WERE 6085 04:31:02,320 --> 04:31:05,290 GOING TO STRUCTURE THEIR VENTURE 6086 04:31:05,290 --> 04:31:09,127 OVER TIME, PARTICIPATING IN ALL 6087 04:31:09,127 --> 04:31:11,429 OF THESE, AND SOME OTHER 6088 04:31:11,429 --> 04:31:13,098 PROGRAMS THEY PARTICIPATED IN, 6089 04:31:13,098 --> 04:31:14,365 NETWORKING EVENTS, PULLED IN 6090 04:31:14,365 --> 04:31:15,533 SOME BUSINESS EXPERTISE THEY 6091 04:31:15,533 --> 04:31:17,368 WERE LOOKING FOR AND HOW THEY 6092 04:31:17,368 --> 04:31:21,873 TRIED TO GO FORWARD WITH 6093 04:31:21,873 --> 04:31:22,774 TECHNICAL EXPERTISE WOULDN'T 6094 04:31:22,774 --> 04:31:25,343 HAVE MADE THE PROGRESS IN ALL 6095 04:31:25,343 --> 04:31:30,048 THE AREAS YOU SEE. 6096 04:31:30,048 --> 04:31:33,918 BETWEEN 2015 AND 2019 MADE A 6097 04:31:33,918 --> 04:31:36,221 PIVOT IN CUSTOMER, TECHNOLOGY 6098 04:31:36,221 --> 04:31:39,290 APPLICATIONS, CHANGES BASED ON 6099 04:31:39,290 --> 04:31:40,425 ADVICE AND EXPERTISE AT THE 6100 04:31:40,425 --> 04:31:45,230 BEGINNING EVER -- OF THEIR WORK 6101 04:31:45,230 --> 04:31:46,097 WITH US. 6102 04:31:46,097 --> 04:31:47,832 I WOULD ENCOURAGE YOU TO SIT 6103 04:31:47,832 --> 04:31:51,236 DOWN, FIND WHAT WORKS FOR YOU, 6104 04:31:51,236 --> 04:31:52,103 MAYBE VENTURE DEVELOPMENT 6105 04:31:52,103 --> 04:31:58,276 FRAMEWORK, I HAD A LINK, 6106 04:31:58,276 --> 04:32:00,678 VENTUREWELL.ORG, AND THE GATES 6107 04:32:00,678 --> 04:32:02,147 SYSTEM THAT RADx HAS USED, 6108 04:32:02,147 --> 04:32:03,615 THINK THROUGH THE THINGS YOU 6109 04:32:03,615 --> 04:32:04,883 NEED TO MOVE FORWARDS. 6110 04:32:04,883 --> 04:32:07,085 I WON'T SPEND TIME ON FUNDING. 6111 04:32:07,085 --> 04:32:09,020 WE'VE HEARD ABOUT FUNDING FROM 6112 04:32:09,020 --> 04:32:10,021 OTHER FOLKS HERE. 6113 04:32:10,021 --> 04:32:13,224 ONE THING I DO WANT TO POINT OUT 6114 04:32:13,224 --> 04:32:15,059 FUNDERS DEPENDING ON WHERE YOU 6115 04:32:15,059 --> 04:32:16,728 ARE AS A VENTURE, AS AN 6116 04:32:16,728 --> 04:32:18,229 ORGANIZATION, WHAT YOU'RE 6117 04:32:18,229 --> 04:32:19,597 THINKING ABOUT, THINK ABOUT 6118 04:32:19,597 --> 04:32:20,999 MOTIVATION OF YOUR FUNDER AND 6119 04:32:20,999 --> 04:32:22,267 THINK ABOUT HOW THEY FIT INTO 6120 04:32:22,267 --> 04:32:25,270 YOUR PLAN AS A RESULT OF 6121 04:32:25,270 --> 04:32:28,339 MOTIVATION. 6122 04:32:28,339 --> 04:32:29,641 THERE ARE MISSION MOTIVATED 6123 04:32:29,641 --> 04:32:34,445 FUNDERS, THAT FIT IS CRITICAL. 6124 04:32:34,445 --> 04:32:36,748 THEY WANT TO SEE YOUR TECH MOVE 6125 04:32:36,748 --> 04:32:37,215 FORWARD. 6126 04:32:37,215 --> 04:32:39,017 THEY ARE FINANCIALLY MOTIVATED. 6127 04:32:39,017 --> 04:32:41,252 THAT'S A DIFFERENT CASE TO MAKE 6128 04:32:41,252 --> 04:32:43,221 TO A FINANCIALLY MOTIVATED 6129 04:32:43,221 --> 04:32:45,723 FUNDER THAN MISSION MOTIVATED 6130 04:32:45,723 --> 04:32:45,957 FUNDER. 6131 04:32:45,957 --> 04:32:47,458 A NUMBER OF OTHER FUNDING 6132 04:32:47,458 --> 04:32:50,228 VEHICLES THAT YOU CAN THINK 6133 04:32:50,228 --> 04:32:50,595 ABOUT. 6134 04:32:50,595 --> 04:32:52,764 THERE ARE DIFFERENT TYPES. 6135 04:32:52,764 --> 04:32:56,935 THIS IS SOMETHING YOU'RE AWARE 6136 04:32:56,935 --> 04:32:59,237 OF, TOUCHED ON IN EARLIER 6137 04:32:59,237 --> 04:32:59,571 PANELS. 6138 04:32:59,571 --> 04:33:01,873 I'M HAPPY TO MAKE THIS SLIDE 6139 04:33:01,873 --> 04:33:05,210 AVAILABLE, I WANT TO POINT OUT 6140 04:33:05,210 --> 04:33:06,411 AS YOU'RE THINKING ABOUT WHERE 6141 04:33:06,411 --> 04:33:08,279 YOU WANT TO GO AND GET THERE, 6142 04:33:08,279 --> 04:33:09,781 IT'S IMPORTANT TO THINK ABOUT 6143 04:33:09,781 --> 04:33:10,982 WHAT TYPE OF FUNDING WILL GET 6144 04:33:10,982 --> 04:33:12,617 YOU THERE AND WHERE YOU MIGHT 6145 04:33:12,617 --> 04:33:13,518 FIND THAT. 6146 04:33:13,518 --> 04:33:16,554 FOR EXAMPLE I USED TO WORK AT A 6147 04:33:16,554 --> 04:33:19,123 LARGE PHILANTHROPY, IF YOU COME 6148 04:33:19,123 --> 04:33:20,859 INTO A LARGE MISSION FOCUS WITH 6149 04:33:20,859 --> 04:33:23,294 AN IDEA NOT ON STRATEGY IT 6150 04:33:23,294 --> 04:33:26,931 DOESN'T MATTER, IT'S NOT A FIT. 6151 04:33:26,931 --> 04:33:28,032 THERE'S UNLIKELY TO BE OPERATION 6152 04:33:28,032 --> 04:33:32,303 SUPPORT FOR YOUR WORK IN THAT 6153 04:33:32,303 --> 04:33:32,637 WAY. 6154 04:33:32,637 --> 04:33:35,473 SOMETHING TO THINK ABOUT AS 6155 04:33:35,473 --> 04:33:36,574 YOU'RE MOVING FORWARD. 6156 04:33:36,574 --> 04:33:38,776 BOB PUT UP A GREAT LIST OF 6157 04:33:38,776 --> 04:33:42,413 DIFFERENT PLACES YOU CAN GO TO 6158 04:33:42,413 --> 04:33:44,582 LOOK FOR NETWORK SUPPORT AND 6159 04:33:44,582 --> 04:33:45,683 INFRASTRUCTURE, PARTICULARLY 6160 04:33:45,683 --> 04:33:45,984 REGIONALLY. 6161 04:33:45,984 --> 04:33:51,155 I WOULD ENCOURAGE YOU TO THINK 6162 04:33:51,155 --> 04:33:52,023 ABOUT ACCELERATOR PROGRAM, 6163 04:33:52,023 --> 04:33:53,458 SOMEPLACE THAT CAN KICK START 6164 04:33:53,458 --> 04:33:58,062 YOUR ACCESS TO ALL OF THOSE 6165 04:33:58,062 --> 04:33:59,797 NETWORKS THIS IS VENTUREWELL'S 6166 04:33:59,797 --> 04:34:03,768 ACCELERATOR PROGRAM, WE HAVE A 6167 04:34:03,768 --> 04:34:05,503 FAMILY OF PROGRAMS YOU CAN 6168 04:34:05,503 --> 04:34:10,742 ENTER, A LOT OF OTHER OPTIONS. 6169 04:34:10,742 --> 04:34:15,046 OUR TRAINING LOOKS LIKE I-CORPS, 6170 04:34:15,046 --> 04:34:25,590 AS BOB SAID A STANDARD PLAYBOOK. 6171 04:34:26,591 --> 04:34:29,394 THE ACCESS WILL BE PROVIDED TO 6172 04:34:29,394 --> 04:34:31,229 THAT ACCELERATORS NETWORK OVER 6173 04:34:31,229 --> 04:34:31,429 TIME. 6174 04:34:31,429 --> 04:34:33,865 DO THINK WHERE ARE YOU, WHAT 6175 04:34:33,865 --> 04:34:39,771 SORT OF ACCELERATOR IS A GOOD 6176 04:34:39,771 --> 04:34:40,738 FIT FOR YOU. 6177 04:34:40,738 --> 04:34:42,607 EVERYBODY WHO HAS TALKED ABOUT 6178 04:34:42,607 --> 04:34:44,142 SUPPORT SAND GROWING YOUR 6179 04:34:44,142 --> 04:34:46,544 VENTURE, BRINGING YOUR IDEA 6180 04:34:46,544 --> 04:34:47,211 FORWARD, BUILDING YOUR NETWORK, 6181 04:34:47,211 --> 04:34:51,716 I WANT TO POINT OUT A COUPLE 6182 04:34:51,716 --> 04:34:52,350 THINGS ABOUT ACADEMIC 6183 04:34:52,350 --> 04:34:55,620 ENTREPRENEURS, THAT'S THE BREAD 6184 04:34:55,620 --> 04:34:58,489 AND BUTTER, SUPPORTING HIGHER 6185 04:34:58,489 --> 04:35:01,859 EDS ECOSYSTEM AND STUDENT 6186 04:35:01,859 --> 04:35:08,232 INNOVATORS AND AS BOB NOTED, 6187 04:35:08,232 --> 04:35:12,470 MUCH BETTER RESOURCE FOR STUDENT 6188 04:35:12,470 --> 04:35:13,371 INNOVATORS, ACADEMIC INNOVATORS, 6189 04:35:13,371 --> 04:35:16,741 FIGURE OUT THE THINGS THEY OFFER 6190 04:35:16,741 --> 04:35:18,042 YOU, LOOK AT ON-CAMPUS 6191 04:35:18,042 --> 04:35:20,044 RESOURCES, ALSO LOOK AT YOUR 6192 04:35:20,044 --> 04:35:21,879 REGIONAL ENVIRONMENT AND THOSE 6193 04:35:21,879 --> 04:35:23,114 OFF-CAMPUS RESOURCES YOU MIGHT 6194 04:35:23,114 --> 04:35:26,417 FIND, TAKE THE OPPORTUNITIES TO 6195 04:35:26,417 --> 04:35:27,618 PARTICIPATE IN COMPETITIONS, AS 6196 04:35:27,618 --> 04:35:28,920 A OPPORTUNITY, EVEN AS ACADEMIC, 6197 04:35:28,920 --> 04:35:31,456 TAKE ADVANTAGE OF ALL THOSE 6198 04:35:31,456 --> 04:35:33,091 NETWORKING OPPORTUNITIES, THERE 6199 04:35:33,091 --> 04:35:34,959 ARE SO MANY NETWORKING 6200 04:35:34,959 --> 04:35:37,061 OPPORTUNITIES AND IN THE 6201 04:35:37,061 --> 04:35:38,229 ACADEMIC SETTING. 6202 04:35:38,229 --> 04:35:40,865 IN YOUR COMMUNITY THERE'S A 6203 04:35:40,865 --> 04:35:42,734 SIMILAR STRUCTURE, NOT ACADEMIC 6204 04:35:42,734 --> 04:35:45,570 BASED BUT A START-UP OPPORTUNITY 6205 04:35:45,570 --> 04:35:47,772 FOUND THROUGH YOUR SBA OR 6206 04:35:47,772 --> 04:35:48,973 SIMILAR AND THERE'S EVERY CITY 6207 04:35:48,973 --> 04:35:53,578 WILL HAVE THEIR OWN SET OF 6208 04:35:53,578 --> 04:35:54,779 INCUBATORS AND ACCELERATORS WITH 6209 04:35:54,779 --> 04:35:56,414 SPECIFIC FOCUS AREAS. 6210 04:35:56,414 --> 04:35:58,616 I'LL DO ONE OR TWO MORE SLIDES 6211 04:35:58,616 --> 04:36:07,358 AND I'M TOLD TO SPEED UP. 6212 04:36:07,358 --> 04:36:09,961 THINK ABOUT WHAT YOU AND YOUR 6213 04:36:09,961 --> 04:36:15,033 PARTNER MIGHT GET OUT OF THAT 6214 04:36:15,033 --> 04:36:16,934 GOING FORWARDS, SET EXPECTATIONS 6215 04:36:16,934 --> 04:36:18,770 IN EARLY, CLEAR ABOUT 6216 04:36:18,770 --> 04:36:19,971 PARTNERSHIPS, SET GOOD GOALS, 6217 04:36:19,971 --> 04:36:22,807 ALWAYS GO IN WITH EXIT PLAN IN 6218 04:36:22,807 --> 04:36:23,141 PLACE. 6219 04:36:23,141 --> 04:36:25,009 I WON'T GO OVER THIS PARTICULAR 6220 04:36:25,009 --> 04:36:27,745 EXAMPLE OF A PILOT STUDY BUT THE 6221 04:36:27,745 --> 04:36:28,946 KEY POINT IS THAT PARTICULAR 6222 04:36:28,946 --> 04:36:30,148 ORGANIZATION DIDN'T JUST GO WITH 6223 04:36:30,148 --> 04:36:30,915 THE FIRST ORGANIZATION THEY 6224 04:36:30,915 --> 04:36:32,984 FOUND TO BE A PILOT STUDY 6225 04:36:32,984 --> 04:36:33,885 PARTNER. 6226 04:36:33,885 --> 04:36:34,685 THEY THOUGHT THROUGH THE 6227 04:36:34,685 --> 04:36:37,155 STRUCTURE AND WHO WOULD BE THE 6228 04:36:37,155 --> 04:36:39,157 BEST FIT, LOOKED AT 20 6229 04:36:39,157 --> 04:36:40,825 ORGANIZATIONS, STARTED TALKING 6230 04:36:40,825 --> 04:36:46,164 TO FIVE, PICKED ONE. 6231 04:36:46,164 --> 04:36:53,071 IT WAS THE BEST LANDSCAPE, BEST 6232 04:36:53,071 --> 04:36:53,271 FIT. 6233 04:36:53,271 --> 04:36:58,976 YOU HERE -- HERE IS A LIST OF 6234 04:36:58,976 --> 04:37:04,682 RESOURCES WITH A COUPLE LINKS. 6235 04:37:04,682 --> 04:37:06,117 WE'VE COMPILED -- AS AN 6236 04:37:06,117 --> 04:37:07,218 ORGANIZATION WE FOCUS ON GROWING 6237 04:37:07,218 --> 04:37:10,188 THE FIELD AND LEARNING 6238 04:37:10,188 --> 04:37:10,521 OPPORTUNITIES. 6239 04:37:10,521 --> 04:37:13,791 YOU'LL FIND OPPORTUNITIES ON THE 6240 04:37:13,791 --> 04:37:16,294 RESOURCE PAGE, WE PARTNER WITH 6241 04:37:16,294 --> 04:37:18,262 COOLEY FOR FORMS AND LEGAL 6242 04:37:18,262 --> 04:37:18,496 ADVICE. 6243 04:37:18,496 --> 04:37:20,798 THEY HAVE A BIG SET OF START-UP 6244 04:37:20,798 --> 04:37:22,967 AND I.P. RESOURCES THAT YOU CAN 6245 04:37:22,967 --> 04:37:26,237 ALSO TAKE ADVANTAGE OF. 6246 04:37:26,237 --> 04:37:36,447 THAT'S IT. 6247 04:37:38,216 --> 04:37:38,616 THANK YOU. 6248 04:37:38,616 --> 04:37:40,952 [APPLAUSE] 6249 04:37:40,952 --> 04:37:44,689 6250 04:37:44,689 --> 04:37:48,226 >> AS THINGS ARE HAPPENING IN 6251 04:37:48,226 --> 04:37:51,395 THE BACKGROUND, I'M KARI 6252 04:37:51,395 --> 04:37:56,901 ASHMONT, TEAM LEAD FOR NIBIB, 6253 04:37:56,901 --> 04:37:58,436 OVERSEE SMALL BUSINESS PROGRAM 6254 04:37:58,436 --> 04:38:01,639 AND HELP WITH RADx ACTIVITIES. 6255 04:38:01,639 --> 04:38:04,041 MIKE MENTIONED I CO-LEAD THE 6256 04:38:04,041 --> 04:38:04,909 BRAIN INITIATIVE DISSEMINATION 6257 04:38:04,909 --> 04:38:05,309 TEAM. 6258 04:38:05,309 --> 04:38:12,316 THANK YOU FOR HAVING ME HERE 6259 04:38:12,316 --> 04:38:13,417 TODAY, MIKE. 6260 04:38:13,417 --> 04:38:16,053 THIS IS THE SMALL BUSINESS 6261 04:38:16,053 --> 04:38:19,590 PROGRAM, FOR THOSE WHO JOINED 6262 04:38:19,590 --> 04:38:21,125 THE WORKSHOP YESTERDAY, I 6263 04:38:21,125 --> 04:38:23,294 RECOGNIZE SOME FACES THIS SHOULD 6264 04:38:23,294 --> 04:38:25,062 SOUND FAMILIAR. 6265 04:38:25,062 --> 04:38:26,697 SO THE SMALL BUSINESS PROGRAM AT 6266 04:38:26,697 --> 04:38:29,100 NIH IS ONE OF OUR BIGGEST 6267 04:38:29,100 --> 04:38:31,402 RESOURCES, YOU THINK THE NIH, 6268 04:38:31,402 --> 04:38:31,636 FUNDING. 6269 04:38:31,636 --> 04:38:34,038 SO WE ARE THE LARGEST SOURCE OF 6270 04:38:34,038 --> 04:38:35,339 EARLY STAGE CAPITAL FOR 6271 04:38:35,339 --> 04:38:36,674 BIOMEDICAL OR LIFE SCIENCE 6272 04:38:36,674 --> 04:38:40,511 ENTREPRENEURS IN THE U.S. 6273 04:38:40,511 --> 04:38:41,379 THIS FUNDING IS NON-DILUTIVE, 6274 04:38:41,379 --> 04:38:45,850 YOU DON'T HAVE TO RETURN IT. 6275 04:38:45,850 --> 04:38:47,518 OFTEN USED AS LEVERAGE TO 6276 04:38:47,518 --> 04:38:50,922 ATTRACT MORE FUNDING FOR SMALL 6277 04:38:50,922 --> 04:38:51,222 BUSINESSES. 6278 04:38:51,222 --> 04:38:54,625 9 PROGRAM HAS TWO COMPONENTS, 6279 04:38:54,625 --> 04:38:57,028 SMALL BUSINESS INNOVATION 6280 04:38:57,028 --> 04:38:59,263 RESEARCH SBIR COMPONENT WHICH 6281 04:38:59,263 --> 04:39:00,831 PROVIDES $1.1 BILLION TO THE 6282 04:39:00,831 --> 04:39:02,533 SMALL BUSINESS COMMUNITY A YEAR. 6283 04:39:02,533 --> 04:39:04,936 AND THE SMALL BUSINESS 6284 04:39:04,936 --> 04:39:07,271 TECHNOLOGY TRANSFER PROGRAM, 6285 04:39:07,271 --> 04:39:08,105 WHICH HAS APPROXIMATELY $150 6286 04:39:08,105 --> 04:39:12,043 MILLION WORTH OF FUNDING PER 6287 04:39:12,043 --> 04:39:12,577 YEAR. 6288 04:39:12,577 --> 04:39:13,811 THERE'S DIFFERENT ENTRY POINTS 6289 04:39:13,811 --> 04:39:15,213 DEPENDING ON THE STAGE OF THE 6290 04:39:15,213 --> 04:39:17,381 PROJECT THAT YOU'RE WORKING ON. 6291 04:39:17,381 --> 04:39:19,250 YOU CAN COME FOR PHASE 1 AS 6292 04:39:19,250 --> 04:39:20,885 CHRIS MENTIONED TO ESTABLISH 6293 04:39:20,885 --> 04:39:21,786 FEASIBILITY PROOF OF CONCEPT 6294 04:39:21,786 --> 04:39:22,420 TYPE WORK. 6295 04:39:22,420 --> 04:39:24,088 YOU MIGHT HAVE BEEN ABLE TO 6296 04:39:24,088 --> 04:39:26,257 ACQUIRE FUNDING FROM A DIFFERENT 6297 04:39:26,257 --> 04:39:28,459 AGENCY AND MIGHT BE ABLE TO COME 6298 04:39:28,459 --> 04:39:30,194 FOR DIRECT TO PHASE 2 FOR FOLLOW 6299 04:39:30,194 --> 04:39:31,829 HAD BEEN ON ACTIVITIES TO 6300 04:39:31,829 --> 04:39:33,731 PROGRESS YOUR TECHNOLOGY DOWN 6301 04:39:33,731 --> 04:39:35,132 THE ROAD TOWARDS 6302 04:39:35,132 --> 04:39:35,566 COMMERCIALIZATION. 6303 04:39:35,566 --> 04:39:38,169 WE DO ALSO OFFER FAST TRACK 6304 04:39:38,169 --> 04:39:39,270 OPPORTUNITY WHICH COMBINES THE 6305 04:39:39,270 --> 04:39:42,807 PHASE 1 AND PHASE 2 INTO A 6306 04:39:42,807 --> 04:39:43,774 SINGLE APPLICATION AND LOWERS 6307 04:39:43,774 --> 04:39:48,713 THE AMOUNT OF TIME BETWEEN THE 6308 04:39:48,713 --> 04:39:54,518 PHASE 1 AND PHASE 2 AND FUNDING 6309 04:39:54,518 --> 04:39:55,286 ASSOCIATED WITH. 6310 04:39:55,286 --> 04:39:56,487 SBIR-ONLY FOR THE DIRECT TO 6311 04:39:56,487 --> 04:39:59,056 PHASE 2 OPTION IF YOU'RE COMING 6312 04:39:59,056 --> 04:40:00,458 IN FROM ANOTHER AGENCY. 6313 04:40:00,458 --> 04:40:02,093 IN ADDITION TO THESE STANDARD 6314 04:40:02,093 --> 04:40:04,495 PHASE 1 AND PHASE 2s WE HAVE A 6315 04:40:04,495 --> 04:40:07,198 PHASE 2B FOR SOME OF THE 6316 04:40:07,198 --> 04:40:08,666 INSTITUTES AND CENTERS AND 6317 04:40:08,666 --> 04:40:09,767 THAT'S AN IMPORTANT REOCCURRING 6318 04:40:09,767 --> 04:40:12,136 THEME AS I WALK THROUGH THIS, 6319 04:40:12,136 --> 04:40:15,373 NOT ALL INSTITUTES AND CENTERS 6320 04:40:15,373 --> 04:40:16,874 PARTICIPATE IN ALL ACTIVITIES. 6321 04:40:16,874 --> 04:40:20,244 PHASE 2B IS JUST AN ADDITIONAL 6322 04:40:20,244 --> 04:40:22,680 PHASE 2 TYPE ACTIVITY AND WE 6323 04:40:22,680 --> 04:40:24,949 HAVE COMMERCIALIZATION PILOT 6324 04:40:24,949 --> 04:40:25,750 PROGRAMS WHICH SUPPORT 6325 04:40:25,750 --> 04:40:26,284 COMMERCIALIZATION-RELATED 6326 04:40:26,284 --> 04:40:27,485 ACTIVITIES IN TERMS OF PUSHING 6327 04:40:27,485 --> 04:40:33,958 YOUR TECHNOLOGY OUT THE DOOR. 6328 04:40:33,958 --> 04:40:35,026 IN TERMS OF FUNDING 6329 04:40:35,026 --> 04:40:36,527 OPPORTUNITIES THE VAST MAJORITY 6330 04:40:36,527 --> 04:40:38,329 OF APPLICATIONS FOR SMALL 6331 04:40:38,329 --> 04:40:41,532 BUSINESS PROGRAM COME THROUGH 6332 04:40:41,532 --> 04:40:42,800 OUR FOUR OMNIBUS SOLICITATIONS, 6333 04:40:42,800 --> 04:40:43,401 CLINICAL TRIALS REQUIRED, 6334 04:40:43,401 --> 04:40:44,969 CLINICAL TRIALS NOT ALLOWED 6335 04:40:44,969 --> 04:40:50,841 VERSION FOR BOTH SBIR AND STTR 6336 04:40:50,841 --> 04:40:51,275 PROGRAMS. 6337 04:40:51,275 --> 04:40:53,678 IN ADDITION THERE ARE A NUMBER 6338 04:40:53,678 --> 04:40:56,113 OF SPECIALIZED MORE FOCUSED TO A 6339 04:40:56,113 --> 04:40:57,281 SPECIFIC AREA FUNDING 6340 04:40:57,281 --> 04:40:58,849 OPPORTUNITIES THAT EITHER 6341 04:40:58,849 --> 04:41:00,685 INDIVIDUAL INSTITUTES OR CENTERS 6342 04:41:00,685 --> 04:41:02,353 OR A GROUP OF INSTITUTES AND 6343 04:41:02,353 --> 04:41:03,854 CENTERS MIGHT PUT OUT. 6344 04:41:03,854 --> 04:41:05,256 I WOULD RECOMMEND REACHING OUT 6345 04:41:05,256 --> 04:41:08,459 TO THE INSTITUTE OR CENTER THAT 6346 04:41:08,459 --> 04:41:09,560 YOU'RE WORKING WITH, AND SEEING 6347 04:41:09,560 --> 04:41:10,261 WHAT OPPORTUNITIES THEY HAVE 6348 04:41:10,261 --> 04:41:11,962 AVAILABLE AND WHETHER OR NOT THE 6349 04:41:11,962 --> 04:41:14,065 OMNIBUS IS THE RIGHT APPROACH OR 6350 04:41:14,065 --> 04:41:16,267 THEY MIGHT HAVE A MORE SPECIFIED 6351 04:41:16,267 --> 04:41:18,369 VERSION THAT WOULD BE 6352 04:41:18,369 --> 04:41:18,803 APPROPRIATE. 6353 04:41:18,803 --> 04:41:20,871 IN THE ABSENCE OF TALKING WITH 6354 04:41:20,871 --> 04:41:23,007 ANYBODY THE SEED WEBSITE IS 6355 04:41:23,007 --> 04:41:23,274 EXCELLENT. 6356 04:41:23,274 --> 04:41:25,976 I DON'T THINK CHRIS PLUGGED IT 6357 04:41:25,976 --> 04:41:26,243 AS. 6358 04:41:26,243 --> 04:41:28,045 AS I'M GOING TO. 6359 04:41:28,045 --> 04:41:31,315 THE SEED WEBSITE IS A WEALTH OF 6360 04:41:31,315 --> 04:41:32,383 INFORMATION FOR ANYONE STARTING 6361 04:41:32,383 --> 04:41:33,317 A SMALL BILLS. 6362 04:41:33,317 --> 04:41:35,152 YOU CAN FIND A LINK TO THE 6363 04:41:35,152 --> 04:41:36,921 FUNDING OPPORTUNITIES ON THEIR 6364 04:41:36,921 --> 04:41:37,922 WEBSITE AS WELL. 6365 04:41:37,922 --> 04:41:40,324 NOW IN ADDITION TO FUNDING 6366 04:41:40,324 --> 04:41:41,926 OPPORTUNITIES OBVIOUSLY WE ALSO 6367 04:41:41,926 --> 04:41:43,260 HAVE OTHER RESOURCES. 6368 04:41:43,260 --> 04:41:44,795 AND THAT CAN STRETCH FROM SOME 6369 04:41:44,795 --> 04:41:47,765 OF THE RESOURCES THAT YOU HERDS 6370 04:41:47,765 --> 04:41:49,300 FROM CHRIS EARLIER TODAY OR WE 6371 04:41:49,300 --> 04:41:51,369 ALSO HAVE ONE AT NIBIB WHICH I 6372 04:41:51,369 --> 04:41:52,903 WILL HAPPILY TALK ABOUT IN MORE 6373 04:41:52,903 --> 04:41:59,844 DETAIL IN A MOMENT CALLED THE 6374 04:41:59,844 --> 04:42:02,346 CONCEPT, C3I PROGRAM, REACH OUT 6375 04:42:02,346 --> 04:42:03,214 TO PROGRAM OFFICERS, WE'RE 6376 04:42:03,214 --> 04:42:05,449 OURSELVES IN SOME WAYS A 6377 04:42:05,449 --> 04:42:08,552 RESOURCE TO YOU IN TERMS OF THE 6378 04:42:08,552 --> 04:42:10,221 HELPING DIRECT YOU TO 6379 04:42:10,221 --> 04:42:10,788 APPROPRIATE PROGRAMS, BEING 6380 04:42:10,788 --> 04:42:13,290 AWARE OF WHAT THE OPTIONS ARE 6381 04:42:13,290 --> 04:42:13,958 OUT THERE. 6382 04:42:13,958 --> 04:42:16,594 THIS SLIDE IS HERE SOLELY FOR 6383 04:42:16,594 --> 04:42:18,295 THE PURPOSE OF EMPHASIZING WHAT 6384 04:42:18,295 --> 04:42:20,231 I'VE ALREADY DONE, WHICH IS TO 6385 04:42:20,231 --> 04:42:23,300 SAY THERE ARE 27 INSTITUTES AND 6386 04:42:23,300 --> 04:42:24,335 CENTERS WITHIN THE NIH. 6387 04:42:24,335 --> 04:42:26,871 WE ALL HAVE OUR OWN FUNDING, OUR 6388 04:42:26,871 --> 04:42:29,273 OWN MISSIONS AND PRIORITY AREAS, 6389 04:42:29,273 --> 04:42:31,075 POLICIES, ET CETERA, AND THAT 6390 04:42:31,075 --> 04:42:31,909 APPLIES TO SMALL BUSINESS 6391 04:42:31,909 --> 04:42:33,677 PROGRAMS THAT RUN WITHIN THESE 6392 04:42:33,677 --> 04:42:35,513 INSTITUTES AND CENTERS AS WELL. 6393 04:42:35,513 --> 04:42:37,381 SO IT'S IMPORTANT TO REALIZE 6394 04:42:37,381 --> 04:42:38,716 THAT WHEN YOU KNOW ONE INSTITUTE 6395 04:42:38,716 --> 04:42:41,452 OR CENTER AT THE NIH, YOU KNOW 6396 04:42:41,452 --> 04:42:43,087 ONE INSTITUTE OR CENTER AT THE 6397 04:42:43,087 --> 04:42:43,254 NIH. 6398 04:42:43,254 --> 04:42:45,156 SO YOU REALLY NEED TO TALK WITH 6399 04:42:45,156 --> 04:42:47,792 PEOPLED SAND MAKE SURE THAT YOU 6400 04:42:47,792 --> 04:42:51,095 HADS ARE UNDERSTANDING HOW THEY 6401 04:42:51,095 --> 04:42:53,397 ASSESS APPLICATIONS, PRIORITY 6402 04:42:53,397 --> 04:42:54,465 AREAS, SO YOU'RE SETTING 6403 04:42:54,465 --> 04:42:55,900 YOURSELVES UP FOR SUCCESS AT 6404 04:42:55,900 --> 04:43:00,838 THAT PEER REVIEW PANEL BUT ALSO 6405 04:43:00,838 --> 04:43:05,543 ADMINISTRATIVE REVIEW LEVEL 6406 04:43:05,543 --> 04:43:09,046 POST-REVIEW PANEL. 6407 04:43:09,046 --> 04:43:10,347 SO WE'RE UNIQUE IN TERMS OF 6408 04:43:10,347 --> 04:43:19,356 INSURE TIGHTS AND -- 6409 04:43:19,356 --> 04:43:22,293 INSTITUTES AND CENTERS, DISEASE 6410 04:43:22,293 --> 04:43:24,595 AGNOSTIC FOCUS ON TOOL 6411 04:43:24,595 --> 04:43:26,630 TECHNOLOGY AND ENGINEERS WITH A 6412 04:43:26,630 --> 04:43:28,132 WIDE VARIETY WE SUPPORT. 6413 04:43:28,132 --> 04:43:30,501 I WON'T GO THROUGH THE LIST ON 6414 04:43:30,501 --> 04:43:33,237 THE SLIDE BUT GENERALLY SPEAKING 6415 04:43:33,237 --> 04:43:36,106 IF YOU ARE APPLYING FOR FUNDING 6416 04:43:36,106 --> 04:43:39,677 THAT IS FOCUSING ON TECHNOLOGY 6417 04:43:39,677 --> 04:43:40,177 DEVELOPMENT, PRODUCTLY 6418 04:43:40,177 --> 04:43:41,245 APPLICABLE AND ULTIMATELY GEARED 6419 04:43:41,245 --> 04:43:42,112 TO IMPROVING HUMAN HEALTH 6420 04:43:42,112 --> 04:43:44,114 THERE'S A CHANCE YOU WOULD FIT 6421 04:43:44,114 --> 04:43:44,849 WITHIN OUR MISSION. 6422 04:43:44,849 --> 04:43:46,817 BUT OF COURSE WITH SUCH A BROAD 6423 04:43:46,817 --> 04:43:49,019 MISSION, THERE'S A LOT OF GRAY 6424 04:43:49,019 --> 04:43:51,088 AREAS, SO AGAIN THE KEY MESSAGE 6425 04:43:51,088 --> 04:43:53,724 HERE IS REACH OUT, SEND A 6426 04:43:53,724 --> 04:43:55,159 DRAFT-SPECIFIC AIMS PAGE AND WE 6427 04:43:55,159 --> 04:43:56,360 CAN GO FROM THERE IN TERMS OF 6428 04:43:56,360 --> 04:43:57,795 HELPING YOU TO DIRECTS YOU TO 6429 04:43:57,795 --> 04:43:59,430 THE RIGHT PLACE. 6430 04:43:59,430 --> 04:44:02,399 NIBIB IS SMALL BUT MIGHTY. 6431 04:44:02,399 --> 04:44:04,435 WE HAVE ABOUT $13.2 MILLION IN 6432 04:44:04,435 --> 04:44:06,537 OUR SMALL BUSINESS ANNUAL BUDGET 6433 04:44:06,537 --> 04:44:09,139 WITH ABOUT 46 ACTIVE AWARDS. 6434 04:44:09,139 --> 04:44:12,343 YOU CAN SEE WE SUPPORT A WIDE 6435 04:44:12,343 --> 04:44:13,444 VARIETY OF TECHNOLOGY 6436 04:44:13,444 --> 04:44:14,311 DEVELOPMENT AREAS. 6437 04:44:14,311 --> 04:44:17,848 AND IN ADDITION TO SOME OF THE 6438 04:44:17,848 --> 04:44:22,453 FUNDING OPPORTUNITIES THAT OTHER 6439 04:44:22,453 --> 04:44:24,822 INSTITUTES HAVE WE'RE 6440 04:44:24,822 --> 04:44:27,925 PARTICIPANTS IN THE BRAIN 6441 04:44:27,925 --> 04:44:31,495 INITIATIVE AND HEAL INITIATIVE. 6442 04:44:31,495 --> 04:44:34,031 AS PROMISED, ONE NON-FUNDING 6443 04:44:34,031 --> 04:44:35,232 RESOURCE NIBIB HAS THAT WE'RE 6444 04:44:35,232 --> 04:44:41,038 PROUD OF IS CALLED THE C3I 6445 04:44:41,038 --> 04:44:44,942 PROGRAM, IS A PROGRAM THAT IS 6446 04:44:44,942 --> 04:44:46,644 BASED ON THE COMMERCIALIZATION 6447 04:44:46,644 --> 04:44:50,114 PROCESS AND IS REALLY GEARED TO 6448 04:44:50,114 --> 04:44:51,982 EDUCATING AND MENTORING 6449 04:44:51,982 --> 04:44:54,752 INNOVATORS HOW TO TRANSLATE 6450 04:44:54,752 --> 04:44:57,821 THEIR IDEAS FROM CONCEPT IN THE 6451 04:44:57,821 --> 04:45:00,190 LAB OUT TO COMMERCIALIZATION. 6452 04:45:00,190 --> 04:45:02,259 THE PROGRAM ITSELF HAS THREE 6453 04:45:02,259 --> 04:45:04,128 COMPONENTS, AND FOR EACH OF THEM 6454 04:45:04,128 --> 04:45:05,429 YOU ARE PAIRED WITH A BUSINESS 6455 04:45:05,429 --> 04:45:08,165 ADVISER AS WELL AS PROJECT 6456 04:45:08,165 --> 04:45:09,266 MANAGER WHO HAS EXPERTISE IN 6457 04:45:09,266 --> 04:45:13,671 YOUR FIELD TO HELP TO GUIDE YOU 6458 04:45:13,671 --> 04:45:15,873 ALONG THIS PROCESS. 6459 04:45:15,873 --> 04:45:18,509 THE FIRST COMPONENT IS THE EC 6460 04:45:18,509 --> 04:45:21,912 3I, THIS IS FOCUSED ON 6461 04:45:21,912 --> 04:45:23,447 EDUCATION, SPECIFICALLY RUN 6462 04:45:23,447 --> 04:45:24,448 DURING THE SUMMERTIME. 6463 04:45:24,448 --> 04:45:27,518 THIS IS BECAUSE THIS PROGRAM IS 6464 04:45:27,518 --> 04:45:28,819 TARGETING ACADEMIC INNOVATORS 6465 04:45:28,819 --> 04:45:31,555 WHO ARE JUST GETTING STARTED AND 6466 04:45:31,555 --> 04:45:33,757 TRYING TO FIGURE OUT IF THEIR 6467 04:45:33,757 --> 04:45:35,125 IDEA, IF THEIR INNOVATION 6468 04:45:35,125 --> 04:45:36,260 ACTUALLY HAS SOME LEGS. 6469 04:45:36,260 --> 04:45:38,596 SO THE PROGRAM IS LARGELY 6470 04:45:38,596 --> 04:45:41,198 FOCUSED ON UNDERSTANDING THE 6471 04:45:41,198 --> 04:45:43,601 MARKET, AND WHAT YOUR VALUE 6472 04:45:43,601 --> 04:45:44,702 PROPOSITION MIGHT BE. 6473 04:45:44,702 --> 04:45:47,538 WE CONSIDER A VERY GOOD OUTCOME 6474 04:45:47,538 --> 04:45:49,306 TO BE THAT YOU MIGHT REALIZE 6475 04:45:49,306 --> 04:45:51,275 WHAT YOU THOUGHT WAS THE BEST 6476 04:45:51,275 --> 04:45:52,910 MARKET ISN'T, AND YOU MIGHT NEED 6477 04:45:52,910 --> 04:45:54,979 TO PIVOT TO A DIFFERENT ONE. 6478 04:45:54,979 --> 04:45:56,213 THAT'S INDEED A SUCCESS BECAUSE 6479 04:45:56,213 --> 04:45:58,716 YOU'VE DONE THAT EARLY ON IN THE 6480 04:45:58,716 --> 04:45:58,949 PROCESS. 6481 04:45:58,949 --> 04:46:01,018 YOU CAN SEE ON THE BOTTOM THAT 6482 04:46:01,018 --> 04:46:03,087 WE ARE NOT THE ONLY PARTICIPANTS 6483 04:46:03,087 --> 04:46:05,122 IN THIS PROGRAM SO WE DO 6484 04:46:05,122 --> 04:46:08,926 ACTUALLY OPEN UP ALL OF C3I TO 6485 04:46:08,926 --> 04:46:09,893 DIFFERENT INSTITUTES AND CENTERS 6486 04:46:09,893 --> 04:46:13,297 ACROSS THE NIH SO DEPENDING WHOM 6487 04:46:13,297 --> 04:46:14,298 YOU'RE WORKING WITH YOU MAY BE 6488 04:46:14,298 --> 04:46:23,374 ABLE TO APPLY TO THE C3I PROGRAM 6489 04:46:23,374 --> 04:46:24,808 IF YOU'RE NOT AN AWARDEE 6490 04:46:24,808 --> 04:46:25,576 DIRECTLY. 6491 04:46:25,576 --> 04:46:28,646 THE SECOND PART IS NAMED THE C3 6492 04:46:28,646 --> 04:46:30,614 #EURBGS PROGRAM FOCUSED ON 6493 04:46:30,614 --> 04:46:32,616 VALIDATION AND EXECUTION, GEARED 6494 04:46:32,616 --> 04:46:37,621 TOWARDS EARLY STAGE SMALL 6495 04:46:37,621 --> 04:46:39,056 BUSINESSES, OR INNOVATORS WHO 6496 04:46:39,056 --> 04:46:42,893 MAY HAVE DONE THIS EC3I PROGRAM, 6497 04:46:42,893 --> 04:46:44,561 A MUCH MORE INTENSIVE 24-WEEK 6498 04:46:44,561 --> 04:46:46,830 PROGRAM THAT HAS AN IN-PERSON 6499 04:46:46,830 --> 04:46:50,768 BOOT CAMP MIDWAY THROUGH AND IS 6500 04:46:50,768 --> 04:46:53,737 FOCUSED TO EVALUATING THAT UNMET 6501 04:46:53,737 --> 04:46:55,939 MARKET KNEELED DOING ADDITIONAL 6502 04:46:55,939 --> 04:46:57,574 NEEDS ASSESSMENTS, UNDERSTANDING 6503 04:46:57,574 --> 04:47:00,577 YOUR REGULATORY AND 6504 04:47:00,577 --> 04:47:01,745 REIMBURSEMENT PATH AND HOPEFULLY 6505 04:47:01,745 --> 04:47:02,746 IDENTIFYING THE KILTER 6506 04:47:02,746 --> 04:47:03,914 EXPERIMENT TO PUSH YOUR 6507 04:47:03,914 --> 04:47:06,984 TECHNOLOGY THOSE NEXT STEPS 6508 04:47:06,984 --> 04:47:08,419 CLOSERS TOWARDS 6509 04:47:08,419 --> 04:47:08,819 COMMERCIALIZATION. 6510 04:47:08,819 --> 04:47:09,753 ULTIMATELY, THIS PROGRAM WILL 6511 04:47:09,753 --> 04:47:11,321 HELP TO PUT TOGETHER A SORT OF 6512 04:47:11,321 --> 04:47:12,956 FIRST DRAFT OF A PITCH TO 6513 04:47:12,956 --> 04:47:14,858 HOPEFULLY LINE YOU UP TO GO OUT 6514 04:47:14,858 --> 04:47:18,362 AND TALK TO OUTSIDE INVESTORS 6515 04:47:18,362 --> 04:47:18,662 AFTERWARDS. 6516 04:47:18,662 --> 04:47:22,966 AND THEN THE LAST COMPONENT IS 6517 04:47:22,966 --> 04:47:25,602 ONE THAT -- SORRY, I'VE GOT 6518 04:47:25,602 --> 04:47:25,903 OVERLAP. 6519 04:47:25,903 --> 04:47:28,505 NIBIB IS THE ONLY PARTICIPANT IN 6520 04:47:28,505 --> 04:47:30,441 THIS ONE, AND THIS IS A 6521 04:47:30,441 --> 04:47:33,377 SUPPLEMENT PROGRAM SO THIS IS 6522 04:47:33,377 --> 04:47:36,113 SPECIFICALLY FOR ACADEMIC 6523 04:47:36,113 --> 04:47:39,049 INNOVATORS WHO HAVE A RESEARCH 6524 04:47:39,049 --> 04:47:41,151 PROBLEM GRANT R01-TYPE PROPOSAL, 6525 04:47:41,151 --> 04:47:43,487 ALREADY HAVE BEEN THROUGH 3CI, 6526 04:47:43,487 --> 04:47:46,323 THE GOAL TO HELP TO CONTINUE ON 6527 04:47:46,323 --> 04:47:49,593 THE MOMENTUM THAT WAS BUILT 6528 04:47:49,593 --> 04:47:52,229 DURING C3I AND TO EXECUTE THOSE 6529 04:47:52,229 --> 04:47:53,764 EXPERIMENTS THAT YOU IDENTIFIED, 6530 04:47:53,764 --> 04:47:54,765 CONTINUE ON THE 6531 04:47:54,765 --> 04:47:59,036 COMMERCIALIZATION PATH IN TERMS 6532 04:47:59,036 --> 04:47:59,903 OF BUILDING STRATEGIC 6533 04:47:59,903 --> 04:48:02,239 PARTNERSHIPS, ALLOW YOU TO PUT 6534 04:48:02,239 --> 04:48:04,408 TOGETHER A COMPELLING SMALL 6535 04:48:04,408 --> 04:48:05,809 BUSINESS APPLICATION TO COME IN 6536 04:48:05,809 --> 04:48:09,113 AND MAKE THAT TRANSITION INTO 6537 04:48:09,113 --> 04:48:09,513 ENTREPRENEURSHIP. 6538 04:48:09,513 --> 04:48:11,281 SO, I THINK WITH THAT AND TIME 6539 04:48:11,281 --> 04:48:18,288 IN MIND I'M GOING TO LEAVE IT 6540 04:48:18,288 --> 04:48:19,389 THERE. 6541 04:48:19,389 --> 04:48:22,025 THE BIGGEST TAKEHOME MESSAGE IS 6542 04:48:22,025 --> 04:48:23,660 PLEASE REACH OUT, HAVE 6543 04:48:23,660 --> 04:48:26,063 CONVERSATIONS IN TERMS OF 6544 04:48:26,063 --> 04:48:30,334 UNDERSTANDING WHAT RESOURCES 6545 04:48:30,334 --> 04:48:32,302 FINANCIAL AND OTHERWISE ARE 6546 04:48:32,302 --> 04:48:32,569 AVAILABLE. 6547 04:48:32,569 --> 04:48:38,275 PART OF OUR JOB IS TO HELP, SO 6548 04:48:38,275 --> 04:48:38,809 THANK YOU. 6549 04:48:38,809 --> 04:48:41,044 [APPLAUSE] 6550 04:48:41,044 --> 04:48:47,084 6551 04:48:47,084 --> 04:48:55,325 6552 04:48:55,325 --> 04:48:57,161 >> THIS IS A BRIEF SUMMARY. 6553 04:48:57,161 --> 04:48:58,428 TALK WITH SOMEONE. 6554 04:48:58,428 --> 04:49:01,465 YOU CAN FIND A LOT OF MATERIAL 6555 04:49:01,465 --> 04:49:03,100 ONLINE, READ STUFF, TAKE ONLINE 6556 04:49:03,100 --> 04:49:04,768 COURSES, YOU NEED TO TALK WITH 6557 04:49:04,768 --> 04:49:06,537 SOMEBODY TO HELP THEM FIGURE OUT 6558 04:49:06,537 --> 04:49:08,839 HOW TO HELP YOU NAVIGATE. 6559 04:49:08,839 --> 04:49:10,941 WE HAVE TIME FOR MAYBE ONE OR 6560 04:49:10,941 --> 04:49:12,242 TWO QUICK QUESTIONS. 6561 04:49:12,242 --> 04:49:15,412 IF NOT I'LL ASK QUESTIONS. 6562 04:49:15,412 --> 04:49:22,553 6563 04:49:22,553 --> 04:49:22,886 YES, MICHAEL? 6564 04:49:22,886 --> 04:49:24,488 >> I WORK WITH THE RADx 6565 04:49:24,488 --> 04:49:24,721 PROGRAM. 6566 04:49:24,721 --> 04:49:26,557 A QUESTION THAT MIGHT BE HELPFUL 6567 04:49:26,557 --> 04:49:27,991 TO THE AUDIENCE. 6568 04:49:27,991 --> 04:49:29,526 CAN YOU EXPLAIN THE DIFFERENCE 6569 04:49:29,526 --> 04:49:37,401 BETWEEN A GRANT AND A CONTRACT? 6570 04:49:37,401 --> 04:49:41,038 >> YES. 6571 04:49:41,038 --> 04:49:43,340 6572 04:49:43,340 --> 04:49:46,310 A GRANT YOU PROPOSE, 6573 04:49:46,310 --> 04:49:47,744 INVESTIGATOR INITIATED, YOUR 6574 04:49:47,744 --> 04:49:50,147 IDEA, PEER REVIEWED, AND IF IT'S 6575 04:49:50,147 --> 04:49:52,583 MERITORIOUS BASED ON PEER REVIEW 6576 04:49:52,583 --> 04:49:53,650 AND LEADERSHIP, INTERNAL 6577 04:49:53,650 --> 04:49:54,751 DISCUSSIONS, YOU GET FUNDED, YOU 6578 04:49:54,751 --> 04:49:56,286 GET THE MONEY, WE EXPECT GOOD 6579 04:49:56,286 --> 04:49:58,689 THINGS AND MAKE SURE YOU'RE 6580 04:49:58,689 --> 04:50:00,224 COMPLYING WITH FEDERAL POLICIES. 6581 04:50:00,224 --> 04:50:02,292 A CONTRACT, WE WANT YOU TO DO 6582 04:50:02,292 --> 04:50:02,559 SOMETHING. 6583 04:50:02,559 --> 04:50:04,261 WE SOLICIT SOMEBODY TO SOLVE 6584 04:50:04,261 --> 04:50:07,097 THIS PARTICULAR PROBLEM WHETHER 6585 04:50:07,097 --> 04:50:10,734 RESEARCH OBJECTIVE OR A PROCESS 6586 04:50:10,734 --> 04:50:11,168 OBJECTIVE. 6587 04:50:11,168 --> 04:50:13,003 YOU PROPOSE, WE REVIEW IN 6588 04:50:13,003 --> 04:50:14,471 COMPARISON WITH OTHER PROPOSALS 6589 04:50:14,471 --> 04:50:16,573 AND PICK THIS ONE, DO THIS, MEET 6590 04:50:16,573 --> 04:50:18,342 MILESTONES, YOU GET PAID. 6591 04:50:18,342 --> 04:50:21,545 THAT'S THE SHORT VERSION. 6592 04:50:21,545 --> 04:50:23,614 6593 04:50:23,614 --> 04:50:25,415 >> I'LL ADD THAT THE TEAMS THAT 6594 04:50:25,415 --> 04:50:26,817 COME THROUGH I-CORPS IF THEY 6595 04:50:26,817 --> 04:50:31,188 HAVE A GRANT YOU ASK WHO THE 6596 04:50:31,188 --> 04:50:32,389 CUSTOMERS CLINICIANS, USERS, END 6597 04:50:32,389 --> 04:50:32,623 USERS. 6598 04:50:32,623 --> 04:50:36,026 IF THEY HAVE A CONTRACT THEY SAY 6599 04:50:36,026 --> 04:50:43,901 IT'S NIH. 6600 04:50:43,901 --> 04:50:45,102 >> IF SOMEBODY IS RECIPIENT OF 6601 04:50:45,102 --> 04:50:50,574 AWARD THROUGH A NETWORK OR HUB 6602 04:50:50,574 --> 04:50:55,178 LIKE POCTRN, MED TECH, ARE THEY 6603 04:50:55,178 --> 04:51:00,550 ELIGIBLE FOR TABA SANDALED NCB 6604 04:51:00,550 --> 04:51:00,817 3I. 6605 04:51:00,817 --> 04:51:03,186 >> THROUGH SEED OFFICE, YES. 6606 04:51:03,186 --> 04:51:04,588 REQUIREMENT IS ONE NIH, COULD 6607 04:51:04,588 --> 04:51:07,457 HAVE BEEN A PRIZE COMPETITION, 6608 04:51:07,457 --> 04:51:09,426 NETWORK, WHATEVER. 6609 04:51:09,426 --> 04:51:12,195 >> AND SAME FOR THE C3I PROGRAM. 6610 04:51:12,195 --> 04:51:15,332 WE RUN THROUGH A CONTRACT, 6611 04:51:15,332 --> 04:51:17,301 COLLABORATION WITH LAB TO 6612 04:51:17,301 --> 04:51:21,371 MARKET, CAN BE FLEXIBLE WITH HOW 6613 04:51:21,371 --> 04:51:23,240 WE ALLOW PARTICIPANTS TO APPLY, 6614 04:51:23,240 --> 04:51:24,007 YEAH. 6615 04:51:24,007 --> 04:51:24,474 >> GREAT. 6616 04:51:24,474 --> 04:51:28,278 QUICK QUESTION FOR REBEKAH. 6617 04:51:28,278 --> 04:51:36,620 THERE'S FOR-PROFIT ACCELERATORS 6618 04:51:36,620 --> 04:51:37,721 VERSUS NON-PROFIT, TALK ABOUT 6619 04:51:37,721 --> 04:51:42,092 THE DIFFERENCE IN WHAT THE 6620 04:51:42,092 --> 04:51:43,760 COMPANY GETS OUT OF IT? 6621 04:51:43,760 --> 04:51:48,031 >> I MAY ASK BOB TO SPEAK IF YOU 6622 04:51:48,031 --> 04:51:49,132 LIKE. 6623 04:51:49,132 --> 04:51:50,400 FROM MY PERSPECTIVE, THE 6624 04:51:50,400 --> 04:51:53,270 CURRICULUM IS LIKELY TO BE 6625 04:51:53,270 --> 04:51:56,440 REALLY SIMILAR BETWEEN -- 6626 04:51:56,440 --> 04:51:58,208 REGARDLESS OF ACCELERATOR, THE 6627 04:51:58,208 --> 04:52:00,944 SAME PLAYBOOK, ACCESS MAY BE 6628 04:52:00,944 --> 04:52:02,913 DIFFERENT, CONTROL, THE EQUITY, 6629 04:52:02,913 --> 04:52:04,681 THE PIECE ACCELERATOR TAKES IS 6630 04:52:04,681 --> 04:52:04,948 DIFFERENT. 6631 04:52:04,948 --> 04:52:07,417 YOU MAY LOSE SOME OF YOUR 6632 04:52:07,417 --> 04:52:09,386 ABILITY TO DIRECT HOW YOU COME 6633 04:52:09,386 --> 04:52:11,021 OUT OF THAT ACCELERATOR AND WHAT 6634 04:52:11,021 --> 04:52:12,656 YOUR ORGANIZATION OR WHAT YOUR 6635 04:52:12,656 --> 04:52:14,558 PRODUCT OR WHO YOUR CUSTOMER IS 6636 04:52:14,558 --> 04:52:15,993 AS YOU GO THROUGH. 6637 04:52:15,993 --> 04:52:17,828 BOB, WOULD YOU WANT TO ADD? 6638 04:52:17,828 --> 04:52:19,696 >> I THINK YOU SAID IT RIGHT. 6639 04:52:19,696 --> 04:52:26,370 THERE'S A VERY BROAD AWARE OF 6640 04:52:26,370 --> 04:52:32,442 TYPES OF ACCELERATORS AND 6641 04:52:32,442 --> 04:52:36,546 INCUBATORS, DO YOUR RESEARCH. 6642 04:52:36,546 --> 04:52:37,748 THE MENTORSHIP NETWORK IS 6643 04:52:37,748 --> 04:52:42,119 IMPORTANT TO UNDERSTAND HOW THEY 6644 04:52:42,119 --> 04:52:42,352 FIT. 6645 04:52:42,352 --> 04:52:48,258 >> WE HAVE A BREAK NEXT FOR 15 6646 04:52:48,258 --> 04:52:48,725 MINUTES. 6647 04:52:48,725 --> 04:52:50,227 SO DON'T BE LATE. 6648 04:52:50,227 --> 04:52:53,163 AND IF YOU SEE US AND HAVE 6649 04:52:53,163 --> 04:52:57,567 QUESTIONS, ASK US, YOU HAVE OUR 6650 04:52:57,567 --> 04:53:01,405 CONTACT INFO IN THE BROCHURE. 6651 04:53:01,405 --> 04:53:02,348 LOOK ONLINE, TALK WITH SOMEBODY. THANKS. 6652 04:53:02,348 --> 04:53:03,983 WE'RE GOING TO GET STARTED 6653 04:53:03,983 --> 04:53:04,217 AGAIN. 6654 04:53:04,217 --> 04:53:14,694 I HOPE YOU ALL HAD A GREAT 6655 04:53:14,694 --> 04:53:14,928 BREAK. 6656 04:53:14,928 --> 04:53:17,530 THIS SESSION STANDS IN BETWEEN 6657 04:53:17,530 --> 04:53:18,765 RAPID PITCH AND E-POSTER EXHIBIT 6658 04:53:18,765 --> 04:53:21,167 SESSIONS BUT YOU HAVE A TREAT 6659 04:53:21,167 --> 04:53:24,904 TODAY BECAUSE NOW WE'LL GO 6660 04:53:24,904 --> 04:53:27,774 THROUGH THE PRESENTATIONS, 6661 04:53:27,774 --> 04:53:29,175 RESOURCES, CAPABILITIES, 6662 04:53:29,175 --> 04:53:30,276 QUESTION-AND-ANSWER FOR THE 6663 04:53:30,276 --> 04:53:32,712 POCTRN CENTERS, WE'RE EXCITED TO 6664 04:53:32,712 --> 04:53:34,914 HAVE THE SIX CENTERS HERE TO 6665 04:53:34,914 --> 04:53:41,087 TALK ABOUT THEIR CENTERS, AND I 6666 04:53:41,087 --> 04:53:43,990 HAVE MY COLLEAGUE JUE CHEN FROM 6667 04:53:43,990 --> 04:53:53,099 NHLBI HOSTING THIS SESSION HERE. 6668 04:53:53,099 --> 04:53:55,101 >> I'M JUE CHEN, PROGRAM OFFICER 6669 04:53:55,101 --> 04:53:56,236 AT THE NATIONAL HEART, LUNG AND 6670 04:53:56,236 --> 04:53:57,570 BLOOD INSTITUTE. 6671 04:53:57,570 --> 04:54:02,442 AND I ALSO SERVE AS SCIENCE 6672 04:54:02,442 --> 04:54:06,446 OFFICER FOR POCTRN NETWORK. 6673 04:54:06,446 --> 04:54:11,050 IT'S MY PLAID TO MODERATE TODAY. 6674 04:54:11,050 --> 04:54:14,020 WE'LL HEAR SIX PRESENTATIONS 6675 04:54:14,020 --> 04:54:16,856 FROM THE SIX POCTRN CENTERS AND 6676 04:54:16,856 --> 04:54:20,593 AFTER THAT HAVE A Q&A SESSION. 6677 04:54:20,593 --> 04:54:24,631 SO OUR FIRST SPEAKER IS DR. GREG 6678 04:54:24,631 --> 04:54:26,599 MARTIN, DIRECTOR OF PREDICTIVE 6679 04:54:26,599 --> 04:54:28,501 HEALTH INSTITUTE AND CENTER FOR 6680 04:54:28,501 --> 04:54:30,870 HEALTH DISCOVERY AND WELL-BEING. 6681 04:54:30,870 --> 04:54:33,106 AND PROFESSOR OF MEDICINE AT 6682 04:54:33,106 --> 04:54:36,776 EMORY SCHOOL OF MEDICINE. 6683 04:54:36,776 --> 04:54:39,879 HE WILL TALK ABOUT THE ATLANTIC 6684 04:54:39,879 --> 04:54:40,880 CENTER FOR MICROSYSTEMS 6685 04:54:40,880 --> 04:54:50,824 ENGINEERED POINT OF CARE 6686 04:54:50,824 --> 04:54:54,427 TECHNOLOGIES. 6687 04:54:54,427 --> 04:55:02,335 >> S MY -- IT IS MY PLEASURE TO 6688 04:55:02,335 --> 04:55:04,637 PRESENT FOR THE TEAM. 6689 04:55:04,637 --> 04:55:07,140 WILBUR LAMB WAS GOING TO BE 6690 04:55:07,140 --> 04:55:10,210 PRESENTING SO I WILL STEP IN FOR 6691 04:55:10,210 --> 04:55:10,410 HIM. 6692 04:55:10,410 --> 04:55:12,278 THANK YOU FOR THE INTRODUCTION. 6693 04:55:12,278 --> 04:55:16,216 WHAT OUR MISSION IS, OUR GOAL IS 6694 04:55:16,216 --> 04:55:17,217 DIFFERENCE THAN OTHER NETWORK 6695 04:55:17,217 --> 04:55:21,487 SITES IN THE SENSE WE FOCUS ON 6696 04:55:21,487 --> 04:55:24,057 ENABLING THE TRANSLATION AND 6697 04:55:24,057 --> 04:55:26,226 ACCELERATION OF TECHNOLOGIES, 6698 04:55:26,226 --> 04:55:28,094 PARTICULARLY IN THE MICROSYSTEMS 6699 04:55:28,094 --> 04:55:30,830 POINT OF CARE BASED, CONDUCTING 6700 04:55:30,830 --> 04:55:32,599 CLINICAL EVALUATION TECHNOLOGY, 6701 04:55:32,599 --> 04:55:35,101 ADDING VALUE IN OTHER AREAS, 6702 04:55:35,101 --> 04:55:36,269 PARTICULARLY REGULATORY 6703 04:55:36,269 --> 04:55:37,403 USABILITY AND OTHER ASPECTS. 6704 04:55:37,403 --> 04:55:38,938 IF YOU WANT MORE INFORMATION 6705 04:55:38,938 --> 04:55:41,374 CLEARLY OUR WEBSITE IS THERE. 6706 04:55:41,374 --> 04:55:42,141 IT'S HELPFUL. 6707 04:55:42,141 --> 04:55:45,078 THE OTHER PART I WILL TOUCH ON 6708 04:55:45,078 --> 04:55:46,946 SO YOU'RE ALL AWARE, WILBUR LAMB 6709 04:55:46,946 --> 04:55:52,852 IS OUR LEAD P.I., MYSELF AS 6710 04:55:52,852 --> 04:55:55,255 CO-P.I., AND ERIC VOGEL, THIRD. 6711 04:55:55,255 --> 04:55:57,390 WE SPAN THREE SYSTEMS, WE CROSS 6712 04:55:57,390 --> 04:56:00,093 FROM OUR EMORY UNIVERSITY SYSTEM 6713 04:56:00,093 --> 04:56:03,596 INTO CHILDREN'S HEALTH CARE 6714 04:56:03,596 --> 04:56:07,166 SYSTEM AND GEORGIA TECH WITH 6715 04:56:07,166 --> 04:56:07,367 ERIC. 6716 04:56:07,367 --> 04:56:11,638 MANY MANY REMEMBER OLIVER BRAND, 6717 04:56:11,638 --> 04:56:14,474 ENGINEERING P.I., INSTITUTE FOR 6718 04:56:14,474 --> 04:56:15,942 ELECTRONICS AND NANOTECHNOLOGY, 6719 04:56:15,942 --> 04:56:21,881 SADLY HE PASSED AWAY 6720 04:56:21,881 --> 04:56:23,683 UNEXPECTEDLY EARLIER THIS YEAR. 6721 04:56:23,683 --> 04:56:28,288 ERIC HAS STEPPED IN, LEADS P.I. 6722 04:56:28,288 --> 04:56:30,924 I WANT TO COVER STRUCTURE AND 6723 04:56:30,924 --> 04:56:32,225 CAPABILITIES, QUICKLY COVERING 6724 04:56:32,225 --> 04:56:35,161 THE CORES WHICH YOU WOULD EXPECT 6725 04:56:35,161 --> 04:56:36,696 IN ANY POCTRN SITES, THE MAIN 6726 04:56:36,696 --> 04:56:39,098 THINGS TO HELP YOU SEE OUR FOCUS 6727 04:56:39,098 --> 04:56:40,767 ON IS CONNECTION INSIDE AND 6728 04:56:40,767 --> 04:56:43,169 OUTSIDE TO THE FLOW ACROSS OUR 6729 04:56:43,169 --> 04:56:44,904 TECHNOLOGY CORE, CLINICAL CORE 6730 04:56:44,904 --> 04:56:46,973 AND DISSEMINATION CORE. 6731 04:56:46,973 --> 04:56:49,575 IT TALKS ABOUT THE DIFFERENT 6732 04:56:49,575 --> 04:56:51,711 CAPABILITIES, I'LL FOCUS ON THE 6733 04:56:51,711 --> 04:56:53,413 NEXT COUPLE SLIDES AND 6734 04:56:53,413 --> 04:56:55,114 ADMINISTRATIVE CORE CONNECTING 6735 04:56:55,114 --> 04:57:01,054 TO THE OTHER SITES AND 6736 04:57:01,054 --> 04:57:03,122 COORDINATE NATION. 6737 04:57:03,122 --> 04:57:07,026 ALL OF THOSE PIECEES SOME 6738 04:57:07,026 --> 04:57:08,061 TOGETHER, ADMINISTRATIVE CORE 6739 04:57:08,061 --> 04:57:09,963 WORKING WITH EXTERNAL ADVISORS 6740 04:57:09,963 --> 04:57:13,633 AND EVERYTHING IN GRANTS 6741 04:57:13,633 --> 04:57:13,933 MANAGEMENT. 6742 04:57:13,933 --> 04:57:16,169 THE MAIN THINGS IN TERMS OF 6743 04:57:16,169 --> 04:57:16,903 RESOURCES, EXPANDED AND CHANGED 6744 04:57:16,903 --> 04:57:19,472 OVER THE LAST FEW YEARS AS WE'VE 6745 04:57:19,472 --> 04:57:21,307 GROWN IN OUR CENTER, HELPED 6746 04:57:21,307 --> 04:57:23,609 RESPOND IN THE PANDEMIC, WORKED 6747 04:57:23,609 --> 04:57:26,679 IN RADx, ADDING SPECIFIC 6748 04:57:26,679 --> 04:57:27,313 AREAS. 6749 04:57:27,313 --> 04:57:28,114 USABILITY, ACCESSIBILITY, HUMAN 6750 04:57:28,114 --> 04:57:29,749 FACTORS WITH HOME LAB TEAM AT 6751 04:57:29,749 --> 04:57:32,952 GEORGIA TECH WHICH IS FANTASTIC 6752 04:57:32,952 --> 04:57:34,821 HAS CREATED SCALE AND ASSESSMENT 6753 04:57:34,821 --> 04:57:36,823 TOOLS AND NOT JUST FOR 6754 04:57:36,823 --> 04:57:38,558 INDIVIDUAL DEVICES BUT ALSO HOME 6755 04:57:38,558 --> 04:57:40,326 LAB MIGHT IMPLY THERE'S A GROUP 6756 04:57:40,326 --> 04:57:42,729 OF PEOPLE WHO ARE WHAT I CALL 6757 04:57:42,729 --> 04:57:43,830 FREE RANGE HUMANS, MEANING 6758 04:57:43,830 --> 04:57:45,832 AVERAGE PEOPLE WHO ARE MORE THAN 6759 04:57:45,832 --> 04:57:46,899 CAPABLE OF PARTICIPATING AND 6760 04:57:46,899 --> 04:57:48,001 WILLING TO PARTICIPATE IN 6761 04:57:48,001 --> 04:57:51,704 STUDIES SO THEY CAN HELP PROVIDE 6762 04:57:51,704 --> 04:57:55,575 GUIDANCE AND 6763 04:57:55,575 --> 04:57:56,242 QUANTITATIVE/QUALITATIVE 6764 04:57:56,242 --> 04:57:57,877 ASSESSMENT. 6765 04:57:57,877 --> 04:58:01,948 WE HAVE THE USABILITY TEAM. 6766 04:58:01,948 --> 04:58:06,686 A NATIONAL EXPERT ON OUR TEAM 6767 04:58:06,686 --> 04:58:08,955 HAS A REGULATORY TEAM AND 6768 04:58:08,955 --> 04:58:09,789 SKILLED IN PROVIDING 6769 04:58:09,789 --> 04:58:11,157 CONSULTATION AND PLANNING FOR 6770 04:58:11,157 --> 04:58:13,860 TEAMS AND TECHNOLOGIES. 6771 04:58:13,860 --> 04:58:16,863 WE DO TRL ASSESSMENT, DEVICE 6772 04:58:16,863 --> 04:58:17,964 DESIGN FABRICATION MATERIALS, 6773 04:58:17,964 --> 04:58:19,399 CHARACTERIZATION, IN ENGINEERING 6774 04:58:19,399 --> 04:58:21,801 CORE AND TECHNOLOGY ASSESSMENT 6775 04:58:21,801 --> 04:58:24,670 AND LOOKING AT WAYS TO THINK 6776 04:58:24,670 --> 04:58:27,073 ABOUT IMPROVING OR CHANGING 6777 04:58:27,073 --> 04:58:28,508 DESIGN TO HELP DEVICES AS 6778 04:58:28,508 --> 04:58:30,676 BROUGHT TO US TO ACCELERATE 6779 04:58:30,676 --> 04:58:31,477 DEVELOPMENT. 6780 04:58:31,477 --> 04:58:32,879 THE CLINICAL CORE PIECE, 6781 04:58:32,879 --> 04:58:36,816 ASSESSMENT AND VALIDATION IN 6782 04:58:36,816 --> 04:58:39,652 TERMS OF IMPLEMENTATION AND 6783 04:58:39,652 --> 04:58:43,723 DISSEMINATION, EDUCATION, ALSO 6784 04:58:43,723 --> 04:58:45,324 CLINICAL AND LABORATORY 6785 04:58:45,324 --> 04:58:48,428 ASSESSMENT, ANOTHER PIECE WE'VE 6786 04:58:48,428 --> 04:58:48,861 GROWN. 6787 04:58:48,861 --> 04:58:51,597 THE LAST THING IS SPECIFIC 6788 04:58:51,597 --> 04:58:53,800 SERVICES, THINGS WE'VE EXPANDED, 6789 04:58:53,800 --> 04:58:54,567 MICROMACHINING, 3D PRINTING, WE 6790 04:58:54,567 --> 04:58:57,370 DO THAT ON A COUPLE CAMPUSES, WE 6791 04:58:57,370 --> 04:59:01,808 HAVE THE ABILITY TO DO 6792 04:59:01,808 --> 04:59:03,209 MICROMACHINING INTERNAL IN OUR 6793 04:59:03,209 --> 04:59:05,278 HOSPITAL UNIVERSITY SYSTEMS ALSO 6794 04:59:05,278 --> 04:59:10,483 WITHIN ACME, AND THEN EXTENDED 6795 04:59:10,483 --> 04:59:11,417 REALITY MULTI-SPACE, COMES WITH 6796 04:59:11,417 --> 04:59:12,985 THE BUILDING ENVIRONMENT AND 6797 04:59:12,985 --> 04:59:14,620 SOME OTHER PROGRAMS WE'RE 6798 04:59:14,620 --> 04:59:16,522 BUILDING, AND THAT'S LINKED TO 6799 04:59:16,522 --> 04:59:17,924 OUR UNIVERSITIES AS WELL. 6800 04:59:17,924 --> 04:59:20,426 AND FINALLY I'LL TOUCH ON THINGS 6801 04:59:20,426 --> 04:59:22,728 WE SHARE INSIDE AND OUTSIDE THE 6802 04:59:22,728 --> 04:59:23,029 NETWORK. 6803 04:59:23,029 --> 04:59:29,936 I'VE TOUCHED ON SOME THINGS LIKE 6804 04:59:29,936 --> 04:59:32,939 SHARING CLINICAL SAMPLES ARE A 6805 04:59:32,939 --> 04:59:34,340 LARGE DATABASE, ANALYTICAL AND 6806 04:59:34,340 --> 04:59:37,276 CLINICAL TESTING, HOME LAB FOR 6807 04:59:37,276 --> 04:59:39,178 USABILITY AND HUMAN FACTORS, 6808 04:59:39,178 --> 04:59:40,379 DEEP MUTATIONAL SCANNING, A 6809 04:59:40,379 --> 04:59:41,681 REALLY IMPORTANT TOOL DURING THE 6810 04:59:41,681 --> 04:59:46,385 COVID PANDEMIC FOR TRYING TO 6811 04:59:46,385 --> 04:59:48,488 UNDERSTAND VARIANTS ACROSS THE 6812 04:59:48,488 --> 04:59:50,123 COVID STRAINS. 6813 04:59:50,123 --> 04:59:50,990 AND OPPORTUNITIES FOR 6814 04:59:50,990 --> 04:59:52,425 COLLABORATION, PARTICULARLY IN 6815 04:59:52,425 --> 04:59:54,393 THE FIELD OF MICROFLUIDICS AND 6816 04:59:54,393 --> 04:59:55,628 MICROSYSTEMS, ANYTHING THAT 6817 04:59:55,628 --> 04:59:58,764 FALSE IN OUR CLINICAL REGULATORY 6818 04:59:58,764 --> 05:00:09,208 USABILITY AND ENGINEERING 6819 05:00:10,510 --> 05:00:10,776 DOMAINS. 6820 05:00:10,776 --> 05:00:20,586 I WILL STOP AND HAND BACK TO JUE 6821 05:00:20,586 --> 05:00:25,158 FOR THE NEXT INTRODUCTION. 6822 05:00:25,158 --> 05:00:28,060 >> DR. DAVE MCMANUS ON 6823 05:00:28,060 --> 05:00:31,497 DEPARTMENT OF MEDICINE, 6824 05:00:31,497 --> 05:00:32,932 UNIVERSITY OF MASSACHUSETTS, 6825 05:00:32,932 --> 05:00:35,268 CHAN MEDICAL SCHOOL, EDITOR IN 6826 05:00:35,268 --> 05:00:37,670 CHIEF OF CARDIOVASCULAR DIGITAL 6827 05:00:37,670 --> 05:00:40,773 HEALTH JOURNAL SHARING RESOURCES 6828 05:00:40,773 --> 05:00:43,176 AND CAPABILITIES OF THE CENTER 6829 05:00:43,176 --> 05:00:45,144 FOR ADVANCING POINT OF CARE IN 6830 05:00:45,144 --> 05:00:54,587 HEART LUNG BLOOD AND SLEEP 6831 05:00:54,587 --> 05:00:55,354 DISEASES. 6832 05:00:55,354 --> 05:00:58,925 >> THANK YOU FOR THE OPPORTUNITY 6833 05:00:58,925 --> 05:01:02,161 TO PRESENT ALONGSIDE THE SISTER 6834 05:01:02,161 --> 05:01:02,595 POCTRNs. 6835 05:01:02,595 --> 05:01:06,732 AS YOU CAN SEE, ONE OF THE 6836 05:01:06,732 --> 05:01:07,633 DISTINGUISHED CHARACTERISTICS IS 6837 05:01:07,633 --> 05:01:10,970 IT IS BORN FROM A MEDICAL DEVICE 6838 05:01:10,970 --> 05:01:12,705 INCUBATOR, EACH CENTER HAS 6839 05:01:12,705 --> 05:01:14,040 SLIGHTLY DIFFERENT HISTORY, THAT 6840 05:01:14,040 --> 05:01:15,141 INFORMS RESOURCES WE PROVIDE SO 6841 05:01:15,141 --> 05:01:19,178 I'M GOING TO COME BACK IN A 6842 05:01:19,178 --> 05:01:19,512 MOMENT. 6843 05:01:19,512 --> 05:01:21,180 SO WE'RE FUNDED THROUGH 6844 05:01:21,180 --> 05:01:23,216 PRIMARILY NATIONAL HEART LUNG 6845 05:01:23,216 --> 05:01:25,851 BLOOD INSTITUTE AS WELL AS 6846 05:01:25,851 --> 05:01:27,420 NATIONAL CENTER FOR 6847 05:01:27,420 --> 05:01:30,122 COMPLEMENTARY AND INTEGRATIVE 6848 05:01:30,122 --> 05:01:30,356 HEALTH. 6849 05:01:30,356 --> 05:01:35,361 OUR FOCUS ON DEVELOPMENT AND 6850 05:01:35,361 --> 05:01:39,765 POINT OF CARE, OUR TEAM IS 6851 05:01:39,765 --> 05:01:42,268 COMPRISED OF PEOPLE, THREE 6852 05:01:42,268 --> 05:01:45,238 P.I.s, AN ENGINEERING P.I., 6853 05:01:45,238 --> 05:01:49,308 CLINICAL P.I., BRIAN BUCHHOLZ 6854 05:01:49,308 --> 05:01:50,943 HAS BEEN WITH THE PROJECT FOR 6855 05:01:50,943 --> 05:01:58,184 MANY YEARS, AND DR. NATE HAFER 6856 05:01:58,184 --> 05:02:00,753 HAS BEEN PUT INTO THE MULTI-P.I. 6857 05:02:00,753 --> 05:02:01,954 ROLE IN THIS RENEWAL. 6858 05:02:01,954 --> 05:02:03,756 YOU CAN SEE A NUMBER OF KEY 6859 05:02:03,756 --> 05:02:05,391 STAKEHOLDERS BUT IF YOU REMEMBER 6860 05:02:05,391 --> 05:02:06,259 NOTHING ELSE FROM MY 6861 05:02:06,259 --> 05:02:11,430 PRESENTATION IT'S THE NAME OF 6862 05:02:11,430 --> 05:02:13,366 MARION PICCARD, AN EXCELLENT 6863 05:02:13,366 --> 05:02:15,568 POINT-OF-CARE CONTACT FOR US 6864 05:02:15,568 --> 05:02:17,003 ADVISER AND SHE'S EXTREMELY 6865 05:02:17,003 --> 05:02:20,373 PLUGGED INTO THE NETWORK OF MED 6866 05:02:20,373 --> 05:02:21,540 DEVICE INNOVATORS AND INCUBATOR 6867 05:02:21,540 --> 05:02:24,043 ACROSS THE EAST COAST. 6868 05:02:24,043 --> 05:02:25,578 A NUMBER OF INDIVIDUALS COMPRISE 6869 05:02:25,578 --> 05:02:26,312 OUR TEAM. 6870 05:02:26,312 --> 05:02:33,686 AS A MORE LATER STAGE TECHNOLOGY 6871 05:02:33,686 --> 05:02:35,988 FOCUSEDDER, WE FOCUS ON CLINICAL 6872 05:02:35,988 --> 05:02:40,559 AND VALIDATION STUDIES, ADDED A 6873 05:02:40,559 --> 05:02:44,297 PHENOCAPABILITY, BRINGING IN A 6874 05:02:44,297 --> 05:02:46,699 PSYCHOLOGIST TO THINK ABOUT 6875 05:02:46,699 --> 05:02:48,000 APPLICATIONS IN VULNERABLE 6876 05:02:48,000 --> 05:02:49,101 POPULATIONS, PRESENTATION ABOUT 6877 05:02:49,101 --> 05:02:50,536 MATERNAL HEALTH ARE SEVERAL 6878 05:02:50,536 --> 05:02:51,737 CARDIOVASCULAR DEVICES AND I'M 6879 05:02:51,737 --> 05:02:53,372 THINKING THERE MAY BE SOME 6880 05:02:53,372 --> 05:02:54,807 CROSS-POLLINATION WITH OUR 6881 05:02:54,807 --> 05:02:56,442 CENTER AS WE LEAVE HERE IN 6882 05:02:56,442 --> 05:02:57,610 INVOLVEMENT OF HER. 6883 05:02:57,610 --> 05:03:03,349 THE OTHER PERSON I WANT TO 6884 05:03:03,349 --> 05:03:03,983 HIGHLIGHT BROUGHT TREMENDOUS 6885 05:03:03,983 --> 05:03:05,017 CAPABILITY IN SIGHT LIST AND 6886 05:03:05,017 --> 05:03:07,153 POINT OF CARE CLINICAL TRIALS. 6887 05:03:07,153 --> 05:03:13,726 HIS WORK WAS CITED BY DR. BILL 6888 05:03:13,726 --> 05:03:15,928 HEEDRICKS, HE AND NEW MEMBERS 6889 05:03:15,928 --> 05:03:17,029 BRING EXCELLENT CAPABILITIES 6890 05:03:17,029 --> 05:03:20,399 THAT WOULD ALLOW US TO GO 6891 05:03:20,399 --> 05:03:23,469 FURTHER WITH HOME-BASED 6892 05:03:23,469 --> 05:03:24,170 SIGHTLESS TRIALS. 6893 05:03:24,170 --> 05:03:27,807 AGAIN, WE HAVE BROUGHT TAKE IN 6894 05:03:27,807 --> 05:03:34,246 THE CONTEXT OF CAPCAT TWO 6895 05:03:34,246 --> 05:03:43,222 UMass CAMPUSES, , LOCAL AND 6896 05:03:43,222 --> 05:03:45,424 WORCESTER, TO GET INCUBATOR 6897 05:03:45,424 --> 05:03:48,294 SPACE, WE PROVIDE ACCESS TO 6898 05:03:48,294 --> 05:03:49,095 TRAINING, I-CORPS TRAINING 6899 05:03:49,095 --> 05:03:51,464 MENTIONED EARLIER, AS WELL AS 6900 05:03:51,464 --> 05:03:56,802 ACCESS TO BIOSAMPLES AND SIMILAR 6901 05:03:56,802 --> 05:03:58,504 RESOURCES OTHER CENTERS OFFER. 6902 05:03:58,504 --> 05:04:01,774 IN ADDITION PARTICULAR FOCUS ON 6903 05:04:01,774 --> 05:04:04,076 CLINICAL RESEARCH DESIGN 6904 05:04:04,076 --> 05:04:04,577 METHODOLOGY, STATISTICAL 6905 05:04:04,577 --> 05:04:05,511 ANALYSIS, USER-CENTERED DESIGN 6906 05:04:05,511 --> 05:04:08,314 AND TRIALS ARE UNIQUE FEATURES I 6907 05:04:08,314 --> 05:04:08,547 THINK. 6908 05:04:08,547 --> 05:04:10,649 SO, ONE OF THE OTHER THINGS WE 6909 05:04:10,649 --> 05:04:12,651 DO DIFFERENCELY IN THE CONTEXT 6910 05:04:12,651 --> 05:04:15,054 OF OUR CENTER, WE ISSUE SURVEYS 6911 05:04:15,054 --> 05:04:16,822 PREVIOUSLY MENTIONED AS PARTS OF 6912 05:04:16,822 --> 05:04:19,458 OUR NEEDS ASSESSMENT THAT'S DONE 6913 05:04:19,458 --> 05:04:26,732 YEARLY BEFORE WE GO LIVE WITH 6914 05:04:26,732 --> 05:04:27,967 CALL FOR APPLICATIONS TO INFORM 6915 05:04:27,967 --> 05:04:31,804 WHAT WE ASK FOR IN TERMS OF OUR 6916 05:04:31,804 --> 05:04:32,471 CALL, INCORPORATING CLINICIAN 6917 05:04:32,471 --> 05:04:34,974 VOICES AS WELL AS PATIENT VOICES 6918 05:04:34,974 --> 05:04:37,176 INTO THIS AND IT'S BEEN HELPFUL 6919 05:04:37,176 --> 05:04:38,677 TO SEE INCREASED INTEREST IN 6920 05:04:38,677 --> 05:04:41,080 THIS AREA AMONG BOTH GROUPS. 6921 05:04:41,080 --> 05:04:47,920 THESE ARE A FEW OF THE 6922 05:04:47,920 --> 05:04:51,424 EDUCATIONAL OPPORTUNITIES, IS A 6923 05:04:51,424 --> 05:04:52,591 12-WEEK ACCELERATOR PROGRAM AND 6924 05:04:52,591 --> 05:04:55,127 A CORE THAT DR. DUNLAP RUNS, 6925 05:04:55,127 --> 05:04:57,763 INCLUDES A NUMBER OF STUDENTS 6926 05:04:57,763 --> 05:05:00,199 AND POTENTIAL INTERNS IN 6927 05:05:00,199 --> 05:05:00,633 START-UP COMPANIES. 6928 05:05:00,633 --> 05:05:04,437 AND ONE OF THE OTHER THINGS WE 6929 05:05:04,437 --> 05:05:06,539 DO WHICH WE STARTED TWO YEARS 6930 05:05:06,539 --> 05:05:09,708 AGO WHICH HAS BEEN SUCCESSFUL IS 6931 05:05:09,708 --> 05:05:11,444 THE SHOWCASE EVENT THAT HAS 6932 05:05:11,444 --> 05:05:13,345 REALLY BECOME A CENTERPIECE FOR 6933 05:05:13,345 --> 05:05:14,880 OUR YEAR. 6934 05:05:14,880 --> 05:05:16,715 SO WE TYPICALLY FUND FOUR OR 6935 05:05:16,715 --> 05:05:18,617 FIVE AWARDEES, WE'VE HAD A TOTAL 6936 05:05:18,617 --> 05:05:19,485 OF 23. 6937 05:05:19,485 --> 05:05:22,021 THEY GO THROUGH PITCH COACHING 6938 05:05:22,021 --> 05:05:26,091 FROM STEVE FLAME, SHOWN EARLIER 6939 05:05:26,091 --> 05:05:28,527 BY DR. SESETTI AND OTHER 6940 05:05:28,527 --> 05:05:29,361 ENTREPRENEURS IN RESIDENCE AT 6941 05:05:29,361 --> 05:05:32,565 NIH OVER THE COURSE OF THE YEAR, 6942 05:05:32,565 --> 05:05:33,499 GRADUATION EVENTS THE AWARDEES 6943 05:05:33,499 --> 05:05:36,969 COME IN FRONT OF A PANEL 6944 05:05:36,969 --> 05:05:39,505 COMPRISED OF VENTURES, STRATEGIC 6945 05:05:39,505 --> 05:05:42,975 INVESTORS, OTHERS FROM JOHNSON & 6946 05:05:42,975 --> 05:05:45,177 JOHNSON, SIEMENS AND OTHER 6947 05:05:45,177 --> 05:05:47,146 PLAYERS IN THE BIOTECH SPACES 6948 05:05:47,146 --> 05:05:48,881 LEADING TO INVESTMENTS IN AT 6949 05:05:48,881 --> 05:05:50,516 LEAST TWO CASES, A GREAT 6950 05:05:50,516 --> 05:05:52,418 OPPORTUNITY FOR NETWORKING AND 6951 05:05:52,418 --> 05:05:53,919 THINKING ABOUT THAT NEXT PHASE 6952 05:05:53,919 --> 05:05:54,720 OF COMMERCIALIZATION. 6953 05:05:54,720 --> 05:05:57,256 THIS IS SOMETHING WE PLAN TO DO 6954 05:05:57,256 --> 05:05:59,992 AGAIN AND HOPE TO ENGAGE A 6955 05:05:59,992 --> 05:06:02,728 NUMBER OF YOU IN THE EXPERIENCE. 6956 05:06:02,728 --> 05:06:05,464 SO TO SUMMARIZE THESE ARE 6957 05:06:05,464 --> 05:06:06,966 RESOURCES WE SHARE. 6958 05:06:06,966 --> 05:06:12,938 WE'VE SHARED WITH DR. MANABI 6959 05:06:12,938 --> 05:06:13,672 SOME INTERACTIVITY, AND OVER THE 6960 05:06:13,672 --> 05:06:20,779 COURSE OF THE YEAR USE A 6961 05:06:20,779 --> 05:06:21,881 STRUCTURED INTERVIEW MONTHLY 6962 05:06:21,881 --> 05:06:24,283 WITH A TEMPLATE AS WELL AS OTHER 6963 05:06:24,283 --> 05:06:25,150 RESOURCES LISTED HERE. 6964 05:06:25,150 --> 05:06:26,886 WE'D LOVE TO WORK WITH YOU MORE 6965 05:06:26,886 --> 05:06:27,887 AND APPRECIATE THE OPPORTUNITY 6966 05:06:27,887 --> 05:06:29,154 TO SPEAK WITH YOU TODAY. 6967 05:06:29,154 --> 05:06:39,365 THANK YOU. 6968 05:06:41,934 --> 05:06:44,870 >> NEXT IS DR. MANAPI LEADING 6969 05:06:44,870 --> 05:06:46,405 THE LONGEST STANDING POCTRN 6970 05:06:46,405 --> 05:06:48,274 CENTER AT INCOMES, ASSOCIATE 6971 05:06:48,274 --> 05:06:49,575 DIRECTOR OF GLOBAL HEALTH 6972 05:06:49,575 --> 05:06:52,111 RESEARCH AND INNOVATION 6973 05:06:52,111 --> 05:06:55,748 PROFESSOR OF MEDICINE. 6974 05:06:55,748 --> 05:06:56,482 THANK YOU. 6975 05:06:56,482 --> 05:06:57,750 >> THANKS, DR. CHEN. 6976 05:06:57,750 --> 05:06:59,952 IT'S NICE TO TALK ABOUT OUR 6977 05:06:59,952 --> 05:07:00,185 CENTER. 6978 05:07:00,185 --> 05:07:02,154 FOR THOSE THAT KNOW, THE CENTER 6979 05:07:02,154 --> 05:07:04,623 WAS FOUNDED BY CHARLOTTE GATOS 6980 05:07:04,623 --> 05:07:05,190 IN 2007. 6981 05:07:05,190 --> 05:07:07,927 WE HAVE THE HONOR OF BEING PART 6982 05:07:07,927 --> 05:07:09,261 OF THIS INCREDIBLE NETWORK FOR 6983 05:07:09,261 --> 05:07:11,230 THE LONGEST PERIOD OF TIME, ALSO 6984 05:07:11,230 --> 05:07:13,332 HAVING LIVED THROUGH A TIME 6985 05:07:13,332 --> 05:07:16,302 POINT-OF-CARE WASN'T A TIME TO 6986 05:07:16,302 --> 05:07:17,836 -- WASN'T A THING TO WHERE IT IS 6987 05:07:17,836 --> 05:07:19,572 A THING. 6988 05:07:19,572 --> 05:07:22,007 WE'VE EXPANDED BEYOND STDs TO 6989 05:07:22,007 --> 05:07:23,275 THINK ABOUT INFECTIOUS DISEASE. 6990 05:07:23,275 --> 05:07:25,945 MY OWN OPINION IS WE'RE AT A 6991 05:07:25,945 --> 05:07:28,447 MOMENT IN TIME, ALL THESE 6992 05:07:28,447 --> 05:07:30,416 PLATFORMS THAT HAVE THE EXACT 6993 05:07:30,416 --> 05:07:32,518 USE CASE AND DISEASE FOR WHICH 6994 05:07:32,518 --> 05:07:33,919 IT COULD BE MODIFIED. 6995 05:07:33,919 --> 05:07:35,354 I THINK THAT'S WHERE OUR EFFORTS 6996 05:07:35,354 --> 05:07:41,060 ARE GOING TO GO IN THIS CYCLE. 6997 05:07:41,060 --> 05:07:42,795 SO, THE CHALLENGE HALF THE 6998 05:07:42,795 --> 05:07:44,530 WORLD'S POPULATION DOESN'T HAVE 6999 05:07:44,530 --> 05:07:50,502 ACCESS TO DIAGNOSTICS. 7000 05:07:50,502 --> 05:07:51,804 OUR MISSION IS TO PROMOTE 7001 05:07:51,804 --> 05:07:52,671 DISEASE DIAGNOSTICS. 7002 05:07:52,671 --> 05:07:57,443 WE TAKE A LOT OF EARLY STAGE, 7003 05:07:57,443 --> 05:07:58,243 MID-STAGE, EVEN MATURE 7004 05:07:58,243 --> 05:07:58,577 TECHNOLOGIES. 7005 05:07:58,577 --> 05:08:02,615 THESE ARE THE CORE LEADS. 7006 05:08:02,615 --> 05:08:03,949 CORES, CLINICAL CORE, 7007 05:08:03,949 --> 05:08:04,717 TECHNOLOGY, DISSEMINATION CORE. 7008 05:08:04,717 --> 05:08:07,152 I HAVE HERE MOST IMPORTANT FOR 7009 05:08:07,152 --> 05:08:09,321 ALL OF YOU STEPHANIE WILL BE 7010 05:08:09,321 --> 05:08:11,957 SITTING AT OUR TABLE, OUR 7011 05:08:11,957 --> 05:08:12,725 COMPANY-FACING LIAISON. 7012 05:08:12,725 --> 05:08:18,130 YOU CAN GET TO HER THROUGH THIS 7013 05:08:18,130 --> 05:08:19,765 PARTICULAR E-MAIL. 7014 05:08:19,765 --> 05:08:22,935 SO WE HAVE DEVELOPED THIS WAY 7015 05:08:22,935 --> 05:08:25,004 BECAUSE CLINICAL CORE DEVELOPED 7016 05:08:25,004 --> 05:08:25,537 BIOREPOSITORY. 7017 05:08:25,537 --> 05:08:27,506 THERE ARE SOME COMPANIES IN THIS 7018 05:08:27,506 --> 05:08:28,807 AUDIENCE THAT BENEFITED FROM 7019 05:08:28,807 --> 05:08:29,041 THAT. 7020 05:08:29,041 --> 05:08:32,778 IF YOU HAVE A CHANCE TO AT LEAST 7021 05:08:32,778 --> 05:08:37,116 TRY OUT YOUR TECHNOLOGY IN 7022 05:08:37,116 --> 05:08:39,218 MATRIX, YOU CAN DO BETTER, 7023 05:08:39,218 --> 05:08:41,520 CLINICAL CAR, AWE HOW A 7024 05:08:41,520 --> 05:08:43,322 DIAGNOSTIC CAN BE USED, IMPACT 7025 05:08:43,322 --> 05:08:45,924 STUDY IN SETTINGS, WHETHER IN 7026 05:08:45,924 --> 05:08:47,026 CINCINNATI IN ADOLESCENCE, 7027 05:08:47,026 --> 05:08:48,460 UGANDA IN RESOURCE LIMITED 7028 05:08:48,460 --> 05:08:52,197 SETTINGS OR EMERGENCY ROOM AT 7029 05:08:52,197 --> 05:08:54,266 HOPKINS, OR STI CLINICIAN. 7030 05:08:54,266 --> 05:08:58,837 THE CORE IS DOING NEEDS 7031 05:08:58,837 --> 05:08:59,772 ASSESSMENTS, IN THE BEGINNING 7032 05:08:59,772 --> 05:09:01,674 NOBODY KNEW WHAT POINT OF CARE 7033 05:09:01,674 --> 05:09:02,808 WAS. 7034 05:09:02,808 --> 05:09:04,977 WHAT DO YOU MEAN, A GRAM STAIN? 7035 05:09:04,977 --> 05:09:06,178 WHICH IS A POINT OF CARE TEST 7036 05:09:06,178 --> 05:09:08,914 BUT NOT WHAT WE WERE 7037 05:09:08,914 --> 05:09:11,116 INTERESTING, INTERESTING TO SEE 7038 05:09:11,116 --> 05:09:12,918 HOW THINGS EVOLVED. 7039 05:09:12,918 --> 05:09:13,619 TRANSITIONING FROM APPLIED 7040 05:09:13,619 --> 05:09:15,554 PHYSICS TO US NOW. 7041 05:09:15,554 --> 05:09:17,089 WE RUN WEEKLY MEETINGS WITH 7042 05:09:17,089 --> 05:09:19,825 COMPANIES SO EVERY MONDAY I MEET 7043 05:09:19,825 --> 05:09:20,926 WITH A COMPANY PROBABLY 40 TIMES 7044 05:09:20,926 --> 05:09:22,561 A YEAR SO WE'RE HAPPY TO MEET 7045 05:09:22,561 --> 05:09:25,664 WITH ANYBODY THAT WANTS TO TALK 7046 05:09:25,664 --> 05:09:26,799 ABOUT STIS, OR OTHER INFECTIOUS 7047 05:09:26,799 --> 05:09:28,233 DISEASE TARGETS THAT THEY MIGHT 7048 05:09:28,233 --> 05:09:29,902 BE THINKING ABOUT WITH THEIR 7049 05:09:29,902 --> 05:09:30,769 PLATFORM. 7050 05:09:30,769 --> 05:09:34,039 WE RUN THE YEARLY SOLICITATION 7051 05:09:34,039 --> 05:09:36,141 THROUGH CIMIT AND THE NETWORK. 7052 05:09:36,141 --> 05:09:37,309 THIS IS ANOTHER WAY TO REPRESENT 7053 05:09:37,309 --> 05:09:38,844 THINGS WE DO. 7054 05:09:38,844 --> 05:09:41,413 WE HAVE A MASSIVE ONLINE FREE 7055 05:09:41,413 --> 05:09:41,647 COURSE. 7056 05:09:41,647 --> 05:09:43,115 WE'VE REALIZED A LOT OF PEOPLE 7057 05:09:43,115 --> 05:09:47,886 DON'T KNOW ENOUGH ABOUT 7058 05:09:47,886 --> 05:09:48,520 GONORRHEA, CHLAMYDIA, SYPHILIS, 7059 05:09:48,520 --> 05:09:49,254 HIV-INFECTED AND SO FORTH. 7060 05:09:49,254 --> 05:09:50,589 YOU CAN TAKE THIS AT YOUR 7061 05:09:50,589 --> 05:09:52,658 LEISURE AND LEARN ABOUT THE 7062 05:09:52,658 --> 05:09:55,060 BASIC ISSUES ENCOUNTERED IN THE 7063 05:09:55,060 --> 05:09:57,129 CLINICAL CONUNDRUMS PART OF STI 7064 05:09:57,129 --> 05:09:58,764 CLINICAL PRACTICE. 7065 05:09:58,764 --> 05:10:00,332 WE THOUGHT ABOUT VALUE-BASED 7066 05:10:00,332 --> 05:10:01,834 ADOPTION WHERE YOU DON'T 7067 05:10:01,834 --> 05:10:06,004 GULLS -- YOU CAN MAKE A GREAT 7068 05:10:06,004 --> 05:10:07,639 DIAGNOSTIC BUT YOU MAY FIND 7069 05:10:07,639 --> 05:10:09,408 AFTER YOU CREATED IT THERE'S NO 7070 05:10:09,408 --> 05:10:10,909 ONE TO ADOPT AND HAVE YOU NO 7071 05:10:10,909 --> 05:10:11,910 COMMERCIAL MARKET SO WE'VE 7072 05:10:11,910 --> 05:10:16,648 THOUGHT ABOUT THAT SPACE AS 7073 05:10:16,648 --> 05:10:17,182 WELL. 7074 05:10:17,182 --> 05:10:18,550 WE DO SELF-ASSESSMENT SYSTEMS 7075 05:10:18,550 --> 05:10:19,184 ENGINEERING. 7076 05:10:19,184 --> 05:10:22,354 IF YOU TAKE THIS ONLINE MODULE 7077 05:10:22,354 --> 05:10:24,790 YOU CAN GET SHUNTED DOWN 7078 05:10:24,790 --> 05:10:25,991 PATHWAYS DEPENDING ON ANSWERS TO 7079 05:10:25,991 --> 05:10:27,726 QUESTIONS AND WE CAN LINK WITH 7080 05:10:27,726 --> 05:10:29,461 SUBJECT MATTER EXPERTS TO HELP 7081 05:10:29,461 --> 05:10:31,997 YOU IN THINKING MORE 7082 05:10:31,997 --> 05:10:35,501 HOLISTICALLY ABOUT YOUR DEVICE. 7083 05:10:35,501 --> 05:10:37,035 WE HAVE BIOREPOSITORIES, AND 7084 05:10:37,035 --> 05:10:40,205 MANY WHO ARE PART OF RADx HAVE 7085 05:10:40,205 --> 05:10:41,406 SEEN THAT. 7086 05:10:41,406 --> 05:10:43,809 WE'VE DONE 92, A SIMILAR NUMBER 7087 05:10:43,809 --> 05:10:44,610 IN STIS. 7088 05:10:44,610 --> 05:10:46,812 DESKTOP EVALUATIONS IS SOMETHING 7089 05:10:46,812 --> 05:10:47,646 WE STARTED DURING COVID. 7090 05:10:47,646 --> 05:10:50,816 THIS HAS BEEN A GREAT WAY FOR US 7091 05:10:50,816 --> 05:10:52,651 TO, WITH PEOPLE WITH 7092 05:10:52,651 --> 05:10:54,887 COLLECTIVELY ABOUT 80 YEARS OF 7093 05:10:54,887 --> 05:10:55,954 POINT OFCARE DEVICE EXPERIENCE 7094 05:10:55,954 --> 05:10:58,056 TO HAVE THEM TRY OUT YOUR DEVICE 7095 05:10:58,056 --> 05:11:02,227 AND TELL WHAT YOU THEY THINK, 7096 05:11:02,227 --> 05:11:03,095 THEY FIND DIFFICULT TO 7097 05:11:03,095 --> 05:11:05,164 UNDERSTAND ABOUT USE OF YOUR 7098 05:11:05,164 --> 05:11:05,497 DEVICE. 7099 05:11:05,497 --> 05:11:07,166 AND TESTING IN CONTEXT TO THINK 7100 05:11:07,166 --> 05:11:08,901 ABOUT IMPACTFUL USE. 7101 05:11:08,901 --> 05:11:10,102 WE HAVE RESEARCH INCUBATORS IN 7102 05:11:10,102 --> 05:11:11,603 THE EMERGENCY ROOM AT HOPKINS, 7103 05:11:11,603 --> 05:11:13,705 IN SINCE GREAT WHERE YOU CAN 7104 05:11:13,705 --> 05:11:14,706 PLACE ADVICE, THOSE RESULTS 7105 05:11:14,706 --> 05:11:17,576 WONTS BE REPORTED TO PATIENTS 7106 05:11:17,576 --> 05:11:19,778 BUT YOU CAN CO-LOCALIZE WITH 7107 05:11:19,778 --> 05:11:21,280 PATIENTS YOU'RE RECRUITING. 7108 05:11:21,280 --> 05:11:22,714 THESE ARE RESOURCES THE CENTER 7109 05:11:22,714 --> 05:11:23,248 HAS. 7110 05:11:23,248 --> 05:11:25,684 I'VE TALKED ABOUT MOST OF THESE. 7111 05:11:25,684 --> 05:11:28,954 AND I THINK WE'LL TRY TO EXPAND 7112 05:11:28,954 --> 05:11:35,527 BENCH TOP EVALUATIONS, I ENJOYED 7113 05:11:35,527 --> 05:11:37,663 THE ACME DESCRIPTION OF THEIR 7114 05:11:37,663 --> 05:11:38,030 EVALUATION. 7115 05:11:38,030 --> 05:11:39,598 OURS IS SIMILAR. 7116 05:11:39,598 --> 05:11:41,200 SOME THINGS WE DON'T DO LIKE 7117 05:11:41,200 --> 05:11:45,604 BOOK END EVALUATION BUS DO HAVE 7118 05:11:45,604 --> 05:11:46,805 STANDARDIZED LIMITED DETECTION 7119 05:11:46,805 --> 05:11:49,441 AND REAL CLINICAL SAMPLES WE CAN 7120 05:11:49,441 --> 05:11:49,775 TRY. 7121 05:11:49,775 --> 05:11:52,277 AND THE FINAL IS BIOREPOSITORY 7122 05:11:52,277 --> 05:11:55,347 SAMPLES ARE AVAILABLE TO PEOPLE 7123 05:11:55,347 --> 05:11:56,682 WHO APPLY TO SOLICITATION, GREAT 7124 05:11:56,682 --> 05:11:57,649 TO AT LEAST APPLY. 7125 05:11:57,649 --> 05:11:59,284 YOU DON'T HAVE TO WIN A 7126 05:11:59,284 --> 05:12:01,019 SOLICITATION BUT AT LEAST TO 7127 05:12:01,019 --> 05:12:02,688 HAVE APPLIED WILL MAKE YOU 7128 05:12:02,688 --> 05:12:04,556 ELIGIBLE FOR SAMPLES WE HAVE. 7129 05:12:04,556 --> 05:12:07,960 WE HAVE MANY OF SAMPLE TYPES 7130 05:12:07,960 --> 05:12:08,827 INCLUDING THROAT, GENITAL, 7131 05:12:08,827 --> 05:12:12,097 RECTAL, AND THEN FOR ALL THE 7132 05:12:12,097 --> 05:12:14,032 BLOOD-BORNE DISEASES WE HAVE A 7133 05:12:14,032 --> 05:12:15,734 WIDE VARIETY OF BLOOD. 7134 05:12:15,734 --> 05:12:17,269 VIRAL HEPATITIS CENTER WITH WHOM 7135 05:12:17,269 --> 05:12:18,904 WE COLLABORATE, IF YOU'RE 7136 05:12:18,904 --> 05:12:20,639 INTERESTED IN SOME OF THESE HEP 7137 05:12:20,639 --> 05:12:22,741 B AND HEP C SAMPLES WE HAVE 7138 05:12:22,741 --> 05:12:23,041 THOSE. 7139 05:12:23,041 --> 05:12:27,713 WITH THAT I THINK I'LL TURN BACK 7140 05:12:27,713 --> 05:12:30,515 OVER TO JUE. 7141 05:12:30,515 --> 05:12:36,655 7142 05:12:36,655 --> 05:12:40,058 >> NEXT IS DR. REBEKAH RICHARDS, 7143 05:12:40,058 --> 05:12:42,895 LEADING THE CENTER FOR 7144 05:12:42,895 --> 05:12:46,198 INNOVATION AND TRANSLATION OF 7145 05:12:46,198 --> 05:12:48,700 POINT OF CAR TECHNOLOGIES FOR 7146 05:12:48,700 --> 05:12:50,769 EQUITABLE CANCER CARE, PROFESSOR 7147 05:12:50,769 --> 05:12:53,171 OF BIOENGINEERING DIRECTOR OF 7148 05:12:53,171 --> 05:12:54,973 RISE 360-DEGREE INSTITUTE FOR 7149 05:12:54,973 --> 05:12:57,743 GLOBAL HEALTH TECHNOLOGIES. 7150 05:12:57,743 --> 05:13:04,016 7151 05:13:04,016 --> 05:13:05,717 >> IT'S A PLEASURE TO BE PART OF 7152 05:13:05,717 --> 05:13:07,953 THE TEAM AND HAVE THE 7153 05:13:07,953 --> 05:13:11,223 OPPORTUNITY TO TELL YOU ABOUT 7154 05:13:11,223 --> 05:13:14,226 CITAC, FOCUSED ON DEVELOPING 7155 05:13:14,226 --> 05:13:16,128 TESTS TO IMPROVE EARLY DETECTION 7156 05:13:16,128 --> 05:13:18,864 AND TREATMENTS OF CANCER, TO 7157 05:13:18,864 --> 05:13:21,133 ADDRESS THE CHALLENGE CURRENT 7158 05:13:21,133 --> 05:13:23,335 TESTS ARE TOO COMPLICATED AND 7159 05:13:23,335 --> 05:13:24,770 TOO EXPENSIVE, ESPECIALLY FOR 7160 05:13:24,770 --> 05:13:27,472 PEOPLE THAT LIVE IN MEDICALLY 7161 05:13:27,472 --> 05:13:28,607 UNDERSERVED AREAS. 7162 05:13:28,607 --> 05:13:31,443 SO, OUR GOALS AS A CENTER ARE TO 7163 05:13:31,443 --> 05:13:34,212 FIRST IDENTIFY WHAT ARE THE HIGH 7164 05:13:34,212 --> 05:13:36,682 PRIORITY CLINICAL NEEDS FOR 7165 05:13:36,682 --> 05:13:37,582 POINT-OF-CARE CANCER 7166 05:13:37,582 --> 05:13:38,350 TECHNOLOGIES. 7167 05:13:38,350 --> 05:13:41,219 AND THEN TO HELP ACCELERATE THE 7168 05:13:41,219 --> 05:13:42,287 DEVELOPMENT OF AFFORDABLE 7169 05:13:42,287 --> 05:13:44,589 TECHNOLOGIES TO MEET THESE 7170 05:13:44,589 --> 05:13:45,157 NEEDS. 7171 05:13:45,157 --> 05:13:48,627 WE WANT TO HELP INVESTIGATORS 7172 05:13:48,627 --> 05:13:49,861 EVALUATE AND IMPROVE CLINICAL 7173 05:13:49,861 --> 05:13:51,296 AND PUBLIC HEALTH IMPACT OF 7174 05:13:51,296 --> 05:13:53,131 THESE POINT OF CARE 7175 05:13:53,131 --> 05:13:56,001 TECHNOLOGIES, IN A DIVERSE RANGE 7176 05:13:56,001 --> 05:13:57,202 OF MEDICALLY UNDERSERVED 7177 05:13:57,202 --> 05:13:59,304 SETTINGS, AND THEN HELP TRAIN 7178 05:13:59,304 --> 05:14:01,907 DEVELOPERS AND USERS TO CREATE 7179 05:14:01,907 --> 05:14:03,041 AND DISSEMINATE POINT-OF-CARE 7180 05:14:03,041 --> 05:14:05,978 TECHNOLOGIES FOR CANCER THAT ARE 7181 05:14:05,978 --> 05:14:06,979 MORE EQUITABLE. 7182 05:14:06,979 --> 05:14:13,218 OUR TEAM IS SHOWN ON THE SIDE. 7183 05:14:13,218 --> 05:14:14,953 MYSELF, AND INCLUDE THE VICE 7184 05:14:14,953 --> 05:14:16,655 PRESIDENT FOR GLOBAL HEALTH AT 7185 05:14:16,655 --> 05:14:20,425 BAYLOR COLLEGE OF MEDICINE. 7186 05:14:20,425 --> 05:14:22,427 SHE IS HER. 7187 05:14:22,427 --> 05:14:24,162 A PROFESSOR OF BIOENGINEERING AT 7188 05:14:24,162 --> 05:14:26,565 RICE WILL BE HERE TOMORROW AND 7189 05:14:26,565 --> 05:14:29,368 THE EXECUTIVE DIRECTOR OF THE 7190 05:14:29,368 --> 05:14:34,806 GLOBAL ONCOLOGY AT M.D. ANDERSON 7191 05:14:34,806 --> 05:14:36,108 CANCER CENTER. 7192 05:14:36,108 --> 05:14:37,642 WE'RE FOCUSED FOR PRIORITY CANS 7193 05:14:37,642 --> 05:14:40,912 SOAR CERVIX, G.I. TRACT, ORAL 7194 05:14:40,912 --> 05:14:42,781 CAVITY, ALTHOUGH OF COURSE WE 7195 05:14:42,781 --> 05:14:44,416 WILL WORK ACROSS THE ENTIRE 7196 05:14:44,416 --> 05:14:45,183 FIELD. 7197 05:14:45,183 --> 05:14:50,322 I TOLD YOU ABOUT OUR U.S. MEMBER 7198 05:14:50,322 --> 05:14:50,989 INSTITUTIONS. 7199 05:14:50,989 --> 05:14:52,424 WE'RE INTERESTED IN UNDERSERVED 7200 05:14:52,424 --> 05:14:55,794 SETTINGS IN TEXAS AND UNITED 7201 05:14:55,794 --> 05:15:03,935 STATES BUT HAVE MEMBER 7202 05:15:03,935 --> 05:15:06,104 INSTITUTIONS WITH BRAZIL, AND 7203 05:15:06,104 --> 05:15:10,575 ALSO A LOW INCOME COUNTRY IN 7204 05:15:10,575 --> 05:15:11,810 MOZAMBIQUE WORKING WITH UEM AND 7205 05:15:11,810 --> 05:15:12,778 MINISTRY OF HEALTH. 7206 05:15:12,778 --> 05:15:18,150 WE HAVE A WIDE VARIETY OF 7207 05:15:18,150 --> 05:15:19,918 CLINICIANS AND TECHNOLOGY 7208 05:15:19,918 --> 05:15:26,792 DEVELOPERS WORKING IN MEDICALLY 7209 05:15:26,792 --> 05:15:27,626 UNDERSERVED REGIONSES IN AFRICA, 7210 05:15:27,626 --> 05:15:28,860 BRAZIL, UNITED STATES. 7211 05:15:28,860 --> 05:15:33,131 WE OFFER ACCESS TO CLINICIANS TO 7212 05:15:33,131 --> 05:15:35,867 HELP UNDERSTAND, TO HELP 7213 05:15:35,867 --> 05:15:38,670 EVALUATE TECHNOLOGIES, AND THEN 7214 05:15:38,670 --> 05:15:40,672 EXPERTS IN USABILITY TO HELP 7215 05:15:40,672 --> 05:15:44,309 DESIGN AND EVALUATE THE 7216 05:15:44,309 --> 05:15:45,444 USABILITY OF TECHNOLOGIES IN 7217 05:15:45,444 --> 05:15:51,083 THESE SETTINGS AND TO LOOK AT 7218 05:15:51,083 --> 05:15:53,652 BARRIERS TO ENABLERS AND 7219 05:15:53,652 --> 05:15:54,719 ADOPTION IN THESE SETTINGS. 7220 05:15:54,719 --> 05:15:58,957 WE HAVE TWO SETS OF UNIQUE 7221 05:15:58,957 --> 05:16:00,392 RESOURCES, FIRST IN 7222 05:16:00,392 --> 05:16:02,260 COMMERCIALIZATION, TEXAS MEDICAL 7223 05:16:02,260 --> 05:16:05,564 CENTER, WE HAVE ACCESS TO A 7224 05:16:05,564 --> 05:16:06,198 WONDERFUL SET OF 7225 05:16:06,198 --> 05:16:08,733 COMMERCIALIZATION RESOURCES THAT 7226 05:16:08,733 --> 05:16:10,202 ARE FOCUSED ON THE COMPANIES 7227 05:16:10,202 --> 05:16:14,005 BASED IN THE U.S. AND IN BRAZIL 7228 05:16:14,005 --> 05:16:17,709 WE HAVE ACCESS TO RESOURCES 7229 05:16:17,709 --> 05:16:19,044 THROUGH A GOVERNMENT-FUNDED 7230 05:16:19,044 --> 05:16:26,084 PROGRAM THAT CAN HELP SUPPORT 7231 05:16:26,084 --> 05:16:26,718 INNOVATIONS TARGETING CUSTOMERS 7232 05:16:26,718 --> 05:16:30,922 IN LOW- AND MIDDLE-INCOME 7233 05:16:30,922 --> 05:16:33,792 COUNTRIES AND FANTASTIC 7234 05:16:33,792 --> 05:16:34,526 MICROFABRICATION TECHNOLOGIES 7235 05:16:34,526 --> 05:16:37,729 FOR FABRICATION AND 7236 05:16:37,729 --> 05:16:38,163 CHARACTERIZATION OF 7237 05:16:38,163 --> 05:16:39,564 TECHNOLOGIES, MY COLLEAGUE WILL 7238 05:16:39,564 --> 05:16:41,466 BE HERE TOMORROW TO SHARE MORE 7239 05:16:41,466 --> 05:16:42,234 INFORMATION ABOUT THESE 7240 05:16:42,234 --> 05:16:42,501 RESOURCES. 7241 05:16:42,501 --> 05:16:44,936 THANK YOU. 7242 05:16:44,936 --> 05:16:50,942 7243 05:16:50,942 --> 05:16:54,980 7244 05:16:54,980 --> 05:16:57,249 >> NEXT IS ASSOCIATE PROFESSOR 7245 05:16:57,249 --> 05:16:58,383 OF MEDICINE AT NORTHWESTERN 7246 05:16:58,383 --> 05:17:00,685 UNIVERSITY AND HE'S GOING TO 7247 05:17:00,685 --> 05:17:03,755 SHARE WITH US THE CENTER FOR 7248 05:17:03,755 --> 05:17:04,623 INNOVATION IN POINT-OF-CARE 7249 05:17:04,623 --> 05:17:15,200 PARTICULAR NOTHING FOR HIV/AIDS 7250 05:17:15,200 --> 05:17:24,176 AND INFECTIOUS DISEASE. 7251 05:17:24,176 --> 05:17:28,213 >> YOU HEARD ABOUT CIFAN 7252 05:17:28,213 --> 05:17:28,680 ALREADY. 7253 05:17:28,680 --> 05:17:31,616 TODAY IT COULD BE AGE RELATED 7254 05:17:31,616 --> 05:17:34,419 INCLUDING CANCER, HEART DISEASE, 7255 05:17:34,419 --> 05:17:38,523 ALL KINDS OF THINGS. 7256 05:17:38,523 --> 05:17:40,759 WE'RE FOCUSED ON LOW AND MIDDLE 7257 05:17:40,759 --> 05:17:41,927 INCOME SETTINGS, SUB-SAHARAN 7258 05:17:41,927 --> 05:17:42,260 AFRICA. 7259 05:17:42,260 --> 05:17:52,737 SALLY IS A CO-P.I. WITH ROB 7260 05:17:55,941 --> 05:18:00,245 MURPHY. 7261 05:18:00,245 --> 05:18:06,952 ROB HAS BUILT RELATIONSHIPS WITH 7262 05:18:06,952 --> 05:18:15,193 ALL THE SITES, VITAL TO WORKING 7263 05:18:15,193 --> 05:18:16,795 WITH GLOBAL PARTNERS. 7264 05:18:16,795 --> 05:18:19,864 KARA IS IN THE KELLOGG SCHOOL OF 7265 05:18:19,864 --> 05:18:21,499 MANAGEMENT, BRINGS MANAGEMENT 7266 05:18:21,499 --> 05:18:32,010 AND STRING FOCUS FOR C-THAN. 7267 05:18:34,813 --> 05:18:40,051 WE'RE MORE SO OUR PARTNERS IN 7268 05:18:40,051 --> 05:18:41,353 SUB-SAHARAN AFRICA. 7269 05:18:41,353 --> 05:18:44,422 WE'RE ENIMAGED WITH ALL SITES, 7270 05:18:44,422 --> 05:18:49,127 PROJECTS ALL ALL SITES, SOUTH 7271 05:18:49,127 --> 05:18:51,563 AFRICA, NIGERIA, MALI, TANZANIA, 7272 05:18:51,563 --> 05:18:55,634 ADDING IN SITES IN SENEGAL AND 7273 05:18:55,634 --> 05:18:58,803 SOUTH AFRICA, AND TWO 7274 05:18:58,803 --> 05:19:04,242 INVESTIGATORS, GOT SO INTERESTED 7275 05:19:04,242 --> 05:19:06,811 IN C-THAN, WE BROUGHT THEM IN. 7276 05:19:06,811 --> 05:19:12,183 WE'RE EXCITED TO HAVE TWO NEW 7277 05:19:12,183 --> 05:19:15,020 SITES, BOTH HAVE DEPARTMENTS OF 7278 05:19:15,020 --> 05:19:16,354 BIOENGINEERING, SCHOOLS OF 7279 05:19:16,354 --> 05:19:17,188 MEDICINE AND OPPORTUNITIES FOR 7280 05:19:17,188 --> 05:19:24,195 TECH DEVELOPMENT. 7281 05:19:24,195 --> 05:19:26,298 OUR RESOURCES, EXPERTISE IN THE 7282 05:19:26,298 --> 05:19:26,965 TECHNOLOGY DEVELOPMENT AND 7283 05:19:26,965 --> 05:19:32,537 MENTORSHIP IN POINT OF CARE TECH 7284 05:19:32,537 --> 05:19:33,538 DEVELOPMENT AND 7285 05:19:33,538 --> 05:19:34,306 COMMERCIALIZATION, CLINICAL 7286 05:19:34,306 --> 05:19:38,677 VALIDATION STUDY DESIGN AND 7287 05:19:38,677 --> 05:19:41,179 CONDUCT, AND MUCH LIKE MANY 7288 05:19:41,179 --> 05:19:44,582 OTHER SITES WE HAVE DONE A LOT 7289 05:19:44,582 --> 05:19:51,489 OF WORK DEVELOPING BIOSPECIMEN 7290 05:19:51,489 --> 05:19:51,890 REPOSITORY. 7291 05:19:51,890 --> 05:19:53,792 ALL SEVEN SITES WE DID SURVEYS 7292 05:19:53,792 --> 05:19:55,427 TO UNDERSTAND SPECIMENS IN TERMS 7293 05:19:55,427 --> 05:20:00,832 OF BEING ABLE TO TEST FOR HIV, 7294 05:20:00,832 --> 05:20:03,635 TB, VIRAL HEPATITIS, CANCERS. 7295 05:20:03,635 --> 05:20:06,504 DISSEMINATION CORE WE'VE DONE 7296 05:20:06,504 --> 05:20:10,909 MANY LMIC NEEDS ASSESSMENTS, 7297 05:20:10,909 --> 05:20:12,310 RESOURCES, MARKET LANDSCAPE, 7298 05:20:12,310 --> 05:20:14,179 ASSESSMENTS THROUGH KARA AND THE 7299 05:20:14,179 --> 05:20:15,413 KELLOGG BUSINESS STUDENTS. 7300 05:20:15,413 --> 05:20:18,016 WE'VE DONE TRAINING IN MARKET 7301 05:20:18,016 --> 05:20:19,217 RESEARCH REGULATORY PATHWAYS, 7302 05:20:19,217 --> 05:20:20,318 TRANSFER TO MANUFACTURING SALES 7303 05:20:20,318 --> 05:20:21,319 AND DISTRIBUTION. 7304 05:20:21,319 --> 05:20:22,587 WE PLAN TO DEVELOP A FEW OTHER 7305 05:20:22,587 --> 05:20:25,890 THINGS DURING THE NEXT FUNDING 7306 05:20:25,890 --> 05:20:26,224 CYCLE. 7307 05:20:26,224 --> 05:20:28,193 WE'VE CONTINUED TO DEVELOP 7308 05:20:28,193 --> 05:20:29,627 EXPERTISE IN TRAINING. 7309 05:20:29,627 --> 05:20:31,930 WE'VE DECIDED TO FOCUS ON FOUR 7310 05:20:31,930 --> 05:20:34,132 WORKING GROUP AREAS FOR 7311 05:20:34,132 --> 05:20:34,733 TECHNOLOGY MOST APPLICABLE TO 7312 05:20:34,733 --> 05:20:38,970 LOW AND MIDDLE INCOME SETTINGS. 7313 05:20:38,970 --> 05:20:46,945 MOLECULAR BIOLOGY, LATERAL FLOW, 7314 05:20:46,945 --> 05:20:52,117 , COME AND SEE OUR TABLE. 7315 05:20:52,117 --> 05:20:54,419 A LOT IS THIS PRODUCT 7316 05:20:54,419 --> 05:20:54,753 ENGINEERING. 7317 05:20:54,753 --> 05:20:57,055 WE CALL IT THE GADGETS. 7318 05:20:57,055 --> 05:21:01,526 WE EIGHTING A NEW -- CREATING A 7319 05:21:01,526 --> 05:21:03,728 NEW WAY TO COLLECT SPUTUM, 7320 05:21:03,728 --> 05:21:05,497 BLOOD, IT'S AS MUCH ABOUT 7321 05:21:05,497 --> 05:21:11,536 TESTING AS ABOUT ENGINEERING, 7322 05:21:11,536 --> 05:21:13,371 HOW YOU COLLECT SAMPLES. 7323 05:21:13,371 --> 05:21:18,042 WE'D LIKE TO DO STANDARDIZATION, 7324 05:21:18,042 --> 05:21:22,013 AND THEN A FEW OTHER ACTIVITIES 7325 05:21:22,013 --> 05:21:23,915 IN THE DISSEMINATION CORE, 7326 05:21:23,915 --> 05:21:25,850 JOURNEY MAPPING, OTHER THINGS. 7327 05:21:25,850 --> 05:21:28,686 WE'RE OPEN TO SHARING WITH 7328 05:21:28,686 --> 05:21:28,920 ANYONE. 7329 05:21:28,920 --> 05:21:33,291 WE'RE CONSTRAINED BY OUR LOCAL 7330 05:21:33,291 --> 05:21:33,958 PARTNER, SITE REGULATIONS, 7331 05:21:33,958 --> 05:21:35,693 OVERSIGHT, AND MATERIAL AND DATA 7332 05:21:35,693 --> 05:21:36,895 TRANSFER AGREEMENTS BUT WE'RE 7333 05:21:36,895 --> 05:21:40,632 OPEN TO WORKING WITH ANY OF YOU. 7334 05:21:40,632 --> 05:21:42,700 THIS IS SOME EXAMPLES OF A FEW 7335 05:21:42,700 --> 05:21:45,870 THINGS WE'VE DONE TO ADVANCE 7336 05:21:45,870 --> 05:21:46,204 TECHNOLOGIES. 7337 05:21:46,204 --> 05:21:49,707 WE'VE HAD A LOT OF PROJECTS, 7338 05:21:49,707 --> 05:21:52,243 SMALLER ONES, MAYBE SOME OTHER 7339 05:21:52,243 --> 05:21:54,212 POCTRN CENTERS. 7340 05:21:54,212 --> 05:21:56,381 AND WE'VE PROVIDED EXPERTISE NOT 7341 05:21:56,381 --> 05:22:00,552 JUST TO THOUGH WE FUNDED, MANY 7342 05:22:00,552 --> 05:22:03,521 TECHNOLOGY HAVE APPLIED AND HAVE 7343 05:22:03,521 --> 05:22:05,290 THIS EXPERIENCE, INDIVIDUALS 7344 05:22:05,290 --> 05:22:06,458 APPLIED, REALLY INTERESTING 7345 05:22:06,458 --> 05:22:07,459 TECHNOLOGIES OR PROJECTS THAT 7346 05:22:07,459 --> 05:22:11,496 COULDN'T FUND OR DIDN'T FIND A 7347 05:22:11,496 --> 05:22:14,699 WAY BUT FOUND A WAY TO APPLY FOR 7348 05:22:14,699 --> 05:22:17,001 ANOTHER YEAR OR FIND ANOTHER 7349 05:22:17,001 --> 05:22:19,437 PATH, OUR MENTORING IS 7350 05:22:19,437 --> 05:22:19,704 IMPORTANT. 7351 05:22:19,704 --> 05:22:22,707 BUSINESS STUDENTS GOING TO DO 7352 05:22:22,707 --> 05:22:23,908 NEEDS ASSESSMENTS, ENGINEERING 7353 05:22:23,908 --> 05:22:27,612 STUDENTS, GRADUATE STUDENTS, IN 7354 05:22:27,612 --> 05:22:30,281 MALI AND THE UNITED STATES, A 7355 05:22:30,281 --> 05:22:32,150 TRAINING OPPORTUNITIES FOR 7356 05:22:32,150 --> 05:22:33,117 UNDERGRADS TO GRADUATE STUDE%T, 7357 05:22:33,117 --> 05:22:43,528 WORKED WITH YOU ON RADx. 7358 05:22:47,332 --> 05:22:47,932 CONTINUED COLLABORATION, 7359 05:22:47,932 --> 05:22:51,636 RESEARCH THROUGH SHARING. 7360 05:22:51,636 --> 05:22:53,638 IF YOU'RE INTERESTED IN 7361 05:22:53,638 --> 05:22:54,038 SPECIMENS. 7362 05:22:54,038 --> 05:22:55,707 WE'RE WORKING ON A SIMILAR 7363 05:22:55,707 --> 05:22:58,309 RESOURCE FOR HIV VIRAL LOAD, 7364 05:22:58,309 --> 05:23:00,278 WE'RE GETTING PLASMA AND WHOLE 7365 05:23:00,278 --> 05:23:04,148 BLOOD WITH KNOWN LEVELS OF 7366 05:23:04,148 --> 05:23:05,016 DETECTABLE VIRUS, DIFFERENT 7367 05:23:05,016 --> 05:23:06,651 LEVELS, TO HELP WITH DEVELOPMENT 7368 05:23:06,651 --> 05:23:11,022 OF POINT OF CARE VIRAL LOAD 7369 05:23:11,022 --> 05:23:11,890 TESTING ACROSS NIH-FUNDED 7370 05:23:11,890 --> 05:23:16,060 NETWORKS TO GET A RESOURCE PUT 7371 05:23:16,060 --> 05:23:18,029 TOGETHER FOR PEOPLE FOR POINT OF 7372 05:23:18,029 --> 05:23:21,633 CARE VIRAL LOAD. 7373 05:23:21,633 --> 05:23:24,802 TECHNICAL VALIDATION, ONE NEW 7374 05:23:24,802 --> 05:23:27,338 SITE AT UNIVERSITY OF WITS, 7375 05:23:27,338 --> 05:23:28,740 LESLIE SCOTT, THEY WERE DOING 7376 05:23:28,740 --> 05:23:34,445 WHAT ACME DID IN TERMS OF 7377 05:23:34,445 --> 05:23:35,647 TECHNICAL VALIDATION, SIMILAR 7378 05:23:35,647 --> 05:23:36,614 TYPE OF PROCESS THERE, 7379 05:23:36,614 --> 05:23:38,182 INTERESTING TO COMPARE TO HOW 7380 05:23:38,182 --> 05:23:40,785 ACME DID IT AND EVERYONE ELSE. 7381 05:23:40,785 --> 05:23:42,987 THEY WOULD BE GOOD TO WORK WITH. 7382 05:23:42,987 --> 05:23:44,088 WE'RE INTERESTED IN WORKING IN 7383 05:23:44,088 --> 05:23:45,757 THE FOUR AREAS I HIGHLIGHTED. 7384 05:23:45,757 --> 05:23:48,293 I WANT TO ACKNOWLEDGE THE GRANTS 7385 05:23:48,293 --> 05:23:49,928 AND FUNDERS. 7386 05:23:49,928 --> 05:23:52,297 THANK YOU. 7387 05:23:52,297 --> 05:23:56,801 [APPLAUSE] 7388 05:23:56,801 --> 05:23:57,802 >> LAST PRESENTATION FOR THIS 7389 05:23:57,802 --> 05:24:06,110 PANEL WILL BE DELIVERED BY DR. 7390 05:24:06,110 --> 05:24:08,947 DAVID ERICKSON, PROFESSOR AND 7391 05:24:08,947 --> 05:24:12,750 SCHOOL OF MECHANICAL AND 7392 05:24:12,750 --> 05:24:14,085 AEROSPACE ENGINEER, CORNELL, 7393 05:24:14,085 --> 05:24:18,256 FOCUSED ON POINT OFCARE 7394 05:24:18,256 --> 05:24:20,158 TECHNOLOGY FOR NUTRITION AND 7395 05:24:20,158 --> 05:24:24,596 CANCER IN GLOBAL HEALTH. 7396 05:24:24,596 --> 05:24:26,931 >> THANK YOU. 7397 05:24:26,931 --> 05:24:29,801 IT'S AN HONOR TO SPEAK, A GREAT 7398 05:24:29,801 --> 05:24:31,669 HONOR TO BE HERE RECOMMENDING 7399 05:24:31,669 --> 05:24:34,839 THE CENTER, A MEMBER OF THIS 7400 05:24:34,839 --> 05:24:38,109 EXPANDED NETWORK AS WELL AS TO 7401 05:24:38,109 --> 05:24:43,281 MEET AND SPEAK WITH EVERYONE 7402 05:24:43,281 --> 05:24:44,015 HERE TODAY. 7403 05:24:44,015 --> 05:24:47,652 WE'RE A NEW CENTER AS NOTED. 7404 05:24:47,652 --> 05:24:49,487 OUR FOCUS AGAIN IS ON CENTER OF 7405 05:24:49,487 --> 05:24:52,223 POINT OF CARE TECHNOLOGY FOR 7406 05:24:52,223 --> 05:24:54,525 NUTRITION, INFECTION, CANCER FOR 7407 05:24:54,525 --> 05:24:55,627 GLOBAL HEALTH, QUITE A BROAD 7408 05:24:55,627 --> 05:24:56,828 LOOK AT THINGS. 7409 05:24:56,828 --> 05:25:03,401 YOU SEE WHY THAT IS IN A BIT. 7410 05:25:03,401 --> 05:25:06,237 OUR FOCUS IS SUPPORTING 7411 05:25:06,237 --> 05:25:06,971 DEVELOPMENT, DEPLOYMENT, 7412 05:25:06,971 --> 05:25:07,572 CLINICAL VALIDATION, 7413 05:25:07,572 --> 05:25:08,439 COMMERCIALIZATION OF POINT OF 7414 05:25:08,439 --> 05:25:12,043 CARE TECHNOLOGIES IN THOSE THREE 7415 05:25:12,043 --> 05:25:12,610 CATEGORIES, NUTRITION, 7416 05:25:12,610 --> 05:25:14,746 INFECTION, CANCER, FROM A GLOBAL 7417 05:25:14,746 --> 05:25:15,546 HEALTH PERSPECTIVE. 7418 05:25:15,546 --> 05:25:17,949 AND WE'LL DO THAT IN LOCATIONS 7419 05:25:17,949 --> 05:25:18,950 WHERE ACCESS TO BETTER 7420 05:25:18,950 --> 05:25:21,786 DIAGNOSTICS CAN HAVE THE LARGEST 7421 05:25:21,786 --> 05:25:23,655 WORLD-WIDE IMPACT. 7422 05:25:23,655 --> 05:25:25,957 WE FOCUS ON TECHNOLOGIES THAT 7423 05:25:25,957 --> 05:25:30,762 CAN IMPROVE -- ADDRESS PRIMARY 7424 05:25:30,762 --> 05:25:32,163 NEEDS OF THE MOST VULNERABLE IN 7425 05:25:32,163 --> 05:25:35,033 THE U.S. AND INTERNATIONALLY. 7426 05:25:35,033 --> 05:25:36,768 AND IN TERMS OF CONTACT I'M 7427 05:25:36,768 --> 05:25:38,870 GOING TO SAY THINGS HERE TODAY. 7428 05:25:38,870 --> 05:25:41,506 IN TERMS OF RESOURCES AND WHAT 7429 05:25:41,506 --> 05:25:44,042 NOT, YOU'RE WELCOME TO TALK TO 7430 05:25:44,042 --> 05:25:45,343 ME AGAIN UPSTAIRS LATER TO TODAY 7431 05:25:45,343 --> 05:25:48,112 BUT IF YOU DON'T GET THAT CHANCE 7432 05:25:48,112 --> 05:25:49,947 THROUGHOUT THE PRESENTATION HERE 7433 05:25:49,947 --> 05:25:52,116 IN THAT CORNER THAT QR CODE, 7434 05:25:52,116 --> 05:25:54,285 TAKE A PICTURE, THAT WILL LINK 7435 05:25:54,285 --> 05:25:56,387 YOU TO THE WEBSITE AND CONNECT 7436 05:25:56,387 --> 05:25:59,891 WITH OUR MAIN POINT OF CONTACT 7437 05:25:59,891 --> 05:26:01,325 THERE, PRIYANKA. 7438 05:26:01,325 --> 05:26:03,594 OUR CENTER, YOU CAN THINK OF THE 7439 05:26:03,594 --> 05:26:05,029 STRUCTURE LIKE THIS. 7440 05:26:05,029 --> 05:26:11,402 AGAIN, IT'S ENABLED BY A 7441 05:26:11,402 --> 05:26:12,270 ONE-OF-A-KIND INTERNATIONAL 7442 05:26:12,270 --> 05:26:14,138 NETWORK ACROSS FOUR CONTINENTS 7443 05:26:14,138 --> 05:26:16,774 TO PROVIDE THE SAME RESOURCES 7444 05:26:16,774 --> 05:26:21,045 BUT IN A SLIGHTLY DIFFERENT WAY. 7445 05:26:21,045 --> 05:26:24,949 THAT CLINICAL TRAINING 7446 05:26:24,949 --> 05:26:26,751 FACILITIES, UNIQUE WORLDWIDE 7447 05:26:26,751 --> 05:26:27,085 PERSPECTIVE. 7448 05:26:27,085 --> 05:26:29,387 WE HAVE FOUR CLINICAL SITES 7449 05:26:29,387 --> 05:26:31,789 INVOLVED IN THE TOP CORNER YOU 7450 05:26:31,789 --> 05:26:34,192 CAN SEE. 7451 05:26:34,192 --> 05:26:41,566 SO IN UGANDA INFECTIOUS DISEASE 7452 05:26:41,566 --> 05:26:43,401 INDIA, ECUADOR AND WEILL CORNELL 7453 05:26:43,401 --> 05:26:44,969 IN NEW YORK CITY. 7454 05:26:44,969 --> 05:26:47,138 IT GIVES OUR CLINICAL REACH 7455 05:26:47,138 --> 05:26:49,140 ACROSS FOUR CONTINENTS, A BROAD 7456 05:26:49,140 --> 05:26:52,076 SET OF USERS AND SPECIMENS THAT 7457 05:26:52,076 --> 05:26:55,379 I'LL TALK ABOUT IN A MINUTE. 7458 05:26:55,379 --> 05:26:59,383 ON THE DISSEMINATION CORE SIDE, 7459 05:26:59,383 --> 05:27:00,718 WE'RE -- NEEDS ASSESSMENT AND 7460 05:27:00,718 --> 05:27:02,487 TRAINING BE DONE THROUGH 7461 05:27:02,487 --> 05:27:04,122 PARTNERSHIP WITH MCGILL 7462 05:27:04,122 --> 05:27:05,223 UNIVERSITY, COMMISSIONERIZATION 7463 05:27:05,223 --> 05:27:06,657 SUPPORT PROVIDED BY COLUMBIA 7464 05:27:06,657 --> 05:27:06,958 UNIVERSITY. 7465 05:27:06,958 --> 05:27:11,162 I'M EXPLAIN SOME PROGRAMS IN A 7466 05:27:11,162 --> 05:27:11,395 MINUTE. 7467 05:27:11,395 --> 05:27:15,466 TECHNOLOGY DEVELOPMENT AND ALL 7468 05:27:15,466 --> 05:27:18,903 THAT WILL HAPPEN AT CORNELL, IN 7469 05:27:18,903 --> 05:27:19,637 ENGINEERING AND NUTRITIONAL 7470 05:27:19,637 --> 05:27:21,205 SCIENCES, AND AIL TALK ABOUT OUR 7471 05:27:21,205 --> 05:27:23,040 INITIAL PROJECTS TO BEGIN WITH 7472 05:27:23,040 --> 05:27:25,143 IN A MINUTE HERE. 7473 05:27:25,143 --> 05:27:28,212 SO, CENTER DIRECTORS, AS 7474 05:27:28,212 --> 05:27:29,413 MENTIONED, SIMILAR TO OTHER 7475 05:27:29,413 --> 05:27:31,682 CENTERS WE HAVE A TECHNICAL, 7476 05:27:31,682 --> 05:27:34,786 ENGINEERING P.I. WHICH IS MYSELF 7477 05:27:34,786 --> 05:27:36,954 ANDED MY GOOD COLLEAGUE WHO 7478 05:27:36,954 --> 05:27:40,024 SHOULD BE HERE TOMORROW IS OUR 7479 05:27:40,024 --> 05:27:42,126 CLINICAL DIRECTOR, BOTH OF US 7480 05:27:42,126 --> 05:27:47,165 HAVE THAT SORT OF EXPERTISE IN 7481 05:27:47,165 --> 05:27:49,200 THOSE AREAS AND OVERLAPPING 7482 05:27:49,200 --> 05:27:51,669 INTERESTS WITHIN GLOBAL HEALTH. 7483 05:27:51,669 --> 05:27:53,971 OTHER CENTER LEADERSHIP INCLUDES 7484 05:27:53,971 --> 05:27:55,640 OUR DISSEMINATION LEADERS, 7485 05:27:55,640 --> 05:27:58,709 CLINICAL LEADERS, AND OUR LAB TO 7486 05:27:58,709 --> 05:28:00,444 MARKET LEADER. 7487 05:28:00,444 --> 05:28:03,514 CLINICAL SITE LEADS AS WELL YOU 7488 05:28:03,514 --> 05:28:09,253 CAN SEE THERE FROM OUR FOUR 7489 05:28:09,253 --> 05:28:10,121 CLINICAL SITES. 7490 05:28:10,121 --> 05:28:13,191 SO WHAT I BELIEVE WE BRING HERE 7491 05:28:13,191 --> 05:28:17,361 IS OVER THE NEXT FIVE YEARS TO 7492 05:28:17,361 --> 05:28:20,898 THIS NETWORK IS GETTING THE 7493 05:28:20,898 --> 05:28:22,300 ABILITY TO VALIDATE 7494 05:28:22,300 --> 05:28:23,835 POINT-OF-CARE TECHNOLOGIES ON A 7495 05:28:23,835 --> 05:28:26,237 BROAD RANGE OF ESTABLISHED 7496 05:28:26,237 --> 05:28:27,338 POPULATIONS IN BIOSPECIMENS 7497 05:28:27,338 --> 05:28:28,773 ACROSS THE FOUR CONTINENT 7498 05:28:28,773 --> 05:28:30,408 NETWORK THAT I MENTIONED. 7499 05:28:30,408 --> 05:28:32,910 I THINK IT'S THE INDIVIDUAL 7500 05:28:32,910 --> 05:28:36,948 SITES THEMSELVES BUT AS WE TALK 7501 05:28:36,948 --> 05:28:37,915 ABOUT CROSS-POLLINATION OF 7502 05:28:37,915 --> 05:28:39,817 DIFFERENT TECHNOLOGIES BEING 7503 05:28:39,817 --> 05:28:40,785 USED IN DIFFERENT SETTINGS, 7504 05:28:40,785 --> 05:28:42,854 BEING ABLE TO USE MULTIPLES OF 7505 05:28:42,854 --> 05:28:46,490 THESE SIDES MIGHT BE AN 7506 05:28:46,490 --> 05:28:47,158 INTERESTING PERSPECTIVE. 7507 05:28:47,158 --> 05:28:50,428 I'LL TALK ABOUT LAB TO MARKET 7508 05:28:50,428 --> 05:28:51,629 ACCELERATION. 7509 05:28:51,629 --> 05:28:54,498 A NUMBER OF UNIQUE TRAINING 7510 05:28:54,498 --> 05:28:55,466 EXERCISES THROUGH THE PROGRAM 7511 05:28:55,466 --> 05:28:57,969 THAT WILL GET STOOD UP IN SHORT 7512 05:28:57,969 --> 05:28:58,169 ORDER. 7513 05:28:58,169 --> 05:29:01,038 I THINK WHAT A LOT OF TRAINING 7514 05:29:01,038 --> 05:29:03,007 EXERCISES WILL BE ARE COUNTRY 7515 05:29:03,007 --> 05:29:03,274 SPECIFIC. 7516 05:29:03,274 --> 05:29:07,078 SO, AGAIN, TRYING TO UNDERSTAND 7517 05:29:07,078 --> 05:29:08,512 HOW MIGHT I APPLY TO THE MARKET 7518 05:29:08,512 --> 05:29:11,249 IN DIFFERENT PART OF THE WORLD, 7519 05:29:11,249 --> 05:29:12,149 TAKING ADVANTAGE OF EDUCATIONAL 7520 05:29:12,149 --> 05:29:14,218 PROGRAMS TO UNDERSTAND WHAT THE 7521 05:29:14,218 --> 05:29:16,954 DIFFERENCES ARE IN A REGULATORY 7522 05:29:16,954 --> 05:29:18,289 ENVIRONMENT SOMEWHERE ELSE, WHAT 7523 05:29:18,289 --> 05:29:20,024 THE DIFFERENCES ARE IN 7524 05:29:20,024 --> 05:29:21,759 COMMERCIALIZATION PATHWAYS AND 7525 05:29:21,759 --> 05:29:22,894 SO FORTH. 7526 05:29:22,894 --> 05:29:27,164 AGAIN, AS WITH OTHER TEAMS YOU 7527 05:29:27,164 --> 05:29:29,133 SEE OUR NETWORK OF CLINICAL -- 7528 05:29:29,133 --> 05:29:32,069 INDUSTRIAL PARTNERS AND THEN 7529 05:29:32,069 --> 05:29:34,272 SIMILAR TO OTHER PEOPLE, AGAIN 7530 05:29:34,272 --> 05:29:35,806 AN SANDAL NEEDS ASSESSMENT 7531 05:29:35,806 --> 05:29:37,975 CONSENSUS, WHAT WE BELIEVE WILL 7532 05:29:37,975 --> 05:29:41,145 BE THE NEXT BIG THINGS TO FOCUS 7533 05:29:41,145 --> 05:29:41,479 ON. 7534 05:29:41,479 --> 05:29:45,082 SO TWO THINGS I WANT TO BRING UP 7535 05:29:45,082 --> 05:29:46,617 HERE, TO MENTION TO THIS GROUP 7536 05:29:46,617 --> 05:29:49,253 AND MAKE IT AVAILABLE TO THIS 7537 05:29:49,253 --> 05:29:51,989 GROUP, AGAIN THESE ARE OUR 7538 05:29:51,989 --> 05:29:53,524 PROGRAMS THAT I THINK WE'RE -- 7539 05:29:53,524 --> 05:29:55,159 WE WANT TO MAKE AVAILABLE AS 7540 05:29:55,159 --> 05:29:59,997 BROADLY AS POSSIBLE, MAYBE NOT 7541 05:29:59,997 --> 05:30:01,565 PART OF THE NETWORK, FEEL FREE 7542 05:30:01,565 --> 05:30:02,633 REACH OUT IF YOU'RE INTERESTED 7543 05:30:02,633 --> 05:30:04,835 IN THESE. 7544 05:30:04,835 --> 05:30:10,675 THE FIRST IS, AS I SAY, IN 7545 05:30:10,675 --> 05:30:11,742 PARTNERSHIP WITH COLUMBIA 7546 05:30:11,742 --> 05:30:15,813 UNIVERSITY, A NETWORK IN AND OF 7547 05:30:15,813 --> 05:30:20,217 THEMSELVES LAB-TO-MARKET 7548 05:30:20,217 --> 05:30:21,752 ACCELERATORS, WE'LL BE STANDING 7549 05:30:21,752 --> 05:30:24,288 UP FOCUSED ON GLOBAL HEALTH. 7550 05:30:24,288 --> 05:30:27,024 SO WE'RE GOING TO SEE HOW THIS 7551 05:30:27,024 --> 05:30:28,559 UPTAKES ITSELF OVER THE NEXT FEW 7552 05:30:28,559 --> 05:30:30,294 YEARS BUT WE IMAGINE THERE WILL 7553 05:30:30,294 --> 05:30:33,698 BE YEARS IN WHICH COUNTRIES 7554 05:30:33,698 --> 05:30:34,565 SPECIFIC AND YEARS BROADLY 7555 05:30:34,565 --> 05:30:36,233 SPECIFIC BUT I THINK IT'S A 7556 05:30:36,233 --> 05:30:37,301 REALLY GREAT OPPORTUNITY FOR 7557 05:30:37,301 --> 05:30:40,137 THOSE OF YOU LOOKING TO, HEY, 7558 05:30:40,137 --> 05:30:41,105 HOW DO I COMMERCIALIZE SOMETHING 7559 05:30:41,105 --> 05:30:42,907 IN ONE OF THESE OTHER PLACES, 7560 05:30:42,907 --> 05:30:45,743 WHAT IS THE POTENTIAL FOR WHAT 7561 05:30:45,743 --> 05:30:47,378 I'M DOING IN SOMEWHERE, WHERE 7562 05:30:47,378 --> 05:30:49,447 I'M NOT WORKING NOW, THIS MIGHT 7563 05:30:49,447 --> 05:30:50,648 BE AN EXCELLENT OPPORTUNITY FOR 7564 05:30:50,648 --> 05:30:55,252 THOSE THAT ARE INTERESTED IN 7565 05:30:55,252 --> 05:30:55,720 THAT. 7566 05:30:55,720 --> 05:30:58,589 THE OTHER THING, WE'VE BUILT UP 7567 05:30:58,589 --> 05:31:00,424 THIS LONG STANDING NETWORK OF 7568 05:31:00,424 --> 05:31:02,827 CLINICAL SITES AROUND THE WORLD 7569 05:31:02,827 --> 05:31:04,929 HERE. 7570 05:31:04,929 --> 05:31:06,797 AGAIN, WE THINK OF THESE AS NOT 7571 05:31:06,797 --> 05:31:11,502 JUST ACCESS TO A PARTICULAR 7572 05:31:11,502 --> 05:31:14,105 PATIENT POPULATION, PARTICULAR 7573 05:31:14,105 --> 05:31:15,773 SAMPLES, ACCESS TO LOCAL 7574 05:31:15,773 --> 05:31:18,209 EXPERTISE ON THE CLINICAL SIDE 7575 05:31:18,209 --> 05:31:19,276 AND TECHNOLOGICAL SIDE, 7576 05:31:19,276 --> 05:31:20,277 MANUFACTURING SIDE. 7577 05:31:20,277 --> 05:31:22,346 SO THESE, AS WE WORK THROUGH THE 7578 05:31:22,346 --> 05:31:24,648 NETWORK OVER THE NEXT FEW YEARS 7579 05:31:24,648 --> 05:31:27,051 WE'RE GOING TO BUILD UP OUR 7580 05:31:27,051 --> 05:31:30,154 SITES TO PROVIDE A BROAD RANGE 7581 05:31:30,154 --> 05:31:31,889 OF -- BRING EXERCISE INTO THIS 7582 05:31:31,889 --> 05:31:34,959 KIND OF NETWORK, MAKE IT 7583 05:31:34,959 --> 05:31:36,827 AVAILABLE MORE BROADLY. 7584 05:31:36,827 --> 05:31:39,463 FINALLY I THOUGHT I WOULD CLOSE 7585 05:31:39,463 --> 05:31:42,400 HERE BY SAYING IN OUR FIRST YEAR 7586 05:31:42,400 --> 05:31:45,703 WE INTEND TO FUND A NUMBER OF 7587 05:31:45,703 --> 05:31:46,837 PROJECTS HERE, AGAIN WHAT YOU 7588 05:31:46,837 --> 05:31:48,739 CAN SEE IS THEY ARE PRETTY BROAD 7589 05:31:48,739 --> 05:31:51,275 RIGHT NOW. 7590 05:31:51,275 --> 05:31:56,747 THEY DO FOCUS ON AGAIN THOSE 7591 05:31:56,747 --> 05:31:58,182 FOUR AREAS, NUTRITION, IN TERMS 7592 05:31:58,182 --> 05:32:00,951 OF ANEMIA, INFECTIOUS DISEASE IN 7593 05:32:00,951 --> 05:32:04,655 TERMS OF MALARIA, AND VARIOUS 7594 05:32:04,655 --> 05:32:09,593 STIS, AND THEN HPV IN TERMS OF 7595 05:32:09,593 --> 05:32:09,994 CANCER. 7596 05:32:09,994 --> 05:32:12,329 WHAT I THINK, THE POINT THINK AS 7597 05:32:12,329 --> 05:32:13,631 WE EVOLVE THINKING ABOUT HOW 7598 05:32:13,631 --> 05:32:15,166 WHAT YOU'RE DOING MIGHT APPLY TO 7599 05:32:15,166 --> 05:32:17,301 ANY NUMBER OF THESE, WONDERING 7600 05:32:17,301 --> 05:32:19,537 WHAT YOU'RE DOING MIGHT APPLY TO 7601 05:32:19,537 --> 05:32:30,214 A DIFFERENCE AREA, COME TO US 7602 05:32:30,214 --> 05:32:33,350 WE'D LOVE TO TALK TO YOU ABOUT 7603 05:32:33,350 --> 05:32:33,517 IT. 7604 05:32:33,517 --> 05:32:35,953 >> WE HAVE ABOUT 15 MINUTES FOR 7605 05:32:35,953 --> 05:32:39,690 QUESTIONS. 7606 05:32:39,690 --> 05:32:42,159 I WOULD LIKE TO INVITE ALL 7607 05:32:42,159 --> 05:32:45,062 SPEAKERS TO THE STAGE. 7608 05:32:45,062 --> 05:32:48,666 AND WHILE YOU ALL THINK ABOUT 7609 05:32:48,666 --> 05:32:50,801 QUESTIONS, AFTER YOU HEARD THE 7610 05:32:50,801 --> 05:32:54,672 HIGH LEVEL OVERVIEW OF THE 7611 05:32:54,672 --> 05:32:57,341 CENTERS AND RESOURCES, THE TEAM 7612 05:32:57,341 --> 05:32:59,076 FOCUSES OF THESE CENTERS IF YOU 7613 05:32:59,076 --> 05:33:01,412 CAN THINK OF ANY QUESTIONS ABOUT 7614 05:33:01,412 --> 05:33:04,548 RESOURCES YOU MIGHT NEED. 7615 05:33:04,548 --> 05:33:11,689 I SEE -- GO AHEAD. 7616 05:33:11,689 --> 05:33:14,425 >> I HAVE A QUESTION ABOUT 7617 05:33:14,425 --> 05:33:17,061 REGULATORY SUPPORT. 7618 05:33:17,061 --> 05:33:20,030 AS YOU KNOW, NAVIGATING POC 7619 05:33:20,030 --> 05:33:22,433 SPACE CAN BE QUITE DIFFICULT IN 7620 05:33:22,433 --> 05:33:24,301 THAT REGARD AND EVEN MURKIER 7621 05:33:24,301 --> 05:33:26,704 WHEN YOU HAVE A DEVICE WHOSE 7622 05:33:26,704 --> 05:33:29,039 INTENDED USE IS PHARMACIES OR AT 7623 05:33:29,039 --> 05:33:29,240 HOME. 7624 05:33:29,240 --> 05:33:32,309 I WAS WONDERING WHAT KIND OF 7625 05:33:32,309 --> 05:33:34,211 REGULATORY SUPPORT YOU HAVE 7626 05:33:34,211 --> 05:33:36,080 THAT'S SPECIFIC FOR POC OR EVEN 7627 05:33:36,080 --> 05:33:36,747 HOME TESTING. 7628 05:33:36,747 --> 05:33:38,682 THANKS. 7629 05:33:38,682 --> 05:33:40,084 >> GREAT QUESTION. 7630 05:33:40,084 --> 05:33:42,620 IT IS SOMETHING WE'VE CERTAINLY 7631 05:33:42,620 --> 05:33:43,821 DEVELOPED MOSTLY BECAUSE OF 7632 05:33:43,821 --> 05:33:46,023 EXPERTISE IN THE TEAM AND YOU 7633 05:33:46,023 --> 05:33:47,658 PROBABLY SAW ERIKA, IF YOU WERE 7634 05:33:47,658 --> 05:33:52,997 HERE THIS MORNING, TALK TO HER 7635 05:33:52,997 --> 05:33:54,532 FOR THE EXPERTISE SPECIFICALLY 7636 05:33:54,532 --> 05:33:56,400 TO YOUR QUESTION. 7637 05:33:56,400 --> 05:33:59,470 WE TRIED TO CREATE 7638 05:33:59,470 --> 05:34:01,505 INFRASTRUCTURE AND ACCESSIBILITY 7639 05:34:01,505 --> 05:34:02,873 TO THAT CONSULTATIVE SERVICE, 7640 05:34:02,873 --> 05:34:04,475 FOR PEOPLE WHO ARE THINKING OF 7641 05:34:04,475 --> 05:34:06,610 CLINICAL USE CASE OR HAVE A 7642 05:34:06,610 --> 05:34:09,113 TECHNOLOGY, TRYING TO FIND 7643 05:34:09,113 --> 05:34:10,080 PATHWAY FOR REGULATORY APPROVAL 7644 05:34:10,080 --> 05:34:12,283 WE CAN HELP THEM WITH THAT. 7645 05:34:12,283 --> 05:34:17,888 A LOT OF EXPERTISE IS AROUND 7646 05:34:17,888 --> 05:34:19,723 POINT OF CARE, CONSUMER USE 7647 05:34:19,723 --> 05:34:21,258 APPLICATION, WE COULD HELP WITH 7648 05:34:21,258 --> 05:34:22,560 ALL OF THOSE. 7649 05:34:22,560 --> 05:34:25,963 IT'S NOT THAT WE PROVIDE, THE 7650 05:34:25,963 --> 05:34:28,499 INTENT IS NOT TO PROVIDE 7651 05:34:28,499 --> 05:34:31,335 REGULATORY SERVICE BUT GET ON 7652 05:34:31,335 --> 05:34:33,170 YOU THE PATHWAY AND UNDERSTAND 7653 05:34:33,170 --> 05:34:34,605 SAND POINT YOU IN THE OTHER 7654 05:34:34,605 --> 05:34:35,940 DIRECTION AND PROBABLY GO 7655 05:34:35,940 --> 05:34:37,474 FURTHER BUT AT LEAST WITHIN THE 7656 05:34:37,474 --> 05:34:39,577 DOMAINS OF WHAT WE CAN DO FOR 7657 05:34:39,577 --> 05:34:40,578 INDIVIDUALS AND PARTICULARLY 7658 05:34:40,578 --> 05:34:41,812 WITHIN TEAMS THAT COME IN AS 7659 05:34:41,812 --> 05:34:43,047 PROJECTS FOR US, THAT'S OUR 7660 05:34:43,047 --> 05:34:44,949 INTEND TO MAKE SURE WE GET THAT 7661 05:34:44,949 --> 05:34:49,853 DONE FOR YOU. 7662 05:34:49,853 --> 05:34:53,791 >> SO AS I WAS LISTENING TO 7663 05:34:53,791 --> 05:34:57,795 PRESENTATIONS, A COMMON THEME OF 7664 05:34:57,795 --> 05:35:00,598 THE PROVIDING ACCESS TO THE CARE 7665 05:35:00,598 --> 05:35:04,635 OR TECHNOLOGY TO BE USED IN 7666 05:35:04,635 --> 05:35:05,636 LOW-RESOURCE SETTINGS, 7667 05:35:05,636 --> 05:35:06,604 DOMESTICALLY OR GLOBALLY. 7668 05:35:06,604 --> 05:35:08,906 I WONDER IF YOU COULD COMMENT ON 7669 05:35:08,906 --> 05:35:12,343 WHAT ARE UNIQUE CHALLENGES IN 7670 05:35:12,343 --> 05:35:13,244 DEVELOPING TECHNOLOGIES FOR 7671 05:35:13,244 --> 05:35:14,478 LOW-RESOURCE SETTINGS AND WHAT 7672 05:35:14,478 --> 05:35:16,981 ARE THE RESOURCES THAT MIGHT BE 7673 05:35:16,981 --> 05:35:22,052 HELPFUL TO OVERCOME THOSE 7674 05:35:22,052 --> 05:35:22,353 CHALLENGES? 7675 05:35:22,353 --> 05:35:23,354 >> I CAN START. 7676 05:35:23,354 --> 05:35:29,927 HAVING LIVED IN UGANDA FOR FIVE 7677 05:35:29,927 --> 05:35:31,428 YEARS, IT'S NOT ALL THE SAME 7678 05:35:31,428 --> 05:35:32,096 THING. 7679 05:35:32,096 --> 05:35:36,934 THERE'S HUB AND SPOKE, 7680 05:35:36,934 --> 05:35:37,901 CENTRALIZED RESOURCES THAT LOOK 7681 05:35:37,901 --> 05:35:39,336 LIKE LABS YOU HAVE IN THE U.S. 7682 05:35:39,336 --> 05:35:40,638 THERE ARE INFRASTRUCTURE ISSUES 7683 05:35:40,638 --> 05:35:42,406 WHERE WE'VE TRIED THINGS THAT 7684 05:35:42,406 --> 05:35:44,942 WORK GREAT HERE, THEY DON'T WORK 7685 05:35:44,942 --> 05:35:45,142 THERE. 7686 05:35:45,142 --> 05:35:49,113 WELL, THEY DON'T WORK WELL IN 7687 05:35:49,113 --> 05:35:50,514 RESOURCE LIMITED SETTINGS 7688 05:35:50,514 --> 05:35:51,282 BECAUSE THERE'S BROWNOUTS, LOW 7689 05:35:51,282 --> 05:35:54,218 ENOUGH THAT YOU GET 7690 05:35:54,218 --> 05:35:54,551 INDETERMINATE. 7691 05:35:54,551 --> 05:35:56,186 HAVING THINGS THAT SEPARATE YOUR 7692 05:35:56,186 --> 05:35:57,521 DEVICE FROM ENERGY OR AT LEAST 7693 05:35:57,521 --> 05:36:00,124 HAVE A WAY TO BUFFER THAT ARE 7694 05:36:00,124 --> 05:36:00,457 IMPORTANT. 7695 05:36:00,457 --> 05:36:01,792 THOSE ARE THE TYPES OF THINGS 7696 05:36:01,792 --> 05:36:03,460 YOU MIGHT NOT THINK ABOUT BUT 7697 05:36:03,460 --> 05:36:05,162 THEY BECOME HUGE PROBLEMS. 7698 05:36:05,162 --> 05:36:07,464 THE OTHER THING IS DUST. 7699 05:36:07,464 --> 05:36:09,033 EVERYTHING I OWNED WAS BROWN 7700 05:36:09,033 --> 05:36:11,101 AFTER FIVE YEARS. 7701 05:36:11,101 --> 05:36:13,070 AND IT'S BECAUSE THERE'S DUST 7702 05:36:13,070 --> 05:36:15,572 EVERYWHERE, PARTICULARLY IN 7703 05:36:15,572 --> 05:36:17,775 URBAN SETTINGS. 7704 05:36:17,775 --> 05:36:19,677 SO THERE'S OPEN AIR CULTURE AND 7705 05:36:19,677 --> 05:36:21,512 THINGS GET GUMMED UP. 7706 05:36:21,512 --> 05:36:22,913 THINGS WITH A SENSOR, WITH 7707 05:36:22,913 --> 05:36:29,186 SOMEBODY WHERE DUST CAN GET IN, 7708 05:36:29,186 --> 05:36:30,754 THE ROBUSTNESS REQUIRED AND 7709 05:36:30,754 --> 05:36:32,089 TEMPERATURE IS MUCH DIFFERENT. 7710 05:36:32,089 --> 05:36:33,657 ONE THING WE MIGHT THINK ABOUT 7711 05:36:33,657 --> 05:36:35,426 SINCE WE HAVE SO MANY PEOPLE 7712 05:36:35,426 --> 05:36:36,794 INTERESTED IN GLOBAL HEALTH IN 7713 05:36:36,794 --> 05:36:41,865 THE CENTER NETWORK WOULD BE TO 7714 05:36:41,865 --> 05:36:46,070 PUT TOGETHER SOME SORT OF -- A 7715 05:36:46,070 --> 05:36:48,439 TECHNICAL PRODUCT PROFILE MOST 7716 05:36:48,439 --> 05:36:51,575 IMPORTANT FOR THOSE SETTINGS. 7717 05:36:51,575 --> 05:36:53,544 >> HI, I'M GOING BACK TO THE 7718 05:36:53,544 --> 05:36:55,312 QUESTION -- OH, IS THIS ALL 7719 05:36:55,312 --> 05:36:55,579 RIGHT? 7720 05:36:55,579 --> 05:36:57,014 OH, SORRY. 7721 05:36:57,014 --> 05:36:58,916 >> I WAS GOING TO ADD ONE THING 7722 05:36:58,916 --> 05:37:00,417 TO THE ANSWER. 7723 05:37:00,417 --> 05:37:03,620 I AGREE WITH EVERYTHING THAT WAS 7724 05:37:03,620 --> 05:37:08,859 SAID BUT THERE'S ALSO MANY 7725 05:37:08,859 --> 05:37:11,528 UNDERRESOURCED SETTINGS THEY ARE 7726 05:37:11,528 --> 05:37:12,930 VERY TOUGH SUPPLY CHAIN 7727 05:37:12,930 --> 05:37:15,999 PRESSURES, THE SUPPLY CHAIN IS 7728 05:37:15,999 --> 05:37:16,767 FRAGILE. 7729 05:37:16,767 --> 05:37:19,370 AND THINKING ABOUT EXPIRATION 7730 05:37:19,370 --> 05:37:22,673 DATES AND WHO IS GOING TO PAY, 7731 05:37:22,673 --> 05:37:25,309 THOSE ISSUES ARE ALSO REALLY, 7732 05:37:25,309 --> 05:37:28,045 REALLY DIFFERENT AND VERY 7733 05:37:28,045 --> 05:37:29,680 SETTING-DEPENDENT, SO I THINK 7734 05:37:29,680 --> 05:37:32,316 PLANNING FOR ADOPTION IS 7735 05:37:32,316 --> 05:37:33,317 ESPECIALLY IMPORTANT. 7736 05:37:33,317 --> 05:37:34,685 >> I KNOW YOU'VE BEEN WAITING TO 7737 05:37:34,685 --> 05:37:37,554 ASK BUT I WANT TO GET A QUICK 7738 05:37:37,554 --> 05:37:39,656 POINT IN, ONE OF THE OTHER MAJOR 7739 05:37:39,656 --> 05:37:41,091 DIFFERENCES IN THE MODEL THAT WE 7740 05:37:41,091 --> 05:37:44,828 HAVE, WHICH IS MORE FOCUSED ON 7741 05:37:44,828 --> 05:37:48,098 THE U.S. IS ALSO SAY RURAL 7742 05:37:48,098 --> 05:37:50,067 HEALTH, ACCESS IN MANY CASES 7743 05:37:50,067 --> 05:37:51,301 SIMILAR SCENARIO THAT YOU WANT 7744 05:37:51,301 --> 05:37:53,470 TO TARGET FOR YOUR POINT OF CARE 7745 05:37:53,470 --> 05:37:54,104 TECHNOLOGY. 7746 05:37:54,104 --> 05:37:54,304 OKAY. 7747 05:37:54,304 --> 05:37:56,440 I TALK ABOUT HOSPITAL AT HOME 7748 05:37:56,440 --> 05:37:58,175 PROGRAMS, WHERE ARE THEY 7749 05:37:58,175 --> 05:37:58,742 DEVELOPING? 7750 05:37:58,742 --> 05:38:01,178 NOT IN RURAL AMERICA BECAUSE 7751 05:38:01,178 --> 05:38:02,579 JUST LOGISTICS OF SETTING YOUR 7752 05:38:02,579 --> 05:38:04,448 CARS OUT AND GETTING YOUR 7753 05:38:04,448 --> 05:38:05,783 PERSONNEL OUT TO THE REQUISITE 7754 05:38:05,783 --> 05:38:07,785 NUMBER OF PATIENT HOMES TO MAKE 7755 05:38:07,785 --> 05:38:09,086 IT FINANCIALLY SUSTAINABLE MAKE 7756 05:38:09,086 --> 05:38:12,289 IT SO THAT THESE TYPES OF 7757 05:38:12,289 --> 05:38:13,490 INNOVATIVE PROGRAMS THAT MIGHT 7758 05:38:13,490 --> 05:38:14,358 LEVERAGE POINT OF CARE 7759 05:38:14,358 --> 05:38:17,194 TECHNOLOGY CAN'T EXIST. 7760 05:38:17,194 --> 05:38:18,295 THINKING ABOUT CLINICAL CARE 7761 05:38:18,295 --> 05:38:19,496 CONSTRUCTS IN THESE REGIONS 7762 05:38:19,496 --> 05:38:22,466 WHICH YOU MIGHT THINK THAT IT'S 7763 05:38:22,466 --> 05:38:23,333 INTUITIVELY UGANDA IS DIFFERENT 7764 05:38:23,333 --> 05:38:26,637 THAN THE U.S. BUT RURAL 7765 05:38:26,637 --> 05:38:28,372 MISSISSIPPI IS AS DIFFERENT FROM 7766 05:38:28,372 --> 05:38:30,808 THE URBAN AREAS IN MILLENIUM AS 7767 05:38:30,808 --> 05:38:32,109 IN SOME CASES UGANDA IS. 7768 05:38:32,109 --> 05:38:35,179 SO I WOULD KEEP THAT IN MIND AS 7769 05:38:35,179 --> 05:38:35,846 WELL. 7770 05:38:35,846 --> 05:38:38,715 SORRY TO KEEP YOU WAITING FOR 7771 05:38:38,715 --> 05:38:39,249 THAT. 7772 05:38:39,249 --> 05:38:40,350 >> I ALSO WOULD LIKE TO SAY IF 7773 05:38:40,350 --> 05:38:47,090 YOU CAN CAN GET A BOTTLE OF 7774 05:38:47,090 --> 05:38:52,062 COKE OR PEPSI, YOU CAN, YOU 7775 05:38:52,062 --> 05:38:55,132 SHOULD GET THIS. 7776 05:38:55,132 --> 05:38:56,200 I FEEL OPTIMISTIC BUT THEY WILL 7777 05:38:56,200 --> 05:38:58,202 HAVE TO HAVE A DIFFERENT SHELF 7778 05:38:58,202 --> 05:38:59,069 LIFE FOR TRANSPORTATION SAND 7779 05:38:59,069 --> 05:38:59,269 HEAT. 7780 05:38:59,269 --> 05:39:01,171 IF YOU CAN DO THAT, PUT IT ON 7781 05:39:01,171 --> 05:39:06,009 THE COKE TRUCK AND GET IT 7782 05:39:06,009 --> 05:39:06,376 ANYWHERE. 7783 05:39:06,376 --> 05:39:07,644 >> SORRY I JUMPED IN. 7784 05:39:07,644 --> 05:39:08,745 I'M GOING TO GO BACK TO WHAT I 7785 05:39:08,745 --> 05:39:11,381 BROUGHT UP AT THE BEGINNING OF 7786 05:39:11,381 --> 05:39:15,219 THE MEETING, PUBLIC HEALTH IN 7787 05:39:15,219 --> 05:39:15,452 AMERICA. 7788 05:39:15,452 --> 05:39:18,589 IF I PUT MY LAB DIRECTOR'S HAT 7789 05:39:18,589 --> 05:39:20,824 WHO, WAIT FOR THE NEXT PANDEMIC, 7790 05:39:20,824 --> 05:39:24,962 NEXT OUTBREAK, WE NEAT -- NEED 7791 05:39:24,962 --> 05:39:27,698 TO GET AWAY FROM SILOED PUBLIC 7792 05:39:27,698 --> 05:39:28,899 HEALTH LABORATORIES, WE NEED TO 7793 05:39:28,899 --> 05:39:32,836 BE IN THE FIELD GOING TO 7794 05:39:32,836 --> 05:39:33,637 VULNERABLE RURAL AREAS. 7795 05:39:33,637 --> 05:39:44,081 WE DID NOT DO WELL IN THE LAST 7796 05:39:44,081 --> 05:39:45,582 PANDEMIC. 7797 05:39:45,582 --> 05:39:46,683 WE NEED AGNOSTIC PLATFORMS TO 7798 05:39:46,683 --> 05:39:47,985 ADAPT TO WHATEVER THE NEW 7799 05:39:47,985 --> 05:39:48,852 PATHOGEN IS. 7800 05:39:48,852 --> 05:39:51,822 HOW DO WE GET PUBLIC HELP 7801 05:39:51,822 --> 05:39:52,689 INVOLVED? 7802 05:39:52,689 --> 05:39:54,992 I LOVE THE RIGOROUS EVALUATION 7803 05:39:54,992 --> 05:39:57,528 OF THESE POINT OF CARE DEVICES 7804 05:39:57,528 --> 05:39:58,829 THAT'S GOING ON, I THINK 7805 05:39:58,829 --> 05:40:02,199 INFORMATION LIKE THAT IS GOING 7806 05:40:02,199 --> 05:40:07,170 TO DO A LOT TO TURN PUBLIC 7807 05:40:07,170 --> 05:40:08,772 HEALTH SCIENTISTS OPINION 7808 05:40:08,772 --> 05:40:09,006 AROUND. 7809 05:40:09,006 --> 05:40:11,208 I HEARD A LOT OF, WELL, IT'S NOT 7810 05:40:11,208 --> 05:40:13,944 AS GOOD AS A LAB TEST WHICH 7811 05:40:13,944 --> 05:40:16,747 IGNORES THE POTENTIAL, THE 7812 05:40:16,747 --> 05:40:18,181 INFORMATION THAT THESE DEVICES 7813 05:40:18,181 --> 05:40:21,485 DO GIVE US. 7814 05:40:21,485 --> 05:40:25,622 SO THERE'S EDUCATION THERE. 7815 05:40:25,622 --> 05:40:27,824 I THINK THE EVALUATION IS GOING 7816 05:40:27,824 --> 05:40:30,093 TO BE INCREDIBLE HELPFUL FOR 7817 05:40:30,093 --> 05:40:30,327 THAT. 7818 05:40:30,327 --> 05:40:32,162 WE ALSO HAVE TO ACCEPT THE FACT 7819 05:40:32,162 --> 05:40:34,298 THAT EVEN WHEN THEY ARE NOT 7820 05:40:34,298 --> 05:40:38,201 PERFECT, THEY ARE OF VALUE, AND 7821 05:40:38,201 --> 05:40:41,371 THE PERFECT MINDSET DOESN'T HELP 7822 05:40:41,371 --> 05:40:41,605 US. 7823 05:40:41,605 --> 05:40:44,508 SO, MY QUESTION TO YOU IS HOW DO 7824 05:40:44,508 --> 05:40:47,644 WE GET PUBLIC HEALTH AND PUBLIC 7825 05:40:47,644 --> 05:40:54,084 HEALTH NEEDS INVOLVED IN THESE 7826 05:40:54,084 --> 05:40:55,319 CONVERSATIONS? 7827 05:40:55,319 --> 05:40:57,854 >> I'M WATCHING FOR FINGERS NEAR 7828 05:40:57,854 --> 05:40:58,755 BUTTON. 7829 05:40:58,755 --> 05:41:00,490 I WON THAT ONE. 7830 05:41:00,490 --> 05:41:03,827 ONE STORY I WANTED TO SAY, FIRST 7831 05:41:03,827 --> 05:41:05,796 YOU MADE SEVEN EXCELLENT POINTS. 7832 05:41:05,796 --> 05:41:08,165 I WILL TACKLE ONE OF THEM WHICH 7833 05:41:08,165 --> 05:41:09,933 IS IN THE CONTEXT OF RADx AT 7834 05:41:09,933 --> 05:41:12,569 LEAST I WANT YOU TO THINK ABOUT 7835 05:41:12,569 --> 05:41:16,206 THE FOLLOWING PROGRAM THAT I 7836 05:41:16,206 --> 05:41:18,609 THINK IS DR. ANDREW -- YEAH, IS 7837 05:41:18,609 --> 05:41:21,278 HE -- YOU'LL BE HEARING A 7838 05:41:21,278 --> 05:41:22,479 DIGITAL HEALTH PANEL LATER WITH 7839 05:41:22,479 --> 05:41:24,915 SOMEONE WHO STOOD UP A 7840 05:41:24,915 --> 05:41:28,652 FASCINATING PROGRAM WHICH WAS 7841 05:41:28,652 --> 05:41:29,653 TAKING THE DIGITAL 7842 05:41:29,653 --> 05:41:31,722 INFRASTRUCTURE THAT HAD BEEN 7843 05:41:31,722 --> 05:41:33,657 BUILT FOR CLINICAL STUDIES POINT 7844 05:41:33,657 --> 05:41:35,759 OF CARE DIAGNOSTICS WORKING ON 7845 05:41:35,759 --> 05:41:37,327 DIRECT PUBLIC HEALTH REPORTING 7846 05:41:37,327 --> 05:41:40,797 SO REGIONS PUBLIC HEALTH OR 7847 05:41:40,797 --> 05:41:42,366 LABORATORY DIRECTOR OR DPH WOULD 7848 05:41:42,366 --> 05:41:44,301 BE NOTIFIED THE SAME MOMENT THE 7849 05:41:44,301 --> 05:41:46,403 PATIENT HAD THEIR RESULTS OF 7850 05:41:46,403 --> 05:41:48,038 THEIR POINT-OF-CARE DIAGNOSTIC. 7851 05:41:48,038 --> 05:41:51,408 I THINK THAT IS ONE ENTREE 7852 05:41:51,408 --> 05:41:54,144 BECAUSE THE CURRENT SYSTEM 7853 05:41:54,144 --> 05:41:56,046 RELIES ON MULTIPLE REPORTERS, 7854 05:41:56,046 --> 05:41:57,214 DROPOUT OF INFORMATION, PUBLIC 7855 05:41:57,214 --> 05:41:58,982 HEALTH RELIES ON GOOD DATA. 7856 05:41:58,982 --> 05:42:01,718 IF POINT OF CARE DEVELOPERS 7857 05:42:01,718 --> 05:42:02,919 COULD CONSIDER USING PLATFORMS 7858 05:42:02,919 --> 05:42:06,423 TO SHARE THAT DATA, BE IT 90% OR 7859 05:42:06,423 --> 05:42:08,492 92%, LET THE PUBLIC HEALTH 7860 05:42:08,492 --> 05:42:10,260 AGENCIES DEAL WITH THAT, GET THE 7861 05:42:10,260 --> 05:42:13,897 DATA TO THEM BECAUSE I THINK 7862 05:42:13,897 --> 05:42:17,401 TIME SENSITIVITY AND ACCURACY 7863 05:42:17,401 --> 05:42:19,703 ARE WEIGHTED CONCERNS, TIME 7864 05:42:19,703 --> 05:42:20,904 SENSITIVITY IF I'M MANAGING 7865 05:42:20,904 --> 05:42:23,407 PUBLIC HEALTH WOULD WEIGH MORE 7866 05:42:23,407 --> 05:42:24,841 HEAVILY, JUST A STORY TO ADDRESS 7867 05:42:24,841 --> 05:42:25,709 YOUR POINT. 7868 05:42:25,709 --> 05:42:28,879 >> TO ADDRESS THE ISSUE OF DATA, 7869 05:42:28,879 --> 05:42:32,883 I MEAN, I KNOW THERE'S A HUGE 7870 05:42:32,883 --> 05:42:34,618 ARGUMENT ABOUT PRIVACY. 7871 05:42:34,618 --> 05:42:37,587 IF WE COULD HAVE HOME USE 7872 05:42:37,587 --> 05:42:43,160 DEVICE, POINT OF CARE DEVICE, 7873 05:42:43,160 --> 05:42:46,997 THAT TRANSMITTED ZIP CODE 7874 05:42:46,997 --> 05:42:49,299 POSITIVITY, MAYBE GENDER, I 7875 05:42:49,299 --> 05:42:50,767 MEAN, THAT IS VALUABLE 7876 05:42:50,767 --> 05:42:54,337 INFORMATION THAT GOES TO THE 7877 05:42:54,337 --> 05:42:55,539 HEALTH DEPARTMENT, MAYBE COUPLED 7878 05:42:55,539 --> 05:42:57,841 WITH DATA FROM PHARMACIES ON HOW 7879 05:42:57,841 --> 05:43:00,977 MANY TESTS ARE BEING PURCHASED 7880 05:43:00,977 --> 05:43:02,212 IN THAT AREA. 7881 05:43:02,212 --> 05:43:04,081 HEY, THERE'S SOMETHING GOING ON 7882 05:43:04,081 --> 05:43:04,514 HERE. 7883 05:43:04,514 --> 05:43:09,386 YOU KNOW, AGAIN NOT PERFECT BUT 7884 05:43:09,386 --> 05:43:09,519 -- 7885 05:43:09,519 --> 05:43:14,424 >> I WAS GOING ADD, OUR CENTER 7886 05:43:14,424 --> 05:43:15,859 IS MORE INTERNATIONAL BUT 7887 05:43:15,859 --> 05:43:17,394 TALKING ABOUT THE INTERNATIONAL 7888 05:43:17,394 --> 05:43:18,462 QUESTION OF REGULATION, 7889 05:43:18,462 --> 05:43:19,696 DESIGNING FOR SETTING, IT'S ALL 7890 05:43:19,696 --> 05:43:20,464 A PARTNERSHIP. 7891 05:43:20,464 --> 05:43:22,866 WE NEED TO PARTNER WITH PUBLIC 7892 05:43:22,866 --> 05:43:25,168 HEALTH AGENCIES EARLY ON, THE 7893 05:43:25,168 --> 05:43:27,404 TECHNOLOGY DEVELOPMENT, AS WE'RE 7894 05:43:27,404 --> 05:43:29,339 DOING WITH ALL OF OUR 7895 05:43:29,339 --> 05:43:30,407 INTERNATIONAL SITES. 7896 05:43:30,407 --> 05:43:33,810 YOU MAY ASK ABOUT SOME 7897 05:43:33,810 --> 05:43:34,911 ENVIRONMENTAL CONDITIONS OR 7898 05:43:34,911 --> 05:43:36,246 REGULATORY ISSUES. 7899 05:43:36,246 --> 05:43:38,915 WE WOULD PROVIDE A RESOURCE TO 7900 05:43:38,915 --> 05:43:41,318 HOOK YOU IN WITH COUNTRIES WHO 7901 05:43:41,318 --> 05:43:42,519 DEALT WITH THESE ISSUES AND KNOW 7902 05:43:42,519 --> 05:43:46,456 WHAT THEY ARE. 7903 05:43:46,456 --> 05:43:48,191 ANDs SIMILAR PROCESS WITH 7904 05:43:48,191 --> 05:43:49,926 PUBLIC HEALTH GETTING THEM 7905 05:43:49,926 --> 05:43:52,129 INVOLVES EARLY ON, MAYBE AS A 7906 05:43:52,129 --> 05:43:53,597 PARTNER, SOMEHOW IN SOME 7907 05:43:53,597 --> 05:43:56,333 CENTERS, I DON'T KNOW HOW THAT 7908 05:43:56,333 --> 05:43:58,201 WOULD WORK, ONE EXAMPLE IS IN 7909 05:43:58,201 --> 05:43:59,870 THE CENTERS FOR AIDS RESEARCH, 7910 05:43:59,870 --> 05:44:02,572 OURS IN CHICAGO, THIRD COAST 7911 05:44:02,572 --> 05:44:03,874 CENTER, ONE OF THE FIRST WITH 7912 05:44:03,874 --> 05:44:05,809 THE CHICAGO DEPARTMENT OF PUBLIC 7913 05:44:05,809 --> 05:44:08,712 HEALTH WITHIN OUR CENTER. 7914 05:44:08,712 --> 05:44:09,813 THERE'S SCIENTIFIC DEVELOPMENT 7915 05:44:09,813 --> 05:44:10,881 CENTERS BUT PUBLIC HEALTH IS 7916 05:44:10,881 --> 05:44:12,649 THERE WITH A SEAT AT THE TABLE, 7917 05:44:12,649 --> 05:44:15,051 MAYBE SOMETHING TO THINK ABOUT 7918 05:44:15,051 --> 05:44:15,252 HERE. 7919 05:44:15,252 --> 05:44:17,120 >> PART IS ALSO MONEY. 7920 05:44:17,120 --> 05:44:19,222 DURING RADx THERE WAS A LOT OF 7921 05:44:19,222 --> 05:44:20,323 MONEY. 7922 05:44:20,323 --> 05:44:23,393 MAKE MY TEST COUNT THOUGH IT'S A 7923 05:44:23,393 --> 05:44:24,828 FRACTURE OF THOSE DONE, TRACKS 7924 05:44:24,828 --> 05:44:26,029 WITH WHERE CASES WERE IN THE 7925 05:44:26,029 --> 05:44:32,402 UNITED STATES. 7926 05:44:32,402 --> 05:44:34,905 THERE MAY BE 1/100 OF A PERCENT, 7927 05:44:34,905 --> 05:44:36,439 IT TRACKS. 7928 05:44:36,439 --> 05:44:37,974 RADx PAID FOR CONCENTRATION 7929 05:44:37,974 --> 05:44:39,276 CAPTURE TECHNOLOGY THAT LED 7930 05:44:39,276 --> 05:44:41,244 TOWEIGHT WATER SURVEILLANCE 7931 05:44:41,244 --> 05:44:44,014 WHICH TURNED OUT TO BE -- WASTE 7932 05:44:44,014 --> 05:44:45,282 WATER SURVEILLANCE WHICH IS 7933 05:44:45,282 --> 05:44:45,749 USEFUL. 7934 05:44:45,749 --> 05:44:47,050 THERE ARE SPILLOVER EFFECTS BUT 7935 05:44:47,050 --> 05:44:48,418 MAKING IT FRONT AND CENTER FROM 7936 05:44:48,418 --> 05:44:53,023 THE BEGINNING IS IMPORTANT. 7937 05:44:53,023 --> 05:44:53,590 RADx UNDERSERVED SPEECH, U-P 7938 05:44:53,590 --> 05:44:55,659 WAS PART OF THE PROGRAM FROM THE 7939 05:44:55,659 --> 05:44:55,926 BEGINNING. 7940 05:44:55,926 --> 05:44:59,362 A LOT OF MONEY MADE SURE PEOPLE 7941 05:44:59,362 --> 05:45:04,634 IN RURAL PLACE WOULDS HAVE 7942 05:45:04,634 --> 05:45:06,303 ACCESS TO DIAGNOSTICS AS PEOPLE 7943 05:45:06,303 --> 05:45:08,171 IN URBAN CENTERS OR TROLLING THE 7944 05:45:08,171 --> 05:45:09,573 KNELT FOR FREE TESTS. 7945 05:45:09,573 --> 05:45:11,541 THE OTHER POINT I MIGHT FLAG 7946 05:45:11,541 --> 05:45:13,510 THAT FOR ANY OF YOU INTERESTED 7947 05:45:13,510 --> 05:45:16,012 IN THIS RIGHT NOW THE FDA HAS A 7948 05:45:16,012 --> 05:45:18,548 COMMENT PERIOD UNTIL DECEMBER 4 7949 05:45:18,548 --> 05:45:20,083 TO LAB DEVELOPED TESTS, 7950 05:45:20,083 --> 05:45:22,018 IMPACTING DISEASES IN THE UNITED 7951 05:45:22,018 --> 05:45:23,787 STATES WHERE INCIDENCE IS LOW IF 7952 05:45:23,787 --> 05:45:27,057 WE GET RIDSED OF ALL LAB 7953 05:45:27,057 --> 05:45:29,025 DEVELOPED TESTS IT WILL 7954 05:45:29,025 --> 05:45:30,694 DESOLATES OUR ABILITY TO, FOR 7955 05:45:30,694 --> 05:45:31,361 EXAMPLE, DIAGNOSE TUBERCULOSIS, 7956 05:45:31,361 --> 05:45:33,296 WE DON'T HAVE MANY CASES BUT 7957 05:45:33,296 --> 05:45:41,071 THAT'S RIDS -- RIDICULOUS WE 7958 05:45:41,071 --> 05:45:43,707 DON'T HAVE THE LEVEL OF 7959 05:45:43,707 --> 05:45:44,007 DIAGNOSTICS. 7960 05:45:44,007 --> 05:45:50,947 I URGE YOU TO WRITE A LETTER TO 7961 05:45:50,947 --> 05:45:52,916 THE FDA BECAUSE MANY OF THOSE 7962 05:45:52,916 --> 05:45:54,117 ARE IMPORTANT. 7963 05:45:54,117 --> 05:45:56,519 NOT TO GET POLITICAL BUT I THINK 7964 05:45:56,519 --> 05:45:57,954 IT'S IMPORTANT. 7965 05:45:57,954 --> 05:46:00,156 >> WONDERING IF EXISTING OLDER 7966 05:46:00,156 --> 05:46:05,629 CENTERS COULD COMMENT ON BASED 7967 05:46:05,629 --> 05:46:07,464 ON USUAL BASED ON PAST 7968 05:46:07,464 --> 05:46:10,400 EXPERIENCE ON RESOURCES FROM 7969 05:46:10,400 --> 05:46:12,836 INNOVATORS COMMUNITY AND ARE 7970 05:46:12,836 --> 05:46:16,640 THERE DIFFERENT TYPES OF 7971 05:46:16,640 --> 05:46:18,074 TECHNOLOGIES REQUIRING DIFFERENT 7972 05:46:18,074 --> 05:46:21,578 SERVICES OR DO WE SEE CHANGE 7973 05:46:21,578 --> 05:46:22,979 OVER TIME? 7974 05:46:22,979 --> 05:46:27,617 >> AS A PREDOMINANTLY 7975 05:46:27,617 --> 05:46:29,119 TECHNOLOGY-SEC TRICK OR 7976 05:46:29,119 --> 05:46:29,920 DISEASE-AGNOSTIC CENTER, IT DOES 7977 05:46:29,920 --> 05:46:31,187 VARY QUITE A LOT. 7978 05:46:31,187 --> 05:46:36,793 WE'VE SEEN OF COURSE FROM 7979 05:46:36,793 --> 05:46:37,427 MICROFLUIDICS, APP DEVELOPMENT, 7980 05:46:37,427 --> 05:46:39,095 CONVENTIONAL POINT OF CARE TESTS 7981 05:46:39,095 --> 05:46:42,832 THAT WE'RE ALL FAMILIAR WITH, 7982 05:46:42,832 --> 05:46:45,001 AND ENGINEERING SIDE THERE'S THE 7983 05:46:45,001 --> 05:46:46,436 ABILITY TO OPTIMIZE OR IMPROVE 7984 05:46:46,436 --> 05:46:49,072 AND MAKE CHANGES THERE. 7985 05:46:49,072 --> 05:46:50,941 THAT'S ONE ASPECT. 7986 05:46:50,941 --> 05:46:54,210 WE HAVE REALLY ACCELERATED 7987 05:46:54,210 --> 05:46:55,979 UNDERSTANDING AND THE ANALYTIC 7988 05:46:55,979 --> 05:46:57,948 VALIDATION PIECES IN THE 7989 05:46:57,948 --> 05:46:59,683 LABORATORY AND CLINIC, AND 7990 05:46:59,683 --> 05:47:01,551 THAT'S ONE I THINK WE REALLY 7991 05:47:01,551 --> 05:47:04,487 HAVE EXPANDED OUR OFFERINGS OF 7992 05:47:04,487 --> 05:47:10,527 EVERYTHING FROM THE STORAGE 7993 05:47:10,527 --> 05:47:11,728 SAMPLES, BIPARTISANSHIP, 7994 05:47:11,728 --> 05:47:14,030 SYNTHETIC SAMPLES AND ABILITY TO 7995 05:47:14,030 --> 05:47:16,299 DO IT PROSPECTSIVELY AND IN 7996 05:47:16,299 --> 05:47:17,200 DIVERSE POPULATIONS, A LOT OF 7997 05:47:17,200 --> 05:47:21,838 WHAT HAS CHANGED IN THE LAST FEW 7998 05:47:21,838 --> 05:47:25,976 YEARS, I'M REWHETHER YOU CAN 7999 05:47:25,976 --> 05:47:30,013 TAINT D. -- RELUCTANT TO THINK 8000 05:47:30,013 --> 05:47:31,147 THE PANDEMIC DID SOMETHING GOOD 8001 05:47:31,147 --> 05:47:32,949 BUT WE'VE LEARNED A LOT. 8002 05:47:32,949 --> 05:47:34,284 >> WE'VE TALKED ABOUT MOVEMENT 8003 05:47:34,284 --> 05:47:37,854 OF HEALTH CARE OUTSIDE OF THE 8004 05:47:37,854 --> 05:47:40,490 TRADITIONAL CONSTRUCT OF 8005 05:47:40,490 --> 05:47:42,859 IN-HOSPITAL OR IN-CLINIC CARE 8006 05:47:42,859 --> 05:47:45,929 BUT USER GROUPS THOUGHT ABOUT 8007 05:47:45,929 --> 05:47:48,231 AND TRAINING REQUIRED TO GET 8008 05:47:48,231 --> 05:47:50,533 THEM TO BE SAVVY USERS HAS 8009 05:47:50,533 --> 05:47:52,302 CHANGED A LOT WITH MORE 8010 05:47:52,302 --> 05:47:56,573 TARGETING OF PARAMEDICS AND 8011 05:47:56,573 --> 05:47:58,508 IN-HOME NURSING, THERAPISTS. 8012 05:47:58,508 --> 05:48:00,744 THE OTHER AS GREG MENTIONED, APP 8013 05:48:00,744 --> 05:48:01,044 DEVELOPMENT. 8014 05:48:01,044 --> 05:48:03,780 NOW EVERYBODY HAS AN APP, THAT 8015 05:48:03,780 --> 05:48:05,915 INTRODUCES A.I. AND OTHER 8016 05:48:05,915 --> 05:48:07,951 ELEMENTS INTO THE CONVERSATION. 8017 05:48:07,951 --> 05:48:13,556 I MENTIONED BEFORE, I DIDN'T 8018 05:48:13,556 --> 05:48:15,725 LINK -- THE CONCEPT OF 8019 05:48:15,725 --> 05:48:17,260 INTEROPERABILITY AND 8020 05:48:17,260 --> 05:48:18,728 ACCESSIBILITY ARE LINKED, 8021 05:48:18,728 --> 05:48:19,696 ADDRESSING HEALTH DISPARITIES, 8022 05:48:19,696 --> 05:48:21,698 THAT'S SOMETHING THAT WE'VE BEEN 8023 05:48:21,698 --> 05:48:23,133 INTENTIONAL ABOUT TALKING MORE 8024 05:48:23,133 --> 05:48:23,967 WITH OUR COMPANIES ABOUT. 8025 05:48:23,967 --> 05:48:25,435 I DON'T KNOW THAT THEY 8026 05:48:25,435 --> 05:48:26,603 NECESSARILY HAVE BEEN DRIVING 8027 05:48:26,603 --> 05:48:29,372 THAT BUT THAT'S MORE PART OF THE 8028 05:48:29,372 --> 05:48:29,939 CONVERSATION. 8029 05:48:29,939 --> 05:48:33,977 ON THE OTHER END ACCESSIBILITY 8030 05:48:33,977 --> 05:48:35,412 AND INTERPRETABILITY AND EXPLAIN 8031 05:48:35,412 --> 05:48:42,285 JACKET PARTICULARLY WITH A -- 8032 05:48:42,285 --> 05:48:42,819 EXPLAINABILITY. 8033 05:48:42,819 --> 05:48:45,789 >> FOR ME IT'S PERFORMANCE AND 8034 05:48:45,789 --> 05:48:47,190 MATRIX AND SAMPLES. 8035 05:48:47,190 --> 05:48:48,425 IT WORKS IN BUFFER, DOESN'T MEAN 8036 05:48:48,425 --> 05:48:51,027 IT'S GOING TO WORK IN A YUCKY 8037 05:48:51,027 --> 05:48:53,663 VAGINAL SWAB, TO BE CLEAR ABOUT 8038 05:48:53,663 --> 05:48:56,166 STIS, AND THE OTHER AREA WHERE 8039 05:48:56,166 --> 05:48:57,934 PEOPLE UNDERESTIMATE IS YOU HAVE 8040 05:48:57,934 --> 05:48:59,369 TO CHOOSE A USE CASE. 8041 05:48:59,369 --> 05:49:01,204 I THINK IT'S SO INTERESTING HOW 8042 05:49:01,204 --> 05:49:02,839 EVERYONE THINKS A TEST CAN BE 8043 05:49:02,839 --> 05:49:04,340 GOOD FOR EVERYONE. 8044 05:49:04,340 --> 05:49:07,577 I REMEMBER THE EARLY PART OF 8045 05:49:07,577 --> 05:49:11,114 RADx A COMPANY AWAY YOU COULD 8046 05:49:11,114 --> 05:49:13,650 USE THIS IN IMMEDIATEAL LAB, 8047 05:49:13,650 --> 05:49:15,585 POINT OF CARE, MAYBE OVER THE 8048 05:49:15,585 --> 05:49:15,919 COUNTER. 8049 05:49:15,919 --> 05:49:19,089 NOT REALISTIC, ALL DIFFERENT USE 8050 05:49:19,089 --> 05:49:21,958 CASES AND TECHNICAL PROFILES, IT 8051 05:49:21,958 --> 05:49:23,827 COULD BE A SMALL MARKET BUT IF 8052 05:49:23,827 --> 05:49:25,562 YOU CREATE SOMETHING FOR THAT 8053 05:49:25,562 --> 05:49:27,864 MARKET YOU WOULD BE VERY 8054 05:49:27,864 --> 05:49:29,399 SUCCESSFUL. 8055 05:49:29,399 --> 05:49:31,501 THOSE ARE THE TWO THINGS, ACCESS 8056 05:49:31,501 --> 05:49:34,104 TO CLINICIANS TO SAY WHICH TEST 8057 05:49:34,104 --> 05:49:35,305 YOU SHOULD MAYBE MULTIPLEX 8058 05:49:35,305 --> 05:49:36,706 TOGETHER OR WHAT WE THINK WOULD 8059 05:49:36,706 --> 05:49:39,709 BE USEFUL SO PICK A USE CASE AND 8060 05:49:39,709 --> 05:49:48,451 THEN SAMPLES IN MATRIX. 8061 05:49:48,451 --> 05:49:50,420 >> AS A TECHNOLOGY DEVELOPER ONE 8062 05:49:50,420 --> 05:49:51,855 OF THE THINGS THAT I'VE SEEN 8063 05:49:51,855 --> 05:49:53,690 THAT'S BEEN QUITE VALUABLE 8064 05:49:53,690 --> 05:49:55,225 THROUGH THIS NETWORK IS HAVING A 8065 05:49:55,225 --> 05:49:56,893 LITTLE BIT OF TALES OR 8066 05:49:56,893 --> 05:49:58,962 UNDERSTANDING OF WHAT THE 8067 05:49:58,962 --> 05:49:59,629 REGULATORY ENVIRONMENT IS GOING 8068 05:49:59,629 --> 05:50:01,564 TO LOOK LIKE WHERE YOU HOPE TO 8069 05:50:01,564 --> 05:50:04,868 GET IN AS EARLY AS POSSIBLE IN 8070 05:50:04,868 --> 05:50:05,401 TECHNOLOGY INVESTIGATOR. 8071 05:50:05,401 --> 05:50:05,768 . 8072 05:50:05,768 --> 05:50:08,571 IT DOESN'T HAVE TO GUIDE BUT 8073 05:50:08,571 --> 05:50:10,206 HAVING AWARENESS AROUND THAT HAS 8074 05:50:10,206 --> 05:50:11,341 BEEN INCREDIBLY VALUABLE IN 8075 05:50:11,341 --> 05:50:13,109 TERMS OF THINGS I'VE BEEN ABLE 8076 05:50:13,109 --> 05:50:15,011 TO GET ACCESS TO MORE QUICKLY 8077 05:50:15,011 --> 05:50:17,247 EARLIER. 8078 05:50:17,247 --> 05:50:23,853 8079 05:50:23,853 --> 05:50:27,123 >> WE'RE IN UNIQUE SETTINGS, A 8080 05:50:27,123 --> 05:50:30,093 KEY ASPECT. 8081 05:50:30,093 --> 05:50:32,495 PROVIDING TECHNICAL EXPERTISE, 8082 05:50:32,495 --> 05:50:35,999 SALLY AND ENGINEERING TEAMS 8083 05:50:35,999 --> 05:50:39,169 HAVE, BUSINESS ASPECTS OF 8084 05:50:39,169 --> 05:50:40,904 MARKETING, UNDERSTANDING MARKET 8085 05:50:40,904 --> 05:50:41,804 LANDSCAPE, NEEDS, CLINICAL 8086 05:50:41,804 --> 05:50:44,107 NEEDS, AND WRAPPED INTO THAT IS 8087 05:50:44,107 --> 05:50:47,744 SOME OF THE REGULATORY 8088 05:50:47,744 --> 05:50:49,179 MANUFACTURING ISSUES THAT KARA 8089 05:50:49,179 --> 05:50:59,689 AND THE KELLOGG TEAM BRING TO 8090 05:50:59,689 --> 05:51:01,124 THE TABLE. 8091 05:51:01,124 --> 05:51:03,726 >> I THANK WE'RE AT TIME. 8092 05:51:03,726 --> 05:51:08,765 PLEASE JOIN ME IN THANKING THE 8093 05:51:08,765 --> 05:51:11,834 PANELISTS AND SPEAKERS FOR TIME 8094 05:51:11,834 --> 05:51:12,135 AND INSIGHT. 8095 05:51:12,135 --> 05:51:22,345 [APPLAUSE] 8096 05:51:41,764 --> 05:51:44,834 >> THIS WILL BE A RAPID PITCH 8097 05:51:44,834 --> 05:51:48,938 SESSION ON THE E-POSTER AND 8098 05:51:48,938 --> 05:51:52,809 EXHIBIT SESSIONS FOR TODAY. 8099 05:51:52,809 --> 05:52:00,216 WE'LL HAVE SUSAN TO GO THROUGH 8100 05:52:00,216 --> 05:52:06,856 THE PRESENTERS FOR TODAY. 8101 05:52:06,856 --> 05:52:07,290 YOU. 8102 05:52:07,290 --> 05:52:09,392 >> THANKS YOU FOR BEING ON THE 8103 05:52:09,392 --> 05:52:09,792 AGENDA. 8104 05:52:09,792 --> 05:52:12,228 WE'RE EXCITED TO HAVE OUR SEVEN 8105 05:52:12,228 --> 05:52:13,630 PRESENTERS HERE TODAY. 8106 05:52:13,630 --> 05:52:16,199 THESE ARE ALL OF OUR COMPANIES 8107 05:52:16,199 --> 05:52:17,233 OR TECHNOLOGIES. 8108 05:52:17,233 --> 05:52:19,369 I WANT TO ASK ALL TEN SEVEN 8109 05:52:19,369 --> 05:52:21,204 PRESENTERS IF YOU COULD COME 8110 05:52:21,204 --> 05:52:23,506 DOWN TO THE FRONT, JUST TO MAKE 8111 05:52:23,506 --> 05:52:25,141 SURE WE'RE READY TO GO. 8112 05:52:25,141 --> 05:52:27,910 WE'LL BE GOING IN THIS ORDER. 8113 05:52:27,910 --> 05:52:33,483 WITH THAT, FIRST UP IS TODD 8114 05:52:33,483 --> 05:52:37,220 ALLEN OF HEMO SONIC, PRESENTING 8115 05:52:37,220 --> 05:52:45,962 THE 15-MINUTE BLOOD CLOT 8116 05:52:45,962 --> 05:52:47,797 ANALYZER. 8117 05:52:47,797 --> 05:52:49,766 >> THANK YOU FOR THIS 8118 05:52:49,766 --> 05:52:53,803 OPPORTUNITY TO PRESENT OUR 8119 05:52:53,803 --> 05:52:54,370 TECHNOLOGY. 8120 05:52:54,370 --> 05:52:59,175 HEMOSONICS WAS FOUNDED IN 8121 05:52:59,175 --> 05:53:00,476 CHARLOTTESVILLE VIRGINIA AT UVA. 8122 05:53:00,476 --> 05:53:01,844 WE HAVE OPERATIONS AND 8123 05:53:01,844 --> 05:53:03,780 MANUFACTURING IN DURHAM, NORTH 8124 05:53:03,780 --> 05:53:04,414 CAROLINA. 8125 05:53:04,414 --> 05:53:08,284 OUR TEAM IS SOLELY FOCUSED ON 8126 05:53:08,284 --> 05:53:09,085 DELIVERING CRITICAL AND 8127 05:53:09,085 --> 05:53:10,019 ACTIONABLE INFORMATION RAPIDLY 8128 05:53:10,019 --> 05:53:11,954 AT THE POINT OF CARE. 8129 05:53:11,954 --> 05:53:20,863 OUR SOLE PRODUCT AT THIS TIME IS 8130 05:53:20,863 --> 05:53:23,166 THE QUANTRA DEVICE. 8131 05:53:23,166 --> 05:53:25,268 BLEEDING SAND TRANSFUSIONS LEAD 8132 05:53:25,268 --> 05:53:27,103 TO WORSE PATIENT OUTCOMES AND 8133 05:53:27,103 --> 05:53:28,104 INCREASING COSTS. 8134 05:53:28,104 --> 05:53:31,407 STANDARD LAB TESTS ARE NOT 8135 05:53:31,407 --> 05:53:33,476 ADEQUATE FOR MANAGING ACUTE 8136 05:53:33,476 --> 05:53:35,378 BLEEDING DUE TO FACTORS THAT 8137 05:53:35,378 --> 05:53:37,747 DELAY RESULTS TO PHYSICIANS. 8138 05:53:37,747 --> 05:53:40,283 WHOLE BLOOD TESTING AT THE POINT 8139 05:53:40,283 --> 05:53:44,120 OF CARE PROVIDES THE MOST RAPID 8140 05:53:44,120 --> 05:53:46,756 ACTIONABLE RESULTS FOR 8141 05:53:46,756 --> 05:53:47,523 CORRECTING THERAPY, THERAPEUTIC 8142 05:53:47,523 --> 05:53:53,096 DECISIONS, TO HELP STOP 8143 05:53:53,096 --> 05:53:53,996 BLEEDING. 8144 05:53:53,996 --> 05:53:56,499 IT IS INNOVATIVE, USES 8145 05:53:56,499 --> 05:53:58,034 ULTRASOUND-BASED TECHNOLOGY TO 8146 05:53:58,034 --> 05:53:59,335 MEASURE ELASTIC PROPERTIES OF 8147 05:53:59,335 --> 05:54:03,272 BLOOD AS THE CLOT FORMS. 8148 05:54:03,272 --> 05:54:04,607 THE CARTRIDGE ELIMINATES NEED 8149 05:54:04,607 --> 05:54:07,110 FOR SAMPLE MANIPULATION AND 8150 05:54:07,110 --> 05:54:07,977 LABORATORY SKILLS. 8151 05:54:07,977 --> 05:54:11,948 THE SAMPLE IS ARTERIAL OR VENOUS 8152 05:54:11,948 --> 05:54:16,452 WHOLE BLOOD, COLLECTED IN 8153 05:54:16,452 --> 05:54:19,055 CITRATED TUBE, WITH CURRENTS FDA 8154 05:54:19,055 --> 05:54:25,528 INDICATION FOR PERIOPERATIVE 8155 05:54:25,528 --> 05:54:26,863 SETTING FOR AASSESSING 8156 05:54:26,863 --> 05:54:28,831 HEMOSTASIS AND LASER FOCUSED ON 8157 05:54:28,831 --> 05:54:32,869 OUR NEXT INDICATION IN MATERNAL 8158 05:54:32,869 --> 05:54:33,736 HEMORRHAGE. 8159 05:54:33,736 --> 05:54:35,972 MANUFACTURING CAPABILITY IS 8160 05:54:35,972 --> 05:54:37,373 UPWARDLY SCALABLE BUT CURRENTLY 8161 05:54:37,373 --> 05:54:40,009 AT 30,000 CARTRIDGES PER MONTH, 8162 05:54:40,009 --> 05:54:41,144 30 DEVICES. 8163 05:54:41,144 --> 05:54:44,614 WE'RE PRIVATELY HELD COMPANY SO 8164 05:54:44,614 --> 05:54:46,916 OUR SALES ARE CONFIDENTIAL BUT 8165 05:54:46,916 --> 05:54:49,852 WE HAVE ANNUAL DOUBLE DIGIT 8166 05:54:49,852 --> 05:54:50,420 GROWTH. 8167 05:54:50,420 --> 05:54:52,488 PERFORMANCE HAS BEEN 8168 05:54:52,488 --> 05:54:55,358 DEMONSTRATED IN SEVERAL STUDIES, 8169 05:54:55,358 --> 05:54:57,026 ANALYTICAL PERFORMANCE 8170 05:54:57,026 --> 05:54:58,761 DEMONSTRATES PRECISION AND 8171 05:54:58,761 --> 05:54:59,128 REPRODUCIBILITY. 8172 05:54:59,128 --> 05:55:00,596 STRONG CORRELATIONS WITH 8173 05:55:00,596 --> 05:55:04,267 STANDARD LAB TESTING AND 8174 05:55:04,267 --> 05:55:10,573 HISTORICAL VISCOELASTIC 8175 05:55:10,573 --> 05:55:10,840 PLATFORM. 8176 05:55:10,840 --> 05:55:12,341 WITH STRONG CONCORDESANCE WITH 8177 05:55:12,341 --> 05:55:17,280 BLEEDING INDICES AND ABILITY TO 8178 05:55:17,280 --> 05:55:19,115 DETECT COAGULOPATHY IN INDICATED 8179 05:55:19,115 --> 05:55:21,217 AREAS OF USE. 8180 05:55:21,217 --> 05:55:23,186 WE'VE DEMONSTRATED REDUCTION IN 8181 05:55:23,186 --> 05:55:28,991 TRANSFUSION REQUIREMENTS, 8182 05:55:28,991 --> 05:55:30,426 ASSOCIATED COSTS. 8183 05:55:30,426 --> 05:55:31,761 QUANTRA ELIMINATES NEED FOR 8184 05:55:31,761 --> 05:55:33,396 SPECIAL LABORATORY SKILLS SUCH 8185 05:55:33,396 --> 05:55:35,898 AS PIPETTING OR REAGENT 8186 05:55:35,898 --> 05:55:38,734 HANDLING, ELIMINATES DRY FOR 8187 05:55:38,734 --> 05:55:40,403 OBTAINING ACTIONABLE RESULTS, 8188 05:55:40,403 --> 05:55:41,237 ALLOWSES FOR ACCURATE 8189 05:55:41,237 --> 05:55:44,540 INTERPRETATION OF RESULTS DUE TO 8190 05:55:44,540 --> 05:55:45,842 OUR INTUITIVE PRIMARY OUTPUT, 8191 05:55:45,842 --> 05:55:47,710 SUPPORTED BY SEVERAL READER 8192 05:55:47,710 --> 05:55:48,711 STUDIES. 8193 05:55:48,711 --> 05:55:51,447 WE HAVE THE BROADEST INDICATION 8194 05:55:51,447 --> 05:55:54,984 FOR POINT OF CARE-BASED 8195 05:55:54,984 --> 05:55:55,651 VISCOELASTING TESTING. 8196 05:55:55,651 --> 05:55:58,588 CHALLENGES INCLUDE ANY TYPE OF 8197 05:55:58,588 --> 05:56:00,022 OFF-LABEL USE, RESULTING IN 8198 05:56:00,022 --> 05:56:01,991 CHANGE OF COMPLEXITY THAT 8199 05:56:01,991 --> 05:56:04,727 INCREASES THE LABOR AND COST 8200 05:56:04,727 --> 05:56:10,233 BURDEN TO THE HEALTH CARE 8201 05:56:10,233 --> 05:56:15,137 SYSTEM. 8202 05:56:15,137 --> 05:56:16,138 OUR VISCOELASTIC TECHNOLOGIES 8203 05:56:16,138 --> 05:56:18,341 CREATE A CHANGE IN WORKFLOW 8204 05:56:18,341 --> 05:56:20,376 ESPECIALLY TO THE LABORATORY. 8205 05:56:20,376 --> 05:56:22,245 AND FINALLY I WOULD SAY WE DO 8206 05:56:22,245 --> 05:56:23,779 HAVE AN INTEREST TO COLLABORATE 8207 05:56:23,779 --> 05:56:26,582 IN THE AREAS OF CLINICAL 8208 05:56:26,582 --> 05:56:28,918 DECISION SUPPORT SOFTWARE, 8209 05:56:28,918 --> 05:56:31,554 A.I.-BASED LEARNING MODELS FOR 8210 05:56:31,554 --> 05:56:32,455 PREDICTION, AND SYNERGISTIC 8211 05:56:32,455 --> 05:56:33,623 TECHNOLOGIES POSITIONED AT THE 8212 05:56:33,623 --> 05:56:35,825 POINT OF CARE AND CRITICAL CARE 8213 05:56:35,825 --> 05:56:36,092 SETTINGS. 8214 05:56:36,092 --> 05:56:38,961 THANK YOU FOR YOUR TIME. 8215 05:56:38,961 --> 05:56:49,171 [APPLAUSE] 8216 05:56:49,372 --> 05:56:50,940 8217 05:56:50,940 --> 05:57:01,517 >> NEXT UP WE HAVE NEURASTASIS 8218 05:57:06,722 --> 05:57:09,559 FOR ACUTE STROKE. 8219 05:57:09,559 --> 05:57:12,094 >> THANK YOU, I'M CO-FOUNDER, 8220 05:57:12,094 --> 05:57:16,232 BASED IN HOUSTON, SPIN OUT 8221 05:57:16,232 --> 05:57:19,435 UNIVERSITY OF TEXAS, SUPPLY 8222 05:57:19,435 --> 05:57:20,636 BACKGROUND IS BIOMEDICAL 8223 05:57:20,636 --> 05:57:21,971 ENGINEERING, OUR COLLABORATORS 8224 05:57:21,971 --> 05:57:28,978 ARE EXPERT IN STROKE, RESEARCH, 8225 05:57:28,978 --> 05:57:29,378 CARE. 8226 05:57:29,378 --> 05:57:30,613 WE'VE RECEIVED SUPPORT THROUGH 8227 05:57:30,613 --> 05:57:32,848 NIH BLUEPRINTED MED TECH 8228 05:57:32,848 --> 05:57:36,085 PROGRAM, WORKING WITH CIMIT. 8229 05:57:36,085 --> 05:57:37,553 WE'RE FOCUSED ON ACUTE ISCHEMIC 8230 05:57:37,553 --> 05:57:42,925 STROKE, ONE OF THE LARGEST 8231 05:57:42,925 --> 05:57:48,965 CAUSES OF ADULT DISABILITY. 8232 05:57:48,965 --> 05:57:56,639 IN THE PAST DECADE 8233 05:57:56,639 --> 05:57:57,773 MECHANOTHROMBECTOMY, STROKE TIME 8234 05:57:57,773 --> 05:57:58,975 IS BRAIN, TWO MILLION NEURONS 8235 05:57:58,975 --> 05:57:59,875 DIE EVERY MINUTE. 8236 05:57:59,875 --> 05:58:03,479 THE ODDS OF A GOOD FUNCTIONAL 8237 05:58:03,479 --> 05:58:04,680 OUTCOME DECLINE RAPIDLY. 8238 05:58:04,680 --> 05:58:07,516 THIS TYPE OF PROCEDURE IS 8239 05:58:07,516 --> 05:58:10,019 PERFORMED AT COMPREHENSIVE 8240 05:58:10,019 --> 05:58:11,554 STROKE CENTERS, PATIENTS HAVE TO 8241 05:58:11,554 --> 05:58:13,356 TRANSFER THROUGH HUB AND SPOKE 8242 05:58:13,356 --> 05:58:13,723 MODEL. 8243 05:58:13,723 --> 05:58:15,791 THIS CAN TAKE HOURS IN THE 8244 05:58:15,791 --> 05:58:16,892 UNITED STATES. 8245 05:58:16,892 --> 05:58:20,363 WHAT WE'RE AIMING TO DO IS USE 8246 05:58:20,363 --> 05:58:21,464 NEUROMODULATION TO SLOW DOWN 8247 05:58:21,464 --> 05:58:24,800 RATE OF DAMAGE IN STROKE 8248 05:58:24,800 --> 05:58:28,237 PATIENTS BEFORE THIS PROCEDURE. 8249 05:58:28,237 --> 05:58:30,806 WE USE ELECTRICAL STIMULATION OF 8250 05:58:30,806 --> 05:58:36,178 THE VAGUS NERVES TO INDUCE 8251 05:58:36,178 --> 05:58:37,279 BRAINSTEM AUTONOMIC REFLEXES, 8252 05:58:37,279 --> 05:58:40,216 IMPROVING BLOOD FLOW AND 8253 05:58:40,216 --> 05:58:41,117 INTERRUPT CELL-DEATH PATHWAYS, 8254 05:58:41,117 --> 05:58:42,985 PACKAGED FOR SINGLE PATIENT USE 8255 05:58:42,985 --> 05:58:46,489 APPLIED ACROSS MULTIPLE CARE 8256 05:58:46,489 --> 05:58:52,762 SETTINGS INCLUDING PATIENT 8257 05:58:52,762 --> 05:58:57,967 TRANSFERS, THIS SHOWS FUNCTIONAL 8258 05:58:57,967 --> 05:58:58,267 STIMULATOR. 8259 05:58:58,267 --> 05:59:02,938 ALMOST 700,000 PEOPLE IN THE 8260 05:59:02,938 --> 05:59:05,875 U.S. SUFFER ISCHEMIC STROKE 8261 05:59:05,875 --> 05:59:06,909 ARTICLE EACH YEAR. 8262 05:59:06,909 --> 05:59:08,544 ACCESS TO THE PROCEDURE REMAINS 8263 05:59:08,544 --> 05:59:08,878 LOW. 8264 05:59:08,878 --> 05:59:10,413 WE'RE AIMING TO SLOW DOWN RATE 8265 05:59:10,413 --> 05:59:12,615 OF DAMAGE TO GET MORE PATIENTS 8266 05:59:12,615 --> 05:59:14,150 TO THIS PROCEDURE AND GIVE THEM 8267 05:59:14,150 --> 05:59:16,452 A CHANCE OF BETTER OUTCOME. 8268 05:59:16,452 --> 05:59:19,755 FIRST INDICATION WILL TARGET 8269 05:59:19,755 --> 05:59:21,957 APPLICATION WITHIN THE EMERGENCY 8270 05:59:21,957 --> 05:59:24,093 ROOM, AFTER THE STROKE IS 8271 05:59:24,093 --> 05:59:28,664 DIAGNOSED, AND TRANSFER DECISION 8272 05:59:28,664 --> 05:59:30,733 IS MADE BUT LONG TERM HOPE TO 8273 05:59:30,733 --> 05:59:32,835 GET IT IN THE COMMUNITY FOR EMS 8274 05:59:32,835 --> 05:59:35,371 FOR EARLY TIME POINTS. 8275 05:59:35,371 --> 05:59:36,539 WE'RE WORKING WITH CIMIT THROUGH 8276 05:59:36,539 --> 05:59:39,075 THE BLUEPRINT MED TECH PROGRAM 8277 05:59:39,075 --> 05:59:44,213 TO CONDUCT ANIMAL SAFETY TESTING 8278 05:59:44,213 --> 05:59:46,282 AND USABILITY TO ENSURE IT 8279 05:59:46,282 --> 05:59:49,118 DOESN'T CAUSE DELAYS, TO APPLY 8280 05:59:49,118 --> 05:59:50,986 FOR EXEMPTION FROM FDA AND 8281 05:59:50,986 --> 05:59:52,621 FEASIBILITIES STUDIES. 8282 05:59:52,621 --> 05:59:53,389 I'LL WRAP UP. 8283 05:59:53,389 --> 05:59:55,591 THANK YOU FOR YOUR TIME. 8284 05:59:55,591 --> 05:59:57,860 [APPLAUSE] 8285 05:59:57,860 --> 06:00:02,698 8286 06:00:02,698 --> 06:00:06,235 >> THANK YOU. 8287 06:00:06,235 --> 06:00:16,679 NEXT UP WE HAVE DR. ANDREA 8288 06:00:17,279 --> 06:00:18,380 CUBET, PREDICTING POSTPARTUM 8289 06:00:18,380 --> 06:00:18,714 DEPRESSION. 8290 06:00:18,714 --> 06:00:20,583 >> THANK YOU FOR BEING HERE. 8291 06:00:20,583 --> 06:00:23,018 I APPRECIATE EVERYTHING YOU DO 8292 06:00:23,018 --> 06:00:24,754 FOR DEVELOPING EARLY 8293 06:00:24,754 --> 06:00:25,254 TECHNOLOGIES. 8294 06:00:25,254 --> 06:00:26,856 IT'S AN IMPRESSIVE FEAT. 8295 06:00:26,856 --> 06:00:28,924 REALLY APPRECIATE THAT. 8296 06:00:28,924 --> 06:00:30,993 THE ENLIGHTEN TEST, OUR STORY 8297 06:00:30,993 --> 06:00:35,698 STARTS ABOUT A DECADE AGO, 8298 06:00:35,698 --> 06:00:40,936 CO-FOUNDERS, NOW HEAD OF SUICIDE 8299 06:00:40,936 --> 06:00:47,777 PREVENTION AT ROYAL INSTITUTE 8300 06:00:47,777 --> 06:00:49,378 CANADA, JENNIFER, IN 2013 TALKED 8301 06:00:49,378 --> 06:00:54,617 ABOUT STRATEGIES TO TRY AND 8302 06:00:54,617 --> 06:00:56,285 PREDICT MENTAL ILLNESS IN 8303 06:00:56,285 --> 06:00:56,919 HUMANS. 8304 06:00:56,919 --> 06:00:59,955 THEY CAME UP WITH HYPOTHESIS 8305 06:00:59,955 --> 06:01:01,223 ABOUT EPIGENETICS. 8306 06:01:01,223 --> 06:01:04,760 THEY PICKED A MODEL FOR HUMAN 8307 06:01:04,760 --> 06:01:07,830 MENTAL ILLNESS REPLICATABLE AND 8308 06:01:07,830 --> 06:01:08,998 COULD BE EASILY STUDIED, 8309 06:01:08,998 --> 06:01:09,665 POSTPARTUM DEPRESSION. 8310 06:01:09,665 --> 06:01:14,703 WOMEN HAVE TWICE THE RATE OF 8311 06:01:14,703 --> 06:01:16,906 MAIN DEPRESSION AS MEN BUT NOT 8312 06:01:16,906 --> 06:01:20,543 BEFORE ADOLESCENCE AND AFTER 8313 06:01:20,543 --> 06:01:22,278 MENOPAUSE, A CLUE IT'S 8314 06:01:22,278 --> 06:01:25,114 HOMOGENOUS BASED AROUND A SEX 8315 06:01:25,114 --> 06:01:25,414 DIFFERENCE. 8316 06:01:25,414 --> 06:01:31,187 A DECADE LATER WE NOW HAVE WELL 8317 06:01:31,187 --> 06:01:32,488 VALIDATED BIOMARKERS, REALLY 8318 06:01:32,488 --> 06:01:42,965 PROVIDE INSIGHT NOT JUST ON 8319 06:01:44,166 --> 06:01:47,269 POSTPARTUM DEPRESSION BUT A 8320 06:01:47,269 --> 06:01:48,504 WHOLE RANGE, PRECISION 8321 06:01:48,504 --> 06:01:50,773 PSYCHIATRY TO PREVENT DISEASE 8322 06:01:50,773 --> 06:01:54,176 BEFORE IT BECOMES A PROBLEM. 8323 06:01:54,176 --> 06:01:56,812 NOW A DECADE AFTER THAT INITIAL 8324 06:01:56,812 --> 06:01:59,315 STUDIES ARE COMPLETED WE HAVE 8325 06:01:59,315 --> 06:02:00,950 NEUROIMAGING DATA TO CONFIRM THE 8326 06:02:00,950 --> 06:02:02,151 PLACES WHERE THEY ARE EXPRESSED 8327 06:02:02,151 --> 06:02:04,687 IN THE HUMAN BRAIN AND WE HAVE A 8328 06:02:04,687 --> 06:02:06,655 MORE COMPELLING DATA THAT THEY 8329 06:02:06,655 --> 06:02:09,058 CAN PREDICT RESPONSEIVENESS TO 8330 06:02:09,058 --> 06:02:10,059 THINGS LIKE SSRIs. 8331 06:02:10,059 --> 06:02:14,230 WE LIKE MANY OTHER PEOPLE ARE 8332 06:02:14,230 --> 06:02:15,831 COMBINING WITH A.I. APPROACH AND 8333 06:02:15,831 --> 06:02:17,833 DIGITAL HEALTH. 8334 06:02:17,833 --> 06:02:21,737 THIS IS WORK FROM ZAK KAMINSKI, 8335 06:02:21,737 --> 06:02:23,873 IT'S ABILITY TO UNDERSTAND AND 8336 06:02:23,873 --> 06:02:25,307 INFER MOOD AND ANXIETY AND 8337 06:02:25,307 --> 06:02:30,713 SOCIAL MEDIA, ANDS WE'VE NOW 8338 06:02:30,713 --> 06:02:32,448 EXTENDED THAT, PEOPLE TALKED 8339 06:02:32,448 --> 06:02:33,482 TODAY ABOUT MATERNAL MORTALITY 8340 06:02:33,482 --> 06:02:38,687 RATES AND CRISIS IN AMERICA, 70% 8341 06:02:38,687 --> 06:02:40,456 INCREASE IN THE LAST DECADE. 8342 06:02:40,456 --> 06:02:44,093 OUR USE IS TO ADDRESS CHALLENGES 8343 06:02:44,093 --> 06:02:46,161 AND MENTAL HEALTH POSTPARTUM, 8344 06:02:46,161 --> 06:02:53,202 THE LEADING CAUSE AFTER 8345 06:02:53,202 --> 06:02:54,069 HEMORRHAGE, SUICIDALITIES, POOR 8346 06:02:54,069 --> 06:02:55,638 OUTCOMES FOR THE MOTHER AND BABY 8347 06:02:55,638 --> 06:02:57,606 AND SOCIETY AS A WHOLE. THERE 8348 06:02:57,606 --> 06:03:02,344 IS CURRENTLY NO SIMPLE TEST FOR 8349 06:03:02,344 --> 06:03:03,145 POSTPARTUM DEPRESSION, SO 8350 06:03:03,145 --> 06:03:09,451 TECHNOLOGY AS I SAID HAS A 8351 06:03:09,451 --> 06:03:10,552 CUSTOMARY GENETIC CHIP, ABILITY 8352 06:03:10,552 --> 06:03:16,025 TO MEASURE DIETARY FACTORS, 8353 06:03:16,025 --> 06:03:20,829 FOLIC ACID, IRON, OMEGA-3 FATTY 8354 06:03:20,829 --> 06:03:23,232 ACIDS, LEAD, MERCURY, SECONDS 8355 06:03:23,232 --> 06:03:25,434 HAND SMOKE, DIESEL FUMES, 8356 06:03:25,434 --> 06:03:26,869 BIOLOGICAL FACTORS, TIME TO 8357 06:03:26,869 --> 06:03:29,872 MENOPAUSE, OTHER FACTORS. 8358 06:03:29,872 --> 06:03:31,573 A DECADE AFTER THE ORIGINAL 8359 06:03:31,573 --> 06:03:35,744 DISCOVERY VALIDATED IN SEVEN 8360 06:03:35,744 --> 06:03:38,480 COHORTS, 600 PATIENTS, THE PRIZE 8361 06:03:38,480 --> 06:03:42,751 IS $65, THAT WILL DROP TO $10 AS 8362 06:03:42,751 --> 06:03:44,119 WE DEVELOP CHIPS. 8363 06:03:44,119 --> 06:03:45,921 CLINICAL IMPACT WE WANT TO MAKE 8364 06:03:45,921 --> 06:03:49,024 THIS TEST STANDARD OF CARE, MOST 8365 06:03:49,024 --> 06:03:54,296 WOMEN GET TO SUFFER GESTATIONAL 8366 06:03:54,296 --> 06:03:59,768 DIABETES, THIRD TRIMESTER, 8367 06:03:59,768 --> 06:04:03,806 POSTPARTUM IS THE MOST COMMON 8368 06:04:03,806 --> 06:04:04,273 COMPLICATION. 8369 06:04:04,273 --> 06:04:05,474 THE BIGGEST CHALLENGES IS 8370 06:04:05,474 --> 06:04:06,675 FINDING A FUNDABLE SOURCE TO GET 8371 06:04:06,675 --> 06:04:08,077 THIS IN THE HANDS OF PEOPLE WHO 8372 06:04:08,077 --> 06:04:09,178 NEED IT. 8373 06:04:09,178 --> 06:04:12,381 IF WE WORK WITH TRIBAL NATIONS 8374 06:04:12,381 --> 06:04:15,417 OR POOR UNDERSERVED COMMUNITIES 8375 06:04:15,417 --> 06:04:16,819 THEY ARE INCREDIBLY ADVERSE TO 8376 06:04:16,819 --> 06:04:19,355 GETTING TESTING. 8377 06:04:19,355 --> 06:04:21,357 IF YOU MENTION GENETIC TESTING 8378 06:04:21,357 --> 06:04:22,324 IT'S EVEN WORSE. 8379 06:04:22,324 --> 06:04:26,362 WE NEED TO BUILD TRUST. 8380 06:04:26,362 --> 06:04:27,997 WE WOULD LOVE TO TALK TO ANYONE 8381 06:04:27,997 --> 06:04:31,700 WORKING IN COMMUNITIES AND WE'RE 8382 06:04:31,700 --> 06:04:32,701 OPEN TO COLLABORATIONS WHERE 8383 06:04:32,701 --> 06:04:37,439 THIS IS A KEY ROLE, FOR EXAMPLE 8384 06:04:37,439 --> 06:04:38,640 HORMONE THERAPY. 8385 06:04:38,640 --> 06:04:40,642 IVF, HORMONAL DEPRESSION IS 8386 06:04:40,642 --> 06:04:41,477 ASSOCIATED WITH CANCER 8387 06:04:41,477 --> 06:04:41,910 TREATMENT. 8388 06:04:41,910 --> 06:04:43,779 ALL THE IMPORTANT CASES WHERE WE 8389 06:04:43,779 --> 06:04:46,181 THINK WE HAVE AN IMPORTANT KEY 8390 06:04:46,181 --> 06:04:46,682 TO HELP PEOPLE. 8391 06:04:46,682 --> 06:04:48,317 THANK YOU SO MUCH. 8392 06:04:48,317 --> 06:04:50,886 [APPLAUSE] 8393 06:04:50,886 --> 06:04:56,792 8394 06:04:56,792 --> 06:04:58,227 >> THANK YOU, ANDREA. 8395 06:04:58,227 --> 06:05:04,333 NEXT UP IS ARMOR MEDICAL, 8396 06:05:04,333 --> 06:05:06,969 PRESENTING MATERNAL ARMOR A 8397 06:05:06,969 --> 06:05:12,574 WEARABLE INNOVATION TO DETECT 8398 06:05:12,574 --> 06:05:16,045 HEMORRHAGE. 8399 06:05:16,045 --> 06:05:19,114 >> THANK YOU, SUSAN. 8400 06:05:19,114 --> 06:05:21,884 HELLO, I'M KELSEY, I'M AN 8401 06:05:21,884 --> 06:05:24,086 ENGINEER, A MOTHER, I'M A 8402 06:05:24,086 --> 06:05:25,287 SURVIVOR OF HEMORRHAGE. 8403 06:05:25,287 --> 06:05:27,022 AND THROUGH MY OWN LIVED 8404 06:05:27,022 --> 06:05:29,992 EXPERIENCES AND BECAUSE I'M 8405 06:05:29,992 --> 06:05:30,826 USUALLY PASSIONATE ABOUT 8406 06:05:30,826 --> 06:05:31,827 TRANSLATING INNOVATIONS WHERE 8407 06:05:31,827 --> 06:05:36,899 THEY CAN TRULY HELP PEOPLE, I 8408 06:05:36,899 --> 06:05:38,767 CO-FOUNDED ARMOR MEDICAL IN 8409 06:05:38,767 --> 06:05:40,969 2020, A BIOMEDICAL DEVICE 8410 06:05:40,969 --> 06:05:42,337 COMPANY PIONEERING SOLUTIONS 8411 06:05:42,337 --> 06:05:43,839 THAT PROTECT AND EMPOWER WOMEN'S 8412 06:05:43,839 --> 06:05:45,374 HEALTH AT EVERY STAGE OF LIFE. 8413 06:05:45,374 --> 06:05:47,242 RIGHT OUT OF THE DATE WE'RE 8414 06:05:47,242 --> 06:05:49,878 STARTING WITH THE GLOBAL LEADING 8415 06:05:49,878 --> 06:05:51,647 CAUSE OF MATERNAL DEATH WHICH IS 8416 06:05:51,647 --> 06:05:54,783 SEVERE BLOOD LOSS AFTER 8417 06:05:54,783 --> 06:05:55,684 DELIVERY, POSTPARTUM HEMORRHAGE. 8418 06:05:55,684 --> 06:05:56,985 WE'VE HEARD ABOUT THIS 8419 06:05:56,985 --> 06:06:01,557 THROUGHOUT THE DAY. 8420 06:06:01,557 --> 06:06:03,225 ONE TRAGEDY THREE TIMES MORE 8421 06:06:03,225 --> 06:06:04,760 DEADLY FOR PEOPLE OF COLOR AND 8422 06:06:04,760 --> 06:06:09,198 FOR EVERY PERSON WHO DIES 100 8423 06:06:09,198 --> 06:06:11,200 MORE SUFFER DEVASTATING 8424 06:06:11,200 --> 06:06:11,767 COMPLICATIONS. 8425 06:06:11,767 --> 06:06:14,002 IMPORTANTLY AS MUCH AS 90% OF 8426 06:06:14,002 --> 06:06:15,971 THE DEATH AND SEVERE 8427 06:06:15,971 --> 06:06:18,373 COMPLICATION FROM HEMORRHAGE IS 8428 06:06:18,373 --> 06:06:19,341 PREVENTIBLE, IF YOU CAN DETECT 8429 06:06:19,341 --> 06:06:24,580 IT EARLY AND TREAT IT EARLY. 8430 06:06:24,580 --> 06:06:28,083 OUR PEOPLE AT ARMOR DEVELOPED 8431 06:06:28,083 --> 06:06:30,052 MATERNAL ARMOR, A WRIST-WORN 8432 06:06:30,052 --> 06:06:31,720 SENSOR THAT DETECTS EARLY 8433 06:06:31,720 --> 06:06:32,888 HEMORRHAGE IN PREGNANT PATIENTS. 8434 06:06:32,888 --> 06:06:35,190 AND IF YOU THINK ABOUT OUR 8435 06:06:35,190 --> 06:06:36,959 PATENTED TECHNOLOGY THE KEY TO 8436 06:06:36,959 --> 06:06:39,261 THIS BREAKTHROUGH IS OUR ABILITY 8437 06:06:39,261 --> 06:06:41,663 TO SENSE THE SUBTLE CHANGES IN 8438 06:06:41,663 --> 06:06:43,198 PERIPHERAL BLOOD FLOW THAT 8439 06:06:43,198 --> 06:06:44,733 HAPPEN DURING THE EARLIEST 8440 06:06:44,733 --> 06:06:46,235 STAGES OF HEMORRHAGE WHEN OUR 8441 06:06:46,235 --> 06:06:47,803 BODY SHUNTS BLOOD FROM OUR 8442 06:06:47,803 --> 06:06:50,539 EXTREMITIES TO OUR CORE TO 8443 06:06:50,539 --> 06:06:51,840 PROTECT VITAL ORGANS. 8444 06:06:51,840 --> 06:06:54,176 AND SO WE HAVE DONE EXTENSIVE 8445 06:06:54,176 --> 06:06:58,747 TESTING ON THIS TECHNOLOGY. 8446 06:06:58,747 --> 06:07:01,483 IT'S BEEN VALIDATED IN 8447 06:07:01,483 --> 06:07:02,918 PRE-CLINICAL SWINE HEMORRHAGE 8448 06:07:02,918 --> 06:07:04,052 MODELS, DOING CLINICAL 8449 06:07:04,052 --> 06:07:04,553 FEASIBILITY TESTING AT 8450 06:07:04,553 --> 06:07:05,787 WASHINGTON UNIVERSITY IN 8451 06:07:05,787 --> 06:07:07,656 ST. LOUIS AND RESULTS FROM THESE 8452 06:07:07,656 --> 06:07:10,292 STUDIES SHOW THE SIGNAL FROM OUR 8453 06:07:10,292 --> 06:07:12,794 DEVICE HAS A STRONG ASSOCIATION 8454 06:07:12,794 --> 06:07:14,429 WITH KNOWN HEMORRHAGE OR BLOOD 8455 06:07:14,429 --> 06:07:17,332 LOSS EVENTS AS WELL AS 8456 06:07:17,332 --> 06:07:17,666 RESUSCITATION. 8457 06:07:17,666 --> 06:07:19,902 IN ADDITION OVER THE LAST YEAR 8458 06:07:19,902 --> 06:07:21,670 WE'VE BEEN TALKING WITH PATIENTS 8459 06:07:21,670 --> 06:07:23,639 AND TALKING WITH PROVIDERS AND 8460 06:07:23,639 --> 06:07:25,474 CO-DESIGNING OUR DIE VICE WITH 8461 06:07:25,474 --> 06:07:27,176 THEM AND AS A RESULT OF THE 8462 06:07:27,176 --> 06:07:28,243 PROGRESS WE'VE MADE WE'RE 8463 06:07:28,243 --> 06:07:30,012 CURRENTLY ON TRACK FOR 8464 06:07:30,012 --> 06:07:31,413 COMPLETING OUR PRE-MARKET 8465 06:07:31,413 --> 06:07:34,483 CLINICAL STUDIES OVER THE NEXT 8466 06:07:34,483 --> 06:07:39,354 YEAR, SO TO SUPPORT REGULATORY 8467 06:07:39,354 --> 06:07:40,355 CLEARANCE AND COMMERCIALIZATION 8468 06:07:40,355 --> 06:07:40,822 IN 2025. 8469 06:07:40,822 --> 06:07:44,326 SEWS WHEN I LOOK AT OUR GOAL, 8470 06:07:44,326 --> 06:07:49,264 WE'RE GOING TO REVOLUTIONIZE BY 8471 06:07:49,264 --> 06:07:50,599 PROVIDING PROVIDERS WITH 8472 06:07:50,599 --> 06:07:52,000 OBJECTIVE TIMELY INFORMATION 8473 06:07:52,000 --> 06:07:54,069 ABOUT A PATIENT'S HEMORRHAGE 8474 06:07:54,069 --> 06:07:54,303 RISK. 8475 06:07:54,303 --> 06:07:58,507 IF YOU THINK ABOUT THIS, WE 8476 06:07:58,507 --> 06:08:01,009 EMPOWER CLINICIANS, WHEN WE 8477 06:08:01,009 --> 06:08:02,344 EMPOWER CLINICIANS TO DETECT 8478 06:08:02,344 --> 06:08:05,280 HEMORRHAGE EARLY WE'RE ENABLING 8479 06:08:05,280 --> 06:08:08,784 THEM TO TREAT IN A TIMELY MANNER 8480 06:08:08,784 --> 06:08:09,685 SAVING LIVES, REDUCING 8481 06:08:09,685 --> 06:08:11,320 COMPLICATIONS AND LOWERING COST 8482 06:08:11,320 --> 06:08:12,654 OF CARE. 8483 06:08:12,654 --> 06:08:14,823 NOW AS I REFLECT ON THE PROCESS 8484 06:08:14,823 --> 06:08:17,659 I'D LIKE TO TAKE A LITTLE BIT OF 8485 06:08:17,659 --> 06:08:20,529 TIME TO THANK HHS FOR BEING 8486 06:08:20,529 --> 06:08:21,597 GENUINELY A CATALYST AND LAUNCH 8487 06:08:21,597 --> 06:08:24,900 PAD FOR OUR COMPANY AND 8488 06:08:24,900 --> 06:08:25,234 TECHNOLOGY. 8489 06:08:25,234 --> 06:08:29,104 THE TECHNOLOGY ITSELF WAS ACTUAL 8490 06:08:29,104 --> 06:08:33,709 BORN OF NICHD K99/R00 AWARD, 8491 06:08:33,709 --> 06:08:35,644 PARTICIPATING IN POCTRN'S 8492 06:08:35,644 --> 06:08:37,879 CHALLENGE IN 2022, GOT AN SBIR 8493 06:08:37,879 --> 06:08:39,948 AWARD FROM THE CDC, AND THEN WE 8494 06:08:39,948 --> 06:08:41,350 GOT INTO RADx. 8495 06:08:41,350 --> 06:08:43,785 SO THIS JOURNEY HAS BEEN 8496 06:08:43,785 --> 06:08:44,086 INCREDIBLE. 8497 06:08:44,086 --> 06:08:46,521 I CAN SAY IT'S BEEN INSTRUMENTAL 8498 06:08:46,521 --> 06:08:47,322 IN OUR SUCCESS. 8499 06:08:47,322 --> 06:08:49,491 AND SO WITH THAT WE'RE SEEKING 8500 06:08:49,491 --> 06:08:51,059 PARTNERSHIPS IN THE AREAS ON THE 8501 06:08:51,059 --> 06:08:52,461 BOARD HERE AND I WELCOME PEOPLE 8502 06:08:52,461 --> 06:08:54,997 TO FIND ME AT THE DEMO AND JOIN 8503 06:08:54,997 --> 06:08:56,832 US IN DARING TO INNOVATE A 8504 06:08:56,832 --> 06:08:58,567 BETTER HEALTH FOR ALL. 8505 06:08:58,567 --> 06:08:59,101 THANK YOU. 8506 06:08:59,101 --> 06:09:01,570 [APPLAUSE] 8507 06:09:01,570 --> 06:09:07,576 8508 06:09:07,576 --> 06:09:10,312 8509 06:09:10,312 --> 06:09:15,050 >> NEXT UP WITH RICE UNIVERSITY 8510 06:09:15,050 --> 06:09:21,957 WE HAVE MARIA BADA, PRESENTING 8511 06:09:21,957 --> 06:09:24,159 ON INTEGRATIVE TESTS AT THE 8512 06:09:24,159 --> 06:09:27,262 POINT OF CARE IN LOW-RESOURCE 8513 06:09:27,262 --> 06:09:29,498 SETTINGS. 8514 06:09:29,498 --> 06:09:34,870 8515 06:09:34,870 --> 06:09:37,472 8516 06:09:37,472 --> 06:09:43,612 >> OUR TEAM IS RESEARCHES AT 8517 06:09:43,612 --> 06:09:47,549 COLLABORATORS AT RICE, M.D. 8518 06:09:47,549 --> 06:09:50,719 ANDERSON. 8519 06:09:50,719 --> 06:09:53,355 CERVICAL CANCER IS PREVENTIBLE, 8520 06:09:53,355 --> 06:09:54,323 MAJORITY CAUSED BY INFECTION, 8521 06:09:54,323 --> 06:09:58,327 WHY THE W.H.O. RECOMMENDS HPV 8522 06:09:58,327 --> 06:10:04,433 DNA TESTING FOR SCREENING. 8523 06:10:04,433 --> 06:10:06,401 TESTING IS EXPENSIVE AND 8524 06:10:06,401 --> 06:10:08,403 REQUIRES TRAINED PERSONNEL AND 8525 06:10:08,403 --> 06:10:10,205 COMPLEX EQUIPMENT DIFFICULT TO 8526 06:10:10,205 --> 06:10:11,907 IMPLEMENT IN THE LOW-RESOURCE 8527 06:10:11,907 --> 06:10:14,776 SETTINGS WHERE THE MAJORITY OF 8528 06:10:14,776 --> 06:10:15,644 CASES OCCUR. 8529 06:10:15,644 --> 06:10:17,946 THIS MAP SHOWS WHERE THE 8530 06:10:17,946 --> 06:10:23,418 MAJORITY OF CERVICAL CANCER 8531 06:10:23,418 --> 06:10:24,486 RELATED DEATHS OCCUR, IN LOW- 8532 06:10:24,486 --> 06:10:25,687 AND MIDDLE-INCOME COUNTRIES. 8533 06:10:25,687 --> 06:10:28,023 THIS ALSO HAPPENS IN THE U.S. 8534 06:10:28,023 --> 06:10:30,225 SEASON HERE IS THE RIO GRANDE 8535 06:10:30,225 --> 06:10:32,194 VALLEY WHERE VERY FEW ELIGIBLE 8536 06:10:32,194 --> 06:10:35,464 WOMEN ARE BEING SCREENED FOR 8537 06:10:35,464 --> 06:10:37,332 CERVICAL CANCER. 8538 06:10:37,332 --> 06:10:39,801 AND WE SEE HIGHER RATES THAT ARE 8539 06:10:39,801 --> 06:10:40,902 SIGNIFICANTLY HIGHER COMPARED TO 8540 06:10:40,902 --> 06:10:44,072 THE REST OF THE UNITED STATES. 8541 06:10:44,072 --> 06:10:46,808 WITH A LOW COST POINT OF CARE 8542 06:10:46,808 --> 06:10:49,878 TEST WE CAN MAKE CERVICAL CANCER 8543 06:10:49,878 --> 06:10:51,079 SCREENING ACCESSIBLE AND PROVIDE 8544 06:10:51,079 --> 06:10:52,714 SCREENING AND TREATMENT IN A 8545 06:10:52,714 --> 06:10:55,050 SINGLE VISIT ALLOWING US TO 8546 06:10:55,050 --> 06:11:00,489 REDUCE THE PATIENTS LOST TO 8547 06:11:00,489 --> 06:11:00,756 FOLLOW-UP. 8548 06:11:00,756 --> 06:11:04,192 OUR TECHNOLOGY IS A TEST FOR THE 8549 06:11:04,192 --> 06:11:07,829 TWO MOST COMMON TYPES, 16 AND 8550 06:11:07,829 --> 06:11:12,667 18, USES POINT OF CARE FRIENDLY 8551 06:11:12,667 --> 06:11:14,770 SAMPLE PREPARATION METHOD, IN 8552 06:11:14,770 --> 06:11:18,607 AND RPA, WE USE A LATERAL FLOW 8553 06:11:18,607 --> 06:11:20,976 READOUT, INTEGRATED ON A 8554 06:11:20,976 --> 06:11:22,411 PLATFORM PICTURED HERE INCLUDING 8555 06:11:22,411 --> 06:11:31,420 TWO HEAT BLOCKS AND ENCLOSED 8556 06:11:31,420 --> 06:11:33,054 CARTRIDGE USING SWAB SAMPLES, 8557 06:11:33,054 --> 06:11:36,425 LESS THAN $5 FOR CONSUMABLES, 8558 06:11:36,425 --> 06:11:37,292 $1,000 FOR INSTRUMENTATION. 8559 06:11:37,292 --> 06:11:41,463 THIS AS A LIMIT OF DETECTION OF 8560 06:11:41,463 --> 06:11:44,933 500 TO 1,000 COPIES AND 93% 8561 06:11:44,933 --> 06:11:47,068 SENSITIVITY FOR HPV 16 AT LOWER 8562 06:11:47,068 --> 06:11:50,672 LIMIT OF DETECTION. 8563 06:11:50,672 --> 06:11:53,341 THE REAGENTS AND INSTRUMENTATION 8564 06:11:53,341 --> 06:11:55,076 ARE COMMERCIALLY PRODUCED 8565 06:11:55,076 --> 06:11:55,377 CURRENTLY. 8566 06:11:55,377 --> 06:11:57,679 OUR TEST HAS POTENTIAL FOR HPV 8567 06:11:57,679 --> 06:11:59,548 DNA TESTING AND TREATMENT TO OF 8568 06:11:59,548 --> 06:12:02,150 IN A SINGLE VISIT SAND LOW COST 8569 06:12:02,150 --> 06:12:04,953 ALTERNATIVE TO MANY CURRENTLY 8570 06:12:04,953 --> 06:12:07,889 AVAILABLE HPV DNA TESTS. 8571 06:12:07,889 --> 06:12:09,224 SOME CHALLENGES INCLUDE 8572 06:12:09,224 --> 06:12:10,525 INCORPORATING MORE HIGH RISK 8573 06:12:10,525 --> 06:12:12,727 TYPES IN THIS ASSAY WHICH WE'RE 8574 06:12:12,727 --> 06:12:15,030 CURRENTLY WORKING ON AND FURTHER 8575 06:12:15,030 --> 06:12:15,897 OPTIMIZING SAMPLE PREPARATION 8576 06:12:15,897 --> 06:12:18,767 METHOD TO REDUCE NUMBER OF USER 8577 06:12:18,767 --> 06:12:21,002 STEPS AND INCREASE AMOUNT OF 8578 06:12:21,002 --> 06:12:23,238 AVAILABLE DNA FOR AMPLIFICATION. 8579 06:12:23,238 --> 06:12:25,006 SOME OPPORTUNITIES TO 8580 06:12:25,006 --> 06:12:26,775 COLLABORATE INCLUDE LATERAL FLOW 8581 06:12:26,775 --> 06:12:29,845 STRIP DESIGN TO IMPROVE 8582 06:12:29,845 --> 06:12:31,646 SENSITIVITY AND REAGENTS TO 8583 06:12:31,646 --> 06:12:34,850 IMPROVE SHELF LIFE OF THE TEST. 8584 06:12:34,850 --> 06:12:36,585 WE COULD USE COLLABORATION AND 8585 06:12:36,585 --> 06:12:37,953 TRAINING TO BUILD CAPACITY. 8586 06:12:37,953 --> 06:12:38,487 THANK YOU. 8587 06:12:38,487 --> 06:12:40,989 [APPLAUSE] 8588 06:12:40,989 --> 06:12:46,895 8589 06:12:46,895 --> 06:12:53,468 8590 06:12:53,468 --> 06:13:04,045 >> AND NEAR-INFRARED IMAGING TO 8591 06:13:07,048 --> 06:13:10,185 DIAGNOSE NERVE INJURIES. 8592 06:13:10,185 --> 06:13:12,020 >> I'M NOT SAMMY, HE COULD NOT 8593 06:13:12,020 --> 06:13:13,955 MAKE IT. 8594 06:13:13,955 --> 06:13:16,725 WE'RE A TEAM OF CLINICIANS AND 8595 06:13:16,725 --> 06:13:21,329 RESEARCHERS AT JOHNS HOPKINS 8596 06:13:21,329 --> 06:13:23,932 FOCUSING ON IMAGING DEVELOPING 8597 06:13:23,932 --> 06:13:28,036 THE FIRST AGENT TO IDENTIFY 8598 06:13:28,036 --> 06:13:29,971 NERVE REGENERATION AND DECIDE 8599 06:13:29,971 --> 06:13:31,273 INTRAOPERATIVE MANAGEMENT OF 8600 06:13:31,273 --> 06:13:34,342 NERVE INJURIES. 8601 06:13:34,342 --> 06:13:36,411 NERVE INJURIES LEAD TO CHRONIC 8602 06:13:36,411 --> 06:13:39,147 DISABILITY, PARALYSIS, PAIN. 8603 06:13:39,147 --> 06:13:41,349 THE MAINSTAY OF THERAPY IS 8604 06:13:41,349 --> 06:13:42,984 SURGICAL MANAGEMENT. 8605 06:13:42,984 --> 06:13:45,487 BUT UNFORTUNATELY OUR ABILITY TO 8606 06:13:45,487 --> 06:13:47,589 RESTORE FUNCTION IS HAMSTRUNG BY 8607 06:13:47,589 --> 06:13:54,963 INABILITY TO ASSESS EXACT 8608 06:13:54,963 --> 06:13:57,899 SEVERITY OF NERVE INJURIES, NO 8609 06:13:57,899 --> 06:13:59,200 TECHNOLOGY CAN VISUALIZE 8610 06:13:59,200 --> 06:14:01,736 LOCATION OF NERVE REGENERATION, 8611 06:14:01,736 --> 06:14:04,472 CRITICAL INFORMATION FOR 8612 06:14:04,472 --> 06:14:06,041 SURGEONS TO UNDERSTAND WHEN, 8613 06:14:06,041 --> 06:14:08,543 WHERE, HOW TO BEST INTERVENE. 8614 06:14:08,543 --> 06:14:10,245 SO AT PRESENT WE'RE ESSENTIALLY 8615 06:14:10,245 --> 06:14:15,650 ALMOST IN THE STONE AGES, MAKING 8616 06:14:15,650 --> 06:14:17,752 VERY CRITICAL CARE DECISIONS, 8617 06:14:17,752 --> 06:14:25,560 HOW NERVES LOOK AND FEEL. 8618 06:14:25,560 --> 06:14:27,796 THIS TECHNOLOGY, MACROPHAGES 8619 06:14:27,796 --> 06:14:30,332 INVADE NERVES AND SO BY 8620 06:14:30,332 --> 06:14:32,634 VISUALIZING MACROPHAGES IN THE 8621 06:14:32,634 --> 06:14:37,706 NERVE WHICH REMAIN, AGAIN, IN 8622 06:14:37,706 --> 06:14:42,644 DEGENERATIVE PORTIONS BUT EFFLUX 8623 06:14:42,644 --> 06:14:45,146 WE CAN GET INVERSE IMAGE AND 8624 06:14:45,146 --> 06:14:46,715 THIS ALLOWS US TO BETTER 8625 06:14:46,715 --> 06:14:51,286 UNDERSTAND WHERE THE NERVE IS 8626 06:14:51,286 --> 06:14:53,154 INJURED AND WE BELIEVE CAN 8627 06:14:53,154 --> 06:14:56,458 ENHANCE MANAGEMENT OF THESE 8628 06:14:56,458 --> 06:14:56,992 INJURIES. 8629 06:14:56,992 --> 06:15:03,498 SO, IN ORDER TO IMAGE THESE 8630 06:15:03,498 --> 06:15:06,434 MACROPHAGES WE'RE USING AN 8631 06:15:06,434 --> 06:15:10,305 INVESTIGATIONAL CLINICAL STAGE 8632 06:15:10,305 --> 06:15:13,708 NERVE REAGENT tPA 713, IT'S 8633 06:15:13,708 --> 06:15:15,210 BEEN TESTED IN CLINICAL STUDIES 8634 06:15:15,210 --> 06:15:18,446 BY OUR GROUP AND OTHERS TO 8635 06:15:18,446 --> 06:15:20,315 DETECT NEURAL INFLAMMATION IN 8636 06:15:20,315 --> 06:15:23,685 THE BRAIN AND PRE-CLINICAL WORK 8637 06:15:23,685 --> 06:15:25,854 WE HAVE SHOWN THERE'S HIGH 8638 06:15:25,854 --> 06:15:30,825 UPTAKE OF DPA IN INJURED NERVES 8639 06:15:30,825 --> 06:15:35,463 IN OUR ANIMAL MODEL AND CONFIRM 8640 06:15:35,463 --> 06:15:38,099 TRANSLATABILITY IN HUMANS WE'VE 8641 06:15:38,099 --> 06:15:39,200 DONE HISTOLOGIC STUDIES 8642 06:15:39,200 --> 06:15:40,835 DEMONSTRATING THAT'S THE 8643 06:15:40,835 --> 06:15:42,704 RECEPTOR FOR DPA HIGHLY 8644 06:15:42,704 --> 06:15:46,441 EXPRESSED IN DEGENERATIVE 8645 06:15:46,441 --> 06:15:49,044 PORTIONS OF HUMAN NERVES. 8646 06:15:49,044 --> 06:15:54,082 THIS AS A PET IMAGING AGENT, 8647 06:15:54,082 --> 06:15:55,617 IT'S CURRENTLY AVAILABLE TO BE 8648 06:15:55,617 --> 06:15:58,019 PURCHASED FOR CLINICAL STUDIES 8649 06:15:58,019 --> 06:16:04,292 BUT WE'RE LOOKING FOR DEVELOPING 8650 06:16:04,292 --> 06:16:06,995 HIGH CAPACITY cGMP PRODUCTION 8651 06:16:06,995 --> 06:16:09,364 OF NEAR-INFRARED VERSION. 8652 06:16:09,364 --> 06:16:14,903 NERVE INJURIES AFFECT 200,000 8653 06:16:14,903 --> 06:16:16,771 AMERICANS EACH YEAR AND THESE 8654 06:16:16,771 --> 06:16:18,640 INJURIES CAN BE SEVERELY 8655 06:16:18,640 --> 06:16:19,407 DEBILITATING, PATIENTS ARE 8656 06:16:19,407 --> 06:16:21,242 GENERALLY OFF WORK FOR SIX 8657 06:16:21,242 --> 06:16:25,814 MONTHS, AROUND A THIRD OF THEM 8658 06:16:25,814 --> 06:16:32,687 RECEIVE LONG-TERM DISABILITY 8659 06:16:32,687 --> 06:16:33,121 PAYMENTS. 8660 06:16:33,121 --> 06:16:34,756 WE'RE GEARING UP BASICALLY FOR 8661 06:16:34,756 --> 06:16:37,392 FIRST CLINICAL STUDIES. 8662 06:16:37,392 --> 06:16:40,562 WE SEEK ASSISTANCE WITH 8663 06:16:40,562 --> 06:16:42,330 COLLABORATORS AND TO MARKETING 8664 06:16:42,330 --> 06:16:44,299 STRATEGY COMMERCIALIZATION AS 8665 06:16:44,299 --> 06:16:45,633 WELL AS FUNDING SUPPORT TO BRING 8666 06:16:45,633 --> 06:16:48,136 TO THE NEXT STEPS. 8667 06:16:48,136 --> 06:16:50,638 I'D LIKE TO ACKNOWLEDGE HELP 8668 06:16:50,638 --> 06:16:55,110 FROM JOHNS HOPKINS AS WELL AS 8669 06:16:55,110 --> 06:17:00,381 BLUEPRINT MED TECH PILOT PROGRAM 8670 06:17:00,381 --> 06:17:02,016 WITH SUPPORT AND ALSO JUST 8671 06:17:02,016 --> 06:17:02,884 GUIDANCE. 8672 06:17:02,884 --> 06:17:03,585 THANK YOU VERY MUCH. 8673 06:17:03,585 --> 06:17:05,720 [APPLAUSE] 8674 06:17:05,720 --> 06:17:10,892 8675 06:17:10,892 --> 06:17:13,428 >> THANK YOU. 8676 06:17:13,428 --> 06:17:16,798 LAST BUT NOT LEAST MICHAEL WITH 8677 06:17:16,798 --> 06:17:21,202 BRAINSTEM BIOMETRICS, CEO AND SO 8678 06:17:21,202 --> 06:17:23,071 FOUNDER, REGULATING DRUG DOSING 8679 06:17:23,071 --> 06:17:26,174 IN ICU PATIENTS. 8680 06:17:26,174 --> 06:17:28,977 >> THANK YOU, SUSAN. 8681 06:17:28,977 --> 06:17:34,983 8682 06:17:34,983 --> 06:17:39,487 8683 06:17:39,487 --> 06:17:40,588 8684 06:17:40,588 --> 06:17:43,424 I'M MICHAEL BOLTON, CEO AND 8685 06:17:43,424 --> 06:17:43,992 FOUNDER. 8686 06:17:43,992 --> 06:17:47,262 OUR PRIMARY MISSION TO REDUCE 8687 06:17:47,262 --> 06:17:48,596 UNNECESSARY OVERMEDICATION IN 8688 06:17:48,596 --> 06:17:50,932 CRITICAL CARE PATIENTS. 8689 06:17:50,932 --> 06:17:52,233 OVERMEDICATION IS ESPECIALLY 8690 06:17:52,233 --> 06:17:56,704 DANGEROUS WITH SEDATIVES AND 8691 06:17:56,704 --> 06:17:58,439 ANALGESICS, A PROBLEM IN 8692 06:17:58,439 --> 06:17:59,507 MEDICINE WORLDWIDE. 8693 06:17:59,507 --> 06:18:00,975 AND UNFORTUNATELY THERE'S NO 8694 06:18:00,975 --> 06:18:01,242 SOLUTION. 8695 06:18:01,242 --> 06:18:03,678 SO IT'S ONE OF THOSE THINGS WE 8696 06:18:03,678 --> 06:18:05,980 ACCEPT AS A SIDE EFFECT OF 8697 06:18:05,980 --> 06:18:08,116 SAVING YOUR LIFE, YOU MAY HAVE A 8698 06:18:08,116 --> 06:18:09,083 LITTLE BIT OVERSEDATION BUT 8699 06:18:09,083 --> 06:18:16,024 WE'LL TAKE ONE FOR THE OTHER. 8700 06:18:16,024 --> 06:18:20,595 OUR PRODUCT IS SIMPLE EYE PATCH 8701 06:18:20,595 --> 06:18:22,997 TO KNOW LEVEL OF EFFECT ON THE 8702 06:18:22,997 --> 06:18:24,632 PATIENT THAT'S ACTING DEEP 8703 06:18:24,632 --> 06:18:26,301 INSIDE THE BRAINSTEM WHICH IS 8704 06:18:26,301 --> 06:18:28,803 THE AREA THAT IS THE ACTING SITE 8705 06:18:28,803 --> 06:18:31,105 FOR THOSE DRUGS AND WE USE THAT 8706 06:18:31,105 --> 06:18:35,376 FEEDBACK TO REGULATE DOSING IN A 8707 06:18:35,376 --> 06:18:37,111 MUCH SMARTER WAY. 8708 06:18:37,111 --> 06:18:39,047 PATIENTS IN THE ICU ARE 8709 06:18:39,047 --> 06:18:41,182 OVERSEDATED BY 50% OF THE TIME 8710 06:18:41,182 --> 06:18:44,452 THEY GET POOR SLEEP, DELIRIOUS, 8711 06:18:44,452 --> 06:18:47,088 LOSE CIRCADIAN RHYTHM, ONE OF 8712 06:18:47,088 --> 06:18:48,189 THE MOST POPULAR PUBLICATIONS 8713 06:18:48,189 --> 06:18:53,261 WHERE NIGHT TURNS TO DAY. 8714 06:18:53,261 --> 06:18:56,331 IT'S A COMPLEX PROBLEM. 8715 06:18:56,331 --> 06:18:57,599 ONE ISSUE IS POLYPHARMACY. 8716 06:18:57,599 --> 06:19:04,239 WE GIVE SEDATIVES ON TOP OF 8717 06:19:04,239 --> 06:19:05,640 OPIOIDS, CREATING UNPREDICTABLE 8718 06:19:05,640 --> 06:19:05,940 BEHAVIOR. 8719 06:19:05,940 --> 06:19:07,275 WHEN TODAY'S STANDARD OF CARE IN 8720 06:19:07,275 --> 06:19:09,110 EVERY HOSPITAL IN THE WORLDS FOR 8721 06:19:09,110 --> 06:19:10,879 DETERMINING THE LEVEL OF 8722 06:19:10,879 --> 06:19:13,948 SEDATION OF THESE DRUGS IS 8723 06:19:13,948 --> 06:19:15,817 STIMULUS RESPONSE EXAM, I MIGHT 8724 06:19:15,817 --> 06:19:17,385 SAYS OPEN YOUR EYES IF YOU CAN 8725 06:19:17,385 --> 06:19:18,786 FEEL ME POKING YOU. 8726 06:19:18,786 --> 06:19:20,622 WE DO THAT TWICE A DAY. 8727 06:19:20,622 --> 06:19:22,724 SO THE CURRENT STANDARD OF CARE 8728 06:19:22,724 --> 06:19:23,791 IS VERY POOR AND IN PARTICULAR 8729 06:19:23,791 --> 06:19:27,195 WHEN YOU GET A PATIENT BELOW THE 8730 06:19:27,195 --> 06:19:29,364 LEVEL OF RESPONSIVENESS, AND WE 8731 06:19:29,364 --> 06:19:30,999 GET NO INFORMATION, OFTENTIMES 8732 06:19:30,999 --> 06:19:33,301 WE BRING THEM INTO A MEDICAL 8733 06:19:33,301 --> 06:19:34,969 COMA WITH SEDATIVES NOT KNOWING 8734 06:19:34,969 --> 06:19:37,372 BECAUSE WE HAVE NO RESPONSIVE 8735 06:19:37,372 --> 06:19:38,640 INFORMATION WHATSOEVER. 8736 06:19:38,640 --> 06:19:43,511 THAT'S REALLY, REALLY BAD FOR 8737 06:19:43,511 --> 06:19:45,213 YOUR HEALTH. 8738 06:19:45,213 --> 06:19:51,352 I WOULD SAY THAT OUR INNOVATIVE 8739 06:19:51,352 --> 06:19:53,688 BRAINSTEM MONITORING SYSTEM WE 8740 06:19:53,688 --> 06:19:54,422 MEASURE A NANOSCALE NEUROTREMOR. 8741 06:19:54,422 --> 06:19:57,959 EYE PRESENT IN AUTISM OF US. 8742 06:19:57,959 --> 06:19:59,127 MANIFESTING IF A MOVEMENT. 8743 06:19:59,127 --> 06:20:02,630 EYEBALLS RIGHT NOW IN A SMALL 8744 06:20:02,630 --> 06:20:06,768 ONE NANOMETER SCALE. 8745 06:20:06,768 --> 06:20:09,404 THAT SIGNAL ORIGINATES IN THE 8746 06:20:09,404 --> 06:20:11,606 AROUSAL CENTER. 8747 06:20:11,606 --> 06:20:14,375 SO WE'VE SHOWN IN A NUMBER EVER 8748 06:20:14,375 --> 06:20:16,978 STUDIES INCLUDING 225 PATIENTS, 8749 06:20:16,978 --> 06:20:18,079 HIGH SENSITIVITY AND SPECIFICITY 8750 06:20:18,079 --> 06:20:20,748 WHEN YOU'RE ABLE TO 8751 06:20:20,748 --> 06:20:21,916 NON-INVASIVELY MONITOR IT'S A 8752 06:20:21,916 --> 06:20:24,319 PROXY FOR LEVEL OF EFFECT ON 8753 06:20:24,319 --> 06:20:25,219 THOSE DRUGS. 8754 06:20:25,219 --> 06:20:28,489 THE SENSOR IS A VERY SAFE LOW 8755 06:20:28,489 --> 06:20:30,091 COST ADHESIVE STRIP, MEASURES 8756 06:20:30,091 --> 06:20:34,195 THE VIBRATION THROUGH THE EYELID 8757 06:20:34,195 --> 06:20:37,799 AND CAN BE DONE WITH EYES OPEN 8758 06:20:37,799 --> 06:20:42,837 OR CLOSED, WE DISPLAY THAT TRACE 8759 06:20:42,837 --> 06:20:44,605 PROPORTIONAL TO DRUG EFFECT, 8760 06:20:44,605 --> 06:20:46,174 THIS DIRECTLY COMPLEMENTS 8761 06:20:46,174 --> 06:20:49,844 EXISTING WORKFLOW IN THE ICU, 8762 06:20:49,844 --> 06:20:51,145 WHERE YEAHS TODAY ROUNDS MIGHT 8763 06:20:51,145 --> 06:20:54,649 BE TWICE AS DAY WITH A PHYSICAL 8764 06:20:54,649 --> 06:20:57,685 EXAM AND WE WOULD ADJUST THE 8765 06:20:57,685 --> 06:20:59,220 DRUG BASED ON OTHER PARAMETERS 8766 06:20:59,220 --> 06:21:02,123 TWICE A DAY WE CAN NOW DO THAT 8767 06:21:02,123 --> 06:21:03,624 IMMEDIATELY AT THE BEDSIDE AT 8768 06:21:03,624 --> 06:21:09,564 THE POINT OF CARE IN A 8769 06:21:09,564 --> 06:21:11,065 CONTINUOUS BASIS. 8770 06:21:11,065 --> 06:21:21,542 SO THE -- I LOST THE -- THE 8771 06:21:23,644 --> 06:21:25,313 COMPANY ITSELF WE'VE GOT A 8772 06:21:25,313 --> 06:21:28,816 NUMBER OF INITIAL CLINICAL 8773 06:21:28,816 --> 06:21:30,885 VALIDATION STUDIES, HIGH 8774 06:21:30,885 --> 06:21:31,919 SENSITIVITY AND SPECIFICITY, 8775 06:21:31,919 --> 06:21:33,121 PRELIMINARY FDA CLEARANCE ON 8776 06:21:33,121 --> 06:21:35,523 DEVICE WE OWN, A HUGE PATENT 8777 06:21:35,523 --> 06:21:37,358 PORTFOLIO SO EVERYTHING IS 8778 06:21:37,358 --> 06:21:40,995 DE-RISKED, WE'RE IN A TWO 8779 06:21:40,995 --> 06:21:43,097 MILLION FUNDING ROUND SAND WOULD 8780 06:21:43,097 --> 06:21:46,267 INVITE YOU TO SUPPORT OUR 8781 06:21:46,267 --> 06:21:48,169 MISSION TO REDUCE OVERMEDICATION 8782 06:21:48,169 --> 06:21:51,639 AND HELP CRITICAL CARE PATIENTS. 8783 06:21:51,639 --> 06:21:54,942 HAPPY TO TALK TO YOU UPSTAIRS 8784 06:21:54,942 --> 06:21:56,377 AFTERWARD ABOUT THE TECHNOLOGY. 8785 06:21:56,377 --> 06:21:56,611 DEVICE. 8786 06:21:56,611 --> 06:21:57,045 THANK YOU. 8787 06:21:57,045 --> 06:21:59,480 [APPLAUSE] 8788 06:21:59,480 --> 06:22:04,419 8789 06:22:04,419 --> 06:22:08,356 THAT CONCLUDES OUR 8790 06:22:08,356 --> 06:22:11,759 PRESENTATION TODAY FOR RAPID 8791 06:22:11,759 --> 06:22:12,193 PITCHES. 8792 06:22:12,193 --> 06:22:14,896 JOIN US UP STAIRS FOR 8793 06:22:14,896 --> 06:22:24,896 CONVERSATION TO FURTHER DISCUSS.